Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"2QUG",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION, HANGING DROP",,"29% PEG 3350, 400 mM NaF, vapor diffusion, hanging drop, temperature 295K",295,"10.1110/ps.037234.108",,"2QUG",44.41,"2","2","Crystal structure of alpha-1-antitrypsin, crystal form A","EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","2QUG"
"2QUH",,"X-RAY DIFFRACTION",2.82,56.41,"VAPOR DIFFUSION, HANGING DROP",6.8,"1.0M Na Citrate, 100mM HEPES, pH6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkm1153",,"2QUH",108.53,"2.4","2.4","Crystal structures of human tryptophanyl-tRNA synthetase in complex with Trp","MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophanyl-tRNA synthetase","1","2QUH"
"2QUI",,"X-RAY DIFFRACTION",2.81,56.29,"VAPOR DIFFUSION, HANGING DROP",7,"1.15M Na citrate, 100mM HEPES, pH7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkm1153",,"2QUI",109.06,"2.4","2.4","Crystal structures of human tryptophanyl-tRNA synthetase in complex with Tryptophanamide and ATP","MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophanyl-tRNA synthetase","1","2QUI"
"2QUJ",,"X-RAY DIFFRACTION",2.83,56.6,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.0M Na Citrate, 100mM HEPES, pH7.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkm1153",,"2QUJ",109.55,"2.42","2.42","Crystal structures of human tryptophanyl-tRNA synthetase in complex with TrpAMP","MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophanyl-tRNA synthetase","1","2QUJ"
"2QUK",,"X-RAY DIFFRACTION",3.62,65.99,"VAPOR DIFFUSION, HANGING DROP",8.2,"PEG3350, PEG1500, Na Citrate,, pH8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkm1153",,"2QUK",54.06,"2.8","2.8","Crystal structures of human tryptophanyl-tRNA synthetase in complex with ATP(putative)","MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophanyl-tRNA synthetase","1","2QUK"
"2QUZ",,"X-RAY DIFFRACTION",2.51,51,"VAPOR DIFFUSION, SITTING DROP",7.6,"37% PEG3350, 50mM TrisHCl pH8, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/humu.20616",,"2QUZ",19.37,"1.49","1.49","Crystal Structure of the activating H-RasK117R mutant in Costello Syndrome, bound to Mg-GDP","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNRCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2QUZ"
"2QV2",,"X-RAY DIFFRACTION",3.17,61.14,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Hepes, 8.5% PEG8000, 400 mM NaCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.devcel.2007.08.004",,"2QV2",39.47,"2.4","2.4","A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway","GPLGSLELSRREFVFENVKFRQLQKEKFQISNNGQVPCHFSFIPKLNDSQYCKPWLRAEPFEGYLEPNETVDISLDVYVSKDSVTILNSGEDKIEDILVLHLDRGKDYFLTISGNYLPSCFGTSLEALCRMKRPIREVPVTKLIDLEEDSFLEKEKSLLQMVPLDEGASERPLQVPKEIWLLVDHLFKYACHQEDLFQTPGMQEELQQIIDCLDTSIPETIPGSNHSVAEALLIFLEALPEPVICYELYQRCLDSAYDPRICRQVISQLPRCHRNVFRYLMAFLRELLKFSEYNSVNANMIATLFTSLLLRPPPNLMARQTPSDRQRAIQFLLGFLLGSEED","Homo sapiens","OCRL, INPP5F, OCRL1","Inositol polyphosphate 5-phosphatase OCRL-1","1","2QV2"
"2QV4",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"2QV4",57.05,"1.97","1.97","Human pancreatic alpha-amylase complexed with nitrite and acarbose","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","2QV4"
"2QW4",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, HANGING DROP",6.8,"15 % PEG 6000, 0.1 M BISTRIS PH 6.4, 0.4 M SODIUM THIOCYANATE, AND 5 % ETHYLENGLYCOL, pH 6.80, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2QW4",121.08,"2.8","2.8","Human NR4A1 ligand-binding domain","MGSSHHHHHHSSGLVPRGSHMGRLPSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPF","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Orphan nuclear receptor NR4A1","1","2QW4"
"2QWX",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"NaCl, Ammonium Sulfate, FAD, Melatonin, DTT, glycerol, 
pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071373","ML1","2QWX",54.13,"1.5","1.5","Crystal Structure of Quinone Reductase II","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","2QWX"
"2QX4",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"Bis Tris, NaCL, Ammonium sulfate, FAD, DTT, Melatonin, Glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071373","ML1","2QX4",53.87,"1.65","1.65","Crystal Structure of Quinone Reductase II","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","2QX4"
"2QX6",,"X-RAY DIFFRACTION",2.43,49.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"BisTris, NaCl, Ammonium sulfate, FAD, DTT, Melatonin, Glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071373","ML1","2QX6",53.87,"1.75","1.75","Crystal Structure of Quinone Reductase II","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","2QX6"
"2QX8",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"BisTris, NaCl, Ammonium Sulfate, FAD, DTT, 2-iodomelatonin, Glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071373","ML2","2QX8",54.37,"1.6","1.6","Crystal Structure of Quinone Reductase II","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","2QX8"
"2QX9",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"BisTris, NaCl, Ammonium sulfate, 2-iodomelatonin, DTT, FAD, glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071373","ML2","2QX9",54.12,"2.31","2.31","Crystal Structure of Quinone Reductase II","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","2QX9"
"2QXG",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, SITTING DROP",6,"25% PEG 3350, 2.5 M lithium sulfate, 0.1 M Bis-Tris, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0707811104",,"2QXG",49.58,"2.6","2.6","Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","2QXG"
"2QXH",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% MPD, 0.1 M sodium cacodylate, 0.2 M magnesium acetate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0707811104",,"2QXH",25.02,"2","2","Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","2QXH"
"2QXI",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% MPD, 0.1 M sodium cacodylate, 0.2 M magnesium acetate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0707811104",,"2QXI",25.02,"1","1","High resolution structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","2QXI"
"2QXJ",,"X-RAY DIFFRACTION",2.02,39.09,,6.5,"30% MPD, 0.1 M sodium cacodylate, 0.2 M magnesium acetate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K, pH 6.50",291,"10.1073/pnas.0707811104",,"2QXJ",25.15,"2.1","2.1","Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and Copper","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","2QXJ"
"2QXS",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.451","RAL","2QXS",59.97,"1.7","1.7","Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene","SIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2QXS"
"2QXW",,"X-RAY DIFFRACTION",2.18,43.57,,5,"120 mM Ammonium Citrate pH 5.0, 20% PEG 6000",,"10.1073/pnas.0711659105","LDT","2QXW",37.44,"0.8","0.8","Perdeuterated alr2 in complex with idd594","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2QXW"
"2QY0",,"X-RAY DIFFRACTION",3.07,60,"VAPOR DIFFUSION, HANGING DROP",7.4,"14% (w/v) PEG 6000, 0.2 M NaCl, 10% (v/v) glycerol, 0.1 M Tris   HCl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1016/j.molimm.2007.09.031",,"2QY0",91.85,"2.6","2.6","Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts","STQACPQPKTLDEFTIIQNLQPQYQFRDYFIATCKQGYQLIEGNQVLHSFTAVCQDDGTWHRAMPRCKIKDCGQPRNLPNGDFRYTTTMGVNTYKARIQYYCHEPYYKMQTRAGSRESEQGVYTCTAQGIWKNEQKGEKIPRCLPVCGKPVNPVEQRQR","Homo sapiens","C1R","Complement C1r subcomponent","1","2QY0"
,,,,,,,,,,,,,,,,"IIGGQKAKMGNFPWQVFTNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTKVLNYVDWIKKEMEEED","Homo sapiens","C1R","Complement C1r subcomponent","2","2QY0"
"2QY7",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, SITTING DROP",9.5,"30% (w/v) PEG3000, 100 mM CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1038/nature06353",,"2QY7",52.3,"2","2","Crystal structure of human epsinR ENTH domain","NYSEIESKVREATNDDPWGPSGQLMGEIAKATFMYEQFPELMNMLWSRMLKDNKKNWRRVYKSLLLLAYLIRNGSERVVTSAREHIYDLRSLENYHFVDEHGKDQGINIRQKVKELVEFAQDDDRLREERKKAKKNKDKYVGVSSDS","Homo sapiens","CLINT1, ENTH, EPN4, EPNR, KIAA0171","Clathrin interactor 1","1","2QY7"
"2QYK",,"X-RAY DIFFRACTION",2.99,58.84,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% PEG400, 200 mM Mg acetate, 0.1M Tris HCl pH 8.5, 5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1042/BJ20070970","NPV","2QYK",78.17,"2.1","2.1","Crystal structure of PDE4A10 in complex with inhibitor NPV","HMNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAI","Homo sapiens","PDE4A, DPDE2","Cyclic AMP-specific phosphodiesterase HSPDE4A10","1","2QYK"
"2QYL",,"X-RAY DIFFRACTION",2.73,54.97,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% PEG3350, 0.1M Tris HCl pH 8.5, 35% ethylene glycol, 200 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1042/BJ20070970","NPV","2QYL",39.33,"1.95","1.95","Crystal structure of PDE4B2B in complex with inhibitor NPV","MSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQS","Homo sapiens","PDE4B, DPDE4","Phosphodiesterase 4B, cAMP-specific","1","2QYL"
"2QYM",,"X-RAY DIFFRACTION",2.74,55.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 100 mM MgCl2, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20070970",,"2QYM",40.74,"1.9","1.9","crystal structure of unliganded PDE4C2","TVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLE","Homo sapiens","PDE4C2, PDE4C, DPDE1","Phosphodiesterase 4C","1","2QYM"
"2QYN",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG3350, 0.1 HEPES pH 7.5, 30% ethylene glycol, 10% isopropanol, 200 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1042/BJ20070970","NPV","2QYN",76.51,"1.57","1.57","Crystal structure of PDE4D2 in complex with inhibitor NPV","TEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","2QYN"
"2QYP",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, HANGING DROP",4,"20 mM NaAcetate, 200 mM ammonium sulfate, 
30% (v/v) pentaerythriol ethoxylate 15/4, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2008.02.016",,"2QYP",20.76,"2.45","2.45","Orthorhombic Crystal Structure of Human Saposin C Dimer in Open Conformation","AYVSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSGTRHHHHHH","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","2QYP"
"2QYQ",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",7,"Initial crystallisation: 32-34% PEG 4OOO or 8000, 0.2 M sodium acetate, 0.1 M sodium acetate pH 4.0. Complex formed by soaking in: 32% PEG 4OOO, 0.2 M sodium chloride, 0.1 M O-phosphotyrosine, 0.1 M hepes pH 7.0., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"2QYQ",21.35,"1.948","1.948","Human raf kinase inhibitor protein (rkip) in complex with o-phosphotyrosine","MPVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVKNRPTSISWDGLDSGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSDYVGSGPPKGTGLHRYVWLVYEQDRPLKCDEPILSNRSGDHRGKFKVASFRKKYELRAPVAGTCYQAEWDDYVPKLYEQLSGK","Homo sapiens","PEBP1, PBP, PEBP","Phosphatidylethanolamine-binding protein 1","1","2QYQ"
"2QZ4",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG 3350, 100mM Bis-Tris pH 6.5, 200mM Ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0006975",,"2QZ4",28.98,"2.22","2.22","Human paraplegin, AAA domain in complex with ADP","MGVSFKDVAGMHEAKLEVREFVDYLKSPERFLQLGAKVPKGALLLGPPGCGKTLLAKAVATEAQVPFLAMAGAEFVEVIGGLGAARVRSLFKEARARAPCIVYIDEIDAVGKKRSTTMSGFSNTEEEQTLNQLLVEMDGMGTTDHVIVLASTNRADILDGALMRPGRLDRHVFIDLPTLQERREIFEQHLKSLKLTQSSTFYSQRLAELTPGFSGADIANICNEAALHAAREGHTSVHTLNFEYAVERVLAGTAKKSKILSK","Homo sapiens","SPG7, CAR, CMAR, PGN","Paraplegin","1","2QZ4"
"2QZD","14","ELECTRON MICROSCOPY",,,,,,,"10.1128/JVI.00931-07",,"2QZD",7.27,"14",,"Fitted structure of SCR4 of DAF into cryoEM density","EIYCPAPPQIDNGIIQGERDHYGYRQSVTYACNKGFTMIGEHSIYCTVNNDEGEWSGPPPECRGC","Homo sapiens","CD55, CR, DAF","Complement decay-accelerating factor","1","2QZD"
"2QZF","14","ELECTRON MICROSCOPY",,,,,,,"10.1128/JVI.00931-07",,"2QZF",6.88,"14",,"SCR1 of DAF from 1ojv fitted into cryoEM density","MQDCGLPPDVPNAQPALEGRTSFPEDTVITYKCEESFVKIPGEKDSVICLKGSQWSDIEEFC","Homo sapiens","CD55, CR, DAF","Complement decay-accelerating factor","1","2QZF"
"2QZH","14","ELECTRON MICROSCOPY",,,,,,,"10.1128/JVI.00931-07",,"2QZH",14.35,"14",,"SCR2/3 of DAF from the NMR structure 1nwv fitted into a cryoEM reconstruction of CVB3-RD complexed with DAF","FRSCEVPTRLNSASLKQPYITQNYFPVGTVVEYECRPGYRREPSLSPKLTCLQNLKWSTAVEFCKKKSCPNPGEIRNGQIDVPGGILFGATISFSCNTGYKLFGSTSSFCLISGSSVQWSDPLPECREH","Homo sapiens","CD55, CR, DAF","Complement decay-accelerating factor","1","2QZH"
"2QZK",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER, 
Crystals were grown with L124671 and inh 416198 was back soaked, pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.08.040","I21","2QZK",45.65,"1.8","1.8","Crystal structure of human Beta Secretase complexed with I21","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QZK"
"2QZL",,"X-RAY DIFFRACTION",2.8,56.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER,
Crystals were grown with inhibitors were back soaked, pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.04.076","IXS","2QZL",46.45,"1.8","1.8","Crystal Structure of human Beta Secretase complexed with IXS","RGSFVEMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QZL"
"2R02",,"X-RAY DIFFRACTION",3.18,61.36,"sitting drop vapor diffusion",5.9,"0.20-0.25 M MgCl2, 7-10% PEG 4000, 0.1 M NaMES, pH 5.9, sitting drop vapor diffusion, temperature 286K",286,"10.1038/nsmb1319",,"2R02",79.37,"2.6","2.6","Crystal Structure of ALIX/AIP1 in complex with the HIV-1 YPLTSL Late Domain","ATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2R02"
,,,,,,,,,,,,,,,,"ELYPLTSLRSL",,,"p6-gag","2","2R02"
"2R03",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.20-0.25 M MgCl2, 7-10% PEG 4000, 0.1 M NaMES, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 286K",286,"10.1038/nsmb1319",,"2R03",79.02,"2.59","2.59","Crystal Structure of ALIX/AIP1 in complex with the YPDL Late Domain","ATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2R03"
,,,,,,,,,,,,,,,,"NLYPDLSE",,,"p6-Gag","2","2R03"
"2R05",,"X-RAY DIFFRACTION",3.21,61.73,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.20-0.25 M MgCl2, 7-10% PEG 4000, 0.1 M NaMES, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 286K",286,"10.1038/nsmb1319",,"2R05",79.34,"2.55","2.55","Crystal Structure of ALIX/AIP1 in complex with the HIV-1 YPLASL Late Domain","ATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2R05"
,,,,,,,,,,,,,,,,"ELYPLASLRSL",,,"p6-Gag","2","2R05"
"2R0B",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION",6.5,"100mM Bis-Tris pH 6.5, 1.8M Ammonium sulfate, VAPOR DIFFUSION, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2R0B",17.98,"1.6","1.6","Crystal structure of human tyrosine phosphatase-like serine/threonine/tyrosine-interacting protein","SLRREMQEILPGLFLGPYSSAMKSKLPVLQKHGITHIICIRQNIEANFIKPNFQQLFRYLVLDIADNPVENIIRFFPMTKEFIDGSLQMGGKVLVHGNAGISRSAAFVIAYIMETFGMKYRDAFAYVQERRFCINPNAGFVHQLQEYEAIYLAK","Homo sapiens","STYX","Serine/threonine/tyrosine-interacting protein","1","2R0B"
"2R0M",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES buffer pH 6.5, 30% PEGMME5000, 200 mM ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/bi7009597",,"2R0M",44.42,"2.7","2.7","The effect of a Glu370Asp Mutation in Glutaryl-CoA Dehydrogenase on Proton Transfer to the Dienolate Intermediate","RPEFDWQDPLVLEEQLTTDEILIRDTFRTYCQERLMPRILLANRNEVFHREIISEMGELGVLGPTIKGYGCAGVSSVAYGLLARELERVDSGYRSAMSVQSSLVMHPIYAYGSEEQRQKYLPQLAKGELLGCFGLTEPNSGSDPSSMETRAHYNSSNKSYTLNGTKTWITNSPMADLFVVWARCEDGCIRGFLLEKGMRGLSAPRIQGKFSLRASATGMIIMDGVEVPEENVLPGASSLGGPFGCLNNARYGIAWGVLGASEFCLHTARQYALDRMQFGVPLARNQLIQKKLADMLTEITLGLHACLQLGRLKDQDKAAPEMVSLLKRNNCGKALDIARQARDMLGGNGISDEYHVIRHAMNLEAVNTYDGTHDIHALILGRAITGIQAFTASK","Homo sapiens","GCDH","Glutaryl-CoA dehydrogenase","1","2R0M"
"2R0N",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"MES buffer, PEG5KMME, Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/bi7009597",,"2R0N",45.2,"2.3","2.3","The effect of a Glu370Asp mutation in Glutaryl-CoA Dehydrogenase on Proton Transfer to the Dienolate Intermediate","RPEFDWQDPLVLEEQLTTDEILIRDTFRTYCQERLMPRILLANRNEVFHREIISEMGELGVLGPTIKGYGCAGVSSVAYGLLARELERVDSGYRSAMSVQSSLVMHPIYAYGSEEQRQKYLPQLAKGELLGCFGLTEPNSGSDPSSMETRAHYNSSNKSYTLNGTKTWITNSPMADLFVVWARCEDGCIRGFLLEKGMRGLSAPRIQGKFSLRASATGMIIMDGVEVPEENVLPGASSLGGPFGCLNNARYGIAWGVLGASEFCLHTARQYALDRMQFGVPLARNQLIQKKLADMLTEITLGLHACLQLGRLKDQDKAAPEMVSLLKRNNCGKALDIARQARDMLGGNGISDEYHVIRHAMNLEAVNTYEGTHDIHALILGRAITGIQAFTASK","Homo sapiens","GCDH","Glutaryl-CoA dehydrogenase","1","2R0N"
"2R0O",,"X-RAY DIFFRACTION",3.06,59.81,"VAPOR DIFFUSION, HANGING DROP",7.1,"100 mM Imidazole, 50 mM NaCl, 1 mM EDTA, 5 % (v/v) glycerol, and 21 % (w/v) polyethylene glycol 5000 mono-methyl-ether, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.jmb.2007.11.084",,"2R0O",54.62,"2.2","2.2","Crystal structure of the actin-binding domain of human alpha-actinin-4 mutant(K255E)","GAMDPEFAWEKQQRKTFTAWCNSHLRKAGTQIENIDEDFRDGLKLMLLLEVISGERLPKPERGKMRVHKINNVNKALDFIASKGVKLVSIGAEEIVDGNAKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYKNVNVQNFHISWKDGLAFNALIHRHRPELIEYDKLRKDDPVTNLNNAFEVAEKYLDIPKMLDAEDIVNTARPDEEAIMTYVSSFYHAFSGALDELN","Homo sapiens","ACTN4","Alpha-actinin-4","1","2R0O"
"2R0R",,"X-RAY DIFFRACTION",2.66,53.84,"VAPOR DIFFUSION, HANGING DROP",5.9,"100 mM BisTris, 2.3 M ammonium sulfate, 100 mM urea, pH 5.9, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2008.02.016",,"2R0R",19.4,"2.5","2.5","Crystal Structure of Human Saposin D variant SapD K9E","AGFCEVCEKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSHHHHHH","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","2R0R"
"2R0U",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M sodium cacodylate buffer, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.09.007","M54","2R0U",37.33,"1.9","1.9","Crystal Structure of Chek1 in Complex with Inhibitor 54","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2R0U"
"2R13",,"X-RAY DIFFRACTION",4.13,70.24,"VAPOR DIFFUSION, HANGING DROP",,"2.0M NaCl, 0.1M Tris-HCl pH5.5-9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.C700172200",,"2R13",9.43,"1.8","1.8","Crystal structure of human mitoNEET reveals a novel [2Fe-2S] cluster coordination","SNARFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","CISD1, C10orf70, ZCD1, MDS029","Zinc finger CDGSH domain-containing protein 1","1","2R13"
"2R15",,"X-RAY DIFFRACTION",2.96,58.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.16M CH3COONH4, 14% (W/V) PEG 20000, pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1038/sj.emboj.7601944",,"2R15",47.09,"2.24","2.24","Crystal structure of the myomesin domains 12 and 13","GSSIALSATDLKIQSTAEGIQLYSFVTYYVEDLKVNWSHNGSAIRYSDRVKTGVTGEQIWLQINEPTPNDKGKYVMELFDGKTGHQKTVDLSGQAYDEAYAEFQRLKQAAIAEKNRARVLGGLPDVVTIQEGKALNLTCNVWGDPPPEVSWLKNEKALAQTDHCNLKFEAGRTAYFTINGVSTADSGKYGLVVKNKYGSETSDFTVSVFIPE","Homo sapiens","MYOM1","Myomesin-1","1","2R15"
"2R1Q",,"X-RAY DIFFRACTION",2.59,52.45,"VAPOR DIFFUSION, HANGING DROP",5.9,"100 mM BisTris, 2.3 M ammonium sulfate, 100 mM urea, pH 5.9, vapor diffusion, hanging drop, temperature 291K",291,"10.1016/j.str.2008.02.016",,"2R1Q",9.78,"2.5","2.5","Crystal Structure of Iodinated Human Saposin D in Space Group C2221","AGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSHHHHHH","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","2R1Q"
"2R1T",,"X-RAY DIFFRACTION",3.14,60.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"29% PEG4K, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"2R1T",39.43,"1.7","1.7","dopamine quinone conjugation to DJ-1","ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAIAAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","DJ-1","1","2R1T"
,,,,,,,,,,,,,,,,"ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAIAAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","DJ-1","2","2R1T"
"2R1U",,"X-RAY DIFFRACTION",3.15,61.01,"VAPOR DIFFUSION, HANGING DROP",6.5,"29%PEG4K, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"2R1U",39.34,"1.5","1.5","DJ-1 activation by catechol quinone modification","ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","Protein DJ-1","1","2R1U"
"2R1V",,"X-RAY DIFFRACTION",3.12,60.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"29% PEG4K, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"2R1V",39.44,"1.7","1.7","Norepinephrine quinone conjugation to DJ-1","ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAIAAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","DJ-1","1","2R1V"
,,,,,,,,,,,,,,,,"ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAIAAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","DJ-1","2","2R1V"
"2R1Z",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"pSDDE peptide, 20% PEG 3350, 0.2 M ammonium chloride, 100 mM NaCl, 5 mM tris-HCl, 1 mM DTT, pH 7.5, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,,,"2R1Z",48.28,"2.1","2.1","Crystal Structure of the BARD1 BRCT Repeat","PLVLIGSGLSSEQQKMLSELAVILKAKKYTEFDSTVTHVVVPGDAVQSTLKCMLGILNGCWILKFEWVKACLRRKVCEQEEKYEIPEGPRRSRLNREQLLPKLFDGCYFYLWGTFKHHPKDNLIKLVTAGGGQILSRKPKPDSDVTQTINTVAYHARPDSDQRFCTQYIIYEDLCNYHPERVRQGKVWKAPSSWFIDCVMSFELLPLDS","Homo sapiens","BARD1","BRCA1-associated RING domain protein 1","1","2R1Z"
"2R24",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",5,"pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1073/pnas.0711659105","LDT","2R24",37.06,"1.752, 2.194","1.752, 2.194","Human Aldose Reductase structure","MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2R24"
"2R27",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.45 M ammonium sulfate, 200 mM NaCl in 50 mM Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.07.043",,"2R27",31.79,"2","2","Constitutively zinc-deficient mutant of human superoxide dismutase (SOD), C6A, H80S, H83S, C111S","MATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERSVGSLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2R27"
"2R2J",,"X-RAY DIFFRACTION",3.03,59.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"disodium succinate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/embor.2008.88",,"2R2J",44.77,"2.6","2.6","crystal structure of human ERp44","GPLGSEITSLDTENIDEILNNADVALVNFYADWCRFSQMLHPIFEEASDVIKEEFPNENQVVFARVDCDQHSDIAQRYRISKYPTLKLFRNGMMMKREYRGQRSVKALADYIRQQKSDPIQEIRDLAEITTLDRSKRNIIGYFEQKDSDNYRVFERVANILHDDCAFLSAFGDVSKPERYSGDNIIYKPPGHSAPDMVYLGAMTNFDVTYNWIQDKCVPLVREITFENGEELTEEGLPFLILFHMKEDTESLEIFQNEVARQLISEKGTINFLHADCDKFRHPLLHIQKTPADCPVIAIDSFRHMYVFGDFKDVLIPGKLKQFVFDLHSGKLHREFHHGPDPTDTAPGEQAQDVASSPPESSFQKLAPSEYRYTLLRDRDEL","Homo sapiens","TXNDC4, ERP44, KIAA0573, UNQ532/PRO1075","Thioredoxin domain-containing protein 4","1","2R2J"
"2R2N",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM Hepes, 15% PEG 10000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M708358200",,"2R2N",191.98,"1.95","1.95","The crystal structure of human kynurenine aminotransferase II in complex with kynurenine","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase mitochondrial","1","2R2N"
"2R2O",,"X-RAY DIFFRACTION",2.31,46.66,"VAPOR DIFFUSION",8,"2.6M Sodium chloride, 18% Ethylene glycol, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M703800200",,"2R2O",31.07,"2","2","Crystal structure of the effector domain of human Plexin B1","MHHHHHHSSGRENLYFQGDVEYRPLTLNALLAVGPGAGEAQGVPVKVLDCDTISQAKEKMLDQLYKGVPLTQRPDPRTLDVEWRSGVAGHLILSDEDVTSEVQGLWRRLNTLQHYKVPDGATVALVPCLTKHVLRENQ","Homo sapiens","PLXNB1, KIAA0407, PLXN5, SEP","Plexin-B1","1","2R2O"
"2R2P",,"X-RAY DIFFRACTION",2.33,47.3,,7.5,"2M Ammonium sulfate, 2% PEG 400, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2R2P",33.98,"2.4","2.4","Kinase domain of human ephrin type-A receptor 5 (EphA5)","MPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNPAHHHHHH","Homo sapiens","EPHA5, EHK1, HEK7, BSK, TYRO4","Ephrin type-A receptor 5","1","2R2P"
"2R2Q",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION",7.5,"25% PEG 3350, 0.2M Sodium chloride, 0.1M Hepes, 5% MPD, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"2R2Q",26.52,"1.65","1.65","Crystal structure of human Gamma-Aminobutyric Acid Receptor-Associated Protein-like 1 (GABARAP1), Isoform CRA_a","GFQYKEDHPFEYRKKEGEKIRKKYPDRVPVIVEKAPKARVPDLDKRKYLVPSDLTVGQFYFLIRKRIHLRPEDALFFFVNNTIPPTSATMGQLYEDNHEEDYFLYVAYSD","Homo sapiens","GABARAPL1, GEC1","Gamma-aminobutyric acid receptor-associated protein-like 1","1","2R2Q"
"2R2W",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, HANGING DROP",5.2,"sodium citrate, ammonium sulfate, lithium sulfate, pH 5.2, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2007.09.020","4PG","2R2W",28.79,"2.01","2.01","Urokinase plasminogen activator B-chain-GPPE complex","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Plasminogen activator, urokinase","1","2R2W"
"2R30",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% PEG 3350, 0.1M Sodium Acetate pH 4.5, Vapor diffusion, Sitting drop, temperature 298K",298,"10.1073/pnas.0709264104",,"2R30",14.64,"3.2","3.2","Crystal Structure of human GITRL mutant","GSHMETAKEPCMAKFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNAAYNDVAPFEVRLYKNKDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS","Homo sapiens","TNFSF18, AITRL, GITRL, TL6, UNQ149/PRO175","Tumor necrosis factor ligand superfamily member 18","1","2R30"
"2R34",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, HANGING DROP",6.7,"Sodium Citrate, Ammonium Sulphate, Magnesium Chloride, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ijbiomac.2008.09.019",,"2R34",12.13,"2.25","2.25","Crystal structure of MN human arg-insulin","RGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2R34"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","2R34"
"2R35",,"X-RAY DIFFRACTION",2.04,39.86,"VAPOR DIFFUSION, HANGING DROP",6.7,"Sodium Citrate, Acetone, Rubidium Chloride, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ijbiomac.2008.09.019",,"2R35",12.06,"2.08","2.08","Crystal structure of RB human arg-insulin","RGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2R35"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","2R35"
"2R36",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",6.7,"Sodium Citrate, Ammonium Sulphate, Nickel Chloride, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ijbiomac.2008.09.019",,"2R36",12.24,"2","2","Crystal structure of ni human ARG-insulin","RGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2R36"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","2R36"
"2R37",,"X-RAY DIFFRACTION",3.39,63.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M PCB pH 8.0, 60% MPD, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2R37",47.22,"1.85","1.85","Crystal structure of human glutathione peroxidase 3 (selenocysteine to glycine mutant)","MQEKSKMDCHGGISGTIYEYGALTIDGEEYIPFKQYAGKYVLFVNVASYGGLTGQYIELNALQEELAPFGLVILGFPCNQFGKQEPGENSEILPTLKYVRPGGGFVPNFQLFEKGDVNGEKEQKFYTFLKNSCPPTSELLGTSDRLFWEPMKVHDIRWNFEKFLVGPDGIPIMRWHHRTTVSNVKMDILSYMRRQAALGVAENLYFQ","Homo sapiens","GPX3, GPXP","Glutathione peroxidase 3","1","2R37"
"2R3A",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 10000, 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0008570",,"2R3A",34.75,"2","2","Methyltransferase domain of human suppressor of variegation 3-9 homolog 2","GPKDNNKTLKPAIAEYIVKKAKQRIALQRWQDELNRRKNHKGMIFVENTVDLEGPPSDFYYINEYKPAPGISLVNEATFGCSCTDCFFQKCCPAEAGVLLAYNKNQQIKIPPGTPIYECNSRCQCGPDCPNRIVQKGTQYSLCIFRTSNGRGWGVKTLVKIKRMSFVMEYVGEVITSEEAERRGQFYDNKGITYLFDLDYESDEFTVDAARYGNVSHFVNHSCDPNLQVFNVFIDNLDTRLPRIALFSTRTINAGEELTFDYQMKGSGDISSDSIDHSPAKKRVRTVCKCGAVTCRGYLN","Homo sapiens","SUV39H2, KMT1B","Histone-lysine N-methyltransferase SUV39H2","1","2R3A"
"2R3F",,"X-RAY DIFFRACTION",2.02,39.01,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SC8","2R3F",34.37,"1.5","1.5","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3F"
"2R3G",,"X-RAY DIFFRACTION",1.98,37.99,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SC9","2R3G",34.32,"1.55","1.55","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3G"
"2R3H",,"X-RAY DIFFRACTION",1.99,38.25,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% v/v PEG 4000, 4% v/v Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCE","2R3H",34.24,"1.5","1.5","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3H"
"2R3I",,"X-RAY DIFFRACTION",2,38.57,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCF","2R3I",34.35,"1.28","1.28","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3I"
"2R3J",,"X-RAY DIFFRACTION",2.04,39.81,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCJ","2R3J",34.41,"1.65","1.65","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3J"
"2R3K",,"X-RAY DIFFRACTION",2.03,39.53,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCQ","2R3K",34.41,"1.7","1.7","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3K"
"2R3L",,"X-RAY DIFFRACTION",2.07,40.57,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCW","2R3L",34.41,"1.65","1.65","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3L"
"2R3M",,"X-RAY DIFFRACTION",2,38.55,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCX","2R3M",34.42,"1.7","1.7","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3M"
"2R3N",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","SCZ","2R3N",34.38,"1.63","1.63","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3N"
"2R3O",,"X-RAY DIFFRACTION",1.97,37.54,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","2SC","2R3O",34.37,"1.8","1.8","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3O"
"2R3P",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","3SC","2R3P",34.46,"1.66","1.66","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3P"
"2R3Q",,"X-RAY DIFFRACTION",1.99,38.27,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868",,"2R3Q",34.44,"1.35","1.35","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3Q"
"2R3R",,"X-RAY DIFFRACTION",2.01,38.91,"VAPOR DIFFUSION",7.4,"50 mM Na-HEPES pH 7.4, 50 mM Ammonium Acetate, 8% PEG 4000, 4% Glycerol, 1 mM TCEP, vapor diffusion, temperature 298K",298,"10.1002/bip.20868","6SC","2R3R",34.38,"1.47","1.47","Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R3R"
"2R3V",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",5.6,"MES buffer, PEG5k MME, ammonium sulfate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi7024386",,"2R3V",169.99,"2.5","2.5","The Biochemical and Structural Basis for Feedback Inhibition of Mevalonate Kinase and Isoprenoid Metabolism","MLSEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERLAVLAFLYLYLSICRKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIPNPLKDGDCVNRWTKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGGALRYHQGKISSLKRSPALQILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAISLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNALGVGHASLDQLCQVTRARGLHSKLTGAGGGGCGITLLKPGLEQPEVEATKQALTSCGFDCLETSIGAPGVSIHSATSLDSRVQQALDGL","Homo sapiens","MVK","Mevalonate kinase","1","2R3V"
"2R3X",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, HANGING DROP",,"A 4uL hanging drop comprising: 2uL 14 mg/mL R15L hGSTA1-1 solution added to 2uL reservoir buffer (5mM S-hexyl-glutathione, 0.1M TrisHCl, pH 7.5, 10 mM DTT, 15% PEG 4000) was left to equilibrate in a sealed 24 plate well with 1 mL of reservoir buffer. Crystals were grown for 3 days before harvesting, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bpc.2009.11.003",,"2R3X",52.04,"1.8","1.8","Crystal structure of an R15L hGSTA1-1 mutant complexed with S-hexyl-glutathione","MAEKPKLHYFNARGLMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","2R3X"
"2R4B",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM Sodium cacodylate, 100mM amonium acetate, 10mM magnesium acetate, 30% PEG8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.0708281105","GW7","2R4B",73.94,"2.4","2.4","ErbB4 kinase domain complexed with a thienopyrimidine inhibitor","MKKGHHHHHHGLETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPN","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","2R4B"
"2R4F",,"X-RAY DIFFRACTION",2.42,49.12,,,,,"10.1021/jm070849r","RIE","2R4F",192.4,"1.7","1.7","Substituted Pyrazoles as Hepatselective HMG-COA reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","2R4F"
"2R4H",,"X-RAY DIFFRACTION",1.99,38.18,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 0.1M Citrate pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2R4H",39.27,"2.05","2.05","Crystal structure of a C1190S mutant of the 6th PDZ domain of human membrane associated guanylate kinase","MHHHHHHSSGVDLGTENLYFQSMDFYTVELERGAKGFGFSLRGGREYNMDLYVLRLAEDGPAERSGKMRIGDEILEINGETTKNMKHSRAIELIKNGGRRVRLFLKRGETSV","Homo sapiens","MAGI1, BAIAP1, BAP1, TNRC19, AIP3","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2R4H"
"2R4V",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION",8,"35%-50% PEG 400, 100mM Tris-HCl, pH8.0, 5mM GSH, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2007.09.041",,"2R4V",29.01,"1.85","1.85","Structure of human CLIC2, crystal form A","MSGLRPGTQVDPEIELFVKAGSDGESIGNCPFCQRLFMILWLKGVKFNVTTVDMTRKPEELKDLAPGTNPPFLVYNKELKTDFIKIEEFLEQTLAPPRYPHLSPKYKESFDVGCNLFAKFSAYIKNTQKEANKNFEKSLLKEFKRLDDYLNTPLLDEIDPDSAEEPPVSRRLFLDGDQLTLADCSLLPKLNIIKVAAKKYRDFDIPAEFSGVWRYLHNAYAREEFTHTCPEDKEIENTYANVAKQKS","Homo sapiens","CLIC2","Chloride intracellular channel protein 2","1","2R4V"
"2R52",,"X-RAY DIFFRACTION",3.64,66.18,"VAPOR DIFFUSION, HANGING DROP",4,"20% 2-propanol, 0.1M sodium citrate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1742-4658.2007.06187.x",,"2R52",32.79,"2.5","2.5","Crystal structure analysis of Bone Morphogenetic Protein-6 (BMP-6)","MAPTSASSRRRQQSRNRSTQSQDVARVSSASDYNSSELKTACRKHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNSNVILKKYRNMVVRACGCH","Homo sapiens","BMP6, VGR","Bone morphogenetic protein 6","1","2R52"
"2R53",,"X-RAY DIFFRACTION",4.69,73.78,"VAPOR DIFFUSION, HANGING DROP",4,"25% 2-Methyl-2,4-pentandiol, 0.1M sodium citrate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1742-4658.2007.06187.x",,"2R53",27.05,"2.1","2.1","Crystal structure analysis of Bone Morphogenetic Protein-6 variant B2 (B2-BMP-6)","MAQAKHKQRKRLKACRKHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNSNVILKKYRNMVVRACGCH","Homo sapiens","BMP6, VGR","Bone morphogenetic protein 6","1","2R53"
"2R55",,"X-RAY DIFFRACTION",2.36,47.87,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG 6000, 0.1M HEPES pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K, VAPOR DIFFUSION, HANGING DROP",277,"10.1371/journal.pone.0019521",,"2R55",51.97,"2.5","2.5","Human StAR-related lipid transfer protein 5","MHHHHHHSSGVDLGTENLYFQSMAAQMSEAVAEKMLQYRRDTAGWKICREGNGVSVSWRPSVEFPGNLYRGEGIVYGTLEEVWDCVKPAVGGLRVKWDENVTGFEIIQSITDTLCVSRTSTPSAAMKLISPRDFVDLVLVKRYEDGTISSNATHVEHPLCPPKPGFVRGFNHPCGCFCEPLPGEPTKTNLVTFFHTDLSGYLPQNVVDSFFPRSMTRFYANLQKAVKQFHE","Homo sapiens","STARD5","StAR-related lipid transfer protein 5","1","2R55"
"2R59",,"X-RAY DIFFRACTION",2.42,49.08,"LIQUID DIFFUSION",,"Co-crystallized with LTA4H by liquid-liquid diffusion in melting-point capillaries. A Tris-buffered (10 mM, pH 7.5) solution of protein and inhibitor in approximately equimolar concentrations (~70 microM) was layered on the precipitate solution containing 28% (weight/volume) polyethylene glycol (Mw 8000), 50 mM Na acetate, 100 mM imidazole, pH 6.8, and 5 mM YbCl3, LIQUID DIFFUSION, temperature 298K",298,"10.1016/j.chembiol.2008.07.018","PH0","2R59",70.85,"1.89","1.89","Leukotriene A4 hydrolase complexed with inhibitor RB3041","HHHHHHPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","2R59"
"2R5G",,"X-RAY DIFFRACTION",1.84,33.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"30%-32% PEG 400, 100mM Tris-HCl, pH7.5, 5mM GSH, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.09.041",,"2R5G",28.39,"1.86","1.86","Structure of human CLIC2, crystal form B","MSGLRPGTQVDPEIELFVKAGSDGESIGNCPFCQRLFMILWLKGVKFNVTTVDMTRKPEELKDLAPGTNPPFLVYNKELKTDFIKIEEFLEQTLAPPRYPHLSPKYKESFDVGCNLFAKFSAYIKNTQKEANKNFEKSLLKEFKRLDDYLNTPLLDEIDPDSAEEPPVSRRLFLDGDQLTLADCSLLPKLNIIKVAAKKYRDFDIPAEFSGVWRYLHNAYAREEFTHTCPEDKEIENTYANVAKQKS","Homo sapiens","CLIC2","Chloride intracellular channel protein 2","1","2R5G"
"2R5T",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION",8.5,"PEG 3350, LiSO4, pH 8.5, vapor diffusion, temperature 293K",293,"10.1110/ps.073161707",,"2R5T",42.93,"1.9","1.9","Crystal Structure of Inactive Serum and Glucocorticoid- Regulated Kinase 1 in Complex with AMP-PNP","GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDSFL","Homo sapiens","SGK, SGK1","Serine/threonine-protein kinase Sgk1","1","2R5T"
"2R64",,"X-RAY DIFFRACTION",2.02,39.05,"VAPOR DIFFUSION, HANGING DROP",7.4,"40mM Hepes, 30mM NaCl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.03.002","740","2R64",34.43,"2.3","2.3","Crystal structure of a 3-aminoindazole compound with CDK2","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","2R64"
"2R6K",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 mg protein per ml, 0.1M Tris-HCl, 10 mM DTT, 19% PEG4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1107/S1744309110019135",,"2R6K",52.1,"2.51","2.51","Crystal structure of an I71V hGSTA1-1 mutant in complex with S-hexylglutathione","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAVLNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","2R6K"
"2R6N",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",,"20 % PEG 4000, 10 % Isopropanol, 0.1 M HEPES pH 7.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2007.09.047","CKE","2R6N",24.16,"1.95","1.95","Crystal structure of a pyrrolopyrimidine inhibitor in complex with human Cathepsin K","GRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","2R6N"
"2R6W",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION",6.8,"100 mM MES pH 6.8, 0.5 M MgCl2, 15% w/v PEG 4000, VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.0710802105","LLB","2R6W",57.57,"2","2","Estrogen receptor alpha ligand-binding domain complexed to a SERM","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2R6W"
"2R6Y",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION",6.8,"100 mM MES pH 6.8, 0.5 M MgCl2, 15% w/v PEG 4000, VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.0710802105","LLC","2R6Y",57.51,"2","2","Estrogen receptor alpha ligand-binding domain in complex with a SERM","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2R6Y"
"2R7B",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm070851i","253","2R7B",36.17,"2.7","2.7","Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","Phosphoinositide-dependent protein kinase 1","1","2R7B"
"2R7E",,"X-RAY DIFFRACTION",4.68,73.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"8-10% PEG 8000, 0.1M Imidazole, 100-300 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1182/blood-2007-08-109918",,"2R7E",176.52,"3.7","3.7","Crystal Structure Analysis of Coagulation Factor VIII","SATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRS","Homo sapiens","F8, F8C","Coagulation factor VIII","1","2R7E"
,,,,,,,,,,,,,,,,"DPLAWDNHYGTQIPKEEWKSQEKSPEKTAFKKKDTILSLNACESNHAIAAINEGQNKPEIEVTWAKQGRTERLCSQNPPVLKRHQREITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYSSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY","Homo sapiens","F8, F8C","Coagulation factor VIII","2","2R7E"
"2R83",,"X-RAY DIFFRACTION",4.08,69.87,,4.5,"3M NACL, 75 MM SODIUM ACETATE, PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, pH 4.50",,"10.1021/bi701651k",,"2R83",65.35,"2.7","2.7","Crystal structure analysis of human synaptotagmin 1 C2A-C2B","GSEKLGKLQYSLDYDFQNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELAGKTLVMAVYDFDRFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEKEEQEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","2R83"
"2R8U",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Tris, 0.1M Na2MoO4, 35% PEG4000, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,,,"2R8U",60.22,"1.35","1.35","Structure of fragment of human end-binding protein 1 (EB1) containing the N-terminal domain at 1.35 A resolution","MAVNVYSTSVTSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKIIPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQETAVAPSLVAPALNKPKKPLTSSSAAPQRPISTQRTAAAPKAGPGVVRKNPGVGNGDDEAAELMQQVNVLKLTVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPDEGGPQEEQEEY","Homo sapiens","MAPRE1","Microtubule-associated protein RP/EB family member 1","1","2R8U"
"2R99",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION, SITTING DROP",6,"34% PEG 8000, 0.2M Ammonium sulfate, 0.1M Bis-Tris pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1371/journal.pbio.1000439",,"2R99",18.99,"1.61","1.61","Crystal structure of cyclophilin ABH-like domain of human peptidylprolyl isomerase E isoform 1","GSPIAKKARSNPQVYMDIKIGNKPAGRIQMLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTNHNGTGGKSIYGKKFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQIEAQGSKDGKPKQKVIIADCGEYV","Homo sapiens","PPIE, CYP33","Peptidyl-prolyl cis-trans isomerase E","1","2R99"
"2R9A",,"X-RAY DIFFRACTION",2.37,48.18,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.molcel.2007.10.024",,"2R9A",53.42,"2.5","2.5","Crystal structure of human XLF","MEELEQGLLMQPWAWLQLAENSLLAKVFITKQGYALLVSDLQQVWHEQVDTSVVSQRAKELNKRLTAPPAAFLCHLDNLLRPLLKDAAHPSEATFSCDCVADALILRVRSELSGLPFYWNFHCMLASPSLVSQHLIRPLMGMSLALQCQVRELATLLHMKDLEIQDYQESGATLIRDRLKTEPFEENSFLEQFMIEKLPEACSIGDGKPFVMNLQDLYMAVTTQHHHHHH","Homo sapiens","NHEJ1, XLF","Non-homologous end-joining factor 1","1","2R9A"
"2R9M",,"X-RAY DIFFRACTION",2.77,55.54,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM NaOAc, 18-35% PEG MME (500-8000), 2 M (NH4)2SO4 with or without 15% glycerol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"Y11","2R9M",50.21,"1.97","1.97","Cathepsin S complexed with Compound 15","LPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHH","Homo sapiens","CTSS","Cathepsin S","1","2R9M"
"2R9N",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM NaOAc, 18-35% PEG MME (500-8000), 2 M (NH4)2SO4 with or without 15% glycerol, pH 4.6, vapor diffusion, hanging drop, temperature 298K",298,,,"2R9N",50.33,"2","2","Cathepsin S complexed with Compound 26","LPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHH","Homo sapiens","CTSS","Cathepsin S","1","2R9N"
"2R9O",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM NaOAc, 18-35% PEG MME (500-8000), 2 M (NH4)2SO4 with or without 15% glycerol, pH 4.6, vapor diffusion, hanging drop, temperature 298K",298,,,"2R9O",50.31,"2","2","Cathepsin S complexed with Compound 8","LPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHH","Homo sapiens","CTSS","Cathepsin S","1","2R9O"
"2R9S",,"X-RAY DIFFRACTION",2.08,40.9,"MICROBATCH",5.5,"25-32% PEG 3350, 100mM NaCl, 1mM AMP-PCP, 2mM MgCl2, 0.4mM Zwittergent 314, 10%(v/v) ethylene glycol, pH 5.5, microbatch, temperature 298K",298,"10.1016/j.bmcl.2007.08.054","255","2R9S",84.04,"2.4","2.4","c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor","NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNS","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2R9S"
"2RA0",,"X-RAY DIFFRACTION",2.16,42.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"20%Peg 3350, 10mM CaCl2, 0.1M Tris-maleate pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm701217r","JNJ","2RA0",32.42,"2.3","2.3","X-ray Structure of FXa in complex with 7-fluoroindazole","VCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X","2","2RA0"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Coagulation factor X","1","2RA0"
"2RA4",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, 2 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444907066164",,"2RA4",18.19,"1.7","1.7","Crystal Structure of Human Monocyte Chemoattractant Protein 4 (MCP-4/CCL13)","MQPDALNVPSTCCFTFSSKKISLQRLKSYVITTSRCPQKAVIFRTKLGKEICADPKEKWVQNYMKHLGRKAHTLKT","Homo sapiens","CCL13, MCP4, NCC1, SCYA13","Small-inducible cytokine A13","1","2RA4"
"2RAH",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION",4.5,"0.2M Ammonium sulfate, 15% isopropanol, 15% ethylene glycol, pH 4.5, vapor diffusion, temperature 298K",298,,"11P","2RAH",43.9,"2","2","Human FDPS synthase in complex with novel inhibitor","MGSSHHHHHHSSGRENLYFQGHMGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase","1","2RAH"
"2RAI",,"X-RAY DIFFRACTION",3.06,59.8,"VAPOR DIFFUSION, HANGING DROP",7,"1.3M Ammonium tartrate dibasic, 0.1M BIS-TRIS propane, pH 7.0 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/sj.emboj.7601889",,"2RAI",91.91,"3.2","3.2","The PX-BAR membrane remodeling unit of Sorting Nexin 9","PLNKFPGFAKPGTEQYLLAKQLAKPKEKIPIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVISESEVFQQFLNFRDEKEWKTGKRKAERDELAGVMIFSTMEPEAPDLDLVEIEQKCEAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLATVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGTHKGAIEKVKESDKLVATSKITLQDKQNMVKRVSIMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM","Homo sapiens","SNX9, SH3PX1, SH3PXD3A","Sorting nexin-9","1","2RAI"
"2RAJ",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION, HANGING DROP",7,"1.3M Ammonium tartrate dibasic, 0.1M BIS-TRIS propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/sj.emboj.7601889",,"2RAJ",45.39,"2.45","2.45","SO4 bound PX-BAR membrane remodeling unit of Sorting Nexin 9","PLNKFPGFAKPGTEQYLLAKQLAKPKEKIPIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVISESEVFQQFLNFRDEKEWKTGKRKAERDELAGVMIFSTMEPEAPDLDLVEIEQKCEAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLATVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGTHKGAIEKVKESDKLVATSKITLQDKQNMVKRVSIMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM","Homo sapiens","SNX9, SH3PX1, SH3PXD3A","Sorting nexin-9","1","2RAJ"
"2RAK",,"X-RAY DIFFRACTION",3.01,59.19,"VAPOR DIFFUSION, HANGING DROP",7,"1.3M Ammonium tartrate dibasic, 0.1M BIS-TRIS propane, pH 7.0 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/sj.emboj.7601889",,"2RAK",45.85,"3","3","PI(3)P bound PX-BAR membrane remodeling unit of Sorting Nexin 9","PLNKFPGFAKPGTEQYLLAKQLAKPKEKIPIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVISESEVFQQFLNFRDEKEWKTGKRKAERDELAGVMIFSTMEPEAPDLDLVEIEQKCEAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLATVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGTHKGAIEKVKESDKLVATSKITLQDKQNMVKRVSIMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM","Homo sapiens","SNX9, SH3PX1, SH3PXD3A","Sorting nexin-9","1","2RAK"
"2RAP",,"X-RAY DIFFRACTION",2.67,53,,8,"25% PEG 8000, 100MM LISO4, 100MM TRIS PH 8., pH 8.0",,"10.1093/emboj/16.18.5582",,"2RAP",19.49,"2.6","2.6","THE SMALL G PROTEIN RAP2A IN COMPLEX WITH GTP","MREYKVVVLGSGGVGKSALTVQFVTGTFIEKYDPTIEDFYRKEIEVDSSPSVLEILDTAGTEQFASMRDLYIKNGQGFILVYSLVNQQSFQDIKPMRDQIIRVKRYEKVPVILVGNKVDLESEREVSSSEGRALAEEWGCPFMETSAKSKTMVDELFAEIVRQMNYA","Homo sapiens","RAP2A","RAP2A","1","2RAP"
"2RB3",,"X-RAY DIFFRACTION",2.63,53.29,"VAPOR DIFFUSION, HANGING DROP",5.9,"100 mM BisTris, 2.3 M ammonium sulfate, 100 mM urea, pH 5.9, vapor diffusion, hanging drop, temperature 291K",291,"10.1016/j.str.2008.02.016",,"2RB3",39.09,"2.1","2.1","Crystal Structure of Human Saposin D","AGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSHHHHHH","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","2RB3"
"2RB4",,"X-RAY DIFFRACTION",2.87,57.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris propane, 2.5 M Ammonium sulfate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1371/journal.pone.0012791",,"2RB4",40.66,"2.8","2.8","Crystal structure of the Helicase domain of human DDX25 RNA helicase","SMLTLNNIRQYYVLCEHRKDKYQALCNIYGSITIGQAIIFCQTRRNAKWLTVEMIQDGHQVSLLSGELTVEQRASIIQRFRDGKEKVLITTNVCARGIDVKQVTIVVNFDLPVKQGEEPDYETYLHRIGRTGRFGKKGLAFNMIEVDELPSLMKIQDHFNSSIKQLNAEDMDEIE","Homo sapiens","DDX25, GRTH","ATP-dependent RNA helicase DDX25","1","2RB4"
"2RB8",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.8M sodium formate, 5% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0707977104",,"2RB8",11.62,"1.45","1.45","High resolution design of a protein loop","MRLDAPSQIEVKDVTDTTALITWMPPSQPVDGFELTYGIKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAKETFTTGLAAALEHHHHHH","Homo sapiens","TNC, HXB","Tenascin","1","2RB8"
"2RBA",,"X-RAY DIFFRACTION",3.54,65.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"8 mg/ml  protein and 20% molar excess DNA duplex in 10mM Tris-HCL, 100 mM NaCl, 0.5mM DTT. Reservoir: 20% PEG 3350, 0.2M K/Na tartrate tetrahydrate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1073/pnas.0711061105",,"2RBA",60.16,"2.79","2.79","Structure of Human Thymine DNA Glycosylase Bound to Abasic and Undamaged DNA","CAGCTCTGTACGTGAGCAGTGGA",,,"DNA (5'-D(*DCP*DAP*DGP*DCP*DTP*DCP*DTP*DGP*DTP*DAP*DCP*DGP*DTP*DGP*DAP*DGP*DCP*DAP*DGP*DTP*DGP*DGP*DA)-3')","1","2RBA"
,,,,,,,,,,,,,,,,"CCACTGCTCANGTACAGAGCTGT",,,"DNA (5'-D(*DCP*DCP*DAP*DCP*DTP*DGP*DCP*DTP*DCP*DAP*(3DR)P*DGP*DTP*DAP*DCP*DAP*DGP*DAP*DGP*DCP*DTP*DGP*DT)-3')","2","2RBA"
,,,,,,,,,,,,,,,,"GSHMASFNGVSEAELLTKTLPDILTFNLDIVIIGINPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","3","2RBA"
"2RBE",,"X-RAY DIFFRACTION",2.17,43.22,,,,,"10.1016/j.bmcl.2007.09.070","ZMG","2RBE",125.94,"1.9","1.9","The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors","MHHHHHHEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","2RBE"
"2RBH",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION, HANGING DROP",4.25,"0.1M potassium acetate buffer pH 4.25, 20% PEG 4000, 0.2M ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1074/jbc.M803623200",,"2RBH",41.94,"2.1","2.1","Gamma-glutamyl cyclotransferase","MANSGCKDVTGPDEESFLYFAYGSNLLTERIHLRNPSAAFFCVARLQDFKLDFGNSQGKTSQTWHGGIATIFQSPGDEVWGVVWKMNKSNLNSLDEQAGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSPQYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIEDIIKKGETQTL","Homo sapiens","C7orf24, GGCT, CRF21","Gamma-glutamyl cyclotransferase","1","2RBH"
"2RBL",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, HANGING DROP",3,"2.0 M Ammonium Sulfate, pH = 3.0, 10% additive 0.1 M cupric chloride, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0707977104",,"2RBL",34.95,"2.1","2.1","High resolution design of a protein loop","MRLDAPSQIEVKDVTDTTALITWSMQLSQLEGIELTYGIKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAKETFTTGLAAALEHHHHHH","Homo sapiens","TNC, HXB","Tenascin","1","2RBL"
"2RC4",,"X-RAY DIFFRACTION",3.21,61.66,"VAPOR DIFFUSION",6.5,"sodium cacodylate, PEG 3350, pH 6.5, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M705812200",,"2RC4",34.9,"3","3","Crystal Structure of the HAT domain of the human MOZ protein","PPDPQVRCPSVIEFGKYEIHTWYSSPYPQEYSRLPKLYLCEFCLKYMKSRTILQQHMKKCGWFHPPANEIYRKNNISVFEVDGNVSTIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTQNDVKGCHLVGYFSKEKHCQQKYNVSCIMILPQYQRKGYGRFLIDFSYLLSKREGQAGSPEKPLSDLGRLSYMAYWKSVILECLYHQNDKQISIKKLSKLTGICPQDITSTLHHLRMLDFRSDQFVRRRREKLIQDHMAKLQLNLRPVDVDPECLRWTPVIVSNSKKK","Homo sapiens","MYST3, MOZ, RUNXBP2, ZNF220, KAT6A","Histone acetyltransferase MYST3","1","2RC4"
"2RCQ",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M sodium citrate, 0.2 M sodium/potassium tartrate, 1.4 M ammonium sulphate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.21848",,"2RCQ",16.84,"1.2","1.2","Crystal structure of human apo Cellular Retinol Binding Protein II (CRBP-II)","MRGSTRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKKLVPR","Homo sapiens","RBP2, CRBP2","Retinol-binding protein II, cellular","1","2RCQ"
"2RCT",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M sodium citrate, 0.2 M sodium/potassium tartrate, 1.4 M ammonium sulfate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.21848",,"2RCT",17.13,"1.2","1.2","Crystal structure of human holo cellular retinol-binding protein II (CRBP-II)","MRGSTRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKKLVPR","Homo sapiens","RBP2, CRBP2","Retinol-binding protein II, cellular","1","2RCT"
"2RCW",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"protein 60mg/ml in 50 mM Tris, 150 mM NaCl, 1.5 mM DTT  
PH 7.5; Well solution contains 1.3 M Ammonium Sulfate, 1.3 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,"AAI","2RCW",39.48,"2.8","2.8","PARP complexed with A620223","KSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2RCW"
"2RCZ",,"X-RAY DIFFRACTION",1.97,37.6,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M Phosphate-citrate, pH 4.2 and 40 % v/v PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M707255200",,"2RCZ",18.01,"1.7","1.7","Structure of the second PDZ domain of ZO-1","GSKVTLVKSRKNEEYGLRLASHIFVKEISQDSLAARDGNIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKLKMVVQRDE","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","2RCZ"
"2RD6",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"protein 60 mg/ml in 50 mM Tris, 150 mM NaCl, 1.5 mM DTT, pH 7.5, 2mM A861146. Well solution: 0.8 M NaCl, 1.8 M Ammonium Sulfate. Crystals are soaked in well solution containing 1mM A861695 from 0.1M DMSO stock. Cryoprotectant: 1.2 M NaCl, 1.6 M Ammonium Sulfate, 20 % Ethylene Glycol, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,"78P","2RD6",39.41,"2.3","2.3","PARP complexed with A861695","KSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2RD6"
"2RD8",,"X-RAY DIFFRACTION",3.82,67.77,"VAPOR DIFFUSION, HANGING DROP",9,"10-20% PEG 4000, 3mM potassium phosphate, 20mM 2-mercaptoethanol, 0.1M TRIS, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi7019386",,"2RD8",71.81,"2.5","2.5","Human Thymidylate Synthase Stabilized in Active Conformation by R163K Mutation: Asymmetry and Reactivity of Cys195","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQKVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","2RD8"
,,,,,,,,,,,,,,,,"MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQKVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","2","2RD8"
"2RDA",,"X-RAY DIFFRACTION",2.94,58.13,"VAPOR DIFFUSION, HANGING DROP",9,"10-20% PEG 4K, 3mM KPi, 20mM BME, 0.1M tris, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi7019386",,"2RDA",215.04,"2.67","2.67","Human Thymidylate Synthase Stabilized in Active Conformation by R163K Mutation: Asymmetry and Reactivity of Cys195","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQKVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","2RDA"
"2RDT",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES,PEG 600, CDST, pH 7.5, temperature 298K, pH 7.50, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/bi701710r","2RD","2RDT",43.41,"1.95","1.95","Crystal Structure of Human Glycolate Oxidase (GO) in Complex with CDST","GSHMASMTGGQQMGRGSMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVSKI","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","2RDT"
"2RDU",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES,PEG 600,glyoxylate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi701710r",,"2RDU",43.17,"1.65","1.65","Crystal Structure of Human Glycolate Oxidase in Complex with Glyoxylate","GSHMASMTGGQQMGRGSMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVSKI","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","2RDU"
"2RDW",,"X-RAY DIFFRACTION",3.34,63.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES,PEG 600, Li2SO4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi701710r",,"2RDW",43.19,"1.95","1.95","Crystal Structure of Human Glycolate Oxidase in Complex with Sulfate","GSHMASMTGGQQMGRGSMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVSKI","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","2RDW"
"2RE9",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, HANGING DROP",6.86,"0.2 M Magnesium formate, pH 6.86, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bbrc.2007.09.097",,"2RE9",61.87,"2.1","2.1","Crystal structure of TL1A at 2.1 A","GLKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL","Homo sapiens","TNFSF15, TL1, VEGI","TNF superfamily ligand TL1A","1","2RE9"
"2REA",,"X-RAY DIFFRACTION",2.85,56.45,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MALEIC ACID/NAOH, 10% GLYCEROL, PH 6.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1186/1472-6807-8-13",,"2REA",14.38,"2.5","2.5","Crystal structures of C2ALPHA-PI3 kinase PX-domain domain indicate conformational change associated with ligand binding.","MDGRIKEVSVFTYHKKYNPDKHYIYVVRILREGQIEPSFVFRTFDEFQELHNKLSIIFPLWKLPGFPNRMVLGRTHIKDVAAKRKIELNSYLQSLMNASTDVAECDLVCTFFHGSHHHHHH","Homo sapiens","PIK3C2A","Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide","1","2REA"
"2RED",,"X-RAY DIFFRACTION",2.85,56.45,,6,"0.1M MALEIC ACID/NAOH, 10% GLYCEROL, PH 6.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1186/1472-6807-8-13",,"2RED",14.93,"2.1","2.1","Crystal structures of C2ALPHA-PI3 kinase PX-domain domain indicate conformational change associated with ligand binding.","MDGRIKEVSVFTYHKKYNPDKHYIYVVRILREGQIEPSFVFRTFDEFQELHNKLSIIFPLWKLPGFPNRMVLGRTHIKDVAAKRKIELNSYLQSLMNASTDVAECDLVCTFFHGSHHHHHH","Homo sapiens","PIK3C2A","Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide","1","2RED"
"2REI",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",7,"Well solution: 20% PEG 3350, 0.2 M NH4 formate, 0.1 M HEPES pH 7.0. Protein solution: 12 mg/mL. Drops: 1:1 ratio of well:protein solution. Crystals cryoprotected by transfer to drop containing mother liquor to which MPD was added to 25%, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"2REI",36.36,"1.6","1.6","Kinase domain of human ephrin type-A receptor 7 (Epha7)","MQEGDEELYFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNSAHHHHHH","Homo sapiens","EPHA7, EHK3, HEK11","Ephrin type-A receptor 7","1","2REI"
"2REL",,"SOLUTION NMR",,,,,,,"10.1006/jmbi.1997.0983",,"2REL",6.01,,,"SOLUTION STRUCTURE OF R-ELAFIN, A SPECIFIC INHIBITOR OF ELASTASE, NMR, 11 STRUCTURES","AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ","Homo sapiens","PI3, WAP3, WFDC14","R-ELAFIN","1","2REL"
"2REN",,"X-RAY DIFFRACTION",2.53,51.39,,,,,"10.1126/science.2493678",,"2REN",37.49,"2.5","2.5","STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2REN"
"2REO",,"X-RAY DIFFRACTION",2.55,51.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Diammonium tartrate, 0.1M MES, 18% PEG 2000, 5% Ethylene glycol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2REO",36.39,"2.651","2.651","Crystal structure of human sulfotransferase 1C3 (Sult1C3) in complex with PAP","GMAKIEKNAPTMEKKPELFNIMEVDGVPTLILSKEWWEKVANFQAKPDDLILATYPKSGTTWMHEILDMILNDGDVEKCKRAQTLDRHAFLELKFPHKEKPDLEFVLEMSSPQLIKTHLPSHLIPPSIWKENCKIVYVARNPKDCLVSYYHFHRMASFMPDPQNLEEFYEKFMSGKVVGGSWFDHVKGWWAAKDMHRILYLFYEDIKKDPKREIEKILKFLEKDISEEILNKIIYHTSFDVMKQNPMTNYTTLPTSIMDHSISPFMRKGMPGDWKNYFTVAQNEEFDKDYQKKMAGSTLTFRTEI","Homo sapiens","SULT1C3","Putative sulfotransferase 1C3","1","2REO"
"2REW",,"X-RAY DIFFRACTION",2.79,55.86,,,,,,"REW","2REW",32.69,"2.35","2.35","Crystal Structure of PPARalpha ligand binding domain with BMS-631707","GSHMEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","2REW"
"2REY",,"X-RAY DIFFRACTION",1.86,33.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2M Ammonium acetate, 0.1M Bis-tris pH 5.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2REY",10.82,"1.55","1.55","Crystal structure of the PDZ domain of human dishevelled 2 (homologous to Drosophila dsh)","SMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKCWETSV","Homo sapiens","DVL2","Segment polarity protein dishevelled homolog DVL-2","1","2REY"
"2RF0",,"X-RAY DIFFRACTION",1.87,34.27,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Sodium malonate, 0.1M Bis-tris-propane pH 8.5, 20.0% PEG 3350, 10.0% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2RF0",39.06,"2","2","Crystal structure of human mixed lineage kinase MAP3K10 SH3 domain","MHHHHHHSSGVDLGTENLYFQSMGTTPAGPVWTAVFDYEAAGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPSGRVGVFPSNYVAP","Homo sapiens","MAP3K10, MLK2, MST","Mitogen-activated protein kinase kinase kinase 10","1","2RF0"
"2RF5",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, SITTING DROP",5.9,"18% PEG 3350, 0.18M Mg formate, 3% Hexanediol, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.058",,"2RF5",29.57,"2.3","2.3","Crystal structure of human tankyrase 1- catalytic PARP domain","MHHHHHHSSGVDLGTENLYFQSMQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQ","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","2RF5"
"2RFI",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, HANGING DROP",9,"16% PEG 4000, 10% Isopropanol, 0.1M Bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1371/journal.pone.0008570","SAH","2RFI",69.28,"1.59","1.59","Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and dimethylated H3K9 peptide","NSQVWSALQMSKALQDSAPDRPSPVERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, KIAA1876, GLP, KMT1D","Histone-lysine N-methyltransferase, H3 lysine-9 specific 5","1","2RFI"
,,,,,,,,,,,,,,,,"TKQTARKSTGG",,,"Histone H3","2","2RFI"
"2RFJ",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M Na/K tartrate, 20.0% PEG 3350, 10.0% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"2RFJ",42.5,"2.05","2.05","Crystal structure of the bromo domain 1 in human bromodomain containing protein, testis specific (BRDT)","SMNTKKNGRLTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Bromodomain testis-specific protein","1","2RFJ"
"2RFN",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION",5,"12% PEG 6000, 1.0M LiCl2, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M705774200","AM7","2RFN",71.92,"2.5","2.5","x-ray structure of c-Met with inhibitor.","MQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","2RFN"
"2RFS",,"X-RAY DIFFRACTION",2.04,39.85,"VAPOR DIFFUSION",7.8,"0.1M HEPES pH 7.8, 15% PEG 4K, 6% 2-propanol, 40mM BME, 3% Ethanol, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M705774200",,"2RFS",35.8,"2.2","2.2","X-ray structure of SU11274 bound to c-Met","MQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","2RFS"
"2RG3",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION",7,"PEG, HEPES, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm700966p",,"2RG3",24.33,"1.8","1.8","Covalent complex structure of elastase","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELA2, ELANE","Leukocyte elastase","1","2RG3"
"2RG5",,"X-RAY DIFFRACTION",2.3,46.48,,,,,"10.1021/jm7009414","279","2RG5",42.49,"2.4","2.4","Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11B","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2RG5"
"2RG6",,"X-RAY DIFFRACTION",2.36,47.91,,,,,"10.1021/jm7009414","287","2RG6",43.02,"1.72","1.72","Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11J","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2RG6"
"2RG8",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"200mM sodium acetate, 28%-30% PEG4000, 8% Jeffamine M-600, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1073/pnas.0712235105",,"2RG8",36.14,"1.8","1.8","Crystal Structure of Programmed for Cell Death 4 Middle MA3 domain","GLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGVPVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGG","Homo sapiens","PDCD4, H731","Programmed cell death protein 4","1","2RG8"
"2RGA",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 10 % PEG 6000, 0.2M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGA",19.47,"1.9","1.9","Crystal structure of H-RasQ61I-GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGIEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGA"
"2RGB",,"X-RAY DIFFRACTION",2.68,54.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGB",19.49,"1.35","1.35","Crystal structure of H-RasQ61K-GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGKEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGB"
"2RGC",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 % PEG 3350, 0.2 M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGC",19.46,"1.6","1.6","Crystal structure of H-RasQ61V-GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGVEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGC"
"2RGD",,"X-RAY DIFFRACTION",2.71,54.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 % PEG 3350, 0.2M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGD",19.47,"2","2","Crystal structure of H-RasQ61L-GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGLEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGD"
"2RGE",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGE",19.49,"1.4","1.4","Crystal structure of H-Ras-GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGE"
"2RGF",,"SOLUTION NMR",,,,,,,"10.1038/nsb0997-694",,"2RGF",11.14,,,"RBD OF RAL GUANOSINE-NUCLEOTIDE EXCHANGE FACTOR (PROTEIN), NMR, 10 STRUCTURES","ALPLYNQQVGDCCIIRVSLDVDNGNMYKSILVTSQDKAPAVIRKAMDKHNLEEEEPEDYELLQILSDDRKLKIPENANVFYAMNSTANYDFVLKKRT","Homo sapiens","HUMAN RALGEF GENE (RALGDS), RALGDS, KIAA1308, RGF","RALGEF-RBD","1","2RGF"
"2RGG",,"X-RAY DIFFRACTION",1.92,35.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 % PEG 3350, 0.2 M Calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2007.10.011",,"2RGG",19.41,"1.45","1.45","Crystal structure of H-RasQ61I-GppNHp, trigonal crystal form","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGIEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2RGG"
"2RGI",,"X-RAY DIFFRACTION",1.69965,27.632162,"VAPOR DIFFUSION",7.4,"0.1 M sodium acetate, 10% isopropanol, 35-40% PEG 4000, pH 7.4, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2008.03.019",,"2RGI",22.26,"1.6","1.6","Crystal structure of Ca2+-free S100A2 at 1.6 A resolution","MMSSSLEQALAVLVTTFHKYSSQEGDKFKLSKGEMKELLHKELPSFVGEKVDEEGLKKLMGSLDENSDQQVDFQEYAVFLALITVMSNDFFQGSPDRP","Homo sapiens","S100A2, S100L","Protein S100-A2","1","2RGI"
"2RGP",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",9,"2M Na/K3PO4, 0.1M Caps pH 9.0 and 0.2M Li2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2008.07.020","HYZ","2RGP",36.71,"2","2","Structure of EGFR in complex with hydrazone, a potent dual inhibitor","ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","2RGP"
"2RGU",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 150mM MgCl2, Tris-HCl pH 8.1, 15% Glycerol, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm701280z","356","2RGU",173.3,"2.6","2.6","Crystal structure of complex of human DPP4 and inhibitor","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2RGU"
"2RGZ",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution (5 mg/ml Protein, 1:1 ratio Heme, 2% DMSO, 0.050 M Potassium chloride, 0.050 M Tris-HCl pH 7.5) mixed in a 1.5:1 ratio with the Well solution (33% PEG DME 500, 0.020 M Magnesium chloride, 0.10 M HEPES pH 7.5). Cryoprotected with well solution, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M707396200",,"2RGZ",62.22,"2.61","2.61","Ensemble refinement of the protein crystal structure of human heme oxygenase-2 C127A (HO-2) with bound heme","MSAEVETSEGVDESEKKNSGALEKENQMRMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQAPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGSTLARETLEDGFPVHDGKGDMRK","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","2RGZ"
"2RHE",,"X-RAY DIFFRACTION",2.57,52.05,,,,,"10.1016/s0022-2836(83)80104-1",,"2RHE",11.84,"1.6","1.6","STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT 1.6 ANGSTROMS RESOLUTION","ESVLTQPPSASGTPGQRVTISCTGSATDIGSNSVIWYQQVPGKAPKLLIYYNDLLPSGVSDRFSASKSGTSASLAISGLESEDEADYYCAAWNDSLDEPGFGGGTKLTVLGQPK","Homo sapiens",,"BENCE-JONES PROTEIN RHE (LIGHT CHAIN)","1","2RHE"
"2RHI",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, HANGING DROP",8,"L3MBTL1(197-526) (15 mg/ml in 25 mM Tris-HCl, pH 8.0, 1 mM DTT) was pre-incubated with two-fold molar excess of H1.5(23-27)K27me2 peptide. Drops were prepared by mixing 1    l complex solution with 1    l reservoir solution (7% PEG3350, 0.2 M NaAc pH 5.0). Rod-like crystals usually appear overnight and are ready for data collection after two days. Crystals were flash-frozen in liquid nitrogen with the reservoir solution augmented with an additional 30% PEG 400 as cryoprotectant prior to data collectioin., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RHI",40.1,"1.66","1.66","Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with H1.5K27me2 at 1.66 angstrom","GSPNSPATGEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSAVDSSGRIVTD","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RHI"
,,,,,,,,,,,,,,,,"KATKK",,,"Histone H1.5","2","2RHI"
"2RHP",,"X-RAY DIFFRACTION",3.23,61.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG [4000], 0.2M sodium acetate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M800223200",,"2RHP",71.37,"2.9","2.9","The Thrombospondin-1 Polymorphism Asn700Ser Associated with Cornoary Artery Disease Causes Local and Long-Ranging Changes in Protein Structure","DGCLSNPCFPGAQCSSFPDGSWSCGFCPVGFLGNGTHCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGNQPVGVGLEAAKTEKQVCEPENPCKDKTHNCHKHAECIYLGHFSDPMYKCECQTGYAGDGLICGEDSDLDGWPSLNLVCATNATYHCIKDNCPHLPNSGQEDFDKDGIGDACDDDDDNDGVTDEKDNCQLLFNPRQADYDKDEVGDRCDNCPYVHNPAQIDTDNNGEGDACSVDIDGDDVFNERDNCPYVYNTDQRDTDGDGVGDHCDNCPLVHNPDQTDVDNDLVGDQCDNNEDIDDDGHQNNQDNCPYISNANQADHDRDGQGDACDPDDDNDGVPDDRDNCRLVFNPDQEDLDGDGRGDICKDDFDNDNIPDIDDVCPENNAISETDFRNFQMVPLDPKGTTQIDPNWVIRHQGKELVQTANSDPGIAVGFDEFGSVDFSGTFYVNTDRDDDYAGFVFGYQSSSRFYVVMWKQVTQTYWEDQPTRAYGYSGVSLKVVNSTTGTGEHLRNALWHTGNTPGQVRTLWHDPRNIGWKDYTAYRWHLTHRPKTGYIRVLVHEGKQVMADSGPIYDQTYAGGRLGLFVFSQEMVYFSDLKYECRDI","Homo sapiens","THBS2, TSP2","Thrombospondin-2","1","2RHP"
"2RHU",,"X-RAY DIFFRACTION",3.17,61.15,"VAPOR DIFFUSION",6.5,"Crystals was generated by pre-incubating the L3MBTL1-H3.3(28-34) (18MG/ML IN 50MM KCL, 25MM TRIS-HCL PH 8.0, 1MM DTT) with a five-fold molar excess of dimethyl-lysine amino acid. Drops were prepared by mixing equal volumes of the complex with reservoir solution (5% PEG10K, 0.1 M Tris-maleate pH 6.5, 0.1 M ammonium sulfate), VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RHU",37.99,"1.9","1.9","Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine and in chimera with histone H3.3(28-34)","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGGGGSAPSTGG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RHU"
"2RHX",,"X-RAY DIFFRACTION",3.04,59.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"Crystals of the Kme2-L3MBTL1(197-526) complex were generated by pre-incubating L3MBTL1 (17MG/ML IN 50MM KCL, 25MM TRIS-HCL PH 8.0, 1MM DTT) with a five-fold molar excess of dimethyl-lysine amino acid. Drops were prepared by mixing equal volumes of the complex with reservoir solution (0.1 M bis-Tris, pH 6.5, 15% PEG MME 5000, 0.15 M ammonium sulfate, and 10 mM DTT)., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RHX",39.91,"2.1","2.1","Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine","GSPNSPATGEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSAVDSSGRIVTD","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RHX"
"2RHY",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"Crystals was generated by pre-incubating the L3MBTL1 (12MG/ML IN 50MM KCL, 25MM TRIS-HCL PH 8.0, 1MM DTT) with a five-fold molar excess of monomethyl-lysine amino acid. Drops were prepared by mixing equal volumes of the complex with reservoir solution (7.5% PEG10K, 0.1 M Tris-maleate pH 6.5, 0.1 M ammonium sulfate), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RHY",36.96,"1.9","1.9","Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to monomethyl-lysine","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RHY"
"2RHZ",,"X-RAY DIFFRACTION",3.14,60.82,"VAPOR DIFFUSION, HANGING DROP",6,"5% PEG10K, 0.1 M Tris-maleate pH 6.0, 0.1 M Na-K-Tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RHZ",36.8,"2.2","2.2","Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355N point mutation","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVNRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RHZ"
"2RI2",,"X-RAY DIFFRACTION",3.16,61.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"5% PEG10K, 0.1 M Tris-maleate pH 6.5, 0.1 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RI2",37.25,"2.2","2.2","Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355A point mutation","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVARMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RI2"
"2RI3",,"X-RAY DIFFRACTION",3.11,60.43,"VAPOR DIFFUSION, HANGING DROP",6,"7.5% PEG10K, 0.1 M Tris-Maleate pH 6.0, 0.1 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RI3",36.81,"2","2","Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358Q point mutation","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMQPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RI3"
"2RI5",,"X-RAY DIFFRACTION",3.07,59.93,"VAPOR DIFFUSION, HANGING DROP",6.5,"7.5% PEG10K, 0.1 M Tris-Maleate pH 6.5, 0.1 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RI5",37.16,"2","2","Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358A point mutation","GPLGSWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMAPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RI5"
"2RI7",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"BPTF Y17E PHD finger-linker-bromodomain (16.5 mg/ml, 20 mM Tris-HCl pH 7.5, 50 mM KCl) was pre-incubated with three-fold molar excess of H3(1-9)K4me2 peptide in the presence of 5 mM MgCl2 for about 30 min on ice. Drops were made by mixing 2   l each of the complex with the reservoir solution: 8.5% isopropanol, 0.085 M Hepes-Na, pH 7.5, 17% PEG 4000, 15% Glycerol. A 0.3   l of 1 M KCl was then added to the drops as additive., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.10.023",,"2RI7",21.64,"1.45","1.45","Crystal structure of PHD finger-linker-bromodomain Y17E mutant from human BPTF in the H3(1-9)K4ME2 bound state","GPLGSDTKLYCICKTPEDESKFYIGCDRCQNWYHGRCVGILQSEAELIDEYVCPQCQSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKA","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","2RI7"
,,,,,,,,,,,,,,,,"ARTKQTARK",,,"histone H3.1","2","2RI7"
"2RIA",,"X-RAY DIFFRACTION",3.23,61.86,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG 8000, 150MM NACL, 10MM CACL2, 100MM HEPES, PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi7020553","289","2RIA",52.81,"1.8","1.8","Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with D-glycero-D-manno-heptose","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2RIA"
"2RIB",,"X-RAY DIFFRACTION",3.18,61.26,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG 8000, 150MM NACL, 10MM CACL2, 100MM HEPES , PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi7020553","GMH","2RIB",52.81,"1.8","1.8","Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptose","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2RIB"
"2RIC",,"X-RAY DIFFRACTION",3.2,61.59,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG 8000, 150MM NACL, 10MM CACL2, 100MM HEPES , PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi7020553",,"2RIC",53.19,"1.8","1.8","Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptopyranosyl-(1-3)-L-glycero-D-manno-heptopyranose","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2RIC"
"2RID",,"X-RAY DIFFRACTION",3.24,62.05,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG 8000, 150MM NACL, 10MM CACL2, 100MM HEPES, PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi7020553","291","2RID",53.06,"1.8","1.8","Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with Allyl 7-O-carbamoyl-L-glycero-D-manno-heptopyranoside","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2RID"
"2RIE",,"X-RAY DIFFRACTION",3.2,61.62,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG 8000, 150MM NACL, 10MM CACL2, 100MM HEPES, PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi7020553",,"2RIE",52.76,"1.6","1.6","Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with 2-deoxy-L-glycero-D-manno-heptose","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2RIE"
"2RIP",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",8,"20%PEG, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.10.063","34Q","2RIP",86.98,"2.9","2.9","Structure of DPPIV in complex with an inhibitor","DSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPPIV, DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2RIP"
"2RIQ",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% ethanol, 100 mM Tris-HCl pH 8.5, 25 mM NaCl, and 0.5 mM TCEP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M708558200",,"2RIQ",18.78,"1.7","1.7","Crystal Structure of the Third Zinc-binding domain of human PARP-1","MVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVALEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2RIQ"
"2RIT",,"X-RAY DIFFRACTION",2.27,45.92,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RIT",34.38,"1.43","1.43","Unliganded B-specific-1,3-galactosyltransferase (GTB)","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RIT"
"2RIV",,"X-RAY DIFFRACTION",2.4,48.75,"EVAPORATION",7.4,"20% PEG 3350, 0.2M sodium sulphate, pH 7.4, EVAPORATION, temperature 298K",298,"10.1074/jbc.M110.171082",,"2RIV",43.47,"1.5","1.5","Crystal structure of the reactive loop cleaved human Thyroxine Binding Globulin","SQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPR","Homo sapiens","SERPINA7, TBG","Thyroxine-binding globulin","1","2RIV"
,,,,,,,,,,,,,,,,"SENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","Thyroxine-binding globulin","2","2RIV"
"2RIW",,"X-RAY DIFFRACTION",2.41,48.98,"EVAPORATION",7.4,"20% PEG 3350, 0.2M CaCl2, pH 7.4, EVAPORATION, temperature 298K",298,"10.1074/jbc.M110.171082",,"2RIW",43.27,"2.04","2.04","The Reactive loop cleaved human Thyroxine Binding Globulin complexed with thyroxine","SLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPR","Homo sapiens","SERPINA7, TBG","Thyroxine-binding globulin","1","2RIW"
,,,,,,,,,,,,,,,,"SENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","Thyroxine-binding globulin","2","2RIW"
"2RIX",,"X-RAY DIFFRACTION",2.28,45.98,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RIX",34.84,"1.75","1.75","B-specific-1,3-galactosyltransferase)(GTB) + UDP","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RIX"
"2RIY",,"X-RAY DIFFRACTION",2.29,46.18,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RIY",34.72,"1.55","1.55","B-specific-1,3-galactosyltransferase (GTB)+H-antigen acceptor","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RIY"
"2RIZ",,"X-RAY DIFFRACTION",2.27,45.93,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RIZ",34.48,"1.45","1.45","Unliganded B-specific-1,3-galactosyltransferase G176R mutant (ABBB)","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RIZ"
"2RJ0",,"X-RAY DIFFRACTION",2.27,45.85,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ0",34.94,"1.52","1.52","B-specific alpha-1,3-galactosyltransferase G176R mutant + UDP+ Mn2+","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ0"
"2RJ1",,"X-RAY DIFFRACTION",2.26,45.68,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ1",35.38,"1.55","1.55","B-specific alpha-1,3-galactosyltransferase (GTB) G176R mutant + UDP + H-antigen disaccharide","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ1"
"2RJ4",,"X-RAY DIFFRACTION",2.28,46.04,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ4",35.27,"1.47","1.47","B-specific alpha-1,3-galactosyltransferase \ G176R +UDP+ADA","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ4"
"2RJ5",,"X-RAY DIFFRACTION",2.27,45.84,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ5",34.91,"1.45","1.45","B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (AABB) +UDP","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ5"
"2RJ6",,"X-RAY DIFFRACTION",2.27,45.76,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ6",34.79,"1.41","1.41","B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (AABB) + H-antigen disaccharide","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ6"
"2RJ7",,"X-RAY DIFFRACTION",2.25,45.38,"hanging drop",7.5,"PEG4000 MPD MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ7",35.4,"1.7","1.7","B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (AABB) + UDPGal + Deoxy-acceptor","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ7"
"2RJ8",,"X-RAY DIFFRACTION",2.25,45.39,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ8",35.18,"1.69","1.69","B-specific alpha-1,3-galactosyltransferase (GTB) +UDP+ H-antigen disaccharide","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ8"
"2RJ9",,"X-RAY DIFFRACTION",2.26,45.62,"hanging drop",7.5,"PEG4000 Glycerol MgCl NH2SO4, pH 7.5, hanging drop, temperature 298K",298,"10.1074/jbc.M708669200",,"2RJ9",35.17,"1.69","1.69","B-specific alpha-1,3-galactosyltransferase (GTB) + UDP+ Amino-deoxy-acceptor","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2RJ9"
"2RJC",,"X-RAY DIFFRACTION",2.76,55.39,"VAPOR DIFFUSION, HANGING DROP",5.1,"4% PEG 4000, 0.1 M Sodium acetate, 0.1 M MES pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1340",,"2RJC",114.91,"2","2","Crystal structure of L3MBTL1 protein in complex with MES","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSASPGG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RJC"
"2RJD",,"X-RAY DIFFRACTION",3.15,60.93,"VAPOR DIFFUSION, HANGING DROP",4.6,"4% PEG 4000, 0.1M Sodium acetate, 1mM H1bK26me2 peptide, 0.1 M Sodium acetate pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1340",,"2RJD",37.75,"1.65","1.65","Crystal structure of L3MBTL1 protein","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSASPGG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RJD"
"2RJE",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, HANGING DROP",4.4,"6% PEG 3350, 0.1M Ammonium sulfate, 20% Glycerol, 0.1 M Sodium acetate pH 4.4 , VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1340",,"2RJE",116.18,"1.86","1.86","Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), orthorhombic form II","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSASPGG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RJE"
,,,,,,,,,,,,,,,,"AKRHRKVLRDN",,,"Histone H4","2","2RJE"
"2RJF",,"X-RAY DIFFRACTION",2.99,58.85,"VAPOR DIFFUSION, HANGING DROP",5,"5% PEG 4000, 0.1M Sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1340",,"2RJF",117.94,"2.05","2.05","Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 12-30), orthorhombic form I","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSASPGG","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2RJF"
,,,,,,,,,,,,,,,,"YKGGAKRHRKVLRDNIQGIT",,,"Histone H4","2","2RJF"
"2RJK",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, SITTING DROP",8.5,"10 MM CACL2, 100 MM TRIS, PH 8.50, 20% METHONAL, VAPOR DIFFUSION, SITTING DROP, TEMPERATUR 290K, temperature 298.0K",298,"10.1021/bi900031w",,"2RJK",20.89,"2.3","2.3","Crystal Structure of Human TL1A Extracellular Domain C95S Mutant","GSHMLKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSESSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL","Homo sapiens","TNFSF15, TL1, VEGI","TNF superfamily ligand TL1A","1","2RJK"
"2RJL",,"X-RAY DIFFRACTION",3.39,63.71,,8.5,"10 MM CACL2, 100 MM TRIS, PH 8.50, 20% METHONAL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K, temperature 298.0K",298,"10.1021/bi900031w",,"2RJL",20.88,"2.05","2.05","Crystal structure of human TL1A extracellular domain C95S/C135S mutant","GSHMLKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSESSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVSEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL","Homo sapiens","TNFSF15, TL1, VEGI","TNF superfamily ligand TL1A","1","2RJL"
"2RJP",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, HANGING DROP",6,"10% PEG 4000, 0.1M MES pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1110/ps.073287008","886","2RJP",139.67,"2.8","2.8","Crystal structure of ADAMTS4 with inhibitor bound","FASLSRFVETLVVADDKMAAFHGAGLKRYLLTVMAAAAKAFKHPSIRNPVSLVVTRLVILGSGEEGPQVGPSAAQTLRSFCAWQRGLNTPEDSDPDHFDTAILFTRQDLCGVSTCDTLGMADVGTVCDPARSCAIVEDDGLQSAFTAAHQLGHVFNMLHDNSKPCISLNGPLSTSRHVMAPVMAHVDPEEPWSPCSARFITDFLDNGYGHCLLDKPEAPLHLPVTFPGKDYDADRQCQLTFGPDSRHCPQLPPPCAALWCSGHLNGHAMCQTKHSPWADGTPCGPAQACMGGRCLHMDQLQDFNIPQADYKDDDDK","Homo sapiens","ADAMTS4, KIAA0688, UNQ769/PRO1563","ADAMTS-4","1","2RJP"
"2RJQ",,"X-RAY DIFFRACTION",2.95,58.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 8000, 0.2 M Ammonium sulfate, 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1110/ps.073287008",,"2RJQ",42.84,"2.6","2.6","Crystal structure of ADAMTS5 with inhibitor bound","SISRARQVELLLVADASMARLYGRGLQHYLLTLASIANRLYSHASIENHIRLAVVKVVVLGDKDKSLEVSKNAATTLKNFCKWQHQHNQLGDDHEEHYDAAILFTREDLCGHHSCDTLGMADVGTICSPERSCAVIEDDGLHAAFTVAHEIGHLLGLSHDDSKFCEETFGSTEDKRLMSSILTSIDASKPWSKCTSATITEFLDDGHGNCLLDLPRKQILGPEELPGQTYDATQQCNLTFGPEYSVCPGMDVCARLWCAVVRQGQMVCLTKKLPAVEGTPCGKGRICLQGKCVDKTKKKYYSTSSHGNWGSWGSWGQCSRSCGGGVQFAYRHCNNPAPRNNGRYCTGKRAIYRSCSLMPCPPNGKSFGSAWSHPQFEK","Homo sapiens","ADAMTS5, ADAMTS11, ADMP2","ADAMTS-5","1","2RJQ"
"2RK3",,"X-RAY DIFFRACTION",3.03,59.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3000, 100 mM HEPES, 200 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi701189c",,"2RK3",21.02,"1.05","1.05","Structure of A104T DJ-1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIATICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","2RK3"
"2RK4",,"X-RAY DIFFRACTION",3.08,59.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3000, 100 mM HEPES, 200 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi701189c",,"2RK4",20.97,"1.15","1.15","Structure of M26I DJ-1","MASKRALVILAKGAEEMETVIPVDVIRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","2RK4"
"2RK6",,"X-RAY DIFFRACTION",3.05,59.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M sodium citrate, 20 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi701189c",,"2RK6",20.23,"1.15","1.15","Structure of E163K DJ-1","GSHMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFKFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","2RK6"
"2RKB",,"X-RAY DIFFRACTION",3.43,64.16,"EVAPORATION",5.6,"50 mM Na-citrate buffer, 10 mM O-methylserine, 200 mM potassium acetate, 5 mM DTT, 15 % PEG-8000, 10 mg/mL protein, pH 5.6, EVAPORATION, temperature 294K",294,"10.1016/j.bbagen.2008.01.020",,"2RKB",169.31,"2.8","2.8","Serine dehydratase like-1 from human cancer cells","QEPFHVVTPLLESWALSQVAGMPVFLKCENVQPSGSFKIRGIGHFCQEMAKKGCRHLVCSSGGNAGIAAAYAARKLGIPATIVLPESTSLQVVQRLQGEGAEVQLTGKVWDEANLRAQELAKRDGWENVPPFDHPLIWKGHASLVQELKAVLRTPPGALVLAVGGGGLLAGVVAGLLEVGWQHVPIIAMETHGAHCFNAAITAGKLVTLPDITSVAKSLGAKTVAARALECMQVCKIHSEVVEDTEAVSAVQQLLDDERMLVEPACGAALAAIYSGLLRRLQAEGCLPPSLTSVVVIVCGGNNINSRELQALKTHLGQ","Homo sapiens","SDSL","Serine dehydratase-like","1","2RKB"
"2RKU",,"X-RAY DIFFRACTION",2.92,57.82,,,,,"10.1111/j.1747-0285.2007.00594.x","R78","2RKU",35.16,"1.95","1.95","Structure of PLK1 in complex with BI2536","AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","2RKU"
"2RKY",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM Tris-HCl, pH8.5, 0.15M Potassium thiocyanate, 20% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.0803556105",,"2RKY",26.91,"1.8","1.8","Crystal structure of the fourth and fifth fibronectin F1 modules in complex with a fragment of staphylococcus aureus fnbpa-1","AEKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSYRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTS","Homo sapiens","FN1, FN","Fibronectin","1","2RKY"
,,,,,,,,,,,,,,,,"NEKNGPIIQNNKFEYKEDTIKET",,,"Fibronectin-binding protein","2","2RKY"
"2RL0",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.2M NACL, 0.1M BIS TRIS, 14% PEG3350, pH6.2, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0803556105",,"2RL0",72.91,"2","2","Crystal structure of the fourth and fifth fibronectin F1 modules in complex with a fragment of staphylococcus aureus fnbpa-5","EKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSYRIGDTWSKKDNRGNLLQCICTGNGRGEWKCER","Homo sapiens","FN1, FN","Fibronectin","1","2RL0"
,,,,,,,,,,,,,,,,"GQVTTESNLVEFDEESTK",,,"Fibronectin-binding protein","2","2RL0"
"2RL5",,"X-RAY DIFFRACTION",3.72,66.9,"VAPOR DIFFUSION, HANGING DROP",8.2,"PEG 4000, lithium sulfate, Tris, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm701129j","2RL","2RL5",36.78,"2.65","2.65","Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","2RL5"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"2RLI",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2007.07.011",,"2RLI",19.56,,,"Solution structure of Cu(I) human Sco2","GSFTGQGDFHLLDHRGRARCKADFRGQWVLMYFGFTHCPDICPDELEKLVQVVRQLEAEPGLPPVQPVFITVDPERDDVEAMARYVQDFHPRLLGLTGSTKQVAQASHSYRVYYNAGPKDEDQDYIVDHSIAIYLLNPDGLFTDYYGRSRSAEQISDSVRRHMAAFRSVLS","Homo sapiens","SCO2","SCO2 protein homolog, mitochondrial","1","2RLI"
"2RLO",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.02.052",,"2RLO",14.33,,,"Split PH domain of PI3-kinase enhancer","RAIPIKQSFLLKRSGNSLNKEWKKKYVTLSSNGFLLYHPSINDYIHSTHGKEMDLLRTTVKVPGKRPPRAISAFGPSASGSAGQAEEENFEFLIVSSTGQTWHFEAASFEERDAWVQAIESQILASLQ","Homo sapiens","CENTG1, AGAP2, KIAA0167","Centaurin-gamma 1","1","2RLO"
"2RLP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M709587200",,"2RLP",14.4,,,"NMR structure of CCP modules 1-2 of complement factor H","EAEAAGDCNELPPRRNTEILTGSWSDQTYPEGTQAIYKCRPGYRSLGNVIMVCRKGEWVALNPLRKCQKRPCGHPGDTPFGTFTLTGGNVFEYGVKAVYTCNEGYQLLGEINYRECDTDGWTNDIPICE","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2RLP"
"2RLQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M709587200",,"2RLQ",14.18,,,"NMR structure of CCP modules 2-3 of complement factor H","EAEAAGPCGHPGDTPFGTFTLTGGNVFEYGVKAVYTCNEGYQLLGEINYRECDTDGWTNDIPICEVVKCLPVTAPENGKIVSSAMEPDREYHFGQAVRFVCNSGYKIEGDEEMHCSDDGFWSKEKPKCV","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2RLQ"
"2RMJ",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2007.11.028",,"2RMJ",15.66,,,"Solution structure of RIG-I C-terminal domain","DSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATGVQTLYSKWKDFHFEKIPFDPAEMSK","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","2RMJ"
"2RMN",,"SOLUTION NMR",,,,,,,"10.1038/srep26707",,"2RMN",25.93,,,"The solution structure of the p63 DNA-binding domain","GSSTFDALSPSPAIPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQQVSDSTKNGDAFRQNTHGIQMT","Homo sapiens","P63, TP63, KET, P73H, P73L, TP73L","Tumor protein 63","1","2RMN"
"2RMX",,"SOLUTION NMR",,,,,,,,,"2RMX",14.36,,,"Solution structure of the SHP-1 C-terminal SH2 domain complexed with a tyrosine-phosphorylated peptide from NKG2A","GSSGSSGWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYSGPSSG","Homo sapiens","PTPN6, HCP, PTP1C","Tyrosine-protein phosphatase non-receptor type 6","1","2RMX"
,,,,,,,,,,,,,,,,"MDNQGVIYSDLNLPP",,,"NKG2-A/NKG2-B type II integral membrane protein","2","2RMX"
"2RMY",,"SOLUTION NMR",,,,,,,"10.1529/biophysj.108.134155",,"2RMY",3.71,,,"Structure of the N-terminal BARpeptide in SDS micelles","MAEMGSKGVTAGKIASNVQKKLTRAQEKVLQKLY","Homo sapiens","BIN1, AMPHL","Myc box-dependent-interacting protein 1","1","2RMY"
"2RMZ",,"SOLUTION NMR",,,,,,,"10.1021/bi800107a",,"2RMZ",4.71,,,"Bicelle-embedded integrin beta3 transmembrane segment","PESPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEF","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2RMZ"
"2RN0",,"SOLUTION NMR",,,,,,,"10.1021/bi800107a",,"2RN0",4.71,,,"Micelle-embedded integrin beta3 transmembrane segment","PESPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEF","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2RN0"
"2RN5",,"SOLUTION NMR",,,,,,,"10.1002/bip.21018",,"2RN5",6.1,,,"Humal Insulin Mutant B31Lys-B32Arg","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2RN5"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKTKR","Homo sapiens","INS","Insulin","2","2RN5"
"2RN9",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M708016200",,"2RN9",7.32,,,"Solution structure of human apoCox17","GSFTMPGLVDSNPAPPESQEKKPLKPCCACPETKKARDACIIEKGEEHCGHLIEAHKECMRALGFKI","Homo sapiens","COX17","Cytochrome c oxidase copper chaperone","1","2RN9"
"2RNB",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M708016200",,"2RNB",7.38,,,"Solution structure of human Cu(I)Cox17","GSFTMPGLVDSNPAPPESQEKKPLKPCCACPETKKARDACIIEKGEEHCGHLIEAHKECMRALGFKI","Homo sapiens","COX17","Cytochrome c oxidase copper chaperone","1","2RNB"
"2RND",,"SOLUTION NMR",,,,,,,"10.1529/biophysj.108.134155",,"2RND",3.71,,,"Structure of the N-terminal BARpeptide in DPC micelles","MAEMGSKGVTAGKIASNVQKKLTRAQEKVLQKLY","Homo sapiens","BIN1, AMPHL","Myc box-dependent-interacting protein 1","1","2RND"
"2RNF",,"X-RAY DIFFRACTION",2.2,42.81,,6.9,"pH 6.9",,"10.1006/jmbi.1998.2288",,"2RNF",28.57,"2.4","2.4","X-RAY CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE 4 IN COMPLEX WITH D(UP)","MQDGMYQRFLRQHVHPEETGGSDRYCNLMMQRRKMTLYHCKRFNTFIHEDIWNIRSICSTTNIQCKNGKMNCHEGVVKVTDCRDTGSSRAPNCRYRAIASTRRVVIACEGNPQVPVHFDG","Homo sapiens","RNASE4, RNS4","RIBONUCLEASE 4","1","2RNF"
"2RNL",,"SOLUTION NMR",,,,,,,,,"2RNL",5.58,,,"Solution structure of the EGF-like domain from human Amphiregulin","GSSGSSGKKNPCNAEFQNFCIHGECKYIEHLEAVTCKCQQEYFGERCGEK","Homo sapiens","AREG, SDGF, AREGB","Amphiregulin","1","2RNL"
"2RNQ",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2008.47",,"2RNQ",7.38,,,"Solution structure of the C-terminal acidic domain of TFIIE alpha","GSEEDEEEDDEFEEVADDPIVMVAGRPFSYSEVSQRPELVAQMTPEEKEAYIAMGQRMFEDLFE","Homo sapiens","GTF2E1, TF2E1","Transcription initiation factor IIE subunit alpha","1","2RNQ"
"2RO1",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1416",,"2RO1",21.17,,,"NMR Solution Structures of Human KAP1 PHD finger-bromodomain","SATICRVCQKPGDLVMCNQCEFCFHLDCHLPALQDVPGEEWSCSLCHVLPDLKEEDGSLSLDGADSTGVVAKLSPANQRKCERVLLALFCHEPCRPLHQLATDSTFSLDQPGGTLDLTLIRARLQEKLSPPYSSPQEFAQDVGRMFKQFNKLTEDKADVQSIIGLQRFFETRMNEAFGDTKFSAVLVEP","Homo sapiens","TRIM28, KAP1, RNF96, TIF1B","Transcription intermediary factor 1-beta","1","2RO1"
"2ROL",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.07.008",,"2ROL",8.7,,,"Structural Basis of PxxDY motif recognition in SH3 binding","GSMGTAGKWVLCNYDFQARNSSELSVKQRDVLEVLDDSRKWWKVRDPAGQEGYVPYNILTPYPG","Homo sapiens","EPS8L1, DRC3, EPS8R1, PP10566","Epidermal growth factor receptor kinase substrate 8-like protein 1","1","2ROL"
,,,,,,,,,,,,,,,,"PPVPNPDYEPIR",,,"12-meric peptide from T-cell surface glycoprotein CD3 epsilon chain","2","2ROL"
"2ROP",,"SOLUTION NMR",,,,,,,"10.1021/bi8004736",,"2ROP",21.14,,,"Solution structure of domains 3 and 4 of human ATP7B","SANQNFNNSETLGHQGSHVVTLQLRIDGMHCKSCVLNIEENIGQLLGVQSIQVSLENKTAQVKYDPSCTSPVALQRAIEALPPGNFKVSLPDGAEGSGTDHRSSSSHSPGSPPRNQVQGTCSTTLIAIAGMTCASCVHSIEGMISQLEGVQQISVSLAEGTATVLYNPAVISPEELRAAIEDMGFEASVVSESCSTNPLGNH","Homo sapiens","ATP7B, PWD, WC1, WND","Copper-transporting ATPase 2","1","2ROP"
"2ROR",,"SOLUTION NMR",,,,,,,,,"2ROR",17.29,,,"Solution structure of the VAV1 SH2 domain complexed with a tyrosine-phosphorylated peptide from SLP76","GSSGSSGKAEAEQNWWEGPPQDLSVHLWYAGPMERAGAESILANRSDGTFLVRQRVKDAAEFAISIKYNVEVKHIKIMTAEGLYRITEKKAFRGLTELVEFYQQNSLKDCFKSLDTTLQFPFKEPEKRTISRSGPSSG","Homo sapiens","VAV1, VAV","Proto-oncogene vav","1","2ROR"
,,,,,,,,,,,,,,,,"GEDDGDYESPNEEEE",,,"15-meric peptide from Lymphocyte cytosolic protein 2","2","2ROR"
"2ROX",,"X-RAY DIFFRACTION",2.22,44.56,,,,,"10.1107/S0907444996003046","T44","2ROX",29.2,"2","2","TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","2ROX"
"2ROY",,"X-RAY DIFFRACTION",2.21,44.36,,,,,"10.1107/S0907444996003046",,"2ROY",28.37,"2.2","2.2","TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","2ROY"
"2RPC",,"SOLUTION NMR",,,,,,,"10.1093/hmg/ddn239",,"2RPC",17.87,,,"Solution structure of the tandem zf-C2H2 domains from the human zinc finger protein ZIC 3","GSSGSSGQPIKQELSCKWIDEAQLSRPKKSCDRTFSTMHELVTHVTMEHVGGPEQNNHVCYWEECPREGKSFKAKYKLVNHIRVHTGEKPFPCPFPGCGKIFARSENLKIHKRTHTGEKPFKCEFEGCDRRFANSSDRKKHMHVHTSDKSGPSSG","Homo sapiens","ZIC3, ZNF203","Zinc finger protein ZIC 3","1","2RPC"
"2RPJ",,"SOLUTION NMR",,,,,,,"10.1002/pro.49",,"2RPJ",4.96,,,"Solution structure of Fn14 CRD domain","GSSGSSGEQAPGTAPCSRGSSWSADLDKCMDCASCRARPHSDFCLGCAAA","Homo sapiens","TNFRSF12A, FN14","Tumor necrosis factor receptor superfamily member 12A","1","2RPJ"
"2RPP",,"SOLUTION NMR",,,,,,,"10.1002/pro.17",,"2RPP",9.96,,,"Solution structure of Tandem zinc finger domain 12 in Muscleblind-like protein 2","GSSGSSGPVRDTKWLTLEVCRQFQRGTCSRSDEECKFAHPPKSCQVENGRVIACFDSLKGRCSRENCKYLHPPTHLKTQLEINSGPSSG","Homo sapiens","MBNL2, MBLL, MBLL39, MLP1","Muscleblind-like protein 2","1","2RPP"
"2RPQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M802528200",,"2RPQ",15.54,,,"Solution Structure of a SUMO-interacting motif of MBD1-containing chromatin-associated factor 1 bound to SUMO-3","MADEKPKEGVKTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG","Homo sapiens","SUMO2, SMT3B, SMT3H2","Small ubiquitin-related modifier 2","1","2RPQ"
,,,,,,,,,,,,,,,,"GSPEFKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQD",,,"Activating transcription factor 7-interacting protein 1","2","2RPQ"
"2RPR",,"SOLUTION NMR",,,,,,,,,"2RPR",10.04,,,"Solution structure of the fifth FLYWCH domain of FLYWCH-type zinc finger-containing protein 1","GSSGSSGLRPLEFLRTSLGGRFLVHESFLYRKEKAAGEKVYWMCRDQARLGCRSRAITQGHRIMVMRSHCHQPDLAGLEALRQRERL","Homo sapiens","FLYWCH1, KIAA1552","FLYWCH-type zinc finger-containing protein 1","1","2RPR"
"2RQ1",,"SOLUTION NMR",,,,,,,"10.1002/prot.22405",,"2RQ1",12.42,,,"Solution structure of the 4.1R FERM alpha lobe domain","GSHMDPAQLTEDITRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMY","Homo sapiens","EPB41, E41P","Protein 4.1","1","2RQ1"
"2RQ4",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkp546",,"2RQ4",12.26,,,"Refinement of RNA binding domain 3 in CUG triplet repeat RNA-binding protein 1","GSSGSSGLTQQSIGAAGSQKEGPEGANLFIYHLPQEFGDQDLLQMFMPFGNVVSAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQSMNGFQIGMKRLKVQLKRSKNDSKSGPSSG","Homo sapiens","CUGBP1, CELF1, BRUNOL2, CUGBP, NAB50","CUG-BP- and ETR-3-like factor 1","1","2RQ4"
"2RQ8",,"SOLUTION NMR",,,,,,,"10.1002/pro.346",,"2RQ8",10.93,,,"Solution NMR structure of titin I27 domain mutant","MLIEVEKPLPGVEVFVGETAHFEIELSEPDVHGQWKLKGQPLAASPDCEIIEDGKKHILILHNCQLGMTGEVSFQAANTKSAANLKVKELLEHHHHHH","Homo sapiens","TTN","Titin","1","2RQ8"
"2RQ9",,"SOLUTION NMR",,,,,,,,,"2RQ9",16.43,,,"Solution structure of human acidic fibroblast growth factor (aFGF) in the presence of a protein stabilizer NDSB-new","MNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSDLEHHHHHH","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2RQ9"
"2RQA",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.007179",,"2RQA",15.62,,,"Solution structure of LGP2 CTD","GPHMQFPVEHVQLLCINCMVAVGHGSDLRKVEGTHHVNVNPNFSNYYNVSRDPVVINKVFKDWKPGGVISCRNCGEVWGLQMIYKSVKLPVLKVRSMLLETPQGRIQAKKWSRVPFSVPDFDFLQHCAENLSDLSLD","Homo sapiens","DHX58, D11LGP2E, LGP2","ATP-dependent RNA helicase DHX58","1","2RQA"
"2RQB",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.007179",,"2RQB",15.57,,,"Solution structure of MDA5 CTD","GPLGSYKNNPSLITFLCKNCSVLACSGEDIHVIEKMHHVNMTPEFKELYIVRENKALQKKCADYQINGEIICKCGQAWGTMMVHKGLDLPCLKIRNFVVVFKNNSTKKQYKKWVELPITFPNLDYSECCLFSDED","Homo sapiens","IFIH1, MDA5, RH116","Interferon-induced helicase C domain-containing protein 1","1","2RQB"
"2RQC",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkp546",,"2RQC",14.17,,,"Solution Structure of RNA-binding domain 3 of CUGBP1 in complex with RNA (UG)3","GSSGSSGLTQQSIGAAGSQKEGPEGANLFIYHLPQEFGDQDLLQMFMPFGNVVSAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQSMNGFQIGMKRLKVQLKRSKNDSKSGPSSG","Homo sapiens","CUGBP1, CELF1, BRUNOL2, CUGBP, NAB50","CUG-BP- and ETR-3-like factor 1","1","2RQC"
,,,,,,,,,,,,,,,,"UGUGUG",,,"5'-R(*UP*GP*UP*GP*UP*G)-3'","2","2RQC"
"2RQP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.092833",,"2RQP",9.69,,,"The Solution Structure of Heterochromatin Protein 1-Binding Protein 74 Histone H1 like domain","GPGMASSPRPKMDAILTEAIKACFQKSGASVVAIRKYIIHKYPSLELERRGYLLKQALKRELNRGVIKQVKGKGASGSFVVVQKSRKT","Homo sapiens","HP1BP3","Heterochromatin protein 1-binding protein 3","1","2RQP"
"2RQT",,"SOLUTION NMR",,,,,,,"10.1021/bi100563z",,"2RQT",7.07,,,"Solution structure of the human DDEF1 SH3 domain","VRRVKTIYDCQADNDDELTFIEGEVIIVTGEEDQEWWIGHIEGQPERKGVFPVSFVHILSD","Homo sapiens","ASAP1, DDEF1, KIAA1249, PAG2","Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1","1","2RQT"
"2RR6",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.06.005",,"2RR6",18.84,,,"Solution structure of the leucine rich repeat of human acidic leucine-rich nuclear phosphoprotein 32 family member B","GSSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDSDAE","Homo sapiens","ANP32B, APRIL, PHAPI2","Acidic leucine-rich nuclear phosphoprotein 32 family member B","1","2RR6"
"2RR8",,"SOLUTION NMR",,,,,,,"10.1007/s10858-010-9434-8",,"2RR8",22.03,,,"Solution structure of calponin homology domain of IQGAP1","GPLGSLTAEEMDERRRQNVAYEYLCHLEEAKRWMEACLGEDLPPTTELEEGLRNGVYLAKLGNFFSPKVVSLKKIYDREQTRYKATGLHFRHTDNVIQWLNAMDEIGLPKIFYPETTDIYDRKNMPRCIYCIHALSLYLFKLGLAPQIQDLYGKVDFTEEEINNMKTELEKYGIQMPAFSKIGGILANEL","Homo sapiens","IQGAP1, KIAA0051","IQGAP1 protein","1","2RR8"
"2RRA",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq854",,"2RRA",13.08,,,"Solution structure of RNA binding domain in human Tra2 beta protein in complex with RNA (GAAGAA)","GSSGSSGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPHT","Homo sapiens","TRA2B, SFRS10","cDNA FLJ40872 fis, clone TUTER2000283, highly similar to Homo sapiens transformer-2-beta (SFRS10) gene","1","2RRA"
,,,,,,,,,,,,,,,,"GAAGAA",,,"5'-R(*GP*AP*AP*GP*AP*A)-3'","2","2RRA"
"2RRB",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq854",,"2RRB",10.89,,,"Refinement of RNA binding domain in human Tra2 beta protein","GPLGSRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPHT","Homo sapiens","TRA2B, SFRS10","cDNA FLJ40872 fis, clone TUTER2000283, highly similar to Homo sapiens transformer-2-beta (SFRS10) gene","1","2RRB"
"2RRD",,"SOLUTION NMR",,,,,,,"10.1093/jb/mvq097",,"2RRD",11.28,,,"Structure of HRDC domain from human Bloom syndrome protein, BLM","GIPEFKQKALVAKVSQREEMVKKCLGELTEVCKSLGKVFGVHYFNIFNTVTLKKLAESLSSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPAEDS","Homo sapiens","BLM, RECQ2, RECQL3","HRDC domain from Bloom syndrome protein","1","2RRD"
"2RRF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.199430",,"2RRF",15.23,,,"The solution structure of the C-terminal region of Zinc finger FYVE domain-containing protein 21","GSSGSSGAEFYDKQLKVLLSGATFLVTFGNSEKPETMTCRLSNNQRYLFLDGDSHYEIEIVHISTVQILTEGFPPGGGNARATGMFLQYTVPGTEGVTQLKLTVVEDVTVGRRQAVAWLVAMHKAAKLLYESRDQSGPSSG","Homo sapiens","ZFYVE21","Zinc finger FYVE domain-containing protein 21","1","2RRF"
"2RRH",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2011.03.009",,"2RRH",3.39,,,"NMR structure of vasoactive intestinal peptide in Methanol","HSDAVFTDNYTRLRKQMAVKKYLNSILNG","Homo sapiens","VIP","VIP peptides","1","2RRH"
"2RRI",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2011.03.009",,"2RRI",3.39,,,"NMR structure of vasoactive intestinal peptide in DPC Micelle","HSDAVFTDNYTRLRKQMAVKKYLNSILNG","Homo sapiens","VIP","Vasoactive intestinal peptide","1","2RRI"
"2RRS",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0020452",,"2RRS",1.97,,,"NMR Structure of LC4 transmembrane segment of CCR5","VFASLPGIIFTRSQKEGL","Homo sapiens","CCR5, CMKBR5","C-C chemokine receptor type 5","1","2RRS"
"2RSG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.367730",,"2RSG",11.18,,,"Solution structure of the CERT PH domain","VERCGVLSKWTNYIHGWQDRWVVLKNNALSYYKSEDETEYGCRGSICLSKAVITPHDFDECRFDISVNDSVWYLRAQDPDHRQQWIDAIEQHKT","Homo sapiens","COL4A3BP, CERT, STARD11, CERT1","Collagen type IV alpha-3-binding protein","1","2RSG"
"2RSH",,"SOLUTION NMR",,,,,,,,,"2RSH",4.14,,,"Solution structures of the DNA-binding domains of immune-related zinc-finger protein ZFAT","GSSGSSGEKFACDYCSFTCLSKGHLKVHIERVHKKIK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RSH"
"2RSI",,"SOLUTION NMR",,,,,,,,,"2RSI",10.71,,,"Solution structures of the DNA-binding domains of immune-related zinc-finger protein ZFAT","GSSGSSGKPYKCPQCSYASAIKANLNVHLRKHTGEKFACDYCSFTCLSKGHLKVHIERVHKKIKQHCRFCKKKYSDVKNLIKHIRDAHDPQD","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RSI"
"2RSJ",,"SOLUTION NMR",,,,,,,,,"2RSJ",10.72,,,"Solution structures of the DNA-binding domains of immune-related zinc-finger protein ZFAT","GSSGSSGKIFTCEYCNKVFKFKHSLQAHLRIHTNEKPYKCPQCSYASAIKANLNVHLRKHTGEKFACDYCSFTCLSKGHLKVHIERVHKKIK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RSJ"
"2RSQ",,"SOLUTION NMR",,,,,,,,,"2RSQ",9.44,,,"Copper(I) loaded form of the first domain of the human copper chaperone for SOD1, CCS","GSFTMASDSGNQGTLCTLEFAVQMTCQSCVDAVRKSLQGVAGVQDVEVHLEDQMVLVHTTLPSQEVQALLEGTGRQAVLKGMGSGQLQN","Homo sapiens","CCS","Copper chaperone for superoxide dismutase","1","2RSQ"
"2RSU",,"SOLUTION NMR",,,,,,,"10.1021/bi301420m",,"2RSU",8.56,,,"Alternative structure of Ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQNRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC, UBA52, UBCEP2","Ubiquitin","1","2RSU"
"2RSV",,"SOLUTION NMR",,,,,,,,,"2RSV",46.07,,,"Solution structure of human full-length vaccinia related kinase 1 (VRK1)","GSSGSSGMPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRKKEIEESKEPGVEDTEWSNTQTEEAIQTRSRTRKRVQK","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","2RSV"
"2RTU",,"SOLUTION NMR",,,,,,,,,"2RTU",10.12,,,"Solution structure of oxidized human HMGB1 A box","GSHMGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKGE","Homo sapiens","HMGB1, HMG1","High mobility group protein B1","1","2RTU"
"2RU6",,"SOLUTION NMR",,,,,,,"10.1021/bi401617n",,"2RU6",8.56,,,"The pure alternative state of ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQNRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2RU6"
"2RUC",,"SOLUTION NMR",,,,,,,"10.1021/bi5007817",,"2RUC",13.12,,,"Solution structure of the peptidyl prolyl cis-trans isomerase domain of human Pin1 with sulfate ion","GSHMEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2RUC"
"2RUD",,"SOLUTION NMR",,,,,,,"10.1021/bi5007817",,"2RUD",13.13,,,"Solution structure of the peptidyl prolyl cis-trans isomerase domain of C113D mutant human Pin1 with sulfate ion","GSHMEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDDSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2RUD"
"2RUG",,"SOLUTION NMR",,,,,,,"10.1002/prot.24651",,"2RUG",12.43,,,"Refined solution structure of the first RNA recognition motif domain in CPEB3","GSSGSSGSRKVFVGGLPPDIDEDEITASFRRFGPLVVDWPHKAESKSYFPPKGYAFLLFQEESSVQALIDACLEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDSGPSSG","Homo sapiens","CPEB3, KIAA0940","Cytoplasmic polyadenylation element-binding protein 3","1","2RUG"
"2RUH",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0109163",,"2RUH",15.03,,,"Chemical Shift Assignments for MIP and MDM2 in bound state","MPRFWEYWLRLMEGGGENLYFQGMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMMASMTGGQQMG","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","2RUH"
"2RUQ",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b00606",,"2RUQ",13.09,,,"solution structure of human Pin1 PPIase mutant C113A","GSHMEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDASSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2RUQ"
"2RUR",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b00606",,"2RUR",13.11,,,"Solution structure of Human Pin1 PPIase C113S mutant","GSHMEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDSSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2RUR"
"2RUT",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUT",4.16,,,"Solution structures of the DNA-binding domain (ZF2) of immune-related zinc-finger protein ZFAT","GSSGSSGKIFTCEYCNKVFKFKHSLQAHLRIHTNEK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUT"
"2RUU",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUU",3.88,,,"Solution structures of the DNA-binding domain (ZF3) of immune-related zinc-finger protein ZFAT","GSSGSSGKPYKCPQCSYASAIKANLNVHLRKHTGEK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUU"
"2RUV",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUV",4.14,,,"Solution structures of the DNA-binding domain (ZF4) of immune-related zinc-finger protein ZFAT","GSSGSSGEKFACDYCSFTCLSKGHLKVHIERVHKKIK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUV"
"2RUW",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUW",4.26,,,"Solution structures of the DNA-binding domain (ZF5) of immune-related zinc-finger protein ZFAT","GSSGSSGIKQHCRFCKKKYSDVKNLIKHIRDAHDPQD","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUW"
"2RUX",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUX",4.27,,,"Solution structures of the DNA-binding domain (ZF6) of immune-related zinc-finger protein ZFAT","GSSGSSGLLYDCHICERKFKNELDRDRHMLVHGDKW","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUX"
"2RUY",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUY",4.21,,,"Solution structures of the DNA-binding domain (ZF10) of immune-related zinc-finger protein ZFAT","GSSGSSGHLYYCSQCHYSSITKNCLKRHVIQKHSNIL","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUY"
"2RUZ",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RUZ",4.08,,,"Solution structures of the DNA-binding domain (ZF11) of immune-related zinc-finger protein ZFAT","GSSGSSGILLKCPTDGCDYSTPDKYKLQAHLKVHTALD","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RUZ"
"2RV0",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV0",4.07,,,"Solution structures of the DNA-binding domain (ZF12) of immune-related zinc-finger protein ZFAT","GSSGSSGRSYSCPVCEKSFSEDRLIKSHIKTNHPEVS","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV0"
"2RV1",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV1",4.22,,,"Solution structures of the DNA-binding domain (ZF13) of immune-related zinc-finger protein ZFAT","GSSGSSGRAMKCPYCDFYFMKNGSDLQRHIWAHEGVK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV1"
"2RV2",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV2",3.99,,,"Solution structures of the DNA-binding domain (ZF14) of immune-related zinc-finger protein ZFAT","GSSGSSGKPFKCSLCEYATRSKSNLKAHMNRHSTEK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV2"
"2RV3",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV3",3.81,,,"Solution structures of the DNA-binding domain (ZF15) of immune-related zinc-finger protein ZFAT","GSSGSSGKTHLCDMCGKKFKSKGTLKSHKLLHTADG","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV3"
"2RV6",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV6",10.72,,,"Solution structures of the DNA-binding domains (ZF2-ZF3-ZF4) of immune-related zinc-finger protein ZFAT","GSSGSSGKIFTCEYCNKVFKFKHSLQAHLRIHTNEKPYKCPQCSYASAIKANLNVHLRKHTGEKFACDYCSFTCLSKGHLKVHIERVHKKIK","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV6"
"2RV7",,"SOLUTION NMR",,,,,,,"10.1007/s10969-015-9196-3",,"2RV7",10.71,,,"Solution structures of the DNA-binding domains (ZF3-ZF4-ZF5) of immune-related zinc-finger protein ZFAT","GSSGSSGKPYKCPQCSYASAIKANLNVHLRKHTGEKFACDYCSFTCLSKGHLKVHIERVHKKIKQHCRFCKKKYSDVKNLIKHIRDAHDPQD","Homo sapiens","ZFAT, KIAA1485, ZFAT1, ZNF406","Zinc finger protein ZFAT","1","2RV7"
"2RVJ",,"SOLUTION NMR",,,,,,,,,"2RVJ",11.83,,,"NMR structure of Epithelial splicing regulatory protein 1","MPPTNVRDCIRLRGLPYAATIEDILDFLGEFATDIRTHGVHMVLNHQGRPSGDAFIQMKSADRAFMAAQKCHKKNMKDRYVEVFQCSAEEMNFVLMGGTLNRLE","Homo sapiens","ESRP1, RBM35A","Epithelial splicing regulatory protein 1","1","2RVJ"
"2SDF",,"SOLUTION NMR",,,,,,,"10.1093/emboj/16.23.6996",,"2SDF",7.85,,,"SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), 30 STRUCTURES","KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALN","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","STROMAL CELL-DERIVED FACTOR-1","1","2SDF"
"2SHP",,"X-RAY DIFFRACTION",2.48,50,,8.5,"pH 8.5",,"10.1016/s0092-8674(00)80938-1",,"2SHP",120.82,"2","2","TYROSINE PHOSPHATASE SHP-2","MKSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDLTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRSIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","SHP-2","1","2SHP"
"2SRC",,"X-RAY DIFFRACTION",3.08,60.07,,6.5,"pH 6.5",,"10.1016/s1097-2765(00)80356-1","PTR","2SRC",52.22,"1.5","1.5","CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP","MVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","TYROSINE-PROTEIN KINASE SRC","1","2SRC"
"2SRT",,"SOLUTION NMR",,,,,,,"10.1038/nsb0294-111",,"2SRT",20.03,,,"CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET","Homo sapiens","HUMAN STROMELYSIN-1, MMP3, STMY1","STROMELYSIN-1","1","2SRT"
"2SSP",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 4000, 100 MM HEPES PH 6.5, 10% DIOXANE, 1 MM DITHIOTHREITOL, VAPOR DIFFUSION, HANGING DROP",,"10.1093/emboj/17.17.5214",,"2SSP",31.79,"2.25","2.25","LEUCINE-272-ALANINE URACIL-DNA GLYCOSYLASE BOUND TO ABASIC SITE-CONTAINING DNA","CTGTXATCTT",,,"DNA (5'-D(*CP*TP*GP*TP*(AAB)P*AP*TP*CP*TP*T)-3')","1","2SSP"
,,,,,,,,,,,,,,,,"AAAGATAACAG",,,"DNA (5'-D(*AP*AP*AP*GP*AP*TP*AP*AP*CP*AP*G)-3')","2","2SSP"
,,,,,,,,,,,,,,,,"MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPASVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG1, UNG15","PROTEIN (URACIL-DNA GLYCOSYLASE)","3","2SSP"
"2STT",,"SOLUTION NMR",,,,,,,"10.1023/a:1018399711996",,"2STT",21.67,,,"SOLUTION NMR STRUCTURE OF THE HUMAN ETS1/DNA COMPLEX, 25 STRUCTURES","TCGAGCCGGAAGTTCGA",,,"DNA (5'-D(*TP*CP*GP*AP*GP*CP*CP*GP*GP*AP*AP*GP*TP*TP*CP*GP*A)-3')","1","2STT"
,,,,,,,,,,,,,,,,"TCGAACTTCCGGCTCGA",,,"DNA (5'-D(*TP*CP*GP*AP*AP*CP*TP*TP*CP*CP*GP*GP*CP*TP*CP*GP*A)-3')","2","2STT"
,,,,,,,,,,,,,,,,"VIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFV","Homo sapiens","ETS1, EWSR2","ETS1","3","2STT"
"2STW",,"SOLUTION NMR",,,,,,,"10.1023/a:1018399711996",,"2STW",21.67,,,"SOLUTION NMR STRUCTURE OF THE HUMAN ETS1/DNA COMPLEX, RESTRAINED REGULARIZED MEAN STRUCTURE","TCGAGCCGGAAGTTCGA",,,"DNA (5'-D(*TP*CP*GP*AP*GP*CP*CP*GP*GP*AP*AP*GP*TP*TP*CP*GP*A)-3')","1","2STW"
,,,,,,,,,,,,,,,,"TCGAACTTCCGGCTCGA",,,"DNA (5'-D(*TP*CP*GP*AP*AP*CP*TP*TP*CP*CP*GP*GP*CP*TP*CP*GP*A)-3')","2","2STW"
,,,,,,,,,,,,,,,,"VIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFV","Homo sapiens","ETS1, EWSR2","ETS1","3","2STW"
"2TCL",,"X-RAY DIFFRACTION",2.05,40.03,,,,,"10.1038/nsb0294-106","RO4","2TCL",19.63,"2.2","2.2","STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR","VLTEGNPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYGRSQNPVQP","Homo sapiens","MMP1, CLG","FIBROBLAST COLLAGENASE","1","2TCL"
"2TGF",,"SOLUTION NMR",,,,,,,"10.1111/j.1432-1033.1991.tb16050.x",,"2TGF",5.56,,,"THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA","VVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLA","Homo sapiens","TGFA","TRANSFORMING GROWTH FACTOR-ALPHA","1","2TGF"
"2TGI",,"X-RAY DIFFRACTION",3.13,60.74,,,,,"10.1126/science.1631557",,"2TGI",12.73,"1.8","1.8","CRYSTAL STRUCTURE OF TRANSFORMING GROWTH FACTOR-BETA2: AN UNUSUAL FOLD FOR THE SUPERFAMILY","ALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS","Homo sapiens","TGFB2","TRANSFORMING GROWTH FACTOR ,BETA 2","1","2TGI"
"2TMP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.273.34.21736",,"2TMP",14.11,,,"N-TERMINAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 (N-TIMP-2), NMR, 49 STRUCTURES","CSCSPVHPQQAFCNADVVIRTKAVSEKEVDSGNDIYGNPIKRIQYEIKQIKMFKGPEKDIEFIYTAPSSAVCGVSLDVGGKKEYLIAGKAEGDGKMHITLCDFIVPWDTLSTTQKKSLNHRYQMGCE","Homo sapiens","TIMP2","TISSUE INHIBITOR OF METALLOPROTEINASES-2","1","2TMP"
"2TRH",,"X-RAY DIFFRACTION",2.2,52.2,,6.5,"PURIFIED PROTEIN (20MG/ML IN 100MM TRIS BUFFER, PH 7.5) WAS CRYSTALLIZED FROM\\ 2.25M AMMONIUM SULFATE, 100MM CITRATE BUFFER, PH 5.5 AT ROOM TEMPERATURE.\\, pH 6.5",,"10.3109/13506129809003843",,"2TRH",27.66,"1.9","1.9","TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION","GPTGTGESKRPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","2TRH"
"2TRY",,"X-RAY DIFFRACTION",2.2,52.5,,6.5,"PURIFIED PROTEIN (25MG/ML IN 100MM TRIS BUFFER, PH 7.5) WAS CRYSTALLIZED FROM 1.5M AMMONIUM SULFATE, 100MM CITRATE BUFFER, PH 5.5, AT ROOM TEMPERATURE., pH 6.5",,"10.3109/13506129809003843",,"2TRY",27.71,"2","2","TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKYYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","2TRY"
"2TUN",,"X-RAY DIFFRACTION",3.57,65.53,,,,,,,"2TUN",104.38,"3.1","3.1","CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR","VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIVVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLLFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","TUMOR NECROSIS FACTOR-ALPHA","1","2TUN"
"2U1A",,"SOLUTION NMR",,,,,,,"10.1021/bi9709811",,"2U1A",9.9,,,"RNA BINDING DOMAIN 2 OF HUMAN U1A PROTEIN, NMR, 20 STRUCTURES","MAPAQPLSENPPNHILFLTNLPEETNELMLSMLFNQFPGFKEVRLVPGRHDIAFVEFDNEVQAGAARDALQGFKITQNNAMKISFAKK","Homo sapiens","PHA, SNRPA","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A","1","2U1A"
"2U2F",,"SOLUTION NMR",,,,,,,"10.1093/emboj/18.16.4523",,"2U2F",9.1,,,"SOLUTION STRUCTURE OF THE SECOND RNA-BINDING DOMAIN OF HU2AF65","AHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNA","Homo sapiens","U2AF2, U2AF65","PROTEIN (SPLICING FACTOR U2AF 65 KD SUBUNIT)","1","2U2F"
"2UP1",,"X-RAY DIFFRACTION",2.3,46.58,,8.5,"pH 8.5",,"10.1101/gad.13.9.1102",,"2UP1",24.35,"2.1","2.1","STRUCTURE OF UP1-TELOMERIC DNA COMPLEX","TAGGGTTAGGG",,,"DNA (5'-D(P*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","2UP1"
,,,,,,,,,,,,,,,,"KEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFVTYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHHLRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKALSKQEMASAS","Homo sapiens","HNRNPA1, HNRPA1","PROTEIN (HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1)","2","2UP1"
"2USN",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, HANGING DROP",7,"HANGING DROP VAPOR DIFFUSION., pH 7.0, vapor diffusion - hanging drop",,"10.1002/pro.5560071008","IN8","2USN",19.33,"2.2","2.2","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYG","Homo sapiens","MMP3, STMY1","STROMELYSIN-1","1","2USN"
"2UUH",,"X-RAY DIFFRACTION",5.07,80,,,,,"10.1038/nature06009",,"2UUH",19.98,"2.15","2.15","Crystal structure of Human Leukotriene C4 Synthase in complex with substrate glutathione","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","LEUKOTRIENE C4 SYNTHASE","1","2UUH"
"2UUI",,"X-RAY DIFFRACTION",5.84,72.83,,,,,"10.1038/nature06009",,"2UUI",22.39,"2","2","Crystal structure of Human Leukotriene C4 Synthase","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","LEUKOTRIENE C4 SYNTHASE","1","2UUI"
"2UUR",,"X-RAY DIFFRACTION",2.2,42,,6.5,"100 MM MES, PH 6.5 10 MM ZNSO4 20% MME-PEG 550",,"10.1074/jbc.M702514200",,"2UUR",27.96,"1.8","1.8","N-terminal NC4 domain of collagen IX","AVKRRPRFPVNSNSNGGNELCPKIRIGQDDLPGFDLISQFQVDKAASRRAIQRVVGSATLQVAYKLGNNVDFRIPTRNLYPSGLPEEYSFLTTFRMTGSTLKKNWNIWQIQDSSGKEQVGIKINGQTQSVVFSYKGLDGSLQTAAFSNLSSLFDSQWHKIMIGVERSSATLFVDCNRIESLPIKPRGPIDIDGFAVLGKLADNPQVSVPFELQWMLIHCDPLRPRRETCHELPARITPSQTTDER","Homo sapiens","COL9A1","COLLAGEN ALPHA-1(IX) CHAIN","1","2UUR"
"2UV2",,"X-RAY DIFFRACTION",3.53,65,,6.5,"18% PEG3350, 0.15M POTASSIUM THIOCYANATE, 10% ETHYLENE GLYCOL, 0.1M BISTRISPROPANE PH6.5, pH 6.50",,"10.1038/emboj.2008.8",,"2UV2",37.97,"2.3","2.3","Crystal Structure Of Human Ste20-Like Kinase Bound To 4-(4-(5- Cyclopropyl-1H-pyrazol-3-ylamino)-quinazolin-2-ylamino)-phenyl)- acetonitrile","MHHHHHHSSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-LIKE SERINE-THREONINE KINASE","1","2UV2"
"2UV3",,"X-RAY DIFFRACTION",2.9,58,,6,"2.4 M AMMONIUM SULPHATE, 0.1 M MES, PH 6.0",,"10.1074/jbc.M611511200",,"2UV3",28.81,"1.8","1.8","Structure of the signal-regulatory protein (SIRP) alpha domain that binds CD47.","EEELQVIQPDKSVSVAAGESAILHCTVTSLIPVGPIQWFRGAGPARELIYNQKEGHFPRVTTVSESTKRENMDFSISISNITPADAGTYYCVKFRKGSPDTEFKSGAGTELSVRAKPSTRHHHHHH","Homo sapiens","SIRPA, BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1","1","2UV3"
"2UV4",,"X-RAY DIFFRACTION",1.78,30.33,,8,"pH 8.00",,"10.1107/S0907444907009110","AMP","2UV4",17.63,"1.33","1.33","Crystal Structure of a CBS domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP","MAHHHHHHEFPKPEFMSKSLEELQIGTYANIAMVRTTTPVYVALGIFVQHRVSALPVVDEKGRVVDIYSKFDVINLAAEKTYNNLDVSVTKALQHRSHYFEGVLKCYLHETLETIINRLVEAEVHRLVVVDENDVVKGIVSLSDILQALVLT","Homo sapiens","PRKAG1","5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT GAMMA-1","1","2UV4"
"2UV5",,"X-RAY DIFFRACTION",1.79,30.91,,8,"pH 8.00",,"10.1107/S0907444907009110",,"2UV5",17.62,"1.69","1.69","Crystal Structure of a CBS domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP","MAHHHHHHEFPKPEFMSKSLEELQIGTYANIAMVRTTTPVYVALGIFVQHRVSALPVVDEKGRVVDIYSKFDVINLAAEKTYNNLDVSVTKALQHRSHYFEGVLKCYLHETLETIINRLVEAEVHRLVVVDENDVVKGIVSLSDILQALVLT","Homo sapiens","PRKAG1","5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT GAMMA-1","1","2UV5"
"2UV6",,"X-RAY DIFFRACTION",1.85,33.14,,8,"pH 8.00",,"10.1107/S0907444907009110","AMP","2UV6",17.6,"2","2","Crystal Structure of a CBS domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP","MAHHHHHHEFPKPEFMSKSLEELQIGTYANIAMVRTTTPVYVALGIFVQHRVSALPVVDEKGRVVDIYSKFDVINLAAEKTYNNLDVSVTKALQHRSHYFEGVLKCYLHETLETIINRLVEAEVHQLVVVDENDVVKGIVSLSDILQALVLT","Homo sapiens","PRKAG1","5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT GAMMA-1","1","2UV6"
"2UV7",,"X-RAY DIFFRACTION",1.86,33.38,,,,,"10.1107/S0907444907009110","AMP","2UV7",17.53,"2","2","Crystal Structure of a CBS domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP","MAHHHHHHEFPKPEFMSKSLEELQIGTYANIAMVRTTTPVYVALGIFVQHRVSALPVVDEKGRVVDIYSKFDVINLAAEKTYNNLDVSVTKALQHRSHYFEGVLKCYLHETLETIINRLVEAEVHGLVVVDENDVVKGIVSLSDILQALVLT","Homo sapiens","PRKAG1","5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT GAMMA-1","1","2UV7"
"2UVL",,"X-RAY DIFFRACTION",2.43,49.04,,,"16% PEG 8000 40MM KPO4 20% GLYCEROL",,"10.1107/S1744309109038597",,"2UVL",22.46,"1.91","1.91","Human BIR3 domain of Baculoviral Inhibitor of Apoptosis Repeat- Containing 3 (BIRC3)","SMRYTVSNLSMQTHAARFKTFFNWPSSVLVNPEQLASAGFYYVGNSDDVKCFCCDGGLRCWESGDDPWVQHAKWFPRCEYLIRIKGQEFIRQVQAS","Homo sapiens","BIRC3, API2, MIHC, RNF49","BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3","1","2UVL"
"2UVM",,"X-RAY DIFFRACTION",1.96,37,,5,"25-30% POLYETHYLENE GLYCOL 3000, 0.1 M SODIUM ACETATE TRIHYDRATE [PH 4.4-5.0], 0.2 M AMMONIUM ACETATE",,"10.1021/cb700019r","GVF","2UVM",15.17,"1.94","1.94","Structure of PKBalpha PH domain in complex with a novel inositol headgroup surrogate, benzene 1,2,3,4-tetrakisphosphate","MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSG","Homo sapiens","AKT1, PKB, RAC","RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE","1","2UVM"
"2UVQ",,"X-RAY DIFFRACTION",2.6,53,,,"0.8-1.0 M SUCCINIC ACID PH 6.7-7.3",,,,"2UVQ",28.67,"3","3","Crystal structure of human uridine-cytidine kinase 1 in complex with ADP","MHHHHHHSSGVDLGTENLYFQSMRPFLIGVSGGTASGKSTVCEKIMELLGQNEVEQRQRKVVILSQDRFYKVLTAEQKAKALKGQYNFDHPDAFDNDLMHRTLKNIVEGKTVEVPTYDFVTHSRLPETTVVYPADVVLFEGILVFYSQEIRDMFHLRLFVDTDSDVRLSRRVLRDVRRGRDLEQILTQYTTFVKPAFEEFCLPTKKYADVIIPRGVDNMVAINLIVQHIQDILNGDICKWHRGGS","Homo sapiens","UCK1, URK1","URIDINE-CYTIDINE KINASE 1","1","2UVQ"
"2UW2",,"X-RAY DIFFRACTION",3.12,60.28,,5.5,"0.1M BISTRIS PH 5.5, 0.12M AMAC, 11% PEG 10K",,,,"2UW2",38.75,"2.8","2.8","Crystal structure of human ribonucleotide reductase subunit R2","SMTKAAAPGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEEVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGPMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFMENISLEGKTNFFEKRVGEYQRMGVMSSPTENSFTLDADF","Homo sapiens","RRM2, RR2","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE M2 SUBUNIT","1","2UW2"
"2UWD",,"X-RAY DIFFRACTION",2.9,58,,6.5,"pH 6.50",,"10.1158/1535-7163.MCT-07-0149","2GG","2UWD",27.14,"1.9","1.9","Inhibition of the HSP90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole, isoxazole amide analogs","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2UWD"
"2UWL",,"X-RAY DIFFRACTION",2.36,33.63,,5.75,"18% PEG6K, 50MM HEPES PH5.75, 10MM CACL2, 150MM NACL",,"10.1016/j.bmcl.2007.03.080","895","2UWL",44.21,"1.9","1.9","Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","1","2UWL"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X","2","2UWL"
"2UWN",,"X-RAY DIFFRACTION",2.2,43,,4.5,"0.1M SODIUM ACETATE, PH4.5, 20% (W/V) PEG3000",,"10.1084/jem.20071069",,"2UWN",22.55,"2.35","2.35","Crystal structure of Human Complement Factor H, SCR domains 6-8 (H402 risk variant), in complex with ligand.","MGLKPCDYPDIKHGGLYHENMRRPYFPVAVGKYYSYYCDEHFETPSGSYWDHIHCTQDGWSPAVPCLRKCYFPYLENGYNQNHGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVKTCSKSSIDIENGFISESQYTYALKEKAKYQCKLGYVTADGETSGSITCGKDGWSAQPTCI","Homo sapiens","CFH, HF, HF1, HF2","HUMAN COMPLEMENT FACTOR H","1","2UWN"
"2UWO",,"X-RAY DIFFRACTION",2.34,47.05,,5.75,"18% PEG6K, 50MM MES PH5.75, 10MM CACL2, 150MM NACL",,"10.1016/j.bmcl.2007.03.080","701","2UWO",44.22,"1.75","1.75","Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","1","2UWO"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X","2","2UWO"
"2UWP",,"X-RAY DIFFRACTION",2.28,45.54,,5.75,"18% PEG6K, 50MM MES PH 5.75, 10MM CACL2, 150MM NACL",,"10.1016/j.bmcl.2007.03.080","894","2UWP",44.28,"1.75","1.75","Factor Xa inhibitor complex","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","1","2UWP"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X","2","2UWP"
"2UWQ",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.05.024",,"2UWQ",9.98,,,"Solution structure of ASPP2 N-terminus","GGSMMPMFLTVYLSNNEQHFTEVPVTPETICRDVVDLCKEPGESDCHLAEVWCGSERPVADNERMFDVLQRFGSQRNEVRFFLRHE","Homo sapiens","TP53BP2, ASPP2, BBP","APOPTOSIS-STIMULATING OF P53 PROTEIN 2","1","2UWQ"
"2UWR",,"X-RAY DIFFRACTION",1.61,23.4,,,"23% PEG8000, 20% ETHANOL, 0.03M POTASSIUM PHOSPHATE",,"10.1107/S1744309107033477",,"2UWR",9.2,"1.34","1.34","High resolution structure of human CD59","MLQCYNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQLENC","Homo sapiens","CD59, MIC11, MIN1, MIN2, MIN3, MSK21","CD59 GLYCOPROTEIN","1","2UWR"
"2UX0",,"X-RAY DIFFRACTION",2.64,53,,7,"0.1 M SPG PH 7.0, 60% MPD",,"10.1371/journal.pbio.1000426",,"2UX0",98.63,"2.46","2.46","Structure of the oligomerisation domain of calcium-calmodulin dependent protein kinase II gamma","SMTEDEDLKVRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPRQ","Homo sapiens","CAMK2G, CAMK, CAMK-II, CAMKG","CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASE (CAM KINASE) II GAMMA","1","2UX0"
"2UX2",,"X-RAY DIFFRACTION",2.13,42,,,"25% PEG8000, 0.03M POTASSIUM PHOSPHATE",,"10.1107/S1744309107033477",,"2UX2",27.3,"1.8","1.8","High resolution structure of human CD59","MLQCYNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQLEN","Homo sapiens","CD59, MIC11, MIN1, MIN2, MIN3, MSK21","CD59 GLYCOPROTEIN","1","2UX2"
"2UXW",,"X-RAY DIFFRACTION",2.41,49,,7,"15% PEG3350, 0.1M SODIUM SUCCINATE PH7.0, pH 7.00",,,,"2UXW",67.72,"1.45","1.45","Crystal structure of human very long chain acyl-CoA dehydrogenase (ACADVL)","MHHHHHHSSGVDLGTENLYFQSMSFAVGMFKGQLTTDQVFPYPSVLNEEQTQFLKELVEPVSRFFEEVNDPAKNDALEMVEETTWQGLKELGAFGLQVPSELGGVGLCNTQYARLVEIVGMHDLGVGITLGAHQSIGFKGILLFGTKAQKEKYLPKLASGETVAAFCLTEPSSGSDAASIRTSAVPSPCGKYYTLNGSKLWISNGGLADIFTVFAKTPVTDPATGAVKEKITAFVVERGFGGITHGPPEKKMGIKASNTAEVFFDGVRVPSENVLGEVGSGFKVAMHILNNGRFGMAAALAGTMRGIIAKAVDHATNRTQFGEKIHNFGLIQEKLARMVMLQYVTESMAYMVSANMDQGATDFQIEAAISKIFGSEAAWKVTDECIQIMGGMGFMKEPGVERVLRDLRIFRIFEGTNDILRLFVALQGCMDKGKELSGLGSALKNPFGNAGLLLGEAGKQLRRRAGLGSGLSLSGLVHPELSRSGELAVRALEQFATVVEAKLIKHKKGIVNEQFLLQRLADGAIDLYAMVVVLSRASRSLSEGHPTAQHEKMLCDTWCIEAAARIREGMAALQSDPWQQELYRNFKSISKALVERGGVVTSNPLGF","Homo sapiens","ACADVL, VLCAD","VERY-LONG-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE","1","2UXW"
"2UYI",,"X-RAY DIFFRACTION",2.7,54,,6,"100 MM BIS-TRIS (PH 6.0) 200 MM AMMONIUM SULFATE, AND 18-20% PEG3350. 10 MM SRCL2",,"10.1016/j.bmcl.2007.04.076","K02","2UYI",83.77,"2.1","2.1","Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 33","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2UYI"
"2UYM",,"X-RAY DIFFRACTION",2.7,54,,6,"100 MM BIS-TRIS (PH 6.0), 200 MM AMMONIUM SULFATE AND 18-20% PEG3350. 10 MM SRCL2",,"10.1016/j.bmcl.2007.04.076","K03","2UYM",83.8,"2.11","2.11","Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 37","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2UYM"
"2UYY",,"X-RAY DIFFRACTION",3.2,61,,,"20% PEG3350 0.20 M KSCN",,,,"2UYY",137.75,"2.5","2.5","Structure of the cytokine-like nuclear factor n-pac","MHHHHHHSSGVDLGTENLYFQSMGSITPTDKKIGFLGLGLMGSGIVSNLLKMGHTVTVWNRTAEKCDLFIQEGARLGRTPAEVVSTCDITFACVSDPKAAKDLVLGPSGVLQGIRPGKCYVDMSTVDADTVTELAQVIVSRGGRFLEAPVSGNQQLSNDGMLVILAAGDRGLYEDCSSCFQAMGKTSFFLGEVGNAAKMMLIVNMVQGSFMATIAEGLTLAQVTGQSQQTLLDILNQGQLASIFLDQKCQNILQGNFKPDFYLKYIQKDLRLAIALGDAVNHPTPMAAAANEVYKRAKALDQSDNDMSAVYRAYIH","Homo sapiens","GLYR1, HIBDL, NDF, NP60, NPAC","N-PAC PROTEIN","1","2UYY"
"2UZ8",,"X-RAY DIFFRACTION",2.25,44.86,,,,,"10.1074/jbc.M800859200",,"2UZ8",40.33,"2","2","The crystal structure of p18, human translation elongation factor 1 epsilon 1","MAAAAELSLLEKSLGLSKGNKYSAQGERQIPVLQTNNGPSLMGLTTIAAHLVKQANKEYLLGSTAEEKAMVQQWLEYRVTQVDGHSSKNDIHTLLMDLNSYLEDKVYLTGYNFTLADILLYYGLHRFIVDLTVQEKEKYLNVSRWFCHIQHYPGIRQHLSSVVFIKNRLYTNSH","Homo sapiens","EEF1E1, AIMP3, P18","EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 EPSILON-1","1","2UZ8"
"2UZ9",,"X-RAY DIFFRACTION",2.65,53.14,,,,,,"XAN","2UZ9",53.84,"2.3","2.3","Human guanine deaminase (guaD) in complex with zinc and its product Xanthine.","MHHHHHHSSGVDLGTENLYFQSMCAAQMPPLAHIFRGTFVHSTWTCPMEVLRDHLLGVSDSGKIVFLEEASQQEKLAKEWCFKPCEIRELSHHEFFMPGLVDTHIHASQYSFAGSSIDLPLLEWLTKYTFPAEHRFQNIDFAEEVYTRVVRRTLKNGTTTACYFATIHTDSSLLLADITDKFGQRAFVGKVCMDLNDTFPEYKETTEESIKETERFVSEMLQKNYSRVKPIVTPRFSLSCSETLMGELGNIAKTRDLHIQSHISENRDEVEAVKNLYPSYKNYTSVYDKNNLLTNKTVMAHGCYLSAEELNVFHERGASIAHCPNSNLSLSSGFLNVLEVLKHEVKIGLGTDVAGGYSYSMLDAIRRAVMVSNILLINKVNEKSLTLKEVFRLATLGGSQALGLDGEIGNFEVGKEFDAILINPKASDSPIDLFYGDFFGDISEAVIQKFLYLGDDRNIEEVYVGGKQVVPFSSSV","Homo sapiens","GDA, KIAA1258","GUANINE DEAMINASE","1","2UZ9"
"2UZC",,"X-RAY DIFFRACTION",2,38,,,"20% PEG3350 0.20 M KSCN",,"10.1002/pro.349",,"2UZC",46.92,"1.5","1.5","Structure of human PDLIM5 in complex with the C-terminal peptide of human alpha-actinin-1","SMSNYSVSLVGPAPWGFRLQGGKDFNMPLTISSLKDGGKAAQANVRIGDVVLSIDGINAQGMTHLEAQNKIKGCTGSLNMTLQRESDL","Homo sapiens","PDLIM5, ENH, L9","PDZ AND LIM DOMAIN 5","1","2UZC"
"2UZG",,"SOLUTION NMR",,,,,,,"10.1110/ps.072967807",,"2UZG",11.12,,,"Zf-UBP domain of VDU1","GSRNHCPHLDSVGEITKEDLIQKSLGTCQDCKVQGPNLWACLENRCSYVGCGESQVDHSTIHSQETKHYLTVNLTTLRVWCYACSKEVFLDRKLGTQ","Homo sapiens","USP33, KIAA1097, VDU1","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 33","1","2UZG"
"2UZN",,"X-RAY DIFFRACTION",2,39,"VAPOR DIFFUSION, HANGING DROP",7,"VAPOR DIFFUSION HANGING DROP, ROOM TEMPERATURE, PEG3350, HEPES PH7.2, AMMONIUM ACETATE, pH 7.00",,"10.1016/j.bmcl.2007.04.110","C96","2UZN",34.34,"2.3","2.3","Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2UZN"
"2UZO",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, HANGING DROP",7,"VAPOR DIFFUSION HANGING DROP, ROOM TEMPERATURE, PEG3350, HEPES PH7.2, AMMONIUM ACETATE, pH 7.00",,"10.1016/j.bmcl.2007.04.110","C62","2UZO",34.33,"2.3","2.3","Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2UZO"
"2UZP",,"X-RAY DIFFRACTION",3.31,62.88,,6.5,"1.8M AMMONIUM SULPHATE, 15MM COBALT CHLORIDE, 0.1M MES PH6.5, pH 6.50",,,,"2UZP",53.3,"2","2","Crystal structure of the C2 domain of human protein kinase C gamma.","SMHTERRGRLQLEIRAPTADEIHVTVGEARNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRLSVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADN","Homo sapiens","PRKCG, PKCG","PROTEIN KINASE C GAMMA TYPE","1","2UZP"
"2UZQ",,"X-RAY DIFFRACTION",2.7,53.4,,7,"PEG 8000, HEPES PH 7.0, GUANIDINIUM CHLORIDE",,,,"2UZQ",141.27,"2.38","2.38","Protein Phosphatase, New Crystal Form","GSPGISGGGGGILELIGDYSKAFLLQTVDGKHQDLKYISPETMVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKRVILIFHCEFSSERGPRMCRFIRERDRAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQDYRPMNHEAFKDELKTFRLKTRSWAGERSRRELCSRLQDQ","Homo sapiens","CDC25B, CDC25HU2","M-PHASE INDUCER PHOSPHATASE 2","1","2UZQ"
"2UZR",,"X-RAY DIFFRACTION",1.7,28.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES PH 7.5 AND 1.4 M SODIUM CITRATE, OR 0.1 M SODIUM ACETATE PH 4.6, 0.2 M AMMONIUM ACETATE AND 15%-30% PEG 3350,",,"10.1038/nature05933",,"2UZR",14.77,"1.94","1.94","A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K)","SMSDVAIVKEGWLHKRGKYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSG","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","2UZR"
"2UZS",,"X-RAY DIFFRACTION",1.64,25.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"GROWN FROM HANGING DROPS IN 0.1 M HEPES PH 7.5 AND 1.4 M SODIUM CITRATE, OR 0.1 M ACETATE PH 4.6, 0.2 M AMMONIUM ACETATE AND 15%-30% PEG 3350,",,"10.1038/nature05933",,"2UZS",15.3,"2.46","2.46","A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K)","XSMSDVAIVKEGWLHKRGKYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSG","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","2UZS"
"2V01",,"X-RAY DIFFRACTION",2.37,47.72,,4,"40-50%MPD, PH4",,"10.1107/S1744309107034525",,"2V01",18.55,"2.15","2.15","Recombinant vertebrate calmodulin complexed with Pb","MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","CALMODULIN","1","2V01"
"2V02",,"X-RAY DIFFRACTION",2.38,47.82,,4,"40-50% MPD, PH4",,"10.1107/S1744309107034525",,"2V02",17.25,"2.2","2.2","Recombinant vertebrate calmodulin complexed with Ba","MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","CALMODULIN","1","2V02"
"2V0A",,"X-RAY DIFFRACTION",2,38,,4.75,"3.5 M AMMONIUM SULPHATE, 100MM NACL, 50MM ACETATE BUFFER PH 4.75",,"10.1073/pnas.0703857104",,"2V0A",32.26,"1.15","1.15","Atomic resolution crystal structure of Human Superoxide Dismutase","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE","1","2V0A"
"2V0D",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, HANGING DROP",7,"VAPOR DIFFUSION HANGING DROP, ROOM TEMPERATURE, PEG3350, HEPES PH7.2, AMMONIUM ACETATE, pH 7.00",,"10.1016/j.bmcl.2007.04.110",,"2V0D",34.22,"2.2","2.2","Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2V0D"
"2V0E",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.06.007",,"2V0E",6.17,,,"BRK domain from human CHD7","SGQLDPDTRIPVINLEDGTRLVGEDAPKNKDLVEWLKLHPTYTVDMPSYVPKNAD","Homo sapiens","CHD7, KIAA1416","CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 7","1","2V0E"
"2V0F",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.06.007",,"2V0F",9.56,,,"BRK domain from human CHD7","GSRNPNKLDINTLTGEERVPVVNKRNGKKMGGAMAPPMKDLPRWLEENPEFAVAPDWTDIVKQSGFVPESMFDRLLTGPVVRGEGAS","Homo sapiens","CHD7, KIAA1416","CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 7","1","2V0F"
"2V0M",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, HANGING DROP",7.2,"HANGING DROP CRYSTALLISATION USING 1:1 RATIO OF PROTEIN AT 20-27 MG/ML IN A SOLUTION CONTAINING 50 MM POTASSIUM PHOSPHATE PH 7.2, 0.2 MM POTASSIUM CHLORIDE, 20% (V/V) GLYCEROL, 2 MM DITHIOTHREITOL, 1MM EDTA",,"10.1073/pnas.0603236103","KKK, KLN","2V0M",228.64,"2.8","2.8","Crystal structure of human P450 3A4 in complex with ketoconazole","MAYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","2V0M"
"2V0O",,"X-RAY DIFFRACTION",3.7,66.97,,9,"18% PEG4000, 300MM NA ACETATE, 100MM TRIS PH 9",,"10.1016/j.str.2007.05.002",,"2V0O",94.76,"2.3","2.3","FCHO2 F-BAR domain","LGSPMAYFVENFWGEKNSGFDVLYHNMKHGQISTKELADFVRERATIEEAYSRSMTKLAKSASNYSQLGTFAPVWDVFKTSTEKLANCHLDLVRKLQELIKEVQKYGEEQVKSHKKTKEEVAGTLEAVQTIQSITQALQKSKENYNAKCVEQERLKKEGATQREIEKAAVKSKKATDTYKLYVEKYALAKADFEQKMTETAQKFQDIEETHLIHIKEIIGSLSNAIKEIHLQIGQVHEEFINNMANTTVESLIQKFAESKGTGKERPGLIEFEECD","Homo sapiens","FCHO2","FCH DOMAIN ONLY PROTEIN 2","1","2V0O"
"2V0R",,"X-RAY DIFFRACTION",2.26,45.06,,7,"pH 7",,"10.1093/nar/gkm516",,"2V0R",55.3,"2.3","2.3","crystal structure of a hairpin exchange variant (LTx) of the targeting LINE-1 retrotransposon endonuclease","MTGSNSHITILTLNINGLNSAIKRHRLASWIKSQDPSVCCIQETHLTCRDTHRLKIKGWRKIYQANGKQKKAGVAILVSDKTDFKPTKIKRDKEGHYIMVKGSIQQEELTILNIYAPNTGAPRFIKQVLSDLQRDLDSHTLIMGDFNTPLSTLDRSTRQKVNKDTQELNSALHQADLIDIYRTLHPKSTEYTYVRVRDGHVSQSKIDHIVGSKALLSKCKRTEIITNYLSDHSAIKLELR","Homo sapiens",,"LTX","1","2V0R"
"2V0S",,"X-RAY DIFFRACTION",2.25,44.86,,7,"pH 7.00",,"10.1093/nar/gkm516",,"2V0S",27.11,"1.8","1.8","crystal structure of a hairpin exchange variant (LR1) of the targeting LINE-1 retrotransposon endonuclease","MTGSNSHITILTLNINGLNSAIKRHRLASWIKSQDPSVCCIQETHLTCRDTHRLKIKGWRKIYQANGKQKKAGVAILVSDKTDFKPTKIKRDKEGHYIMVKGSIQQEELTILNIYAPNTGAPRFIKQVLSDLQRDLDSHTLIMGDFNTPLSTLDRSTRQKVNKDTQELNSALHQADLIDIYRTLHPKSTEYTFSTANGESKIDHIVGSKALLSKCKRTEIITNYLSDHSAIKLELR","Homo sapiens",,"LR1","1","2V0S"
"2V0V",,"X-RAY DIFFRACTION",2,39,,7.5,"PEG 4000 18%, ISOPROPANOL 10%, 100 MM HEPES PH 7.5",,"10.1016/j.jmb.2007.08.037",,"2V0V",87.78,"2.4","2.4","Crystal Structure of Rev-Erb beta","MSKSPYVDPHKSGHEIWEEFSMSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLGSKKYSVDDLHSMGAGDLLNSMFEFSEKLNALQLSDEEMSLFTAVVLVSADRSGIENVNSVEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSLNNMHSEELLAFKVHP","Homo sapiens","NR1D2","ORPHAN NUCLEAR RECEPTOR NR1D2","1","2V0V"
"2V0Z",,"X-RAY DIFFRACTION",3.17,61.25,,3,"pH 3.00",,"10.1016/s1074-5521(00)00134-4","C41","2V0Z",76.08,"2.2","2.2","Crystal Structure of Renin with Inhibitor 10 (Aliskiren)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V0Z"
"2V10",,"X-RAY DIFFRACTION",3.27,62.38,,4.5,"pH 4.50",,"10.1016/s1074-5521(00)00134-4","C61","2V10",75.5,"3.1","3.1","Crystal Structure of Renin with Inhibitor 9","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V10"
"2V11",,"X-RAY DIFFRACTION",3.26,62.3,,3,"pH 3.00",,"10.1016/s1074-5521(00)00134-4","C80","2V11",75.55,"3.1","3.1","Crystal Structure of Renin with Inhibitor 6","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V11"
"2V12",,"X-RAY DIFFRACTION",3.26,62.3,,4.5,"pH 4.50",,"10.1016/s1074-5521(00)00134-4","C39","2V12",75.52,"3.2","3.2","Crystal Structure of Renin with Inhibitor 8","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V12"
"2V13",,"X-RAY DIFFRACTION",3.1,60.38,,3,"pH 3",,"10.1016/s1074-5521(00)00134-4","C40","2V13",37.73,"2.8","2.8","Crystal Structure of Renin with Inhibitor 7","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V13"
"2V14",,"X-RAY DIFFRACTION",2.32,46.2,,8.8,"25% PEG 3350, 0.1 M TRIS PH 8.8, 0.2 M NH4OAC",,"10.1038/sj.emboj.7601800",,"2V14",15.93,"2.2","2.2","Kinesin 16B Phox-homology domain (KIF16B)","DLKDPIKISIPRYVLCGQGKDAHFEFEVKITVLDETWTVFRRYSRFREMHKTLKLKYAELAALEFPPKKLFGNKDERVIAERRSHLEKYLRDFFSVMLQSATSPLHINKVGLTLSKHTICEFSPFFKKGVFDYS","Homo sapiens","KIF16B, C20orf23, KIAA1590, SNX23","KINESIN-LIKE MOTOR PROTEIN C20ORF23","1","2V14"
"2V16",,"X-RAY DIFFRACTION",3.26,62.3,,4.5,"pH 4.5",,"10.1016/s1074-5521(00)00134-4","C47","2V16",75.51,"2.8","2.8","Crystal Structure of Renin with Inhibitor 3","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","2V16"
"2V1N",,"SOLUTION NMR",,,,,,,"10.1110/ps.073079107",,"2V1N",13.69,,,"SOLUTION STRUCTURE OF THE REGION 51-160 OF HUMAN KIN17 REVEALS A WINGED HELIX FOLD","GQRQLLLASENPQQFMDYFSEEFRNDFLELLRRRFGTKRVHNNIVYNEYISHREHIHMNATQWETLTDFTKWLGREGLCKVDETPKGWYIQYIDRDPETIRRQLELEKKKK","Homo sapiens","KIN, BTCD, KIN17","PROTEIN KIN HOMOLOG","1","2V1N"
"2V1W",,"X-RAY DIFFRACTION",2.68,54.05,,8.5,"20% PEG 10000, 0.2M MAGNESIUM CHLORIDE, 0.1M TRIS PH8.5, pH 8.50",,"10.1002/pro.349",,"2V1W",19.49,"1.9","1.9","Crystal structure of human LIM protein RIL (PDLIM4) PDZ domain bound to the C-terminal peptide of human alpha-actinin-1","SMPHSVTLRGPSPWGFRLVGGRDFSAPLTISRVHAGSKAALAALCPGDLIQAINGESTELMTHLEAQNRIKGCHDHLTLSVSRPEGESDL","Homo sapiens","PDLIM4, RIL","PDZ AND LIM DOMAIN PROTEIN 4","1","2V1W"
"2V1X",,"X-RAY DIFFRACTION",2.51,51.01,,7.5,"0.2M SODIUM BROMIDE,20% PEG3350, 10% ETHYLENE GLYCOL, 0.1M BIS TRIS PROPANE PH7.5, pH 7.50",,"10.1073/pnas.0806908106",,"2V1X",136.25,"2","2","Crystal structure of human RECQ-like DNA helicase","MCLEDSDAGASNEYDSSPAAWNKEDFPWSGKVKDILQNVFKLEKFRPLQLETINVTMAGKEVFLVMPTGGGKSLCYQLPALCSDGFTLVICPLISLMEDQLMVLKQLGISATMLNASSSKEHVKWVHAEMVNKNSELKLIYVTPEKIAKSKMFMSRLEKAYEARRFTRIAVDEVHCCSQWGHDFRPDYKALGILKRQFPNASLIGLTATATNHVLTDAQKILCIEKCFTFTASFNRPNLYYEVRQKPSNTEDFIEDIVKLINGRYKGQSGIIYCFSQKDSEQVTVSLQNLGIHAGAYHANLEPEDKTTVHRKWSANEIQVVVATVAFGMGIDKPDVRFVIHHSMSKSMENYYQESGRAGRDDMKADCILYYGFGDIFRISSMVVMENVGQQKLYEMVSYCQNISKCRRVLMAQHFDEVWNSEACNKMCDNCCKDSAFERKNITEYCRDLIKILKQAEELNEKLTPLKLIDSWMGKGAAKLRVAGVVAPTLPREDLEKIIAHFLIQQYLKEDYSFTAYATISYLKIGPKANLLNNEAHAITMQVTKSTQNSFRAESSQTCHSEQGDKKMEAENLYFQSHHHHHHDYKDDDDK","Homo sapiens","RECQL, RECQ1, RECQL1","ATP-DEPENDENT DNA HELICASE Q1","1","2V1X"
"2V24",,"X-RAY DIFFRACTION",2.7,55,,6.5,"0.1 M NACACOD PH6.5, 14.4% PEG10K, 0.16 M CAAC2, 20% GLYCEROL, pH 6.50",,"10.1016/j.jmb.2010.06.017",,"2V24",22.82,"2.2","2.2","Structure of the human SPRY domain-containing SOCS box protein SSB-4","SMGAEPGRPARLDQLLDMPAAGLAVQLRHAWNPEDRSLNVFVKDDDRLTFHRHPVAQSTDGIRGKVGHARGLHAWQINWPARQRGTHAVVGVATARAPLHSVGYTALVGSDAESWGWDLGRSRLYHDGKNQPGVAYPAFLGPDEAFALPDSLLVVLDMDEGTLSFIVDGQYLGVAFRGLKGKKLYPVVSAVWGHCEVTMRYINGLDPE","Homo sapiens","SPSB4, SSB4","SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 4","1","2V24"
"2V30",,"X-RAY DIFFRACTION",2.65,53.28,,,,,,,"2V30",61.91,"2","2","Human orotidine 5'-phosphate decarboxylase domain of uridine monophospate synthetase (UMPS) in complex with its product UMP.","MHHHHHHSSGVDLGTENLYFQSMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLG","Homo sapiens","UMPS, OK/SW-cl.21","OROTIDINE 5'-PHOSPHATE DECARBOXYLASE","1","2V30"
"2V37",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M708335200",,"2V37",11.76,,,"Solution structure of the N-terminal extracellular domain of human T- cadherin","SIVVSPILIPENQRQPFPRDVGKVVDSDRPERSKFRLTGKGVDQEPKGIFRINENTGSVSVTRTLDREVIAVYQLFVETTDVNGKTLEGPVPLEVIVIDQNDNRP","Homo sapiens","CDH13, CDHH","CADHERIN-13","1","2V37"
"2V3D",,"X-RAY DIFFRACTION",2.3,47,,6.5,"0.2 M (NH4)2SO42-, 0.1 M TRIS PH 6.5, 25% (W/V) PEG3350",,"10.1074/jbc.M705005200","NBV","2V3D",116.07,"1.96","1.96","acid-beta-glucosidase with N-butyl-deoxynojirimycin","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2V3D"
"2V3E",,"X-RAY DIFFRACTION",2.3,47,,7.5,"0.2 M NH4COOCH3, 0.1 M HEPES PH 7.5, 25% (W/V) PEG 3350",,"10.1074/jbc.M705005200","NND","2V3E",115.63,"2","2","acid-beta-glucosidase with N-nonyl-deoxynojirimycin","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2V3E"
"2V3F",,"X-RAY DIFFRACTION",2.3,47.6,,6.5,"AMSO4 0.2M, BIS-TRIS PH6.5, PEG 3350 25%, HEXAMINECOCL",,"10.1111/j.1467-7652.2007.00263.x",,"2V3F",116.05,"1.95","1.95","acid-beta-glucosidase produced in carrot","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2V3F"
"2V3Q",,"X-RAY DIFFRACTION",1.88,49.46,,6,"50MM CACODYLATE BUFFER PH 6, AMMONIUM SULFATE 2M AND SODIUM CHLORIDE 1MM",,"10.1002/prot.21866",,"2V3Q",39.77,"1.89","1.89","Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein","DINGGGATLPQKLYLTPDVLTAGFAPYIGVGSGKGKIAFLENKYNQFGTDTTKNVHWAGSDSKLTATELATYAADKEPGWGKLIQVPSVATSVAIPFRKAGANAVDLSVKELCGVFSGRIADWSGITGAGRSGPIQVVYRAESSGTTELFTRFLNAKCTTEPGTFAVTTTFANSYSLGLTPLAGAVAATGSDGVMAALNDTTVAEGRITYISPDFAAPTLAGLDDATKVARVGKGVVNGVAVEGKSPAAANVSAAISVVPLPAAADRGNPDVWVPVFGATTGGGVVAYPDSGYPILGFTNLIFSQCYANATQTGQVRDFFTKHYGTSANNDAAIEANAFVPLPSNWKAAVRASFLTASNALSIGNTNVCNGKGRPQ","Homo sapiens",,"HUMAN PHOSPHATE BINDING PROTEIN","1","2V3Q"
"2V40",,"X-RAY DIFFRACTION",2.8,56.4,,8.2,"0.1 M TRIS PH 8.2, 0.2 M TRI-METHYLAMINE N-OXIDE, 24% PEG 2000 MME",,,,"2V40",51.25,"1.9","1.9","Human Adenylosuccinate synthetase isozyme 2 in complex with GDP","MHHHHHHSSGVDLGTENLYFQSMPRARPGGNRVTVVLGAQWGDEGKGKVVDLLAQDADIVCRCQGGNNAGHTVVVDSVEYDFHLLPSGIINPNVTAFIGNGVVIHLPGLFEEAEKNVQKGKGLEGWEKRLIISDRAHIVFDFHQAADGIQEQQRQEQAGKNLGTTKKGIGPVYSSKAARSGLRMCDLVSDFDGFSERFKVLANQYKSIYPTLEIDIEGELQKLKGYMEKIKPMVRDGVYFLYEALHGPPKKILVEGANAALLDIDFGTYPFVTSSNCTVGGVCTGLGMPPQNVGEVYGVVKAYTTRVGIGAFPTEQDNEIGELLQTRGREFGVTTGRKRRCGWLDLVLLKYAHMINGFTALALTKLDILDMFTEIKVGVAYKLDGEIIPHIPANQEVLNKVEVQYKTLPGWNTDISNARAFKELPVNAQNYVRFIEDELQIPVKWIGVGKSRESMIQLF","Homo sapiens","ADSS2, ADSS","ADENYLOSUCCINATE SYNTHETASE ISOZYME 2","1","2V40"
"2V4B",,"X-RAY DIFFRACTION",2.96,58.06,,7,"0.2-0.6M SODIUM ACETATE, 0.05M CADMIUM SULPHATE, 0.1M HEPES PH 7.0, 12-22% GLYCEROL",,"10.1016/j.jmb.2007.07.047",,"2V4B",67.39,"2","2","Crystal Structure of Human ADAMTS-1 catalytic Domain and Cysteine- Rich Domain (apo-form)","FVSSHRYVETMLVADQSMAEFHGSGLKHYLLTLFSVAARLYKHPSIRNSVSLVVVKILVIHDEQKGPEVTSNAALTLRNFCNWQKQHNPPSDRDAEHYDTAILFTRQDLCGSQTCDTLGMADVGTVCDPSRSCSVIEDDGLQAAFTTAHELGHVFNMPHDDAKQCASLNGVNQDSHMMASMLSNLDHSQPWSPCSAYMITSFLDNGHGECLMDKPQNPIQLPGDLPGTSYDANRQCQFTFGEDSKHCPDAASTCSTLWCTGTSGGVLVCQTKHFPWADGTSCGEGKWCINGKCVNKLVPR","Homo sapiens","ADAMTS1, KIAA1346, METH1","ADAMTS-1","1","2V4B"
"2V4L",,"X-RAY DIFFRACTION",2.49,50,,7.5,"RESERVOIR: 16-17% PEG 4000, 250 MM (NH4)2SO4 AND 100MM TRIS PH 7.5 PROTEIN: 4 MG/ML IN A BUFFER CONTAINING 0.5 MM (NH4)2SO4, 20 MM TRIS PH 7.2, 1% ETHYLENE GLYCOL, 0.02% CHAPS AND 5 MM DTT DROPS WERE 1MICROLITER PROTEIN PLUS 1 MICROLITER RESERVOIR",,"10.1038/nchembio.117","ABJ","2V4L",111.03,"2.5","2.5","complex of human phosphoinositide 3-kinase catalytic subunit gamma (p110 gamma) with PIK-284","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","2V4L"
"2V4M",,"X-RAY DIFFRACTION",3.05,59.32,,,,,,,"2V4M",170.58,"2.29","2.29","The isomerase domain of human glutamine-fructose-6-phosphate transaminase 1 (GFPT1) in complex with fructose 6-phosphate","MGHHHHHHQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","GLUCOSAMINE--FRUCTOSE-6-PHOSPHATE AMINOTRANSFERASE [ISOMERIZING] 1","1","2V4M"
"2V4U",,"X-RAY DIFFRACTION",2.72,54.9,,7,"0.1M HEPES, PH 7.0, 0.02 M MGCL2, 30% POLYACRYLIC ACID 5100. CRYSTALS WERE SOAKED WITH 20.6 MM DON FOR 90 MIN",,,,"2V4U",32.77,"2.3","2.3","Human CTP synthetase 2 - glutaminase domain in complex with 5-OXO-L- NORLEUCINE","MHHHHHHSSGVDLGTENLYFQSMKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLS","Homo sapiens","CTPS2","CTP SYNTHASE 2","1","2V4U"
"2V5N",,"X-RAY DIFFRACTION",2.5,51,,7.5,"0.2 M POTASSIUM SODIUM TARTRATE, 20% (W/V) PEG 3350, pH 7.5",,"10.1038/sj.emboj.7601938",,"2V5N",33.42,"3.2","3.2","STRUCTURE OF HUMAN IGF2R DOMAINS 11-12","MKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYSEKGLVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACEQATECSVRNGSSIVDLSPLIHRTGGYEAYDESEDDASDTNPDFYINICQPLNPMHAVPCPAGAAVCKVPIDGPPIDIGRVAGPPILNPIANEIYLNFESSTPCLADKHFNYTSLIAFHCKRGVSMGTPKLLRTSECDFVFEWETPVVCPDEVKHHHHHH","Homo sapiens","IGF2R, MPRI","CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR","1","2V5N"
"2V5O",,"X-RAY DIFFRACTION",3.3,63,,6.4,"0.1 M MES PH6.4, 2.5% (W/V) PEG 3000",,"10.1038/sj.emboj.7601938",,"2V5O",70.07,"2.91","2.91","STRUCTURE OF HUMAN IGF2R DOMAINS 11-14","MKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYSEKGLVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACEQATECSVRNGSSIVDLSPLIHRTGGYEAYDESEDDASDTNPDFYINICQPLNPMHAVPCPAGAAVCKVPIDGPPIDIGRVAGPPILNPIANEIYLNFESSTPCLADKHFNYTSLIAFHCKRGVSMGTPKLLRTSECDFVFEWETPVVCPDEVRMDGCTLTDEQLLYSFNLSSLSTSTFKVTRDSRTYSVGVCTFAVGPEQGGCKDGGVCLLSGTKGASFGRLQSMKLDYRHQDEAVVLSYVNGDRCPPETDDGVPCVFPFIFNGKSYEECIIESRAKLWCSTTADYDRDHEWGFCRHSNSYRTSSIIFKCDEDEDIGRPQVFSEVRGCDVTFEWKTKVVCPPKKLECKFVQKHKTYDLRLLSSLTGSWSLVHNGVSYYINLCQKIYKGPLGCSERASICRRTTTGDVQVLGLVHTQKLGVIGDKVVVTYSKGYPCGGNKTASSVIELTCTKTVGRPAFKRFDIDSCTYYFSWDSRAACAVKHHHHHH","Homo sapiens","IGF2R, MPRI","CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR","1","2V5O"
"2V5T",,"X-RAY DIFFRACTION",3.8,67.64,,8.5,"30% PEG-4000, 0.2 M LITHIUM SULFATE, 0.1 M TRIS HYDROCHLORIDE PH 8.5.",,"10.1016/j.str.2010.12.014",,"2V5T",22.15,"2","2","Crystal structure of NCAM2 Ig2-3","SMLTFREVVSPQEFKQGEDAEVVCRVSSSPAPAVSWLYHNEEVTTISDNRFAMLANNNLQILNINKSDEGIYRCEGRVEARGEIDFRDIIVIVNVPPAISMPQKSFNATAERGEEMTFSCRASGSPEPAISWFRNGKLIEENEKYILKGSNTELTVRNIINSDGGPYVCRATNKAGEDEKQAFLQVFVQ","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2V5T"
"2V5X",,"X-RAY DIFFRACTION",2.72,54.4,"VAPOR DIFFUSION, HANGING DROP",,"HDAC8 POINT MUTANT Y306F, IN 50 MM TRIS-HCL PH 8.0, 5% GLYCEROL, 1 MM DTT, 150 MM KCL, WAS CONCENTRATED TO 217 UM, RESPECTIVELY. Y306F-HDAC8 PLUS 15 MOLAR EXCESSES OF SUBSTRATE, WAS CRYSTALLIZED AT RT BY THE HANGING-DROP METHOD IN 50 MM TRIS-HCL PH 8.0, 50 MM MGCL2, 10% PEG 4,000, 2 MM TRI(2-CARBOXYETHYL)PHOSPHIN (TCEP) AND 30 MM GLYCYL-GLYCYL-GLYCINE.",,"10.1038/sj.embor.7401047","V5X","2V5X",87.94,"2.25","2.25","Crystal structure of HDAC8-inhibitor complex","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRADMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","HISTONE DEACETYLASE 8","1","2V5X"
"2V5Y",,"X-RAY DIFFRACTION",3.07,60,,7,"100MM BIS-TRIS-PROPANE, PH 6.5 22.5% (W/V) PEG-SMEAR, 200MM K-THIOCYANATE",,"10.1126/science.1144646",,"2V5Y",83.29,"3.1","3.1","Crystal structure of the receptor protein tyrosine phosphatase mu ectodomain","ETFSGGCLFDEPYSTCGYSQSEGDDFNWEQVNTLTKPTSDPWMPSGSFMLVNASGRPEGQRAHLLLPQLKENDTHCIDFHYFVSSKSNSPPGLLNVYVKVNNGPLGNPIWNISGDPTRTWNRAELAISTFWPNFYQVIFEVITSGHQGYLAIDEVKVLGHPCTRTPHFLRIQNVEVNAGQFATFQCSAIGRTVAGDRLWLQGIDVRDAPLKEIKVTSSRRFIASFNVVNTTKRDAGKYRCMIRTEGGVGISNYAELVVKEPPVPIAPPQLASVGATYLWIQLNANSINGDGPIVAREVEYCTASGSWNDRQPVDSTSYKIGHLDPDTEYEISVLLTRPGEGGTGSPGPALRTRTKCADPMRGPRKLEVVEVKSRQITIRWEPFGYNVTRCHSYNLTVHYCYQVGGQEQVREEVSWDTENSHPQHTITNLSPYTNVSVKLILMNPEGRKESQELIVQTDEDLPGAVPTESIQGSTFEEKIFLQWREPTQTYGVITLYEITYKAVSSFDPEIDLSNQSGRVSKLGNETHFLFFGLYPGTTYSFTIRASTAKGFGPPATNQFTTKISAPSMPAYELETPLNQTDNTVTVMLKPAHSRGAPVSVYQIVVEEERPRRTKKTTEILKCYPVPIHFQNASLLNSQYYFAAEFPADSLQAAQPFTIGDNKTYNGYWNTPLLPYKSYRIYFQAASRANGETKIDCVQVATKGAATPKPVPEPEKQTDHTVKGTKHHHHHH","Homo sapiens","PTPRM, PTPRL1","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE MU","1","2V5Y"
"2V5Z",,"X-RAY DIFFRACTION",2.61,52.51,,,,,"10.1021/jm070677y","SAG","2V5Z",119.85,"1.6","1.6","Structure of human MAO B in complex with the selective inhibitor safinamide","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE (FLAVIN-CONTAINING) B","1","2V5Z"
"2V60",,"X-RAY DIFFRACTION",2.58,51.92,,,,,"10.1021/jm070677y","C17","2V60",119.88,"2","2","Structure of human MAO B in complex with the selective inhibitor 7-(3- chlorobenzyloxy)-4-carboxaldehyde-coumarin","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE (FLAVIN-CONTAINING) B","1","2V60"
"2V61",,"X-RAY DIFFRACTION",2.52,50.74,,,,,"10.1021/jm070677y","C18","2V61",119.91,"1.7","1.7","Structure of human MAO B in complex with the selective inhibitor 7-(3- chlorobenzyloxy)-4-(methylamino)methyl-coumarin","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE (FLAVIN-CONTAINING) B","1","2V61"
"2V62",,"X-RAY DIFFRACTION",2,39,,7,"0.1 M SUCCINIC ACID PH=7.0 15% PEG3350",,"10.1016/j.str.2008.10.018",,"2V62",78.85,"1.7","1.7","Structure of vaccinia-related kinase 2","MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTKGQSINVH","Homo sapiens","VRK2","SERINE/THREONINE-PROTEIN KINASE VRK2","1","2V62"
"2V66",,"X-RAY DIFFRACTION",2.11,41.32,,6.8,"4% PEG 8000, 50 MM SODIUM PHOSPHATE PH 6.8, 100 MM NACL. PROTEIN CONCENTRATION 20 MG/ML. CRYOBUFFER = RESERVOIR PLUS 17% PEG 400.",,"10.1016/j.str.2007.09.015",,"2V66",53.07,"2.1","2.1","Crystal Structure of the coiled-coil domain of Ndel1 (a.a. 58 to 169) C","AEQRNRDLQADNQRLKYEVEALKEKLEHQYAQSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIVSLEDFEQRLNQAIERNAFLESELDEKESLLVSVQ","Homo sapiens","NDEL1, EOPA, MITAP1, NUDEL","NUCLEAR DISTRIBUTION PROTEIN NUDE-LIKE 1","1","2V66"
"2V6H",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, HANGING DROP",7.3,"HANGING DROP; 20 C; 18%PEG, 0.1M BUFFER, PH 7.3",293,"10.1016/j.jmb.2008.02.044",,"2V6H",12.05,"1.55","1.55","Crystal structure of the C1 domain of cardiac myosin binding protein-C","DDPIGLFVMRPQDGEVTVGGSITFSARVAGASLLKPPVVKWFKGKWVDLSSKVGQHLQLHDSYDRASKVYLFELHITDAQPAFTGSYRCEVSTKDKFDCSNFNLTVHE","Homo sapiens","MYBPC3","MYOSIN-BINDING PROTEIN C, CARDIAC-TYPE","1","2V6H"
"2V6Z",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkn497",,"2V6Z",11.09,,,"Solution Structure of Amino-Terminal Domain of Human DNA Polymerase Epsilon Subunit B","MGSSHHHHHHSQDPNSSSARLQVDMAPERLRSRALSAFKLRGLLLRGEAIKYLTEALQSISELELEDKLEKIINAVEKQPLSSNMIERSVVEAAVQESS","Homo sapiens","POLE2, DPE2","DNA POLYMERASE EPSILON SUBUNIT 2","1","2V6Z"
"2V70",,"X-RAY DIFFRACTION",2.7,54.6,,5.6,"15% PEG 4000, 0.2M NH4 ACETATE, 0.1M NACITRATE, PH=5.6.",,"10.1107/S0907444907035470",,"2V70",100.43,"3.01","3.01","Third LRR domain of human Slit2","GSLACPEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLRKKRIVTGNPRCQKPYFLKEIPIQDVAIQDFTCDDAHHHHHH","Homo sapiens","SLIT2, SLIL3","SLIT HOMOLOG 2 PROTEIN N-PRODUCT","1","2V70"
"2V76",,"X-RAY DIFFRACTION",2.39,48.6,,7.5,"2M AMONIUM SULFATE, 2% PEG 400, 0.1M NA HEPES PH 7.5",,"10.1074/jbc.M709435200",,"2V76",49.2,"1.6","1.6","Crystal structure of the human dok1 PTB domain","PLGSQFWVTVQRTEAAERCGLHGSYVLRVEAERLTLLTVGAQSQILEPLLSWPYTLLRRYGRDKVMFSFEAGRRCPSGPGTFTFQTAQGNDIFQAVETAIHRQKAQG","Homo sapiens","DOK1","DOCKING PROTEIN 1","1","2V76"
"2V77",,"X-RAY DIFFRACTION",2.75,55.22,,7.5,"22% (W/V) PAY 5100, HEPES 0.1 M, MAGNESIUM CHLORIDE 0.02 M (PH 7.5)",,"10.1107/S0907444908013474","PAY","2V77",70.84,"1.603","1.603","Crystal Structure of Human Carboxypeptidase A1","ARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHPY","Homo sapiens","CPA1, CPA","CARBOXYPEPTIDASE A1","1","2V77"
"2V7A",,"X-RAY DIFFRACTION",3.2,61,,,"20% PEG 4000 ,1M HEPES PH 7.0, 0.1 M MGCL2,",,"10.1158/0008-5472.CAN-07-1825","627","2V7A",67.28,"2.5","2.5","Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358","GPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1","2V7A"
"2V7C",,"X-RAY DIFFRACTION",2.12,43,,7.5,"14% POLYETHYLENE GLYCOL 4000, 10% ISOPROPANOL, 100MM HEPES (PH 7.5)",,"10.1016/j.jmb.2007.08.037",,"2V7C",44.64,"2.4","2.4","Crystal Structure of Rev-Erb beta","MSKSPYVDPHKSGHEIWEEFSMSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLSGKKYSVDDLHSMGAGDLLNSMFEFSEKLNALQLSDEEMSLFTAVVLVSADRSGIENVNSVEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSLNNMHSEELLAFKVHP","Homo sapiens","NR1D2","ORPHAN NUCLEAR RECEPTOR NR1D2","1","2V7C"
"2V7O",,"X-RAY DIFFRACTION",2.59,50.7,,7,"0.10M MAGNESIUM CHLORIDE, 0.1M HEPES PH7, 20% PEG6K, 10% ETHYLENE GLYCOL",,"10.1371/journal.pbio.1000426",,"2V7O",39.08,"2.25","2.25","Crystal structure of human calcium-calmodulin-dependent protein kinase II gamma","MHHHHHHSSGVDLGTENLYFQSMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSVG","Homo sapiens","CAMK2G, CAMK, CAMK-II, CAMKG","CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II GAMMA CHAIN","1","2V7O"
"2V7R",,"X-RAY DIFFRACTION",2.33,59.4,,,"40 MM SODIUM CACODYLATE, PH 6.0, 12 MM SPERMINE TETRA-HCL, 12 MM SODIUM CHLORIDE, 80 MM POTASSIUM CHLORIDE, 10% (V/V) MPD, EQUILIBRATED AGAINST 35% (V/V) MPD AT ROOM TEMPERATURE",,"10.1016/j.bbrc.2008.01.175",,"2V7R",4.43,"1.2","1.2","Crystal structure of a human tRNAGly microhelix at 1.2 Angstrom resolution","GCGUUGG","Homo sapiens",,"HUMAN TRNAGLY MICROHELIX","1","2V7R"
,,,,,,,,,,,,,,,,"CCAACGC","Homo sapiens",,"HUMAN TRNAGLY MICROHELIX","2","2V7R"
"2V8E",,"X-RAY DIFFRACTION",2.2,43,,4.5,"0.1M SODIUM ACETATE, PH4.5, 20% (W/V) PEG3000",,"10.1084/jem.20071069",,"2V8E",22.72,"2.5","2.5","Crystal structure of Human Complement Factor H, SCR domains 6-8 (H402 risk variant), in complex with ligand.","MGLKPCDYPDIKHGGLYHENMRRPYFPVAVGKYYSYYCDEHFETPSGSYWDHIHCTQDGWSPAVPCLRKCYFPYLENGYNQNHGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVKTCSKSSIDIENGFISESQYTYALKEKAKYQCKLGYVTADGETSGSITCGKDGWSAQPTCI","Homo sapiens","CFH, HF, HF1, HF2","COMPLEMENT FACTOR H","1","2V8E"
"2V90",,"X-RAY DIFFRACTION",2.1,42,,5.5,"2M (NH4)2SO4, 0.1M BIS-TRIS, PH=5.5",,,,"2V90",61.83,"2","2","Crystal structure of the 3rd PDZ domain of intestine- and kidney- enriched PDZ domain IKEPP (PDZD3)","SMKPRCLHLEKGPQGFGFLLREEKGLDGRPGQFLWEVDPGLPAKKAGMQAGDRLVAVAGESVEGLGHEETVSRIQGQGSCVSLTVVDPEADRETSV","Homo sapiens","PDZD3, IKEPP, NHERF4, PDZK2, DLNB27","PDZ DOMAIN-CONTAINING PROTEIN 3","1","2V90"
"2V9K",,"X-RAY DIFFRACTION",2.49,48.5,,8,"20% PEG-4000, 0.15 M MGCL2, 0.1 M HEPES PH 7.5, 20% GLYCEROL",,"10.1016/j.jmb.2007.08.053",,"2V9K",61.16,"2","2","Crystal structure of human PUS10, a novel pseudouridine synthase.","GMFPLTEENKHVAQLLLNTGTCPRCIFRFCGVDFHAPYKLPYKELLNELQKFLETEKDELILEVMNPPPKKIRLQELEDSIDNLSQNGEGRISVSHVGSTASKNSNLNVCNVCLGILQEFCEKDFIKKVCQKVEASGFEFTSLVFSVSFPPQLSVREHAAWLLVKQEMGKQSLSLGRDDIVQLKEAYKWITHPLFSEELGVPIDGKSLFEVSVVFAHPETVEDCHFLAAICPDCFKPAKNKQSVFTRMAVMKALNKIKEEDFLKQFPCPPNSPKAVCAVLEIECAHGAVFVAGRYNKYSRNLPQTPWIIDGERKLESSVEELISDHLLAVFKAESFNFSSSGREDVDVRTLGNGRPFAIELVNPHRVHFTSQEIKELQQKINNSSNKIQVRDLQLVTREAIGHMKEGEEEKTKTYSALIWTNKAIQKKDIEFLNDIKDLKIDQKTPLRVLHRRPLAVRARVIHFMETQYVDEHHFRLHLKTQAGTYIKEFVHGDFGRTKPNIGSLMNVTADILELDVESVDVDWPPALDD","Homo sapiens","PUS10, CCDC139, DOBI","UNCHARACTERIZED PROTEIN FLJ32312","1","2V9K"
"2V9Q",,"X-RAY DIFFRACTION",2.8,56,,6.5,"18-20% PEG 3350, 0.2M K THIOCYNATE, 0.1M MES, PH=6.5",,"10.1073/pnas.0705310104",,"2V9Q",23.99,"2.5","2.5","First and second Ig domains from human Robo1","GSLRQEDFPPRIVEHPSDLIVSKGEPATLNCKAEGRPTPTIEWYKGGERVETDKDDPRSHRMLLPSGSLFFLRIVHGRKSRPDEGVYVCVARNYLGEAVSHDASLEVAILRDDFRQNPSDVMVAVGEPAVMECQPPRGHPEPTISWKKDGSPLDDKDERITIRGGKLMITYTRKSDAGKYVCVGTNMVGERESEVAELTVLERPSFVKAAAH","Homo sapiens","ROBO1, DUTT1","ROUNDABOUT HOMOLOG 1","1","2V9Q"
"2V9R",,"X-RAY DIFFRACTION",2.1,42,,5.6,"12% PEG 6000, 0.1M LISO4, 0.1M NA CITRATE, pH 5.6",,"10.1073/pnas.0705310104",,"2V9R",23.78,"2","2","First and second Ig domains from human Robo1 (Form 2)","GSLRQEDFPPRIVEHPSDLIVSKGEPATLNCKAEGRPTPTIEWYKGGERVETDKDDPRSHRMLLPSGSLFFLRIVHGRKSRPDEGVYVCVARNYLGEAVSHDASLEVAILRDDFRQNPSDVMVAVGEPAVMECQPPRGHPEPTISWKKDGSPLDDKDERITIRGGKLMITYTRKSDAGKYVCVGTNMVGERESEVAELTVLERPSFVKAAAH","Homo sapiens","ROBO1, DUTT1","ROUNDABOUT HOMOLOG 1","1","2V9R"
"2V9S",,"X-RAY DIFFRACTION",2.4,49,,5.6,"20-24% PEG 4000, 20% ISOPROPANOL, 0.1M NA CITRATE, PH=5.6",,"10.1073/pnas.0705310104",,"2V9S",99.03,"2","2","Second LRR domain of human Slit2","GSLHCPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKFRCSAAAHHHHHH","Homo sapiens","SLIT2, SLIL3","SLIT HOMOLOG 2 PROTEIN N-PRODUCT","1","2V9S"
"2V9Y",,"X-RAY DIFFRACTION",2.29,46.4,,5.2,"0.1 M BIS-TRIS PH 5.2, 27% PEG 3350, 0.2 M AMMONIUM SULFATE, 0.2 MG/ML OF CHYMOTRYPSIN WAS ADDED PRIOR TO CRYSTALLISATION.",,"10.1093/nar/gkq595",,"2V9Y",71.95,"2.1","2.1","Human aminoimidazole ribonucleotide synthetase","HHHHHHKVDLGGFAGLFDLKAAGFKDPLLASGTDGVGTKLKIAQLCNKHDTIGQDLVAMCVNDILAQGAEPLFFLDYFSCGKLDLSVTEAVVAGIAKACGKAGCALLGGETAEMPDMYPPGEYDLAGFAVGAMERDQKLPHLERITEGDVVVGIASSGLHSNGFSLVRKIVAKSSLQYSSPAPDGCGDQTLGDLLLTPTRIYSHSLLPVLRSGHVKAFAHITGGGLLENIPRVLPEKLGVDLDAQTWRIPRVFSWLQQEGHLSEEEMARTFNCGVGAVLVVSKEQTEQILRGIQQHKEEAWVIGSVVARAEGSPRVKVKNLIESMQINGSVLKN","Homo sapiens","GART, PGFT, PRGS","PHOSPHORIBOSYLFORMYLGLYCINAMIDINE CYCLO-LIGASE","1","2V9Y"
"2VA5",,"X-RAY DIFFRACTION",2.96,58.15,,,"20-22.5% (W/V) PEG 5000 MONOMETHYLETHYL (MME), 200 MM SODIUM CITRATE (PH 6.6) AND 200 MM AMMONIUM IODIDE",,"10.1021/jm070829p","C8C","2VA5",50.7,"2.75","2.75","X-ray crystal structure of beta secretase complexed with compound 8c","MASMTGGQQMGRGSMAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1 .","1","2VA5"
"2VA6",,"X-RAY DIFFRACTION",3.06,59.49,,,"20-22.5% (W/V) PEG 5000 MONOMETHYLETHYL (MME), 200 MM SODIUM CITRATE (PH 6.6) AND 200 MM AMMONIUM IODIDE",,"10.1021/jm070829p","H24","2VA6",50.9,"2.5","2.5","X-ray crystal structure of beta secretase complexed with compound 24","MASMTGGQQMGRGSMAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA SECRETASE 1","1","2VA6"
"2VA7",,"X-RAY DIFFRACTION",3.07,51.78,,,,,"10.1021/jm070829p","C27","2VA7",50.93,"2.2","2.2","X-ray crystal structure of beta secretase complexed with compound 27","MASMTGGQQMGRGSMAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1 .","1","2VA7"
"2VAC",,"X-RAY DIFFRACTION",2.01,38.8,,8,"0.01M ZINC CHLORIDE,10% ETHYLENE GLYCOL,20% PEG6000, 0.1M TRIS PH8.0",,,,"2VAC",15.44,"1.7","1.7","Structure of N-terminal Actin Depolymerizing Factor homology (ADF-H) domain of human twinfilin-2","SMGIHATEELKEFFAKARAGSVRLIKVVIEDEQLVLGASQEPVGRWDQDYDRAVLPLLDAQQPCYLLYRLDSQNAQGFEWLFLAWSPDNSPVRLKMLYAATRATVKKEFGGGHIKDELFGTVKDDLSFAGYQKH","Homo sapiens","TWF2, PTK9L, MSTP011","TWINFILIN-2","1","2VAC"
"2VAF",,"X-RAY DIFFRACTION",8.02,84.55,,,,,"10.1016/j.jmb.2007.08.055",,"2VAF",44,"3.8","3.8","Crystal structure of Human Cardiac Calsequestrin","GLNFPTYDGKDRVVSLSEKNFKQVLKKYDLLCLYYHEPVSSDKVTQKQFQLKEIVLELVAQVLEHKAIGFVMVDAKKEAKLAKKLGFDEEGSLYILKGDRTIEFDGEFAADVLVEFLLDLIEDPVEIISSKLEVQAFERIEDYIKLIGFFKSEDSEYYKAFEEAAEHFQPYIKFFATFDKGVAKKLSLKMNEVDFYEPFMDEPIAIPNKPYTEEELVEFVKEHQRPTLRRLRPEEMFETWEDDLNGIHIVAFAEKSDPDGYEFLEILKQVARDNTDNPDLSILWIDPDDFPLLVAYWEKTFKIDLFRPQIGVVNVTDADSVWMEIPDDDDLPTAEELEDWIEDVLSGKINTEDDDEDDDDDDNSDEEDNDDSDDDDDE","Homo sapiens","CASQ2","CALSEQUESTRIN-2","1","2VAF"
"2VAG",,"X-RAY DIFFRACTION",2.57,52.9,,7,"2.1M SODIUM MALATE PH7.0",,"10.1016/j.chembiol.2010.11.009","V25","2VAG",40.08,"1.8","1.8","Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","DUAL SPECIFICITY PROTEIN KINASE CLK1","1","2VAG"
"2VAJ",,"X-RAY DIFFRACTION",2.75,55.28,,,,,"10.1016/j.jmb.2008.07.084",,"2VAJ",10.36,"2.701","2.701","Crystal structure of NCAM2 Ig1 (I4122 cell unit)","LQVTISLSKVELSVGESKFFTCTAIGEPESIDWYNPQGEKIISTQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQEATVVLEIYQ","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2VAJ"
"2VB5",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.03.002",,"2VB5",11.75,,,"Solution structure of W60G mutant of human beta2-microglobulin","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDGSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","BETA-2-MICROGLOBULIN","1","2VB5"
"2VC8",,"X-RAY DIFFRACTION",1.77,30.6,,4.1,"40 MM NA-PROPIONATE, 20 MM NA-CACODYLATE, 40 MM BIS-TRIS-PROPANE, PH=4.1, 32% PEG1500",,"10.1128/MCB.01506-07",,"2VC8",8.99,"1.31","1.31","Crystal structure of the LSm domain of human EDC3 (enhancer of decapping 3)","GAMATDWLGSIVSINCGDSLGVYQGRVSAVDQVSQTISLTRPFHNGVKCLVPEVTFRAGDITELKILEIPGPGDNQHFGDLHQT","Homo sapiens","EDC3, LSM16, YJDC, YJEFN2, PP844","ENHANCER OF MRNA-DECAPPING PROTEIN 3","1","2VC8"
"2VCI",,"X-RAY DIFFRACTION",2.9,58,,,,,"10.1021/jm701018h","2GJ","2VCI",27.07,"2","2","4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2VCI"
"2VCJ",,"X-RAY DIFFRACTION",2.9,58,,,,,"10.1021/jm701018h","2EQ","2VCJ",27.06,"2.5","2.5","4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2VCJ"
"2VCQ",,"X-RAY DIFFRACTION",2.2,44,,8.4,"30% PEG6000, 1% DIOXANE, 5MM DTT, 5MM GSH, 0.05 M TRISHCL PH8.4",,"10.1021/jm701509k","D25","2VCQ",95.35,"1.95","1.95","Complex structure of prostaglandin D2 synthase at 1.95A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VCQ"
"2VCT",,"X-RAY DIFFRACTION",2.28,45.56,"VAPOR DIFFUSION, HANGING DROP",7.8,"HANGING DROP VAPOUR TECHNIQUE WAS USED. 5 UL OF RESERVOIR SOLUTION [100 MM TRIS-HCL PH 7.8, 18% (V/V) PEG 4000, AND 2 MM DITHIOTHREITOL] WAS MIXED WITH 5 UL OF PROTEIN SOLUTION (10 MG/ML IN 10 MM TRIS-HCL PH 7.8), 1UL OF 200 MM SPERMINE AND 1UL OF 20 MM ANDROSTENE DIONE.",,"10.1016/j.jmb.2010.01.023",,"2VCT",206.87,"2.1","2.1","Glutathione transferase A2-2 in complex with delta-4-andostrene-3-17- dione","MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMILLLPFTQPEEQDAKLALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRF","Homo sapiens","GSTA2, GST2","GLUTATHIONE S-TRANSFERASE A2","1","2VCT"
"2VCV",,"X-RAY DIFFRACTION",2.09,40.79,"VAPOR DIFFUSION, HANGING DROP",7.8,"HANGING VAPOUR DROP TECHIQUE WAS USED. 5 UL OF RESERVOIR SOLUTION [100 MM TRIS-HCL PH 7.8, 18% (V/V) PEG 4000, AND 2 MM DITHIOTHREITOL] WAS MIXED WITH 5 UL OF PROTEIN SOLUTION (10 MG/ML IN 10 MM TRIS-HCL PH 7.8), 1UL OF 200 MM SPERMINE AND 1UL OF 25 MM ANDROSTENE DIONE.",,"10.1016/j.jmb.2010.01.023",,"2VCV",413.49,"1.8","1.8","Glutathione transferase A3-3 in complex with glutathione and delta-4- androstene-3-17-dione","MAGKPKLHYFNGRGRMEPIRWLLAAAGVEFEEKFIGSAEDLGKLRNDGSLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYTEGMADLNEMILLLPLCRPEEKDAKIALIKEKTKSRYFPAFEKVLQSHGQDYLVGNKLSRADISLVELLYYVEELDSSLISNFPLLKALKTRISNLPTVKKFLQPGSPRKPPADAKALEEARKIFRF","Homo sapiens","GSTA3","GLUTATHIONE S-TRANSFERASE A3","1","2VCV"
"2VCW",,"X-RAY DIFFRACTION",2.28,46,,8.4,"30% PEG6000, 1% DIOXANE, 5MM DTT, 5MM GSH, 0.05 M TRISHCL PH8.4",,"10.1021/jm701509k","ZZA","2VCW",94.59,"1.95","1.95","Complex structure of prostaglandin D2 synthase at 1.95A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VCW"
"2VCX",,"X-RAY DIFFRACTION",2.27,45.96,,8.4,"PEG 6000 30%, TCEP 5MM, GSH 5MM, DIOXANE 1%, MGCL2 5MM, TRISHCL (PH8.4) 50 MM",,"10.1021/jm701509k","D26","2VCX",95.44,"2.1","2.1","Complex structure of prostaglandin D2 synthase at 2.1A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VCX"
"2VCY",,"X-RAY DIFFRACTION",2.7,54.4,,8.5,"2M AMMONIUM SULFATE, 100 MM TRIS HCL, PH 8.5",,"10.1016/j.jmb.2008.04.041",,"2VCY",75.5,"2.41","2.41","Crystal Structure of 2-Enoyl Thioester Reductase of Human FAS II","MASSYSASAEPARVRALVYGHHGDPAKVVELKNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLGTWRTEAVFSEEALIQVPSDIPLQSAATLGVNPCTAYRMLMDFEQLQPGDSVIQNASNSGVGQAVIQIAAALGLRTINVVRDRPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGKSSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKKDHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISSKQILTM","Homo sapiens","MECR, NBRF1, CGI-63","TRANS-2-ENOYL-COA REDUCTASE","1","2VCY"
"2VCZ",,"X-RAY DIFFRACTION",2.3,46,,8.4,"30% PEG6000, 1% DIOXANE, 5MM DTT, 5MM GSH, 0.05 M TRISHCL PH8.4",,"10.1021/jm701509k",,"2VCZ",94.9,"1.95","1.95","Complex structure of prostaglandin D2 synthase at 1.95A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VCZ"
"2VD0",,"X-RAY DIFFRACTION",2.3,46,,8.4,"30% PEG6000, 1% DIOXANE, 5MM DTT, 5MM GSH, 0.05 M TRISHCL PH8.4",,"10.1021/jm701509k","D27","2VD0",94.82,"2.2","2.2","Complex structure of prostaglandin D2 synthase at 2.2A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VD0"
"2VD1",,"X-RAY DIFFRACTION",2.3,46,,8.4,"PEG 6000 30%, TCEP 5MM, GSH 5MM, DIOXANE 1%, MGCL2 5MM, TRISHCL (PH8.4) 50 MM",,"10.1021/jm701509k","D28","2VD1",95.08,"2.25","2.25","Complex structure of prostaglandin D2 synthase at 2.25A.","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE","1","2VD1"
"2VD5",,"X-RAY DIFFRACTION",3.16,61.13,,7,"1M AMMONIUM SULPHATE, 1.5% PEG 3350, 0.1M BIS-TRIS PH7.0",,"10.1002/pro.82",,"2VD5",93.01,"2.8","2.8","Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII","SMQQLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRDSEVPGPTP","Homo sapiens","DMPK, DM1PK, MDPK","DMPK PROTEIN","1","2VD5"
"2VD6",,"X-RAY DIFFRACTION",2.41,48.46,,,,,,,"2VD6",231.33,"2","2","Human adenylosuccinate lyase in complex with its substrate N6-(1,2- Dicarboxyethyl)-AMP, and its products AMP and fumarate.","MHHHHHHSSGVDLGTENLYFQSMAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQEMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAE","Homo sapiens","ADSL, AMPS","ADENYLOSUCCINATE LYASE","1","2VD6"
"2VD7",,"X-RAY DIFFRACTION",2.54,51.65,,5.5,"20% PEG3350 0.1M CITRATE PH 5.5",,"10.1021/jm800936s","PD2","2VD7",89.23,"2.25","2.25","Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROTEIN 3A","1","2VD7"
"2VDX",,"X-RAY DIFFRACTION",1.89,48,,7.4,"10-20% PEG3350, 0.2M NACL, pH 7.4",,"10.1016/j.jmb.2008.05.012",,"2VDX",83.46,"1.84","1.84","Crystal Structure of the reactive loop Cleaved Corticosteroid Binding Globulin","SNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTTQANFSRITQDAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","1","2VDX"
"2VDY",,"X-RAY DIFFRACTION",1.93,34,,7.4,"10-20% PEG3350, 0.2M NACL, pH 7.4",,"10.1016/j.jmb.2008.05.012","HCY","2VDY",84.1,"2.3","2.3","Crystal structure of the reactive loop cleaved Corticosteroid Binding Globulin complexed with Cortisol","SNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTTQANFSRITQDAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","1","2VDY"
"2VEU",,"X-RAY DIFFRACTION",2.93,57.63,,8.5,"100 MM TRIS PH 8.5, 17% PEG 20000, 100 MM MAGNESIUM",,"10.1016/j.bmcl.2007.11.012","IZ1","2VEU",37.97,"2.4","2.4","Crystal structure of protein tyrosine phosphatase 1B in complex with an isothiazolidinone-containing inhibitor","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","2VEU"
"2VEV",,"X-RAY DIFFRACTION",2.71,54.27,,8.5,"100 MM TRIS PH 8.5, 17% PEG 20, 000, 100 MM MAGNESIUM CHLORIDE",,"10.1016/j.bmcl.2007.11.012","IZ2","2VEV",38.01,"1.8","1.8","CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","2VEV"
"2VEW",,"X-RAY DIFFRACTION",2.78,55.34,,8.5,"100 MM TRIS PH 8.5, 17% PEG 20, 000, 100 MM MAGNESIUM CHLORIDE",,"10.1016/j.bmcl.2007.11.012","IZ3","2VEW",37.97,"2","2","CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","2VEW"
"2VEX",,"X-RAY DIFFRACTION",2.86,56.66,,8.5,"100 MM TRIS PH 8.5, 17% PEG 20, 000, 100 MM MAGNESIUM CHLORIDE",,"10.1016/j.bmcl.2007.11.012","IZ4","2VEX",37.97,"2.2","2.2","CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","2VEX"
"2VEY",,"X-RAY DIFFRACTION",2.81,55.95,,8.5,"100 MM TRIS PH 8.5, 17% PEG 20, 000, 100 MM MAGNESIUM CHLORIDE",,"10.1016/j.bmcl.2007.11.012","IZ5","2VEY",37.96,"2.2","2.2","CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","2VEY"
"2VF6",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION",4.6,"0.2M AMMONIUM SULFATE, 15% ISOPROPANOL, 15% ETHYLENE GLYCOL, 0.1M SODIUM ACETATE PH 4.5, VAPOR DIFFUSION, TEMPERATURE 298K",298,,"M0N","2VF6",43.87,"2.1","2.1","Human FDPS synthase in complex with minodronate","MGSSHHHHHHSSGRENLYFQGHMGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","FARNESYL PYROPHOSPHATE SYNTHETASE","1","2VF6"
"2VFJ",,"X-RAY DIFFRACTION",3.4,63,,,"1.3-1.6 M MAGNESIUM SULPHATE, 0.1 M MES [PH 6.5-6.9]",,"10.1042/BJ20071399",,"2VFJ",172.82,"3.2","3.2","Structure of the A20 Ovarian Tumour (OTU) domain","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWGVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","TUMOR NECROSIS FACTOR","1","2VFJ"
"2VFK",,"X-RAY DIFFRACTION",2.1,42,,7.5,"0.1 M TRIS HCL PH 8, 10 % PEG 8K, 7 MM DTT",,"10.1016/j.jmb.2007.11.037","AMP","2VFK",23.57,"1.5","1.5","AKAP18 delta central domain - AMP","YQPNYFLSIPITNKKITAGIKVLQNSILRQDNRLTKAMVGDGSFHITLLVMQLLNEDEVNIGTDALLELKPFVEEILEGKHLTLPFHGIGTFQGQVGFVKLADGDHVSALLEIAETAKRTFQEKGILAGESRTFKPHLTFMKLSKAPMLWKKGVRKIEPGLYEQFIDHRFGEEILYQIDLCSMLKKKQSNGYYHCESSIVIGEKD","Homo sapiens",,"AKAP18 DELTA","1","2VFK"
"2VFL",,"X-RAY DIFFRACTION",2.1,42,,7.5,"0.1 M TRIS HCL PH 8, 10 % PEG 8K, 7 MM DTT",,"10.1016/j.jmb.2007.11.037",,"2VFL",23.55,"2.25","2.25","AKAP18 delta central domain - CMP","YQPNYFLSIPITNKKITAGIKVLQNSILRQDNRLTKAMVGDGSFHITLLVMQLLNEDEVNIGTDALLELKPFVEEILEGKHLTLPFHGIGTFQGQVGFVKLADGDHVSALLEIAETAKRTFQEKGILAGESRTFKPHLTFMKLSKAPMLWKKGVRKIEPGLYEQFIDHRFGEEILYQIDLCSMLKKKQSNGYYHCESSIVIGEKD","Homo sapiens",,"AKAP18 DELTA","1","2VFL"
"2VFX",,"X-RAY DIFFRACTION",2.9,57.1,"VAPOR DIFFUSION, HANGING DROP",8,"VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2",293,"10.1371/journal.pbio.0060050",,"2VFX",288.68,"1.95","1.95","Structure of the Symmetric Mad2 Dimer","GMALQLSREQGITARGSAEIVAEFFSFGINSILYQRGIYPSETFTRVQKYGLTLLVTTDLELIKYLNNVVEQLKDWLYKSSVQKLVVVISNIESGEVLERWQFDIESDKTAKDDSAPREKSQKAIQDEIRSVIRQITATVTFLPLLEVSCSFDLLIYTDKDLVVPEKWEESGPQFITNSEEVRLRSFTTTIHKVNSMVAYKIPVND","Homo sapiens","MAD2L1, MAD2","MITOTIC SPINDLE ASSEMBLY CHECKPOINT PROTEIN MAD2A","1","2VFX"
"2VFY",,"X-RAY DIFFRACTION",2.1,42,,7.5,"0.1 M TRIS HCL PH 8, 10 % PEG 8K, 7 MM DTT",,"10.1016/j.jmb.2007.11.037",,"2VFY",23.23,"1.8","1.8","AKAP18 delta central domain","YQPNYFLSIPITNKKITAGIKVLQNSILRQDNRLTKAMVGDGSFHITLLVMQLLNEDEVNIGTDALLELKPFVEEILEGKHLTLPFHGIGTFQGQVGFVKLADGDHVSALLEIAETAKRTFQEKGILAGESRTFKPHLTFMKLSKAPMLWKKGVRKIEPGLYEQFIDHRFGEEILYQIDLCSMLKKKQSNGYYHCESSIVIGEKD","Homo sapiens",,"AKAP18 DELTA","1","2VFY"
"2VGB",,"X-RAY DIFFRACTION",2.5,50.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"RECOMBINANT WILD-TYPE RPK WAS CRYSTALLIZED USING THE VAPOR DIFFUSION METHOD AT 22 C. WELL SOLUTIONS CONSISTED OF 50 MM MES/KOH, PH 6.4, 10 MM MNSO4, AND 10-14% W/V PEG8000. HANGING DROPS WERE FORMED BY MIXING EQUAL VOLUMES OF 12 MG/ML PROTEIN IN 50 MM KCL, 5 MM FBP, 5 MM PHOSPHOGLYCOLATE, 20 MM POTASSIUM PHOSPHATE, PH 7.0, AND WELL SOLUTIONS.",295,"10.1074/jbc.M202107200",,"2VGB",230.26,"2.73","2.73","HUMAN ERYTHROCYTE PYRUVATE KINASE","LTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","PYRUVATE KINASE ISOZYMES R/L","1","2VGB"
"2VGE",,"X-RAY DIFFRACTION",2.09,40.73,,,"22% PEG3350, 0.3 M KCL2, 17.5% MPD",,"10.1016/j.str.2007.11.012",,"2VGE",25.31,"2.1","2.1","Crystal structure of the C-terminal region of human iASPP","MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQRSKVKHHHHHH","Homo sapiens","PPP1R13L, IASPP, NKIP1, PPP1R13BL, RAI","RELA-ASSOCIATED INHIBITOR","1","2VGE"
"2VGF",,"X-RAY DIFFRACTION",2.6,52.25,,6.4,"pH 6.4",,"10.1074/jbc.M202107200",,"2VGF",230.38,"2.75","2.75","HUMAN ERYTHROCYTE PYRUVATE KINASE: T384M mutant","LTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPMRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","PYRUVATE KINASE ISOZYMES R/L","1","2VGF"
"2VGG",,"X-RAY DIFFRACTION",2.52,50.9,,6.4,"pH 6.4",,"10.1074/jbc.M202107200",,"2VGG",230.18,"2.74","2.74","HUMAN ERYTHROCYTE PYRUVATE KINASE: R479H MUTANT","LTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGHSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","PYRUVATE KINASE ISOZYMES R/L","1","2VGG"
"2VGH",,"SOLUTION NMR",,,,,,,"10.1016/s0969-2126(98)00065-3",,"2VGH",6.5,,,"HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE","ARQENPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR","Homo sapiens","VEGFA, VEGF","VASCULAR ENDOTHELIAL GROWTH FACTOR-165","1","2VGH"
"2VGI",,"X-RAY DIFFRACTION",2.5,50.35,,6.4,"pH 6.4",,"10.1074/jbc.M202107200",,"2VGI",230.37,"2.87","2.87","HUMAN ERYTHROCYTE PYRUVATE KINASE: R486W MUTANT","LTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSWYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","PYRUVATE KINASE ISOZYMES R/L","1","2VGI"
"2VGZ",,"X-RAY DIFFRACTION",2.44,49.11,,,,,"10.1074/jbc.M707925200",,"2VGZ",95.91,"2.3","2.3","CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE II","MLENYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE","1","2VGZ"
"2VH0",,"X-RAY DIFFRACTION",1.83,32.91,"VAPOR DIFFUSION, HANGING DROP",5.85,"CRYSTALLISATION WAS CARRIED OUT USING THE HANGING DROP VAPOUR DIFFUSION METHOD IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG 6K, 50MM MES-NAOH (PH5.7-6.0), 5MM CACL2 AND 50MM NACL., pH 5.85",,"10.1016/j.bmcl.2007.11.019","GSI","2VH0",44.35,"1.7","1.7","Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VH0"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","ACTIVATED FACTOR XA LIGHT CHAIN","2","2VH0"
"2VH6",,"X-RAY DIFFRACTION",1.83,32.62,"VAPOR DIFFUSION, HANGING DROP",5.85,"CRYSTALLISATION WAS CARRIED OUT USING THE HANGING DROP VAPOUR DIFFUSION METHOD IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG 6K, 50MM MES-NAOH (PH5.7-6.0), 5MM CACL2 AND 50MM NACL, pH 5.85",,"10.1016/j.bmcl.2007.11.023","GSV","2VH6",44.32,"1.95","1.95","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VH6"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","ACTIVATED FACTOR XA LIGHT CHAIN","2","2VH6"
"2VH7",,"X-RAY DIFFRACTION",2.6,52,,7.5,"10%(V/V) 2-PROPANOL, 20%(W/V) PEG 4000, 0.1 M NA HEPES BUFFER PH 7.5",,"10.1371/journal.pbio.1001027",,"2VH7",11.28,"1.45","1.45","Crystal structure of human common-type acylphosphatase","MAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGQLQGPISKVRHMQEWLETRGSPKSHIDKANFNNEKVILKLDYSDFQIVK","Homo sapiens","ACYP1, ACYPE","ACYLPHOSPHATASE-1","1","2VH7"
"2VHF",,"X-RAY DIFFRACTION",2.7,56,,6.5,"1.5-2% PEG 20000, 0.1 M MES [PH6.3], pH 6.5",,"10.1016/j.molcel.2007.12.018",,"2VHF",86.95,"2.8","2.8","Structure of the CYLD USP domain","GLEIMIGKKKGIQGHYNSCYLDSTLFCLFAFSSVLDTVLLRPKEKNDVEYYSETQELLRTEIVNPLRIYGYVCATKIMKLRKILEKVEAASGFTSEEKDPEEFLNILFHHILRVEPLLKIRSAGQKVQDCYFYQIFMEKNEKVGVPTIQQLLEWSFINSNLKFAEAPSCLIIQMPRFGKDFKLFKKIFPSLELNITDLLEDTPRQCRICGGLAMYECRECYDDPDISAGKIKQFCKTCNTQVHLHPKRLNHKYNPVSLPKDLPDWDWRHGCIPCQNMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNIPQVTPCPEVGEYLKMSLEDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK","Homo sapiens","CYLD, CYLD1, KIAA0849, HSPC057","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE CYLD","1","2VHF"
"2VHS",,"X-RAY DIFFRACTION",2.16,42.54,,6,"pH 6",,"10.1039/b718264c",,"2VHS",95.65,"1.5","1.5","Cathsilicatein, a chimera","APRSVDWREKGYVTPVKNQGQCGASYAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDVGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFSSDCSSSSLNHAMLVVGYGFISNNQKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHSILICATEIN","1","2VHS"
"2VIE",,"X-RAY DIFFRACTION",2.01,43.31,"VAPOR DIFFUSION",3.2,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.019","VG0","2VIE",44.3,"1.9","1.9","Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl) benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VIE"
"2VIG",,"X-RAY DIFFRACTION",2.58,52.43,,8,"0.2M AMMONIUM CHLORIDE, 20% PEG6000, 10% ETHYLENE GLYCOL, 0.1M TRIS-HCL PH8.0",,,,"2VIG",348.33,"1.9","1.9","Crystal structure of human short-chain acyl CoA dehydrogenase","MQSVELPETHQMLLQTCRDFAEKELFPIAAQVDKEHLFPAAQVKKMGGLGLLAMDVPEELGGAGLDYLAYAIAMEEISRGCASTGVIMSVNNSLYLGPILKFGSKEQKQAWVTPFTSGDKIGCFALSEPGNGSDAGAASTTARAEGDSWVLNGTKAWITNAWEASAAVVFASTDRALQNKSISAFLVPMPTPGLTLGKKEDKLGIRGSSTANLIFEDCRIPKDSILGEPGMGFKIAMQTLDMGRIGIASQALGIAQTALDCAVNYAENRMAFGAPLTKLQVIQFKLADMALALESARLLTWRAAMLKDNKKPFIKEAAMAKLAASEAATAISHQAIQILGGMGYVTEMPAERHYRDARITEIYEGTSEIQRLVIAGHLLRSYRSAENLYFQ","Homo sapiens","ACADS","SHORT-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE,","1","2VIG"
"2VIJ",,"X-RAY DIFFRACTION",2.01,62,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.020",,"2VIJ",44.94,"1.6","1.6","Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(1,2,3,4- tetrahydro-1-naphthalenylamino)propyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VIJ"
"2VIN",,"X-RAY DIFFRACTION",1.77,29.94,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.05M COMPOUND, 27.5% PEG4000, 0.2M HEPES PH=6.6, 0.1M (NH4)(CH3COO)",,"10.1021/jm701359z","505","2VIN",28.78,"1.9","1.9","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIN"
"2VIO",,"X-RAY DIFFRACTION",1.84,32.58,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.05M COMPOUND, 28% PEG4000, 0.29M HEPES PH=6.6, 5% GLYCEROL",,"10.1021/jm701359z","L1O","2VIO",28.75,"1.8","1.8","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIO"
"2VIP",,"X-RAY DIFFRACTION",1.71,27.7,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.01M COMPOUND, 28% PEG4000, 0.29M HEPES PH=6.6, 5% GLYCEROL, 0.001M NA(CH3COO), 0.001M (NH4)2SO4, 10% DMSO",,"10.1021/jm701359z","L1R","2VIP",28.98,"1.72","1.72","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIP"
"2VIQ",,"X-RAY DIFFRACTION",1.8,31.31,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.04M COMPOUND, 28% PEG4000, 5% GLYCEROL, 0.29M BISTRIS PH=6.6, 0.001M NA(CH3COO), 0.001M (NH4)2SO4",,"10.1021/jm701359z","D55","2VIQ",28.88,"2","2","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIQ"
"2VIV",,"X-RAY DIFFRACTION",1.86,39.54,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.04M COMPOUND, 28% PEG4000, 5% GLYCEROL, 0.29M BISTRIS PH=6.6, 0.001M NA(CH3COO), 0.001M (NH4)2SO4",,"10.1021/jm701359z","VG2","2VIV",28.91,"1.72","1.72","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIV"
"2VIW",,"X-RAY DIFFRACTION",1.86,33.37,,6.6,"PROTEIN WAS CRYSTALLIZED FROM 22-24% PEG4000, 0.17M (NH4)2SO4, 15% GLYCEROL, 0.1M NA(CH3COO) PH=4.0; THEN SOAKED IN 0.001M COMPOUND, 28% PEG4000, 5% GLYCEROL, 0.29M BISTRIS PH=6.6, 0.001M NA(CH3COO), 0.001M (NH4)2SO4",,"10.1021/jm701359z","D56","2VIW",28.95,"2.05","2.05","Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1","2VIW"
"2VIY",,"X-RAY DIFFRACTION",2.04,44.78,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.017","VG3","2VIY",44.33,"1.82","1.82","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(pentylsulfonyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VIY"
"2VIZ",,"X-RAY DIFFRACTION",2.11,41.14,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.017","VG4","2VIZ",44.34,"1.6","1.6","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2-oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VIZ"
"2VJ2",,"X-RAY DIFFRACTION",2.5,48,,7,"8.5% (W/V) PEG4000, 100MM IMIDAZOLE -MALATE, PH7.0",,"10.1038/nsmb.1457",,"2VJ2",37.8,"2.5","2.5","Human Jagged-1, domains DSL and EGFs1-3","MRGSHHHHHHGSIEGRSAVTCDDYYYGFGCNKFCRPRDDFFGHYACDQNGNKTCMEGWMGPECNRAICRQGCSPKHGSCKLPGDCRCQYGWQGLYCDKCIPHPGCVHGICNEPWQCLCETNWGGQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEI","Homo sapiens","JAG1, JAGL1","JAGGED-1","1","2VJ2"
"2VJ3",,"X-RAY DIFFRACTION",2.2,46,,5.7,"30% (W/V) PEG-5000-MME, 100MM SODIUM ACETATE, PH5.7",,"10.1038/nsmb.1457",,"2VJ3",15.13,"2.6","2.6","Human Notch-1 EGFs 11-13","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","2VJ3"
"2VJ6",,"X-RAY DIFFRACTION",2.01,44.81,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.019","VG5","2VJ6",44.33,"1.8","1.8","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VJ6"
"2VJ7",,"X-RAY DIFFRACTION",2.1,41.03,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.019","VG6","2VJ7",44.33,"1.6","1.6","Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-5-(2-oxo-1-pyrrolidinyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VJ7"
"2VJ8",,"X-RAY DIFFRACTION",2.89,57.47,"LIQUID DIFFUSION",6.8,"PEG8000, IMIDAZOLE, SODIUM ACETATE,YTTERBIUM CHLORIDE, BESTATIN, PH 6.8, LIQUID DIFFUSION,TEMPERATURE 298K",298,"10.1096/fj.01-1017fje","HA2","2VJ8",70.48,"1.8","1.8","Complex of human leukotriene A4 hydrolase with a hydroxamic acid inhibitor","MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","LTA4H PROTEIN","1","2VJ8"
"2VJ9",,"X-RAY DIFFRACTION",2.12,41.61,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2007.12.019","VG7","2VJ9",44.25,"1.6","1.6","Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl) benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VJ9"
"2VJZ",,"X-RAY DIFFRACTION",1.77,37,,7.5,"pH 7.5",,"10.1002/prot.22213",,"2VJZ",11.91,"1.8","1.8","Crystal structure form ultalente insulin microcrystals","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2VJZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2VJZ"
"2VK0",,"X-RAY DIFFRACTION",1.78,30.48,,5.5,"pH 5.5",,"10.1002/prot.22213",,"2VK0",12.05,"2.2","2.2","Crystal structure form ultalente insulin microcrystals","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2VK0"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2VK0"
"2VKC",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.09.005",,"2VKC",15.19,,,"Solution structure of the B3BP Smr domain","MGSSHHHHHHSSHMLVPRGSLQQGTLHEQKMKEANHLAAIEIFEKVNASLLPQNVLDLHGLHVDEALEHLMRVLEKKTEEFKQNGGKPYLSVITGRGNHSQGGVARIKPAVIKYLISHSFRFSEIKPGCLKVMLK","Homo sapiens","N4BP2, B3BP, KIAA1413","NEDD4-BINDING PROTEIN 2","1","2VKC"
"2VKI",,"X-RAY DIFFRACTION",2.2,44,,8.5,"0.2 M LITHIUM SULPHATE, 0.1 M TRIS HYDROCHLORIDE [PH 8.5] 30 % (W/V) PEG 4000",,"10.1128/MCB.02032-07",,"2VKI",17.74,"1.8","1.8","Structure of the PDK1 PH domain K465E mutant","GSNIEQYIHDLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVENNLILKMGPVDERKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEVWRQRYQSHPDAAVQ","Homo sapiens","PDPK1, PDK1","3-PHOPSHOINOSITIDE DEPENDENT PROTEIN KINASE 1","1","2VKI"
"2VKM",,"X-RAY DIFFRACTION",2.9,56,,6.5,"12% PEG 8000, NACACODYLATE BUFFER, PH 6.5. 15MG/ML PROTEIN CONCENTRATION. ROOM TEMPERATURE.",,"10.1016/j.bmcl.2007.12.028","BSD","2VKM",175.89,"2.05","2.05","Crystal structure of GRL-8234 bound to BACE (Beta-secretase)","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VKM"
"2VKP",,"X-RAY DIFFRACTION",3.38,64,,6.5,"0.8M POTASSIUM CITRATE, 0.1M SODIUM CACODYLATE PH6.5",,,,"2VKP",24.42,"1.9","1.9","Crystal structure of BTB domain from BTBD6","SMFNNELMADVHFVVGPPGATRTVPAHKYVLAVGSSVFYAMFYGDLAEVKSEIHIPDVEPAAFLILLKYMYSDEIDLEADTVLATLYAAKKYIVPALAKACVNFLETSL","Homo sapiens","BTBD6, BDPL","BTB/POZ DOMAIN-CONTAINING PROTEIN 6","1","2VKP"
"2VKQ",,"X-RAY DIFFRACTION",2.6,52.5,,,"24% PEG1500, 20% GLYCEROL",,,,"2VKQ",33.29,"2.5","2.5","Crystal structure of human cytosolic 5'-nucleotidase III (cN-III, NT5C3) in complex with beryllium trifluoride","MGSSHHHHHHSSGLVPRGSNPTRVEEIICGLIKGGAAKLQIITDFDMTLSRFSYKGKRCPTCHNIIDNCKLVTDECRKKLLQLKEKYYAIEVDPVLTVEEKYPYMVEWYTKSHGLLVQQALPKAKLKEIVAESDVMLKEGYENFFDKLQQHSIPVFIFSAGIGDVLEEVIRQAGVYHPNVKVVSNFMDFDETGVLKGFKGELIHVFNKHDGALRNTEYFNQLKDNSNIILLGDSQGDLRMADGVANVEHILKIGYLNDRVDELLEKYMDSYDIVLVQDESLEVANSILQKIL","Homo sapiens","NT5C3A, NT5C3, P5N1, UMPH1, HSPC233","CYTOSOLIC 5'-NUCLEOTIDASE III","1","2VKQ"
"2VKT",,"X-RAY DIFFRACTION",2.9,57.6,,7,"0.1 M HEPES PH 7, 26% POLYACRYLIC ACID 5100, 0.02 M MGCL2",,,,"2VKT",32.62,"2.5","2.5","HUMAN CTP SYNTHETASE 2 - GLUTAMINASE DOMAIN","MHHHHHHSSGVDLGTENLYFQSMKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLS","Homo sapiens","CTPS2","CTP SYNTHASE 2","1","2VKT"
"2VKW",,"X-RAY DIFFRACTION",2.08,40.28,,5.2,"pH 5.2",,"10.1016/j.jmb.2008.01.030",,"2VKW",46.68,"2.3","2.3","Human NCAM, FN3 domains 1 and 2","APLAQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVREPSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTAAAHHHHHH","Homo sapiens","NCAM1, NCAM","NEURAL CELL ADHESION MOLECULE 1,140 KDA ISOFORM","1","2VKW"
"2VKX",,"X-RAY DIFFRACTION",3.06,59.48,,4.6,"pH 4.6",,"10.1016/j.jmb.2008.01.030",,"2VKX",139.82,"2.7","2.7","Human NCAM, FN3 domains 1 and 2, M610R mutant","APLAQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVREPSAPKLEGQRGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTAAAHHHHHH","Homo sapiens","NCAM1, NCAM","NEURAL CELL ADHESION MOLECULE","1","2VKX"
"2VL2",,"X-RAY DIFFRACTION",2.72,54.8,,8,"NACL 0.1M TRIS PH 8 0.1M PEG 3350 20%",,"10.1016/j.abb.2008.04.036",,"2VL2",54.86,"1.925","1.925","Oxidized and reduced forms of human peroxiredoxin 5","RGSHHHHHHGSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","PEROXIREDOXIN-5","1","2VL2"
,,,,,,,,,,,,,,,,"RGSHHHHHHGSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","PEROXIREDOXIN-5","2","2VL2"
"2VL3",,"X-RAY DIFFRACTION",2.7,54.4,,8,"NACL 0.1 M TRIS PH 8 0.1 M PEG 3350 20%",,"10.1016/j.abb.2008.04.036",,"2VL3",54.58,"1.83","1.83","Oxidized and reduced forms of human peroxiredoxin 5","RGSHHHHHHGSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","PEROXIREDOXIN-5","1","2VL3"
"2VL9",,"X-RAY DIFFRACTION",2.22,44.53,,6.5,"PEG 8000 20% SODIUM CACODYLATE 0.1 M PH 6.5 SODIUM ACETATE 0.1 M 6-AMINOCAPROIC ACID 3% W/V",,"10.1016/j.abb.2008.04.036",,"2VL9",73.24,"2.7","2.7","Oxidized form of human peroxiredoxin 5","MRGSHHHHHHGSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVASLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","PEROXIREDOXIN-5","1","2VL9"
"2VLE",,"X-RAY DIFFRACTION",2.2,44.9,,6.5,"100 MM MES PH 6.5, 100 MM GUANIDINE-HCL, 3 MM DITHIOTHREITOL, 5% DMSO (V/V), 10% PEG 6000 (W/V) AND 2MM DAIDZIN",,"10.1021/jm800488j","DZN","2VLE",435.09,"2.4","2.4","The structure of daidzin, a naturally occurring anti alcohol- addiction agent, in complex with human mitochondrial aldehyde dehydrogenase","AVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL","1","2VLE"
"2VLM",,"X-RAY DIFFRACTION",2.36,47.52,,,,,"10.1016/j.immuni.2007.12.018",,"2VLM",49.81,"1.98","1.98","The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain","MVDGGITQSPKYLFRKEGQNVTLSCEQNLNHDAMYWYRQDPGQGLRLIYYSQIVNDFQKGDIAEGYSVSREKKESFPLTVTSAQKNPTAFYLCASSSRSSYEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"JM22 TCR BETA CHAIN","2","2VLM"
,,,,,,,,,,,,,,,,"MQLLEQSPQFLSIQEGENLTVYCNSSSVFSSLQWYRQEPGEGPVLLVTVVTGGEVKKLKRLTFQFGDARKDSSLHITAAQPGDTGLYLCAGAGSQGNLIFGKGTKLSVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSK","Homo sapiens",,"JM22 TCR ALPHA CHAIN","1","2VLM"
"2VM5",,"X-RAY DIFFRACTION",1.8,32.2,,5,"0.1M CITRIC ACID, PH 5, 20% PEG 6000",,"10.1107/S1744309109038597",,"2VM5",12.53,"1.8","1.8","HUMAN BIR2 DOMAIN OF BACULOVIRAL INHIBITOR OF APOPTOSIS REPEAT- CONTAINING 1 (BIRC1)","SMRVKNLKSRLRGGKMRYQEEEARLASFRNWPFYVQGISPCVLSEAGFVFTGKQDTVQCFSCGGCLGNWEEGDDPWKEHAKWFPKCEFLRSKKSSEEITQYIQSYK","Homo sapiens","NAIP, BIRC1","BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 1","1","2VM5"
"2VM8",,"X-RAY DIFFRACTION",2.47,49.88,,,,,"10.1111/j.1742-4658.2008.06601.x",,"2VM8",220.46,"1.9","1.9","Human CRMP-2 crystallised in the presence of Mg","MHHHHHHSSGVDLGTENLYFQSMTSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAE","Homo sapiens","DPYSL2, CRMP2, ULIP2","DIHYDROPYRIMIDINASE-RELATED PROTEIN 2","1","2VM8"
"2VN0",,"X-RAY DIFFRACTION",3.82,67.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, HEPES, LISO4, MEOH, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K",294,"10.1074/jbc.M802180200",,"2VN0",55.37,"2.7","2.7","CYP2C8DH COMPLEXED WITH TROGLITAZONE","MAKKTSSKGKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPVHHHH","Homo sapiens","CYP2C8","CYTOCHROME P450 2C8","1","2VN0"
"2VN8",,"X-RAY DIFFRACTION",3.55,65,,5.6,"36% MPD, 0.135M AMMONIUM ACETATE, 0.09M SODIUM CITRATE PH5.6",,,,"2VN8",84.34,"2.1","2.1","Crystal structure of human Reticulon 4 interacting protein 1 in complex with NADPH","MHHHHHHSSGVDLGTENLYFQSMAWVIDKYGKNEVLRFTQNMMMPIIHYPNEVIVKVHAASVNPIDVNMRSGYGATALNMKRDPLHVKIKGEEFPLTLGRDVSGVVMECGLDVKYFKPGDEVWAAVPPWKQGTLSEFVVVSGNEVSHKPKSLTHTQAASLPYVALTAWSAINKVGGLNDKNCTGKRVLILGASGGVGTFAIQVMKAWDAHVTAVCSQDASELVRKLGADDVIDYKSGSVEEQLKSLKPFDFILDNVGGSTETWAPDFLKKWSGATYVTLVTPFLLNMDRLGIADGMLQTGVTVGSKALKHFWKGVHYRWAFFMASGPCLDDIAELVDAGKIRPVIEQTFPFSKVPEAFLKVERGHARGKTVINVV","Homo sapiens","RTN4IP1, NIMP","RETICULON-4-INTERACTING PROTEIN 1","1","2VN8"
"2VN9",,"X-RAY DIFFRACTION",2.85,57,,7.5,"1.6 M NAKPO4 HEPES PH 7.5",,"10.1371/journal.pbio.1000426",,"2VN9",69.92,"2.3","2.3","Crystal Structure of Human Calcium Calmodulin dependent Protein Kinase II delta isoform 1, CAMKD","SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTML","Homo sapiens","CAMK2D, CAMKD","CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II DELTA CHAIN","1","2VN9"
"2VNA",,"X-RAY DIFFRACTION",2.8,56,,7,"2.2M SODIUM MALONATE PH 7.0",,,,"2VNA",40.08,"2.17","2.17","Structure of Human Zinc-binding Alcohol Dehydrogenase 1 (ZADH1)","MMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEIAENLYFQ","Homo sapiens","PTGR2, ZADH1","PROSTAGLANDIN REDUCTASE 2","1","2VNA"
"2VNM",,"X-RAY DIFFRACTION",1.98,43.59,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1021/jm800138h","CM8","2VNM",45,"1.79","1.79","Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VNM"
"2VNN",,"X-RAY DIFFRACTION",2.02,38.75,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1021/jm800138h","CM7","2VNN",44.39,"1.87","1.87","Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-1- methyl-3,4-dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9- carboxamide 2,2-dioxide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2VNN"
"2VNS",,"X-RAY DIFFRACTION",2.32,47.01,,5.6,"0.01M FECL3, 40-100MM NA3.CITRATE AND 4% V/V JEFFAMINE M600 PH5.6",,"10.1073/pnas.0801318105",,"2VNS",46.82,"2","2","Crystal Structure of the Membrane Proximal Oxidoreductase Domain of Human Steap3, the Dominant Ferric Reductase of the Erythroid Transferrin Cycle","MPEEMDKPLISLHLVDSDSSLAKVPDEAPKVGILGSGDFARSLATRLVGSGFKVVVGSRNPKRTARLFPSAAQVTFQEEAVSSPEVIFVAVFREHYSSLCSLSDQLAGKILVDVSNPTEQEHLQHRESNAEYLASLFPTCTVVKAFNVISAWTLQAGPRDGNRQVPICGDQPEAKRAVSEMALAMGFMPVDMGSLASAWEVEAMPLRLLPAWKVP","Homo sapiens","STEAP3, TSAP6","METALLOREDUCTASE STEAP3","1","2VNS"
"2VNT",,"X-RAY DIFFRACTION",2.63,53.28,,,,,"10.1021/jm061066t","QGG","2VNT",190.26,"2.2","2.2","UROKINASE-TYPE PLASMINOGEN ACTIVATOR INHIBITOR COMPLEX WITH A 1-(7- SULPHOAMIDOISOQUINOLINYL)GUANIDINE","KPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1","2VNT"
"2VO1",,"X-RAY DIFFRACTION",2.85,44.33,,,,,"10.1107/S1744309106018136",,"2VO1",66.52,"2.8","2.8","CRYSTAL STRUCTURE OF THE SYNTHETASE DOMAIN OF HUMAN CTP SYNTHETASE","MHHHHHHSSGVDLGTENLYFQSMKYILVTGGVISGIGKGIIASSVGTILKSCGLHVTSIKIDPYINIDAGTFSPYEHGEVFVLDDGGEVDLDLGNYERFLDIRLTKDNNLTTGKIYQYVINKERKGDYLGKTVQVVPHITDAIQEWVMRQALIPVDEDGLEPQVCVIELGGTVGDIESMPFIEAFRQFQFKVKRENFCNIHVSLVPQPSSTGEQKTKPTQNSVRELRGLGLSPDLVVCRCSNPLDTSVKEKISMFCHVEPEQVICVHDVSSIYRVPLLLEEQGVVDYFLRRLDLP","Homo sapiens","CTPS1, CTPS","CTP SYNTHASE 1","1","2VO1"
"2VOM",,"X-RAY DIFFRACTION",2.59,52.58,,8.5,"100 MM TRIS PH 8.5, 20% PEG MME2000, 4% POLYPROPYLENE GLYCOL P400, 10 MM NICL2",,"10.1074/jbc.M802145200",,"2VOM",106.8,"1.85","1.85","Structural basis of human triosephosphate isomerase deficiency. Mutation E104D and correlation to solvent perturbation.","GSAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGDSDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","TRIOSEPHOSPHATE ISOMERASE","1","2VOM"
"2VPF",,"X-RAY DIFFRACTION",2.7,54,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROP, CRYSTALLIZED FROM 14 % PEG3350, 10% ISOPROPANOL, 0.2 M AMMONIUM ACETATE PH 5.6, vapor diffusion - hanging drop",,"10.1016/s0969-2126(97)00284-0",,"2VPF",95.59,"1.93","1.93","VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION","GQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD","Homo sapiens","VEGFA, VEGF","VASCULAR ENDOTHELIAL GROWTH FACTOR","1","2VPF"
"2VPH",,"X-RAY DIFFRACTION",2.09,40,,5,"20% PEG 3350, 0.20M (NH4)2H(CIT), PH 5",,,,"2VPH",22.08,"1.9","1.9","Crystal structure of the human protein tyrosine phosphatase, non- receptor type 4, PDZ domain","SMDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPNAVESTV","Homo sapiens","PTPN4","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4","1","2VPH"
"2VPI",,"X-RAY DIFFRACTION",2.38,40.11,,5.5,"0.2 M AMMONIUM ACETATE 0.1 M BIS-TRIS PH 5.5 25% PEG 3350",,,,"2VPI",47.64,"2.4","2.4","Human GMP synthetase - glutaminase domain","MHHHHHHSSGVDLGTENLYFQSMEGAVVILDAGAQYGKVIDRRVRELFVQSEIFPLETPAFAIKEQGFRAIIISGGPNSVYAEDAPWFDPAIFTIGKPVLGICYGMQMMNKVFGGTVHKKSVREDGVFNISVDNTCSLFRGLQKEEVVLLTHGDSVDKVADGFKVVARSGNIVAGIANESKKLYGAQFHPEVGLTENGKVILKNFLYDIAGCSGTFTV","Homo sapiens","GMPS","GMP SYNTHASE","1","2VPI"
"2VPJ",,"X-RAY DIFFRACTION",1.77,30.42,,4.6,"0.2M AMMONIUM ACETATE, 0.1M SODIUM ACETATE PH4.6, 30% PEG4K",,"10.1074/jbc.M112.437996",,"2VPJ",33.02,"1.85","1.85","Crystal structure of the Kelch domain of human KLHL12","SMQGPRTRARLGANEVLLVVGGFGSQQSPIDVVEKYDPKTQEWSFLPSITRKRRYVASVSLHDRIYVIGGYDGRSRLSSVECLDYTADEDGVWYSVAPMNVRRGLAGATTLGDMIYVSGGFDGSRRHTSMERYDPNIDQWSMLGDMQTAREGAGLVVASGVIYCLGGYDGLNILNSVEKYDPHTGHWTNVTPMATKRSGAGVALLNDHIYVVGGFDGTAHLSSVEAYNIRTDSWTTVTSMTTPRCYVGATVLRGRLYAIAGYDGNSLLSSIECYDPIIDSWEVVTSMGTQRCDAGVCVLRE","Homo sapiens","KLHL12, C3IP1","KELCH-LIKE PROTEIN 12","1","2VPJ"
"2VPK",,"X-RAY DIFFRACTION",1.88,41.39,,6.5,"0.2 M NA/KPO4, 0.1 M BIS-TRIS PROPANE PH 6.5, 20% PEG 3350.",,,,"2VPK",13.46,"2","2","Crystal structure of the BTB domain of human myoneurin","SMSHHCEHLLERLNKQREAGFLCDCTIVIGEFQFKAHRNVLASFSEYFGAIYRSTSENNVFLDQSQVKADGFQKLLEFIYTGTLNLDSWNVKEIHQAADYLKVEEVVTKCKIKMED","Homo sapiens","MYNN, OSZF, ZBTB31, SBBIZ1","MYONEURIN","1","2VPK"
"2VQ3",,"X-RAY DIFFRACTION",2.31,46.84,,5.6,"0.01M FECL3, 40-100MM NA3.CITRATE, 4% V/V JEFFAMINE M600 PH5.6",,"10.1073/pnas.0801318105",,"2VQ3",48.31,"2","2","Crystal Structure of the Membrane Proximal Oxidoreductase Domain of Human Steap3, the Dominant Ferric Reductase of the Erythroid Transferrin Cycle","MPEEMDKPLISLHLVDSDSSLAKVPDEAPKVGILGSGDFARSLATRLVGSGFKVVVGSRNPKRTARLFPSAAQVTFQEEAVSSPEVIFVAVFREHYSSLCSLSDQLAGKILVDVSNPTEQEHLQHRESNAEYLASLFPTCTVVKAFNVISAWTLQAGPRDGNRQVPICGDQPEAKRAVSEMALAMGFMPVDMGSLASAWEVEAMPLRLLPAWKVP","Homo sapiens","STEAP3, TSAP6","METALLOREDUCTASE STEAP3","1","2VQ3"
"2VQJ",,"X-RAY DIFFRACTION",2.85,57,,6.5,"1.6M AMMONIUM SULPHATE, 0.1M MES PH 6.5, 10% DIOXANE 1MM DTT",,"10.1074/jbc.M803514200","TFG","2VQJ",45.49,"2.1","2.1","Structure of HDAC4 catalytic domain bound to a trifluoromethylketone inhbitor","GAMTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQJ"
"2VQM",,"X-RAY DIFFRACTION",2.95,58,,6.4,"1.5M AMMONIUM SULPHATE 0.1M MES PH 6.4 10% DIOXANE 1MM DTT",,"10.1074/jbc.M803514200","HA3","2VQM",45.05,"1.8","1.8","Structure of HDAC4 catalytic domain bound to a hydroxamic acid inhbitor","GAMTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQM"
"2VQO",,"X-RAY DIFFRACTION",2.9,57,,6.5,"1.6M AMMONIUM SULPHATE, 0.1M MES PH 6.5, 10% DIOXANE, 1MM DTT",,"10.1074/jbc.M803514200","TFG","2VQO",90.3,"2.15","2.15","Structure of HDAC4 catalytic domain with a gain-of-function muation bound to a trifluoromethylketone inhbitor","GAMTKPRFTTGLVYDTLMLKHQCTAGSSSSHPEHAGRIQSIWSRLQETGLRGKCEAIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGYDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQO"
"2VQQ",,"X-RAY DIFFRACTION",2.85,57,,6.5,"1.6M AMMONIUM SULPHATE, 0.1M MES PH 6.5, 10% DIOXANE 1MM DTT",,"10.1074/jbc.M803514200","TFG","2VQQ",90.25,"1.9","1.9","Structure of HDAC4 catalytic domain (a double cysteine-to-alanine mutant) bound to a trifluoromethylketone inhbitor","GAMTKPRFTTGLVYDTLMLKHQCTAGSSSSHPEHAGRIQSIWSRLQETGLRGKCEAIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQQ"
"2VQV",,"X-RAY DIFFRACTION",2.9,58,,6.5,"0.1M MES PH 6.5, 1.6M AMMONIUM SULPHATE, 10% DIOXANE 1MM DTT",,"10.1074/jbc.M803514200",,"2VQV",90.28,"3.3","3.3","Structure of HDAC4 catalytic domain with a gain-of-function mutation bound to a hydroxamic acid inhibitor","GAMTKPRFTTGLVYDTLMLKHQCTAGSSSSHPEHAGRIQSIWSRLQETGLRGKCEAIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGYDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQV"
"2VQW",,"X-RAY DIFFRACTION",4.9,71,,7.5,"0.1M HEPES PH 7.5, 18% PEG 10000, 1MM DTT",,"10.1074/jbc.M803514200",,"2VQW",44.71,"3","3","Structure of inhibitor-free HDAC4 catalytic domain (with gain-of- function mutation His332Tyr)","GAMTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGYDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVT","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","2VQW"
"2VR2",,"X-RAY DIFFRACTION",2.33,47.35,,7.5,"0.1M HEPES PH 7.5, 70% MPD",,,,"2VR2",59.43,"2.8","2.8","Human Dihydropyrimidinase","MHHHHHHSSGVDLGTENLYFQSMAAPSRLLIRGGRVVNDDFSEVADVLVEDGVVRALGHDLLPPGGAPAGLRVLDAAGKLVLPGGIDTHTHMQFPFMGSRSIDDFHQGTKAALSGGTTMIIDFAIPQKGGSLIEAFETWRSWADPKVCCDYSLHVAVTWWSDQVKEEMKILVQDKGVNSFKMFMAYKDLYMVTDLELYEAFSRCKEIGAIAQVHAENGDLIAEGAKKMLALGITGPEGHELCRPEAVEAEATLRAITIASAVNCPLYIVHVMSKSAAKVIADARRDGKVVYGEPIAASLGTDGTHYWNKEWHHAAHHVMGPPLRPDPSTPDFLMNLLANDDLTTTGTDNCTFNTCQKALGKDDFTKIPNGVNGVEDRMSVIWEKGVHSGKMDENRFVAVTSTNAAKIFNLYPRKGRIAVGSDADIVIWDPKGTRTISAKTHHQAVNFNIFEGMVCHGVPLVTISRGKVVYEAGVFSVTAGDGKFIPRKPFAEYIYKRIKQRDRTCTPTPVERAPYKGEVATLKSRVTKEDATAGTRKQAHP","Homo sapiens","DPYS","DIHYDROPYRIMIDINASE","1","2VR2"
"2VR6",,"X-RAY DIFFRACTION",2.27,35,,7,"20% P3350 0.2 M NA THYOCYANATE, pH 7.0",,"10.1074/jbc.M801522200",,"2VR6",32.49,"1.3","1.3","Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.3 A resolution","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2VR6"
"2VR7",,"X-RAY DIFFRACTION",2.4,40,,7,"20% PEG3350, 0.2M SODIUM THIOCYANATE, pH 7.0",,"10.1074/jbc.M801522200",,"2VR7",32.85,"1.58","1.58","Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.58 A resolution","XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2VR7"
"2VR8",,"X-RAY DIFFRACTION",2.4,40,,7,"20% PEG3350, 0.2M SODIUM THIOCYANATE, pH 7.0",,"10.1074/jbc.M801522200",,"2VR8",32.88,"1.36","1.36","Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.36 A resolution","XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2VR8"
"2VRD",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2004.04.078",,"2VRD",7.34,,,"THE STRUCTURE OF THE ZINC FINGER FROM THE HUMAN SPLICEOSOMAL PROTEIN U1C","MPKFYCDYCDTYLTHDSPSVRKTHCSGRKHKENVKDYYQKWMEEQAQSLIDKTTAAFQQGK","Homo sapiens","SNRPC","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN C","1","2VRD"
"2VRE",,"X-RAY DIFFRACTION",2.31,46.84,,,"0.2M CA(AC)2, 0.1M CACODYLATE PH 6.5, 18% PEG 8K",,,,"2VRE",98.56,"1.95","1.95","crystal structure of human peroxisomal delta3,5,delta2,4-dienoyl coa isomerase","MHHHHHHSSGVDLGTENLYFQSMAPDHSYESLRVTSAQKHVLHVQLNRPNKRNAMNKVFWREMVECFNKISRDADCRAVVISGAGKMFTAGIDLMDMASDILQPKGDDVARISWYLRDIITRYQETFNVIERCPKPVIAAVHGGCIGGGVDLVTACDIRYCAQDAFFQVKEVDVGLAADVGTLQRLPKVIGNQSLVNELAFTARKMMADEALGSGLVSRVFPDKEVMLDAALALAAEISSKSPVAVQSTKVNLLYSRDHSVAESLNYVASWNMSMLQTQDLVKSVQATTENKELKT","Homo sapiens","ECH1","DELTA(3,5)-DELTA(2,4)-DIENOYL-COA ISOMERASE","1","2VRE"
"2VRF",,"X-RAY DIFFRACTION",2.59,52.45,,8.2,"1.4 M NA-CITRATE, HEPES PH 8.2",,,,"2VRF",41.57,"2","2","CRYSTAL STRUCTURE OF THE HUMAN BETA-2-SYNTROPHIN PDZ DOMAIN","SMPVRRVRVVKQEAGGLGISIKGGRENRMPILISKIFPGLAADQSRALRLGDAILSVNGTDLRQATHDQAVQALKRAGKEVLLEVKFIREVNTVV","Homo sapiens","SNTB2, D16S2531E, SNT2B2, SNTL","BETA-2-SYNTROPHIN","1","2VRF"
"2VRG",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.06.042",,"2VRG",14.03,,,"Structure of human MCFD2","GSHMEEPAASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSLQ","Homo sapiens","MCFD2, SDNSF","MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2","1","2VRG"
"2VRL",,"X-RAY DIFFRACTION",2.7,55.25,,,"12% PEG4000 100MM ADA PH 6.5 70MM LITHIUM SULPHATE",,"10.1021/bi8002814",,"2VRL",119.43,"2.4","2.4","Structure of human MAO B in complex with benzylhydrazine","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","2VRL"
"2VRM",,"X-RAY DIFFRACTION",2.7,54,,,"12% PEG4000, 100MM ADA PH 6.5, 70MM LITHIUM SULPHATE",,"10.1021/bi8002814",,"2VRM",119.46,"2.3","2.3","Structure of human MAO B in complex with phenyethylhydrazine","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","2VRM"
"2VSC",,"X-RAY DIFFRACTION",2.6,52.5,,5.5,"200 NL 17 MG/ML CD47 PLUS 100 NL RESERVOIR (0.2 M MGCL2, 0.1 M BIS-TRIS PH 5.5, 25% W/V PEG 3350) EQUILIBRATED AGAINST 95 UL OF RESERVOIR AT 20.5 C.",,"10.1016/j.molcel.2008.05.026",,"2VSC",60.78,"1.9","1.9","Structure of the immunoglobulin-superfamily ectodomain of human CD47","QLLFNKTKSVEFTFGNDTVVIPCFVTNMEAQNTTEVYVKWKFKGRDIYTFDGALNKSTVPTDFSSAKIEVSQLLKGDASLKMDKSDAVSHTGNYTCEVTELTREGETIIELKYRVVSWSTRHHHHHH","Homo sapiens","CD47, MER6","LEUKOCYTE SURFACE ANTIGEN CD47","1","2VSC"
"2VSP",,"X-RAY DIFFRACTION",2.36,47.83,,,"50% PEG 300; 0.20M NACL; 0.1M NA/K-PO4 PH 6.2",,,,"2VSP",39.18,"2.41","2.41","Crystal structure of the fourth PDZ domain of PDZ domain-containing protein 1","SMKPKLCRLAKGENGYGFHLNAIRGLPGSFIKEVQKGGPADLAGLEDEDVIIEVNGVNVLDEPYEKVVDRIQSSGKNVTLLVCGKKAQDTV","Homo sapiens","PDZK1, CAP70, NHERF3, PDZD1","PDZ DOMAIN-CONTAINING PROTEIN 1","1","2VSP"
"2VSR",,"X-RAY DIFFRACTION",2.8,55.5,,8,"pH 8",,"10.1038/nsmb.1474","9HO","2VSR",63.79,"2.05","2.05","hPPARgamma Ligand binding domain in complex with 9-(S)-HODE","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VSR"
"2VST",,"X-RAY DIFFRACTION",2.8,55.5,,8,"pH 8",,"10.1038/nsmb.1474",,"2VST",63.49,"2.35","2.35","hPPARgamma Ligand binding domain in complex with 13-(S)-HODE","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VST"
"2VSV",,"X-RAY DIFFRACTION",2.1,42,,7.5,"0.2M SODIUM ACETATE, 20% PEG3350; 10% ETHYLENE GLYCOL, pH 7.5",,,,"2VSV",24.56,"1.82","1.82","Crystal structure of the PDZ domain of human rhophilin-2","MHHHHHHSSGVDLGTENLYFQSMPRSIRFTAEEGDLGFTLRGNAPVQVHFLDPYCSASVAGAREGDYIVSIQLVDCKWLTLSEVMKLLKSFGEDEIEMKVVSLLDEVTF","Homo sapiens","RHPN2","RHOPHILIN-2","1","2VSV"
"2VSW",,"X-RAY DIFFRACTION",2.46,50.1,,,"0.2 M NANO3, 0.1 M BIS-TRIS-PROPANE PH 8.5, 20% PEG 3350.",,,,"2VSW",34.15,"2.2","2.2","The structure of the rhodanese domain of the human dual specificity phosphatase 16","MIGTQIVTERLVALLESGTEKVLLIDSRPFVEYNTSHILEAININCSKLMKRRLQQDKVLITELIQHSAKHKVDIDCSQKVVVYDQSSQDVASLSSDCFLTVLLGKLEKSFNSVHLLAGGFAEFSRCFPGLCEGKSTLVPTCISQPAHHHHHH","Homo sapiens","DUSP16, KIAA1700, MKP7","DUAL SPECIFICITY PROTEIN PHOSPHATASE 16","1","2VSW"
"2VSZ",,"X-RAY DIFFRACTION",4.8,68,,6.75,"2.1 M SODIUM MALONATE [PH 6.75]",,"10.1091/mbc.e08-04-0345",,"2VSZ",34.21,"2.3","2.3","Crystal Structure of the ELMO1 PH domain","GPLGSPILELKEKIQPEILELIKQQRLNRLVEGTCFRKLNARRRQDKFWYCRLSPNHKVLHYGDLEESPQGEVPHDSLQDKLPVADIKAVVTGKDCPHMKEKGALKQNKEVLELAFSILYDSNCQLNFIAPDKHEYCIWTDGLNALLGK","Homo sapiens","ELMO1, KIAA0281","ENGULFMENT AND CELL MOTILITY PROTEIN 1","1","2VSZ"
"2VT0",,"X-RAY DIFFRACTION",2.4,48,"MICROBATCH",6.5,"0.2M AMMONIUM SULFATE; 0.1M TRIS PH 6.5; 25% W/V PEG 3350; CRYSTALLIZATION UNDER OIL",,"10.1515/BC.2008.163",,"2VT0",115.8,"2.15","2.15","X-ray structure of a conjugate with conduritol-beta-epoxide of acid-beta-glucosidase overexpressed in cultured plant cells","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2VT0"
"2VT5",,"X-RAY DIFFRACTION",2.75,54.94,,,"RESERVOIR = 0.1M HEPES, PH7.0, 0.1M AMMONIUM ACETATE, 12% PEG 3350",,"10.1016/j.bmcl.2008.06.103","ROK","2VT5",297.08,"2.2","2.2","FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2VT5"
"2VT8",,"X-RAY DIFFRACTION",2.28,46,,8,"20% PEG 3350, 0.1 M AMMONIUM IODIDE, pH 8",,"10.1074/jbc.M709900200",,"2VT8",34.4,"2.6","2.6","Structure of a conserved dimerisation domain within Fbox7 and PI31","SHMAGLEVLFASAAPAITCRQDALVCFLHWEVVTHGYCGLGVGDQPGPNDKKSELLPAGWNNNKDLYVLRYEYKDGSRKLLVKAITVESSMILNVLEYGSQQVADLTLNLDDYIDAEHLGDFHRTYKNSEELRSRIVSGIITPIHEQWEKANV","Homo sapiens","PSMF1","PROTEASOME INHIBITOR PI31 SUBUNIT","1","2VT8"
"2VTA",,"X-RAY DIFFRACTION",2.02,38.5,,,"0.1M HEPES/NAOH PH7.4, 42.5MM AMMONIUM ACETATE, 7%(W/V)PEG 3350",,"10.1021/jm800382h","LZ1","2VTA",34.28,"2","2","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTA"
"2VTG",,"X-RAY DIFFRACTION",4,69,,,,,"10.1111/j.1742-4658.2008.06605.x",,"2VTG",17.28,"2.45","2.45","Crystal Structure of Human Iba2, trigonal crystal form","MSGELSNRFQGGKAFGLLKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVMMFEGKANESSPKPVGPPPERDIASLP","Homo sapiens","AIF1L, C9orf58, IBA2, UNQ672/PRO1306","IONIZED CALCIUM-BINDING ADAPTER MOLECULE 2","1","2VTG"
"2VTH",,"X-RAY DIFFRACTION",1.96,36.9,,6.7,"0.1M HEPES/NAOH PH7.4, 0.0475M AMMONIUM ACETATE, 12% W/V PEG 3350, pH 6.7",,"10.1021/jm800382h","LZ2","2VTH",34.29,"1.9","1.9","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTH"
"2VTI",,"X-RAY DIFFRACTION",1.97,36.96,,6.7,"0.1M HEPES/NAOH PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZ3","2VTI",34.29,"2","2","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTI"
"2VTJ",,"X-RAY DIFFRACTION",2.07,40.15,,6.7,"0.1M HEPES/NAOH, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZ4","2VTJ",34.35,"2.2","2.2","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTJ"
"2VTL",,"X-RAY DIFFRACTION",1.92,35.41,,6.7,"0.1M HEPES/NAOH, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZ5","2VTL",34.16,"2","2","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTL"
"2VTM",,"X-RAY DIFFRACTION",1.97,36.94,,6.7,"0.1M HEPES/NAOH PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZM","2VTM",34.12,"2.25","2.25","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTM"
"2VTN",,"X-RAY DIFFRACTION",2.07,40.1,,6.7,"0.1M HEPES/NAOH PH6.7, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350",,"10.1021/jm800382h","LZ7","2VTN",34.24,"2.2","2.2","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTN"
"2VTO",,"X-RAY DIFFRACTION",1.99,37.7,,6.7,"0.1M HEPES/NAOH, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZ8","2VTO",34.3,"2.19","2.19","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTO"
"2VTP",,"X-RAY DIFFRACTION",1.98,37.29,,6.7,"0.1M HEPES/NAOH PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZ9","2VTP",34.34,"2.15","2.15","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTP"
"2VTQ",,"X-RAY DIFFRACTION",1.99,37.58,,6.7,"0.1M HEPES/NAOH, PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG 3350, pH 6.7",,"10.1021/jm800382h","LZA","2VTQ",34.33,"1.9","1.9","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTQ"
"2VTR",,"X-RAY DIFFRACTION",1.92,35.54,,6.7,"0.1M HEPES/NAOH PH7.0 0.0475M AMMONIUM ACETATE 12% W/V PEG3350, pH 6.7",,"10.1021/jm800382h","LZB","2VTR",34.21,"1.89","1.89","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTR"
"2VTS",,"X-RAY DIFFRACTION",1.97,36.94,,6.7,"0.1M HEPES/NAOH, PH6.7, 0.0475M AMMONIUM ACETATE, 12% W/V PEG3350",,"10.1021/jm800382h","LZC","2VTS",34.29,"1.9","1.9","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTS"
"2VTT",,"X-RAY DIFFRACTION",2.02,38.7,,6.7,"0.1M HEPES/NAOH, PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG 3350, pH 6.7",,"10.1021/jm800382h","LZD","2VTT",34.33,"1.68","1.68","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VTT"
"2VU3",,"X-RAY DIFFRACTION",1.92,35.5,,6.7,"0.1M HEPES/NAOH PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG 3350, pH 6.7",,"10.1021/jm800382h","LZE","2VU3",34.36,"1.85","1.85","Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VU3"
"2VUE",,"X-RAY DIFFRACTION",2.4,50.1,,7,"SEE PAPER, pH 7",,"10.1016/j.jmb.2008.06.016",,"2VUE",134.31,"2.42","2.42","Human serum albumin complexed with 4Z,15E-bilirubin-IX-alpha","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2VUE"
"2VUF",,"X-RAY DIFFRACTION",2.62,52.72,,7,"SEE PAPER, pH 7",,"10.1016/j.jmb.2008.06.016",,"2VUF",135.21,"3.05","3.05","Human serum albumin complexed with fusidic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2VUF"
"2VUK",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",7.2,"SITTING DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES PH 7.2, 19 % PEG 4000, 5 MM DTT. CRYSTALS WERE SOAKED WITH 10 MM PHIKAN083 IN CRYO BUFFER CONTAINING 100 MM HEPES PH 7.2, 10 MM SODIUM PHOSPHATE PH 7.2, 19 % PEG 4000, 20 % GLYCEROL, 150 MM KCL.",294,"10.1073/pnas.0805326105","P83","2VUK",49.43,"1.5","1.5","Structure of the p53 core domain mutant Y220C bound to the stabilizing small-molecule drug PhiKan083","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2VUK"
"2VUQ",,"X-RAY DIFFRACTION",2.07,40.21,,6,"10% (V/V) MPD, 40 MM SODIUM CACODYLATE, PH 6.0, 12 MM SPERMINE TETRACHLORIDE, 80 MM POTASSIUM CHLORIDE, EQUILIBRATED AGAINST 35 % (V/V) MPD AT 294 K.",294,"10.1016/j.bbrc.2009.01.127",,"2VUQ",4.42,"1.18","1.18","Crystal structure of a human tRNAGly acceptor stem microhelix (derived from the gene sequence DG9990) at 1.18 Angstroem resolution","GCAUUGG","Homo sapiens",,"5'-R(*GP*CP*AP*UP*UP*GP*GP)-3'","1","2VUQ"
,,,,,,,,,,,,,,,,"CCAAUGC","Homo sapiens",,"5'-R(*CP*CP*AP*AP*UP*GP*CP)-3'","2","2VUQ"
"2VUW",,"X-RAY DIFFRACTION",2.62,61.96,,,"0.1 M SPG, 60% MPG",,"10.1073/pnas.0901989106",,"2VUW",39.39,"1.8","1.8","Structure of human haspin kinase domain","SMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","SERINE/THREONINE-PROTEIN KINASE HASPIN","1","2VUW"
"2VUX",,"X-RAY DIFFRACTION",3.2,60,,6.5,"0.1M NACACODYLATE PH 6.5, 2.3M AMMONIUM SULFATE, 0.2M SODIUM CHLORIDE. CHYMOTRYPSIN WAS ADDED TO A RATIO CHYMOTRYPSIN:PROTEIN OF 1:100 PRIOR TO CRYSTALLISATION",,,,"2VUX",76.04,"2.8","2.8","Human ribonucleotide reductase, subunit M2 B","MHHHHHHSSGVDLGTENLYFQSMSDTNESEIKSNEEPLLRKSSRRFVIFPIQYPDIWKMYKQAQASFWTAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNENLVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKREFLFNAIETMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKPSEERVREIIVDAVKIEQEFLTEALPVGLIGMNCILMKQYIEFVADRLLVELGFSKVFQAENPFDFMENISLEGKTN","Homo sapiens","RRM2B, P53R2","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SUBUNIT M2 B","1","2VUX"
"2VV0",,"X-RAY DIFFRACTION",2.8,55.5,"VAPOR DIFFUSION",8,"PH 8, TRIS 100MM, 0.7M NACITRATE, 1MM TCEP, 0.5MM EDTA, VAPOUR DIFFUSION, DARK, UNDER NITROGEN, 22 DEGREES CELSIUS",295,"10.1038/nsmb.1474",,"2VV0",63.56,"2.55","2.55","hPPARgamma Ligand binding domain in complex with DHA","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VV0"
"2VV1",,"X-RAY DIFFRACTION",2.8,55.5,"VAPOR DIFFUSION",8,"PH 8, TRIS 100MM, 0.7M NACITRATE, 1MM TCEP, 0.5MM EDTA, VAPOUR DIFFUSION, DARK, UNDER NITROGEN, 22 DEGREES CELSIUS",295,"10.1038/nsmb.1474",,"2VV1",63.6,"2.2","2.2","hPPARgamma Ligand binding domain in complex with 4-HDHA","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VV1"
,,,,,,,,,,,,,,,,"GALNPESSDLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2","2VV1"
"2VV2",,"X-RAY DIFFRACTION",2.8,55.5,"VAPOR DIFFUSION",8,"PH 8, TRIS 100MM, 0.7M NA CITRATE, 1MM TCEP, 0.5MM EDTA, VAPOUR DIFFUSION, DARK, UNDER NITROGEN, 22 DEGREES CELCIUS",295,"10.1038/nsmb.1474",,"2VV2",63.85,"2.75","2.75","hPPARgamma Ligand binding domain in complex with 5-HEPA","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VV2"
"2VV3",,"X-RAY DIFFRACTION",2.8,55.5,"VAPOR DIFFUSION",8,"TRIS 100MM PH 8, 0.7M NA-CITRATE, 1MM TCEP, 0.5MM EDTA, VAPOUR DIFFUSION, DARK, UNDER NITROGEN, 22 DEGREES CELSIUS",295,"10.1038/nsmb.1474",,"2VV3",63.24,"2.85","2.85","hPPARgamma Ligand binding domain in complex with 4-oxoDHA","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VV3"
"2VV4",,"X-RAY DIFFRACTION",2.8,55.5,"VAPOR DIFFUSION",8,"PH 8, TRIS 100MM, 0.7M NACITRATE, 1MM TCEP, 0.5MM EDTA, VAPOUR DIFFUSION, DARK, UNDER NITROGEN, 22 DEGREES CELSIUS",295,"10.1038/nsmb.1474",,"2VV4",63.53,"2.35","2.35","hPPARgamma Ligand binding domain in complex with 6-oxoOTE","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2VV4"
,,,,,,,,,,,,,,,,"GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMQSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2","2VV4"
"2VV9",,"X-RAY DIFFRACTION",2,39,,7.5,"8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,"10.1016/j.bmcl.2008.06.027","IM9","2VV9",34.44,"1.9","1.9","CDK2 in complex with an imidazole piperazine","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2VV9"
"2VVA",,"X-RAY DIFFRACTION",2.11,42,,,"2.4 M (NH4)2(SO4). 0.1 M TRIS PH = 8.5",,"10.1073/pnas.0904184106","SO4","2VVA",29.72,"1.56","1.56","Human carbonic anhydrase in complex with CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2VVA"
"2VVB",,"X-RAY DIFFRACTION",2.13,42,,,"2.4 M (NH4)2SO4. 0.1 M TRIS PH 8.5",,"10.1073/pnas.0904184106","SO4, BCT","2VVB",29.84,"1.66","1.66","Human carbonic anhydrase II in complex with bicarbonate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2VVB"
"2VVC",,"X-RAY DIFFRACTION",2.26,45.6,,,,,"10.1016/j.ejmech.2008.12.025","LZF","2VVC",67.56,"1.95","1.95","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VVC"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VVC"
"2VVK",,"X-RAY DIFFRACTION",1.97,37.5,,4.6,"8% PEG 4K, 0.1M NAACETATE PH 4.6",,"10.1016/j.str.2009.03.017",,"2VVK",6.46,"1.6","1.6","Grb2 SH3C (1)","GSVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVN","Homo sapiens","GRB2, ASH","GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2","1","2VVK"
"2VVU",,"X-RAY DIFFRACTION",2.24,45.1,,,,,"10.1016/j.ejmech.2008.12.025","H22","2VVU",33.77,"2.3","2.3","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VVU"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VVU"
"2VVV",,"X-RAY DIFFRACTION",2.17,43.4,,,,,"10.1016/j.ejmech.2008.12.025","H21","2VVV",33.77,"1.73","1.73","Aminopyrrolidine-related triazole Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VVV"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VVV"
"2VWI",,"X-RAY DIFFRACTION",2.46,49.68,,,,,"10.1002/prot.22238",,"2VWI",140.25,"2.15","2.15","Structure of the OSR1 kinase, a hypertension drug target","MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK","Homo sapiens","OXSR1, KIAA1101, OSR1","SERINE/THREONINE-PROTEIN KINASE OSR1","1","2VWI"
"2VWL",,"X-RAY DIFFRACTION",2.23,44.8,,,,,"10.1016/j.ejmech.2008.12.025","LZH","2VWL",33.84,"1.8","1.8","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VWL"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VWL"
"2VWM",,"X-RAY DIFFRACTION",2.25,45.3,,,,,"10.1016/j.ejmech.2008.12.025","LZI","2VWM",67.66,"1.96","1.96","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VWM"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VWM"
"2VWN",,"X-RAY DIFFRACTION",2.15,42.8,,,,,"10.1016/j.ejmech.2008.12.025","H25","2VWN",33.88,"1.61","1.61","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VWN"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VWN"
"2VWO",,"X-RAY DIFFRACTION",2.14,42.2,,,,,"10.1016/j.ejmech.2008.12.025","LZG","2VWO",33.91,"1.6","1.6","Aminopyrrolidine Factor Xa inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2VWO"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2VWO"
"2VWR",,"X-RAY DIFFRACTION",2.03,39.5,,4.2,"40% PEG 300, 0.1M CITRATE/PO4 PH 4.2",,,,"2VWR",10.31,"1.3","1.3","Crystal structure of the second pdz domain of numb-binding protein 2","SMEILQVALHKRDSGEQLGIKLVRRTDEPGVFILDLLEGGLAAQDGRLSSNDRVLAINGHDLKYGTPELAAQIIQASGERVNLTIARPGKPEIEL","Homo sapiens","LNX2, PDZRN1","LIGAND OF NUMB PROTEIN X 2","1","2VWR"
"2VWU",,"X-RAY DIFFRACTION",2.4,48.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 4 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",277,"10.1016/j.bmcl.2008.04.015","7X1","2VWU",34.41,"2","2","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWU"
"2VWV",,"X-RAY DIFFRACTION",2.2,38.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"CRYSTALLIZATION CONDITIONS: PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.04.015","7X3","2VWV",34.35,"1.9","1.9","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWV"
"2VWW",,"X-RAY DIFFRACTION",2.3,44,"VAPOR DIFFUSION, SITTING DROP",7.5,"CRYSTALLIZATION CONDITIONS: PROTEIN\: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR\: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP\:18 DEGREES C SITTING DROP\: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.04.015","7X2","2VWW",34.37,"1.9","1.9","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWW"
"2VWX",,"X-RAY DIFFRACTION",2.03,38.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.09.087","7X4","2VWX",34.45,"1.65","1.65","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWX"
"2VWY",,"X-RAY DIFFRACTION",2.07,40.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.09.087","7X5","2VWY",34.43,"1.65","1.65","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWY"
"2VWZ",,"X-RAY DIFFRACTION",2.07,43,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.09.087","7X6","2VWZ",34.44,"1.65","1.65","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VWZ"
"2VX0",,"X-RAY DIFFRACTION",2.14,42.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.04.015","7X7","2VX0",34.43,"2.1","2.1","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VX0"
"2VX1",,"X-RAY DIFFRACTION",2.08,40.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 18 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",291,"10.1016/j.bmcl.2008.09.087","7X8","2VX1",34.39,"1.65","1.65","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2VX1"
"2VX2",,"X-RAY DIFFRACTION",2.35,47.7,,,"0.20M NA(FORM); 0.1M BTPROP PH 8.5, 20.0% PEG350, 10.0% ETGLY",,,,"2VX2",281.53,"2.3","2.3","Crystal structure of human enoyl Coenzyme A hydratase domain- containing protein 3 (ECHDC3)","MHHHHHHSSGVDLGTENLYFQSMGAGRRESEPRPTSARQLDGIRNIVLSNPKKRNTLSLAMLKSLQSDILHDADSNDLKVIIISAEGPVFSSGHDLKELTEEQGRDYHAEVFQTCSKVMMHIRNHPVPVIAMVNGLATAAGCQLVASCDIAVASDKSSFATPGVNVGLFCSTPGVALARAVPRKVALEMLFTGEPISAQEALLHGLLSKVVPEAELQEETMRIARKIASLSRPVVSLGKATFYKQLPQDLGTAYYLTSQAMVDNLALRDGQEGITAFLQKRKPVWSH","Homo sapiens","ECHDC3, PP1494, PP8332","ENOYL-COA HYDRATASE DOMAIN-CONTAINING PROTEIN 3","1","2VX2"
"2VX3",,"X-RAY DIFFRACTION",3.02,59,,8.5,"34% PEG 300, 0.1 M LISO4, TRIS PH 8.5",,"10.1016/j.str.2013.03.012",,"2VX3",183.32,"2.4","2.4","Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A","MHHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION- REGULATED KINASE 1A","1","2VX3"
"2VXD",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M801706200",,"2VXD",6.18,,,"The structure of the C-terminal domain of Nucleophosmin","GGSVEDIKAKMQASIEKGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL","Homo sapiens","NPM1, NPM","NUCLEOPHOSMIN","1","2VXD"
"2VXO",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",5.2,"0.1M NAAC,PH 5.2,1.6M AMSO4, 0.2M NACL",,"10.1016/j.jmb.2013.06.032",,"2VXO",156.45,"2.5","2.5","Human GMP synthetase in complex with XMP","MHHHHHHSSGVDLGTENLYFQSMGHHHYEGAVVILDAGAQYGKVIDRRVRELFVQSEIFPLETPAFAIKEQGFRAIIISGGPNSVYAEDAPWFDPAIFTIGKPVLGICYGMQMMNKVFGGTVHKKSVREDGVFNISVDNTCSLFRGLQKEEVVLLTHGDSVDKVADGFKVVARSGNIVAGIANESKKLYGAQFHPEVGLTENGKVILKNFLYDIAGCSGTFTVQNRELECIREIKERVGTSKVLVLLSGGVDSTVCTALLNRALNQEQVIAVHIDNGFMRKRESQSVEEALKKLGIQVKVINAAHSFYNGTTTLPISDEDRTPRKRISKTLNMTTSPEEKRKIIGDTFVKIANEVIGEMNLKPEEVFLAQGTLRPDLIESASLVASGKAELIKTHHNDTELIRKLREEGKVIEPLKDFHKDEVRILGRELGLPEELVSRHPFPGPGLAIRVICAEEPYICKDFPETNNILKIVADFSASVKKPHTLLQRVKACTTEEDQEKLMQITSLHSLNAFLLPIKTVGVQGDCRSYSYVCGISSKDEPDWESLIFLARLIPRMCHNVNRVVYIFGPPVKEPPTDVTPTFLTTGVLSTLRQADFEAHNILRESGYAGKISQMPVILTPLHFDRDPLQKQPSCQRSVVIRTFITSDFMTGIPATPGNEIPVEVVLKMVTEIKKIPGISRIMYDLTSKPPGTTEWE","Homo sapiens","GMPS","GMP SYNTHASE [GLUTAMINE-HYDROLYZING]","1","2VXO"
"2VXP",,"X-RAY DIFFRACTION",2.93,57.9,,,,,,,"2VXP",28.51,"2.5","2.5","The fourth FAS1 domain structure of human Bigh3","MGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNEAFRALPPRERSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLQ","Homo sapiens","TGFBI, BIGH3","TRANSFORMING GROWTH FACTOR-BETA-INDUCED PROTEIN IG-H3","1","2VXP"
"2VXV",,"X-RAY DIFFRACTION",2.7,54.1,,10.5,"ABT-325 FAB FRAGMENT (20 MG/ML, 2 MICROLITERS [UL]) WAS MIXED WITH 2 UL OF A RESERVOIR SOLUTION CONSISTING OF 25 TO 30% POLYETHYLENEGLYCOL (PEG) 400, 100 MM CAPS, PH 10.5 AND SUSPENDED OVER THE RESERVOIR AT 277 K. ROD-LIKE CRYSTALS APPEARED WITHIN ONE DAY.",277,"10.1074/jbc.M109.023887",,"2VXV",47.78,"1.49","1.49","Crystal structure of human IgG ABT-325 Fab Fragment","EVQLVQSGTEVKKPGESLKISCKGSGYTVTSYWIGWVRQMPGKGLEWMGFIYPGDSETRYSPTFQGQVTISADKSFNTAFLQWSSLKASDTAMYYCARVGSGWYPYTFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"HUMAN IGG ABT-325","1","2VXV"
,,,,,,,,,,,,,,,,"EIVMTQSPATLSVSPGERATLSCRASESISSNLAWYQQKPGQAPRLFIYTASTRATDIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPSITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"HUMAN IGG ABT-325","2","2VXV"
"2VXW",,"X-RAY DIFFRACTION",2.43,48.9,,5.5,"pH 5.5",,"10.1002/prot.22542",,"2VXW",31.67,"1.7","1.7","Structural and Functional Studies of the Potent Anti-HIV Chemokine Variant P2-RANTES","FSPLSSQSSACCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C MOTIF CHEMOKINE 5","1","2VXW"
"2VY4",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2008.11.013",,"2VY4",4.25,,,"U11-48K CHHC ZN-FINGER DOMAIN","GSDEVVICPYDSNHHMPKSSLAKHMASCRLRKMGYTK","Homo sapiens","SNRNP48, C6orf151","U11/U12 SMALL NUCLEAR RIBONUCLEOPROTEIN 48 KDA PROTEIN","1","2VY4"
"2VY5",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2008.11.013",,"2VY5",4.25,,,"U11-48K CHHC Zn-finger protein domain","GSDEVVICPYDSNHHMPKSSLAKHMASCRLRKMGYTK","Homo sapiens","SNRNP48, C6orf151","U11/U12 SMALL NUCLEAR RIBONUCLEOPROTEIN 48 KDA PROTEIN","1","2VY5"
"2VYI",,"X-RAY DIFFRACTION",2.7,54.4,,,"4M SODIUM FORMATE",,"10.1021/bi800758a",,"2VYI",28.86,"2.4","2.4","Crystal Structure of the TPR domain of Human SGT","GPLGSEEDSAEAERLKTEGNEQMKVENFEAAVHFYGKAIELNPANAVYFCNRAAAYSKLGNYAGAVQDCERAICIDPAYSKAYGRMGLALSSLNKHVEAVAYYKKALELDPDNETYKSNLKIAELKLREAP","Homo sapiens","SGTA, SGT, SGT1","SGTA PROTEIN","1","2VYI"
"2VYT",,"X-RAY DIFFRACTION",2.53,51,,9.5,"0.1M CHES, PH 9.5 40% PEG 600 5MM MONOMETHYLATD LYSINE 10MM MBT",,"10.1016/j.jmb.2008.07.081","MLZ","2VYT",49.77,"1.9","1.9","The MBT repeats of human SCML2 bind to peptides containing mono methylated lysine.","GSTSSVQRDDFHWEEYLKETGSISAPSECFRQSQIPPVNDFKVGMKLEARDPRNATSVCIATVIGITGARLRLRLDGSDNRNDFWRLVDSPDIQPVGTCEKEGDLLQPPLGYQMNTSSWPMFLLETLNGSEMASATLFKKEPPKPPLNNFKVGMKLEAIDKKNPYLICPATIGDVKGDEVHITFDGWSGAFDYWCKYDSRDIFPAGWCRLTGDVLQPPGTS","Homo sapiens","SCML2","SEX COMB ON MIDLEG-LIKE PROTEIN 2","1","2VYT"
"2VZ2",,"X-RAY DIFFRACTION",2.68,53.73,,6.5,"pH 6.5",,"10.1021/jm8011867",,"2VZ2",120.27,"2.3","2.3","Human MAO B in complex with mofegiline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","2VZ2"
"2VZ5",,"X-RAY DIFFRACTION",2.5,51,,,"15% W/V PEG 3350, 0.15 M ZN ACETATE, 0.1 M NA ACETATE PH 3.8",,,,"2VZ5",15.96,"1.738","1.738","Structure of the PDZ domain of Tax1 (human T-cell leukemia virus type I) binding protein 3","MHHHHHHSSGVDLGTENLYFQSMVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQSLQKAVQQSMLSETEV","Homo sapiens","TAX1BP3, TIP1","TAX1-BINDING PROTEIN 3","1","2VZ5"
"2VZ6",,"X-RAY DIFFRACTION",3.98,69,,8.5,"12% PEG6000, 0.1M TRIS PH8.5",,"10.1371/journal.pbio.1000426",,"2VZ6",72.24,"2.3","2.3","Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804","MHHHHHHSSGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA","Homo sapiens","CAMK2A, CAMKA, KIAA0968","CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA CHAIN","1","2VZ6"
"2VZC",,"X-RAY DIFFRACTION",2.5,50.36,,7.5,"12% (W/V) PEG 8000, 35% (V/V) MPD, 0.1M HEPES PH 7.5",,"10.1016/j.str.2008.08.007",,"2VZC",30.76,"1.05","1.05","Crystal structure of the C-terminal calponin homology domain of alpha parvin","SGRHERDAFDTLFDHAPDKLNVVKKTLITFVNKHLNKLNLEVTELETQFADGVYLVLLMGLLEGYFVPLHSFFLTPDSFEQKVLNVSFAFELMQDGGLEKPKPRPEDIVNCDLKSTLRVLYNLFTKYRNVE","Homo sapiens","PARVA, MXRA2","ALPHA-PARVIN","1","2VZC"
"2VZE",,"X-RAY DIFFRACTION",2.42,49.2,,,"0.2M AMMONIUM ACETATE, 0.1M TRIS PH 8.5, 25% PEG 3350",,"10.1016/j.jmb.2009.03.064",,"2VZE",191.07,"2.45","2.45","Crystal structure of human acyl-CoA synthetase medium-chain family member 2A (L64P mutation) in complex with AMP","MGHHHHHHSSGVDLGTENLYFQSMSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRPPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRADDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVVKAFVVLASQFLSHDPEQLTKELQQHVKSVTAPYKYPRKIEFVLNLPKTVTGKIQRAKLRDKEWKMSGKARAQ","Homo sapiens","ACSM2A, ACSM2, MACS2","ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL","1","2VZE"
"2W05",,"X-RAY DIFFRACTION",2,38,,7.4,"8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,"10.1016/j.bmcl.2008.09.024","FRT","2W05",34.41,"1.9","1.9","Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2W05"
"2W06",,"X-RAY DIFFRACTION",2.1,41,,7.4,"8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,"10.1016/j.bmcl.2008.09.024","FRV","2W06",34.39,"2.04","2.04","Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5c","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2W06"
"2W08",,"X-RAY DIFFRACTION",2.4,48.39,,8,"0.06M TRIS-HCL PH8, 16% PEG 550MME, 0.01M CACL2, 0.08M NACL, 0.1% NAN3, 14.2MG/ML PROTEIN, 50MM LIGAND",,"10.1073/pnas.0902640106","TPO","2W08",118.91,"1.7","1.7","The structure of serum amyloid P component bound to 0-phospho- threonine","HTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV","Homo sapiens","APCS, PTX2","SERUM AMYLOID P-COMPONENT","1","2W08"
"2W0D",,"X-RAY DIFFRACTION",2.05,40.14,,6.2,"100 MM IMIDAZOLE,1.1-1.6 M SODIUM ACETATE, 1 MM 1,3-DIAMINO-PROPANE, PH 6.2, 291K",291,"10.1021/jm801388q","CGS","2W0D",76.34,"2","2","Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGHHHHH","Homo sapiens","MMP12, HME","MACROPHAGE METALLOELASTASE","1","2W0D"
"2W0G",,"X-RAY DIFFRACTION",2.36,48,,,,,"10.1074/jbc.M806715200",,"2W0G",15.52,"1.88","1.88","HSP90 CO-CHAPERONE CDC37","HKTFVEKYEKQIKHFGMLRRWDDSQKYLSDNVHLVCEETANYLVIWCIDLEVEEKCALMEQVAHQTIVMQFILELAKSLKVDPRACFRQFFTKIKTADRQYMEGFNDELEAFKERVRGRAKLRIEKAMK","Homo sapiens","CDC37, CDC37A","HSP90 CO-CHAPERONE CDC37","1","2W0G"
"2W0I",,"X-RAY DIFFRACTION",2.6,53,,6.5,"2.6M SODIUM MALONATE, 0.1M BISTRIS PH6.5",,,,"2W0I",15.72,"1.8","1.8","Structure Of C-Terminal Actin Depolymerizing Factor Homology (Adf-H) Domain Of Human Twinfilin-2","SMPLQPEAQRALQQLKQKMVNYIQMKLDLERETIELVHTEPTDVAQLPSRVPRDAARYHFFLYKHTHEGDPLESVVFIYSMPGYKCSIKERMLYSSCKSRLLDSVEQDFHLEIAKKIEIGDGAELTAEFLDDEVH","Homo sapiens","TWF2, PTK9L, MSTP011","TWINFILIN-2","1","2W0I"
"2W0J",,"X-RAY DIFFRACTION",3.1,59.7,,7.8,"0.1 M HEPES PH 7.8, 0.2 M MAGNESIUM NITRATE, 14% W/V PEG3350, 16% V/V ETHYLENE GLYCOL. PROTEIN WAS INCUBATED WITH 1MM INHIBITOR PRIOR TO CRYSTALLIZATION",,"10.1002/pro.16","ZAT","2W0J",37.03,"2.05","2.05","Crystal structure of Chk2 in complex with NSC 109555, a specific inhibitor","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2W0J"
"2W0K",,"X-RAY DIFFRACTION",2.85,56.8,,,,,"10.1016/j.jmb.2009.11.038",,"2W0K",23.92,"2.35","2.35","Crystal structure of the recombinant variable domain 6JAL2","NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","V1-22","V1-22 PROTEIN","1","2W0K"
"2W0L",,"X-RAY DIFFRACTION",2.84,56.64,,,,,,,"2W0L",47.68,"2.2","2.2","CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2","NFMLTQPPSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","V1-22","V1-22 protein","1","2W0L"
"2W0T",,"SOLUTION NMR",,,,,,,"10.1002/pro.51",,"2W0T",4.67,,,"Solution structure of the FCS zinc finger domain of human LMBL2","GSGSEPAVCEMCGIVGTREAFFSKTKRFCSVSCSRSYSSNSKK","Homo sapiens","L3MBTL2","LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE 2 PROTEIN","1","2W0T"
"2W0U",,"X-RAY DIFFRACTION",3.07,59.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALLISATION WAS PERFORMED BY THE HANGING DROP VAPOR DIFFUSION METHOD, USING A PRECIPITANT SOLUTION CONTAINING 200 MM NACL, 100 MM MMT AT PH 7.5, AND 15% (W/V) POLYETHYLENE GLYCOL 1000",,"10.1107/S1744309109041670",,"2W0U",166.82,"2.84","2.84","CRYSTAL STRUCTURE OF HUMAN GLYCOLATE OXIDASE IN COMPLEX WITH THE INHIBITOR 5-[(4-CHLOROPHENYL)SULFANYL]- 1,2,3-THIADIAZOLE-4-CARBOXYLATE.","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVSKI","Homo sapiens","HAO1, GOX1","HYDROXYACID OXIDASE 1","1","2W0U"
"2W0X",,"X-RAY DIFFRACTION",3.43,64,,7.5,"1.6M AMMONIUM SULFATE, 0.1M HEPES PH 7.5, 5% PEG400, 1MM FESO4, 2MM SUBSTRATE",,"10.1016/j.bmcl.2010.08.032","PD2","2W0X",40.93,"2.12","2.12","FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1 ALPHA INHIBITOR","1","2W0X"
"2W17",,"X-RAY DIFFRACTION",2.06,40.3,,7.5,"8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,"10.1016/j.bmcl.2008.10.102","I19","2W17",34.51,"2.15","2.15","CDK2 in complex with the imidazole pyrimidine amide, compound (S)-8b","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2W17"
"2W18",,"X-RAY DIFFRACTION",2.41,48.9,,6,"100 MM MES PH 6.0, 50 MM KH2PO4, 12-20% (W/V) PEG 8000",,"10.1038/embor.2009.126",,"2W18",39.62,"1.9","1.9","Crystal structure of the C-terminal WD40 domain of human PALB2","GPHMSVEQTETAELPASDSINPGNLQLVSELKNPSGSCSVDVSAMFWERAGCKEPCIITACEDVVSLWKALDAWQWEKLYTWHFAEVPVLQIVPVPDVYNLVCVALGNLEIREIRALFCSSDDESEKQVLLKSGNIKAVLGLTKRRLVSSSGTLSDQQVEVMTFAEDGGGKENQFLMPPEETILTFAEVQGMQEALLGTTIMNNIVIWNLKTGQLLKKMHIDDSYQASVCHKAYSEMGLLFIVLSHPCAKESESLRSPVFQLIVINPKTTLSVGVMLYCLPPGQAGRFLEGDVKDHCAAAILTSGTIAIWDLLLGQCTALLPPVSDQHWSFVKWSGTDSHLLAGQKDGNIFVYHYS","Homo sapiens","PALB2, FANCN","PARTNER AND LOCALIZER OF BRCA2","1","2W18"
"2W1C",,"X-RAY DIFFRACTION",2.72,54.42,,,,,"10.1021/jm800984v","L0C","2W1C",32.74,"3.24","3.24","Structure determination of Aurora Kinase in complex with inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2W1C"
"2W1D",,"X-RAY DIFFRACTION",2.91,57.33,,,,,"10.1021/jm800984v","L0D","2W1D",32.34,"2.97","2.97","Structure determination of Aurora Kinase in complex with inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2W1D"
"2W1E",,"X-RAY DIFFRACTION",2.8,56.3,,,,,"10.1021/jm800984v","L0E","2W1E",32.58,"2.93","2.93","Structure determination of Aurora Kinase in complex with inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2W1E"
"2W1F",,"X-RAY DIFFRACTION",2.77,55.25,,,,,"10.1021/jm800984v","L0F","2W1F",32.46,"2.85","2.85","Structure determination of Aurora Kinase in complex with inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2W1F"
"2W1G",,"X-RAY DIFFRACTION",2.82,56.07,,,,,"10.1021/jm800984v","L0G","2W1G",32.7,"2.71","2.71","Structure determination of Aurora Kinase in complex with inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2W1G"
"2W1H",,"X-RAY DIFFRACTION",1.99,38,,,,,"10.1021/jm800984v","L0F","2W1H",34.28,"2.15","2.15","Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi- targeted Kinase Inhibitor with Potent Aurora Kinase Activity","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2W1H"
"2W1I",,"X-RAY DIFFRACTION",2.36,47.56,,,,,"10.1021/jm800984v","L0I","2W1I",77.56,"2.6","2.6","Structure determination of Aurora Kinase in complex with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG","Homo sapiens","JAK2","JAK2","1","2W1I"
"2W1O",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq231",,"2W1O",14.41,,,"NMR structure of dimerization domain of human ribosomal protein P2","AMRYVASYLLAALGGNSSPSAKDIKKILDSVGIEADDDRLNKVISELNGKNIEDVIAQGIGKLASVPAGG","Homo sapiens","RPLP2, D11S2243E, RPP2","60S ACIDIC RIBOSOMAL PROTEIN P2","1","2W1O"
"2W26",,"X-RAY DIFFRACTION",2.42,48.88,,,,,"10.1021/jm050101d","RIV","2W26",32.42,"2.08","2.08","Factor Xa in complex with BAY59-7939","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2W26"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTL","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","2","2W26"
"2W2C",,"X-RAY DIFFRACTION",2.86,57,,4.6,"30% PEG400, 0.1M CADMIUM CHLORIDE, 0.1M SODIUM ACETATE PH4.6",,"10.1371/journal.pbio.1000426",,"2W2C",231.3,"2.7","2.7","STRUCTURE OF THE TETRADECAMERIC OLIGOMERISATION DOMAIN OF CALCIUM- CALMODULIN DEPENDENT PROTEIN KINASE II DELTA","SMSNTTIEDEDVKARKQEIIKVTEQLIEAINNGDFEAYTKICDPGLTAFEPEALGNLVEGMDFHRFYFENALSKSNKPIHTIILNPHVHLVGDDAACIAYIRLTQYMDGSGMPKTMQSEETRVWHRRDGKWQNVHFHRSGSPTV","Homo sapiens","CAMK2D, CAMKD","CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II DELTA CHAIN","1","2W2C"
"2W2I",,"X-RAY DIFFRACTION",2.29,46.34,,,,,"10.1074/jbc.M111.283689","PD2","2W2I",124.73,"2.1","2.1","Crystal structure of the human 2-oxoglutarate oxygenase LOC390245","MHHHHHHSSGVDLGTENLYFQSMKSVHSSPQNTSHTIMTFYPTMEEFADFNTYVAYMESQGAHQAGLAKVIPPKEWKARQMYDDIEDILIATPLQQVTSGQGGVFTQYHKKKKAMRVGQYRRLANSKKYQTPPHQNFADLEQRYWKSHPGNPPIYGADISGSLFEESTKQWNLGHLGTILDLLEQECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHFGEPKTWYVVPPEHGQHLERLARELFPDISRGCEAFLRHKVALISPTVLKENGIPFNCMTQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGESTVTFSMDPFVRIVQPESYELWKHR","Homo sapiens","KDM4E, KDM4DL","2-OXOGLUTARATE OXYGENASE","1","2W2I"
"2W2J",,"X-RAY DIFFRACTION",2.2,44.18,,6.3,"20 MM NH4CL, 20.0% PEG 6K, 10.0% GLYCEROL, pH 6.3",,"10.1002/prot.22411",,"2W2J",33.75,"1.6","1.6","Crystal structure of the human carbonic anhydrase related protein VIII","SMADLSFIEDTVAFPEKEEDEEEEEEGVEWGYEEGVEWGLVFPDANGEYQSPINLNSREARYDPSLLDVRLSPNYVVCRDCEVTNDGHTIQVILKSKSVLSGGPLPQGHEFELYEVRFHWGRENQRGSEHTVNFKAFPMELHLIHWNSTLFGSIDEAVGKPHGIAIIALFVQIGKEHVGLKAVTEILQDIQYKGKSKTIPCFNPNTLLPDPLLRDYWVYEGSLTIPPCSEGVTWILFRYPLTISQLQIEEFRRLRTHVKGAELVEGCDGILGDNFRPTQPLSDRVIRAAFQ","Homo sapiens","CA8, CALS","CARBONIC ANHYDRASE-RELATED PROTEIN","1","2W2J"
"2W2T",,"X-RAY DIFFRACTION",2.55,52,,7,"RAC2(2-192)GDP WAS CRYSTALLIZED USING A PROTEIN CONCENTRATION OF 20 MG/ML WITH PRECIPITANT (20% PEG3350, 100 MM BIS-TRIS PROPANE PH 7.0) AND AT A CONSTANT TEMPERATURE OF 4C",277,"10.1016/j.molcel.2009.02.023",,"2W2T",20.78,"1.95","1.95","Rac2 (G12V) in complex with GDP","GGGSGGSQAIKCVVVGDVAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDSKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASYENVRAKWFPEVRHHCPSTPIILVGTKLDLRDDKDTIEKLKEKKLAPITYPQGLALAKEIDSVKYLECSALTQRGLKTVFDEAIRAVLCP","Homo sapiens","RAC2","RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2","1","2W2T"
"2W2V",,"X-RAY DIFFRACTION",2.7,54,,7,"RAC2(2-177)GTPGS WAS CRYSTALLIZED USING A PROTEIN CONCENTRATION OF 25 MG/ML WITH PRECIPITANT (18% PEG3350, 300 MM SODIUM/POTASSIUM TARTRATE) AND AT A CONSTANT TEMPERATURE OF 20C",293,"10.1016/j.molcel.2009.02.023",,"2W2V",83.06,"2","2","Rac2 (G12V) in complex with GTPgS","GGGSGGSMQAIKCVVVGDVAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDSKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASYENVRAKWFPEVRHHCPSTPIILVGTKLDLRDDKDTIEKLKEKKLAPITYPQGLALAKEIDSVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC2","RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2","1","2W2V"
"2W2W",,"X-RAY DIFFRACTION",3.1,60,,7,"PLCSPPH(Y495F) WAS CRYSTALLIZED USING A PROTEIN CONCENTRATION OF 36 MG/ML WITH PRECIPITANT (20% PEG3350, 100 MM BIS-TRIS PROPANE PH 7.5) AT A CONSTANT TEMPERATURE OF 20C",293,"10.1016/j.molcel.2009.02.023",,"2W2W",170.43,"2.8","2.8","PLCg2 Split Pleckstrin Homology (PH) Domain","GGGSGGSKKDEHKQQGELYMWDSIDQKWTRHFCAIADAKLSFSDDIEQTMEEDNPLGSLCRGILDLNTYNVVKAPQGKNQKSFVFILEPKQQGDPPVEFATDKVEELFEWFQSIREITWKIDTK","Homo sapiens","PLCG2","1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE GAMMA-2","1","2W2W"
"2W3A",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, HANGING DROP",8.75,"HUMAN DHFR/FOLATE COMPLEX WAS MIXED WITH NADPH AND TRIMETHOPRIM (BOTH 2 MM FINAL). CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION AT 277 K BY MIXING EQUAL VOLUMES OF PROTEIN/NADPH/TMP WITH RESERVOIR (24% PEG 4000, 200 MM LI2SO4, 100 MM TRIS.HCL, PH 8.75). TRUNCATED TRIANGULAR CRYSTALS APPEARED SLOWLY, IN ABOUT A MONTH. THE CRYSTAL WAS CRYOPROTECTED WITH 15% GLYCEROL AND FLASH-COOLED IN LIQUID N2.",277,,"TOP","2W3A",45.31,"1.5","1.5","HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","DIHYDROFOLATE REDUCTASE","1","2W3A"
"2W3B",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, HANGING DROP",8.75,"HUMAN DHFR/FOLATE COMPLEX WAS MIXED WITH NADPH AND 6-((2,5-DIETHOXYPHENYL)AMINOMETHYL)-2, 4-DIAMINO-5-METHYLPYRIDO(2,3-D)PYRIMIDINE (SRI-8686) (BOTH 2 MM FINAL). CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION AT 277 K BY MIXING EQUAL VOLUMES OF PROTEIN/NADPH/SRI-8686 WITH RESERVOIR (24% PEG 4000, 200 MM LI2SO4, 100 MM TRIS.HCL, PH 8.75). TRUNCATED TRIANGULAR CRYSTALS APPEARED SLOWLY, IN ABOUT A MONTH. THE CRYSTAL WAS CRYOPROTECTED WITH 15% GLYCEROL AND FLASH-COOLED IN LIQUID N2.",277,,"VG9","2W3B",46.15,"1.27","1.27","HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR, 6-((2,5- DIETHOXYPHENYL)AMINOMETHYL)-2,4-DIAMINO-5-METHYLPYRIDO(2,3-D) PYRIMIDINE (SRI-8686)","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","DIHYDROFOLATE REDUCTASE","1","2W3B"
"2W3C",,"X-RAY DIFFRACTION",3.8,68,,7.5,"pH 7.5",,"10.1371/journal.pone.0004656",,"2W3C",64.66,"2.22","2.22","Globular head region of the human general vesicular transport factor p115","YRLEVGIQAMEHLIHVLQTDRSDSEIIGYALDTLYNIISNEEEEEVEENSTRQSEDLGSQFTEIFIKQQENVTLLLSLLEEFDFHVRWPGVKLLTSLLKQLGPQVQQIILVSPMGVSRLMDLLADSREVIRNDGVLLLQALTRSNGAIQKIVAFENAFERLLDIISEEGNSDGGIVVEDCLILLQNLLKNNNSNQNFFKEGSYIQRMKPWFEVGDENSGWSAQKVTNLHLMLQLVRVLVSPTNPPGATSSCQKAMFQCGLLQQLCTILMATGVPADILTETINTVSEVIRGCQVNQDYFASVNAPSNPPRPAIVVLLMSMVNERQPFVLRCAVLYCFQCFLYKNQKGQGEIVSTLLPSTIDATGNSVSAGQLLCGGLFSTDSLSNWCAAVALAHALQENATQKEQLLRVQLATSIGNPPVSLLQQCTNILSQGSKIQTRVGLLMLLCTWLSNCPIAVTHFLHNSANVPFLTGQIAENLGEEEQLVQGLCALLLGISIYFNDNSLESYMKEKLKQLIEKRIGKENFIEKLGFISKHELYSRASQKPQPNFPSPEYMIFDHEFTKLVKELEGVITKAIY","Homo sapiens","USO1, VDP","GENERAL VESICULAR TRANSPORT FACTOR P115","1","2W3C"
"2W3I",,"X-RAY DIFFRACTION",2.34,46.91,,,,,"10.1016/j.bmc.2009.01.063","L1C","2W3I",32.51,"1.9","1.9","Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","COAGULATION FACTOR X, HEAVY CHAIN","1","2W3I"
,,,,,,,,,,,,,,,,"LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","COAGULATION FACTOR X, LIGHT CHAIN","2","2W3I"
"2W3K",,"X-RAY DIFFRACTION",2.4,48.3,,,,,"10.1016/j.bmc.2009.01.063","L1D","2W3K",32.49,"2.05","2.05","Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","COAGULATION FACTOR X, HEAVY CHAIN","1","2W3K"
,,,,,,,,,,,,,,,,"LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","COAGULATION FACTOR X, LIGHT CHAIN","2","2W3K"
"2W3L",,"X-RAY DIFFRACTION",2.23,44.5,,,,,"10.1016/j.bmcl.2008.10.113","DRO","2W3L",34.9,"2.1","2.1","Crystal Structure of Chimaeric Bcl2-xL and Phenyl Tetrahydroisoquinoline Amide Complex","YDNREIVMKYIHYKLSQRGYEWDAGADSEVVHKTLREAGDDFSRRYRRDFAEMSSGLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSM","Homo sapiens","BCL2","APOPTOSIS REGULATOR BCL-2","1","2W3L"
"2W3M",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, HANGING DROP",8.75,"HUMAN DHFR/FOLATE COMPLEX WAS MIXED WITH NADPH (2 MM FINAL). CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION AT 277 K BY MIXING EQUAL VOLUMES OF PROTEIN/NADPH/FOLATE WITH RESERVOIR (24% PEG 4000, 200 MM LI2SO4, 100 MM TRIS.HCL, PH 8.75). TRUNCATED TRIANGULAR CRYSTALS APPEARED SLOWLY, IN ABOUT A MONTH. THE CRYSTAL WAS CRYOPROTECTED WITH 15% GLYCEROL AND FLASH-COOLED IN LIQUID N2.",277,,,"2W3M",45.34,"1.6","1.6","HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","DIHYDROFOLATE REDUCTASE","1","2W3M"
"2W44",,"X-RAY DIFFRACTION",2.1,42,,7,"150 MM NA/K-PHOSPHATE PH 7.0 AND 7.5 % (V/V) ETHANOL",,"10.1021/bi1000118",,"2W44",16.39,"2","2","Structure DeltaA1-A4 insulin","QCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN","1","2W44"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","INSULIN","2","2W44"
"2W4C",,"X-RAY DIFFRACTION",1.87,34.38,,6,"16MG/ML K99A IN 20MMTRIS, 0.2MNACL, PH7.5 K99A WAS CRYSTALLIZED IN 0.1M BIS-TRIS, 0.1M NAOAC, PH6.0 WITH 25% PEG3350 AS CYROPROTECTANT",,"10.1371/journal.pbio.1001027",,"2W4C",11.22,"1.52","1.52","Human common-type acylphosphatase variant, A99","MAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGQLQGPISKVRHMQEWLETRGSPKSHIDKANFNNEKVILKLDYSDFQIVA","Homo sapiens","ACYP1, ACYPE","ACYLPHOSPHATASE-1","1","2W4C"
"2W4F",,"X-RAY DIFFRACTION",1.95,37.1,,6.3,"0.15 M AMMONIUM CL PH 6.3, 20 % PEG 1000, 15% ETHYLENE GLYCOL",,,,"2W4F",10.4,"1.3","1.3","CRYSTAL STRUCTURE OF THE FIRST PDZ DOMAIN OF HUMAN SCRIB1","SMEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRERETSV","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","PROTEIN LAP4","1","2W4F"
"2W4J",,"X-RAY DIFFRACTION",3.23,61.95,,,,,,,"2W4J",32.36,"1.3","1.3","X-ray structure of a DAP-Kinase 2-277","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2W4J"
"2W4K",,"X-RAY DIFFRACTION",2.95,58.38,,,,,"10.1016/j.chembiol.2013.12.008",,"2W4K",35.15,"1.9","1.9","X-ray structure of a DAP-Kinase 2-302","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAAR","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2W4K"
"2W4L",,"X-RAY DIFFRACTION",2.1,41.55,,,,,,,"2W4L",121.45,"2.1","2.1","Human dCMP deaminase","MSCKKRDDYLEWPEYFMAVAFLSAQRSKDPNSQVGACIVNSENKIVGIGYNGMPNGCSDDVLPWRRTAENKLDTKYPYVCHAELNAIMNKNLTDVKGCSMYVALFPCNECAKLIIQAGIKEVIFMSDKYHDSDEATAARLLFNMAGVTFRKFIPKCSKIVIDFDSINSRPSAHHHHHH","Homo sapiens","DCTD","DEOXYCYTIDYLATE DEAMINASE","1","2W4L"
"2W4M",,"X-RAY DIFFRACTION",5.33,76.95,,,"0.8M NA_PHOSPHATE_(NA_H2_PO4)-4M, 0.16M K_PHOSPHATE_(K2_H_PO4)-4M AT 20 DEGREES C",293,,,"2W4M",30.69,"2.6","2.6","The Crystal Structure of human N-acetylneuraminic acid phosphatase, NANP","MHHHHHHSSGVDLGTENLYFQSMGLSRVRAVFFDLDNTLIDTAGASRRGMLEVIKLLQSKYHYKEEAEIICDKVQVKLSKECFHPYNTCITDLRTSHWEEAIQETKGGAANRKLAEECYFLWKSTRLQHMTLAEDVKAMLTELRKEVRLLLLTNGDRQTQREKIEACACQSYFDAVVVGGEQREEKPAPSIFYYCCNLLGVQPGDCVMVGDTLETDIQGGLNAGLKATVWINKNGIVPLKSSPVPHYMVSSVLELPALLQSIDCKVSMST","Homo sapiens","NANP, C20orf147, HDHD4","N-ACYLNEURAMINATE-9-PHOSPHATASE","1","2W4M"
"2W4O",,"X-RAY DIFFRACTION",2.02,39.05,,5.5,"17% PEG 10K; 0.10M (NH4)(AC); 0.1M BIS-TRIS PH 5.5",,,,"2W4O",39.75,"2.17","2.17","Crystal structure of Human CAMK4 in complex with 4-Amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)","MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASSRLG","Homo sapiens","CAMK4, CAMK, CAMK-GR, CAMKIV","CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE IV","1","2W4O"
"2W4P",,"X-RAY DIFFRACTION",1.85,33.7,,7,"2.4M SODIUM MALONATE, PH7.0 25% GLYCEROL",,"10.1371/journal.pbio.1001027",,"2W4P",11.3,"1.7","1.7","Human common-type acylphosphatase variant, A99G","MAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGQLQGPISKVRHMQEWLETRGSPKSHIDKANFNNEKVILKLDYSDFQIVG","Homo sapiens","ACYP1, ACYPE","ACYLPHOSPHATASE-1","1","2W4P"
"2W4Q",,"X-RAY DIFFRACTION",2.55,51.8,,,"0.1M TRIS PH 8.5; 2M (NH4)2SO4",,,,"2W4Q",41.4,"2","2","Crystal structure of human zinc-binding alcohol dehydrogenase 1 (ZADH1) in ternary complex with NADP and 18beta-glycyrrhetinic acid","MMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEIAENLYFQ","Homo sapiens","PTGR2, ZADH1","PROSTAGLANDIN REDUCTASE 2","1","2W4Q"
"2W4R",,"X-RAY DIFFRACTION",2.78,55.8,,7.5,"pH 7.5",,"10.1093/nar/gkp059",,"2W4R",66.14,"2.6","2.6","Crystal structure of the regulatory domain of human LGP2","AAQRENQRQQFPVEHVQLLCINCMVAVGHGSDLRKVEGTHHVNVNPNFSNYYNVSRDPVVINKVFKDWKPGGVISCRNCGEVWGLQMIYKSVKLPVLKVRSMLLETPQGRIQAKKWSRVPFSVPDFDFLQHCAENLSDLSLD","Homo sapiens","DHX58, D11LGP2E, LGP2","PROBABLE ATP-DEPENDENT RNA HELICASE DHX58","1","2W4R"
"2W50",,"X-RAY DIFFRACTION",2.4,53,"VAPOR DIFFUSION, SITTING DROP",4.6,"CRYSTALS OF CDNF AT 10-20 MG/ML WERE GROWN IN SITTING DROPS OVER A RESERVOIR SOLUTION OF 100 MM NA-ACETATE, PH 4.6, 0.2 M NH4-ACETATE AND 25-30 % MME-PEG 2000.",,"10.1093/protein/gzn080",,"2W50",23.88,"1.6","1.6","N-terminal domain of human conserved dopamine neurotrophic factor (CDNF)","RPGADCEVCKEFLNRFYKSLIDRGVNFSLDTIEKELISFCLDTKGKENRLCYYLGATKDAATKILSEVTRPMSVHMPAMKICEKLKKLDSQICELKYEKTLD","Homo sapiens","CDNF, ARMETL1","ARMET-LIKE PROTEIN 1","1","2W50"
"2W51",,"X-RAY DIFFRACTION",3,53,"VAPOR DIFFUSION, HANGING DROP",6.5,"NEEDLE CRYSTALS OF MANF WERE TYPICALLY OBTAINED WITHIN 1 TO 2 WEEKS AT 4 C OVER A RESERVOIR SOLUTION OF 100 MM SODIUM CACODYLATE BUFFER, PH 6.5, 0.2 M MGAC2 AND 12-18 % PEG 8000.",277,"10.1093/protein/gzn080",,"2W51",18.2,"2.8","2.8","Human mesencephalic astrocyte-derived neurotrophic factor (MANF)","LRPGDCEVCISYLGRFYQDLKDRDVTFSPATIENELIKFCREARGKENRLCYYIGATDDAATKIINEVSKPLAHHIPVEKICEKLKKKDSQICELKYDKQIDLSTVDLKKLRVKELKKILDDWGETCKGCAEKSDYIRKINELMPKYAPKAASARTDL","Homo sapiens","MANF, ARMET, ARP","PROTEIN ARMET","1","2W51"
"2W5A",,"X-RAY DIFFRACTION",2.55,57.04,,,"50 MM TRIS, PH 8.5 2-10% PEG8000",,"10.1016/j.jmb.2008.12.033",,"2W5A",33.36,"1.55","1.55","Human Nek2 kinase ADP-bound","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2W5A"
"2W5B",,"X-RAY DIFFRACTION",2.56,51.91,,,"50 MM TRIS, PH 8.5 2-10% PEG8000",,"10.1016/j.jmb.2008.12.033",,"2W5B",33.22,"2.4","2.4","Human Nek2 kinase ATPgammaS-bound","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2W5B"
"2W5H",,"X-RAY DIFFRACTION",2.55,51.85,,,"50 MM TRIS, PH 8.5 2-10% PEG8000",,"10.1016/j.jmb.2008.12.033",,"2W5H",32.63,"2.33","2.33","Human Nek2 kinase Apo","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2W5H"
"2W5Y",,"X-RAY DIFFRACTION",2.32,47,,6.8,"0.1 M SODIUM CACODYLATE, PH6.5, 2 % PEG 8000, 30 % 2-METHYL-2,4-PENTANDIOL, pH 6.8",,"10.1016/j.molcel.2008.12.029","SAH","2W5Y",22.63,"2","2","Binary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenosylhomocysteine.","GPLGSHMHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","HISTONE-LYSINE N-METHYLTRANSFERASE HRX","1","2W5Y"
"2W7A",,"X-RAY DIFFRACTION",2.2,44,,7,"2.2 M NA-MALONATE, PH7.0",,"10.1073/pnas.0809964106",,"2W7A",23.35,"1.4","1.4","Structure of the human LINE-1 ORF1p central domain","GAMGNLRLIGVPESDVENGTKLENTLQDIIQENFPNLARQANVQIQEIQRTPQRYSSRRATPRHIIVRFTKVEMKEKMLRAAREKGRVTLKGKPIRLTVD","Homo sapiens","L1RE1, LRE1","LINE-1 ORF1P","1","2W7A"
"2W7O",,"X-RAY DIFFRACTION",4.4,74.6,,7,"175 MM NACL, 25 MM HEPES PH 7.3, 5 MM GLYCEROL, 2.5 MM 2-MERCHAPTOETHANOL, 0.5 MM TECEP, 5 MM CACL2, 5 MM DGTP, 9% PEG5000MME, 0.1 M AMMONIUM ACETATE, 10 MM MES PH 6.5",,"10.1074/jbc.M109.003905",,"2W7O",136.22,"3.16","3.16","Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct","MGLNDNKAGMEGLDKEKINKIIMEATKGSRFYGNELKKEKQVNQRIENMMQQKAQITSQQLRKAQLQVDRFAMELEQSRNLSNTIVHIDMDAFYAAVEMRDNPELKDKPIAVGSMSMLSTSNYHARRFGVRAAMPGFIAKRLCPQLIIVPPNFDKYRAVSKEVKEILADYDPNFMAMSLDEAYLNITKHLEERQNWPEDKRRYFIKMGSSVENDNPGKEVNKLSEHERSISPLLFEESPSDVQPPGDPFQVNFEEQNNPQILQNSVVFGTSAQEVVKEIRFRIEQKTTLTASAGIAPNTMLAKVCSDKNKPNGQYQILPNRQAVMDFIKDLPIRKVSGIGKVTEKMLKALGIITCTELYQQRALLSLLFSETSWHYFLHISLGLGSTHLTRDGERKSMSVERTFSEINKAEEQYSLCQELCSELAQDLQKERLKGRTVTIKLKNVNFEVKTRASTVSSVVSTAEEIFAIAKELLKTEIDADFPHPLRLRLMGVRISSFPNEEDRKHQQ","Homo sapiens","POLK, DINB1","DNA POLYMERASE KAPPA","1","2W7O"
,,,,,,,,,,,,,,,,"GGGGGAAGGATTC",,,"5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*C)-3'","2","2W7O"
,,,,,,,,,,,,,,,,"TCACGGAATCCTTCCCCC",,,"5'-D(TP*CP*AP*CP*8OGP*GP*AP*AP*TP*CP*CP*TP* TP*CP*CP*CP*CP*C)-3'","3","2W7O"
"2W7P",,"X-RAY DIFFRACTION",4.4,75.7,,7,"70 MM NACL,1.35 MM KCL, 2.1 MM NA2HPO4, 0.75 MM KH2PO4, PH 7.4, 5 MM GLYCEROL, 0.5 MM EDTA, 0.5 MM DTT, 2.5 MM 2-MERCHAPTOETHANOL, 0.05% NONIDET P-40, 2.5 MM CACL2, 2.5 MM DATP, 11% PEG5000MME, 0.1 M AMMONIUM ACETATE,10 MM MES PH 6.5",,"10.1074/jbc.M109.003905",,"2W7P",136.19,"3.71","3.71","Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct","MGLNDNKAGMEGLDKEKINKIIMEATKGSRFYGNELKKEKQVNQRIENMMQQKAQITSQQLRKAQLQVDRFAMELEQSRNLSNTIVHIDMDAFYAAVEMRDNPELKDKPIAVGSMSMLSTSNYHARRFGVRAAMPGFIAKRLCPQLIIVPPNFDKYRAVSKEVKEILADYDPNFMAMSLDEAYLNITKHLEERQNWPEDKRRYFIKMGSSVENDNPGKEVNKLSEHERSISPLLFEESPSDVQPPGDPFQVNFEEQNNPQILQNSVVFGTSAQEVVKEIRFRIEQKTTLTASAGIAPNTMLAKVCSDKNKPNGQYQILPNRQAVMDFIKDLPIRKVSGIGKVTEKMLKALGIITCTELYQQRALLSLLFSETSWHYFLHISLGLGSTHLTRDGERKSMSVERTFSEINKAEEQYSLCQELCSELAQDLQKERLKGRTVTIKLKNVNFEVKTRASTVSSVVSTAEEIFAIAKELLKTEIDADFPHPLRLRLMGVRISSFPNEEDRKHQQ","Homo sapiens","POLK, DINB1","DNA POLYMERASE KAPPA","1","2W7P"
,,,,,,,,,,,,,,,,"GGGGGAAGGATTC",,,"5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*C)-3'","2","2W7P"
,,,,,,,,,,,,,,,,"TCACGGAATCCTTCCCCC",,,"5'-D(TP*CP*AP*CP*8OGP*GP*AP*AP*TP*CP*CP*TP* TP*CP*CP*CP*CP*C)-3'","3","2W7P"
"2W7R",,"X-RAY DIFFRACTION",2.06,40.38,,,"75MM NA PHOSPHATE, 91MM K PHOSPHATE",,"10.1002/pro.349",,"2W7R",21.4,"1.6","1.6","Structure of the PDZ domain of Human Microtubule associated serine- threonine kinase 4","SMQPIVIHSSGKNYGFTIRAIRVYVGDSDIYTVHHIVWNVEEGSPACQAGLKAGDLITHINGEPVHGLVHTEVIELLLKSGNKVSITTTPFENTETSV","Homo sapiens","MAST4, KIAA0303","MICROTUBULE-ASSOCIATED SERINE/THREONINE-PROTEIN KINASE 4","1","2W7R"
"2W7X",,"X-RAY DIFFRACTION",3.1,60,,7.8,"0.1 M HEPES PH 7.8, 0.1 M MAGNESIUM NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1124/jpet.109.154997","D1A","2W7X",37.15,"2.07","2.07","Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel Chk2 inhibitor PV1019","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2W7X"
"2W86",,"X-RAY DIFFRACTION",1.99,38.2,,7.5,"100 MM TRIS PH 7.5, 200 MM NAI, 16% PEG 3350",,"10.1016/j.str.2009.03.014",,"2W86",15.99,"1.8","1.8","Crystal structure of fibrillin-1 domains cbEGF9hyb2cbEGF10, calcium saturated form","SADIDECESSPCINGVCKNSPGSFICECSSESTLDPTKTICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLGAAWGSPCTLCQVDPICGKGYSRIKGTQCEDIDECEVFPGVCKNGLCVNTRGSFKCQCPSGMTLDATGRICL","Homo sapiens","FBN1, FBN","FIBRILLIN-1","1","2W86"
"2W8N",,"X-RAY DIFFRACTION",3.52,64.78,,7.25,"100 MM HEPES, PH 7.25, 1.9 M LITHIUM SULFATE",,"10.1038/emboj.2009.40",,"2W8N",53.06,"2","2","The crystal structure of the oxidized form of human SSADH","GRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTCVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL","Homo sapiens","ALDH5A1, SSADH","SUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL","1","2W8N"
"2W8O",,"X-RAY DIFFRACTION",3.81,67.48,,7.25,"100 MM HEPES PH 7.25, 1.9 M LITHIUM SULFATE",,"10.1038/emboj.2009.40",,"2W8O",53.24,"3.4","3.4","The crystal structure of the reduced form of human SSADH","GRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTCVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL","Homo sapiens","ALDH5A1, SSADH","SUCCINIC SEMIALDEHYDE DEHYDROGENASE MITOCHONDRIAL","1","2W8O"
"2W8P",,"X-RAY DIFFRACTION",3.69,66.44,,7.25,"100 MM HEPES 7.25, 1.9 M LITHIUM SULFATE",,"10.1038/emboj.2009.40",,"2W8P",53.3,"2.3","2.3","The crystal structure of human C340A SSADH","GRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTAVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL","Homo sapiens","ALDH5A1, SSADH","SUCCINIC SEMIALDEHYDE DEHYDROGENASE MITOCHONDRIAL","1","2W8P"
"2W8Q",,"X-RAY DIFFRACTION",3.68,66.29,,7.25,"100 MM HEPES PH 7.25, 1.9 M LITHIUM SULFATE",,"10.1038/emboj.2009.40",,"2W8Q",53.43,"2.4","2.4","The crystal structure of human SSADH in complex with SSA.","GRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTAVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL","Homo sapiens","ALDH5A1, SSADH","SUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL","1","2W8Q"
"2W8R",,"X-RAY DIFFRACTION",3.69,66.4,,7.25,"pH 7.25",,"10.1038/emboj.2009.40",,"2W8R",53.83,"2.4","2.4","The crystal structure of human SSADH in complex with NAD+","GRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTAVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL","Homo sapiens","ALDH5A1, SSADH","SUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL","1","2W8R"
"2W8Y",,"X-RAY DIFFRACTION",2.12,41.46,,6.5,"22.5% PEG4000, 0.1M HEPES 6.5, 100 MM LI2SO4",,"10.1074/jbc.M109.007872","486, NDR","2W8Y",60.82,"1.8","1.8","RU486 bound to the progesterone receptor in a destabilized agonistic conformation","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","2W8Y"
"2W98",,"X-RAY DIFFRACTION",2.58,52.43,,,"2.1M NA(MALATE)",,,,"2W98",82.98,"1.85","1.85","CRYSTAL STRUCTURE OF HUMAN ZINC-BINDING ALCOHOL DEHYDROGENASE 1 (ZADH1) IN TERNARY COMPLEX WITH NADP AND PHENYLBUTAZONE","MMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEIAENLYFQ","Homo sapiens","PTGR2, ZADH1","PROSTAGLANDIN REDUCTASE 2","1","2W98"
"2W9N",,"X-RAY DIFFRACTION",2.8,55,,7,"22% PEG 3350 AND 200 MM ZNOAC, pH 7",,"10.1038/embor.2009.55",,"2W9N",17.46,"2.25","2.25","crystal structure of linear di-ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","UBIQUITIN","1","2W9N"
"2WA0",,"X-RAY DIFFRACTION",3.7,66.81,,8,"2.6 M NACL, 0.1 M TRIS PH 8",,"10.1371/journal.pone.0148762",,"2WA0",27.42,"2.3","2.3","Crystal structure of the human MAGEA4","MHHHHHHSSGVDLGTENLYFQSMDAESLFREALSNKVDELAHFLLRKYRAKELVTKAEMLERVIKNYKRCFPVIFGKASESLKMIFGIDVKEVDPTSNTYTLVTCLGLSYDGLLGNNQIFPKTGLLIIVLGTIAMEGDSASEEEIWEELGVMGVYDGREHTVYGEPRKLLTQDWVQENYLEYRQVPGSNPARYEFLWGPRALAETSYVKVLEHVVRVNARVRIAYPSLREAALLEEEEGV","Homo sapiens","MAGEA4, MAGE4","MELANOMA-ASSOCIATED ANTIGEN 4","1","2WA0"
"2WA3",,"X-RAY DIFFRACTION",3.57,65.3,,7.5,"1.5 M AMMONIUM SULFATE, 100MM HEPES PH 7.5, 3% PEG400, 1MM FESO4, 28MG/ML PROTEIN, 10MM SUBSTRATE",,"10.1016/j.bmcl.2010.08.032","A29","2WA3",40.55,"2.5","2.5","FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3-hydroxyphenyl)-2-oxoacetic acid","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","2WA3"
"2WA4",,"X-RAY DIFFRACTION",3.68,66,,7.5,"1.5M AMMONIUM SULFATE, 100MM HEPES PH 7.5, 3% PEG400, 1MM FESO4, 28MB/ML PROTEIN, 10MM SUBSTRATE. CRYSTALS ARE DEEP RED.",,"10.1016/j.bmcl.2010.08.032","069","2WA4",40.79,"2.5","2.5","FACTOR INHIBITING HIF-1 ALPHA WITH N,3-dihydroxybenzamide","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","2WA4"
"2WA5",,"X-RAY DIFFRACTION",2.5,44,,5.7,"PROTEIN WAS CRYSTALLIZED FROM 1 M LITHIUM SULFATE, 0.5 M AMMONIUM SULFATE, 0.1 M SODIUM CITRATE, PH 5.7 AND 1 MM DTT",,"10.1016/j.jmb.2009.06.009",,"2WA5",28.47,"1.9","1.9","Crystal structure of human filamin B actin binding domain at 1.9 Angstroms resolution","GAMAPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKL","Homo sapiens","FLNB, FLN1L, FLN3, TABP, TAP","FILAMIN-B","1","2WA5"
"2WA6",,"X-RAY DIFFRACTION",2.6,46,,7.5,"PROTEIN WAS CRYSTALLIZED FROM 10% PEG 6000, 5% MPD, 0.1 M HEPES PH 7.5.",,"10.1016/j.jmb.2009.06.009",,"2WA6",28.23,"1.95","1.95","Structure of the W148R mutant of human filamin b actin binding domain at 1.95 Angstrom resolution","GAMAPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGRIQNKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKL","Homo sapiens","FLNB, FLN1L, FLN3, TABP, TAP","FILAMIN-B","1","2WA6"
"2WA7",,"X-RAY DIFFRACTION",2.5,45,,6.5,"PROTEIN WAS CRYSTALLIZED FROM 20% PEG 8000, 0.2 M MAGNESIUM ACETATE AND 0.1 M SODIUM CACODYLATE PH 6.5.",,"10.1016/j.jmb.2009.06.009",,"2WA7",28.42,"1.85","1.85","Structure of the M202V mutant of human filamin b actin binding domain at 1.85 Angstrom resolution","GAMAPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKCVNKRIGNLQTDLSDGLRLIALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNAREAVQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKL","Homo sapiens","FLNB, FLN1L, FLN3, TABP, TAP","FILAMIN-B","1","2WA7"
"2WAH",,"X-RAY DIFFRACTION",2.9,58,,6,"20% PEG 6000, 0.1 M MES PH 6.0",,"10.1016/j.jmb.2009.02.033",,"2WAH",49.55,"2.51","2.51","Crystal Structure of an IgG1 Fc Glycoform (Man9GlcNAc2)","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKATPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSP","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","2WAH"
"2WAJ",,"X-RAY DIFFRACTION",2.3,46,,,"18% PEG3350, 0.1M SODIUM HEPES PH7.5",,"10.1016/j.bmcl.2009.02.098","SNB","2WAJ",42.41,"2.4","2.4","Crystal structure of human Jnk3 complexed with a 1-aryl-3,4- dihydroisoquinoline inhibitor","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","MITOGEN-ACTIVATED PROTEIN KINASE 10","1","2WAJ"
"2WAL",,"X-RAY DIFFRACTION",3.69,66.4,,5.5,"2 M MALONATE, 0.1 M BENZONATE, PH 5.5",,,,"2WAL",34.42,"2.4","2.4","Crystal Structure of human GADD45gamma","MTLEEVRGQDTVPESTARMQGAGKALHELLLSAQRQGCLTAGVYESAKVLNVDPDNVAFCVLAAGEEDEGDIALQIHFTLIQAFCCENDIDIVRVGDVQRLAAIVGAGEEAGAPGDLHCILISNPNEDAWKDPALEKLSLFCEESRSVNDWVPSITLPE","Homo sapiens","GADD45G, CR6, DDIT2","GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE PROTEIN GADD45 GAMMA","1","2WAL"
"2WB8",,"X-RAY DIFFRACTION",2.13,41.73,,,,,"10.1073/pnas.0908485106",,"2WB8",39.96,"2.15","2.15","Crystal structure of Haspin kinase","LGSIEISNKKASDAEKVYGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","SERINE/THREONINE-PROTEIN KINASE HASPIN","1","2WB8"
"2WBB",,"X-RAY DIFFRACTION",2.6,52.34,,,"0.1M AMMONIUM ACETATE 0.1M HEPES PH7 25% PEG 3350",,"10.1016/j.bmcl.2009.11.093","RO3","2WBB",297.89,"2.22","2.22","FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2WBB"
"2WBD",,"X-RAY DIFFRACTION",2.8,55.68,,,"0.1M AMMONIUM ACETATE, 0.1M HEPES PH 7.0, 15% PEG 3350",,"10.1016/j.bmcl.2009.11.093","RO5","2WBD",298,"2.4","2.4","FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2WBD"
"2WBI",,"X-RAY DIFFRACTION",3.53,64.84,,,"50% PEG 300, 0.20 M NACL, 0.1 M NA/K-PO4, PH 6.2",,,,"2WBI",97.19,"2.8","2.8","Crystal structure of human acyl-CoA dehydrogenase 11","SMSKRTFSTVLPQIDTTGQLFVQTRKGQEVLIKVKHFMKQHILPAEKEVTEFYVQNENSVDKWGKPLVIDKLKEMAKVEGLWNLFLPAVSGLSHVDYALIAEETGKCFFAPDVFNCQAPDTGNMEVLHLYGSEEQKKQWLEPLLQGNITSCFCMTEPDVASSDATNIECSIQRDEDSYVINGKKWWSSGAGNPKCKIAIVLGRTQNTSLSRHKQHSMILVPMNTPGVKIIRPLSVFGYTDNFHGGHFEIHFNQVRVPATNLILGEGRGFEISQGRLGPGRIHHCMRTVGLAERALQIMCERATQRIAFKKKLYAHEVVAHWIAESRIAIEKIRLLTLKAAHSMDTLGSAGAKKEIAMIKVAAPRAVSKIVDWAIQVCGGAGVSQDYPLANMYAITRVLRLADGPDEVHLSAIATMELRDQAKRLTAKI","Homo sapiens","ACAD11","ACYL-COA DEHYDROGENASE FAMILY MEMBER 11","1","2WBI"
"2WC8",,"X-RAY DIFFRACTION",1.89,34.41,,7.5,"0.2M TRI-AMMONIIUM CITRATE PH 7.0, 34% PEG 3350 MME",,"10.1016/j.jmb.2009.06.004",,"2WC8",43.72,"1.88","1.88","S100A12 complex with zinc in the absence of calcium","MGGSTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKAAHYHTHKE","Homo sapiens","S100A12","PROTEIN S100-A12","1","2WC8"
"2WCB",,"X-RAY DIFFRACTION",3.21,61,,7.5,"34% PEG 3350, MME, 0.2M TRI AMMONIUM CITRATE PH 7.0",,"10.1016/j.jmb.2009.06.004",,"2WCB",21.76,"1.73","1.73","S100A12 complex with zinc in the absence of calcium","MGGSTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKAAHYHTHKE","Homo sapiens","S100A12","PROTEIN S100-A12","1","2WCB"
"2WCE",,"X-RAY DIFFRACTION",2.7,55,,7.5,"1.4M NA-CITRATE, PH 7.5",,"10.1016/j.jmb.2009.06.004",,"2WCE",21.86,"1.77","1.77","calcium-free (apo) S100A12","MGGSTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISMVAIALKAAHYHTHKE","Homo sapiens","S100A12","PROTEIN S100-A12","1","2WCE"
"2WCF",,"X-RAY DIFFRACTION",2.4,48.6,,6,"25% PEG1500, 0.1M MMT PH6.0",,"10.1016/j.jmb.2009.06.004",,"2WCF",64.81,"2.78","2.78","calcium-free (apo) S100A12","MGGSTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKAAHYHTHKE","Homo sapiens","S100A12","PROTEIN S100-A12","1","2WCF"
"2WCG",,"X-RAY DIFFRACTION",2.2,45,,6.5,"0.2M (NH4)2SO4, 0.1M TRIS PH 6.5, 25%(W/V) PEG3350",,"10.1002/cbic.200900142","MT5","2WCG",116.54,"2.3","2.3","X-ray structure of acid-beta-glucosidase with N-octyl(cyclic guanidine)-nojirimycin in the active site","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2WCG"
"2WCY",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M901993200",,"2WCY",16.98,,,"NMR solution structure of factor I-like modules of complement C7.","GSHMNPLTQAVPKCQRWEKLQNSRCVCKMPYECGPSLDVCAQDERSKRILPLTVCKMHVLHCQGRNYTLTGRDSCTLPASAEKACGACPLWGKCDAESSKCVCREASECEEEGFSICVEVNGKEQTMSECEAGALRCRGQSISVTSIRPCAAETQ","Homo sapiens","C7","COMPLEMENT COMPONENT C7","1","2WCY"
"2WD1",,"X-RAY DIFFRACTION",1.98,39,,,,,"10.1016/j.bmcl.2009.03.110","ZZY","2WD1",33.57,"2","2","Human c-Met Kinase in complex with azaindole inhibitor","LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","2WD1"
"2WD2",,"X-RAY DIFFRACTION",2.2,45,"VAPOR DIFFUSION, HANGING DROP",8,"100 MM TRIS-HCL, 1 MM ZNSO4, 2.5 M AMMONIUM SULFATE; 30 MM 2-MERCAPTOETHANOL, 0.5 MM 2-(3-METHOXYBENZYL)-6-O-SULFAMOYL-7-METHOXY-1,2,3,4- TETRAHYDROISOQUINOLINE, PH 8.0, VAPOUR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1039/c002558e",,"2WD2",29.81,"1.49","1.49","A chimeric microtubule disruptor with efficacy on a taxane resistant cell line","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WD2"
"2WD3",,"X-RAY DIFFRACTION",2.08,40.995,"VAPOR DIFFUSION, HANGING DROP",8,"100 MM TRIS-HCL, 1 MM ZNSO4, 2.5 M AMMONIUM SULFATE; 30 MM 2-MERCAPTOETHANOL, 0.5 MM 5'-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-3-CHLORO-2'- CYANOBIPHENYL-4-YL SULFAMATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1021/jm901705h","MS4","2WD3",30,"1.8","1.8","Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors based on a Biphenyl Template","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WD3"
"2WD9",,"X-RAY DIFFRACTION",2.43,49.39,,,"0.2M AM ACETATE, 0.1M TRIS PH 8.5, 25% PEG 3350",,"10.1016/j.jmb.2009.03.064",,"2WD9",190.29,"2.6","2.6","CRYSTAL STRUCTURE OF HUMAN ACYL-COA SYNTHETASE MEDIUM-CHAIN FAMILY MEMBER 2A (L64P MUTATION) IN COMPLEX WITH IBUPROFEN","MGHHHHHHSSGVDLGTENLYFQSMSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRPPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRADDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVVKAFVVLASQFLSHDPEQLTKELQQHVKSVTAPYKYPRKIEFVLNLPKTVTGKIQRAKLRDKEWKMSGKARA","Homo sapiens","ACSM2A, ACSM2, MACS2","ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL","1","2WD9"
"2WDP",,"X-RAY DIFFRACTION",2.37,48.13,,6,"1.5 M AMMONIUM CHLORIDE, 0.1 M SODIUM ACETATE AT PH 4.6",,"10.1042/BJ20090540",,"2WDP",133.53,"1.95","1.95","Crystal Structure of Ligand Free Human Caspase-6","MSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSN","Homo sapiens","CASP6, MCH2","CASPASE-6","1","2WDP"
"2WEF",,"X-RAY DIFFRACTION",1.81,31.52,,,,,,,"2WEF",34.48,"1.8","1.8","Human 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1) in complex with AMP, PO4 and Magnesium","MTVLMRLVASAYSIAQKAGMIVRRVIAEGDLGIVEKTCATDLQTKADRLAQMSICSSLARKFPKLTIIGEEDLPSEEVDQELIEDSQWEEILKQPCPSQYSAIKEEDLVVWVDPLDGTKEYTEGLLDNVTVLIGIAYEGKAIAGVINQPYYNYEAGPDAVLGRTIWGVLGLGAFGFQLKEVPAGKHIITTTRSHSNKLVTDCVAAMNPDAVLRVGGAGNKIIQLIEGKASAYVFASPGCKKWDTCAPEVILHAVGGKLTDIHGNVLQYHKDVKHMNSAGVLATLRNYDYYASRVPESIKNALVPAHHHHHH","Homo sapiens","BPNT1","3'(2')\, 5'-BISPHOSPHATE NUCLEOTIDASE 1","1","2WEF"
"2WEG",,"X-RAY DIFFRACTION",1.85,32.84,,,,,"10.1002/cmdc.200900386","FBV","2WEG",29.49,"1.1","1.1","Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WEG"
"2WEH",,"X-RAY DIFFRACTION",1.97,37.13,,,,,"10.1002/cmdc.200900386","FB1","2WEH",29.51,"2.09","2.09","Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WEH"
"2WEJ",,"X-RAY DIFFRACTION",1.91,35.14,,,,,"10.1002/cmdc.200900386","FB2","2WEJ",29.47,"1.45","1.45","Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WEJ"
"2WEK",,"X-RAY DIFFRACTION",2.26,45.61,,,"25% 1,2 PROPANDIOL, 10% GLYCEROL, 0.1M NA/K-PO4 PH 6.2",,,,"2WEK",77.11,"1.9","1.9","Crystal structure of the human MGC45594 gene product in complex with diclofenac","SMMQKLVVTRLSPNFREAVTLSRDCPVPLPGDGDLLVRNRFVGVNASDINYSAGRYDPSVKPPFDIGFEGIGEVVALGLSASARYTVGQAVAYMAPGSFAEYTVVPASIATPVPSVKPEYLTLLVSGTTAYISLKELGGLSEGKKVLVTAAAGGTGQFAMQLSKKAKCHVIGTCSSDEKSAFLKSLGCDRPINYKTEPVGTVLKQEYPEGVDVVYESVGGAMFDLAVDALATKGRLIVIGFISGYQTPTGLSPVKAGTLPAKLLKKSASVQGFFLNHYLSKYQAAMSHLLEMCVSGDLVCEVDLGDLSPEGRFTGLESIFRAVNYMYMGKNTGKIVVELPH","Homo sapiens","PTGR3, ZADH2","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","1","2WEK"
"2WEO",,"X-RAY DIFFRACTION",1.91,35,,,,,"10.1002/cmdc.200900386","FBW","2WEO",29.57,"1.4","1.4","Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2WEO"
"2WEW",,"X-RAY DIFFRACTION",2.35,47.56,,7.2,"ABOUT 1-2 MICROL OF PROTEIN (10-16 MG/ML IN 20 MM TRIS-HCL, PH 7.2) WERE MIXED WITH 1-2 MICROL OF 30 % PEG1500 (W/V, IN DEIONISED WATER) AND EQUILIBRATED AGAINST 700 MICROL OF RESERVOIR SOLUTION CONTAINING 30 % PEG1500.",,"10.1016/j.jmb.2009.08.071",,"2WEW",19.53,"1.95","1.95","Crystal structure of human apoM in complex with myristic acid","GSHMNQCPEHSQLTTLGVDGKEFPEVHLGQWYFIAGAAPTKEELATFDPVDNIVFNMAAGSAPMQLHLRATIRMKDGLCVPRKWIYHLTEGSTDLRTEGRPDMKTELFSSSCPGGIMLNETGQGYQRFLLYNRSPHPPEKCVEEFKSLTSCLDSKAFLLTPRNQEACELSNN","Homo sapiens","APOM, G3A, NG20, HSPC336","APOLIPOPROTEIN M","1","2WEW"
"2WEX",,"X-RAY DIFFRACTION",2.39,47.82,,7.2,"ABOUT 1-2 MICROL OF PROTEIN (10-16 MG/ML IN 20 MM TRIS-HCL, PH 7.2) WERE MIXED WITH 1-2 MICROL OF 30 % PEG1500 (W/V, IN DEIONISED WATER) AND EQUILIBRATED AGAINST 700 MICROL OF RESERVOIR SOLUTION CONTAINING 30 % PEG1500.",,"10.1016/j.jmb.2009.08.071",,"2WEX",19.61,"2","2","Crystal structure of human apoM in complex with glycerol 1- myristic acid","GSHMNQCPEHSQLTTLGVDGKEFPEVHLGQWYFIAGAAPTKEELATFDPVDNIVFNMAAGSAPMQLHLRATIRMKDGLCVPRKWIYHLTEGSTDLRTEGRPDMKTELFSSSCPGGIMLNETGQGYQRFLLYNRSPHPPEKCVEEFKSLTSCLDSKAFLLTPRNQEACELSNN","Homo sapiens","APOM, G3A, NG20, HSPC336","APOLIPOPROTEIN M","1","2WEX"
"2WEY",,"X-RAY DIFFRACTION",2.06,40.46,,7.25,"16% PEG3350, 60 MM BETA-MERCAPTOETHANOL,0.1 M HEPES PH 7.25,0.2 M MGCL2",,"10.1107/S0907444909017855","EV1","2WEY",79.78,"2.8","2.8","Human PDE-papaverine complex obtained by ligand soaking of cross- linked protein crystals","HMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","1","2WEY"
"2WEZ",,"X-RAY DIFFRACTION",2.02,38.65,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.165","ZYE","2WEZ",44.32,"1.7","1.7","Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WEZ"
"2WF0",,"X-RAY DIFFRACTION",2.03,38.96,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.165","ZY0","2WF0",44.37,"1.6","1.6","Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-8-(2-oxo-1-pyrrolidinyl)-6-quinolinecarboxamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WF0"
"2WF1",,"X-RAY DIFFRACTION",2.02,62,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.150","ZY1","2WF1",44.35,"1.6","1.6","Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4- dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2- dioxide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WF1"
"2WF2",,"X-RAY DIFFRACTION",2.08,62,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.150","ZY2","2WF2",44.37,"1.8","1.8","Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1H,6H-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WF2"
"2WF3",,"X-RAY DIFFRACTION",2.08,40.33,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.150","ZY3","2WF3",44.71,"2.08","2.08","Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WF3"
"2WF4",,"X-RAY DIFFRACTION",2.06,44.71,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2009.03.149","ZY4","2WF4",44.33,"1.8","1.8","Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl)-1,3,4,6- tetrahydro(1,2)thiazepino(5,4,3-cd)indole-8-carboxamide 2,2-dioxide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WF4"
"2WFD",,"X-RAY DIFFRACTION",3.45,63.2,,,"0.2 M SODIUM CITRATE TRIBASIC DIHYDRATE PH 8.3, 20% W/V POLYETHYLENE GLYCOL 3350",,"10.1016/j.jmb.2009.04.073",,"2WFD",56.94,"3.25","3.25","Structure of the human cytosolic leucyl-tRNA synthetase editing domain","AMGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYME","Homo sapiens","LARS1, KIAA1352, LARS","LEUCYL-TRNA SYNTHETASE, CYTOPLASMIC","1","2WFD"
"2WFH",,"X-RAY DIFFRACTION",2.25,45.02,,8.5,"0.2 M LISO4, 0.1 M TRIS PH 8.5, 30% PEG 4000",,"10.1038/embor.2009.95",,"2WFH",43.02,"1.8","1.8","The Human Slit 2 Dimerization Domain D4","GSRCPTECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPGEMADKLLLTTPSKKFTCAAAHHHHHH","Homo sapiens","SLIT2, SLIL3","SLIT HOMOLOG 2 PROTEIN C-PRODUCT","1","2WFH"
"2WFI",,"X-RAY DIFFRACTION",1.93,36.1,,8.5,"28-32% PEG 4000 (W/V), 0.2M MGCL2, 0.1M TRIS PH 8.5",,"10.1002/anie.200900481",,"2WFI",19.94,"0.75","0.75","Atomic resolution crystal structure of the PPIase domain of human cyclophilin G","GAMGIKVQRPRCFFDIAINNQPAGRVVFELFSDVCPKTCENFRCLCTGEKGTGKSTQKPLHYKSCLFHRVVKDFMVQGGDFSEGNGRGGESIYGGFFEDESFAVKHNKEFLLSMANRGKDTNGSQFFITTKPTPHLDGHHVVFGQVISGQEVVREIENQKTDAASKPFAEVRILSCGEL","Homo sapiens","PPIG","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE G","1","2WFI"
"2WFN",,"X-RAY DIFFRACTION",4.4,71,,,"1.7 M LITHIUM SULFATE, 0.1 M HEPES PH 7.5",,"10.1107/S0907444909037330",,"2WFN",63.18,"3.2","3.2","Filamin A actin binding domain","MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPK","Homo sapiens","FLNA, FLN, FLN1","FILAMIN-A","1","2WFN"
"2WFQ",,"X-RAY DIFFRACTION",1.8,35.5,,,"0.1 M TRIS-HCL, PH 8.5 0.2 M LITHIUM SULFATE 0.2 M SODIUM THIOCYANATE 30% (W/V) PEG4000",,"10.1038/nsmb.1607",,"2WFQ",19.01,"1.85","1.85","Crystal structure of the N-terminal signalling domain of human Dhh without calcium","QLVPLLYKQFVPGVPERTLGASGPAEGRVARGSERFRDLVPNYNPDIIFKDEENSGADRLMTERCKERVNALAIAVMNMWPGVRLRVTEGWDEDGHHAQDSLHYEGRALDITTSDRDRNKYGLLARLAVEAGFDWVYYESRNHVHVSVKADNSLAVKLEHHHHHH","Homo sapiens","DHH","DESERT HEDGEHOG PROTEIN N-PRODUCT","1","2WFQ"
"2WFR",,"X-RAY DIFFRACTION",1.75,34.14,,,"0.1 M TRIS-HCL, PH 8.5 0.2 M LITHIUM SULFATE 0.2 M SODIUM THIOCYANATE 30% (W/V) PEG4000",,"10.1038/nsmb.1607",,"2WFR",19.19,"1.95","1.95","Crystal structure of the N-terminal signalling domain of human Dhh with calcium","QLVPLLYKQFVPGVPERTLGASGPAEGRVARGSERFRDLVPNYNPDIIFKDEENSGADRLMTERCKERVNALAIAVMNMWPGVRLRVTEGWDEDGHHAQDSLHYEGRALDITTSDRDRNKYGLLARLAVEAGFDWVYYESRNHVHVSVKADNSLAVKLEHHHHHH","Homo sapiens","DHH","DESERT HEDGEHOG PROTEIN N-PRODUCT","1","2WFR"
"2WFT",,"X-RAY DIFFRACTION",4.88,74.6,,,"0.1 M TRIS-HCL, PH 8.5 3.5 M POTASSIUM FORMATE",,"10.1038/nsmb.1607",,"2WFT",102.43,"2.8","2.8","Crystal structure of the human HIP ectodomain","HNCFCIQEVVSGLRQPVGALHSGDGSQRLFILEKEGYVKILTPEGEIFKEPYLDIHKLVQSGIKGGDERGLLSLAFHPNYKKNGKLYVSYTTNQERWAIGPHDHILRVVEYTVSRKNPHQVDLRTARVFLEVAELHRKHLGGQLLFGPDGFLYIILGDGMITLDDMEEMDGLSDFTGSVLRLDVDTDMCNVPYSIPRSNPHFNSTNQPPEVFAHGLHDPGRCAVDRHPTDININLTILCSDSNGKNRSSARILQIIKGKDYESEPSLLEFKPFSNGPLVGGFVYRGCQSERLYGSYVFGDRNGNFLTLQQSPVTKQWQEKPLCLGTSGSCRGYFSGHILGFGEDELGEVYILSSSKSMTQTHNGKLYKIVDPKRPLMPEECRATVQPAQTLTSECSRLCRNGYCTPTGKCCCSPGWEGDFCRTAKCEPACRHGGVCVRPNKCLCKKGYLGPQCEQVDR","Homo sapiens","HHIP, HIP, UNQ5825/PRO19644","HEDGEHOG-INTERACTING PROTEIN","1","2WFT"
"2WGH",,"X-RAY DIFFRACTION",2.21,43.99,,,,,"10.1038/nsmb.2007",,"2WGH",155.45,"2.3","2.3","Human Ribonucleotide reductase R1 subunit (RRM1) in complex with dATP and Mg.","MAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRAHHHHHH","Homo sapiens","RRM1, RR1","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE SUBUNIT","1","2WGH"
"2WGJ",,"X-RAY DIFFRACTION",2.36,47.5,"VAPOR DIFFUSION, HANGING DROP",4.6,"CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION AT 13 DEGREES CELCIUS. 1-2 MICROLITERS OF PROTEIN SOLUTION AT 7-15 MG/ML WAS MIXEDWITH AN EQUAL VOLUME OF PRECIPITATING SOLUTION (0-275 MM SODIUM CHLORIDE, 21% (W/V PEG 3350, 50 MM CITRATE-PHOSPHATE PH 4.6)",286,"10.1021/jm2007613","VGH","2WGJ",35.33,"2","2","X-ray Structure of PF-02341066 bound to the kinase domain of c-Met","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","2WGJ"
"2WGP",,"X-RAY DIFFRACTION",2.46,49.6,,5.4,"0.1M SODIUM CITRATE PH 5.4, 1.1 M AMMONIUM PHOSPHATE MONOBASIC,0.1 M NDSB-256 CRYOPROTECTED WITH 20% GLYCEROL",,"10.1107/S0907444909023762",,"2WGP",42.78,"1.88","1.88","Crystal structure of human dual specificity phosphatase 14","SSRGHSTLPRTLMAPRMISEGDIGGIAQITSSLFLGRGSVASNRHLLQARGITCIVNATIEIPNFNWPQFEYVKVPLADMPHAPIGLYFDTVADKIHSVSRKHGATLVHCAAGVSRSATLCIAYLMKFHNVCLLEAYNWVKARRPVIRPNVGFWRQLIDYERQLFGKSTVKMVQTPYGIVPDVYEKESRH","Homo sapiens","DUSP14, MKP6","DUAL SPECIFICITY PROTEIN PHOSPHATASE 14","1","2WGP"
"2WGX",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",7.2,"SITTING DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML IN 25 MM SODIUM PHOSPHATE PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES PH 7.2, 19 % PEG 4000, 5 MM DTT.",294,"10.1093/protein/gzp018",,"2WGX",49.3,"1.75","1.75","HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I-N268D","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNFMCYSSCMGGMNRRPILIIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2WGX"
"2WH5",,"X-RAY DIFFRACTION",6.24,80.3,,,"0.24M K_THIOCYANATE; 26W/V PEG_3350",,,,"2WH5",82.32,"2.6","2.6","Crystal structure of human acyl-CoA binding domain 4 complexed with stearoyl-CoA","SMSPEPDCQKQFQAAVSVIQNLPKNGSYRPSYEEMLRFYSYYKQATMGPCLVPRPGFWDPIGRYKWDAWNSLGKMSREEAMSAYITEMKLVAQKVIDTVPLGEVAE","Homo sapiens","ACBD4, HMFT0700","ACYL-COA-BINDING DOMAIN-CONTAINING PROTEIN 4","1","2WH5"
"2WI1",,"X-RAY DIFFRACTION",2.9,57.5,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ2","2WI1",26.81,"2.3","2.3","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2WI1"
"2WI2",,"X-RAY DIFFRACTION",2.9,55.3,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ3","2WI2",53.59,"2.09","2.09","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2WI2"
"2WI3",,"X-RAY DIFFRACTION",2.8,61,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ3","2WI3",26.78,"1.9","1.9","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN, HSP 90-ALPHA","1","2WI3"
"2WI4",,"X-RAY DIFFRACTION",2.7,62.1,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ4","2WI4",26.95,"2.4","2.4","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN, HSP 90-ALPHA","1","2WI4"
"2WI5",,"X-RAY DIFFRACTION",2.8,60.2,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ5","2WI5",26.96,"2.1","2.1","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2WI5"
"2WI6",,"X-RAY DIFFRACTION",2.9,59.9,,6.5,"pH 6.5",,"10.1021/jm900357y","ZZ6","2WI6",26.97,"2.18","2.18","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN, HSP90-ALPHA","1","2WI6"
"2WI7",,"X-RAY DIFFRACTION",2.8,60.1,,6.5,"pH 6.5",,"10.1021/jm900357y","2KL","2WI7",27.08,"2.5","2.5","Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2WI7"
"2WID",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091",,"2WID",62.56,"2.3","2.3","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWTDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WID"
"2WIF",,"X-RAY DIFFRACTION",3.15,60.9,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091",,"2WIF",62.35,"2.25","2.25","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WIF"
"2WIG",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091","TC3","2WIG",62.38,"2.15","2.15","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWTDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WIG"
"2WIJ",,"X-RAY DIFFRACTION",3.2,61.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091","TN7","2WIJ",62.31,"2.1","2.1","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WIJ"
"2WIK",,"X-RAY DIFFRACTION",3.2,61.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091","TC5","2WIK",62.36,"2.1","2.1","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WIK"
"2WIL",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M AMMONIUM SULFATE, 100 MM MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1042/BJ20090091",,"2WIL",123.55,"3.1","3.1","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WIL"
"2WIM",,"X-RAY DIFFRACTION",2.93,58,,4.5,"14 % PEG-3350, 20 MM CACL2, 0.1 M CITRIC ACID PH 4.5",,"10.1016/j.str.2010.12.014",,"2WIM",65.98,"3","3","Crystal structure of NCAM2 IG1-3","SMALLQVTISLSKVELSVGESKFFTCTAIGEPESIDWYNPQGEKIISTQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQEATVVLEIYQKLTFREVVSPQEFKQGEDAEVVCRVSSSPAPAVSWLYHNEEVTTISDNRFAMLANNNLQILNINKSDEGIYRCEGRVEARGEIDFRDIIVIVNVPPAISMPQKSFNATAERGEEMTFSCRASGSPEPAISWFRNGKLIEENEKYILKGSNTELTVRNIINSDGGPYVCRATNKAGEDEKQAFLQVFVQHHHHHH","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2WIM"
"2WJ7",,"X-RAY DIFFRACTION",2.9,57.7,"VAPOR DIFFUSION, HANGING DROP",,"4 DAYS AT 16 DEGREESC IN 100 MM BICINE PH 9.0, 55% 2-METHYL-2,4-PENTANDIOL, AT A PROTEIN CONCENTRATION OF 20 MG/ML USING 1 UL PROTEIN SOLUTION AND 2 UL RESERVOIR SOLUTION.",289,"10.1016/j.jmb.2009.07.069",,"2WJ7",53.65,"2.631","2.631","human alphaB crystallin","GAMEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVSGPER","Homo sapiens","CRYAB, CRYA2, HSPB5","ALPHA-CRYSTALLIN B CHAIN","1","2WJ7"
"2WJO",,"X-RAY DIFFRACTION",3.5,64.6,,7.5,"11% PEG8000 50MM HEPES PH7.5 200MM NACL 15% GLYCEROL 10% ACETONITRILE",,"10.1021/jm900818s",,"2WJO",46.47,"2.5","2.5","human Bace (beta secretase) in complex with Cyclohexanecarboxylic acid (2-(2-am ino-6-phenoxy-4H-quinazolin-3-yl)-2 -cyclohexyl-ethyl)- amide","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTLMTIAYGDLHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2WJO"
"2WJU",,"X-RAY DIFFRACTION",2.39,48.06,"VAPOR DIFFUSION, HANGING DROP",8,"THE CRYSTALS WERE OBTAINED BY HANGING DROP VAPOUR TECHNIQUE BY MIXING 5 UL OF RESERVOIR SOLUTION [100 MM TRIS-HCL PH 7.8, 18% (V/V) PEG 4000, AND 2 MM DITHIOTHREITOL] WITH 5 UL OF PROTEIN SOLUTION (10 MG/ML IN 10 MM TRIS-HCL PH 7.8), 1UL OF 200 MM SPERMINE AND 1 UL OF 25 MM GLUTATHIONE",,"10.1016/j.jmb.2010.01.023",,"2WJU",208.18,"2.3","2.3","Glutathione transferase A2-2 in complex with glutathione","MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMILLLPFTQPEEQDAKLALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRF","Homo sapiens","GSTA2, GST2","GLUTATHIONE-S-TRANSFERASE A2-2","1","2WJU"
"2WJW",,"X-RAY DIFFRACTION",2.41,49,,,"0.08M SODIUM ACETATE, PH 4.6 0.16M AMMONIUM SULPHATE 20 (W/V) PEG4000 20% (V/V) GLYCEROL",,"10.1016/j.jmb.2009.07.082",,"2WJW",44.19,"1.8","1.8","Crystal structure of the human ionotropic glutamate receptor GluR2 ATD region at 1.8 A resolution","NSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTPHIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDGTHPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNIKFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLE","Homo sapiens","GRIA2, GLUR2","GLUTAMATE RECEPTOR 2","1","2WJW"
"2WJX",,"X-RAY DIFFRACTION",3.58,66,,,"0.2M BIS-TRIS PROPANE, PH 7.5 0.2M POTASSIUM/SODIUM TARTRATE 20% (W/V) PEG3350",,"10.1016/j.jmb.2009.07.082",,"2WJX",131.33,"4.1","4.1","Crystal structure of the human ionotropic glutamate receptor GluR2 ATD region at 4.1 A resolution","NSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTPHIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDGTHPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNIKFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLE","Homo sapiens","GRIA2, GLUR2","GLUTAMATE RECEPTOR 2","1","2WJX"
"2WJY",,"X-RAY DIFFRACTION",3.23,62,,6,"1.6M AMMONIUM SULPHATE, 100 MM MES PH 6, 10% DIOXANE",,"10.1038/emboj.2009.175",,"2WJY",90.95,"2.5","2.5","Crystal structure of the complex between human nonsense mediated decay factors UPF1 and UPF2 Orthorhombic form","TKDLPIHACSYCGIHDPACVVYCNTSKKWFCNGRGNTSGSHIVNHLVRAKCKEVTLHKDGPLGETVLECYNCGCRNVFLLGFIPAKADSVVVLLCRQPCASQSSLKDINWDSSQWQPLIQDRCFLSWLVKIPSEQEQLRARQITAQQINKLEELWKENPSATLEDLEKPGVDEEPQHVLLRYEDAYQYQNIFGPLVKLEADYDKKLKESQTQDNITVRWDLGLNKKRIAYFTLPKTDSDMRLMQGDEICLRYKGDLAPLWKGIGHVIKVPDNYGDEIAIELRSSVGAPVEVTHNFQVDFVWKSTSFDRMQSALKTFAVDETSVSGYIYHKLLGHEVEDVIIKCQLPKRFTAQGLPDLNHSQVYAVKTVLQRPLSLIQGPPGTGKTVTSATIVYHLARQGNGPVLVCAPSNIAVDQLTEKIHQTGLKVVRLCAKSREAIDSPVSFLALHNQIRNMDSMPELQKLQQLKDETGELSSADEKRYRALKRTAERELLMNADVICCTCVGAGDPRLAKMQFRSILIDESTQATEPECMVPVVLGAKQLILVGDHCQLGPVVMCKKAAKAGLSQSLFERLVVLGIRPIRLQVQYRMHPALSAFPSNIFYEGSLQNGVTAADRVKKGFDFQWPQPDKPMFFYVTQGQEEIASSGTSYLNRTEAANVEKITTKLLKAGAKPDQIGIITPYEGQRSYLVQYMQFSGSLHTKLYQEVEIASVDAFQGREKDFIILSCVRANEHQGIGFLNDPRRLNVALTRARYGVIIVGNPKALSKQPLWNHLLNYYKEQKVLVEGPLNNLRESLMQFS","Homo sapiens","UPF1, KIAA0221, RENT1","REGULATOR OF NONSENSE TRANSCRIPTS 1","1","2WJY"
"2WK5",,"X-RAY DIFFRACTION",2.22,44,,,"1M SODIUM-ACETATE (PH 5.2), 25% PEG 4000, 0.1M AMMONIUM ACETATE",,"10.1016/j.bbrc.2009.06.104",,"2WK5",200.11,"2.99","2.99","Structural features of native human thymidine phosphorylase and in complex with 5-iodouracil","MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ","Homo sapiens","TYMP, ECGF1","THYMIDINE PHOSPHORYLASE","1","2WK5"
"2WK6",,"X-RAY DIFFRACTION",2.44,49,,,"2.8-3.5 M SODIUM-FORMATE, 100 MM 5-IUR",,"10.1016/j.bbrc.2009.06.104","IUR","2WK6",100.48,"2.5","2.5","Structural features of native human thymidine phosphorylase and in complex with 5-iodouracil","MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ","Homo sapiens","TYMP, ECGF1","THYMIDINE PHOSPHORYLASE","1","2WK6"
"2WKL",,"X-RAY DIFFRACTION",2.7,55.36,,7,"1 M (NH4)2SO4/0.1 M HEPES, PH 7.0, 0.5% (W/V) PEG8000",,"10.1093/glycob/cwp138",,"2WKL",114.12,"2.7","2.7","Velaglucerase alfa","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2WKL"
"2WKM",,"X-RAY DIFFRACTION",2.42,48.85,"VAPOR DIFFUSION, HANGING DROP",4.6,"CRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD USING 1.2 MICROLITERS OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD PLUS A 5 FOLD MOLAR EXCESS OF PHA-00665752) AND 1.2 MICROLITERS OF MOTHER LIQUOR SOLUTION (0.05 M CITRATE-PHOSHPHATE 4.6, 0-0.275 M NACL, AND 21% W/V PEG 3350).",286,"10.1021/jm2007613","PFY","2WKM",35.52,"2.2","2.2","X-ray Structure of PHA-00665752 bound to the kinase domain of c-Met","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","2WKM"
"2WKO",,"X-RAY DIFFRACTION",2.14,42,,6.5,"20% P3350, 0.2 M AMMONIUM IODIDE, pH 6.5",,"10.1016/j.abb.2009.09.020",,"2WKO",32.39,"1.97","1.97","Structure of metal loaded Pathogenic SOD1 Mutant G93A.","XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDAVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WKO"
,,,,,,,,,,,,,,,,"XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDAVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","2","2WKO"
"2WL1",,"X-RAY DIFFRACTION",2.11,41.6,,,"0.2M KSCN 25% PEG 2K MME 0.1M TRIS-ACOH, PH 7.5 20C",293,"10.1016/j.jmb.2009.08.059",,"2WL1",21.37,"1.35","1.35","Pyrin PrySpry domain","NVPELIGAQAHAVNVILDAETAYPNLIFSDDLKSVRLGNKWERLPDGPQRFDSCIIVLGSPSFLSGRRYWEVEVGDKTAWILGACKTSISRKGNMTLSPENGYWVVIMMKENEYQASSVPPTRLLIKEPPKRVGIFVDYRVGSISFYNVTARSHIYTFASCSFSGPLQPIFSPGTRDGGKNTAPLTICPVG","Homo sapiens","MEFV, MEF, TRIM20","PYRIN","1","2WL1"
"2WL8",,"X-RAY DIFFRACTION",3.6,65.53,,,"2.0M SODIUM MALONATE, PH 5.5",,"10.1038/emboj.2010.115",,"2WL8",57.47,"2.05","2.05","X-ray crystal structure of Pex19p","GAMGMDEGDGEGNILPIMQSIMQNLLSKDVLYPSLKEITEKYPEWLQSHRESLPPEQFEKYQEQHSVMCKICEQFEAETPTDSETTQKARFEMVLDLMQQLQDLGHPPKELAGEMPPGLNFDLDAL","Homo sapiens","PEX19, HK33, PXF, OK/SW-cl.22","PEROXISOMAL BIOGENESIS FACTOR 19","1","2WL8"
"2WM1",,"X-RAY DIFFRACTION",2,50,,7.5,"pH 7.5",,"10.1111/j.1742-4658.2009.07372.x",,"2WM1",38.41,"2.01","2.01","The crystal structure of human alpha-amino-beta-carboxymuconate- epsilon-semialdehyde decarboxylase in complex with 1,3- dihydroxyacetonephosphate suggests a regulatory link between NAD synthesis and glycolysis","MKIDIHSHILPKEWPDLKKRFGYGGWVQLQHHSKGEAKLLKDGKVFRVVRENCWDPEVRIREMDQKGVTVQALSTVPVMFSYWAKPEDTLNLCQLLNNDLASTVVSYPRRFVGLGTLPMQAPELAVKEMERCVKELGFPGVQIGTHVNEWDLNAQELFPVYAAAERLKCSLFVHPWDMQMDGRMAKYWLPWLVGMPAETTIAICSMIMGGVFEKFPKLKVCFAHGGGAFPFTVGRISHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPLGELEPGKLIESMEEFDEETKNKLKAGNALAFLGLERKQFE","Homo sapiens","ACMSD","2-AMINO-3-CARBOXYMUCONATE-6-SEMIALDEHYDE DECARBOXYLASE","1","2WM1"
"2WM3",,"X-RAY DIFFRACTION",3.26,62.24,,,"2.1M SODIUM MALATE PH 7.0",,,,"2WM3",34.89,"1.85","1.85","Crystal structure of NmrA-like family domain containing protein 1 in complex with niflumic acid","SMVDKKLVVVFGGTGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVTNYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAPDGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLANMFRFYALRPDRDIELTLRLNPKALTLDQWLEQHKGDFNL","Homo sapiens","NMRAL1, HSCARG","NMRA-LIKE FAMILY DOMAIN CONTAINING PROTEIN 1","1","2WM3"
"2WM8",,"X-RAY DIFFRACTION",2.55,51.78,,,"0.2M NA3(CIT),20% PEG 3350",,,,"2WM8",21.52,"1.75","1.75","Crystal structure of human magnesium-dependent phosphatase 1 of the haloacid dehalogenase superfamily (MGC5987)","MHHHHHHSSGVDLGTENLYFQSMARLPKLAVFDLDYTLWPFWVDTHVDPPFHKSSDGTVRDRRGQDVRLYPEVPEVLKRLQSLGVPGAAASRTSEIEGANQLLELFDLFRYFVHREIYPGSKITHFERLQQKTGIPFSQMIFFDDERRNIVDVSKLGVTCIHIQNGMNLQTLSQGLETFAKAQTGPL","Homo sapiens","MDP1","MAGNESIUM-DEPENDENT PHOSPHATASE 1","1","2WM8"
"2WMD",,"X-RAY DIFFRACTION",2.98,58.9,,,"60% TACSIMATE",,,,"2WMD",34.36,"2","2","Crystal structure of NmrA-like family domain containing protein 1 in complex with NADP and 2-(4-chloro-phenylamino)-nicotinic acid","SMVDKKLVVVFGGTGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVTNYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAPDGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLANMFRFYALRPDRDIELTLRLNPKALTLDQWLEQHKGDFNL","Homo sapiens","NMRAL1, HSCARG","NMRA-LIKE FAMILY DOMAIN CONTAINING PROTEIN 1","1","2WMD"
"2WMQ",,"X-RAY DIFFRACTION",2.7,55,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j",,"2WMQ",33.27,"2.48","2.48","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMQ"
"2WMR",,"X-RAY DIFFRACTION",2.6,53.4,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j","ZYR","2WMR",33.25,"2.43","2.43","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMR"
"2WMS",,"X-RAY DIFFRACTION",2.8,55.3,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j",,"2WMS",33.32,"2.7","2.7","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMS"
"2WMT",,"X-RAY DIFFRACTION",2.7,54.1,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j",,"2WMT",33.27,"2.55","2.55","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMT"
"2WMU",,"X-RAY DIFFRACTION",2.7,54.9,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j","ZYU","2WMU",33.25,"2.6","2.6","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMU"
"2WMV",,"X-RAY DIFFRACTION",2.6,52.9,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j","ZYV","2WMV",33.28,"2.009","2.009","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMV"
"2WMW",,"X-RAY DIFFRACTION",3,59,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j","ZYW","2WMW",33.36,"2.43","2.43","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMW"
"2WMX",,"X-RAY DIFFRACTION",3,58.3,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm900314j","ZY6","2WMX",33.35,"2.45","2.45","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2WMX"
"2WNA",,"X-RAY DIFFRACTION",1.41,12.73,,5.5,"DROP: 2 MM G(BR)CGCGC, 10% 2-METHYL-2,4-PENTANEDIOL, 40 MM SODIUM CACODYLATE (PH 5.5), 20 MM COBALT HEXAMINE, 80 MM SODIUM CHLORIDE, 20 MM MAGNESIUM CHLORIDE RESERVOIR: 35 % MPD",,"10.1039/b916851f",,"2WNA",1.98,"0.97","0.97","Crystal structure of the GNA 3'-G(Br)CGCGC-2'","GCGCGC","Homo sapiens",,"GNA","1","2WNA"
"2WND",,"X-RAY DIFFRACTION",2.19,43.4,,,,,"10.1002/pro.274",,"2WND",11.08,"1.6","1.6","Structure of an S100A7 triple mutant","SNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLAGVFEKKDKNEDKKIDFSEFLSLMGDIATDYHKKSHGAAPCS","Homo sapiens","S100A7, PSOR1, S100A7C","PROTEIN S100-A7","1","2WND"
"2WNG",,"X-RAY DIFFRACTION",2.85,56.9,"VAPOR DIFFUSION, SITTING DROP",6.5,"SITTING DROPS CONTAINING 100 NL SIRP (18.6 MG/ML) PLUS 100 NL PRECIPITANT (1.0 M TRI-SODIUM CITRATE, 0.1 M SODIUM CACODYLATE, PH 6.5) WERE EQUILIBRATED AT 20.5C AGAINST 95 UL RESERVOIRS OF PRECIPITANT. CRYSTALS WERE CRYO-PROTECTED BY A QUICK SWEEP THROUGH PERFLUOROPOLYETHER PFO-X125/03 (LANCASTER SYNTHESIS).",,"10.1074/jbc.M109.017566",,"2WNG",36.43,"2.49","2.49","complete extracellular structure of human signal regulatory protein (SIRP) alpha","EEELQVIQPDKSVSVAAGESAILHCTVTSLIPVGPIQWFRGAGPARELIYNQKEGHFPRVTTVSESTKRENMDFSISISNITPADAGTYYCVKFRKGSPDTEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSTRHHHHHH","Homo sapiens","SIRPA, BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1","1","2WNG"
"2WNO",,"X-RAY DIFFRACTION",3.09,59.93,,7.5,"100MM HEPES PH 7.5 200MM MGSO4 22% (W/V) PEG 1000",,"10.1074/jbc.M115.669838",,"2WNO",16.77,"2.3","2.3","X-ray Structure of CUB_C domain from TSG-6","NPHAKECGGVFTDPKQIFKSPGFPNEYEDNQICYWHIRLKYGQRIHLSFLDFDLEDDPGCLADYVEIYDSYDDVHGFVGRYCGDELPDDIISTGNVMTLKFLSDASVTAGGFQIKYVAMDPVSKSSQGKNTSTTSTGNKNFLAGRFSHL","Homo sapiens","TNFAIP6, TSG6","TUMOR NECROSIS FACTOR-INDUCIBLE GENE 6 PROTEIN","1","2WNO"
"2WNP",,"X-RAY DIFFRACTION",2.2,43.61,,,,,"10.1074/jbc.M109.065854",,"2WNP",24.33,"1.21","1.21","M-ficolin mutant Y271F","SCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRVDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESFANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2WNP"
"2WNS",,"X-RAY DIFFRACTION",1.95,36.52,,,,,,,"2WNS",46,"1.9","1.9","Human Orotate phosphoribosyltransferase (OPRTase) domain of Uridine 5' -monophosphate synthase (UMPS) in complex with its substrate orotidine 5'-monophosphate (OMP)","MALGPLVTGLYDVQAFKFGDFVLKSGLSSPIYIDLRGIVSRPRLLSQVADILFQTAQNAGISFDTVCGVPYTALPLATVICSTNQIPMLIRRKETKDYGTKRLVEGTINPGETCLIIEDVVTSGSSVLETVEVLQKEGLKVTDAIVLLDREQGGKDKLQAHGIRLHSVCTLSKMLEILEQQKKVDAETVGRVKRFIQEAHHHHHH","Homo sapiens","UMPS, OK/SW-cl.21","OROTATE PHOSPHORIBOSYLTRANSFERASE","1","2WNS"
"2WNT",,"X-RAY DIFFRACTION",2.32,47.08,,,"20% PEG 3350, 0.20M NA(FORM)",,,,"2WNT",74.63,"2.4","2.4","Crystal Structure of the Human Ribosomal protein S6 kinase","MHHHHHHSSGVDLGTENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKPTPQLKPIES","Homo sapiens","RPS6KA1, MAPKAPK1A, RSK1","RIBOSOMAL PROTEIN S6 KINASE","1","2WNT"
"2WO1",,"X-RAY DIFFRACTION",2.2,45.1,,8.5,"30% PEG 4000, 8% PROPAN-1-OL, AND 100 MM TRIS PH 8.5",,"10.1016/j.str.2009.07.018",,"2WO1",43.23,"1.85","1.85","Crystal Structure of the EphA4 Ligand Binding Domain","ETGEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKRTKHHHHHH","Homo sapiens","EPHA4, HEK8, SEK, TYRO1","EPHRIN TYPE-A RECEPTOR","1","2WO1"
"2WO8",,"X-RAY DIFFRACTION",2.46,50.1,,5.2,"100MM MES PH 5.2-5.6, 16-20% PEG 5KMME, 200MM AMMONIUM SULPHATE",,"10.1016/j.bmcl.2009.07.155","077","2WO8",75.68,"2","2","MMP12 complex with a beta hydroxy carboxylic acid","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGDPKEN","Homo sapiens","MMP12, HME","MACROPHAGE METALLOELASTASE","1","2WO8"
"2WO9",,"X-RAY DIFFRACTION",2.53,51.47,,5.2,"100MM MES PH5.2-5.6, 16-20% PEG, 5KMME, 200MM AMMONIUM SULPHATE",,"10.1016/j.bmcl.2009.07.155","068","2WO9",76.28,"1.7","1.7","MMP12 complex with a beta hydroxy carboxylic acid","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGDPKEN","Homo sapiens","MMP12, HME","MACROPHAGE METALLOELASTASE","1","2WO9"
"2WOA",,"X-RAY DIFFRACTION",2.43,49.5,,5.2,"100MM MES PH5.2-5.6, 16-20% PEG, 5KMME, 200MM AMMONIUM SULPHATE",,"10.1016/j.bmcl.2009.07.155","576","2WOA",76.02,"2.3","2.3","MMP12 complex with a beta hydroxy carboxylic acid","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGDPKEN","Homo sapiens","MMP12, HME","MACROPHAGE METALLOELASTASE","1","2WOA"
"2WOG",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG 3350, 0.15M SODIUM TARTRATE DIBASIC DIHYDRATE, 0.1M MES PH 6.5",277,"10.1042/BJ20091207","ZZD","2WOG",125.61,"2","2","Intermediate and final states of human kinesin Eg5 in complex with S-trityl-L-cysteine","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2WOG"
"2WOR",,"X-RAY DIFFRACTION",3.15,60.6,,,,,"10.1021/bi901330g","2AN","2WOR",11.75,"1.7","1.7","co-structure of S100A7 with 1,8 ANS","SNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQ","Homo sapiens","S100A7, PSOR1, S100A7C","PROTEIN S100-A7","1","2WOR"
"2WOS",,"X-RAY DIFFRACTION",3.12,60.27,,,,,"10.1021/bi901330g","6AN","2WOS",11.75,"1.7","1.7","Structure of human S100A7 in complex with 2,6 ANS","SNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQ","Homo sapiens","S100A7, PSOR1, S100A7C","PROTEIN S100-A7","1","2WOS"
"2WOT",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP METHOD. DROPS PROTEIN-PRECIPITANT 1-1, PROTEIN: 10MG/ML ALK5, PRECIPITANT: 20-30% PEG8K, 100 MM PCTP BUFFER PH 8.5-9.2, 0.2 M NAAC",,"10.1021/jm900807w","ZZG","2WOT",35.46,"1.85","1.85","ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine","GGTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-BETA RECEPTOR TYPE-1","1","2WOT"
"2WOU",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP METHOD. DROPS PROTEIN-PRECIPITANT 1-1, PROTEIN: 10MG/ML ALK5, PRECIPITANT: 20-30% PEG8K, 100 MM PCTP BUFFER PH 8.5-9.2, 0.2 M NAAC",,"10.1021/jm900807w","ZZF","2WOU",35.37,"2.3","2.3","ALK5 IN COMPLEX WITH 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamide","GGTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-BETA RECEPTOR TYPE-1","1","2WOU"
"2WQ9",,"X-RAY DIFFRACTION",3.11,60.13,,,"3.5 TO 4.2 M NACL, 1M HEPES PH 7.2",,,,"2WQ9",20.79,"1.65","1.65","Crystal Structure of RBP4 bound to Oleic Acid","ERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYC","Homo sapiens","RBP4, PRO2222","RETINOL-BINDING PROTEIN 4","1","2WQ9"
"2WQB",,"X-RAY DIFFRACTION",3.36,63,,7.5,"5 MG/ML PROTEIN, 5% (W/V) PEG6000, 5% (V/V) MPD, 100MM MOPS PH7.5, 293K",293,"10.1016/j.bmcl.2009.10.001","QQ1","2WQB",37.38,"2.95","2.95","Structure of the Tie2 kinase domain in complex with a thiazolopyrimidine inhibitor","GALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA","Homo sapiens","TEK, TIE2, VMCM, VMCM1","ANGIOPOIETIN-1 RECEPTOR","1","2WQB"
"2WQE",,"X-RAY DIFFRACTION",2.24,45.18,,,"17% (W/V) PEG3350, 15% (V/V) GLYCEROL",,"10.1074/jbc.M109.032722",,"2WQE",31.79,"2.5","2.5","Structure of S155R Aurora-A somatic mutant","QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2WQE"
"2WQI",,"X-RAY DIFFRACTION",1.8,32,"VAPOR DIFFUSION, SITTING DROP",6.2,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 15 MG/ML IN 20 MM TRIS (PH 8.5), 50 MM NACL. CRYSTALLIZATION BUFFER: 0.1 M SODIUM CITRATE (PH 6.2), 40% PEG 600.",290,"10.1073/pnas.0905867106",,"2WQI",24.53,"1.7","1.7","Crystal structure of the human p73 tetramerization domain","GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQRP","Homo sapiens","TP73, P73","TUMOR PROTEIN P73","1","2WQI"
"2WQJ",,"X-RAY DIFFRACTION",2.9,58,"VAPOR DIFFUSION, SITTING DROP",8.5,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 10 MG/ML IN 20 MM TRIS (PH 8.5), 50 MM NACL. CRYSTALLIZATION BUFFER: 0.1 M TRIS (PH 8.5), 0.9 M AMMONIUM PHOSPHATE.",290,"10.1073/pnas.0905867106",,"2WQJ",117,"2","2","Crystal structure of a truncated variant of the human p73 tetramerization domain","GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQ","Homo sapiens","TP73, P73","TUMOR PROTEIN P73","1","2WQJ"
"2WQM",,"X-RAY DIFFRACTION",2.89,57.4,,,"100 MM HEPES, PH 7.5, 15% PEG 5000 MME, 400 MM AMMONIUM SULFATE",,"10.1016/j.molcel.2009.09.038",,"2WQM",35.82,"2.1","2.1","Structure of apo human Nek7","MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH","Homo sapiens","NEK7","SERINE/THREONINE-PROTEIN KINASE NEK7","1","2WQM"
"2WQN",,"X-RAY DIFFRACTION",2.88,57.39,,,"100MM HEPES 7.5, 15% PEG 5000MME, 400MM AMMONIUM SULFATE",,"10.1016/j.molcel.2009.09.038",,"2WQN",36.28,"2.3","2.3","Structure of ADP-bound human Nek7","MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH","Homo sapiens","NEK7","SERINE/THREONINE-PROTEIN KINASE NEK7","1","2WQN"
"2WQO",,"X-RAY DIFFRACTION",3.22,61.78,,,"2-10% PEG8000, 50MM TRIS PH 8.5,",,"10.1016/j.molcel.2009.09.038",,"2WQO",33.15,"2.167","2.167","STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2WQO"
"2WQR",,"X-RAY DIFFRACTION",2.7,54,,8.5,"THE PROTEIN CONCENTRATION WAS 1.9 MG/ML. CRYSTALS GREW AT 18 DEGREES C WITH 14% PEG 8000, 200MM LITHIUM SULPHATE, 100MM TRIS-HCL PH 8.5 AS PRECIPITANT.",291,"10.1038/nsmb.2044",,"2WQR",74.57,"1.9","1.9","The high resolution crystal structure of IgE Fc","CSRDFTPPTVKILQSSCDGGGHFPPTIQLLCLVSGYTPGTIQITWLEDGQVMDVDLSTASTTQEGELASTQSELTLSQKHWLSDRTYTCQVTYQGHTFEDSTKKCADSNPRGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVQLTWSRASGKPVNHSTRKEEKQRNGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAFATPEWPGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSRLEVTRAEWEQKDEFICRAVHEAASPSQTVQRAVSVNPG","Homo sapiens","IGHE","IG EPSILON CHAIN C REGION","1","2WQR"
"2WR6",,"X-RAY DIFFRACTION",3.7,40.2,,,"3.5-4.2M NACL, 0.1M HEPES, PH 7.2",,,,"2WR6",20.43,"1.8","1.8","Structure of the complex of RBP4 with linoleic acid","GERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYC","Homo sapiens","RBP4, PRO2222","RETINOL-BINDING PROTEIN 4","1","2WR6"
"2WRU",,"X-RAY DIFFRACTION",2.3,47,,3,"0.32 M NA2SO4, PH 3.0",,"10.1073/pnas.0911785107",,"2WRU",5.43,"1.57","1.57","Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2","FVNQHLCGSHLVEALYLVCGERGFFA","Homo sapiens","INS","INSULIN B CHAIN","2","2WRU"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WRU"
"2WRV",,"X-RAY DIFFRACTION",2.3,43,,8.2,"0.1 NA CITRATE, 0.3 M TRIS PH 8.2, 0.6 MM ZN ACETATE, 0.06% PHENOL",,"10.1073/pnas.0911785107",,"2WRV",5.44,"2.15","2.15","Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WRV"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFH","Homo sapiens","INS","INSULIN B CHAIN","2","2WRV"
"2WRW",,"X-RAY DIFFRACTION",2.3,46,,3,"0.015 M CS2SO4 PH 3.0",,"10.1073/pnas.0911785107",,"2WRW",5.32,"2.41","2.41","Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WRW"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFP","Homo sapiens","INS","INSULIN B CHAIN","2","2WRW"
"2WRX",,"X-RAY DIFFRACTION",2.4,48,,3,"0.18 M LI2SO4, 0.1M NA ACETATE PH 3.0",,"10.1073/pnas.0911785107",,"2WRX",11.5,"1.5","1.5","Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WRX"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFATPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2WRX"
"2WS0",,"X-RAY DIFFRACTION",2.3,47,,7.5,"0.75 DILUTION IN WATER OF STOCK OF 0.1 M NA CITRATE,0.3M TRIS PH 7.5,0.6 MM ZN ACETATE, 0.06% PHENOL",,"10.1073/pnas.0911785107",,"2WS0",5.74,"2.1","2.1","Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WS0"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFATPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2WS0"
"2WS1",,"X-RAY DIFFRACTION",2.3,47,,3,"0.055 M NA2SO4 PH 3.0",,"10.1073/pnas.0911785107",,"2WS1",5.89,"1.6","1.6","Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WS1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFXTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2WS1"
"2WS4",,"X-RAY DIFFRACTION",2.3,47,,3,"0.055M NA2SO4 PH 3.0",,"10.1073/pnas.0911785107",,"2WS4",5.32,"1.9","1.9","Semi-synthetic analogue of human insulin ProB26-DTI in monomer form","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WS4"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFP","Homo sapiens","INS","INSULIN B CHAIN","2","2WS4"
"2WS6",,"X-RAY DIFFRACTION",2.43,49,,8.2,"6% TRIS PH 8.2, 0.1 M NA CITRATE, 0.02% ZN ACETATE, 0.06% PHENOL",,"10.1073/pnas.0911785107",,"2WS6",35.82,"1.5","1.5","Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WS6"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","2WS6"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFXTPKT","Homo sapiens","INS","INSULIN B CHAIN","3","2WS6"
"2WS7",,"X-RAY DIFFRACTION",2.2,44,,7.5,"5 MM ZN ACETATE,35 MM NA CITRATE,0.7% PHENOL,).7M NACL,0.3M TRIS PH 7.5",,"10.1073/pnas.0911785107",,"2WS7",32.7,"2.59","2.59","Semi-synthetic analogue of human insulin ProB26-DTI","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","2WS7"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFP","Homo sapiens","INS","INSULIN B CHAIN","2","2WS7"
"2WSL",,"X-RAY DIFFRACTION",2.8,55.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES BUFFER PH 6.5, 2.1M AMMONIUM SULFATE",293,"10.1042/BJ20090091",,"2WSL",62.22,"2","2","Aged Form of Human Butyrylcholinesterase Inhibited by Tabun Analogue TA4","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2WSL"
"2WT8",,"X-RAY DIFFRACTION",2.5,50.77,,,"100 MM MES, PH 6.0, 18% PEG 6000, 200 MM NH4CL",,"10.1016/j.jmb.2009.11.029",,"2WT8",43.43,"1.6","1.6","Structure of the N-terminal BRCT domain of human microcephalin (Mcph1)","GAMAAPILKDVVAYVEVWSSNGTENYSKTFTTQLVDMGAKVSKTFNKQVTHVIFKDGYQSTWDKAQKRGVKLVSVLWVEKCRTAGAHIDESLFPAAN","Homo sapiens","MCPH1","MICROCEPHALIN","1","2WT8"
"2WTC",,"X-RAY DIFFRACTION",3.25,62,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2009.11.058","VGM","2WTC",37.51,"3","3","CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2WTC"
"2WTD",,"X-RAY DIFFRACTION",3.41,63.91,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2009.11.058","ZZK","2WTD",37.69,"2.75","2.75","Crystal structure of Chk2 in complex with an inhibitor","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2WTD"
"2WTI",,"X-RAY DIFFRACTION",3.27,0.62,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2009.11.058","WTI","2WTI",37.71,"2.5","2.5","CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","CHECKPOINT KINASE 2","1","2WTI"
"2WTJ",,"X-RAY DIFFRACTION",3.29,0.63,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2009.11.058","WTJ","2WTJ",37.83,"2.1","2.1","CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","CHECKPOINT KINASE 2","1","2WTJ"
"2WTT",,"X-RAY DIFFRACTION",2,39.8,"VAPOR DIFFUSION, SITTING DROP",6.2,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 15 MG/ML IN 20 MM TRIS (PH 8.5), 50 MM NACL. CRYSTALLIZATION BUFFER: 0.1 M SODIUM CITRATE (PH 6.2), 40% PEG 600.",290,"10.1073/pnas.0905867106",,"2WTT",99.61,"2.3","2.3","Structure of the human p73 tetramerization domain (crystal form II)","GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQRP","Homo sapiens","TP73, P73","TUMOR PROTEIN P73","1","2WTT"
"2WTV",,"X-RAY DIFFRACTION",4.2,70.7,,,"0.8M NAH2PO4 1.2M K2HPO4 0.1M NA ACETATE, PH 4.5",,"10.1042/BJ20091530","ZZL","2WTV",136.19,"2.4","2.4","Aurora-A Inhibitor Structure","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED KINASE, AURORA-A, AURORA-RELATED KINASE 1, HARK1","1","2WTV"
"2WTW",,"X-RAY DIFFRACTION",2.65,53.56,,,"0.1M MES SODIUM SALT PH6.5, 2.0M AMMONIUM SULFATE, 5%(W/V) PEG 400",,"10.1042/BJ20091530","ZZL","2WTW",33.47,"3.302","3.302","Aurora-A Inhibitor Structure (2nd crystal form)","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED KINASE, AURORA-A, AURORA-RELATED KINASE 1, HARK1","1","2WTW"
"2WU6",,"X-RAY DIFFRACTION",2.53,51.4,,,"0.2M (NH4)2SO4, 0.1M BIS-TRIS PH 5.5, 25% PEG 3350",,"10.1016/j.chembiol.2010.11.009","DKI","2WU6",46.09,"1.92","1.92","Crystal Structure of the Human CLK3 in complex with DKI","MHHHHHHSSGVDLGTENLYFQSMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","DUAL SPECIFICITY PROTEIN KINASE CLK3","1","2WU6"
"2WU7",,"X-RAY DIFFRACTION",2.28,46.17,,,"0.2M (NH4)2SO4, 0.1M BIS-TRIS PH 5.5, 25% PEG 3350",,"10.1016/j.chembiol.2010.11.009","V25","2WU7",45.68,"2.25","2.25","Crystal Structure of the Human CLK3 in complex with V25","MHHHHHHSSGVDLGTENLYFQSMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","DUAL SPECIFICITY PROTEIN KINASE CLK3","1","2WU7"
"2WUL",,"X-RAY DIFFRACTION",2.66,53.8,,6.5,"50% PEG300, 0.2 M MGCL2, 0.1 M CACODYLATE PH 6.5, 0.01 M SPERMINE TETRAHYDROCHLORIDE",,"10.1042/BJ20101286",,"2WUL",53.29,"2.4","2.4","CRYSTAL STRUCTURE OF THE HUMAN GLUTAREDOXIN 5 WITH BOUND GLUTATHIONE IN AN FES CLUSTER","SMGAGGGGSAEQLDALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVRDYAAYNVLDDPELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGIHSALLDE","Homo sapiens","GLRX5, C14orf87","GLUTAREDOXIN RELATED PROTEIN 5","1","2WUL"
"2WUT",,"X-RAY DIFFRACTION",2.79,55.64,,8.5,"pH 8.5",,"10.1371/journal.pone.0010300",,"2WUT",15.38,"1.85","1.85","Crystal structure of human myelin protein P2 in complex with palmitate","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","2WUT"
"2WV8",,"X-RAY DIFFRACTION",3.23,61.57,,,,,"10.1002/cmdc.200900454","VGN","2WV8",40.95,"1.9","1.9","Complex of human dihydroorotate dehydrogenase with the inhibitor 221290","TGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","DIHYDROOROTATE DEHYDROGENASE, MITOCHONDRIAL","1","2WV8"
"2WVI",,"X-RAY DIFFRACTION",2.47,49,,8,"22.5% (W/V) PEG 8000, 0.17 M TRIS PH 8.0, 0.01 M PRASEODYMIUM(III) ACETATE",,"10.1074/jbc.M109.082016",,"2WVI",20.06,"1.8","1.8","Crystal Structure of the N-terminal Domain of BubR1","QQKRAFEYEIRFYTGNDPLDVWDRYISWTEQNYPQGGKESNMSTLLERAVEALQGEKRYYSDPRFLNLWLKLGRLCNEPLDMYSYLHNQGIGVSLAQFYISWAEEYEARENFRKADAIFQEGIQQKAEPLERLQSQHRQFQARVSRQTLLALEKEEEEEVFESS","Homo sapiens","BUB1B, BUBR1, MAD3L, SSK1","MITOTIC CHECKPOINT SERINE/THREONINE-PROTEIN KINASE BUB1 BETA","1","2WVI"
"2WVJ",,"X-RAY DIFFRACTION",2.7,43,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROPS WITH EQUAL AMOUNTS OF PROTEIN, 10 MG PER ML CONTAINING 5 MM TTP AND TRAY SOLUTION COMPOSED OF SODIUM CITRATE PH 5.6, 2-PROPANOL AND PEG 4000.",,"10.1111/j.1742-4658.2012.08554.x",,"2WVJ",174.96,"2.2","2.2","Mutation of Thr163 to Ser in Human Thymidine Kinase Shifts the Specificity from Thymidine towards the Nucleoside Analogue Azidothymidine","MSCINLPTVLPGSPSKTRGQIQVILGPMFSGKSTELMRRVRRFQIAQYKCLVIKYAKDTRYSSSFCTHDRNTMEALPACLLRDVAQEALGVAVIGIDEGQFFPDIVEFCEAMANAGKTVIVAALDGTFQRKPFGAILNLVPLAESVVKLTAVCMECFREAAYSKRLGTEKEVEVIGGADKYHSVCRLCYFKKA","Homo sapiens","TK1","THYMIDINE KINASE, CYTOSOLIC","1","2WVJ"
"2WWE",,"X-RAY DIFFRACTION",2.06,40.4,,5.5,"0.1M TRI-SODIUM CITRATE DIHYDRATE PH 5.5, 20% PEG3000",,,,"2WWE",14.98,"1.25","1.25","Crystal structure of the phox homology domain of human phosphoinositide-3-kinase-C2-gamma","MHHHHHHSSGVDLGTENLYFQSMSIERATILGFSKKSSNLYLIQVTHSNNETSLTEKSFEQFSKLHSQLQKQFASLTLPEFPHWWHLPFTNSDHRRFRDLNHYMEQILNVSHEVTNSDCVLSFFLSE","Homo sapiens","PIK3C2G","PHOSPHOINOSITIDE-3-KINASE, CLASS 2, GAMMA POLYPEPTIDE","1","2WWE"
"2WWJ",,"X-RAY DIFFRACTION",2.68,54,,7.5,"PROTEIN STOCK 11MG/ML JMJD2A, 10MM HEPES PH7.5, 500MM NACL, 5% GLYCEROL, 0.75MM INHIBITOR 10A. RESERVOIR: 0.1M CITRATE PH5.5, 18.5% PEG3350, 4MM NICL2. 1:1 PROTEIN/RESERVOIR",,"10.1021/jm901680b","Y28","2WWJ",82,"2.6","2.6","STRUCTURE OF JMJD2A COMPLEXED WITH INHIBITOR 10A","TLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFT","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","LYSINE-SPECIFIC DEMETHYLASE 4A","1","2WWJ"
"2WWP",,"X-RAY DIFFRACTION",1.92,36,,7,"20% PEG3350, 0.2 M SODIUM THIOCYANATE, pH 7",,"10.1194/jlr.M035410",,"2WWP",39.68,"2","2","Crystal structure of the human lipocalin-type prostaglandin D synthase","MAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQAHHHHHH","Homo sapiens","PTGDS, PDS","PROSTAGLANDIN-H2 D-ISOMERASE","1","2WWP"
"2WWR",,"X-RAY DIFFRACTION",2.7,54.5,,,"0.1M SODIUM CACODYLATE PH 6.75, 10% PEG 8K, 0.25M MAGNESIUM ACETATE TETRAHYDRATE",,"10.1016/j.jmb.2006.05.018",,"2WWR",143.53,"2.82","2.82","Crystal Structure of Human Glyoxylate Reductase Hydroxypyruvate Reductase","ASMRPVRLMKVFVTRRIPAEGRVALARAADCEVEQWDSDEPIPAKELERGVAGAHGLLCLLSDHVDKRILDAAGANLKVISTMSVGIDHLALDEIKKRGIRVGYTPDVLTDTTAELAVSLLLTTCRRLPEAIEEVKNGGWTSWKPLWLCGYGLTQSTVGIIGLGRIGQAIARRLKPFGVQRFLYTGRQPRPEEAAEFQAEFVSTPELAAQSDFIVVACSLTPATEGLCNKDFFQKMKETAVFINISRGDVVNQDDLYQALASGKIAAAGLDVTSPEPLPTNHPLLTLKNCVILPHIGSATHRTRNTMSLLAANNLLAGLRGEPMPSELKL","Homo sapiens","GRHPR, GLXR, MSTP035","GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE","1","2WWR"
"2WWU",,"X-RAY DIFFRACTION",3.36,0.63,,,"1.5 M (NH4)2SO4, 0.1 M SODIUM ACETATE PH 4.25",,"10.1016/j.febslet.2009.12.055",,"2WWU",44.35,"2.15","2.15","Crystal structure of the catalytic domain of PHD finger protein 8","SMPVKTGSPTFVRELRSRTFDSSDEVILKPTGNQLTVEFLEENSFSVPILVLKKDGLGMTLPSPSFTVRDVEHYVGSDKEIDVIDVTRQADCKMKLGDFVKYYYSGKREKVLNVISLEFSDTRLSNLVETPKIVRKLSWVENLWPEECVFERPNVQKYCLMSVRDSYTDFHIDFGGTSVWYHVLKGEKIFYLIRPTNANLTLFECWSSSSNQNEMFFGDQVDKCYKCSVKQGQTLFIPTGWIHAVLTPVDCLAFGGNFLHSLNIEMQLKAYEIEKRLSTADLFRFPNFETICWYVGKHILDIFRGLRENRRHPASYLVHGGKALNLAFRAWTRKEALPDHEDEIPETVRTVQLIKDLAREIRLVEDIFQQN","Homo sapiens","PHF8, KIAA1111, ZNF422","PHD FINGER PROTEIN 8","1","2WWU"
"2WWW",,"X-RAY DIFFRACTION",2.5,50.75,,,"CUSTOM.",,"10.1074/jbc.M110.177717",,"2WWW",157.89,"2.64","2.64","Crystal Structure of Methylmalonic Acidemia Type A Protein","SMKDHTEGLSDKEQRFVDKLYTGLIQGQRACLAEAITLVESTHSRKKELAQVLLQKVLLYHREQEQSNKGKPLAFRVGLSGPPGAGKSTFIEYFGKMLTERGHKLSVLAVDPSSCTSGGSLLGDKTRMTELSRDMNAYIRPSPTRGTLGGVTRTTNEAILLCEGAGYDIILIETVGVGQSEFAVADMVDMFVLLLPPAGGDELQGIKRGIIEMADLVAVTKSDGDLIVPARRIQAEYVSALKLLRKRSQVWKPKVIRISARSGEGISEMWDKMKDFQDLMLASGELTAKRRKQQKVWMWNLIQESVLEHFRTHPTVREQIPLLEQKVLIGALSPGLAADFLLKAFKSRD","Homo sapiens","MMAA","METHYLMALONIC ACIDURIA TYPE A PROTEIN, MITOCHONDRIAL","1","2WWW"
"2WX3",,"X-RAY DIFFRACTION",3.6,66,,6,"50MM MES (PH 6.0), 1.2M NA-MALONATE",,"10.1073/pnas.0909871106",,"2WX3",17.38,"2.31","2.31","Asymmetric trimer of the human DCP1a C-terminal domain","GPHMADLSIILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL","Homo sapiens","DCP1A, SMIF","MRNA-DECAPPING ENZYME 1A","1","2WX3"
"2WXW",,"X-RAY DIFFRACTION",5.7,78,,8,"2-2.5N NACL, 0.2M CACL2, 0.1M TRIS-HCL, PH8",,"10.1038/nature09505",,"2WXW",49.9,"3.3","3.3","Crystal structure of human angiotensinogen","SDRVYIHPFHLVIHNESTCEQLAKANAGKPKDPTFIPAPIQAKTSPVDEKALQDQLVLVAAKLDTEDKLRAAMVGMLANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTELDVAAEKIDRFMQAVTGWKTGCSLMGASVDSTLAFNTYVHFQGKMKGFSLLAEPQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFTESACLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHTELNLQKLSNDRIRVGEVLNSIFFELEADEREPTESTQQLNKPEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLSTA","Homo sapiens","AGT, SERPINA8","ANGIOTENSINOGEN","1","2WXW"
"2WYA",,"X-RAY DIFFRACTION",2.53,51.4,,,"25% PEG3350, 0.1M BISTRIS PH 6.5, 0.2M AMMONIUM SULPHATE",,"10.1016/j.jmb.2010.03.034",,"2WYA",208.98,"1.7","1.7","CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL- COENZYME A SYNTHASE 2 (HMGCS2)","SMPKDVGILALEVYFPAQYVDQTDLEKYNNVEAGKYTVGLGQTRMGFCSVQEDINSLCLTVVQRLMERIQLPWDSVGRLEVGTETIIDKSKAVKTVLMELFQDSGNTDIEGIDTTNACYGGTASLFNAANWMESSSWDGRYAMVVCGDIAVYPSGNARPTGGAGAVAMLIGPKAPLALERGLRGTHMENVYDFYKPNLASEYPIVDGKLSIQCYLRALDRCYTSYRKKIQNQWKQAGSDRPFTLDDLQYMIFHTPFCKMVQKSLARLMFNDFLSASSDTQTSLYKGLEAFGGLKLEDTYTNKDLDKALLKASQDMFDKKTKASLYLSTHNGNMYTSSLYGCLASLLSHHSAQELAGSRIGAFSYGSGLAASFFSFRVSQDAAPGSPLDKLVSSTSDLPKRLASRKCVSPEEFTEIMNQREQFYHKVNFSPPGDTNSLFPGTWYLERVDEQHRRKYARRPV","Homo sapiens","HMGCS2","HYDROXYMETHYLGLUTARYL-COA SYNTHASE, MITOCHONDRIAL","1","2WYA"
"2WYG",,"X-RAY DIFFRACTION",1.85,33.54,"VAPOR DIFFUSION",5.75,"CRYSTALLISATION WAS CARRIED OUT USING VAPOUR DIFFUSION IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG6K, 50MM MES-NAOH (PH5.5-6), 5MM CACL2 AND 50MM NACL., pH 5.75",,"10.1016/j.bmcl.2009.11.077","461","2WYG",44.23,"1.88","1.88","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2WYG"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2WYG"
"2WYJ",,"X-RAY DIFFRACTION",1.83,32.82,"VAPOR DIFFUSION, HANGING DROP",5.75,"CRYSTALLISATION WAS CARRIED OUT USING HANG DROP VAPOUR DIFFUSION METHODS IN 2UL DROPS CONTAINING 1:1 RATIO PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG6K, 50MM MES-NAOH (PH5.5-6), 5MM CACL2 AND 50MM NACL, pH 5.75",,"10.1016/j.bmcl.2009.11.077","898","2WYJ",44.23,"2.38","2.38","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2WYJ"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2WYJ"
"2WYQ",,"X-RAY DIFFRACTION",3.04,59.5,,7.5,"0.1 M HEPES PH 7.5, 2% PEG 400 AND 2.0 M AMMONIUM SULFATE, AT ROOM TEMPERATURE",,"10.1093/protein/gzq084",,"2WYQ",9.77,"1.651","1.651","THE CRYSTAL STRUCTURE OF THE UBIQUITIN-LIKE (UBL) DOMAIN OF HHR23A (HUMAN HOMOLOGUE A OF RAD23)","GIPMAVTITLKTLQQQTFKIRMEPDETVKVLKEKIEAEKGRDAFPVAGQKLIYAGKILSDDVPIRDYRIDEKNFVVVMVTKTKAG","Homo sapiens","RAD23A","UV EXCISION REPAIR PROTEIN RAD23 HOMOLOG A","1","2WYQ"
"2WYT",,"X-RAY DIFFRACTION",2.05,40,,4.75,"150 MM NACL, 2-3M AMMONIUM SULPHATE, 100 MM NA ACETATE BUFFER PH 4.75",,"10.1021/jm9017948",,"2WYT",32.72,"1","1","1.0 A resolution structure of L38V SOD1 mutant","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGVTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WYT"
"2WYZ",,"X-RAY DIFFRACTION",2.1,40,,7.5,"150 MM NACL, 3.0 M AMMONIUM SULPHATE, 100 MM TRIS PH 7.5",,"10.1021/jm9017948",,"2WYZ",32.76,"1.7","1.7","L38V SOD1 mutant complexed with UMP","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGVTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WYZ"
"2WZ0",,"X-RAY DIFFRACTION",2.1,40,,7.5,"150 MM NACL,3.0 M AMMONIUM SULPHATE, 100 MM TRIS-HCL PH 7.5",,"10.1021/jm9017948",,"2WZ0",32.6,"1.72","1.72","L38V SOD1 mutant complexed with aniline.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGVTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WZ0"
"2WZ1",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN WAS CONCENTRATED TO 12 MG/ML IN PURIFICATION BUFFER (10MM HEPES, 500MM NACL, 5% GLYCEROL, 10% GALACTOSE, 0.5MM TCEP)AND SET UP IN SITTING DROP IN A 1:2 RATIO WITH HAMPTON INDEX SCREEN - B8 (1.4M TRI-SODIUM CITRATE DIHYDRATE, 0.1M HEPES, PH 7.5).",,"10.1371/journal.pone.0057644",,"2WZ1",49.5,"1.63","1.63","STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN SOLUBLE GUANYLATE CYCLASE 1 BETA 3.","HKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDDAENLYFQ","Homo sapiens","GUCY1B1, GUC1B3, GUCSB3, GUCY1B3","GUANYLATE CYCLASE SOLUBLE SUBUNIT BETA-1","1","2WZ1"
"2WZ5",,"X-RAY DIFFRACTION",2.2,40,,4.75,"150 MM NACL, 2.0-3.0 M AMMONIUM SULPHATE, 100 MM ACETATE BUFFER PH 4.75",,"10.1021/jm9017948",,"2WZ5",32.54,"1.5","1.5","L38V SOD1 mutant complexed with L-methionine.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGVTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WZ5"
"2WZ6",,"X-RAY DIFFRACTION",2.2,40,,4.75,"150 MM NACL, 2.0-3.0 M AMMONIUM SULPHATE, 100 MM ACETATE BUFFER PH 4.75",,"10.1021/jm9017948",,"2WZ6",32.98,"1.55","1.55","G93A SOD1 mutant complexed with Quinazoline.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDAVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2WZ6"
"2WZ9",,"X-RAY DIFFRACTION",2.21,44.49,,,"1.4 M AMMONIUM CITRATE, PH 7",,,,"2WZ9",16.63,"1.55","1.55","Crystal structure of the thioredoxin domain of human TXNL2","SMAAGAAEAAVAAVEEVGSAGQFEELLRLKAKSLLVVHFWAPWAPQCAQMNEVMAELAKELPQVSFVKLEAEGVPEVSEKYEISSVPTFLFFKNSQKIDRLDGAHAPELTKKVQRHASSGSFLPSAKVKVDTDPNSSSVDKLAAALEHHHHHH","Homo sapiens","GLRX3, PICOT, TXNL2, HUSSY-22","GLUTAREDOXIN-3","1","2WZ9"
"2WZB",,"X-RAY DIFFRACTION",2.22,50,,6.5,"22% PEG2000MME, 0.1M BIS/TRIS PH 6.5",,"10.1021/ja100974t","3PG","2WZB",45.3,"1.47","1.47","The catalytically active fully closed conformation of human phosphoglycerate kinase in complex with ADP, 3PG and magnesium trifluoride","SLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2WZB"
"2WZC",,"X-RAY DIFFRACTION",2.19,50,,6.5,"22% PEG2000MME, 0.1M BIS/TRIS PH 6.5",,"10.1021/ja100974t","3PG","2WZC",45.32,"1.5","1.5","The catalytically active fully closed conformation of human phosphoglycerate kinase in complex with ADP, 3PG and aluminium tetrafluoride","SLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2WZC"
"2WZD",,"X-RAY DIFFRACTION",2.19,50,,6.5,"22% PEG2000MME, 0.1M BIS/TRIS PH 6.5",,"10.1021/ja100974t","3PG","2WZD",45.37,"1.56","1.56","The catalytically active fully closed conformation of human phosphoglycerate kinase K219A mutant in complex with ADP, 3PG and aluminium trifluoride","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADAIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2WZD"
"2WZO",,"X-RAY DIFFRACTION",2.12,41.45,,7.5,"1.0M POTASSIUM/SODIUM TARTRATE, 100MM HEPES, PH7.5, AT 17OC. 20% GLYCEROL USED AS A CRYOPROTECTANT.",,"10.1002/pro.404",,"2WZO",16.14,"1.6","1.6","The structure of the FYR domain","GRPVFPIGLGGLTVYSLGEIITDRPGFHDESAIYPVGYCSTRIYASMKCPDQKCLYTCQIKDGGVQPQFEIVPEDDPQNAIVSSSADACHAELLRTISTTMGKLMPNLLPAGADFFGFSHPAIHNLIQSCPGARKCINYQWVKFDV","Homo sapiens","TBRG1, NIAM","TRANSFORMING GROWTH FACTOR BETA REGULATOR 1","1","2WZO"
"2X0U",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",7.2,"SITTING DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES PH 7.2, 19% PEG 4000, 5 MM DTT. SOAKING BUFFER: SATURATED SOLUTION OF SMALL MOLECULE LIGAND IN 100 MM HEPES PH 7.2, 10 MM SODIUM PHOSPHATE PH 7.2, 19% PEG 4000, 20% GLYCEROL, 150 MM KCL.",294,"10.1016/j.chembiol.2009.12.011",,"2X0U",49.4,"1.6","1.6","STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO A 2-amino substituted benzothiazole scaffold","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2X0U"
"2X0V",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",7.2,"SITTING DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES PH 7.2, 19 % PEG 4000, 5 MM DTT. SOAKING BUFFER: SATURATED SOLUTION OF SMALL MOLECULE LIGAND IN 100 MM HEPES PH 7.2, 10 MM SODIUM PHOSPHATE PH 7.2, 19 % PEG 4000, 20 % GLYCEROL, 150 MM KCL.",294,"10.1016/j.chembiol.2009.12.011",,"2X0V",49.54,"1.8","1.8","STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 4-(trifluoromethyl)benzene-1,2-diamine","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2X0V"
"2X0W",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES PH 7.2, 19% PEG 4000, 5 MM DTT. SOAKING BUFFER: SATURATED SOLUTION OF SMALL MOLECULE LIGAND IN 100 MM HEPES PH 7.2, 10 MM SODIUM PHOSPHATE PH 7.2, 19% PEG 4000, 20% GLYCEROL, 150 MM KCL.",294,"10.1016/j.chembiol.2009.12.011",,"2X0W",49.4,"2.1","2.1","STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 5,6-dimethoxy- 2-methylbenzothiazole","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2X0W"
"2X10",,"X-RAY DIFFRACTION",3.04,59.21,,,"1/3 V/V: PROTEIN, 1/3 V/V: 20 % POLYETHYLENE GLYCOL 6000, 1 M LICL, 0.1 M TRIS PH 8 1/3 V/V: 0.4 M NON-DETERGENT SULFOBETAINE 256",,"10.1038/nsmb.1782",,"2X10",60.68,"3","3","Crystal structure of the complete EphA2 ectodomain","MGILPSPGMPALLSLVSLLSVLLMGCVAKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSPEGSGNGTKHHHHHH","Homo sapiens","EPHA2, ECK","EPHRIN TYPE-A RECEPTOR 2","1","2X10"
"2X13",,"X-RAY DIFFRACTION",2.03,43.28,,6.5,"0.1M BIS/TRIS PH 6.5 21% P2000MME",,,"3PG","2X13",45.18,"1.74","1.74","The catalytically active fully closed conformation of human phosphoglycerate kinase in complex with ADP and 3phosphoglycerate","SLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2X13"
"2X14",,"X-RAY DIFFRACTION",2.12,41.47,,6.5,"0.1M BIS/TRIS PH 6.5, 21% P2000MME",,,"3PG","2X14",45.2,"1.9","1.9","The catalytically active fully closed conformation of human phosphoglycerate kinase K219A mutant in complex with AMP-PCP and 3PG","SLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADAIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2X14"
"2X15",,"X-RAY DIFFRACTION",2.16,43,,6.5,"0.1M BIS/TRIS PH 6.5, 21% P2000MME",,,"3PG","2X15",45.95,"2.1","2.1","The catalytically active fully closed conformation of human phosphoglycerate kinase in complex with ADP and 1,3- bisphosphoglycerate","SLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2X15"
"2X18",,"X-RAY DIFFRACTION",2.45,49.81,,,"0.2M PROLINE, 0.1M HEPES PH 7.5, 10% PEG3350",,,,"2X18",115.26,"1.46","1.46","The crystal structure of the PH domain of human AKT3 protein kinase","SMSDVTIVKEGWVQKRGEYIKNWRPRYFLLKTDGSFIGYKEKPQDVDLPYPLNNFSVAKCQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMN","Homo sapiens","AKT3, PKBG","RAC-GAMMA SERINE/THREONINE-PROTEIN KINASE","1","2X18"
"2X1H",,"X-RAY DIFFRACTION",2.26,46,,,"1.6M NA MALONATE PH7.0, 1% W/V JEFFAMINE ED 2001, 0.1M HEPES PH 8.0",,,,"2X1H",80.69,"1.75","1.75","Crystal structure of the human MGC45594 gene product in complex with raloxifene","MHHHHHHSSGVDLGTENLYFQSMMQKLVVTRLSPNFREAVTLSRDCPVPLPGDGDLLVRNRFVGVNASDINYSAGRYDPSVKPPFDIGFEGIGEVVALGLSASARYTVGQAVAYMAPGSFAEYTVVPASIATPVPSVKPEYLTLLVSGTTAYISLKELGGLSEGKKVLVTAAAGGTGQFAMQLSKKAKCHVIGTCSSDEKSAFLKSLGCDRPINYKTEPVGTVLKQEYPEGVDVVYESVGGAMFDLAVDALATKGRLIVIGFISGYQTPTGLSPVKAGTLPAKLLKKSASVQGFFLNHYLSKYQAAMSHLLEMCVSGDLVCEVDLGDLSPEGRFTGLESIFRAVNYMYMGKNTGKIVVELPH","Homo sapiens","PTGR3, ZADH2","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","1","2X1H"
"2X1V",,"X-RAY DIFFRACTION",2.82,56.07,,7.6,"18% POLYETHYLENE GLYCOL (PEG) 6000, 100 MM HEPES PH 7.4, 150 MM MGCL2.",,,,"2X1V",19.35,"1.7","1.7","Crystal Structure of the activating H-Ras I163F mutant in Costello Syndrome, bound to MG-GDP","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREFRQH","Homo sapiens","HRAS, HRAS1","GTPASE HRAS","1","2X1V"
"2X25",,"X-RAY DIFFRACTION",2.64,53.55,,,,,"10.1038/nchembio.342",,"2X25",18.64,"1.2","1.2","Free acetyl-CypA orthorhombic form","HHHHHVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTKWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A","1","2X25"
"2X29",,"X-RAY DIFFRACTION",4.03,69.53,,,"0.1M SODIUM CHLORIDE, 0.1M BIS-TRIS PH6.5, 1.5M AMMONIUM SULFATE",,"10.1074/jbc.M109.084442",,"2X29",17.82,"2.3","2.3","Crystal structure of human4-1BB ligand ectodomain","DPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSLTGGLSYKEDTKELVVAKAGVYYVFFQMELRRVVAGEGSGSVSLALHLMPLRSAAGAAALALTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRVTPEIPA","Homo sapiens","TNFSF9","TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 9","1","2X29"
"2X2A",,"X-RAY DIFFRACTION",2.87,57.14,,,,,"10.1038/nchembio.342",,"2X2A",36.44,"1.4","1.4","Free acetyl-CypA trigonal form","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTKWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A","1","2X2A"
"2X2E",,"X-RAY DIFFRACTION",2.04,39,"VAPOR DIFFUSION, HANGING DROP",8.5,"HANGING DROP VAPOR DIFFUSION IN 0.1M TRIS PH 8.5, 25% PEG 3350, 200MM NACL, 25-35% NAF USING A DROP SIZE OF 2-10 MICROL AND A RESERVOIR VOLUME OF 750 MICROL. CRYSTALS GREW IN 4-5 DAYS AT EITHER 17C OR 20C.",,"10.1038/nature09032",,"2X2E",80.72,"2","2","Dynamin GTPase dimer, long axis form","GPEFSMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDKHGTDSRVDEMLRMYHALKEALSIIGNINTTTV","Homo sapiens","DNM1, DNM","DYNAMIN-1","1","2X2E"
"2X2F",,"X-RAY DIFFRACTION",1.97,37.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"HANGING DROP VAPOR DIFFUSION IN 0.1M TRIS PH 8.5, 25% PEG 3350, 200MM NACL, 25-35% NAF USING A DROP SIZE OF 2-10 MICROL AND A RESERVOIR VOLUME OF 750 MICROL. CRYSTALS GREW IN 4-5 DAYS AT EITHER 17C OR 20C.",,"10.1038/nature09032",,"2X2F",80.72,"2","2","Dynamin 1 GTPase dimer, short axis form","GPEFSMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDKHGTDSRVDEMLRMYHALKEALSIIGNINTTTV","Homo sapiens","DNM1, DNM","DYNAMIN-1","1","2X2F"
"2X2K",,"X-RAY DIFFRACTION",2.9,57.7,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 4.5 MG/ML IN 20 MM TRIS-HCL PH 8, 100MM NACL,1MM DTT, 1MM EDTA RESERVOIR 1.85 M SODIUM FORMATE, 0.1 SODIUM CITRATE PH 5.5, 0.2M LITHIUM CHLORIDE VAPOUR DIFFUSION, SITTING DROP, 289 K",289,"10.1016/j.bmc.2010.01.011","X2K","2X2K",36.18,"2.6","2.6","Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","2X2K"
"2X2L",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 4.5 MG/ML IN 20 MM TRIS-HCL PH 8, 100MM NACL,1MM DTT, 1MM EDTA RESERVOIR 1.85 M SODIUM FORMATE, 0.1 SODIUM CITRATE PH 5.5, 0.2M LITHIUM CHLORIDE VAPOUR DIFFUSION, SITTING DROP,289 K",289,"10.1016/j.bmc.2010.01.011","X2L","2X2L",36.24,"2","2","Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","2X2L"
"2X2M",,"X-RAY DIFFRACTION",2.72,54.9,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 4.5 MG/ML IN 20 MM TRIS-HCL PH 8, 100MM NACL, 1MM DTT, 1MM EDTA RESERVOIR 1.75 M SODIUM FORMATE, 0.1 SODIUM CITRATE PH 5.5, 0.15 M POTASSIUM THIOCYANATE VAPOUR DIFFUSION, SITTING DROP, 289 K",289,"10.1016/j.bmc.2010.01.011","X2M","2X2M",72.28,"2.5","2.5","Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","2X2M"
"2X2R",,"X-RAY DIFFRACTION",2.78,55.75,,6,"25% PEG3350, 0.15M SODIUM TARTRATE DIBASIC DIHYDRATE, 0.1M MES PH6.0",,"10.1021/jm100991m","X2O","2X2R",125.55,"2.2","2.2","Crystal structure of human kinesin Eg5 in complex with (R)-2-amino-3-((4-chlorophenyl)diphenylmethylthio)propanoic acid","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2X2R"
"2X2U",,"X-RAY DIFFRACTION",3.77,67.4,,7.5,"1.6 M (NH4)2SO4, 50 MM TRIS PH 7.5, 4% (V/V) 1\,4 BUTANEDIOL AT 15 DEG C.",288,"10.1038/nsmb.1808",,"2X2U",30.07,"2","2","First two Cadherin-like domains from Human RET","LYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWIRIQEDTGLLYLQRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPQISVAYRLLEGEGLPFRSAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPEFEN","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","2X2U"
"2X35",,"X-RAY DIFFRACTION",2.61,52.42,,8.5,"20% PEG 3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 10 MM NACL",,"10.1038/nsmb.1797",,"2X35",15.25,"2","2","Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1.","GGSEDEDSPLDALDLVWAKCRGYPSYPALIIDPKMPREGMFHHGVPIPVPPLEVLKLGEQMTQEAREHLYLVLFFDNKRTWQWLPRTKLVPLGVNQDLDKEKMLEGRKSNIRKSVQIAYHRALQHRSKVQGE","Homo sapiens","BRPF1, BR140","PEREGRIN","1","2X35"
"2X36",,"X-RAY DIFFRACTION",2.53,51,,6.5,"0.1 M BIS-TRIS PROPANOL PH 6.5, 0.25 M SODIUM ACETATE, 28% PEG 3350",,"10.1002/pro.376",,"2X36",134.55,"2","2","Structure of the proteolytic domain of the Human Mitochondrial Lon protease","VERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER","Homo sapiens","LONP1, PRSS15","LON PROTEASE HOMOLOG, MITOCHONDRIAL","1","2X36"
"2X44",,"X-RAY DIFFRACTION",2.87,57.16,,7.5,"0.02 M MAGNESIUM CHLORIDE, 0.1 M HEPES PH 7.5, 22 % W/V POLYACRYLIC ACID 5100 SODIUM SALT, 0.4 M NDSB-256 (OR 6 % 1,6-DIAMINOHEXANE).",,"10.1016/j.jmb.2010.04.011",,"2X44",14.09,"2.6","2.6","Structure of a strand-swapped dimeric form of CTLA-4","MKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPSPDSDLVPR","Homo sapiens","CTLA4, CD152","CYTOTOXIC T-LYMPHOCYTE PROTEIN 4","1","2X44"
"2X47",,"X-RAY DIFFRACTION",1.86,33.94,,,"0.2M (NH4)2SO4, 0.1M HEPES PH 7.5, 25% PEG 3350",,"10.1074/jbc.M110.206771",,"2X47",26.55,"1.7","1.7","Crystal structure of human MACROD1","TSTDWKEAKSFLKGLSDKQREEHYFCKDFVRLKKIPTWKEMAKGVAVKVEEPRYKKDKQLNEKISLLRSDITKLEVDAIVNAANSSLLGGGGVDGCIHRAAGPLLTDECRTLQSCKTGKAKITGGYRLPAKYVIHTVGPIAYGEPSASQAAELRSCYLSSLDLLLEHRLRSVAFPCISTGVFGYPCEAAAEIVLATLREWLEQHKDKVDRLIICVFLEKDEDIYRSRLPHYFPVA","Homo sapiens","MACROD1, LRP16","MACRO DOMAIN-CONTAINING PROTEIN 1","1","2X47"
"2X4D",,"X-RAY DIFFRACTION",2.27,45.76,,,"0.3M NA FORMATE, 25W/V PEG 3350",,,,"2X4D",59.14,"1.92","1.92","Crystal structure of human phospholysine phosphohistidine inorganic pyrophosphate phosphatase LHPP","SMAPWGKRLAGVRGVLLDISGVLYDSGAGGGTAIAGSVEAVARLKRSRLKVRFCTNESAASRAELVGQLQRLGFDISEQEVTAPAPAACQILKERGLRPYLLIHDGVRSEFDQIDTSNPNCVVIADAGESFSYQNMNNAFQVLMELEKPVLISLGKGRYYAATSGLMLDVGPYMKALEYACGIKAEVVGKPSPEFFKSALQAIGVEAHQAVMIGDDIVGDVGGAQRCGMRALQVRTGKFRPSDEHHPEVKADGYVDNLAEAVDLLLQHADK","Homo sapiens","LHPP","PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE","1","2X4D"
"2X4F",,"X-RAY DIFFRACTION",2.62,53.12,,,"2M AMMONIUM_SULFATE, 2.5% W/V PEG 400, PH 8.0 HEPES",,,,"2X4F",86.17,"2.67","2.67","The Crystal Structure of the human myosin light chain kinase LOC340156.","MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQDFVTK","Homo sapiens","MYLK4, SGK085","MYOSIN LIGHT CHAIN KINASE FAMILY MEMBER 4","1","2X4F"
"2X4Z",,"X-RAY DIFFRACTION",2.22,44.23,,,,,"10.1073/pnas.0911863107","7KC","2X4Z",34.1,"2.1","2.1","Crystal Structure of the Human p21-Activated Kinase 4 in Complex with PF-03758309","GSHMSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","SERINE/THREONINE-PROTEIN KINASE PAK 4","1","2X4Z"
"2X57",,"X-RAY DIFFRACTION",3.18,61,,4.2,"40% PEG300 0.1M CITRATE PHOSPHATE PH4.2",,,,"2X57",39.79,"2.1","2.1","Crystal structure of the extracellular domain of human Vasoactive intestinal polypeptide receptor 2","MHHHHHHSSGVDLGTENLYFQSMRFHLEIQEEETKCAELLRSQTEKHKACSGVWDNITCWRPANVGETVTVPCPKVFSNFYSKAGNISKNCTSDGWSETFPDFVDACGYSDPEDES","Homo sapiens","VIPR2, VIP2R","VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2","1","2X57"
"2X5Y",,"X-RAY DIFFRACTION",2.23,45,,,"20 % PEG 3350, 0.2M NA-FLUORIDE",,"10.1074/jbc.M114.630160",,"2X5Y",20.31,"1.05","1.05","Human ZC3HAV1 (ARTD13), C-terminal domain","SSKKYKLSEIHHLHPEYVRVSEHFKASMKNFKIEKIKKIENSELLDKFTWKKSQMKEEGKLLFYATSRAYVESICSNNFDSFLHETHENKYGKGIYFAKDAIYSHKNCPYDAKNVVMFVAQVLVGKFIEGNITYTSPPPQFDSCVDTRSNPSVFVIFQKDQVYPQYVIEYTED","Homo sapiens","ZC3HAV1, ZC3HDC2, PRO1677","ZINC FINGER CCCH-TYPE ANTIVIRAL PROTEIN 1","1","2X5Y"
"2X69",,"X-RAY DIFFRACTION",4.69,73.78,,,,,"10.1038/emboj.2010.256",,"2X69",38.97,"2.65","2.65","X-ray Structure of Macrophage Inflammatory Protein-1 alpha polymer","ASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA","Homo sapiens","CCL3, G0S19-1, MIP1A, SCYA3","C-C MOTIF CHEMOKINE 3","1","2X69"
"2X6D",,"X-RAY DIFFRACTION",2.7,54.17,,,"100MM BICINE PH 9.0, 2.0 M AMMONIUM SULFATE",,"10.1021/jm100262j","X6D","2X6D",33.72,"2.796","2.796","Aurora-A bound to an inhibitor","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2X6D"
"2X6E",,"X-RAY DIFFRACTION",2.5,51,,,"0.1 M NACL, 0.1 M HEPES, PH 7.5 1.6 M AMMONIUM SULFATE.",,"10.1021/jm100262j","YM4","2X6E",33.5,"3.35","3.35","Aurora-A bound to an inhibitor","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2X6E"
"2X6G",,"X-RAY DIFFRACTION",2.02,39.12,,,"0.2M NH4AC, 0.1M HEPES (PH7.8), 26% PEG3350",,"10.1038/emboj.2010.256",,"2X6G",139.49,"2.18","2.18","X-ray Structure of Macrophage Inflammatory Protein-1 alpha (D27A)","ASLAADTPTACCFSYTSRQIPQNFIAAYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA","Homo sapiens","CCL3, G0S19-1, MIP1A, SCYA3","C-C MOTIF CHEMOKINE 3","1","2X6G"
"2X6L",,"X-RAY DIFFRACTION",3.11,60.2,,,,,"10.1038/emboj.2010.256",,"2X6L",39.4,"2.602","2.602","X-ray Structure of Macrophage Inflammatory Protein-1 beta","APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN","Homo sapiens","CCL4, LAG1, MIP1B, SCYA4","C-C MOTIF CHEMOKINE 4","1","2X6L"
"2X6U",,"X-RAY DIFFRACTION",2.2,44.21,,6.5,"pH 6.5",,"10.1016/j.jmb.2010.04.052",,"2X6U",23.86,"1.9","1.9","Crystal structure of human TBX5 in the DNA-free form","GAMEGIKVFLHERELWLKFHEVGTEMIITKAGRRMFPSYKVKVTGLNPKTKYILLMDIVPADDHRYKFADNKWSVTGKAEPAMPGRLYVHPDSPATGAHWMRQLVSFQKLKLTNNHLDPFGHIILNSMHKYQPRLHIVKADENNGFGSKNTAFCTHVFPETAFIAVTSYQNHKITQLKIENNPFAKGFRGSDDMELHRMSRMQ","Homo sapiens","TBX5","T-BOX TRANSCRIPTION FACTOR TBX5","1","2X6U"
"2X7A",,"X-RAY DIFFRACTION",2.2,43.84,,5,"0.02M MGCL2, 0.1M BIS TRIS PH5.0, 20% POLYACRYLIC ACID",,"10.1016/j.chom.2010.03.005",,"2X7A",76.36,"2.77","2.77","Structural basis of HIV-1 tethering to membranes by the Bst2-tetherin ectodomain","QAATCNHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVR","Homo sapiens","BST2","BONE MARROW STROMAL ANTIGEN 2","1","2X7A"
"2X7C",,"X-RAY DIFFRACTION",2.76,55.54,,8,"25% PEG3350, 0.2M K2HPO4, 0.1M HEPES PH8.0",,"10.1021/jm100421n","KZ9","2X7C",83.59,"1.9","1.9","Crystal structure of human kinesin Eg5 in complex with (S)-enastron","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2X7C"
"2X7D",,"X-RAY DIFFRACTION",2.69,54.32,,6.5,"30% PEG 3350, 0.2M K2HPO4, 0.1M HEPES PH 8.0",,"10.1021/jm100421n","EGB","2X7D",83.67,"2.3","2.3","Crystal structure of human kinesin Eg5 in complex with (S)-dimethylenastron","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2X7D"
"2X7E",,"X-RAY DIFFRACTION",2.76,55.54,,8,"30% PEG3350, 0.2M K2HPO4, 0.1M HEPES PH8.0",,"10.1021/jm100421n",,"2X7E",83.77,"2.4","2.4","Crystal structure of human kinesin Eg5 in complex with (R)-fluorastrol","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2X7E"
"2X7F",,"X-RAY DIFFRACTION",2.49,50.64,,,"150 MM NA-MALONATE (PH 7.0), 25% (W/V) PEG 3350, 5% (V/V) ETHYLENE GLYCOL, 100 MM BIS-TRIS-PROPANE (PH 9.5)",,,,"2X7F",187.96,"2.8","2.8","Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor","SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDETEYEYSG","Homo sapiens","TNIK, KIAA0551","TRAF2 AND NCK-INTERACTING PROTEIN KINASE","1","2X7F"
"2X7G",,"X-RAY DIFFRACTION",3.6,65.82,,4.75,"0.5M AMMONIUM SULPHATE, 0.1M SODIUM ACETATE PH4.75",,,,"2X7G",45.84,"2.5","2.5","Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B","SMGSDDEEQEDPADYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS","Homo sapiens","SRPK2","UNCHARACTERIZED PROTEIN SRPK2","1","2X7G"
"2X7H",,"X-RAY DIFFRACTION",2.47,50.21,,,"0.5M NA MALONATE PH7.0, 0.25W/V JEFFAMINE ED 2001_PH7.0, 8PH HEPES.",,,,"2X7H",82.7,"1.6","1.6","Crystal structure of the human MGC45594 gene product in complex with fenoprofen","MHHHHHHSSGVDLGTENLYFQSMQGSAIPQAMQKLVVTRLSPNFREAVTLSRDCPVPLPGDGDLLVRNRFVGVNASDINYSAGRYDPSVKPPFDIGFEGIGEVVALGLSASARYTVGQAVAYMAPGSFAEYTVVPASIATPVPSVKPEYLTLLVSGTTAYISLKELGGLSEGKKVLVTAAAGGTGQFAMQLSKKAKCHVIGTCSSDEKSAFLKSLGCDRPINYKTEPVGTVLKQEYPEGVDVVYESVGGAMFDLAVDALATKGRLIVIGFISGYQTPTGLSPVKAGTLPAKLLKKSASVQGFFLNHYLSKYQAAMSHLLEMCVSGDLVCEVDLGDLSPEGRFTGLESIFRAVNYMYMGKNTGKIVVELPH","Homo sapiens","PTGR3, ZADH2","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","1","2X7H"
"2X7O",,"X-RAY DIFFRACTION",3.8,67,,7.2,"1.5 M AMMONIUM SULFATE, 0.1 M GLYCINE PH 7.25",,"10.1021/jm100812a","ZOP","2X7O",197.08,"3.7","3.7","Crystal structure of TGFbRI complexed with an indolinone inhibitor","EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-BETA RECEPTOR TYPE I","1","2X7O"
"2X7S",,"X-RAY DIFFRACTION",1.9,35.5,"VAPOR DIFFUSION, HANGING DROP",8,"100 MM TRIS-HCL, 1 MM ZNSO4, 2.5 M AMMONIUM SULFATE; 30 MM 2-MERCAPTOETHANOL, 5% GLYCEROL; 0.5 MM 2-METHOXYESTRADIOL 3-O-SULFAMATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1021/bi902178w","WZC","2X7S",30.24,"1.64","1.64","Structures of human carbonic anhydrase II inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2X7S"
"2X7T",,"X-RAY DIFFRACTION",2.1,40.6,"VAPOR DIFFUSION, HANGING DROP",8,"100 MM TRIS-HCL, 1 MM ZNSO4, 2.5 M AMMONIUM SULFATE; 30 MM 2-MERCAPTOETHANOL, 0.5 MM 2-METHOXYESTRADIOL 3-O-SULFAMATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1021/bi902178w","WZB","2X7T",29.84,"1.89","1.89","Structures of human carbonic anhydrase II inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2X7T"
"2X7U",,"X-RAY DIFFRACTION",1.8,31.9,"VAPOR DIFFUSION, HANGING DROP",8,"100 MM TRIS-HCL, 1 MM ZNSO4, 2.38 M AMMONIUM SULFATE; 30 MM 2-MERCAPTOETHANOL, 2.5% GLYCEROL; 0.5 MM 2-METHOXYESTRADIOL 3-O-SULFAMATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1021/bi902178w","WZA","2X7U",29.95,"2.12","2.12","Structures of human carbonic anhydrase II inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","2X7U"
"2X7Z",,"X-RAY DIFFRACTION",3.37,63.5,"VAPOR DIFFUSION",8.4,"VAPOR DIFFUSION, 100MM TRIS-HCL PH 8.4, 2.4M AMMONIUM SULPHATE",,"10.1074/jbc.M110.110833",,"2X7Z",10.57,"2","2","Crystal Structure of the SAP97 PDZ2 I342W C378A mutant protein domain","GSKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHWPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVALEEVTHEEAVTALKNTSDFVYLKVAKPTS","Homo sapiens","DLG1","DISKS LARGE HOMOLOG 1","1","2X7Z"
"2X81",,"X-RAY DIFFRACTION",3.12,60.3,,7.6,"0.2M K2HPO4, 20% PEG3350, 1MM TRIS(HYDROXYPROPYL)PHOSPHINE, pH 7.6",,"10.1021/cb100053q","ZZL","2X81",31.92,"2.91","2.91","STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054","GAMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2X81"
"2X8A",,"X-RAY DIFFRACTION",2.53,51.45,,,,,,,"2X8A",30,"2.6","2.6","Human Nuclear Valosin containing protein Like (NVL), C-terminal AAA- ATPase domain","SMTVPNVTWADIGALEDIREELTMAILAPVRNPDQFKALGLVTPAGVLLAGPPGCGKTLLAKAVANESGLNFISVKGPELLNMYVGESERAVRQVFQRAKNSAPCVIFFDEVDALCPRRSDRETGASVRVVNQLLTEMDGLEARQQVFIMAATNRPDIIDPAILRPGRLDKTLFVGLPPPADRLAILKTITKNGTKPPLDADVNLEAIAGDLRCDCYTGADLSALVREASICALRQEMARQKSGNEKGELKVSHKHFEEAFKKVRSSISKKDQI","Homo sapiens","NVL, NVL2","NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE","1","2X8A"
"2X8D",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",6.8,"HANGING DROP. 3UL PLUS 3UL PROTEIN: 7 MG/ML, 25MM TRIS PH7.5, 500MM NACL, 5% GLYCEROL. 5MM DTT WELL: 15-17% (W/V) PEG8000, 250MM AMMONIUM SULPHATE, 2% (V/V) GLYCEROL AND 100 MM SODIUM CACODYLATE PH 6.8",,"10.1016/j.bmcl.2010.07.015","X8D","2X8D",33.43,"1.9","1.9","Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2X8D"
"2X8E",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"HANGING DROP 3UL PLUS 3UL PROTEIN: 7 MG/ML, 25MM TRIS PH7.5, 500MM NACL, 5% GLYCEROL, 5MM DTT, 2MM COMPOUND WELL: 12-16% (W/V) PEG3350, 100-200MM AMMONIUM SULPHATE, 2% (V/V) GLYCEROL AND 100 MM SODIUM CACODYLATE PH 6.5",,"10.1016/j.bmcl.2010.07.015","X8E","2X8E",32.31,"2.5","2.5","Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2X8E"
"2X8I",,"X-RAY DIFFRACTION",2.28,45.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"HANGING DROP 3 UL PLUS 3UL PROTEIN: 7MG/ML, 2MM COMPOUND, 25MM TRIS PH7.5, 500MM NACL, 5% GLYCEROL. 5MM DTT WELL: 16-22% (W/V) PEG3350, 150MM AMMONIUM SULPHATE AND 100 MM BES PH 6.5",,"10.1016/j.bmcl.2010.07.015","X8I","2X8I",33.62,"1.92","1.92","Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2X8I"
"2X9E",,"X-RAY DIFFRACTION",3,59,,6.5,"12% PEG 20000, 0.1 M MES PH 6.5",,"10.1158/0008-5472.CAN-10-2101","SVE","2X9E",36.92,"3.1","3.1","HUMAN MPS1 IN COMPLEX WITH NMS-P715","GPANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKA","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","2X9E"
"2X9F",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",7.5,"PROTEIN: 12MG/ML IN 50MM MOPS PH 6.5, 50MM NACL, 1MM DTT RESERVOIR: 25% PEG 5000 MME, 0.1M TRIS PH 7.5, 0.15M MGCL2, 15% GLYCEROL TEMP: 4 DEGREES C SITTING DROP: 2 UL PROTEIN, 0.6 UL RESERVOIR",277,"10.1016/j.bmcl.2010.08.100","X9F","2X9F",34.36,"1.75","1.75","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2X9F"
"2XA4",,"X-RAY DIFFRACTION",2.77,55.66,"VAPOR DIFFUSION, HANGING DROP",6,"HANGING DROP 20 DEG C. 1.5UL PROTEIN PLUS 1UL WELL PROTEIN: 8.7MG/ML IN 20MM TRIS/HCL PH 8.5, 100MM NACL, 1MM DTT WELL: 28% W/V PEG3350, 200MM AMMONIUM ACETATE, 100MM SODIUM CITRATE PH 6.0",293,"10.1021/jm1011319","AZ5","2XA4",70.86,"2.04","2.04","Inhibitors of Jak2 Kinase domain","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","2XA4"
"2XA6",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.126185",,"2XA6",9.22,,,"Structural basis for homodimerization of the Src-associated during mitosis, 68 kD protein (Sam68) Qua1 domain","GAMEPENKYLPELMAEKDSLDPSFTHAMQLLTAEIEKIQKG","Homo sapiens","KHDRBS1, SAM68","KH DOMAIN-CONTAINING\,RNA-BINDING\,SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1","1","2XA6"
"2XA8",,"X-RAY DIFFRACTION",3.57,65,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.0 M AMMONIUM SULFATE, 0.1 M NA HEPES PH 7.5, 2% W/V PEG400.",,"10.1038/srep11581",,"2XA8",47.22,"2.42","2.42","Crystal structure of the Fab domain of omalizumab at 2.41A","EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKV","Homo sapiens",,"OMALIZUMAB HEAVY CHAIN","1","2XA8"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"OMALIZUMAB LIGHT CHAIN","2","2XA8"
"2XAB",,"X-RAY DIFFRACTION",2.55,51.79,,,,,"10.1021/jm100060b","VHD","2XAB",56.51,"1.9","1.9","Structure of HSP90 with an inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA,","1","2XAB"
"2XAE",,"X-RAY DIFFRACTION",2.74,55.17,,6,"24% POLYETHYLENE GLYCOL-3350, 0.25 M AMMONIUM SULPHATE, 0.01 M TRIMETHYLAMINE HYDROCHLORIDE AND 0.1 M MES PH 6.0",,"10.1021/jm100991m","2XA","2XAE",126.04,"2.6","2.6","Crystal structure of human kinesin Eg5 in complex with (R)-2-amino-3-((S)-2-methyl-1,1-diphenylbutylthio)propanoic acid","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","2XAE"
"2XB1",,"X-RAY DIFFRACTION",2.3,46.12,,,"6% PEG 1000, 1.6 M (NH4)2SO4, 100 MM HEPES PH 7.5, 45 MM HCL",,"10.1016/j.jmb.2010.07.007",,"2XB1",23.09,"1.9","1.9","Crystal structure of the human Pygo2 PHD finger in complex with the B9L HD1 domain","GLVYPCGACRSEVNDDQDAILCEASCQKWFHRECTGMTESAYGLLTTEASAVWACDLCLKTKEGSGSGSGSQFVYVFTTHLANTAAEAVLQGRADSILAYHQQNV","Homo sapiens","PYGO2, PP7910, BCL9L, DLNB11","PYGOPUS HOMOLOG 2, B-CELL CLL/LYMPHOMA 9-LIKE PROTEIN","1","2XB1"
"2XB7",,"X-RAY DIFFRACTION",2.2,44,,8.5,"18% PEG3350, 0.1 M TRIS/HCL PH 8.5",,"10.1021/bi1005514","GUI","2XB7",35.95,"2.5","2.5","Structure of Human Anaplastic Lymphoma Kinase in complex with NVP- TAE684","GPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEE","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","2XB7"
"2XBA",,"X-RAY DIFFRACTION",2.2,44,,,"20% PEG3350, 0.15 M DL-MALIC ACID",,"10.1021/bi1005514","571","2XBA",35.79,"1.95","1.95","Structure of Human Anaplastic Lymphoma Kinase in complex with PHA- E429","GPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEE","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","2XBA"
"2XBF",,"X-RAY DIFFRACTION",2.32,47,,6,"100 MM NA-MES, PH 6.0, 4% PEG 400, 35 MM CACL2, 5 MM TCEP",,"10.1038/embor.2011.21",,"2XBF",46.07,"2.503","2.503","Nedd4 HECT structure","GPLGSRDYKRKYEFFRRKLKKQNDIPNKFEMKLRRATVLEDSYRRIMGVKRADFLKARLWIEFDGEKGLDYGGVAREWFFLISKEMFNPYYGLFEYSATDNYTLQINPNSGLCNEDHLSYFKFIGRVAGMAVYHGKLLDGFFIRPFYKMMLHKPITLHDMESVDSEYYNSLRWILENDPTELDLRFIIDEELFGQTHQHELKNGGSEIVVTNKNKKEYIYLVIQWRFVNRIQKQMAAFKEGFFELIPQDLIKIFDENELELLMCGLGDVDVNDWREHTKYKNGYSANHQVIQWFWKAVLMMDSEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQSFTVEQWGTPEKLPRAHTCFNRLDLPPYESFEELWDKLQMAIENTQGFDGVD","Homo sapiens","NEDD4, KIAA0093, NEDD4-1, PIG53","E3 UBIQUITIN-PROTEIN LIGASE NEDD4","1","2XBF"
"2XBJ",,"X-RAY DIFFRACTION",3.41,64,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1021/jm101150b","XBJ","2XBJ",37.7,"2.3","2.3","Crystal Structure of Chk2 in complex with an inhibitor","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2XBJ"
"2XBV",,"X-RAY DIFFRACTION",2.25,45.5,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","XBV","2XBV",33.82,"1.66","1.66","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XBV"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XBV"
"2XBW",,"X-RAY DIFFRACTION",2.22,45,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","455","2XBW",33.86,"1.72","1.72","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XBW"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XBW"
"2XBX",,"X-RAY DIFFRACTION",2.3,47,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","RR8","2XBX",33.86,"1.85","1.85","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XBX"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XBX"
"2XBY",,"X-RAY DIFFRACTION",2.37,48,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126",,"2XBY",33.85,"2.02","2.02","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XBY"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XBY"
"2XC0",,"X-RAY DIFFRACTION",2.3,46.7,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","8NC","2XC0",33.87,"2.05","2.05","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XC0"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XC0"
"2XC4",,"X-RAY DIFFRACTION",2.18,44,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","IVK","2XC4",33.86,"1.67","1.67","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XC4"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XC4"
"2XC5",,"X-RAY DIFFRACTION",2.31,46.7,,6.5,"PH 6.5",,"10.1016/j.bmcl.2010.06.126","OYJ","2XC5",33.88,"1.7","1.7","Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2XC5"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2XC5"
"2XC7",,"SOLUTION NMR",,,,,,,"10.1261/rna.2009910",,"2XC7",13.07,,,"Solution Structure of PHAX-RBD in complex with ssRNA","GAMAEDSQEKVADEISFRLQEPKKDLIARVVRIIGNKKAIELLMETAEVEQNGGLFIMNGSRRRTPGGVFLNLLKNTPSISEEQIKDIFYIENQKEYENKKAAR","Homo sapiens","PHAX, RNUXA","PHOSPHORYLATED ADAPTER RNA EXPORT PROTEIN","1","2XC7"
,,,,,,,,,,,,,,,,"AUCG",,,"5'-(AP*UP*CP*GP)-3'","2","2XC7"
"2XCG",,"X-RAY DIFFRACTION",2.56,51.63,,6.5,"PEG 4000 12%, LISO4 70MM, ADA 0.1M PH 6.5",,"10.1074/jbc.M110.169482","XCG","2XCG",120.41,"1.9","1.9","Tranylcypromine-inhibited human monoamine oxidase B in complex with 2- (2-benzofuranyl)-2-imidazoline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XCG"
"2XCH",,"X-RAY DIFFRACTION",2.9,57.3,,,"2.0 M AMMONIUM SULFATE,0.1 M TRIS PH8.5",,"10.1016/j.bmcl.2010.05.070","CKG","2XCH",36.96,"2","2","Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor","MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1","1","2XCH"
"2XCK",,"X-RAY DIFFRACTION",2.9,57.3,,,"2.0 M AMMONIUM SULFATE, 0.1 M TRIS PH 8.5",,"10.1016/j.bmcl.2010.05.070","MH4","2XCK",36.61,"2.3","2.3","Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor","MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1","1","2XCK"
"2XCV",,"X-RAY DIFFRACTION",3.16,61,,,,,"10.1016/j.jmb.2011.02.059",,"2XCV",64.69,"2.3","2.3","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monophosphate and 2,3-bisphosphoglycerate","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XCV"
"2XCW",,"X-RAY DIFFRACTION",3.16,61,,,,,"10.1016/j.jmb.2011.02.059",,"2XCW",65.41,"1.9","1.9","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monophosphate and ATP","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XCW"
"2XCX",,"X-RAY DIFFRACTION",3.16,61,,,"0.1 M BICINE PH9.0, 10% PEG6000",,"10.1016/j.jmb.2011.02.059",,"2XCX",64.33,"2.3","2.3","Crystal structure of the apoform of the D52N variant of cytosolic 5'- nucleotidase II","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XCX"
"2XD7",,"X-RAY DIFFRACTION",1.75,29.84,,,"0.05M MGCL2; 0.1M HEPES PH 7.5; 30% MPEG 550",,,,"2XD7",83.35,"2.09","2.09","Crystal structure of the macro domain of human core histone H2A","DGPGDGFTILSSKSLVLGQKLSLTQSDISHIGSMRVEGIVHPTTAEIDLKEDIGKALEKAGGKEFLETVKELRKSQGPLEVAEAAVSQSSGLAAKFVIHCHIPQWGSDKCEEQLEETIKNCLSAAEDKKLKSVAFPPFPSGRNCFPKQTAAQVTLKAISAHFDDSSASSLKNVYFLLFDSESIGIYVQEMAKL","Homo sapiens","MACROH2A2, H2AFY2","CORE HISTONE MACRO-H2A.2","1","2XD7"
"2XDG",,"X-RAY DIFFRACTION",2.09,41,,7,"20% PEG6000, 0.15M MGCL2, 10% ETHYLENE GLYCOL, 0.1M TRIS PH7.0",,,,"2XDG",20.25,"1.95","1.95","Crystal structure of the extracellular domain of human growth hormone releasing hormone receptor.","SMLREDESACLQAAEEMPQTTLGCPATWDGLLCWPTAGSGEWVTLPCPDFFSHFSSESGAVKRDCTITGWSEPFPPYPVACPVPLELLAEEE","Homo sapiens","GHRHR","GROWTH HORMONE-RELEASING HORMONE RECEPTOR","1","2XDG"
"2XDK",,"X-RAY DIFFRACTION",2.07,40.57,,,,,"10.1021/jm100059d","XDK","2XDK",28.13,"1.97","1.97","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XDK"
"2XDL",,"X-RAY DIFFRACTION",2.68,53.71,,,,,"10.1021/jm100059d","2DL","2XDL",28.18,"1.98","1.98","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XDL"
"2XDP",,"X-RAY DIFFRACTION",3.04,59.51,,,"0.2M (NH4)2SO4; 0.1M TRIS PH 8.5; 25% PEG 3350",,,,"2XDP",14.25,"1.56","1.56","Crystal structure of the tudor domain of human JMJD2C","SMCEKVISVGQTVITKHRNTRYYSCRVMAVTSQTFYEVMFDDGSFSRDTFPEDIVSRDCLKLGPPAEGEVVQVKWPDGKLYGAKYFGSNIAHMYQVEFEDGSQIAMKREDIYTLDEELPKRVK","Homo sapiens","KDM4C, GASC1, JHDM3C, JMJD2C, KIAA0780","LYSINE-SPECIFIC DEMETHYLASE 4C","1","2XDP"
"2XDS",,"X-RAY DIFFRACTION",2.65,53.53,,,,,"10.1021/jm100059d",,"2XDS",28.22,"1.97","1.97","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XDS"
"2XDU",,"X-RAY DIFFRACTION",2.84,56.68,,,,,"10.1021/jm100059d","LGA","2XDU",26.8,"1.74","1.74","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XDU"
"2XDV",,"X-RAY DIFFRACTION",5.35,77,,,"12% PEG 3350; 0.005M COCL2; 0.005M MGCL2; 0.005M CDCL2; 0.005M NICL2; 0.1M HEPES PH 7.5",,"10.1038/nature13263",,"2XDV",51.48,"2.57","2.57","Crystal Structure of the Catalytic Domain of FLJ14393","SMAAGGPSALNFDSPSSLFESLISPIKTETFFKEFWEQKPLLIQRDDPALATYYGSLFKLTDLKSLCSRGMYYGRDVNVCRCVNGKKKVLNKDGKAHFLQLRKDFDQKRATIQFHQPQRFKDELWRIQEKLECYFGSLVGSNVYITPAGSQGLPPHYDDVEVFILQLEGEKHWRLYHPTVPLAREYSVEAEERIGRPVHEFMLKPGDLLYFPRGTIHQADTPAGLAHSTHVTISTYQNNSWGDFLLDTISGLVFDTAKEDVELRTGIPRQLLLQVESTTVATRRLSGFLRTLADRLEGTKELLSSDMKKDFIMHRLPPYSAGDGAELSTPGGKLPRLDSVVRLQFKDHIVLTVLPDQDQSDETQEKMVYIYHSLKNSRETHMMGNEEETEFHGLRFPLSHLDALKQIWNSPAISVKDLKLTTDEEKESLVLSLWTECLIQVV","Homo sapiens","RIOX2, MDIG, MINA, MINA53, NO52","MYC-INDUCED NUCLEAR ANTIGEN","1","2XDV"
"2XDX",,"X-RAY DIFFRACTION",1.99,38.24,,,,,"10.1021/jm100059d","WOE","2XDX",28.2,"2.42","2.42","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XDX"
"2XE6",,"X-RAY DIFFRACTION",2.25,45.3,,8,"30% PEG4000, 100MM TRIS PH 8.0",,"10.1074/jbc.M110.206813","3PG","2XE6",44.86,"1.74","1.74","The complete reaction cycle of human phosphoglycerate kinase: The open binary complex with 3PG","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2XE6"
"2XE7",,"X-RAY DIFFRACTION",2.15,42.8,,8,"30% PEG4000, 100MM TRIS PH 8.0",,"10.1074/jbc.M110.206813","3PG","2XE7",45.29,"2.2","2.2","The complete reaction cycle of human phosphoglycerate kinase: The open ternary complex with 3PG and ADP","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2XE7"
"2XE8",,"X-RAY DIFFRACTION",2.25,45.3,,8,"30% PEG4000, 100MM TRIS PH 8.0",,"10.1074/jbc.M110.206813","3PG","2XE8",45.36,"1.79","1.79","The complete reaction cycle of human phosphoglycerate kinase: The open ternary complex with 3PG and AMP-PNP","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2XE8"
"2XEB",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq380",,"2XEB",10.64,,,"NMR STRUCTURE OF THE PROTEIN-UNBOUND SPLICEOSOMAL U4 SNRNA 5' STEM LOOP","GAUCGUAGCCAAUGAGGUU","Homo sapiens",,"5'-R(P*GP*AP*UP*CP*GP*UP*AP*GP*CP*CP*AP*AP*UP*GP*AP* GP*GP*UP*U)-3'","1","2XEB"
,,,,,,,,,,,,,,,,"GCCGAGGCGCGAUC","Homo sapiens",,"5'-R(P*GP*CP*CP*GP*AP*GP*GP*CP*GP*CP*GP*AP*UP*C)-3'","2","2XEB"
"2XEF",,"X-RAY DIFFRACTION",3.29,62.62,,8,"33% (V/V) PENTAERYTHRITOL PROPOXYLATE PO/OH 5/4, 1% (W/V) PEG 3350, 100 MM TRIS-HCL, pH 8.0",,"10.1021/ja104591m","AR8","2XEF",83.69,"1.59","1.59","Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P8","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVQPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2XEF"
"2XEG",,"X-RAY DIFFRACTION",3.29,62.64,,8,"33% (V/V) PENTAERYTHRITOL PROPOXYLATE PO/OH 5/4, 1% (W/V) PEG 3350, 100 MM TRIS-HCL, pH 8.0",,"10.1021/ja104591m","CI9","2XEG",83.51,"1.59","1.59","Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P4","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVQPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2XEG"
"2XEI",,"X-RAY DIFFRACTION",3.28,62.47,,8,"33% (V/V) PENTAERYTHRITOL PROPOXYLATE PO/OH 5/4, 1% (W/V) PEG 3350, 100 MM TRIS-HCL, pH 8.0",,"10.1021/ja104591m","ARK","2XEI",83.41,"1.69","1.69","Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P2","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2XEI"
"2XEJ",,"X-RAY DIFFRACTION",3.29,62.59,,8,"33% (V/V) PENTAERYTHRITOL PROPOXYLATE PO/OH 5/4, 1% (W/V) PEG 3350, 100 MM TRIS-HCL, pH 8.0",,"10.1021/ja104591m","OKD","2XEJ",83.36,"1.78","1.78","Human glutamate carboxypeptidase II in complex with ARM-M4, urea- based inhibitor","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVQPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2XEJ"
"2XEQ",,"X-RAY DIFFRACTION",2.58,52.4,,7.8,"0.1 M BIS-TRIS-PROPANE, PH 7.8, 10% PEG3350, 0.2 M NA3-CITRATE",,"10.1038/emboj.2010.124",,"2XEQ",118.42,"3.1","3.1","Human PatL1 C-terminal domain","GPQDPDKRRKTLVIIEKTYSLLLDVEDYERRYLLSLEEERPALMDDRKHKICSMYDNLRGKLPGQERPSDDHFVQIMCIRKGKRMVARILPFLSTEQAADILMTTARNLPFLIKKDAQDEVLPCLLSPFSLLLYHLPSVSITSLLRQLMNLPQSAATPALSNPHLTAVLQNKFGLSLLLILLSRGEDLQSSDPATESTQNNQWTEVMFMATRELLRIPQAALAKPISIPTNLVSLFSRYVDRQKLNLLETKLQLVQ","Homo sapiens","PATL1, OK/KNS-cl.5","PAT1 HOMOLOG 1,","1","2XEQ"
"2XER",,"X-RAY DIFFRACTION",2.54,51.6,,8.5,"0.1 M TRIS, PH 8.5, 1.15 M AMMONIUM SULFATE, 0.15 M LITHIUM SULFATE, 8% GLYCEROL",,"10.1038/emboj.2010.124",,"2XER",85.68,"2.95","2.95","Human PatL1 C-terminal domain (loop variant with sulfates)","GPQDPDKRRKTLVIIEKTYSLLLDVEDYERRYLLSLEEERPALMDDRKHKICSMYDNLRGKLPGQERPSDDHFVQIMCIRKGKRMVARILPFLSTEQAADILMTTARNLPFLIKKDAQDEVLPCLLSPFSLLLYHLPSVSITSLLRQLMNLPGSPHLTAVLQNKFGLSLLLILLSRGEDLQSSDPATESTQNNQWTEVMFMATRELLRIPQAALAKPISIPTNLVSLFSRYVDRQKLNLLETKLQLVQ","Homo sapiens","PATL1, OK/KNS-cl.5","PAT1 HOMOLOG 1","1","2XER"
"2XES",,"X-RAY DIFFRACTION",2.4,48,,7,"12% PEG3350, 0.2 M KSCN, pH 7",,"10.1038/emboj.2010.124",,"2XES",57.93,"2.1","2.1","Human PatL1 C-terminal domain (loop variant)","GPQDPDKRRKTLVIIEKTYSLLLDVEDYERRYLLSLEEERPALMDDRKHKICSMYDNLRGKLPGQERPSDDHFVQIMCIRKGKRMVARILPFLSTEQAADILMTTARNLPFLIKKDAQDEVLPCLLSPFSLLLYHLPSVSITSLLRQLMNLPGSPHLTAVLQNKFGLSLLLILLSRGEDLQSSDPATESTQNNQWTEVMFMATRELLRIPQAALAKPISIPTNLVSLFSRYVDRQKLNLLETKLQLVQ","Homo sapiens","PATL1, OK/KNS-cl.5","PROTEIN PAT1 HOMOLOG 1","1","2XES"
"2XEU",,"X-RAY DIFFRACTION",1.91,35.17,,,,,"10.1038/nsmb.2108",,"2XEU",7.88,"1.5","1.5","Ring domain","GAMVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNANTCPTCRKKINHKRYHPIYI","Homo sapiens","RNF4, SNURF, RES4-26","RING FINGER PROTEIN 4","1","2XEU"
"2XEW",,"X-RAY DIFFRACTION",3.42,64,,3.5,"3M SODIUM CHLORIDE, 0.1 M SODIUM CITRATE PH3.5",,"10.1038/nsmb.1873",,"2XEW",104.6,"2.2","2.2","Crystal structure of K11-linked diubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","UBIQUITIN","1","2XEW"
"2XEY",,"X-RAY DIFFRACTION",2.7,54.9,,,"DL-MALIC ACID/PEG3350",,"10.1016/j.bmcl.2010.05.096","YVQ","2XEY",33.34,"2.7","2.7","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2XEY"
"2XEZ",,"X-RAY DIFFRACTION",2.7,54.3,,,"DL-MALIC ACID/PEG3350",,"10.1016/j.bmcl.2010.05.096","XEZ","2XEZ",33.67,"2.25","2.25","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2XEZ"
"2XF0",,"X-RAY DIFFRACTION",2.4,49.1,,,"DL-MALIC ACID/PEG3350",,"10.1016/j.bmcl.2010.05.096","4UB","2XF0",33.55,"2.4","2.4","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2XF0"
"2XFI",,"X-RAY DIFFRACTION",2.01,38.32,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2010.05.111","XFI","2XFI",44.37,"1.73","1.73","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-((methylsulfonyl)(phenyl)amino)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2XFI"
"2XFJ",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2010.05.111","VG5","2XFJ",44.33,"1.8","1.8","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2XFJ"
"2XFK",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION",,"CRYSTALS GROWN BY VAPOUR DIFFUSION AT 20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH 3.2",293,"10.1016/j.bmcl.2010.05.111","AA9","2XFK",44.41,"1.8","1.8","Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDE","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","2XFK"
"2XFN",,"X-RAY DIFFRACTION",2.68,54.18,,6.5,"pH 6.5",,"10.1074/jbc.M110.169482","XCG","2XFN",120.14,"1.6","1.6","Human monoamine oxidase B in complex with 2-(2-benzofuranyl)-2- imidazoline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XFN"
"2XFO",,"X-RAY DIFFRACTION",2.72,54.78,,6.5,"pH 6.5",,"10.1074/jbc.M110.169482","XCG","2XFO",119.8,"2.1","2.1","tranylcypromine-inhibited human monoamine oxidase B Ile199Ala mutant in complex with 2-(2-benzofuranyl)-2-imidazoline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIASTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XFO"
"2XFP",,"X-RAY DIFFRACTION",2.68,54.07,,6.5,"pH 6.5",,"10.1074/jbc.M110.169482","ISN","2XFP",120.09,"1.66","1.66","Isatin-inhibited human monoamine oxidase B in complex with 2-(2- benzofuranyl)-2-imidazoline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XFP"
"2XFQ",,"X-RAY DIFFRACTION",2.7,54.46,,6.5,"pH 6.5",,"10.1074/jbc.M110.169482",,"2XFQ",120.15,"2.2","2.2","Rasagiline-inhibited human monoamine oxidase B in complex with 2-(2- benzofuranyl)-2-imidazoline","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XFQ"
"2XFU",,"X-RAY DIFFRACTION",2.6,53,,6.5,"pH 6.5",,"10.1074/jbc.M110.169482",,"2XFU",119.11,"2.2","2.2","Human monoamine oxidase B with tranylcypromine","SNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","2XFU"
"2XG3",,"X-RAY DIFFRACTION",1.73,29,,7.5,"pH 7.5",,"10.1021/ja105852y",,"2XG3",16.21,"1.2","1.2","Human galectin-3 in complex with a benzamido-N-acetyllactoseamine inhibitor","ALIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","2XG3"
"2XG7",,"X-RAY DIFFRACTION",4.2,70,,8.5,"8% PEG8000, 0.1M TRIS-HCL PH 8.5",,"10.1073/pnas.1008206107",,"2XG7",23.37,"3.45","3.45","Crystal Structure of BST2-Tetherin Ectodomain expressed in HEK293T cells","EACRDGLRAVMECRNVTHLLQQELTEAQKGFQDVEAQAATCNHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVRIADKGT","Homo sapiens","BST2","BONE MARROW STROMAL ANTIGEN 2","1","2XG7"
"2XH1",,"X-RAY DIFFRACTION",2.41,48.96,,7,"pH 7.0",,"10.1021/jm100464k",,"2XH1",96.23,"2.1","2.1","Crystal structure of human KAT II-inhibitor complex","ENYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE, MITOCHONDRIAL","1","2XH1"
"2XHD",,"X-RAY DIFFRACTION",2.45,49.75,,,,,"10.1021/jm1005429","7T9","2XHD",59.66,"1.8","1.8","Crystal structure of N-((2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H- inden-2-yl)-2-propanesulfonamide in complex with the ligand binding domain of the human GluA2 receptor","GANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRTPVNLAVLKLSEQGVLDKLKNKWWYDKGECGA","Homo sapiens","GRIA2, GLUR2","GLUTAMATE RECEPTOR 2","1","2XHD"
"2XHI",,"X-RAY DIFFRACTION",2.6,53,,,,,"10.1016/j.str.2010.09.023",,"2XHI",49.84,"1.55","1.55","Separation-of-function mutants unravel the dual reaction mode of human 8-oxoguanine DNA glycosylase","MGSHHHHHHSQDPNSMPARALLPRRMGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTCVADKICLMALDKPQAVPVNVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSRHAQEPPAKRRKGSKGPEG","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-GLYCOSYLASE/DNA LYASE","1","2XHI"
,,,,,,,,,,,,,,,,"GGTAGACCTGGACGC",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","2","2XHI"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*GP*CP*GP*TP*CP*CP*AP*(8OG)P*GP*TP*CP*TP*AP*CP*C)-3'","3","2XHI"
"2XHR",,"X-RAY DIFFRACTION",2.61,52.82,,,,,"10.1021/jm100059d","C0P","2XHR",28.36,"2.2","2.2","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90, HSP90A, HSP90AA1, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XHR"
"2XHT",,"X-RAY DIFFRACTION",1.95,36.92,,,,,"10.1021/jm100059d","C0Y","2XHT",28.22,"2.27","2.27","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XHT"
"2XHX",,"X-RAY DIFFRACTION",1.9,34.89,,,,,"10.1021/jm100059d","T5M","2XHX",28.27,"2.801","2.801","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90, HSP90A, HSP90AA1, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XHX"
"2XIJ",,"X-RAY DIFFRACTION",2.39,48.46,,,"30% PEG3350, 0.1 M BIS-TRIS PH 5.5, 0.3 M NH4-SULPHATE",,"10.1074/jbc.M110.177717",,"2XIJ",87.32,"1.95","1.95","Crystal structure of human methylmalonyl-CoA mutase in complex with adenosylcobalamin","MSPHYLRQVKESSGSRLIQQRLLHQQQPLHPEWAALAKKQLKGKNPEDLIWHTPEGISIKPLYSKRDTMDLPEELPGVKPFTRGPYPTMYTFRPWTIRQYAGFSTVEESNKFYKDNIKAGQQGLSVAFDLATHRGYDSDNPRVRGDVGMAGVAIDTVEDTKILFDGIPLEKMSVSMTMNGAVIPVLANFIVTGEEQGVPKEKLTGTIQNDILKEFMVRNTYIFPPEPSMKIIADIFEYTAKHMPKFNSISISGYHMQEAGADAILELAYTLADGLEYSRTGLQAGLTIDEFAPRLSFFWGIGMNFYMEIAKMRAGRRLWAHLIEKMFQPKNSKSLLLRAHCQTSGWSLTEQDPYNNIVRTAIEAMAAVFGGTQSLHTNSFDEALGLPTVKSARIARNTQIIIQEESGIPKVADPWGGSYMMECLTNDVYDAALKLINEIEEMGGMAKAVAEGIPKLRIEECAARRQARIDSGSEVIVGVNKYQLEKEDTVEVLAIDNTSVRNRQIEKLKKIKSSRDQALAERCLAALTECAASGDGNILALAVDASRARCTVGEITDALKKVFGEHKANDRMVSGAYRQEFGESKEITSAIKRVHKFMEREGRRPRLLVAKMGQDGHDRGAKVIATGFADLGFDVDIGPLFQTPREVAQQAVDADVHAVGVSTLAAGHKTLVPELIKELNSLGRPDILVMCGGVIPPQDYEFLFEVGVSNVFGPGTRIPKAAVQVLDDIEKCLEKKQQSVAENLYFQSHHHHHHDYKDDDDK","Homo sapiens","MMUT, MUT","METHYLMALONYL-COA MUTASE, MITOCHONDRIAL","1","2XIJ"
"2XIK",,"X-RAY DIFFRACTION",2.56,51.9,,,"0.2M K3(CIT),0.1M BTPROP 8.5, 20% PEG3350,10% ETGLY",,,,"2XIK",34.19,"1.97","1.97","Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)","SMAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKSE","Homo sapiens","STK25, SOK1, YSK1","SERINE/THREONINE PROTEIN KINASE 25","1","2XIK"
"2XIO",,"X-RAY DIFFRACTION",2.24,45.09,,,"0.1M MES 6.5;12% W/V PEG 20K",,,,"2XIO",34.28,"1.19","1.19","Structure of putative deoxyribonuclease TATDN1 isoform a","MKFIDIGINLTDPMFRGIYRGVQKHQDDLQDVIGRAVEIGVKKFMITGGNLQDSKDALHLAQTNGMFFSTVGCHPTRCGEFEKNNPDLYLKELLNLAENNKGKVVAIGECGLDFDRLQFCPKDTQLKYFEKQFELSEQTKLPMFLHCRNSHAEFLDITKRNRDRCVGGVVHSFDGTKEAAAALIDLDLYIGFNGCSLKTEANLEVLKSIPSEKLMIETDAPWCGVKSTHAGSKYIRTAFPTKKKWESGHCLKDRNEPCHIIQILEIMSAVRDEDPLELANTLYNNTIKVFFPVIAENLYFQ","Homo sapiens","TATDN1, CDA11","PUTATIVE DEOXYRIBONUCLEASE TATDN1","1","2XIO"
"2XIQ",,"X-RAY DIFFRACTION",2.75,55.3,,,"20% PEG3350, 0.1 M BIS-TRIS PH 5.5, 0.1 M NH4-SULPHATE",,"10.1074/jbc.M110.177717",,"2XIQ",174.54,"1.95","1.95","Crystal structure of human methylmalonyl-CoA mutase in complex with adenosylcobalamin and malonyl-CoA","MSPHYLRQVKESSGSRLIQQRLLHQQQPLHPEWAALAKKQLKGKNPEDLIWHTPEGISIKPLYSKRDTMDLPEELPGVKPFTRGPYPTMYTFRPWTIRQYAGFSTVEESNKFYKDNIKAGQQGLSVAFDLATHRGYDSDNPRVRGDVGMAGVAIDTVEDTKILFDGIPLEKMSVSMTMNGAVIPVLANFIVTGEEQGVPKEKLTGTIQNDILKEFMVRNTYIFPPEPSMKIIADIFEYTAKHMPKFNSISISGYHMQEAGADAILELAYTLADGLEYSRTGLQAGLTIDEFAPRLSFFWGIGMNFYMEIAKMRAGRRLWAHLIEKMFQPKNSKSLLLRAHCQTSGWSLTEQDPYNNIVRTAIEAMAAVFGGTQSLHTNSFDEALGLPTVKSARIARNTQIIIQEESGIPKVADPWGGSYMMECLTNDVYDAALKLINEIEEMGGMAKAVAEGIPKLRIEECAARRQARIDSGSEVIVGVNKYQLEKEDTVEVLAIDNTSVRNRQIEKLKKIKSSRDQALAERCLAALTECAASGDGNILALAVDASRARCTVGEITDALKKVFGEHKANDRMVSGAYRQEFGESKEITSAIKRVHKFMEREGRRPRLLVAKMGQDGHDRGAKVIATGFADLGFDVDIGPLFQTPREVAQQAVDADVHAVGVSTLAAGHKTLVPELIKELNSLGRPDILVMCGGVIPPQDYEFLFEVGVSNVFGPGTRIPKAAVQVLDDIEKCLEKKQQSVAENLYFQSHHHHHHDYKDDDDK","Homo sapiens","MMUT, MUT","METHYLMALONYL-COA MUTASE, MITOCHONDRIAL","1","2XIQ"
"2XIR",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"PROTEIN PRODUCTION, PROTEIN PURIFICATION, AND COCRYSTALLIZATION WERE PERFORMED AS PREVIOUSLY DESCRIBED (PUBLISHED INTERNATIONAL PATENT APPLICATION WO 2004/092217 HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. 2 MICROLITERS OF A 7.7 MG/ML PROTEIN SOLUTION (IN 50 MM HEPES 7.5, 30 MM SODIUM CHLORIDE, 5 MM DTT, AND 5% DMSO) WAS MIXED WITH 2 MICROLITERS OF CRYSTALLIZATION SOLUTION (100 MM HEPES PH 7.5, 20% PEG 6K AND 5% MPD) AND SUSPENDED OVER 1 ML OF CRYSTALLIZATION SOLUTION PLUS 5 MICROLITERS BME.",286,,,"2XIR",36.66,"1.5","1.5","Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-morpholinoethoxy)quinolin-4-yloxy) benzofuran-3-carboxamide)","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","2XIR"
"2XIX",,"X-RAY DIFFRACTION",3.28,62.8,,5.5,"0.9 M (NH4)2HPO4, 0.1 M SODIUM CITRATE PH=5.5, 0.2M NACL",,"10.1107/S0907444910054144","XIX","2XIX",34.57,"2.4","2.4","Protein kinase Pim-1 in complex with fragment-1 from crystallographic fragment screen","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1","1","2XIX"
"2XIY",,"X-RAY DIFFRACTION",3.28,62.8,,5.5,"0.9 M (NH4)2HPO4,0.1 M SODIUM CITRATE PH=5.5 , 0.2M NACL",,"10.1107/S0907444910054144","XIY","2XIY",34.74,"2.2","2.2","Protein kinase Pim-1 in complex with fragment-2 from crystallographic fragment screen","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1","1","2XIY"
"2XIZ",,"X-RAY DIFFRACTION",3.28,62.8,,5.5,"0.8 M (NH4)2HPO4, 0.1M SODIUM CITRATE PH 5.5, 0.2 M NACL",,"10.1107/S0907444910054144","XIZ","2XIZ",34.54,"2.21","2.21","Protein kinase Pim-1 in complex with fragment-3 from crystallographic fragment screen","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1","1","2XIZ"
"2XJ0",,"X-RAY DIFFRACTION",3.28,62.8,,5.5,"0.9 M (NH4)2HPO4, 0.1 M SODIUM CITRATE PH=5.5, 0.2M NACL",,"10.1107/S0907444910054144","XJ0","2XJ0",34.47,"3.1","3.1","Protein kinase Pim-1 in complex with fragment-4 from crystallographic fragment screen","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1","1","2XJ0"
"2XJ1",,"X-RAY DIFFRACTION",3.28,62.8,,5.5,"0.9 M (NH4)2HPO4,0.1 M SODIUM CITRATE PH=5.5 , 0.2M NACL",,"10.1107/S0907444910054144","XJ1","2XJ1",34.73,"2.13","2.13","Protein kinase Pim-1 in complex with small molecule inibitor","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1","1","2XJ1"
"2XJ2",,"X-RAY DIFFRACTION",3.28,62.8,,5.75,"0.8 M (NH4)2HPO4, 0.1 M SODIUM CITRATE PH 5.75, 0.2 M NACL",,"10.1107/S0907444910054144","985","2XJ2",34.73,"2.2","2.2","Protein kinase Pim-1 in complex with small molecule inhibitor","GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1","1","2XJ2"
"2XJB",,"X-RAY DIFFRACTION",3.16,61,,,"0.1 M BICINE PH 9.0, 10% PEG6000",,"10.1016/j.jmb.2011.02.059",,"2XJB",65.12,"2.3","2.3","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with deoxyguanosine monophosphate and deoxyadenosine triphosphate","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XJB"
"2XJC",,"X-RAY DIFFRACTION",3.16,61,,,"0.1 M BICINE PH 9.0, 10% PEG6000",,"10.1016/j.jmb.2011.02.059",,"2XJC",65.92,"2","2","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with guanosine monophosphate and diadenosine tetraphosphate","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XJC"
"2XJD",,"X-RAY DIFFRACTION",3.16,61,,,"0.1 M BICINE PH 9, 10% PEG6000",,"10.1016/j.jmb.2011.02.059",,"2XJD",65.16,"2","2","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inorganic phosphate and deoxyadenosine triphosphate","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XJD"
"2XJE",,"X-RAY DIFFRACTION",3.16,61,,,"0.1 M BICINE PH 9, 10% PEG6000",,"10.1016/j.jmb.2011.02.059",,"2XJE",65.06,"2.3","2.3","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with uridine 5'-monophosphate and adenosine triphosphate","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XJE"
"2XJF",,"X-RAY DIFFRACTION",3.19,61.5,,,"0.1 M BICINE PH 9.0, 10% PEG 6000.",,"10.1016/j.jmb.2011.02.059",,"2XJF",64.67,"2.1","2.1","Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II with a covalently modified Asn52","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2XJF"
"2XJG",,"X-RAY DIFFRACTION",1.96,36.79,,,,,"10.1021/jm100060b","XJG","2XJG",28.28,"2.25","2.25","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XJG"
"2XJJ",,"X-RAY DIFFRACTION",2.25,45.41,,,,,"10.1021/jm100060b","L81","2XJJ",56.66,"1.9","1.9","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDVQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XJJ"
"2XJK",,"X-RAY DIFFRACTION",2.22,44.6,,6,"25% PEG 6000, 0.1M MES (PH 6.0), 0.01M ZNCL2",,"10.1021/ja1057136",,"2XJK",16.14,"1.45","1.45","Monomeric Human Cu,Zn Superoxide dismutase","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEEDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2XJK"
"2XJL",,"X-RAY DIFFRACTION",2.21,44.3,,5,"25% PEG 6000, 0.1M SODIUM ACETATE (PH 5.0), 0.01M ZNCL2",,"10.1021/ja1057136",,"2XJL",16.14,"1.55","1.55","Monomeric Human Cu,Zn Superoxide dismutase without Cu ligands","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFSVSEEEDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVSEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2XJL"
"2XJX",,"X-RAY DIFFRACTION",1.59,22.19,,,,,"10.1021/jm100060b","XJX","2XJX",28.37,"1.66","1.66","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XJX"
"2XK2",,"X-RAY DIFFRACTION",2.06,40.26,,,,,"10.1021/jm100059d","ADP","2XK2",28.41,"1.95","1.95","Structure of HSP90 with small molecule inhibitor bound","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2XK2"
"2XK3",,"X-RAY DIFFRACTION",2.61,52.8,,,"2-10% PEG8000, 100MM TRIS PH6.8",,"10.1021/jm1008727","XK3","2XK3",33.06,"2.2","2.2","Structure of Nek2 bound to Aminopyrazine compound 35","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XK3"
"2XK4",,"X-RAY DIFFRACTION",2.62,53,,,,,"10.1021/jm1008727","OL2","2XK4",33.3,"2.1","2.1","Structure of Nek2 bound to aminopyrazine compound 17","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XK4"
"2XK5",,"X-RAY DIFFRACTION",2.8,56,,7,"19-20 % PEG 3350, 0.2 M ZINC ACETATE, pH 7",,"10.1038/nchembio.426",,"2XK5",17.62,"3","3","Crystal structure of K6-linked diubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","RPS27A, UBA80, UBCEP1","UBIQUITIN","1","2XK5"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPQQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","RPS27A, UBA80, UBCEP1","UBIQUITIN","2","2XK5"
"2XK6",,"X-RAY DIFFRACTION",2.62,53.05,,,"2-10% PEG8000, 100MM TRIS PH6.8",,"10.1021/jm1008727","EQH","2XK6",33.08,"2.2","2.2","Structure of Nek2 bound to aminopyrazine compound 36","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XK6"
"2XK7",,"X-RAY DIFFRACTION",2.58,52.37,,,,,"10.1021/jm1008727","30E","2XK7",33.29,"1.992","1.992","Structure of Nek2 bound to aminopyrazine compound 23","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XK7"
"2XK8",,"X-RAY DIFFRACTION",2.55,51.8,,,"2-10% PEG8000, 100MM TRIS PH6.8",,"10.1021/jm1008727","5R1","2XK8",33.22,"2.001","2.001","Structure of Nek2 bound to aminopyrazine compound 15","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XK8"
"2XK9",,"X-RAY DIFFRACTION",3.05,59.7,,7.8,"0.1 M HEPES PH 7.8, 0.1 M MAGNESIUM NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1016/j.jsb.2011.09.008","XK9","2XK9",36.83,"2.35","2.35","Structural analysis of checkpoint kinase 2 (Chk2) in complex with inhibitor PV1533","SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","CHECKPOINT KINASE 2","1","2XK9"
"2XKC",,"X-RAY DIFFRACTION",2.51,51.09,,,"2-10% PEG8000, 100MM TRIS PH6.8",,"10.1021/jm1008727","4VQ","2XKC",33.2,"2.5","2.5","Structure of Nek2 bound to aminopyrazine compound 14","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XKC"
"2XKD",,"X-RAY DIFFRACTION",2.56,51.94,,,,,"10.1021/jm1008727","T3M","2XKD",33.15,"1.96","1.96","Structure of Nek2 bound to aminopyrazine compound 12","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XKD"
"2XKE",,"X-RAY DIFFRACTION",2.56,51.87,,,"2-10% PEG8000, 100MM TRIS PH 6.8",,"10.1021/jm1008727","WI2","2XKE",33.13,"2.203","2.203","Structure of Nek2 bound to Aminipyrazine Compound 5","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XKE"
"2XKF",,"X-RAY DIFFRACTION",2.53,51.47,,,"2-10% PEG8000, 100MM TRIS PH6.8",,"10.1021/jm1008727","BX1","2XKF",33.19,"2.35","2.35","Structure of Nek2 bound to aminopyrazine compound 2","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XKF"
"2XKS",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2010.11.028",,"2XKS",11.75,,,"Prion-like conversion during amyloid formation at atomic resolution","IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","BETA-2-MICROGLOBULIN","1","2XKS"
"2XKU",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2010.11.028",,"2XKU",11.15,,,"Prion-like conversion during amyloid formation at atomic resolution","MIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","BETA-2-MICROGLOBULIN","1","2XKU"
"2XKW",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION",7.5,"PROTEIN CONC. 17MG/ML, 50 MM TRIS PH 8.0,0.1M NACL, 0.5 MM DTT, 2 MM EDTA. RESERVOIR: 20% PEG4000,10% ISOPROPANOL, 0.1M HEPES PH 7.5 , VAPOR DIFFUSION,TEMPERATURE 292K",292,,"P1B","2XKW",63.95,"2.02","2.02","LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE","LNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2XKW"
"2XM8",,"X-RAY DIFFRACTION",3.5,64.89,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1021/jm101150b","B4W","2XM8",37.42,"3.4","3.4","Co-crystal structure of a small molecule inhibitor bound to the kinase domain of Chk2","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2XM8"
"2XM9",,"X-RAY DIFFRACTION",3.43,64.15,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1021/jm101150b","LWH","2XM9",37.55,"2.5","2.5","Structure of a small molecule inhibitor with the kinase domain of Chk2","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2XM9"
"2XMB",,"X-RAY DIFFRACTION",2.82,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K",298,"10.1042/BJ20101648",,"2XMB",62.52,"2.1","2.1","G117H mutant of human butyrylcholinesterase in complex with sulfate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGHFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XMB"
"2XMC",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K",298,"10.1042/BJ20101648",,"2XMC",62.3,"2.4","2.4","G117H mutant of human butyrylcholinesterase in complex with fluoride anion","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGHFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XMC"
"2XMD",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N -MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K",298,"10.1042/BJ20101648",,"2XMD",62.71,"2.3","2.3","G117H mutant of human butyrylcholinesterase in complex with echothiophate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGHFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XMD"
"2XMG",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K",298,"10.1042/BJ20101648",,"2XMG",62.4,"2.7","2.7","G117H mutant of human butyrylcholinesterase in complex with VX","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGHFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XMG"
"2XML",,"X-RAY DIFFRACTION",2.55,51.74,,,"0.2M NA_NITRATE; 15% PEG_3350; 5% V/V ETHYLENE_GLYCOL; 0.1M BIS_TRIS_PROPANE PH 6.2",,"10.1074/jbc.M111.283689","OGA","2XML",81.69,"2.55","2.55","Crystal structure of human JMJD2C catalytic domain","SMEVAEVESPLNPSCKIMTFRPSMEEFREFNKYLAYMESKGAHRAGLAKVIPPKEWKPRQCYDDIDNLLIPAPIQQMVTGQSGLFTQYNIQKKAMTVKEFRQLANSGKYCTPRYLDYEDLERKYWKNLTFVAPIYGADINGSIYDEGVDEWNIARLNTVLDVVEEECGISIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHFGEPKSWYAIPPEHGKRLERLAQGFFPSSSQGCDAFLRHKMTLISPSVLKKYGIPFDKITQEAGEFMITFPYGYHAGFNHGFNCAESTNFATVRWIDYGKVAKLCTCRKDMVKISMDIFVRKFQPDRYQLWKQGKDIYTIDHTK","Homo sapiens","KDM4C, GASC1, JHDM3C, JMJD2C, KIAA0780","LYSINE-SPECIFIC DEMETHYLASE 4C","1","2XML"
"2XMQ",,"X-RAY DIFFRACTION",2.7,55,,,"9% PEG 8000, 0.2 M CALCIUM ACETATE, 0.1 M SODIUM CACODYLATE (PH 6.4 TO 7.5).",,"10.1074/jbc.M110.170803",,"2XMQ",94.19,"2.81","2.81","Crystal structure of human NDRG2 protein provides insight into its role as a tumor suppressor","AKTHSVETPYGSVTFTVYGTPKPKRPAILTYHDVGLNYKSCFQPLFQFEDMQEIIQNFVRVHVDAPGMEEGAPVFPLGYQYPSLDQLADMIPCVLQYLNFSTIIGVGVGAGAYILARYALNHPDTVEGLVLINIDPNAKGWMDWAAHKLTGLTSSIPEMILGHLFSQEELSGNSELIQKYRNIITHAPNLDNIENYWNSYNNRRDLNFERGGDITLRCPVMLVVGDQAPHEDAVVECNSKLDPTQTSFLKMADSGGQPQLTQPGKLTEAFKYFLQGMGYMA","Homo sapiens","NDRG2, KIAA1248, SYLD","PROTEIN NDRG2","1","2XMQ"
"2XMR",,"X-RAY DIFFRACTION",2.7,54,,,"16% PEG 8000, 0.2 M CALCIUM ACETATE, 0.1 M MES (PH 6.8 TO 7.1)",,"10.1074/jbc.M110.170803",,"2XMR",94.16,"2","2","Crystal structure of human NDRG2 protein provides insight into its role as a tumor suppressor","AKTHSVETPYGSVTFTVYGTPAPARPAILTYHDVGLNYKSCFQPLFQFEDMQEIIQNFVRVHVDAPGMEEGAPVFPLGYQYPSLDQLADMIPCVLQYLNFSTIIGVGVGAGAYILARYALNHPDTVEGLVLINIDPNAKGWMDWAAHKLTGLTSSIPEMILGHLFSQEELSGNSELIQKYRNIITHAPNLDNIELYWNSYNNRRDLNFERGGDITLRCPVMLVVGDQAPHEDAVVECNSKLDPTQTSFLKMADSGGQPQLTQPGKLTEAFKYFLQGMGYMA","Homo sapiens","NDRG2, KIAA1248, SYLD","PROTEIN NDRG2","1","2XMR"
"2XMS",,"X-RAY DIFFRACTION",3.76,67,,,"1.5 M NACL AND 0.1 M IMIDAZOLE (PH 7.0 TO 8.0)",,"10.1074/jbc.M110.170803",,"2XMS",31.58,"2.15","2.15","Crystal structure of human NDRG2 protein provides insight into its role as a tumor suppressor","AKTHSVETPYGSVTFTVYGTPYPYRPAILTYHDVGLNYKSCFQPLFQFEDMQEIIQNFVRVHVDAPGMEEGAPVFPLGYQYPSLDQLADMIPCVLQYLNFSTIIGVGVGAGAYILARYALNHPDTVEGLVLINIDPNAKGWMDWAAHKLTGLTSSIPEMILGHLFSQEELSGNSELIQKYRNIITHAPNLDNIELYWNSYNNRRDLNFERGGDITLRCPVMLVVGDQAPHEDAVVECNSKLDPTQTSFLKMADSGGQPQLTQPGKLTEAFKYFLQGMGYMA","Homo sapiens","NDRG2, KIAA1248, SYLD","PROTEIN NDRG2","1","2XMS"
"2XMY",,"X-RAY DIFFRACTION",1.84,32.5,,6.8,"10% PEG 3350, NAF, PH 7.0",,"10.1016/j.chembiol.2010.07.016","CDK","2XMY",34.41,"1.9","1.9","Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2XMY"
"2XN3",,"X-RAY DIFFRACTION",2.35,48,,5.4,"20% PEG3350, PH 5.4",,"10.1074/jbc.M110.171082","ID8","2XN3",43.25,"2.09","2.09","Crystal structure of thyroxine-binding globulin complexed with mefenamic acid","SQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPR","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","1","2XN3"
,,,,,,,,,,,,,,,,"SENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","2","2XN3"
"2XN4",,"X-RAY DIFFRACTION",2.14,42.59,,,"0.2M (NH4)2SO4, 0.1M MES PH 6.5, 30% PEG 5000 MME, 0.2M NASCN",,"10.1074/jbc.M112.437996",,"2XN4",66.41,"1.99","1.99","Crystal structure of the kelch domain of human KLHL2 (Mayven)","SMSVRTRLRTPMNLPKLMVVVGGQAPKAIRSVECYDFKEERWHQVAELPSRRCRAGMVYMAGLVFAVGGFNGSLRVRTVDSYDPVKDQWTSVANMRDRRSTLGAAVLNGLLYAVGGFDGSTGLSSVEAYNIKSNEWFHVAPMNTRRSSVGVGVVGGLLYAVGGYDVASRQCLSTVECYNATTNEWTYIAEMSTRRSGAGVGVLNNLLYAVGGHDGPLVRKSVEVYDPTTNAWRQVADMNMCRRNAGVCAVNGLLYVVGGDDGSCNLASVEYYNPTTDKWTVVSSCMSTGRSYAGVTVIDKRL","Homo sapiens","KLHL2","KELCH-LIKE PROTEIN 2","1","2XN4"
"2XN5",,"X-RAY DIFFRACTION",2.35,48,,5.4,"20% PEG3350, pH 5.4",,"10.1074/jbc.M110.171082","FUN","2XN5",43.91,"1.7","1.7","Crystal structure of thyroxine-binding globulin complexed with Furosemide","SSQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSIPNTF","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","1","2XN5"
,,,,,,,,,,,,,,,,"LHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","2","2XN5"
"2XN6",,"X-RAY DIFFRACTION",2.35,48,,5.4,"20% PEG3350, PH 5.4",,"10.1074/jbc.M110.171082",,"2XN6",45.03,"1.29","1.29","Crystal structure of thyroxine-binding globulin complexed with thyroxine-fluoresein","SSQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSIPNTF","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","1","2XN6"
,,,,,,,,,,,,,,,,"LHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","2","2XN6"
"2XN7",,"X-RAY DIFFRACTION",2.35,48,,5.4,"20% PEG3350, PH 5.4",,"10.1074/jbc.M110.171082",,"2XN7",44.49,"1.43","1.43","Crystal structure of thyroxine-binding globulin complexed with thyroxine-fluoresein (T405-CF)","SSQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSIPNTF","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","1","2XN7"
,,,,,,,,,,,,,,,,"LHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","THYROXINE-BINDING GLOBULIN","2","2XN7"
"2XNB",,"X-RAY DIFFRACTION",1.84,32.5,,6.8,"10% PEG 3350, NAF, PH 7.0",,"10.1016/j.chembiol.2010.07.016","Y8L","2XNB",34.36,"1.85","1.85","Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2XNB"
"2XNE",,"X-RAY DIFFRACTION",2.73,54.97,,,"0.2M SODIUM CITRATE, 20% PEG 3350",,"10.1016/j.bmcl.2010.08.091","ASH","2XNE",32.03,"2.8","2.8","Structure of Aurora-A bound to an imidazopyrazine inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2XNE"
"2XNF",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1997",,"2XNF",18.28,,,"The Mediator Med25 activator interaction domain: Structure and cooperative binding of VP16 subdomains","MSVSNKLLAWSGVLEWQEKPKPASVDANTKLTRSLPCQVYVNHGENLKTEQWPQKLIMQLIPQQLLTTLGPLFRNSRMVQFHFTNKDLESLKGLYRIMGNGFAGCVHFPHTAPCEVRVLMLLYSSKKKIFMGLIPYDQSGFVNGIRQVITNLEHHHHHH","Homo sapiens","MED25, ACID1, ARC92, PTOV2, TCBAP0758","MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION SUBUNIT 25","1","2XNF"
"2XNG",,"X-RAY DIFFRACTION",2.75,55.27,,,,,"10.1016/j.bmcl.2010.08.091","A0H","2XNG",33.33,"2.605","2.605","Structure of Aurora-A bound to a selective imidazopyrazine inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2XNG"
"2XNH",,"X-RAY DIFFRACTION",3.84,0.68,,6.8,"0.1M TRIS-HCL PH 6.8, 0.5M KI, 5% (V/V) GLYCEROL, 22.5% (W/V), 10% PEG 3350",,"10.1093/nar/gkq743",,"2XNH",36.02,"2.8","2.8","Structure and function of the Rad9-binding region of the DNA damage checkpoint adaptor TopBP1","MSRNDKEPFFVKFLKSSDNSKCFFKALESIKEFQSEEYLQIITEEEALKIKENDRSLYICDPFSGVVFDHLKKLGCRIVGPQVVIFCMHHQRCVPRAEHPVYNMVMSDVTISCTSLEKEKREEVHKYVQMMGGRVYRDLNVSVTHLIAGEVGSKKYLVAANLKKPILLPSWIKTLWEKSQEKKITRYTDINMEDFKCPIFLGCIICVTGLCGLDRKEVQQLTVKHGGQYMGQLKMNECTHLIVQEPKGQKYECAKRWNVHCVTTQWFFDSIEKGFCQDESIYKTEPR","Homo sapiens","TOPBP1, KIAA0259","DNA TOPOISOMERASE 2-BINDING PROTEIN 1","1","2XNH"
"2XNK",,"X-RAY DIFFRACTION",2.58,0.52,,7.5,"0.1 M TRIS-HCL PH 7.5, 0.4 M MGCL2, 25% PEG 4000, 4% GLYCEROL, 0.01 M SPERMIDINE TETRA-HCL",,"10.1093/nar/gkq743",,"2XNK",138.27,"2.6","2.6","Structure and function of the Rad9-binding region of the DNA damage checkpoint adaptor TopBP1","GPMSRNDKEPFFVKFLKSSDNSKCFFKALESIKEFQSEEYLQIITEEEALKIKENDRSLYICDPFSGVVFDHLKKLGCRIVGPQVVIFCMHHQRCVPRAEHPVYNMVMSDVTISCTSLEKEKREEVHKYVQMMGGRVYRDLNVSVTHLIAGEVGSKKYLVAANLKKPILLPSWIKTLWEKSQEKKITRYTDINMEDFKCPIFLGCIICVTGLCGLDRKEVQQLTVKHGGQYMGQLKMNECTHLIVQEPKGQKYECAKRWNVHCVTTQWFFDSIEKGFCQDESIYKTEPRPEA","Homo sapiens","TOPBP1, KIAA0259","DNA TOPOISOMERASE 2-BINDING PROTEIN 1","1","2XNK"
"2XNM",,"X-RAY DIFFRACTION",2.6,52.66,,,,,"10.1021/jm1011726","WGZ","2XNM",33.93,"1.85","1.85","Structure of NEK2 bound to CCT","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XNM"
"2XNN",,"X-RAY DIFFRACTION",2.58,52.34,,,,,"10.1021/jm1011726","430","2XNN",33.64,"2.5","2.5","Structure of Nek2 bound to CCT242430","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XNN"
"2XNO",,"X-RAY DIFFRACTION",2.6,52.65,,,,,"10.1021/jm1011726","ED8","2XNO",34.12,"1.98","1.98","Structure of Nek2 bound to CCT243779","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XNO"
"2XNP",,"X-RAY DIFFRACTION",2.62,53.08,,,,,"10.1021/jm1011726","WCX","2XNP",33.65,"1.98","1.98","Structure of Nek2 bound to CCT244858","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2XNP"
"2XO2",,"X-RAY DIFFRACTION",2.2,43.5,,8.5,"2.0 M AMMONIUM SULFATE, 20 MM CALCIUM CHLORIDE, 0.1 M TRIS/HCL, PH 8.5",,,,"2XO2",36.28,"2.8","2.8","Human Annexin V with incorporated Methionine analogue Azidohomoalanine","AAQVLRGTVTDFPGFDERADAETLRKAAKGLGTDEESILTLLTSRSNAQRQEISAAFKTLFGRDLLDDLKSELTGKFEKLIVALAKPSRLYDAYELKHALKGAGTNEKVLTEIIASRTPEELRAIKQVYEEEYGSSLEDDVVGDTSGYYQRALVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEKFITIFGTRSVSHLRKVFDKYATISGFQIEETIDRETSGNLEQLLLAVVKSIRSIPAYLAETLYYAAKGAGTDDHTLIRVAVSRSEIDLFNIRKEFRKNFATSLYSAIKGDTSGDYKKALLLLCGEDD","Homo sapiens","ANXA5, ANX5, ENX2, PP4","ANNEXIN A5","1","2XO2"
"2XO3",,"X-RAY DIFFRACTION",2.4,48.4,,8.5,"2.0 M AMMONIUM SULFATE, 20 MM CALCIUM CHLORIDE, 0.1 M TRIS/HCL, PH 8.5",,,,"2XO3",36.08,"2.3","2.3","Human Annexin V with incorporated Methionine analogue Homopropargylglycine","MAQVLRGTVTDFPGFDERADAETLRKAMKGLGTDEESILTLLTSRSNAQRQEISAAFKTLFGRDLLDDLKSELTGKFEKLIVALMKPSRLYDAYELKHALKGAGTNEKVLTEIIASRTPEELRAIKQVYEEEYGSSLEDDVVGDTSGYYQRMLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEKFITIFGTRSVSHLRKVFDKYMTISGFQIEETIDRETSGNLEQLLLAVVKSIRSIPAYLAETLYYAMKGAGTDDHTLIRVMVSRSEIDLFNIRKEFRKNFATSLYSMIKGDTSGDYKKALLLLCGEDD","Homo sapiens","ANXA5, ANX5, ENX2, PP4","ANNEXIN A5","1","2XO3"
"2XOC",,"X-RAY DIFFRACTION",2.86,57.05,,,"12% PEG 20000, 0.1M MES PH 6.5 0.1M KCL",,"10.1074/jbc.M110.159855",,"2XOC",60.04,"1.89","1.89","C-terminal cysteine-rich domain of human CHFR bound to mADPr","GAMDLLELSDVDSESSDISQPYVVCRQCPEYRRQAAQPPHCPAPEGEPGAPQALGDAPSTSVSLTTAVQDYVCPLQGSHALCTCCFQPMPDRRVEREQDPRVAPQQCAVCLQPFCHLYWGCTRTGCYGCLAPFCELNLGDKCLDGVLNNNSYESDILKNYLATRGLTWKNMLTESLVALQRGVFLLSDYRVTGDTVLCYCCGLRSFRELTYQYRQNIPASELPVAVTSRPDCYWGRNCRTQVKAHHAMKFNHICEQTRFKN","Homo sapiens","CHFR, RNF196","E3 UBIQUITIN-PROTEIN LIGASE CHFR","1","2XOC"
"2XOY",,"X-RAY DIFFRACTION",2.96,58.51,,,"12% PEG 20000, 0.1M MES PH6.5, 0.1M KCL",,"10.1074/jbc.M110.159855",,"2XOY",59.67,"2.6","2.6","C-terminal cysteine-rich domain of human CHFR bound to P(1),P(2)- Diadenosine-5'-pyrophosphate","GAMDLLELSDVDSESSDISQPYVVCRQCPEYRRQAAQPPHCPAPEGEPGAPQALGDAPSTSVSLTTAVQDYVCPLQGSHALCTCCFQPMPDRRVEREQDPRVAPQQCAVCLQPFCHLYWGCTRTGCYGCLAPFCELNLGDKCLDGVLNNNSYESDILKNYLATRGLTWKNMLTESLVALQRGVFLLSDYRVTGDTVLCYCCGLRSFRELTYQYRQNIPASELPVAVTSRPDCYWGRNCRTQVKAHHAMKFNHICEQTRFKN","Homo sapiens","CHFR, RNF196","E3 UBIQUITIN-PROTEIN LIGASE CHFR","1","2XOY"
"2XOZ",,"X-RAY DIFFRACTION",2.88,57.3,,,"12% PEG 20000, 0.1M MES PH 6.5, 0.1M KCL",,"10.1074/jbc.M110.159855",,"2XOZ",59.89,"2.374","2.374","C-terminal cysteine rich domain of human CHFR bound to AMP","GAMDLLELSDVDSESSDISQPYVVCRQCPEYRRQAAQPPHCPAPEGEPGAPQALGDAPSTSVSLTTAVQDYVCPLQGSHALCTCCFQPMPDRRVEREQDPRVAPQQCAVCLQPFCHLYWGCTRTGCYGCLAPFCELNLGDKCLDGVLNNNSYESDILKNYLATRGLTWKNMLTESLVALQRGVFLLSDYRVTGDTVLCYCCGLRSFRELTYQYRQNIPASELPVAVTSRPDCYWGRNCRTQVKAHHAMKFNHICEQTRFKN","Homo sapiens","CHFR, RNF196","E3 UBIQUITIN-PROTEIN LIGASE CHFR","1","2XOZ"
"2XP0",,"X-RAY DIFFRACTION",2.77,55.66,,,"12% PEG 20000, 0.1M MES PH 6.5, 0.1M KCL",,"10.1074/jbc.M110.159855",,"2XP0",62.13,"1.978","1.978","C-terminal cysteine-rich domain of human CHFR","GAMVRRSFSDEEGSSEDLLELSDVDSESSDISQPYVVCRQCPEYRRQAAQPPHCPAPEGEPGAPQALGDAPSTSVSLTTAVQDYVCPLQGSHALCTCCFQPMPDRRVEREQDPRVAPQQCAVCLQPFCHLYWGCTRTGCYGCLAPFCELNLGDKCLDGVLNNNSYESDILKNYLATRGLTWKNMLTESLVALQRGVFLLSDYRVTGDTVLCYCCGLRSFRELTYQYRQNIPASELPVAVTSRPDCYWGRNCRTQVKAHHAMKFNHICEQTRFKN","Homo sapiens","CHFR, RNF196","E3 UBIQUITIN-PROTEIN LIGASE CHFR","1","2XP0"
"2XP2",,"X-RAY DIFFRACTION",1.99,38.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"CO-CRYSTALS OF ALK KINASE DOMAIN WITH PF-02341066 WERE OBTAINED AT 13 DEGREES C BY USING HANGING-DROP VAPOR-DIFFUSION. 0.5 MICROLITERS OF 1:3 MOLAR RATIO OF 14.9 MG/ML PROTEIN SOLUTION TO PF02341066 WAS MIXED WITH 0.5 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 7-10% (W/V) MEPEG 5K, 0.1M MES, PH6.0-6.5 AND 0.15M (NH4)2SO4.",286,"10.1021/jm2007613","VGH","2XP2",37.36,"1.9","1.9","Structure of the Human Anaplastic Lymphoma Kinase in Complex with Crizotinib (PF-02341066)","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","TYROSINE-PROTEIN KINASE RECEPTOR","1","2XP2"
"2XP3",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","B21","2XP3",19.29,"2","2","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP3"
"2XP4",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","G14","2XP4",19.26,"1.8","1.8","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP4"
"2XP5",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4FF","2XP5",19.27,"1.9","1.9","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP5"
"2XP6",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4G2","2XP6",19.25,"1.9","1.9","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMAKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP6"
"2XP7",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4F8","2XP7",19.3,"2","2","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP7"
"2XP8",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4FY","2XP8",19.37,"2.1","2.1","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP8"
"2XP9",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063",,"2XP9",19.45,"1.9","1.9","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XP9"
"2XPA",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4G5","2XPA",19.37,"1.9","1.9","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XPA"
"2XPB",,"X-RAY DIFFRACTION",2.87,57,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2M AMMONIUM SULPHATE, 0.1M HEPES BUFFER, 1% PEG 400, 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K",277,"10.1016/j.bmcl.2010.09.063","4GE","2XPB",19.44,"2","2","DISCOVERY OF CELL-ACTIVE PHENYL-IMIDAZOLE PIN1 INHIBITORS BY STRUCTURE-GUIDED FRAGMENT EVOLUTION","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1","1","2XPB"
"2XPH",,"X-RAY DIFFRACTION",2.6,52.76,,,"CRYSTALS FORMED FROM 1 TO 1 OF RESERVOIR SOLUTION (1.8 M AMMONIUM SULFATE, 50 MM COCL2 AND 100 MM MES PH 6.5) AND PROTEIN SOLUTION (20 MG/ML IN 20 MM TRIS/HCL (PH 8.0), AND 50 MM NACL).",,"10.1107/S1744309111005835",,"2XPH",56.77,"2.4","2.4","Crystal structure of human SENP1 with the bound cobalt","GAMADIGSDSEDEFPEITEEMEKEIKNVFRNGNQDEVLSEAFRLTITRKDIQTLNHLNWLNDEIINFYMNMLMERSKEKGLPSVHAFNTFFFTKLKTAGYQAVKRWTKKVDVFSVDILLVPIHLGVHWCLAVVDFRKKNITYYDSMGGINNEACRILLQYLKQESIDKKRKEFDTNGWQLFSKKSQEIPQQMNGSDCGMFACKYADCITKDRPINFTQQHMPYFRKRMVWEILHRKLL","Homo sapiens","SENP1","SENTRIN-SPECIFIC PROTEASE 1","1","2XPH"
"2XQF",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K .",298,"10.1074/jbc.M110.209569",,"2XQF",62.02,"2.1","2.1","X-ray Structure of human butyrylcholinesterase inhibited by racemic VX","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XQF"
"2XQG",,"X-RAY DIFFRACTION",2.8,5,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1, M 2-(N -MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K .",298,"10.1074/jbc.M110.209569",,"2XQG",62.2,"2.3","2.3","X-ray Structure of human butyrylcholinesterase inhibited by racemic VR","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XQG"
"2XQI",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.6,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K.",298,"10.1074/jbc.M110.209569",,"2XQI",62.09,"2.6","2.6","X-ray Structure of human butyrylcholinesterase inhibited by racemic CVX","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XQI"
"2XQJ",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K .",298,"10.1074/jbc.M110.209569",,"2XQJ",62.15,"2.4","2.4","X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R)","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XQJ"
"2XQK",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE 2.1 M, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 0.1 M, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K .",298,"10.1074/jbc.M110.209569",,"2XQK",62.11,"2.4","2.4","X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S)","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2XQK"
"2XR5",,"X-RAY DIFFRACTION",1.8,31,"VAPOR DIFFUSION, HANGING DROP",6.5,"VAPOR DIFFUSION, HANGING DROP, 293K. 20% PEG 3350, 200 MM NACL, 100 MM CACODYLATE PH 6.5, CRYOPROTECTED IN PARATONE-N.",293,"10.1021/ja3053305",,"2XR5",19.73,"1.42","1.42","Crystal structure of the complex of the carbohydrate recognition domain of human DC-SIGN with pseudo dimannoside mimic.","MASWSHPQFEKIEGRHPCPWEWTFFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLSDLNQEGTWQWVDGSPLLPSFKQYWNRGEPNNVGEEDCAEFSGNGWNDDKCNLAKFWICKKSAASCSRDEEQFLSPAPATPNPPPA","Homo sapiens","CD209, CLEC4L","CD209 ANTIGEN","1","2XR5"
"2XR6",,"X-RAY DIFFRACTION",1.8,31,"VAPOR DIFFUSION, HANGING DROP",6.5,"VAPOR DIFFUSION, HANGING DROP, 293K. 35% PEG 3350, 200MM NACL, 100MM CACODYLATE PH 6.5, CRYOPROTECTED IN PARATONE-N",293,"10.1021/cb500054h",,"2XR6",20.41,"1.35","1.35","Crystal structure of the complex of the carbohydrate recognition domain of human DC-SIGN with pseudo trimannoside mimic.","MASWSHPQFEKIEGRERLSHPCPWEWTFFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLSDLNQEGTWQWVDGSPLLPSFKQYWNRGEPNNVGEEDCAEFSGNGWNDDKCNLAKFWICKKSAASSSRDEEQFLSPAPATPNPPPA","Homo sapiens","CD209, CLEC4L","CD209 ANTIGEN","1","2XR6"
"2XRC",,"X-RAY DIFFRACTION",2.65,54,,4,"20.0-23.5% PEG 1500, 0.1M SODIUM SUCCINATE PH 4.0, 1MM CACL2",,"10.1073/pnas.1102167108",,"2XRC",259.34,"2.69","2.69","Human complement factor I","KVTYTSQEDLVEKKCLAKKYTHLSCDKVFCQPWQRCIEGTCVCKLPYQCPKNGTAVCATNRRSFPTYCQQKSLECLHPGTKFLNNGTCTAEGKFSVSLKHGNTDSEGIVEVKLVDQDKTMFICKSSWSMREANVACLDLGFQQGADTQRRFKLSDLSINSTECLHVHCRGLETSLAECTFTKRRTMGYQDFADVVCYTQKADSPMDDFFQCVNGKYISQMKACDGINDCGDQSDELCCKACQGKGFHCKSGVCIPSQYQCNGEVDCITGEDEVGCAGFASVAQEETEILTADMDAERRRIKSLLPKLSCGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRASKTHRYQIWTTVVDWIHPDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPACVPWSPYLFQPNDTCIVSGWGREKDNERVFSLQWGEVKLISNCSKFYGNRFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWISYHVGRPFISQYNV","Homo sapiens","CFI, IF","HUMAN COMPLEMENT FACTOR I","1","2XRC"
"2XRE",,"X-RAY DIFFRACTION",2.74,55.11,"VAPOR DIFFUSION, SITTING DROP",,"CRYSTALLIZATION WAS PERFORMED USING A SITTING-DROP VAPOUR-DIFFUSION METHOD. CRYSTALS APPEARED FROM EQUAL VOLUMES OF PROTEIN SOLUTION (20 MG/ML IN 20 MM TRIS/HCL, PH 8.0, AND 50 MM NACL) AND RESERVOIR SOLUTION CONTAINING 100 MM COCL2, 0.1M MES, PH 6.5, AND 1.8 M (NH4)2SO4.",,"10.1107/S1744309111005835",,"2XRE",55.74,"2.45","2.45","Detection of cobalt in previously unassigned human SENP1 structure","DSEDEFPEITEEMEKEIKNVFRNGNQDEVLSEAFRLTITRKDIQTLNHLNWLNDEIINFYMNMLMERSKEKGLPSVHAFNTFFFTKLKTAGYQAVKRWTKKVDVFSVDILLVPIHLGVHWCLAVVDFRKKNITYYDSMGGINNEACRILLQYLKQESIDKKRKEFDTNGWQLFSKKSQEIPQQMNGSDCGMFACKYADCITKDRPINFTQQHMPYFRKRMVWEILHRKLL","Homo sapiens","SENP1","SENTRIN-SPECIFIC PROTEASE 1","1","2XRE"
"2XRF",,"X-RAY DIFFRACTION",2.4,48.4,,8,"0.2 MGCL2, 0.1 M TRIS PH 8, 25% PEG6000",,,,"2XRF",103.22,"2.3","2.3","Crystal structure of human uridine phosphorylase 2","MRFVHVKNPYLDLMDEDILYHLDLGTKTHNLPAMFGDVKFVCVGGSPNRMKAFALFMHKELGFEEAEEDIKDICAGTDRYCMYKTGPVLAISHGMGIPSISIMLHELIKLLHHARCCDVTIIRIGTSGGIGIAPGTVVITDIAVDSFFKPRFEQVILDNIVTRSTELDKELSEELFNCSKEIPNFPTLVGHTMCTYDFYEGQGRLDGALCSFSREKKLDYLKRAFKAGVRNIEMESTVFAAMCGLCGLKAAVVCVTLLDRLDCDQINLPHDVLVEYQQRPQLLISNFIRRRLGLCDAHHHHHH","Homo sapiens","UPP2","URIDINE PHOSPHORYLASE 2","1","2XRF"
"2XRI",,"X-RAY DIFFRACTION",2.23,44.9,,8.5,"0.1M TRIS PH 8.5 20% PEG MONOMETHYL ETHER 2000 0.2M TRIMETHYLAMINE N-OXIDE",,,,"2XRI",25.9,"2.15","2.15","Crystal structure of human ERI1 exoribonuclease 3","MHHHHHHSSGVDLGTENLYFQSMSFPPQRYHYFLVLDFEATCDKPQIHPQEIIEFPILKLNGRTMEIESTFHMYVQPVVHPQLTPFCTELTGIIQAMVDGQPSLQQVLERVDEWMAKEGLLDPNVKSIFVTCGDWDLKVMLPGQCQYLGLPVADYFKQWINLKKAYSFAMGCWPKNGLLDMNKGLSLQHIGRPHSGIDDCKNIANIMKTLAYRGFIFKQTSKPF","Homo sapiens","ERI3, PINT1, PRNPIP, PRNPIP1","ERI1 EXORIBONUCLEASE 3","1","2XRI"
"2XRU",,"X-RAY DIFFRACTION",2.74,54.7,,5.6,"15% PEG 5000 MME, 0.2 M LITHIUM SULFATE, 0.1 M SODIUM CITRATE PH 5.6 & 2 MM DTT",,"10.1016/j.bmc.2010.07.048","400","2XRU",32.9,"2.9","2.9","AURORA-A T288E COMPLEXED WITH PHA-828300","GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2XRU"
"2XS6",,"X-RAY DIFFRACTION",1.91,35.7,,6.5,"PROTEIN WAS CRYSTALLIZED FROM 0.1 M NACL, 0.85 M TRI-SODIUM CITRATE DIHYDRATE AND 0.1 M SODIUM CACODYLATE PH 6.5.",,"10.1111/febs.13655",,"2XS6",22.99,"2.09","2.09","CRYSTAL STRUCTURE OF THE RHOGAP DOMAIN OF HUMAN PIK3R2","MHHHHHHSSGVDLGTENLYFQSMGLTLPDLPEQFSPPDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLALPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVARRAPALGPAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVA","Homo sapiens","PIK3R2","PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT BETA","1","2XS6"
"2XSI",,"X-RAY DIFFRACTION",2.66,54,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XSI",68.67,"2.7","2.7","Human serum albumin complexed with dansyl-L-glutamate and myristic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKEEQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XSI"
"2XSN",,"X-RAY DIFFRACTION",2.85,56.92,,,"0.2 M AMMONIUM ACETATE, 0.1 M TRI-SODIUM CITRATE, 30% PEG 4K.",,,,"2XSN",156.6,"2.68","2.68","Crystal Structure of Human Tyrosine Hydroxylase Catalytic Domain","MVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIGAENLYFQ","Homo sapiens","TH, TYH","TYROSINE 3-MONOOXYGENASE","1","2XSN"
"2XSQ",,"X-RAY DIFFRACTION",2.48,50.41,,7.5,"PROTEIN WAS MIXED WITH 5MM MGCL2 AND 2MM IDP PRIOR SETTING-UP THE PLATES. THEN IT WAS CRYSTALLIZED FROM 20MM MGCL2, 22% W/V POLYACRYLIC ACID 5100 AND 0.1M HEPES PH 7.5.",,"10.1371/journal.pone.0131507",,"2XSQ",24.32,"1.72","1.72","Crystal structure of human Nudix motif 16 (NUDT16) in complex with IMP and magnesium","MHHHHHHSSGVDLGTENLYFQSMAGARRLELGEALALGSGWRHVCHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 SNORNA-DECAPPING ENZYME","1","2XSQ"
"2XSS",,"X-RAY DIFFRACTION",2.13,45,,,"16% PEG 3350, 0.06 M CITRIC ACID, 0.04 M BIS-TRIS PROPANE",,"10.1002/prot.22989",,"2XSS",41.35,"2.5","2.5","Crystal structure of GAFb from the human phosphodiesterase 5","MASWSHPQFEKGAETASLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYA","Homo sapiens","PDE5A, PDE5","CGMP-SPECIFIC 3', 5'-CYCLIC PHOSPHODIESTERASE","1","2XSS"
"2XST",,"X-RAY DIFFRACTION",2.04,39.67,,,"0.1 M HEPES PH7.5, 1.4 M TRI-SODIUM CITRATE DIHYDRATE",,,,"2XST",18.08,"1.63","1.63","Crystal Structure of the Human Lipocalin 15","SMQAEVLLQPDFNAEKFSGLWYVVSMASDCRVFLGKKDHLSMSTRAIRPTEEGGLHVHMEFPGADGCNQVDAEYLKVGSEGHFRVPALGYLDVRIVDTDYSSFAVLYIYKELEGALSTMVQLYSRTQDVSPQALKSFQDFYPTLGLPKDMMVMLPQSDACN","Homo sapiens","LCN15, UNQ2541/PRO6093","LIPOCALIN 15","1","2XST"
"2XSW",,"X-RAY DIFFRACTION",2.23,44.78,,7,"PROTEIN WAS INCUBATE WITH 1MM PHOSPHATIDYLINOSITOL-3,4,5-TRIPHOSPHATE AND 2MM MGCL2 PRIOR SETTING-UP THE PLATES. PROTEIN WAS THEN CRYSTALLIZED AGAINST 0.2M MGCL2, 10% W/V PEG8K AND 0.1M TRIS PH 7.",,,,"2XSW",81.41,"1.9","1.9","Crystal structure of human INPP5E","MEGSLLASGALLGADELARYFPDRNVALFVATWNMQGQKELPPSLDEFLLPAEADYAQDLYVIGVQEGCSDRREWETRLQETLGPHYVLLSSAAHGVLYMSLFIRRDLIWFCSEVECSTVTTRIVSQIKTKGALGISFTFFGTSFLFITSHFTSGDGKVAERLLDYTRTVQALVLPRNVPDTNPYRSSAADVTTRFDEVFWFGDFNFRLSGGRTVVDALLCQGLVVDVPALLQHDQLIREMRKGSIFKGFQEPDIHFLPSYKFDIGKDTYDSTSKQRTPSYTDRVLYRSRHKGDICPVSYSSCPGIKTSDHRPVYGLFRVKVRPGRDNIPLAAGKFDRELYLLGIKRRISAHHHHHH","Homo sapiens","INPP5E","72 KDA INOSITOL POLYPHOSPHATE 5-PHOSPHATASE","1","2XSW"
"2XSX",,"X-RAY DIFFRACTION",2.65,53.62,,,"0.1M NA_ACETATE, 25% PEG_8000, 0.1M CACODYLATE PH 7",,,,"2XSX",95.58,"1.7","1.7","Crystal structure of human beta enolase ENOB","SMAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINSTLGPALLQKKLSVADQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK","Homo sapiens","ENO3","BETA-ENOLASE","1","2XSX"
"2XT3",,"X-RAY DIFFRACTION",2.32,47.13,,6,"pH 6.0",,"10.1107/S0907444911053042",,"2XT3",37.87,"1.882","1.882","HUMAN KIF7, A KINESIN INVOLVED IN HEDGEHOG SIGNALLING","GAMGLPGAEEAPVRVALRVRPLLPKELLHGHQSCLQVEPGLGRVTLGRDRHFGFHVVLAEDAGQEAVYQACVQPLLEAFFEGFNATVFAYGQTGSGKTYTMGEASVASLLEDEQGIVPRAMAEAFKLIDENDLLDCLVHVSYLEVYKEEFRDLLEVGTASRDIQLREDERGNVVLCGVKEVDVEGLDEVLSLLEMGNAARHTGATHLNHLSSRSHTVFTVTLKQRGRAPSRLPRPAPGQLLVSKFHFVDLAGSERVLKTGSTGELRKESIQINSSLLALGNVISALGDPQRRGSNIPYRDSKITRILKDSLGGNAKTVMIACVSPSSSDFDETLNTLNYASRAQ","Homo sapiens","KIF7, UNQ340/PRO539","KINESIN-LIKE PROTEIN KIF7","1","2XT3"
"2XTC",,"X-RAY DIFFRACTION",2.52,51.2,,7.4,"17% PEG 4000, 0.2 M MGCL2, 0.1 M TRIS/HCL PH8.5, pH 7.4",,"10.1038/nsmb.1983",,"2XTC",19.68,"2.22","2.22","Structure of the TBL1 tetramerisation domain","MSITSDEVNFLVYRYLQESGFSHSAFTFGIESHISQSNINGTLVPPAALISILQKGLQYVEAEISINEDGTVFDGRPIESLSLIDAVMPD","Homo sapiens","TBL1X, TBL1","F-BOX-LIKE/WD REPEAT-CONTAINING PROTEIN TBL1X","1","2XTC"
"2XTD",,"X-RAY DIFFRACTION",3.27,62.39,,4.5,"15% MPD, 0.05 M SODIUM ACETATE PH 4.5",,"10.1038/nsmb.1983",,"2XTD",15.57,"3.2","3.2","Structure of the TBL1 tetramerisation domain","MSITSDEVNFLVYRYLQESGFSHSAFTFGIESHISQSNINGTLVPPAALISILQKGLQYVEAEISINEDGT","Homo sapiens","TBL1X, TBL1","TBL1 F-BOX-LIKE/WD REPEAT-CONTAINING PROTEIN TBL1X","1","2XTD"
"2XTE",,"X-RAY DIFFRACTION",4.61,73.34,,6.5,"0.1 M MES PH6.5, 2.0 M NACL, 0.175 M SODIUM ACETATE, 19 % GLYCEROL",,"10.1038/nsmb.1983",,"2XTE",118.09,"3.9","3.9","Structure of the TBL1 tetramerisation domain","MSITSDEVNFLVYRYLQESGFSHSAFTFGIESHISQSNINGTLVPPAALISILQKGLQYVEAEISINEDGTVFDGRPIESLSLIDAVMPD","Homo sapiens","TBL1X, TBL1","F-BOX-LIKE/WD REPEAT-CONTAINING PROTEIN TBL1X","1","2XTE"
"2XTM",,"X-RAY DIFFRACTION",2.35,48.15,,7.5,"12.5% 2-PROPANOL, 30% GLYCEROL, PH 7.5",,"10.1073/pnas.1010322107","GDP","2XTM",52.99,"1.7","1.7","Crystal structure of GDP-bound human GIMAP2, amino acid residues 1- 234","MDQNEHSHWGPHAKGQCASRSELRIILVGKTGTGKSAAGNSILRKQAFESKLGSQTLTKTCSKSQGSWGNREIVIIDTPDMFSWKDHCEALYKEVQRCYLLSAPGPHVLLLVTQLGRYTSQDQQAAQRVKEIFGEDAMGHTIVLFTHKEDLNGGSLMDYMHDSDNKALSKLVAACGGRICAFNNRAEGSNQDDQVKELMDCIEDLLMEKNGDHYTNGLYSLIQRSKCGPVGSDE","Homo sapiens","GIMAP2, IMAP2","GTPASE IMAP FAMILY MEMBER 2","1","2XTM"
"2XTN",,"X-RAY DIFFRACTION",2.22,45.59,,7.5,"6% 2-PROPANOL, 10 MM ATP, pH 7.5",,"10.1073/pnas.1010322107","GTP","2XTN",26.43,"1.9","1.9","Crystal structure of GTP-bound human GIMAP2, amino acid residues 1- 234","MDQNEHSHWGPHAKGQCASRSELRIILVGKTGTGKSAAGNSILRKQAFESKLGSQTLTKTCSKSQGSWGNREIVIIDTPDMFSWKDHCEALYKEVQRCYLLSAPGPHVLLLVTQLGRYTSQDQQAAQRVKEIFGEDAMGHTIVLFTHKEDLNGGSLMDYMHDSDNKALSKLVAACGGRICAFNNRAEGSNQDDQVKELMDCIEDLLMEKNGDHYTNGLYSLIQRSKCGPVGSDE","Homo sapiens","GIMAP2, IMAP2","GTPASE IMAP FAMILY MEMBER 2","1","2XTN"
"2XTO",,"X-RAY DIFFRACTION",2.26,46.08,,7.5,"19% 2-PROPANOL, pH 7.5",,"10.1073/pnas.1010322107","GDP","2XTO",54.37,"2.8","2.8","Crystal structure of GDP-bound human GIMAP2, amino acid residues 21- 260","SELRIILVGKTGTGKSAAGNSILRKQAFESKLGSQTLTKTCSKSQGSWGNREIVIIDTPDMFSWKDHCEALYKEVQRCYLLSAPGPHVLLLVTQLGRYTSQDQQAAQRVKEIFGEDAMGHTIVLFTHKEDLNGGSLMDYMHDSDNKALSKLVAACGGRICAFNNRAEGSNQDDQVKELMDCIEDLLMEKNGDHYTNGLYSLIQRSKCGPVGSDERVKEFKQSLIKYMETQRSYTALAEAN","Homo sapiens","GIMAP2, IMAP2","GTPASE IMAP FAMILY MEMBER 2","1","2XTO"
"2XTP",,"X-RAY DIFFRACTION",2.15,42.62,,7.5,"11-12% 2-PROPANOL, 15% GLYCEROL, pH 7.5",,"10.1073/pnas.1010322107",,"2XTP",29.35,"1.5","1.5","Crystal structure of nucleotide-free human GIMAP2, amino acid residues 1-260","MDQNEHSHWGPHAKGQCASRSELRIILVGKTGTGKSAAGNSILRKQAFESKLGSQTLTKTCSKSQGSWGNREIVIIDTPDMFSWKDHCEALYKEVQRCYLLSAPGPHVLLLVTQLGRYTSQDQQAAQRVKEIFGEDAMGHTIVLFTHKEDLNGGSLMDYMHDSDNKALSKLVAACGGRICAFNNRAEGSNQDDQVKELMDCIEDLLMEKNGDHYTNGLYSLIQRSKCGPVGSDERVKEFKQSLIKYMETQRSYTALAEAN","Homo sapiens","GIMAP2, IMAP2","GTPASE IMAP FAMILY MEMBER 2","1","2XTP"
"2XU1",,"X-RAY DIFFRACTION",2.14,42.5,,4,"20% PEG 2000, PH 4",,"10.1002/anie.201006781","424","2XU1",98.78,"1.45","1.45","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDAGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2XU1"
"2XU3",,"X-RAY DIFFRACTION",1.93,36.6,,8.2,"0.1 M CITRIC ACID PH 3.5 25 % PEG 3350",,"10.1002/anie.201006781","XU3","2XU3",25.19,"0.9","0.9","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2XU3"
"2XU4",,"X-RAY DIFFRACTION",2.13,42.4,,3.5,"0.1 M CITRIC ACID PH 3.5, 25 % PEG 3350",,"10.1002/anie.201006781","DJT","2XU4",24.89,"1.12","1.12","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2XU4"
"2XU5",,"X-RAY DIFFRACTION",2.02,39.3,,3.5,"0.1 M CITRIC ACID PH 3.5, 25 % PEG 3350",,"10.1002/anie.201006781","XU5","2XU5",24.99,"1.6","1.6","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2XU5"
"2XUB",,"X-RAY DIFFRACTION",2.82,0.56,,7.5,"pH 7.5",,"10.1038/nsmb.1996",,"2XUB",60.69,"2.8","2.8","Human RPC62 subunit structure","MTQAEIKLCSLLLQEHFGEIVEKIGVHLIRTGSQPLRVIAHDTGTSLDQVKKALCVLVQHNLVSYQVHKRGVVEYEAQCSRVLRMLRYPRYIYTTKTLYSDTGELIVEELLLNGKLTMSAVVKKVADRLTETMEDGKTMDYAEVSNTFVRLADTHFVQRCPSVPTTENSDPGPPPPAPTLVINEKDMYLVPKLSLIGKGKRRRSSDEDAAGEPKAKRPKYTTDNKEPIPDDGIYWQANLDRFHQHFRDQAIVSAVANRMDQTSSEIVRTMLRMSEITTSSSAPFTQPLSSNEIFRSLPVGYNISKQVLDQYLTLLADDPLEFVGKSGDSGGGMYVINLHKALASLATATLESVVQERFGSRCARIFRLVLQKKHIEQKQVEDFAMIPAKEAKDMLYKMLSENFMSLQEIPKTPDHAPSRTFYLYTVNILSAARMLLHRCYKSIANLIERRQFETKENKRLLEKSQRVEAIIASMQATGAEEAQLQEIEEMITAPERQQLETLKRNVNKLDASEIQVDETIFLLESYIECTMKRQ","Homo sapiens","POLR3C","DNA-DIRECTED RNA POLYMERASE III SUBUNIT RPC3","1","2XUB"
"2XUE",,"X-RAY DIFFRACTION",2.53,51.04,,8.5,"MORPHEUS SCREEN (MOLECULAR DIMENSIONS) CONDITION A12 (0.03M MGCL2, 0.03M CACL2, 0.1M TRIS HCL/BICINE PH 8.5, 12.5%V/V MPD, 12.5%W/V PEG1000, 12.5%W/V PEG3350)",,"10.1038/nature11262",,"2XUE",116.57,"2","2","CRYSTAL STRUCTURE OF JMJD3","DVVRASRNAKVKGKFRESYLSPAQSVKPKINTEEKLPREKLNPPTPSIYLESKRDAFSPVLLQFCTDPRNPITVIRGLAGSLRLNLGLFSTKTLVEASGEHTVEVRTQVQQPSDENWDLTGTRQIWPCESSRSHTTIAKYAQYQASSFQESLQEEKESEDEESEEPDSTTGTPPSSAPDPKNHHIIKFGTNIDLSDAKRWKPQLQELLKLPAFMRVTSTGNMLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFAVHEHYWETISAFCDRHGVDYLTGSWWPILDDLYASNIPVYRFVQRPGDLVWINAGTVHWVQATGWCNNIAWNVGPLTAYQYQLALERYEWNEVKNVKSIVPMIHVSWNVARTVKISDPDLFKMIKFCLLQSMKHCQVQRESLVRAGKKIAYQGRVKDEPAYYCNECDVEVFNILFVTSENGSRNTYLVHCEGCARRRSAGLQGVVVLEQYRTEELAQAYDAFTLAPASTSRHHHHHH","Homo sapiens","KDM6B, JMJD3, KIAA0346","LYSINE-SPECIFIC DEMETHYLASE 6B","1","2XUE"
"2XUS",,"X-RAY DIFFRACTION",1.95,37,,5.25,"0.1 M SODIUM CITRATE PH 5.25, 1.5 M AMMONIUM SULPHATE",,"10.1016/j.jmb.2011.07.006",,"2XUS",12.17,"1.912","1.912","Crystal Structure of the BRMS1 N-terminal region","SEDYERRRSECVSEMLDLEKQFSELKEKLFRERLSQLRLRLEEVGAERA","Homo sapiens","BRMS1","BREAST CANCER METASTASIS-SUPPRESSOR 1","1","2XUS"
"2XUU",,"X-RAY DIFFRACTION",2.41,49.05,,5.5,"0.2 M LISO4 0.1 M BIS-TRIS PH 5.5 25% PEG 4000 0.002% NAN3",,"10.1016/j.chembiol.2013.12.008",,"2XUU",39.14,"1.8","1.8","Crystal structure of a DAP-kinase 1 mutant","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKWKQSVRLISLCQRLSRSFLSRSNMSVARSD","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2XUU"
"2XV4",,"X-RAY DIFFRACTION",2.82,0.56,,7.5,"BTP PH 7.5 GLYCEROL 10% PEG 3350 TACSIMATE 12%",,"10.1038/nsmb.1996",,"2XV4",60.98,"2.95","2.95","Structure of Human RPC62 (partial)","MTQAEIKLCSLLLQEHFGEIVEKIGVHLIRTGSQPLRVIAHDTGTSLDQVKKALCVLVQHNLVSYQVHKRGVVEYEAQCSRVLRMLRYPRYIYTTKTLYSDTGELIVEELLLNGKLTMSAVVKKVADRLTETMEDGKTMDYAEVSNTFVRLADTHFVQRCPSVPTTENSDPGPPPPAPTLVINEKDMYLVPKLSLIGKGKRRRSSDEDAAGEPKAKRPKYTTDNKEPIPDDGIYWQANLDRFHQHFRDQAIVSAVANRMDQTSSEIVRTMLRMSEITTSSSAPFTQPLSSNEIFRSLPVGYNISKQVLDQYLTLLADDPLEFVGKSGDSGGGMYVINLHKALASLATATLESVVQERFGSRCARIFRLVLQKKHIEQKQVEDFAMIPAKEAKDMLYKMLSENFMSLQEIPKTPDHAPSRTFYLYTVNILSAARMLLHRCYKSIANLIERRQFETKENKRLLEKSQRVEAIIASMQATGAEEAQLQEIEEMITAPERQQLETLKRNVNKLDASEIQVDETIFLLESYIECTMKRQ","Homo sapiens","POLR3C","DNA-DIRECTED RNA POLYMERASE III SUBUNIT RPC3","1","2XV4"
"2XV5",,"X-RAY DIFFRACTION",2.1,41,,8.5,"73% MPD, 10 MM TRIS-HCL, PH 8.5 AND 100 MM NACL, 293 K",293,"10.1016/j.jmb.2011.02.037",,"2XV5",17.9,"2.4","2.4","Human lamin A coil 2B fragment","GGSARERDTSRRLLAEKEREMAEMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEERLRLSPSPTSQRS","Homo sapiens","LMNA, LMN1","LAMIN-A/C","1","2XV5"
"2XV7",,"X-RAY DIFFRACTION",2.5,50,,4.2,"A SINGLE VEGF-D CRYSTAL GREW IN 6 WEEKS AT ROOM TEMPERATURE OVER A RESERVOIR SOLUTION OF 0.1 M PHOSPHATE/CITRATE BUFFER AT PH 4.2, 40 % ETHANOL (V/V), 5 % PEG 1000 (W/V).",,"10.1182/blood-2010-08-301549",,"2XV7",14.1,"2.9","2.9","Crystal structure of vascular endothelial growth factor D","DPTFYDIETLKVIDEEWQRTQCSPRETAVEVASELGKSTNTFFKPPCVNVFRCGGCCNEESLICMNTSTSYISKQLFEISVPLTSVPELVPVKVANHTGCKCLPTAHHHHHH","Homo sapiens","VEGFD, FIGF","VASCULAR ENDOTHELIAL GROWTH FACTOR D","1","2XV7"
"2XVD",,"X-RAY DIFFRACTION",2.09,41.15,,7.5,"PH 7.5",,"10.1016/j.bmcl.2011.03.009","AS6","2XVD",34.52,"1.7","1.7","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2XVD"
"2XVQ",,"X-RAY DIFFRACTION",2.6,53,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XVQ",133.79,"2.9","2.9","Human serum albumin complexed with dansyl-L-sarcosine","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XVQ"
"2XVS",,"X-RAY DIFFRACTION",2.05,40,,8.5,"0.18M SODIUM IODIDE, 0.02M SODIUM ACETATE, 20% PEG3350, 10% ETHYLENE GLYCOL, 0.45% DMSO, 0.1M BIS-TRIS-PROPANE PH8.5",,"10.1073/pnas.1113731109",,"2XVS",18.66,"1.8","1.8","Crystal structure of human TTC5 (Strap) C-terminal OB domain","SMRQREQQLLEFLDRLTSLLESKGKVKTKKLQSMLGSLRPAHLGPCSDGHYQSASGQKVTLELKPLSTLQPGVNSGAVILGKVVFSLTTEEKVPFTFGLVDSDGPCYAVMVYNIVQSWGVLIGDSVAIPEPNLRLHRIQHKGKDYSFSSVRVETPLLLVVNGKPQG","Homo sapiens","TTC5","TETRATRICOPEPTIDE REPEAT PROTEIN 5","1","2XVS"
"2XVT",,"X-RAY DIFFRACTION",1.75,35.87,,7.5,"0.1M CALCIUM CHLORIDE, 26% PEG MONOMETHYLETHER 350, 0.1M HEPES PH 7.5",,,,"2XVT",65.36,"2.05","2.05","Structure of the extracellular domain of human RAMP2","SMTGTPGSEGGTVKNYETAVQFCWNHYKDQMDPIEKDWCDWAMISRPYSTLRDCLEHFAELFDLGFPNPLAERIIFETHQIHFANCSLVQPTFS","Homo sapiens","RAMP2","RECEPTOR ACTIVITY-MODIFYING PROTEIN 2","1","2XVT"
"2XVU",,"X-RAY DIFFRACTION",2.6,53,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XVU",134.6,"2.6","2.6","Human serum albumin complexed with dansyl-L-asparagine","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XVU"
"2XVV",,"X-RAY DIFFRACTION",2.66,54,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XVV",68.64,"2.4","2.4","Human serum albumin complexed with dansyl-L-asparagine and myristic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKEEQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XVV"
"2XVW",,"X-RAY DIFFRACTION",2.66,54,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XVW",68.73,"2.65","2.65","Human serum albumin complexed with dansyl-L-arginine and myristic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKEEQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XVW"
"2XW0",,"X-RAY DIFFRACTION",2.6,53,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XW0",134.74,"2.4","2.4","Human serum albumin complexed with dansyl-L-phenylalanine","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XW0"
"2XW1",,"X-RAY DIFFRACTION",2.6,53,,7,"SEE PAPER, pH 7",,"10.1016/j.jsb.2010.10.004",,"2XW1",133.84,"2.5","2.5","Human serum albumin complexed with dansyl-L-norvaline","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2XW1"
"2XW9",,"X-RAY DIFFRACTION",2.17,43.5,,6,"pH 6.0",,"10.1126/science.1195821",,"2XW9",24.79,"1.2","1.2","Crystal Structure of Complement Factor D mutant S183A","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDAGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","COMPLEMENT FACTOR D","1","2XW9"
"2XWA",,"X-RAY DIFFRACTION",2.05,39.5,,6,"pH 6.0",,"10.1126/science.1195821",,"2XWA",48.89,"2.8","2.8","Crystal Structure of Complement Factor D Mutant R202A","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","COMPLEMENT FACTOR D","1","2XWA"
"2XWC",,"X-RAY DIFFRACTION",2.42,49.13,,,"1.2M SODIUM POTASSIUM TARTRATE, 0.25% PEG MME 5000, 0.1M TRIS PH 9",,"10.1016/j.jmb.2012.08.005",,"2XWC",23.73,"1.82","1.82","Crystal structure of the DNA binding domain of human TP73 refined at 1.8 A resolution","MAPVIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREAENLYFQ","Homo sapiens","TP73, P73","TUMOUR PROTEIN P73","1","2XWC"
"2XWD",,"X-RAY DIFFRACTION",2.1,42,,6.5,"0.2M (NH4)2SO4, 0.1 M TRIS PH 6.5, 25% W/V PEG3350",,"10.1039/c1ob05200d","LGS","2XWD",116.24,"2.66","2.66","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6O-(N'-(N-OCTYL)IMINO)NOJIRIMYCIN IN THE ACTIVE SITE","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2XWD"
"2XWE",,"X-RAY DIFFRACTION",2.1,42,,6.5,"0.2N (NH4)2SO4, 0.1M TRIS PH 6.5, 25% W/V PEG3350",,"10.1039/c1ob05200d","AMF","2XWE",115.58,"2.31","2.31","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6S-(N'-(N-OCTYL)IMINO)-6-THIONOJIRIMYCIN IN THE ACTIVE SITE","EFARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQLLVDTM","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2XWE"
"2XWR",,"X-RAY DIFFRACTION",2.2,45,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 5.4 MG/ML IN 25 MM SODIUM PHOSPHATE, PH 7.2, 220 MM NACL, AND 5 MM DTT. RESERVOIR SOLUTION: 100 MM BIS-TRIS, PH 5.5, 23% PEG 3350, 200 MM AMMONIUM SULFATE.",290,"10.1016/j.jmb.2011.03.047",,"2XWR",46.3,"1.68","1.68","Crystal structure of the DNA-binding domain of human p53 with extended N terminus","PSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2XWR"
"2XX3",,"X-RAY DIFFRACTION",2.52,51.23,,7.5,"pH 7.5",,"10.1021/jm1011462",,"2XX3",26.88,"2","2","HUMAN THYMIDYLATE KINASE COMPLEXED WITH thymidine butenyl phosphonate monophosphate and ADP","MGSSHHHHHHSSGLVPRGSHMAARRGALIVLEGVDRAGKSTQSRKLVEALCAAGHRAELLRFPERSTEIGKLLSSYLQKKSDVEDHSVHLLFSANRWEQVPLIKEKLSQGVTLVVDRYAFSGVAFTGAKENFSLDWCKQPDVGLPKPDLVLFLQLQLADAAKRGAFGHERYENGAFQERALRCFHQLMKDTTLNWKMVDASKSIEAVHEDIRVLSEDAIRTATEKPLGELWK","Homo sapiens","DTYMK, CDC8, TMPK, TYMK","THYMIDYLATE KINASE","1","2XX3"
"2XXZ",,"X-RAY DIFFRACTION",2.17,43.3,,,,,,"8XQ","2XXZ",76.26,"1.8","1.8","Crystal structure of the human JMJD3 jumonji domain","SMLPREKLNPPTPSIYLESKRDAFSPVLLQFCTDPRNPITVIRGLAGSLRLNLGLFSTKTLVEASGEHTVEVRTQVQQPSDENWDLTGTRQIWPCESSRSHTTIAKYAQYQASSFQESLQEEKESEDEESEEPDSTTGTPPSSAPDPKNHHIIKFGTNIDLSDAKRWKPQLQELLKLPAFMRVTSTGNMLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFAVHEHYWETISAFCDRHGVDYLTGSWWPILDDLYASNIPVYRFVQRPGDLVWINAGTVHWVQATGWCNNIAWNVGPLTAYQYQLALERYEWNEV","Homo sapiens","KDM6B, JMJD3, KIAA0346","LYSINE-SPECIFIC DEMETHYLASE 6B","1","2XXZ"
"2XY1",,"X-RAY DIFFRACTION",2.1,41.32,,7,"25% PEG-6000, 0.1 M HEPES PH7.0",,"10.1016/j.str.2010.12.014",,"2XY1",21.72,"1.979","1.979","CRYSTAL STRUCTURE OF NCAM2 IG3-4","SMPAISMPQKSFNATAERGEEMTFSCRASGSPEPAISWFRNGKLIEENEKYILKGSNTELTVRNIINSDGGPYVCRATNKAGEDEKQAFLQVFVQPHIIQLKNETTYENGQVTLVCDAEGEPIPEITWKRAVDGFTFTEGDKSLDGRIEVKGQHGSSSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYLDIE","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2XY1"
"2XY2",,"X-RAY DIFFRACTION",2.44,49.68,,8.5,"30 % PEG-4000, 0.2 M SODIUM ACETATE TRIHYDRATE, 0.1 M TRIS HYDROCHLORIDE PH 8.5.",,"10.1016/j.str.2010.12.014",,"2XY2",21.51,"1.82","1.82","CRYSTAL STRUCTURE OF NCAM2 IG1-2","ALLQVTISLSKVELSVGESKFFTCTAIGEPESIDWYNPQGEKIISTQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQEATVVLEIYQKLTFREVVSPQEFKQGEDAEVVCRVSSSPAPAVSWLYHNEEVTTISDNRFAMLANNNLQILNINKSDEGIYRCEGRVEARGEIDFRDIIVIVNV","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2XY2"
"2XY9",,"X-RAY DIFFRACTION",2.5,52,,4.7,"13.5% PEG4000,50MM SODIUM ACETATE, PH 4.7 AND 0.01MM ZNSO4",,"10.1042/BJ20102123","3ES","2XY9",70.44,"1.97","1.97","Human Angiotensin converting enzyme in complex with phosphinic tripeptide","DEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPA","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","2XY9"
"2XYC",,"X-RAY DIFFRACTION",3.58,65.68,,7.5,"5MM HEPES PH 7.5, 10% PEG 3350, 0.1M AMMONIUM PHOSPHATE, 10MM TRIMETHYLAMINE HYDROCHLORIDE",,"10.1016/j.str.2010.12.014",,"2XYC",33.7,"2.51","2.51","CRYSTAL STRUCTURE OF NCAM2 IGIV-FN3I","QPHIIQLKNETTYENGQVTLVCDAEGEPIPEITWKRAVDGFTFTEGDKSLDGRIEVKGQHGSSSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYLDIEYAPKFISNQTIYYSWEGNPINISCDVKSNPPASIHWRRDKLVLPAKNTTNLKTYSTGRKMILEIAPTSDNDFGRYNCTATNHIGTRFQEYILALADVPSSPYGVKIIELSQTTAKVSFNKPDSHGGVPIHHYQVDVKEVASEIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSKIEIFQTLPV","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2XYC"
"2XYD",,"X-RAY DIFFRACTION",2.87,57.1,,8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",,"10.1042/BJ20102123","3ES","2XYD",146.47,"2.15","2.15","human Angiotenisn converting enzyme N-domain in complex with Phosphinic tripeptide","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEG","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","2XYD"
"2XYG",,"X-RAY DIFFRACTION",2.51,50.96,,,"15% PEG6000, 0.1M SODIUM CITRATE, PH 5.0",,"10.1107/S1744309111018604",,"2XYG",27.89,"1.54","1.54","Caspase-3:CAS329306","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIET","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P17","1","2XYG"
,,,,,,,,,,,,,,,,"HKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P12","2","2XYG"
"2XYH",,"X-RAY DIFFRACTION",2.49,50.58,,,,,"10.1107/S1744309111018604",,"2XYH",27.69,"1.89","1.89","Caspase-3:CAS60254719","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIET","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P17","1","2XYH"
,,,,,,,,,,,,,,,,"HKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P12","2","2XYH"
"2XYJ",,"X-RAY DIFFRACTION",2.58,51.9,,8,"PEG3350 11%, TRIS 100MM PH 8, CACL2 300MM",,"10.1002/cmdc.201100047",,"2XYJ",68.21,"2.3","2.3","Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy","MKKGHHHHHHGGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1","2XYJ"
"2XYN",,"X-RAY DIFFRACTION",4.2,70.69,"VAPOR DIFFUSION, SITTING DROP",7,"0.8M SODIUM SUCCINATE, PH 7, VAPOUR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1021/jm101506n","VX6","2XYN",103.96,"2.81","2.81","HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680","MGHHHHHHSSGVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDS","Homo sapiens","ABL2, ABLL, ARG","TYROSINE-PROTEIN KINASE ABL2","1","2XYN"
"2XYP",,"X-RAY DIFFRACTION",2.53,51.47,,,,,"10.1107/S1744309111018604",,"2XYP",27.87,"1.86","1.86","Caspase-3:CAS26049945","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIET","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P17","1","2XYP"
,,,,,,,,,,,,,,,,"HKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","CASPASE-3 SUBUNIT P12","2","2XYP"
"2XYW",,"X-RAY DIFFRACTION",2.91,57.42,,7,"PEG8000 8%,BISTRISPROPANE 40MM, PH7, PROPANEDIOL 5%, KCL 300MM, DTT 5MM, EDTA 1MM, pH 7.0",,"10.1002/cmdc.201100047",,"2XYW",67.66,"3.14","3.14","Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy","MKKGHHHHHHGGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1","2XYW"
"2XYX",,"X-RAY DIFFRACTION",2.89,57.16,,7,"PEG8000 10% - BISTRISPROPANE 40MM PH 7 - DTT 5MM - KCL 300MM - PROPANEDIOL 5% - EDTA 1MM",,"10.1002/cmdc.201100047",,"2XYX",67.59,"2.7","2.7","Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy","MKKGHHHHHHGGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1","2XYX"
"2XZA",,"X-RAY DIFFRACTION",2.3,47.3,,6.5,"0.1M ADA BUFFER PH 6.5 0.1M MGCL2 20% PEG6000",,"10.1073/pnas.1108460108",,"2XZA",46.46,"1.5","1.5","Crystal Structure of recombinant A.17 antibody FAB fragment","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLTTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"FAB A.17 HEAVY CHAIN","1","2XZA"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB A.17 LIGHT CHAIN","2","2XZA"
"2XZC",,"X-RAY DIFFRACTION",2.36,47.9,,6.5,"0.1M ADA BUFFER PH 6.5, 0.1M MGCL2, 20% PEG6000",,"10.1073/pnas.1108460108","XOP","2XZC",46.78,"1.36","1.36","Crystal Structure of phosphonate-modified recombinant A.17 antibody FAB fragment","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLTTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"FAB A.17 HEAVY CHAIN","1","2XZC"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB A.17 LIGHT CHAIN","2","2XZC"
"2XZG",,"X-RAY DIFFRACTION",2.72,54.75,,8,"20% PEG 3350, 150 MM POTASSIUM ACETATE, 0.1 M TRIS, PH 8.0.",,"10.1016/j.cell.2011.06.025","VH1","2XZG",41.44,"1.7","1.7","Clathrin Terminal Domain Complexed with Pitstop 1","FMAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGAMQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKHDVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGAEELF","Homo sapiens","CLTC, CLH17, CLTCL2, KIAA0034","CLATHRIN HEAVY CHAIN 1","1","2XZG"
"2XZP",,"X-RAY DIFFRACTION",3.73,67.05,,6,"50MM SODIUM CITRATE PH 6.0, 1.5M SODIUM MALONATE",,"10.1016/j.molcel.2011.02.010",,"2XZP",70.51,"2.72","2.72","Upf1 helicase","GHMRYEDAYQYQNIFGPLVKLEADYDKKLKESQTQDNITVRWDLGLNKKRIAYFTLPKTDSDMRLMQGDEICLRYKGDLAPLWKGIGHVIKVPDNYGDEIAIELRSSVGAPVEVTHNFQVDFVWKSTSFDRMQSALKTFAVDETSVSGYIYHKLLGHEVEDVIIKCQLPKRFTAQGLPDLNHSQVYAVKTVLQRPLSLIQGPPGTGKTVTSATIVYHLARQGNGPVLVCAPSNIAVDQLTEKIHQTGLKVVRLCAKSREAIDSPVSFLALHNQIRNMDSMPELQKLQQLKDETGELSSADEKRYRALKRTAERELLMNADVICCTCVGAGDPRLAKMQFRSILIDESTQATEPECMVPVVLGAKQLILVGDHCQLGPVVMCKKAAKAGLSQSLFERLVVLGIRPIRLQVQYRMHPALSAFPSNIFYEGSLQNGVTAADRVKKGFDFQWPQPDKPMFFYVTQGQEEIASSGTSYLNRTEAANVEKITTKLLKAGAKPDQIGIITPYEGQRSYLVQYMQFSGSLHTKLYQEVEIASVDAFQGREKDFIILSCVRANEHQGIGFLNDPRRLNVALTRARYGVIIVGNPKALSKQPLWNHLLNYYKEQKVLVEGPLNNLRESLMQFS","Homo sapiens","UPF1, KIAA0221, RENT1","REGULATOR OF NONSENSE TRANSCRIPTS 1","1","2XZP"
"2XZS",,"X-RAY DIFFRACTION",2.53,51.5,,6.5,"0.2 M MAGNESIUM ACETATE TETRAHYDRATE, 0.1 M SODIUM CACODYLATE, PH 6.5 AND 10% PEG 8000",,"10.1016/j.str.2016.03.020",,"2XZS",71.83,"2","2","Death associated protein kinase 1 residues 1-312","GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKWKQSVRLI","Homo sapiens","DAPK1, DAPK","DEATH ASSOCIATED KINASE 1","1","2XZS"
"2XZZ",,"X-RAY DIFFRACTION",2.87,57.19,,,"0.7 M (NH4)2SO4, 1% PEG3350, 0.1 M BIS-TRIS (PH 5.5)",,,,"2XZZ",10.99,"2.3","2.3","Crystal structure of the human transglutaminase 1 beta-barrel domain","SMYFQSMLSLTLLGAAVVGQECEVQIVFKNPLPVTLTNVVFRLEGSGLQRPKILNVGDIGGNETVTLRQSFVPVRPGPRQLIASLDSPQLSQVHGVIQVDVA","Homo sapiens","TGM1, KTG","PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE K","1","2XZZ"
"2Y05",,"X-RAY DIFFRACTION",2.75,55.34,,,"10% PEG 10K, 8% ETGLY, 0.1M HEPES, PH 7.5",,,,"2Y05",147.69,"2.2","2.2","Crystal structure of human leukotriene B4 12-hydroxydehydrogenase in complex with NADP and raloxifene","SMTKTWTLKKHFVGYPTNSDFELKTSELPPLKNGEVLLEALFLTVDPYMRVAAKRLKEGDTMMGQQVAKVVESKNVALPKGTIVLASPGWTTHSISDGKDLEKLLTEWPDTIPLSLALGTVGMPGLTAYFGLLEICGVKGGETVMVNAAAGAVGSVVGQIAKLKGCKVVGAVGSDEKVAYLQKLGFDVVFNYKTVESLEETLKKASPDGYDCYFDNVGGEFSNTVIGQMKKFGRIAICGAISTYNRTGPLPPGPPPEIVIYQELRMEAFVVYRWQGDARQKALKDLLKWVLEGKIQYKEYIIEGFENMPAAFMGMLKGDNLGKTIVKA","Homo sapiens","PTGR1, LTB4DH","PROSTAGLANDIN REDUCTASE 1","1","2Y05"
"2Y0A",,"X-RAY DIFFRACTION",2.97,58.6,,6,"5% PEG 6000, 0.1M MES, PH 6.0",,,,"2Y0A",37.46,"2.6","2.6","Structure of DAPK1 construct residues 1-304","GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIEWHE","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2Y0A"
"2Y0J",,"X-RAY DIFFRACTION",2.25,45.36,,8.9,"100 MM TRIS-HCL PH8.9, 5 MM CACL2, 11-12% PEG 3350",,"10.1016/j.bmcl.2011.04.067","AXC","2Y0J",80.13,"2.43","2.43","Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors, part 2, Lead-optimisation.","MEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWRHHHHHH","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","2Y0J"
"2Y1H",,"X-RAY DIFFRACTION",2.26,45.53,,,"0.02M ZN_CL, 20% W/V PEG 6000 AND 10% V/V ETHYLENE GLYCOL",,,,"2Y1H",60.95,"2.5","2.5","Crystal structure of the human TatD-domain protein 3 (TATDN3)","SMGVGLVDCHCHLSAPDFDRDLDDVLEKAKKANVVALVAVAEHSGEFEKIMQLSERYNGFVLPCLGVHPVQGLPPEDQRSVTLKDLDVALPIIENYKDRLLAIGEVGLDFSPRFAGTGEQKEEQRQVLIRQIQLAKRLNLPVNVHSRSAGRPTINLLQEQGAEKVLLHAFDGRPSVAMEGVRAGYFFSIPPSIIRSGQKQKLVKQLPLTSICLETDSPALGPEKQVRNEPWNISISAEYIAQVKGISVEEVIEVTTQNALKLFPKLRHLLQK","Homo sapiens","TATDN3","PUTATIVE DEOXYRIBONUCLEASE TATDN3","1","2Y1H"
"2Y1K",,"X-RAY DIFFRACTION",3.15,61,,6.5,"0.1 M MES PH 6.5, 2.1 M AMMONIUM SULFATE.",,"10.1021/tx100447k",,"2Y1K",62.65,"2.5","2.5","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2Y1K"
"2Y1M",,"X-RAY DIFFRACTION",3.52,65.04,,9,"0.1 M TRIS-HCL, PH 9.0-9.5, 3.7-4.0 M SODIUM FORMATE, 5 MM DTT",,"10.1038/nsmb.2231",,"2Y1M",270.6,"2.67","2.67","Structure of native c-Cbl","PPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKMETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELKGIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQNPDLTGLCEPTPQDHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPIVVDPFD","Homo sapiens","CBL, CBL2, RNF55","E3 UBIQUITIN-PROTEIN LIGASE","1","2Y1M"
"2Y1W",,"X-RAY DIFFRACTION",2.43,49.5,,8.5,"20-30% PEG 2000K, 0.1 M TRIS-HCL PH 8.5, 0.2 M TRIMETHYLAMINE N-OXIDE DIHYDRATE.",,"10.1042/BJ20102161","849","2Y1W",160.97,"2.1","2.1","CRYSTAL STRUCTURE OF COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) IN COMPLEX WITH SINEFUNGIN AND INDOLE INHIBITOR","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTTPS","Homo sapiens","CARM1, PRMT4","HISTONE-ARGININE METHYLTRANSFERASE CARM1","1","2Y1W"
"2Y1X",,"X-RAY DIFFRACTION",2.5,50.1,,8.5,"20-30% PEG 2000K, 0.1 M TRIS-HCL PH 8.5, 0.2 M TRIMETHYLAMINE N-OXIDE DIHYDRATE",,"10.1042/BJ20102161","SAH, 845","2Y1X",161.59,"2.4","2.4","CRYSTAL STRUCTURE OF COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) IN COMPLEX WITH SINEFUNGIN AND INDOLE INHIBITOR","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTTPS","Homo sapiens","CARM1, PRMT4","HISTONE-ARGININE METHYLTRANSFERASE CARM1","1","2Y1X"
"2Y1Y",,"X-RAY DIFFRACTION",1.99,38,"VAPOR DIFFUSION, SITTING DROP",9,"SITTING DROPS, 20 MG/ML PROTEIN IN 25 MM TRIS, PH8.5, 200 MM NACL. EQUILIBRATED AGAINST MOTHER LIQUOR OF 110 MM BICINE, PH 9.0, 40% MPD",,"10.1016/j.jmb.2011.02.020",,"2Y1Y",10.43,"2","2","Human alphaB crystallin ACD(residues 71-157)","GAMEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSMSSDGVLTVNGPRKQVSGPER","Homo sapiens","CRYAB, CRYA2, HSPB5","ALPHA-CRYSTALLIN B CHAIN,","1","2Y1Y"
"2Y1Z",,"X-RAY DIFFRACTION",2.49,50.6,,7.4,"PROTEIN AT 16.5 MG/ML IN BUFFER (25 MM TRISHCL, PH 7.5, 25 MM NACL) WAS MIXED 1:1 WITH MOTHER LIQUOR (36% MPD, 0.18M POTASSIUM CHLORIDE)",,"10.1016/j.jmb.2011.02.020",,"2Y1Z",21.77,"2.5","2.5","Human alphaB Crystallin ACD R120G","GAMEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHGKYRIPADVDPLTITSSMSSDGVLTVNGPRKQVSGPER","Homo sapiens","CRYAB, CRYA2, HSPB5","ALPHA-CRYSTALLIN B CHAIN","1","2Y1Z"
"2Y22",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",9,"SITTING DROPS WITH 20 MG/ML PROTEIN IN 25 MM TRIS, PH 8.5, 200 MM NACL EQUILIBRATED AGAINST 110 MM BICINE, PH 9.0, 55% MPD",,"10.1016/j.jmb.2011.02.020",,"2Y22",65.33,"3.7","3.7","Human AlphaB-crystallin Domain (residues 67-157)","GAMEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSMSSDGVLTVNGPRKQVSGPER","Homo sapiens","CRYAB, CRYA2, HSPB5","ALPHA-CRYSTALLIN B","1","2Y22"
"2Y23",,"X-RAY DIFFRACTION",3.11,60.5,,7.5,"0.18M MAGNESIUM ACETATE 20% W/V POLYETHYLENE GLYCOL 3350, pH 7.5",,"10.1371/journal.pbio.1001261",,"2Y23",36.4,"2.5","2.5","CRYSTAL STRUCTURE OF THE MYOMESIN DOMAINS MY9-MY11","GIDPFTKEVVVNVDDDGVISLNFECDKMTPKSEFSWSKDYVSTEDSPRLEVESKGNKTKMTFKDLGMDDLGIYSCDVTDTDGIASSYLIDEEELKRLLALSHEHKFPTVPVKSELAVEILEKGQVRFWMQAEKLSGNAKVNYIFNEKEIFEGPKYKMHIDRNTGIIEMFMEKLQDEDEGTYTFQLQDGKATNHSTVVLVGDVFKKLQKEAEFQRQEWIRKQGPHFVEYLSWEVTGECNVLLKCKVANIKKETHIVWYKDEREISVDEKHDFKDGICTLLITEFSKKDAGIYEVILKDDRGKDKSRLKLVDEA","Homo sapiens","MYOM1","MYOMESIN","1","2Y23"
"2Y25",,"X-RAY DIFFRACTION",4.59,73.22,,6,"MES PH 6, 220 MM LI2SO4, 13% PEG 8K.",,"10.1371/journal.pbio.1001261",,"2Y25",142.77,"3.5","3.5","Crystal structure of the myomesin domains My11-My13","GIDPFTGPHFVEYLSWEVTGECNVLLKCKVANIKKETHIVWYKDEREISVDEKHDFKDGICTLLITEFSKKDAGIYEVILKDDRGKDKSRLKLVDEAFKELMMEVCKKIALSATDLKIQSTAEGIQLYSFVTYYVEDLKVNWSHNGSAIRYSDRVKTGVTGEQIWLQINEPTPNDKGKYVMELFDGKTGHQKTVDLSGQAYDEAYAEFQRLKQAAIAEKNRARVLGGLPDVVTIQEGKALNLTCNVWGDPPPEVSWLKNEKALASDDHCNLKFEAGRTAYFTINGVSTADSGKYGLVVKNKYGSETSDFTVSVFIPE","Homo sapiens","MYOM1","MYOMESIN","1","2Y25"
"2Y29",,"X-RAY DIFFRACTION",1.73,29,,8.5,"AB16-21 FORM III CRYSTALS WERE OBTAINED AFTER THE SEGMENT WAS DISSOLVED IN WATER AT 5 MG/ML AND MIXED WITH 0.2M AMMONIUM ACETATE, 0.1 M TRIS BUFFER PH 8.5 AND 30% ISOPROPANOL.",,"10.1073/pnas.1112600108",,"2Y29",0.72,"2.3","2.3","Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph III","KLVFFA","Homo sapiens","APP, A4, AD1","AMYLOID BETA A4 PROTEIN","1","2Y29"
"2Y2A",,"X-RAY DIFFRACTION",1.71,28,,5.5,"AB16-21 FORM I CRYSTALS WERE OBTAINED AFTER THE SEGMENT WAS DISSOLVED IN WATER AT 5 MG/ML AND MIXED WITH 0.2 M AMMONIUM ACETATE, 0.1 M BIS-TRIS PH 5.5, 45 % V/V MPD",,"10.1073/pnas.1112600108",,"2Y2A",0.78,"1.91","1.91","Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph I","KLVFFA","Homo sapiens","APP, A4, AD1","AMYLOID BETA A4 PROTEIN","1","2Y2A"
"2Y33",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"APPROX. 20 MG/ML APO-PHD2, 1MM ZN-ACETATE, 1MM FG2, VAPOR DIFFUSION, SITTING DROP, 30% PEG 4000 (W/V), 0.2M SODIUM ACETATE, 0.1 M TRIS-HCL PH 8.5; PRE-GROWN CRYSTALS WERE SOAKED WITH 50 MM GSNO FOR 12 HR.",,"10.1016/j.jmb.2011.04.075","UN9","2Y33",28.47,"2","2","S-nitrosylated PHD2 (GSNO soaked) in complex with Zn(II) and UN9","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","2Y33"
"2Y34",,"X-RAY DIFFRACTION",2.53,51.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M AMMONIUM SULFATE, 4% DIOXANE, 0.1M MES PH6.5, VAPOR DIFFUSION, HANGING DROP, PRE-GROWN CRYSTALS WERE EXPOSED TO NITRIC OXIDE SATURATED SOLUTION (1 ML, DENSITY 1.34 G/L) FOR AN HOUR.",,"10.1016/j.jmb.2011.04.075","UN9","2Y34",28.74,"2.01","2.01","S-nitrosylated PHD2 (NO exposed) in complex with Fe(II) and UN9","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","2Y34"
"2Y3I",,"X-RAY DIFFRACTION",2.29,46.33,,6.5,"26% PEG 2000MME, 0.1 M BIS/TRIS PH 6.5 .",,"10.1016/j.jmb.2011.04.048","3PG","2Y3I",90.71,"2.9","2.9","The structure of the fully closed conformation of human PGK in complex with L-ADP, 3PG and the TSA aluminium tetrafluoride","MSMSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSN","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2Y3I"
"2Y3J",,"X-RAY DIFFRACTION",1.41,13.04,,7,"AB3035 WAS DISSOLVED IN WATER AT 1MG/ML AND MIXED WITH 2 M SODIUM CHLORIDE, pH 7",,"10.1073/pnas.1112600108",,"2Y3J",4.93,"1.99","1.99","Structure of segment AIIGLM from the amyloid-beta peptide (Ab, residues 30-35)","AIIGLM","Homo sapiens","APP, A4, AD1","AMYLOID BETA A4 PROTEIN","1","2Y3J"
"2Y3K",,"X-RAY DIFFRACTION",1.53,19.82,,5.6,"AB3542 CRYSTALS (FIRST DISSOLVED IN WATER) WERE FOUND IN 1.5-YEAR-OLD TRAYS SET AT 0.5 MG/ML IN 1.26 M NA PHOSPHATE MONOBASIC MONOHYDRATE, 0.14 M K PHOSPHATE DIBASIC, PH 5.6 (CRYSTAL FORM I)",,"10.1073/pnas.1112600108",,"2Y3K",5.96,"1.9","1.9","Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymorph 1","MVGGVVIA","Homo sapiens","APP, A4, AD1","AMYLOID BETA A4 PROTEIN","1","2Y3K"
"2Y3L",,"X-RAY DIFFRACTION",1.38,10.91,,7.5,"AB3542 CRYSTALS (FIRST DISSOLVED IN WATER) WERE FOUND IN 1.5-YEAR-OLD TRAYS SET AT 0.5 MG/ML IN 0.1 M HEPES PH 7.5, 0.5 M MG FORMATE (CRYSTAL FORM II)",,"10.1073/pnas.1112600108",,"2Y3L",2.98,"2.1","2.1","Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymorph 2","MVGGVVIA","Homo sapiens","APP, A4, AD1","AMYLOID BETA A4 PROTEIN","1","2Y3L"
"2Y43",,"X-RAY DIFFRACTION",2,38,,5.5,"15% PEG 3350, 100 MM AMMONIUM ACETATE, 100 MM BIS-TRIS PH 5.5 .",,"10.1016/j.jmb.2011.04.051",,"2Y43",23.01,"1.8","1.8","Rad18 ubiquitin ligase RING domain structure","MDSLAESRWPPGLAVMKTIDDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSYKTQCPTCCVTVTEPDLKNNRILDELVKSLNFARNHLLQFALES","Homo sapiens","RAD18, RNF73","E3 UBIQUITIN-PROTEIN LIGASE RAD18","1","2Y43"
"2Y4P",,"X-RAY DIFFRACTION",2.78,55.75,,8,"0.1 M TRIS PH 8.0, 0.1 M MGCL2, 15% (W/V) PEG 4000, 0.5 MM AMPPCP, 0.5 MM PMSF.",,,,"2Y4P",130.9,"2.65","2.65","Dimeric structure of DAPK-1 catalytic domain","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2Y4P"
"2Y4Q",,"SOLUTION NMR",,,,,,,"10.1002/pro.2513",,"2Y4Q",9.1,,,"Solution structure of the EF-hand domain of Human Polycystin 2","GGSLKKNTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLD","Homo sapiens","PKD2, TRPP2","POLYCYSTIN-2","1","2Y4Q"
"2Y4T",,"X-RAY DIFFRACTION",3.9,69,,,"0.1 M HEPES, PH 8.2, 1.4 M SUCCINIC ACID, 1% (W/V) PEG MME 2000",,"10.1371/journal.pone.0022337",,"2Y4T",155.84,"3","3","Crystal structure of the human co-chaperone P58(IPK)","MHHHHHHSSGVDLGTENLYFQSMADVEKHLELGKKLLAAGQLADALSQFHAAVDGDPDNYIAYYRRATVFLAMGKSKAALPDLTKVIQLKMDFTAARLQRGHLLLKQGKLDEAEDDFKKVLKSNPSENEEKEAQSQLIKSDEMQRLRSQALNAFGSGDYTAAIAFLDKILEVCVWDAELRELRAECFIKEGEPRKAISDLKAASKLKNDNTEAFYKISTLYYQLGDHELSLSEVRECLKLDQDHKRCFAHYKQVKKLNKLIESAEELIRDGRYTDATSKYESVMKTEPSIAEYTVRSKERICHCFSKDEKPVEAIRVCSEVLQMEPDNVNALKDRAEAYLIEEMYDEAIQDYETAQEHNENDQQIREGLEKAQRLLKQSQKRDYYKILGVKRNAKKQEIIKAYRKLALQWHPDNFQNEEEKKKAEKKFIDIAAAKEVLSDPEMRKKFDDG","Homo sapiens","DNAJC3, P58IPK, PRKRI","DNAJ HOMOLOG SUBFAMILY C MEMBER 3","1","2Y4T"
"2Y4U",,"X-RAY DIFFRACTION",3.98,69,,,"0.1 M TRIS, PH 8.5, 1.3 M SUCCINIC ACID, 1% (W/V) PEG MME 2000.",,"10.1371/journal.pone.0022337",,"2Y4U",52.37,"3.2","3.2","Crystal structure of human P58(IPK) in space group P312","MHHHHHHSSGVDLGTENLYFQSMADVEKHLELGKKLLAAGQLADALSQFHAAVDGDPDNYIAYYRRATVFLAMGKSKAALPDLTKVIQLKMDFTAARLQRGHLLLKQGKLDEAEDDFKKVLKSNPSENEEKEAQSQLIKSDEMQRLRSQALNAFGSGDYTAAIAFLDKILEVCVWDAELRELRAECFIKEGEPRKAISDLKAASKLKNDNTEAFYKISTLYYQLGDHELSLSEVRECLKLDQDHKRCFAHYKQVKKLNKLIESAEELIRDGRYTDATSKYESVMKTEPSIAEYTVRSKERICHCFSKDEKPVEAIRVCSEVLQMEPDNVNALKDRAEAYLIEEMYDEAIQDYETAQEHNENDQQIREGLEKAQRLLKQSQKRDYYKILGVKRNAKKQEIIKAYRKLALQWHPDNFQNEEEKKKAEKKFIDIAAAKEVLSDPEMRKKFDDG","Homo sapiens","DNAJC3, P58IPK, PRKRI","DNAJ HOMOLOG SUBFAMILY C MEMBER 3","1","2Y4U"
"2Y4W",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.04.051",,"2Y4W",17.33,,,"Solution structure of human ubiquitin conjugating enzyme Rad6b","MSTPARRRLMRDFKRLQEDPPVGVSGAPSENNIMQWNAVIFGPEGTPFEDGTFKLVIEFSEEYPNKPPTVRFLSKMFHPNVYADGSICLDILQNRWSPTYDVSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWNDS","Homo sapiens","UBE2B, RAD6B","UBIQUITIN-CONJUGATING ENZYME E2 B","1","2Y4W"
"2Y5C",,"X-RAY DIFFRACTION",2.79,55.91,,,"1.6 M SODIUM CITRATE",,,,"2Y5C",24.44,"1.7","1.7","Structure of human ferredoxin 2 (Fdx2)in complex with 2Fe2S cluster","MASDVVNVVFVDRSGQRIPVSGRVGDNVLHLAQRHGVDLEGACEASLACSTCHVYVSEDHLDLLPPPEEREDDMLDMAPLLQENSRLGCQIVLTPELEGAEFTLPKITR","Homo sapiens","FDX2, FDX1L","ADRENODOXIN-LIKE PROTEIN, MITOCHONDRIAL","1","2Y5C"
"2Y5F",,"X-RAY DIFFRACTION",2.12,42,,,,,"10.1002/chem.201102571","XWG","2Y5F",32.89,"1.29","1.29","FACTOR XA - CATION INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y5F"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y5F"
"2Y5G",,"X-RAY DIFFRACTION",2.11,42,,,,,"10.1002/chem.201102571","FJD","2Y5G",32.83,"1.29","1.29","FACTOR XA - CATION INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y5G"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y5G"
"2Y5H",,"X-RAY DIFFRACTION",2.12,42,,,,,"10.1002/chem.201102571","Y5H","2Y5H",32.83,"1.33","1.33","FACTOR XA - CATION INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y5H"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y5H"
"2Y5K",,"X-RAY DIFFRACTION",2.61,52.81,,,"RESERVOIR: 0.1M HEPES, PH 7.0, 0.1 M AMMONIUM ACETATE, 12% PEG 3350.",,"10.1016/j.bmcl.2011.04.044","YCU","2Y5K",149.27,"2.1","2.1","Orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatase","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2Y5K"
"2Y5L",,"X-RAY DIFFRACTION",2.68,54.11,,,,,"10.1016/j.bmcl.2011.04.044","RO8","2Y5L",298.05,"2.2","2.2","orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatase","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2Y5L"
"2Y6C",,"X-RAY DIFFRACTION",2.48,50.34,,,,,"10.1002/cmdc.201000550","TQI","2Y6C",18.92,"1.7","1.7","The Discovery of MMP7 inhibitors Exploiting a Novel Selectivity Trigger","GYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLY","Homo sapiens","MMP7, MPSL1, PUMP1","MATRILYSIN","1","2Y6C"
"2Y6D",,"X-RAY DIFFRACTION",2.32,47.1,,,,,"10.1002/cmdc.201000550","TQJ","2Y6D",20.13,"1.6","1.6","The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger","GYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","MATRILYSIN","1","2Y6D"
"2Y6E",,"X-RAY DIFFRACTION",2.94,58,,8.5,"PROTEIN WAS CRYSTALLIZED FROM 100MM BIS-TRIS PROPANE (PH8.5), 25MM NA2SO4, 18% PEG3350, THEN SOAKED IN 25% ETHYLENEGLYCOL",,"10.1038/ncomms6399",,"2Y6E",254.46,"2.4","2.4","Structure of the D1D2 domain of USP4, the conserved catalytic domain","GMHIQPGLCGLGNLGNTCFMNSALQCLSNTAPLTDYFLKDEYEAEINRDNPLGMKGEIAEAYAELIKQMWSGRDAHVAPRMFKTQVGRFAPQFSGYQQQDSQELLAFLLDGLHEDLNRVKKKPYLELKDANGRPDAVVAKEAWENHRLRNDSVIVDTFHGLFKSTLVCPECAKVSVTFDPFCYLTLPLPLKKDRVMEGPMLQPQKKKKTTVALRDCIELFTTMETLGEHDPWYCPNCKKHQQATKKFDLWSLPKILVVHLKRFSYNRYWRDKLDTVVEFPIRGLNMSEFVCNLSARPYVYDLIAVSNHYGAMGVGHYTAYAKNKLNGKWYYFDDSNVSLASEDQIVTKAAYVLFYQRRDDEFYKTPS","Homo sapiens","USP4, UNP, UNPH","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 4","1","2Y6E"
"2Y6W",,"X-RAY DIFFRACTION",2.1,41.46,,6.5,"5% (W/V) PEG 3000, 40% (W/V) PEG 400, 0.1M MES PH 6.5.",,"10.1016/j.str.2011.07.015",,"2Y6W",39.69,"2","2","Structure of a Bcl-w dimer","MGSHHHHHHGARQMATPASAPDTRALVADFVGYKLRQKGYVSGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVGQVQEWMVEYLETRLADWIHSSGGWAEFTALYGDGALEEARRLRE","Homo sapiens","BCL2L2, BCLW, KIAA0271","BCL-2-LIKE PROTEIN 2","1","2Y6W"
"2Y73",,"X-RAY DIFFRACTION",2.2,45,,7.4,"0.7 M POTASSIUM/SODIUM TARTRATE, 100 MM IMIDAZOLE PH7.4, 200 MM NACL, 2M SODIUM FORMATE",,"10.1021/bi200117z",,"2Y73",173.31,"2.6","2.6","THE NATIVE STRUCTURES OF SOLUBLE HUMAN PRIMARY AMINE OXIDASE AOC3","MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","MEMBRANE PRIMARY AMINE OXIDASE","1","2Y73"
"2Y74",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.7M POTASSIUM/SODIUM TARTRATE, 100MM IMIDAZOLE (PH 7.4), 200MM NACL",,"10.1021/bi200117z",,"2Y74",173.2,"2.95","2.95","THE CRYSTAL STRUCTURE OF HUMAN SOLUBLE PRIMARY AMINE OXIDASE AOC3 IN THE OFF-COPPER CONFORMATION","MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","MEMBRANE PRIMARY AMINE OXIDASE","1","2Y74"
"2Y7A",,"X-RAY DIFFRACTION",2.72,54.8,,7,"5 MM MOPS PH 7, 1 MM MNCL2, 1 MM DTT, 0.1 M AMSO4, 10% (W/V) PEG 3350.",,,,"2Y7A",139.16,"2.06","2.06","Crystal structure of unliganded GTB P156L","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQLAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPMNHQAVRNP","Homo sapiens","ABO","ABO GLYCOSYLTRANSFERASE","1","2Y7A"
"2Y7B",,"X-RAY DIFFRACTION",2.03,39.33,,,"20% PEG3350, 100 MM BIS-TRIS PH 5.5, 40% ACETONITRILE",,,,"2Y7B",16.22,"1.9","1.9","Crystal structure of the PH domain of human Actin-binding protein anillin ANLN","VNSSVEERGFLTIFEDVSGFGAWHRRWCVLSGNCISYWTYPDDEKRKNPIGRINLANCTSRQIEPANREFCARRNTFELITVRPQREDDRETLVSQCRDTLCVTKNWLSADTKEERDLWMQKLNQVLVDIRLWQ","Homo sapiens","ANLN","ACTIN-BINDING PROTEIN ANILLIN","1","2Y7B"
"2Y7J",,"X-RAY DIFFRACTION",1.95,36.99,,,"25% PEG 3350; 0.1 M BIS-TRIS 5.5",,,"B49","2Y7J",171.27,"2.5","2.5","Structure of human phosphorylase kinase, gamma 2","MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER","Homo sapiens","PHKG2","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM","1","2Y7J"
"2Y7X",,"X-RAY DIFFRACTION",2.23,44.39,,5.75,"16-20% PEG 6K, 50 MM MES PH 5.5-6, 5 MM CACL2, 50 MM NACL WITH SEEDING.",,"10.1016/j.bmcl.2011.01.129","MZA","2Y7X",44.3,"1.9","1.9","The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y7X"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y7X"
"2Y7Z",,"X-RAY DIFFRACTION",1.84,33.06,"VAPOR DIFFUSION",5.75,"CRYSTALLISATION WAS CARRIED OUT USING VAPOUR DIFFUSION IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG6K, 50MM MES-NAOH (PH 5.5-6), 5MM CACL2 AND 50MM NACL.",,"10.1016/j.bmcl.2011.01.131","C0Z","2Y7Z",44.31,"1.84","1.84","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y7Z"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y7Z"
"2Y80",,"X-RAY DIFFRACTION",2.29,45.86,"VAPOR DIFFUSION",5.75,"CRYSTALLISATION WAS CARRIED OUT USING VAPOUR DIFFUSION IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG 6K, 50 MM MES-NAOH (PH 5.5-6), 5 MM CACL2 AND 50 MM NACL.",,"10.1016/j.bmcl.2011.01.131","439","2Y80",44.31,"1.9","1.9","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y80"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y80"
"2Y81",,"X-RAY DIFFRACTION",1.81,49.3,"VAPOR DIFFUSION",5.75,"CRYSTALLISATION WAS CARRIED OUT USING VAPOUR DIFFUSION IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG 6K, 50 MM MES-NAOH (PH 5.5-6), 5 MM CACL2 AND 50 MM NACL.",,"10.1016/j.bmcl.2011.01.131","931","2Y81",44.31,"1.7","1.7","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y81"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y81"
"2Y82",,"X-RAY DIFFRACTION",1.84,49.9,"VAPOR DIFFUSION",5.75,"CRYSTALLISATION WAS CARRIED OUT USING VAPOUR DIFFUSION IN 2UL DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN AND WELL SOLUTION. WELL SOLUTION CONTAINED 16-20% PEG 6K, 50 MM MES-NAOH (PH 5.5-6), 5 MM CACL2 AND 50 MM NACL.",,"10.1016/j.bmcl.2011.01.131","930","2Y82",44.31,"2.2","2.2","Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2Y82"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2Y82"
"2Y8F",,"X-RAY DIFFRACTION",2.53,51.34,,7.5,"30% PEG 3350, 50 MM TRIS PH 8.5",,"10.1371/journal.pone.0017011",,"2Y8F",62.78,"2.1","2.1","Structure of the Ran-binding domain from human RanBP3 (wild type)","GAMKVEVITGEEAESNVLQMQCKLFVFDKTSQSWVERGRGLLRLNDMASTDDGTLQSRLVMRTQGSLRLILNTKLWAQMQIDKASEKSIRITAMDTEDQGVKVFLISASSKDTGQLYAALHHRILALRSRVEQEQEAK","Homo sapiens","RANBP3","RAN-BINDING PROTEIN 3","1","2Y8F"
"2Y8G",,"X-RAY DIFFRACTION",2.8,56.13,,7.5,"1.5 M LI2SO4, 100 MM HEPES PH 7.5",,"10.1371/journal.pone.0017011",,"2Y8G",31.15,"1.61","1.61","Structure of the Ran-binding domain from human RanBP3 (E352A-R353V double mutant)","GAMKVEVITGEEAESNVLQMQCKLFVFDKTSQSWVAVGRGLLRLNDMASTDDGTLQSRLVMRTQGSLRLILNTKLWAQMQIDKASEKSIRITAMDTEDQGVKVFLISASSKDTGQLYAALHHRILALRSRVEQEQEAK","Homo sapiens","RANBP3","RAN-BINDING PROTEIN 3","1","2Y8G"
"2Y92",,"X-RAY DIFFRACTION",4.81,77,,,,,"10.1073/pnas.1104780108",,"2Y92",16.07,"3.01","3.01","Crystal structure of MAL adaptor protein","GPSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","TOLL/INTERLEUKIN-1 RECEPTOR DOMAIN-CONTAINING ADAPTER PROTEIN,","1","2Y92"
"2Y95",,"SOLUTION NMR",,,,,,,"10.1261/rna.2747411",,"2Y95",4.49,,,"Solution structure of AUCG tetraloop hairpin found in human Xist RNA A-repeats essential for X-inactivation","GGCGCAUCGGCGCC","Homo sapiens",,"5'-R(*GP*GP*CP*GP*CP*AP*UP*CP*GP*GP*CP*GP*CP*C)-3'","1","2Y95"
"2Y96",,"X-RAY DIFFRACTION",2.86,57,,6,"10 MG/ML PROTEIN, 0.2M AMMONIUM SULFATE, 25% W/V PEG3350, ROOM TEMPERATURE, pH 6",,"10.1107/S090744491100970X",,"2Y96",51.15,"2.38","2.38","Structure of human dual-specificity phosphatase 27","TSGEVKTSLKNAYSSAKRLSPKMEEEGEEEDYCTPGAFELERLFWKGSPQYTHVNEVWPKLYIGDEATALDRYRLQKAGFTHVLNAAHGRWNVDTGPDYYRDMDIQYHGVEADDLPTFDLSVFFYPAAAFIDRALSDDHSKILVHCVMGRSRSATLVLAYLMIHKDMTLVDAIQQVAKNRCVLPNRGFLKQLRELDKQLVQQRRRSQRQDGEEEDGREL","Homo sapiens","DUSP29, DUPD1, DUSP27","DUAL SPECIFICITY PHOSPHATASE DUPD1","1","2Y96"
"2Y9R",,"X-RAY DIFFRACTION",2.43,49.32,,6.5,"35% PEG 400, 0.1M BIS-TRIS PH 6.5",,,,"2Y9R",12.07,"1.9","1.9","Crystal structure of the M10 domain of Titin","GSSRGIPPKIEALPSDISIDEGKVLTVACAFTGEPTPEVTWSCGGRKIHSQEQGRFHIENTDDLTTLIIMDVQKQDGGLYTLSLGNEFGSDSATVNIHIRSI","Homo sapiens","TTN","TITIN","1","2Y9R"
"2Y9T",,"SOLUTION NMR",,,,,,,"10.1111/j.1742-4658.2011.08194.x",,"2Y9T",9.33,,,"Structural basis of p63a SAM domain mutants involved in AEC syndrome","GSYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSHLLRTPSS","Homo sapiens","TP63, KET, P63, P73H, P73L, TP73L","TUMOR PROTEIN 63","1","2Y9T"
"2Y9U",,"X-RAY DIFFRACTION",1.87,34.13,,6.4,"100 MM SODIUM CITRATE, PH 6.4, 500MM LITHIUM SULPHATE, 500MM AMMONIUM SULPHATE, 5MM DTT",,"10.1111/j.1742-4658.2011.08194.x",,"2Y9U",8,"1.6","1.6","Structural basis of p63a SAM domain mutants involved in AEC syndrome","GSTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFS","Homo sapiens","TP63, KET, P63, P73H, P73L, TP73L","TUMOR PROTEIN 63","1","2Y9U"
"2YAC",,"X-RAY DIFFRACTION",2.77,55.53,,6,"pH 6.0",,"10.1016/j.bmcl.2011.03.054","937","2YAC",36.39,"2.2","2.2","Crystal structure of Polo-like kinase 1 in complex with NMS-P937","GPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","SERINE/THREONINE-PROTEIN KINASE PLK1","1","2YAC"
"2YAD",,"X-RAY DIFFRACTION",2.84,56.32,,,,,"10.1073/pnas.1114740109",,"2YAD",112.25,"2.2","2.2","BRICHOS domain of Surfactant protein C precursor protein","GSGMKETAAAKFERQHMDSPDLGTDDDDKAMAHMSQKHTEMVLEMSIGAPEAQQRLALSEHLVTTATFSIGSTGLVVYDYQQLLIAYKPAPGTCCYIMKIAPESIPSLEALTRKVHNFQMECSLQAKPAVPTSKLGQAEGRDAGSAPSGGDPAFLGMAVSTLCGEVPLYYI","Homo sapiens","SFTPC, SFTP2","SURFACTANT PROTEIN C BRICHOS DOMAIN","1","2YAD"
"2YAK",,"X-RAY DIFFRACTION",3.33,63.11,,,"100 MM TRIS PH 7.2, 7.5-10% PEG 6000.",,"10.1021/ja1112996","OSV","2YAK",33.43,"2.2","2.2","Structure of death-associated protein Kinase 1 (dapk1) in complex with a ruthenium octasporine ligand (OSV)","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","2YAK"
"2YAN",,"X-RAY DIFFRACTION",4.99,72.31,,,"0.1 M ACETATE PH 4.5, 2 M(NH4)2 SO4.",,,,"2YAN",25.05,"1.9","1.9","Crystal structure of the second glutaredoxin domain of human TXNL2","SMAPKLEERLKVLTNKASVMLFMKGNKQEAKCGFSKQILEILNSTGVEYETFDILEDEEVRQGLKAYSNWPTYPQLYVKGELVGGLDIVKELKENGELLPILRGE","Homo sapiens","GLRX3, PICOT, TXNL2, HUSSY-22","GLUTAREDOXIN-3","1","2YAN"
"2YAT",,"X-RAY DIFFRACTION",2.83,56.49,,7,"20% POLYETHYLENE GLYCOL MONOMETHYL ETHER 5000, 5% TACSIMATE25, 0.1 M HEPES, PH 7.0.",,"10.1021/jm200192y",,"2YAT",29.68,"2.602","2.602","Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex","MSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","ESTROGEN RECEPTOR","1","2YAT"
"2YB6",,"X-RAY DIFFRACTION",2.08,41.9,,5.5,"pH 5.5",,"10.1073/pnas.1017516108",,"2YB6",17.44,"1.5","1.5","Native human Rad6","MSTPARRRLMRDFKRLQEDPPVGVSGAPSENNIMQWNAVIFGPEGTPFEDGTFKLVIEFSEEYPNKPPTVRFLSKMFHPNVYADGSICLDILQNRWSPTYDVSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWNDS","Homo sapiens","UBE2B, RAD6B","UBIQUITIN-CONJUGATING ENZYME E2 B","1","2YB6"
"2YB9",,"X-RAY DIFFRACTION",2.38,48.34,,,,,"10.1016/j.bmcl.2011.03.109","HA0","2YB9",80.03,"2.4","2.4","Crystal Structure of Human Neutral Endopeptidase complexed with a heteroarylalanine diacid.","GICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","NEPRILYSIN","1","2YB9"
"2YBE",,"X-RAY DIFFRACTION",2.29,46.33,,6.5,"29% PEG 2000MME, 0.1 M BIS/TRIS PH 6.25 .",,"10.1016/j.jmb.2011.04.048","3PG","2YBE",45.45,"2","2","The structure of the fully closed conformation of human PGK in complex with L-ADP, 3PG and the TSA aluminium tetrafluoride at 2.0 A resolution","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","2YBE"
"2YBG",,"X-RAY DIFFRACTION",2.2,45,,,"PROTEIN SOLUTION: 5 MG/ML PROTEIN IN 20 MM CITRATE BUFFER PH 6.1, 150 MM NACL, 10 MM DTT. CRYSTALLIZATION BUFFER: 26% (W/V) PEG 3350, 43 MM SODIUM ACETATE AND 100 MM HEPES, PH 7.5",,"10.1073/pnas.1105028108",,"2YBG",90.45,"1.9","1.9","Structure of Lys120-acetylated p53 core domain","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2YBG"
"2YBK",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M CITRATE PH 5.5, 4MM NICL2, 20% PEG 3350, VAPOUR DIFFUSION, SITTING DROP, TEMPERATURE 277K.",277,"10.1038/embor.2011.43","2HG","2YBK",89.23,"2.4","2.4","JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","LYSINE-SPECIFIC DEMETHYLASE 4A","1","2YBK"
"2YBT",,"X-RAY DIFFRACTION",3.2,62,,7.4,"75% SATURATED NACL, 0.1 M HEPES PH 7.4",,"10.1016/j.chembiol.2011.02.017","DW0","2YBT",261.12,"2.22","2.22","Crystal structure of human acidic chitinase in complex with bisdionin C","EAEAYQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNIKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPA","Homo sapiens","CHIA","ACIDIC MAMMALIAN CHITINASE","1","2YBT"
"2YBU",,"X-RAY DIFFRACTION",3.2,62,,7.4,"75% SATURATED NACL, 0.1 M HEPES PH 7.4",,"10.1016/j.chembiol.2011.02.017","CX9","2YBU",260.95,"2.25","2.25","Crystal structure of human acidic chitinase in complex with bisdionin F","EAEAYQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNIKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPA","Homo sapiens","CHIA","ACIDIC MAMMALIAN CHITINASE","1","2YBU"
"2YBX",,"X-RAY DIFFRACTION",2.51,56.5,,7.5,"0.2 M MAGNESIUM FORMATE, 16% PEG3350, 2 MM BENZYL(1,3,5)TRIPHOSPHATE, pH 7.5",,,,"2YBX",90.72,"2.56","2.56","Crystal Structure of Human Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDGEEEGESDGTHPVGTPPDSPGNTLNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PI5P4KA, PIP5K2, PIP5K2A","PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASE TYPE-2 ALPHA","1","2YBX"
"2YC0",,"X-RAY DIFFRACTION",3.1,63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES PH7.5, 1.6M AMMONIUM SULFATE, 6% PEG400, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1038/embor.2011.43","2HG","2YC0",41.48,"2.15","2.15","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH R-2-HYDROXYGLUTARATE","GSHMAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","2YC0"
"2YCF",,"X-RAY DIFFRACTION",3.02,59.3,,7.8,"0.1M HEPES PH 7.8, 0.1 M MAGNESIUM NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1016/j.jsb.2011.09.008","YCF","2YCF",36.96,"1.77","1.77","Crystal Structure of Checkpoint Kinase 2 in complex with Inhibitor PV1531","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YCF"
"2YCQ",,"X-RAY DIFFRACTION",3.05,59.7,,7.8,"0.1M HEPES PH 7.8, 0.1M MAGNESIUM NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1016/j.jsb.2011.09.008","UPX","2YCQ",37.03,"2.05","2.05","Crystal structure of checkpoint kinase 2 in complex with inhibitor PV1115","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YCQ"
"2YCR",,"X-RAY DIFFRACTION",3.04,59.5,,7.8,"0.1M HEPES PH 7.8, 0.1M MAGNESIUM NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1016/j.jsb.2011.09.008","HCW","2YCR",37.1,"2.2","2.2","Crystal structure of checkpoint kinase 2 in complex with inhibitor PV976","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTAKPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YCR"
"2YCS",,"X-RAY DIFFRACTION",3.05,59.7,,7.8,"0.1M HEPES PH 7.8, 0.1M MAGNESIUM SULFATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL",,"10.1016/j.jsb.2011.09.008","NXP","2YCS",36.96,"2.35","2.35","Crystal structure of checkpoint kinase 2 in complex with PV788","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YCS"
"2YD0",,"X-RAY DIFFRACTION",3.08,60.08,,,"1.4M KCITRATE, 100 MM CACODYLATE (PH 5.7), 170 MM N-DODECYL-BETA-MALTOSIDE",,"10.1073/pnas.1101262108",,"2YD0",104.18,"2.7","2.7","Crystal structure of the soluble domain of human endoplasmic reticulum aminopeptidase 1 ERAP1","PFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGNLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALNSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASICPTDGVKGMDGFCSRSQHSSSSSHWHQEGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLERKK","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1","1","2YD0"
"2YD2",,"X-RAY DIFFRACTION",2.38,50,,6.2,"0.2M AMMONIUM IODIDE, 20% W/V PEG 3350, PH 6.2 .",,"10.1126/science.1200840",,"2YD2",24.32,"2.552","2.552","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Sigma","ETGEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRVRRVAGTKHHHHHH","Homo sapiens","PTPRS","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE S","1","2YD2"
"2YD3",,"X-RAY DIFFRACTION",2.89,56,,6.6,"0.2M SODIUM SULPHATE, 20% W/V PEG 3350, PH 6.6 .",,"10.1126/science.1200840",,"2YD3",22.33,"2.3","2.3","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Sigma","ETGEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRVR","Homo sapiens","PTPRS","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE S","1","2YD3"
"2YD5",,"X-RAY DIFFRACTION",2.51,52,,5.6,"0.1 M SODIUM ACETATE TRIHYDRATE, 20% ISOPROPANOL, 20% (W/V) PEG 4000, 0.25 MM HEPARIN DP10, PH 5.6 .",,"10.1126/science.1200840",,"2YD5",23.38,"2.2","2.2","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase LAR","ETGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEVIEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFKDFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAGTKHHHHHH","Homo sapiens","PTPRF, LAR","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F","1","2YD5"
"2YD6",,"X-RAY DIFFRACTION",2.13,44,,5.6,"0.085M TRI-SODIUM CITRATE DIHYDRATE, 25% PEG 4000, 15% GLYCEROL, PH 5.6 .",,"10.1126/science.1200840",,"2YD6",23.7,"1.35","1.35","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Delta","ETGETPPRFTRTPVDQTGVSGGVASFICQATGDPRPKIVWNKKGKKVSNQRFEVIEFDDGSGSVLRIQPLRTPRDEAIYECVASNNVGEISVSTRLTVLREDQIPRGFPTIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDTSNNNGRIKQLRSESIGALQIEQSEESDQGKYECVATNSAGTRYSAPANLYVRGTKHHHHHH","Homo sapiens","PTPRD","PTPRD PROTEIN","1","2YD6"
"2YD7",,"X-RAY DIFFRACTION",2.33,48,,,"20% W/V PEG 3350, 0.2M AMMONIUM DI-HYDROGEN PHOSPHATE .",,"10.1126/science.1200840",,"2YD7",47.25,"1.98","1.98","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase Delta","ETGETPPRFTRTPVDQTGVSGGVASFICQATGDPRPKIVWNKKGKKVSNQRFEVIEFDDGSGSVLRIQPLRTPRDEAIYECVASNNVGEISVSTRLTVLREDQIPRGFPTIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDTSNNNGRIKQLRSESIGALQIEQSEESDQGKYECVATNSAGTRYSAPANLYVRGTKHHHHHH","Homo sapiens","PTPRD","PTPRD PROTEIN","1","2YD7"
"2YD8",,"X-RAY DIFFRACTION",2.75,56,,6,"0.1 M MES, 30% PEG 6000, PH 6.0 .",,"10.1126/science.1200840",,"2YD8",23.88,"2.05","2.05","Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase LAR in complex with sucrose octasulphate","ETGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEVIEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFKDFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAGTKHHHHHH","Homo sapiens","PTPRF, LAR","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F","1","2YD8"
"2YD9",,"X-RAY DIFFRACTION",3.48,64,,7.5,"20% PEG 3350, 0.2 M SODIUM IODIDE, 0.1 M BIS-TRIS PROPANE, PH 7.5 .",,"10.1126/science.1200840",,"2YD9",34.64,"2.6","2.6","Crystal structure of the N-terminal Ig1-3 module of Human Receptor Protein Tyrosine Phosphatase Sigma","ETGEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRVQNVAPRFSILPMSHEIMPGGNVNITCVAVGSPMPYVKWMQGAEDLTPEDDMPVGRNVLELTDVKDSANYTCVAMSSLGVIEAVAQITVKSLPKAGTKHHHHHH","Homo sapiens","PTPRS","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE S","1","2YD9"
"2YDE",,"X-RAY DIFFRACTION",3.1,63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES PH7.5, 1.6M AMMONIUM SULPHATE, 6% PEG400, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1038/embor.2011.43","S2G","2YDE",41.53,"2.28","2.28","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH S-2-HYDROXYGLUTARATE","GSHMAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","2YDE"
"2YDF",,"X-RAY DIFFRACTION",2.6,53,,7,"SEE PAPER, pH 7",,"10.1186/1472-6807-11-18","IO3","2YDF",137.72,"2.75","2.75","HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","2YDF"
"2YDI",,"X-RAY DIFFRACTION",2.32,47,,,,,"10.1021/jm300025r","YDI","2YDI",33.49,"1.6","1.6","Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YDI"
"2YDJ",,"X-RAY DIFFRACTION",2.32,47,,,,,"10.1021/jm300025r","YDJ","2YDJ",64.72,"1.85","1.85","Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YDJ"
"2YDK",,"X-RAY DIFFRACTION",2.47,50.2,,,,,"10.1021/jm300025r","YDK","2YDK",32.74,"1.9","1.9","Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YDK"
"2YDL",,"X-RAY DIFFRACTION",3,59,,,"0.1M CITRATE PH 5.5, 2.0 M AMMONIUM SULPHATE",,"10.1371/journal.pone.0073018",,"2YDL",8.03,"2.05","2.05","Crystal structure of SH3C from CIN85","ASDYCKVIFPYEAQNDDELTIKEGDIVTLINKDCIDVGWWEGELNGRRGVFPDNFVKLLPPLEHHHHHH","Homo sapiens","SH3KBP1, CIN85","SH3 DOMAIN-CONTAINING KINASE-BINDING PROTEIN 1","1","2YDL"
"2YDM",,"X-RAY DIFFRACTION",2.3,47,,4.7,"100MM SODIUM ACETATE, 10UM ZINC SULPHATE, 15% PEG4000, pH 4.7",,"10.1111/j.1742-4658.2011.08276.x","SLC","2YDM",69.31,"2.44","2.44","Structural characterization of angiotensin-I converting enzyme in complex with a selenium analogue of captopril","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWQQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN CONVERTING ENZYME","1","2YDM"
"2YDO",,"X-RAY DIFFRACTION",3.95,68.9,,7.6,"0.05 M TRISHCL, PH 7.6, 9.6% PEG 200, 22.9%. PEG 300",,"10.1038/nature10136","ADN","2YDO",36.91,"3","3","Thermostabilised HUMAN A2a Receptor with adenosine bound","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILVGVLAIPFAIAISTGFCAACHGCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAENLYFQ","Homo sapiens","ADORA2A, ADORA2","ADENOSINE RECEPTOR A2A","1","2YDO"
"2YDV",,"X-RAY DIFFRACTION",4.01,69.3,,6.4,"0.05 M ADA NAOH, PH 6.4, 23.6% V/V PEG 400, 4% V/V 2-PROPANOL.",,"10.1038/nature10136","NEC","2YDV",37.87,"2.6","2.6","Thermostabilised HUMAN A2a Receptor with NECA bound","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILVGVLAIPFAIAISTGFCAACHGCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAENLYFQ","Homo sapiens","ADORA2A, ADORA2","ADENOSINE RECEPTOR A2A","1","2YDV"
"2YDW",,"X-RAY DIFFRACTION",2.07,42.2,,5.5,"17.5% PEG 3350, 0.2 M (NH4)2SO4, 0.1 M BIS TRIS PH 5.5.",,"10.1021/jm200108t","WSH","2YDW",54.71,"1.9","1.9","Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GW841819X","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","2YDW"
"2YDX",,"X-RAY DIFFRACTION",4.75,74.09,,,,,"10.1042/BJ20121580",,"2YDX",185.6,"2.8","2.8","Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit","MNRRVLVTGATGLLGRAVHKEFQQNNWHAVGCGFRRARPKFEQVNLLDSNAVHHIIHDFQPHVIVHCAAERRPDVVENQPDAASQLNVDASGNLAKEAAAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFHAENLYFQ","Homo sapiens","MAT2B, TGR, MSTP045, Nbla02999, UNQ2435/PRO4995","METHIONINE ADENOSYLTRANSFERASE 2 SUBUNIT BETA","1","2YDX"
"2YDY",,"X-RAY DIFFRACTION",2.5,50.81,,,,,"10.1042/BJ20121580",,"2YDY",36.15,"2.25","2.25","Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit in Orthorhombic crystal form","MNRRVLVTGATGLLGRAVHKEFQQNNWHAVGCGFRRARPKFEQVNLLDSNAVHHIIHDFQPHVIVHCAAERRPDVVENQPDAASQLNVDASGNLAKEAAAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFHAENLYFQ","Homo sapiens","MAT2B, TGR, MSTP045, Nbla02999, UNQ2435/PRO4995","METHIONINE ADENOSYLTRANSFERASE 2 SUBUNIT BETA","1","2YDY"
"2YE2",,"X-RAY DIFFRACTION",2.58,52.37,,6.5,"pH 6.5",,"10.1021/jm200350g","XQI","2YE2",28.8,"1.9","1.9","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE2"
"2YE3",,"X-RAY DIFFRACTION",2.55,51.71,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YE3",28.71,"1.95","1.95","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE3"
"2YE4",,"X-RAY DIFFRACTION",2.49,50.58,,6.5,"pH 6.5",,"10.1021/jm200350g","2FY","2YE4",28.69,"2.3","2.3","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE4"
"2YE5",,"X-RAY DIFFRACTION",2.53,51.38,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YE5",28.66,"1.73","1.73","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE5"
"2YE6",,"X-RAY DIFFRACTION",2.53,51.42,,6.5,"pH 6.5",,"10.1021/jm200350g","2AE","2YE6",28.66,"2.56","2.56","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE6"
"2YE7",,"X-RAY DIFFRACTION",2.57,52.17,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YE7",28.79,"2.2","2.2","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE7"
"2YE8",,"X-RAY DIFFRACTION",2.65,53.51,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YE8",28.76,"2.3","2.3","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE8"
"2YE9",,"X-RAY DIFFRACTION",2.61,52.89,,6.5,"pH 6.5",,"10.1021/jm200350g","2D4","2YE9",28.92,"2.2","2.2","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YE9"
"2YEA",,"X-RAY DIFFRACTION",2.56,51.93,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEA",28.68,"1.73","1.73","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEA"
"2YEB",,"X-RAY DIFFRACTION",2.61,52.82,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEB",28.69,"2.4","2.4","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEB"
"2YEC",,"X-RAY DIFFRACTION",2.55,51.77,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEC",28.86,"2.1","2.1","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEC"
"2YED",,"X-RAY DIFFRACTION",2.55,51.78,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YED",28.69,"2.1","2.1","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YED"
"2YEE",,"X-RAY DIFFRACTION",2.67,54.01,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEE",28.9,"2.3","2.3","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFQGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEE"
"2YEF",,"X-RAY DIFFRACTION",2.03,39.29,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEF",29.05,"1.55","1.55","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEF"
"2YEG",,"X-RAY DIFFRACTION",2.67,53.9,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEG",57.21,"2.5","2.5","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEG"
"2YEH",,"X-RAY DIFFRACTION",2.69,54.3,,6.5,"pH 6.5",,"10.1021/jm200350g",,"2YEH",28.83,"2.1","2.1","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEH"
"2YEI",,"X-RAY DIFFRACTION",2.8,56.04,,6.5,"pH 6.5",,"10.1021/jm200350g","XQI","2YEI",28.92,"2.2","2.2","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEI"
"2YEJ",,"X-RAY DIFFRACTION",2.62,53.13,,6.5,"pH 6.5",,"10.1021/jm200350g","ZZ3","2YEJ",28.92,"2.2","2.2","HSP90 inhibitors and drugs from fragment and virtual screening","MGHHHHHHHHHHSSGHIDDADKHMDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YEJ"
"2YEK",,"X-RAY DIFFRACTION",2,38.61,,7,"26% PEG 3350, 0.2 M (NH4)2SO4, 0.1 M HEPES PH 7.0.",,"10.1021/jm200108t","EAM","2YEK",54.71,"1.98","1.98","Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET)","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","2YEK"
"2YEL",,"X-RAY DIFFRACTION",2.14,42.6,,5.5,"17.5% PEG 3350, 0.2 M (NH4)2SO4, 0.1 M BIS TRIS PH 5.5.",,"10.1021/jm200108t","WSH","2YEL",15.58,"1.65","1.65","Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","HUMAN BRD4","1","2YEL"
"2YEM",,"X-RAY DIFFRACTION",2.7,54.8,,8.5,"2.5 M (NH4)2SO4, 0.1 M TRIS PH 8.5.",,"10.1021/jm200108t","WSH","2YEM",30.97,"2.3","2.3","Crystal Structure of the Second Bromodomain of Human Brd4 with the inhibitor GW841819X","SMKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","2YEM"
"2YER",,"X-RAY DIFFRACTION",2.4,48.74,,7.5,"pH 7.5",,"10.1016/j.bmcl.2012.01.043","TQ1","2YER",32.59,"1.83","1.83","Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YER"
"2YEX",,"X-RAY DIFFRACTION",2.46,50,,7.5,"pH 7.5",,"10.1016/j.bmcl.2012.01.043","YEX","2YEX",32.85,"1.3","1.3","Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YEX"
"2YF0",,"X-RAY DIFFRACTION",3.99,69.14,,,,,,,"2YF0",59.79,"2.65","2.65","Human Myotubularin related protein 6 (MTMR6)","MEHIRTTKVEQVKLLDRFSTSNKSLTGTLYLTATHLLFIDSHQKETWILHHHIASVEKLALTTSGCPLVIQCKNFRTVHFIVPRERDCHDIYNSLLQLSKQAKYEDLYAFSYNPKQNDSERLQGWQLIDLAEEYKRMGVPNSHWQLSDANRDYKICETYPRELYVPRIASKPIIVGSSKFRSKGRFPVLSYYHQDKEAAICRCSQPLSGFSARCLEDEHLLQAISKANPVNRYMYVMDTRPKLNAMANRAAGKGYENEDNYSNIRFQFVGIENIHVMRSSLQKLLEVNGTKGLSVNDFYSGLESSGWLRHIKAVMDAAVFLAKAITVENASVLVHCSDGWDRTSQVCSLGSLLLDSYYRTIKGFMVLIEKDWISFGHKFSERCGQLDGDPKEVSPVFTQFLECVWHLTEQFPQAFEFSEAFLLQIHEHIHSCQFGNFLGNCQKEREELKLKEKTYSLWPFLLEDQKKYLNPLYSSESHRFTVLEPNTVSFNFKFWRNMYHQFDRTAHHHHHH","Homo sapiens","MTMR6","MYOTUBULARIN-RELATED PROTEIN 6","1","2YF0"
"2YFE",,"X-RAY DIFFRACTION",2.6,52,,8,"0.8M TRI-SODIUM CITRATE, 0.1M IMIDAZOLE, PH 8.0",,"10.1073/pnas.1116971109","YFE","2YFE",66.07,"2","2","Ligand binding domain of human PPAR gamma in complex with amorfrutin 1","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","2YFE"
"2YFX",,"X-RAY DIFFRACTION",2.2,44.6,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 7 MG/ML)CONTAINING 0.8 MM CRIZOTINIB WERE COMBINED WITH A SOLUTION CONTAINING: 0.15 M AMMONIUM SULFATE, 10% MONOMETHYLETHER PEG5K AND 0.1M MES PH 5.6.",286,"10.1021/jm401805h","VGH","2YFX",37.38,"1.7","1.7","Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","TYROSINE-PROTEIN KINASE RECEPTOR","1","2YFX"
"2YG2",,"X-RAY DIFFRACTION",2.46,49.98,,,"0.15 M LITHIUM SULFATE MONOHYDRATE, 0.1 M CITRIC ACID PH 3.5, 18 % W/V PEG6000",,"10.1073/pnas.1103187108","FLC","2YG2",39.43,"1.7","1.7","Structure of apolioprotein M in complex with Sphingosine 1-Phosphate","GSHMNQCPEHSQLTTLGVDGKEFPEVHLGQWYFIAGAAPTKEELATFDPVDNIVFNMAAGSAPMQLHLRATIRMKDGLCVPRKWIYHLTEGSTDLRTEGRPDMKTELFSSSCPGGIMLNETGQGYQRFLLYNRSPHPPEKCVEEFKSLTSCLDSKAFLLTPRNQEACELSNN","Homo sapiens","APOM, G3A, NG20, HSPC336","APOLIPOPROTEIN M","1","2YG2"
"2YGD","9.4","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1111014108",,"2YGD",484.61,"9.4, 9.4",,"Molecular architectures of the 24meric eye lens chaperone alphaB- crystallin elucidated by a triple hybrid approach","MDIAIHHPWIRRPFFPFHSPSRLFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLRAPSWFDTGLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVTAAPKK","Homo sapiens","CRYAB, CRYA2, HSPB5","ALPHA-CRYSTALLIN B CHAIN","1","2YGD"
"2YGN",,"X-RAY DIFFRACTION",2.87,57,,6.5,"PEG 8000 30 % W/V, 200 MM SODIUM ACETATE, 100 MM SODIUM CACODYLATE PH 6.5 .",,"10.1038/nsmb.2081",,"2YGN",18.62,"1.85","1.85","WIF domain of human Wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine","ETGSLYLWIDAHQARVLIGFEEDILIVSEGKMAPFTHDFRKAQQRMPAIPVNIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQDGVAAFEVDVIVMNSEGNTILKTPQNAIFFKTCQGTKHHHHHH","Homo sapiens","WIF1, UNQ191/PRO217","WNT INHIBITORY FACTOR 1","1","2YGN"
"2YGO",,"X-RAY DIFFRACTION",2.45,50,,7,"1.3 M DIAMMONIUM TARTRATE, 100 MM BIS-TRIS PROPANE PH 7.0",,"10.1038/nsmb.2081",,"2YGO",22.05,"1.85","1.85","WIF domain-EGF-like domain 1 of human Wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine","ETGSLYLWIDAHQARVLIGFEEDILIVSEGKMAPFTHDFRKAQQRMPAIPVNIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQDGVAAFEVDVIVMNSEGNTILKTPQNAIFFKTCQQAECPGGCRNGGFCNERRICECPDGFHGPHCEGTKHHHHHH","Homo sapiens","WIF1, UNQ191/PRO217","WNT INHIBITORY FACTOR 1","1","2YGO"
"2YGP",,"X-RAY DIFFRACTION",2.29,50,,7,"1.1 M DIAMMONIUM TARTRATE, PH 7.0, 20 MM SPERMIDINE, 0.5 MM CACL2",,"10.1038/nsmb.2081",,"2YGP",22.27,"2.222","2.222","WIF domain-EGF-like domain 1 Met77Trp of human Wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine","ETGSLYLWIDAHQARVLIGFEEDILIVSEGKMAPFTHDFRKAQQRWPAIPVNIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQDGVAAFEVDVIVMNSEGNTILKTPQNAIFFKTCQQAECPGGCRNGGFCNERRICECPDGFHGPHCEGTKHHHHHH","Homo sapiens","WIF1, UNQ191/PRO217","WNT INHIBITORY FACTOR 1","1","2YGP"
"2YGQ",,"X-RAY DIFFRACTION",8.53,82,,5.7,"0.75 M SODIUM SUCCINATE PH 5.7, 35 MG/ML SUCROSE OCTASULFATE",,"10.1038/nsmb.2081",,"2YGQ",37.73,"3.951","3.951","WIF domain-epidermal growth factor (EGF)-like domains 1-3 of human Wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine","ETGSLYLWIDAHQARVLIGFEEDILIVSEGKMAPFTHDFRKAQQRMPAIPVNIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQDGVAAFEVDVIVMNSEGNTILKTPQNAIFFKTCQQAECPGGCRNGGFCNERRICECPDGFHGPHCEKALCTPRCMNGGLCVTPGFCICPPGFYGVNCDKANCSTTCFNGGTCFYPGKCICPPGLEGEQCEISKCPQPCRNGGKCIGKSKCKCSKGYQGDLCSKPVCEPGCGAHGTCHEPNKCQCQEGWHGRHCNKRYEASLIGTKHHHHHH","Homo sapiens","WIF1, UNQ191/PRO217","WNT INHIBITORY FACTOR 1","1","2YGQ"
"2YGS",,"X-RAY DIFFRACTION",2.02,33,,6,"pH 6.0",,"10.1038/21124",,"2YGS",10.64,"1.6","1.6","CARD DOMAIN FROM APAF-1","MDAKARNCLLQHREALEKDIKTSYIMDHMISDGFLTISEEEKVRNEPTQQQRAAMLIKMILKKDNDSYVSFYNALLHEGYKDLAALLHDGIP","Homo sapiens","APAF-1, APAF1, KIAA0413","APOPTOTIC PROTEASE ACTIVATING FACTOR 1","1","2YGS"
"2YGW",,"X-RAY DIFFRACTION",3.15,60.99,,,"10% PEG 20000,0.1M MES (PH 6.5)",,"10.1016/j.str.2013.05.001",,"2YGW",102.92,"2.8","2.8","Crystal structure of human MCD","GTENLYFQSMDELLRRAVPPTPAYELRAATPAPAEGQCADFVSFYGGLAETAQRAELLGRLARGFGVDHGQVAEQSAGVLHLRQQQREAAVLLQAEDRLRYALVPRYRGLFHHISKLDGGVRFLVQLRADLLEAQALKLVEGPDVREMNGVLKGMLSEWFSSGFLNLERVTWHSPCEVLQKISEAEAVHPVKNWMDMKRRVGPYRRCYFFSHCSTPGEPLVVLHVALTGDISSNIQAIVKEHPPSETAAANKITAAIFYSISLTQQGLQGVELGTFLIKRVVKELQREFPHLGVFSSLSPIPGFTKWLLGLLNSQTKEHGRNELFTDSECKEISEITGGPINETLKLLLSSSEWVQSEKLVRALQTPLMRLCAWYLYGEKHRGYALNPVANFHLQNGAVLWRINWMADVSLRGITGSCGLMANYRYFLEETGPNSTSYLGSKIIKASEQVLSLVAQFQKN","Homo sapiens","MLYCD","MALONYL-COA DECARBOXYLASE, MITOCHONDRIAL","1","2YGW"
"2YH0",,"SOLUTION NMR",,,,,,,"10.1038/nature10171",,"2YH0",21.51,,,"Solution structure of the closed conformation of human U2AF65 tandem RRM1 and RRM2 domains","GAMARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGMSENPSVYVPGVVSTVVPDSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNA","Homo sapiens","U2AF2, U2AF65","SPLICING FACTOR U2AF 65 KDA SUBUNIT","1","2YH0"
"2YHD",,"X-RAY DIFFRACTION",2.4,47.4,,7.5,"0.35 M NA2HPO4/K2HPO4, 0.1 M (NH4)2HPO4, 7.0% PEG 400, 50 MM TRIS-HCL, PH 7.5.",,"10.1021/jm200532b","TES, AV6","2YHD",29.71,"2.2","2.2","Human androgen receptor in complex with AF2 small molecule inhibitor","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","ANDROGEN RECEPTOR","1","2YHD"
"2YHF",,"X-RAY DIFFRACTION",2.35,47.56,,8,"100MM TRIS PH8.0, 30% PEG 6000",,"10.1074/jbc.M111.226142",,"2YHF",124.5,"1.9","1.9","1.9 Angstrom Crystal Structure of CLEC5A","MCPKDWEFYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDITDAEKYFIGLIYHREEKRWRWINNSVFNGNVTNQNQNFNCATIGLTKTFDAASCDISYRRICEKNA","Homo sapiens","CLEC5A, CLECSF5, MDL1","C-TYPE LECTIN DOMAIN FAMILY 5 MEMBER A","1","2YHF"
"2YHN",,"X-RAY DIFFRACTION",2.02,39,,7.5,"0.1 M SODIUM ACETATE PH 7-8, 16-20% MPD.",,"10.1101/gad.2056211",,"2YHN",17.98,"3","3","The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor","GAQQTRVLQEKLRKLKEAMLCMVCCEEEINSTFCPCGHTVCCESCAAQLQSCPVCRSRVEHVQHVYLPTHTSLLNLTVI","Homo sapiens","MYLIP, BZF1, IDOL, BM-023, PP5242","E3 UBIQUITIN-PROTEIN LIGASE MYLIP","1","2YHN"
"2YHV",,"X-RAY DIFFRACTION",2.27,45.33,"VAPOR DIFFUSION",8.4,"CRYSTALS WERE GROWN AT 13 DEGREE CELSIUS BY VAPOR DIFFUSION AFTER MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH 2 MICROLITERS OF A RESERVOIR SOLUITON CONTAINING: 0.1 M TRIS PH 8.4, 0.2 M LITHIUM SULFATE, 0.1% (W/V) B-OCTYLGLUCOSIDE, AND 20% (W/V) PEG 3350.",286,"10.1021/jm401805h",,"2YHV",38.61,"1.9","1.9","Structure of L1196M Mutant Anaplastic Lymphoma Kinase","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","2YHV"
"2YHW",,"X-RAY DIFFRACTION",2.83,56.57,,,"0.2 M CALCIUM ACETATE, 0.1 M SODIUM CACODYLATE PH 6.5 AND 40% PEG 300.",,"10.1074/jbc.M111.318170","BM3","2YHW",38,"1.64","1.64","High-resolution crystal structures of N-Acetylmannosamine kinase: Insights about substrate specificity, activity and inhibitor modelling.","MGSSHHHHHHSSGLVPRGSHMENLYFQGTLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLNGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMSVPKDEAVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYTTRR","Homo sapiens","GNE, GLCNE","BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE","1","2YHW"
"2YHY",,"X-RAY DIFFRACTION",2.82,56.37,,,"0.2 M CALCIUM ACETATE, 0.1M SODIUM CACODYLATE PH 6.5, 40% PEG 300.",,"10.1074/jbc.M111.318170","BM3","2YHY",38.7,"1.82","1.82","Structure of N-Acetylmannosamine kinase in complex with N- acetylmannosamine and ADP","MGSSHHHHHHSSGLVPRGSHMENLYFQGTLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLDGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMSVPKDEAVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYTTRR","Homo sapiens","GNE, GLCNE","BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE","1","2YHY"
"2YI0",,"X-RAY DIFFRACTION",2.9,58,,7,"pH 7",,"10.1371/journal.pone.0044642","YI0","2YI0",26.22,"1.6","1.6","Structural characterization of 5-Aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YI0"
"2YI1",,"X-RAY DIFFRACTION",2.85,56.82,,,"0.2 M CALCIUM ACETATE, 0.1M SODIUM CACODYLATE PH 6.5 AND 40% PEG 300",,"10.1074/jbc.M111.318170",,"2YI1",38.67,"2.15","2.15","Crystal structure of N-Acetylmannosamine kinase in complex with N- acetyl mannosamine 6-phosphate and ADP.","MGSSHHHHHHSSGLVPRGSHMENLYFQGTLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLDGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMSVPKDEAVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYTTRR","Homo sapiens","GNE, GLCNE","BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE","1","2YI1"
"2YI5",,"X-RAY DIFFRACTION",2.83,57,,7,"pH 7",,"10.1371/journal.pone.0044642","YI5","2YI5",26.22,"2.5","2.5","Structural characterization of 5-Aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YI5"
"2YI6",,"X-RAY DIFFRACTION",2.9,58,,7,"pH 7",,"10.1371/journal.pone.0044642","6QM","2YI6",26.22,"1.8","1.8","Structural characterization of 5-Aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YI6"
"2YI7",,"X-RAY DIFFRACTION",2.9,58,,7,"pH 7",,"10.1371/journal.pone.0044642","BZ8","2YI7",26.23,"1.4","1.4","Structural characterization of 5-Aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YI7"
"2YIG",,"X-RAY DIFFRACTION",2.26,45.61,,,"10-27% PEG 3350, 1.5 M AMMONIUM FORMATE, 0.1 M TRIS/HCL PH 8.5",,"10.1016/j.bmcl.2011.05.075","5EL","2YIG",39.87,"1.7","1.7","MMP13 in complex with a novel selective non zinc binding inhibitor","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","COLLAGENASE 3","1","2YIG"
"2YIQ",,"X-RAY DIFFRACTION",3,59.5,,7.8,"0.1M HEPES PH 7.8, 0.2M MAGNESIUM NITRATE, 14%W/V PEG 3350, 16%V/V ETHYLENE GLYCOL",,"10.1016/j.febslet.2011.08.050","YIQ","2YIQ",37,"1.89","1.89","Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1322","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YIQ"
"2YIR",,"X-RAY DIFFRACTION",3,60,,7.8,"0.1M HEPES PH 7.8, 0.2M MAGNESIUM NITRATE, 14%W/V PEG3350, 16%V/V ETHYLENE GLYCOL",,"10.1016/j.febslet.2011.08.050","YIR","2YIR",37.03,"2.1","2.1","Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1352","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YIR"
"2YIS",,"X-RAY DIFFRACTION",2.27,45.8,,,,,"10.1021/jm200677b","YIS","2YIS",42.17,"2","2","triazolopyridine inhibitors of p38 kinase.","SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","2YIS"
"2YIT",,"X-RAY DIFFRACTION",3,60,,7.6,"0.1M HEPES PH 7.8, 0.2M MAGNESIUM NITRATE, 14%W/V PEG3350, 16%V/V ETHYLENE GLYCOL",,"10.1016/j.febslet.2011.08.050","YIT","2YIT",37.02,"2.2","2.2","Structural analysis of checkpoint kinase 2 in complex with PV1162, a novel inhibitor","MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","2YIT"
"2YIW",,"X-RAY DIFFRACTION",2.24,45.01,,,,,"10.1021/jm200677b","YIW","2YIW",42.01,"2","2","triazolopyridine inhibitors of p38 kinase","SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","2YIW"
"2YIX",,"X-RAY DIFFRACTION",3.03,59.35,,,,,"10.1021/jm200677b","YIX","2YIX",40.63,"2.3","2.3","Triazolopyridine Inhibitors of p38","ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLD","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","2YIX"
"2YIY",,"X-RAY DIFFRACTION",4.08,69.87,,7.5,"0.1 M TRIS-HCL PH 7.5, 0.6 M SODIUM CITRATE, 0.2 M NACL, 10 MM DTT.",,,,"2YIY",35.23,"2.49","2.49","Crystal structure of compound 8 bound to TAK1-TAB","SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGE","Homo sapiens","TAB1, MAP3K7IP1, MAP3K7, TAK1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1","1","2YIY"
"2YJ2",,"X-RAY DIFFRACTION",1.96,37.2,,6.5,"0.1M BIS-TRIS PH 6.5, 25 % PEG 3350",,"10.1002/cmdc.201100353","YJ2","2YJ2",24.86,"1.15","1.15","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2YJ2"
"2YJ8",,"X-RAY DIFFRACTION",1.96,37.5,,5.5,"0.1 M BIS-TRIS PH 5.5, 0.2M SODIUM ACETATE, 25 % PEG 3350",,"10.1002/cmdc.201100353","YJ8","2YJ8",24.91,"1.3","1.3","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2YJ8"
"2YJ9",,"X-RAY DIFFRACTION",2.06,40.4,,6.5,"0.1 M BIS-TRIS 6.5, 20% PEG MME 5000",,"10.1002/cmdc.201100353","YJ9","2YJ9",24.85,"1.35","1.35","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2YJ9"
"2YJB",,"X-RAY DIFFRACTION",1.75,29.6,,6.5,"0.1 M BIS-TRIS PH 6.5, 0.2 M NACL, 25% PEG 3350",,"10.1002/cmdc.201100353","YJ9","2YJB",24.85,"1.4","1.4","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2YJB"
"2YJC",,"X-RAY DIFFRACTION",1.95,37.1,,,"0.1M MAGNESIUM FORMATE, 15 % PEG 3350",,"10.1002/cmdc.201100353","424","2YJC",24.73,"1.14","1.14","CATHEPSIN L WITH A NITRILE INHIBITOR","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","2YJC"
"2YJR",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS WERE GROWN BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES CELSIUS BY MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH 2 MICROLITERS OF A RESERVOIR SOLUTION CONTAINING 22% (W/V) PEG 3350, 0.1 M TRIS PH 8.5, 0.2M LITHIUM SULFATE, 0.1% (W/V) BETA-OCTYLGLUCOSIDE.",286,,,"2YJR",38.56,"1.9","1.9","Structure of F1174L Mutant Anaplastic Lymphoma Kinase","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","2YJR"
"2YJS",,"X-RAY DIFFRACTION",2.16,43.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS WERE GROWN BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGRESS CELCIUS BY MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH A RESERVOIR SOLUTION CONTAINING: 21% (W/V) PEG 3350, 0.1 M TRIS PH 8.5, 0.2M LITHIUM SULFATE, AND 0.1% (W/V) BETA-OCTYLGLCOSIDE.",286,,,"2YJS",38.66,"1.9","1.9","Structure of C1156Y Mutant Anaplastic Lymphoma Kinase","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","2YJS"
"2YJW",,"X-RAY DIFFRACTION",3.14,60.79,,7.5,"NA CITRATE 1.3 M., pH 7.5",,"10.1021/jm200784m","YJW","2YJW",23.63,"1.61","1.61","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YJW"
"2YJX",,"X-RAY DIFFRACTION",3.18,61.37,,7.5,"pH 7.5",,"10.1021/jm200784m","YJX","2YJX",23.66,"1.83","1.83","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YJX"
"2YK1",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, SITTING DROP",6,"SITTING DROP, 5% PEG 3000, 0.1 M MES PH 6.0, 30% (V/V) PEG 200, 10 MG/ML PROTEIN, 20 MM NICOTINE.",,"10.1016/j.jmb.2011.10.042","NCT","2YK1",45.44,"1.85","1.85","Structure of human anti-nicotine Fab fragment in complex with nicotine","QMQLLESGPGLVKPSETLSLTCTVSGGSIWGWIRQPPGKGLEWIGSIYSSGSTYYNPSLKSRVTTSVDTSKNQFSLRLSSVTAADTAVYYCVAWFGDLLSLKGVELWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKV","Homo sapiens",,"FAB FRAGMENT, HEAVY CHAIN","1","2YK1"
,,,,,,,,,,,,,,,,"QSELTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSAWVFGGGTQLDILGQPKAAPSVTLFPPSSEELQAPKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"FAB FRAGMENT, LIGHT CHAIN","2","2YK1"
"2YK2",,"X-RAY DIFFRACTION",3.21,61.68,,7.5,"pH 7.5",,"10.1021/jm200784m","YJX, YJW","2YK2",23.93,"1.74","1.74","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YK2"
"2YK9",,"X-RAY DIFFRACTION",2.7,54.13,,7.5,"pH 7.5",,"10.1021/jm200784m","YK9","2YK9",23.66,"1.32","1.32","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YK9"
"2YKB",,"X-RAY DIFFRACTION",3.17,61.24,,7.5,"pH 7.5",,"10.1021/jm200784m","YKB","2YKB",23.76,"1.93","1.93","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YKB"
"2YKC",,"X-RAY DIFFRACTION",3.16,61.11,,7.5,"pH 7.5",,"10.1021/jm200784m","YKC","2YKC",23.76,"1.67","1.67","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YKC"
"2YKE",,"X-RAY DIFFRACTION",3.19,61.47,,7.5,"pH 7.5",,"10.1021/jm200784m","YKE","2YKE",23.81,"1.43","1.43","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YKE"
"2YKI",,"X-RAY DIFFRACTION",3.2,61.55,,7.5,"pH 7.5",,"10.1021/jm200784m","YKI","2YKI",23.8,"1.67","1.67","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YKI"
"2YKJ",,"X-RAY DIFFRACTION",3.2,61.5,,7.5,"pH 7.5",,"10.1021/jm200784m","YKJ","2YKJ",23.78,"1.46","1.46","Tricyclic series of Hsp90 inhibitors","GHMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2YKJ"
"2YKL",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, SITTING DROP",6.5,"SITTING DROP, 0.1 M SODIUM CACODYLATE PH 6.5, 0.2 M MGCL2, 31% PEG MME 2000, 10 MG/ML PROTEIN, 20MM NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE.",,"10.1016/j.jmb.2011.10.042",,"2YKL",45.72,"2.1","2.1","Structure of human anti-nicotine Fab fragment in complex with nicotine-11-yl-methyl-(4-ethylamino-4-oxo)-butanoate","QMQLLESGPGLVKPSETLSLTCTVSGGSIWGWIRQPPGKGLEWIGSIYSSGSTYYNPSLKSRVTTSVDTSKNQFSLRLSSVTAADTAVYYCVAWFGDLLSLKGVELWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVD","Homo sapiens",,"FAB FRAGMENT, HEAVY CHAIN","1","2YKL"
,,,,,,,,,,,,,,,,"QSELTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSAWVFGGGTQLDILGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"FAB FRAGMENT, LIGHT CHAIN","2","2YKL"
"2YKO",,"X-RAY DIFFRACTION",2.5,51,,7,"100 MM NA-HEPES PH7.0, 1.1 M NA-MALONATE",,"10.1038/nsmb.2097",,"2YKO",84.14,"2.1","2.1","Structure of the human LINE-1 ORF1p trimer","MASLRSRCDQLEERVSAAEDEINEIKREGKFREKRIKRNEQSLQEIWDYVKRPNLRLIGVPESDVENGTKLENTLQDIIQENFPNLARQANVQIQEIQRTPQRYSSRRATPRHIIVRFTKVEMKEKMLRAAREKGRVTLKGKPIRLTVDLSAETLQARREWGPIFNILKEKNFQPRISYPAKLSFISEGEIKYFIDKQMLRDFVTTRPALKELLKEALNMERNNRYQHHHHHH","Homo sapiens","L1RE1, LRE1","LINE-1 ORF1P","1","2YKO"
"2YKP",,"X-RAY DIFFRACTION",2.6,53,,,"200 MM K-CITRATE, 20 % PEG 3350",,"10.1038/nsmb.2097",,"2YKP",81.75,"3.1","3.1","Structure of the human LINE-1 ORF1p trimer","MASLRSRCDQLEERVSAAEDEINEIKREGKFREKRIKRNEQSLQEIWDYVKRPNLRLIGVPESDVENGTKLENTLQDIIQENFPNLARQANVQIQEIQRTPQRYSSRRATPRHIIVRFTKVEMKEKMLRAAREKGRVTLKGKPIRLTVDLSAETLQARREWGPIFNILKEKNFQPRISYPAKLSFISEGEIKYFIDKQMLRDFVTTRPALKELLKEALNMERNHHHHHH","Homo sapiens","L1RE1, LRE1","LINE-1 ORF1P","1","2YKP"
"2YKQ",,"X-RAY DIFFRACTION",2.6,52,,8.5,"100 MM TRIS-CL PH 8.5, 100 MM MG-ACETATE, 12 % PEG 8000",,"10.1038/nsmb.2097",,"2YKQ",82.45,"3.1","3.1","Structure of the human LINE-1 ORF1p trimer","MASLRSRCDQLEERVSAAEDEINEIKREGKFREKRIKRNEQSLQEIWDYVKRPNLRLIGVPESDVENGTKLENTLQDIIQENFPNLARQANVQIQEIQRTPQRYSSRRATPRHIIVRFTKVEMKEKMLRAAREKGRVTLKGKPIRLTVDLSAETLQARREWGPIFNILKEKNFQPRISYPAKLSFISEGEIKYFIDKQMLRDFVTTRPALKELLKEALNMERNHHHHHH","Homo sapiens","L1RE1, LRE1","LINE-1 ORF1P","1","2YKQ"
"2YL2",,"X-RAY DIFFRACTION",2.11,41.87,,,"20% PEG 3350, 200 MM NA(MALONATE) PH 7.0",,,,"2YL2",120.48,"2.3","2.3","Crystal structure of human acetyl-CoA carboxylase 1, biotin carboxylase (BC) domain","SMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLI","Homo sapiens","ACACA, ACAC, ACC1, ACCA","ACETYL-COA CARBOXYLASE 1","1","2YL2"
"2YLF",,"X-RAY DIFFRACTION",1.91,35.69,,7.5,"pH 7.5",,"10.1074/jbc.M111.257782",,"2YLF",25.84,"2.05","2.05","Crystal structure of the human Spir-1 KIND domain","MSYYHHHHHHDYDIPTTENLYFQGAMGSSRDALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTESDAPNHYQAVCRALFAETMELHTFLT","Homo sapiens","SPIRE1, KIAA1135, SPIR1","PROTEIN SPIRE HOMOLOG 1","1","2YLF"
"2YLM",,"X-RAY DIFFRACTION",3.9,68.46,,6,"10% PEG 4000, 200 MM NACL, 100 MM MES PH 6.0.",,"10.1016/j.molcel.2011.06.034",,"2YLM",61.96,"2.7","2.7","Mechanism of USP7 (HAUSP) activation by its C-terminal ubiquitin-like domain (HUBL) and allosteric regulation by GMP-synthetase.","GPLGSEAHLYMQVQIVAEDQFCGHQGNDMYDEEKVKYTVFKVLKNSSLAEFVQSLSQTMGFPQDQIRLWPMQARSNGTKRPAMLDNEADGNKTMIELSDNENPWTIFLETVDPELAASGATLPKFDKDHDVMLFLKMYDPKTRSLNYCGHIYTPISCKIRDLLPVMCDRAGFIQDTSLILYEEVKPNLTERIQDYDVSLDKALDELMDGDIIVFQKDDPENDNSELPTAKEYFRDLYHRVDVIFCDKTIPNDPGFVVTLSNRMNYFQVAKTVAQRLNTDPMLLQFFKSQGYRDGPGNPLRHNYEGTLRDLLQFFKPRQPKKLYYQQLKMKITDFENRRSFKCIWLNSQFREEEITLYPDKHGCVRDLLEECKKAVELGEKASGKLRLLEIVSYKIIGVHQEDELLECLSPATSRTFRIEEIPLDQVDIDKENEMLVTVAHFHKEVFGTFGIPFLLRIHQGEHFREVMKRIQSLLDIQEKEFEKFKFAIVMMGRHQYINEDEYEVNLKDFEPQPGNMSHPRPWLGLDHFNK","Homo sapiens","USP7, HAUSP","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7","1","2YLM"
"2YLO",,"X-RAY DIFFRACTION",2.4,48,,7.5,"pH 7.5",,"10.1021/jm201098n","TES, YLO","2YLO",30.66,"2.5","2.5","TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING","IEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","ANDROGEN RECEPTOR","1","2YLO"
"2YLP",,"X-RAY DIFFRACTION",2.4,48,,7.5,"pH 7.5",,"10.1021/jm201098n","TES","2YLP",30.91,"2.3","2.3","TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING","IEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","ANDROGEN RECEPTOR","1","2YLP"
"2YLQ",,"X-RAY DIFFRACTION",2.4,48,,7.5,"pH 7.5",,"10.1021/jm201098n","TES, YLQ","2YLQ",30.61,"2.4","2.4","TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING","IEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","ANDROGEN RECEPTOR","1","2YLQ"
"2YLY",,"X-RAY DIFFRACTION",2.93,57.98,,,,,"10.1016/j.bmcl.2011.08.041","SU4","2YLY",55.19,"3.2","3.2","Sulfonamides as selective Estrogen Receptor beta Agonists.","LDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDDSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVL","Homo sapiens","ESR2, ESTRB, NR3A2","ESTROGEN RECEPTOR BETA","1","2YLY"
"2YM3",,"X-RAY DIFFRACTION",3,59,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm2007326","YM3","2YM3",33.66,"2.007","2.007","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM3"
"2YM4",,"X-RAY DIFFRACTION",2.95,58.3,,,"DL-MALIC ACID, PEG 3350.",,"10.1021/jm2007326","4YM","2YM4",33.64,"2.35","2.35","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM4"
"2YM5",,"X-RAY DIFFRACTION",2.7,54.15,,,"DL-MALIC ACID, PEG 3350.",,"10.1021/jm2007326","YM5","2YM5",33.44,"2.03","2.03","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM5"
"2YM6",,"X-RAY DIFFRACTION",2.94,58.2,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm2007326","YM6","2YM6",33.64,"2.01","2.01","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM6"
"2YM7",,"X-RAY DIFFRACTION",2.96,58.5,,,"DL-MALIC ACID/PEG3350",,"10.1021/jm2007326","YM7","2YM7",33.91,"1.81","1.81","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM7"
"2YM8",,"X-RAY DIFFRACTION",2.96,58.5,,,"DL-MALIC ACID, PEG 3350.",,"10.1021/jm2007326","YM8","2YM8",33.98,"2.07","2.07","Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","SERINE/THREONINE-PROTEIN KINASE CHK1","1","2YM8"
"2YMK",,"X-RAY DIFFRACTION",2.71,54.56,,6.5,"0.2 M ZN(AC)2, 0.1 M NA-CACODYLATE, 18% PEG8000 AT PH 6.5",,"10.1073/pnas.1214739110",,"2YMK",14.87,"2.49","2.49","Crystal structure of the hexameric anti-microbial peptide channel dermcidin","SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL","Homo sapiens","DCD, AIDD, DSEP","DCD-1","1","2YMK"
"2YN8",,"X-RAY DIFFRACTION",2.72,54.79,,7,"pH 7",,"10.1093/protein/gzt032",,"2YN8",68,"2.11","2.11","ephB4 kinase domain inhibitor complex","GSSDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","2YN8"
"2YOB",,"X-RAY DIFFRACTION",2.52,51.28,,,"15% PEG 3350, 0.1M BIS-TRIS PH 5.2, 150MM LI2SO4 AND 5% W/V OCTYL-B-D-GLUCOSIDE",,"10.1371/journal.pone.0071963",,"2YOB",86.62,"1.9","1.9","High resolution AGXT_M structure","MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVMDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALVAQA","Homo sapiens","AGXT, AGT1, SPAT","SERINE--PYRUVATE AMINOTRANSFERASE","1","2YOB"
"2YPD",,"X-RAY DIFFRACTION",2.26,45.72,,,"13% PEG3350, 200 MM SODIUM MALONATE",,,,"2YPD",94.64,"2.1","2.1","Crystal structure of the Jumonji domain of human Jumonji domain containing 1C protein","MIPHSWICEKHILWLKDYKNSSNWKLFKECWKQGQPAVVSGVHKKMNISLWKAESISLDFGDHQADLLNCKDSIISNANVKEFWDGFEEVSKRQKNKSGETVVLKLKDWPSGEDFKTMMPARYEDLLKSLPLPEYCNPEGKFNLASHLPGFFVRPDLGPRLCSAYGVVAAKDHDIGTTNLHIEVSDVVNILVYVGIAKGNGILSKAGILKKFEEEDLDDILRKRLKDSSEIPGALWHIYAGKDVDKIREFLQKISKEQGLEVLPEHDPIRDQSWYVNKKLRQRLLEEYGVRTCTLIQFLGDAIVLPAGALHQVQNFHSCIQVTEDFVSPEHLVESFHLTQELRLLKEEINYDDKLQVKNILYHAVKEMVRALKIHEDEVEDMEENAENLYFQ","Homo sapiens","JMJD1C, JHDM2C, KIAA1380, TRIP8","PROBABLE JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROT EIN 2C","1","2YPD"
"2YPR",,"X-RAY DIFFRACTION",3.96,68.95,,,"14% PEG3350, 5% GLYCEROL, 100 MM CITRATE PH 5.3",,"10.1074/jbc.M115.646737",,"2YPR",23.72,"2.64","2.64","Crystal structure of the DNA binding ETS domain of human protein FEV","SMKGSGQIQLWQFLLELLADRANAGCIAWEGGHGEFKLTDPDEVARRWGERKSKPNMNYDKLSRALRYYYDKNIMSKVHGKRYAYRFDFQGLAQACQPPPAH","Homo sapiens","FEV, PET1","PROTEIN FEV","1","2YPR"
"2YPS",,"X-RAY DIFFRACTION",3.54,65.3,,,"3.5M FORMATE",,,,"2YPS",62.61,"2.6","2.6","Crystal structure of the PX domain of human sorting nexin 3","SMPPSNFLEIDVSNPQTVGVGRGRFTTYEIRVKTNLPIFKLKESTVRRRYSDFEWLRSELERESKVVVPPLPGKAFLRQLPFRGDDGIFDDNFIEERKQGLEQFINKVAGHPLAQNERCLHMFLQDEIIDKSYT","Homo sapiens","SNX3","SORTING NEXIN-3","1","2YPS"
"2YPU",,"X-RAY DIFFRACTION",3.93,68.68,,,,,"10.1016/j.ejmech.2014.04.009",,"2YPU",230,"2.8","2.8","human insulin degrading enzyme E111Q in complex with inhibitor compound 41367","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","INSULIN-DEGRADING ENZYME","1","2YPU"
"2YQ8",,"X-RAY DIFFRACTION",2.4,46,,8.5,"26-29% PEGMME 2000, 200MM KSCN AND 5MM DTT, 5MM SPERMINE TETRAHYDROCHLORIDE, pH 8.5",,"10.1016/j.str.2013.09.005",,"2YQ8",55.6,"2.987","2.987","Crystal structure of the SeMet-labeled N-terminal domain and peptide substrate binding domain of alpha subunit of prolyl-4 hydroxylase type I from human.","MHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWAEKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQYFPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDCFELGKVAYTEADYYHTELWMEQALRQLDEGEISTIDKVSVLDYLSYAVYQQGDLDKALLLTKKLLELDPEHQRANGNLKYFEYIMAKE","Homo sapiens","P4HA1, P4HA","PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-1","1","2YQ8"
"2YQE",,"SOLUTION NMR",,,,,,,,,"2YQE",11.47,,,"Solution structure of the ARID domain of JARID1D protein","GSSGSSGTRVKLNYLDQIAKFWEIQGSSLKIPNVERKILDLYSLSKIVIEEGGYEAICKDRRWARVAQRLHYPPGKNIGSLLRSHYERIIYPYEMFQSGA","Homo sapiens","SMCY, HY, HYA, JARID1D, KIAA0234, KDM5D","Jumonji/ARID domain-containing protein 1D","1","2YQE"
"2YQF",,"SOLUTION NMR",,,,,,,,,"2YQF",12.21,,,"Solution structure of the death domain of Ankyrin-1","GSSGSSGPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRNLKPDR","Homo sapiens","ANK1, ANK","Ankyrin-1","1","2YQF"
"2YQG",,"SOLUTION NMR",,,,,,,,,"2YQG",13.64,,,"Solution structure of the first cadherin domain from human Desmoglein-2","GSSGSSGQKRAWITAPVALREGEDLSKKNPIAKIHSDLAEERGLKITYKYTGKGITEPPFGIFVFNKDTGELNVTSILDREETPFFLLTGYALDARGNNVEKPLELRIKVLDINDNEPVFTQD","Homo sapiens","DSG2, CDHF5","Desmoglein-2","1","2YQG"
"2YQI",,"SOLUTION NMR",,,,,,,,,"2YQI",8.89,,,"Solution structure of the second HMG-box domain from high mobility group protein B3","GSSGSSGNAPKRPPSGFFLFCSEFRPKIKSTNPGISIGDVAKKLGEMWNNLNDSEKQPYITKAAKLKEKYEKDVADYKSKG","Homo sapiens","HMGB3, HMG2A, HMG4","High mobility group protein B3","1","2YQI"
"2YQK",,"SOLUTION NMR",,,,,,,,,"2YQK",7.3,,,"Solution structure of the SANT domain in Arginine-glutamic acid dipeptide (RE) repeats","GSSGSSGIEKCWTEDEVKRFVKGLRQYGKNFFRIRKELLPNKETGELITFYYYWKKTSGPSSG","Homo sapiens","RERE, ARG, ARP, ATN1L, KIAA0458","Arginine-glutamic acid dipeptide repeats protein","1","2YQK"
"2YQL",,"SOLUTION NMR",,,,,,,,,"2YQL",6.33,,,"Solution structure of the PHD domain in PHD finger protein 21A","GSSGSSGHEDFCSVCRKSGQLLMCDTCSRVYHLDCLDPPLKTIPKGMWICPRCQDQ","Homo sapiens","PHF21A, BHC80, KIAA1696, BM-006","PHD finger protein 21A","1","2YQL"
"2YQM",,"SOLUTION NMR",,,,,,,,,"2YQM",10,,,"Solution structure of the FYVE domain in zinc finger FYVE domain-containing protein 12","GSSGSSGIKEVNQALKGHAWLKDDEATHCRQCEKEFSISRRKHHCRNCGHIFCNTCSSNELALPSYPKPVRVCDSCHTLLLQRCSSTAS","Homo sapiens","RUFY1, RABIP4, ZFYVE12","RUN and FYVE domain-containing protein 1","1","2YQM"
"2YQP",,"SOLUTION NMR",,,,,,,,,"2YQP",6.7,,,"Solution structure of the zf-HIT domain in DEAD (Asp-Glu-Ala-Asp) box polypeptide 59","GSSGSSGFSKTQRWAEPGEPICVVCGRYGEYICDKTDEDVCSLECKAKHLLQVKEKEEKS","Homo sapiens","RP11-92G12.2, DDX59, ZNHIT5","Probable ATP-dependent RNA helicase DDX59","1","2YQP"
"2YQQ",,"SOLUTION NMR",,,,,,,,,"2YQQ",6.09,,,"Solution structure of the zf-HIT domain in zinc finger HIT domain-containing protein 3 (TRIP-3)","GSSGSSGLKCSTVVCVICLEKPKYRCPACRVPYCSVVCFRKHKEQCNPETSGPSSG","Homo sapiens","ZNHIT3, TRIP3","Zinc finger HIT domain-containing protein 3","1","2YQQ"
"2YQR",,"SOLUTION NMR",,,,,,,,,"2YQR",12.83,,,"Solution structure of the KH domain in KIAA0907 protein","GSSGSSGGMHYVQDKLFVGLEHAVPTFNVKEKVEGPGCSYLQHIQIETGAKVFLRGKGSGCIEPASGREAFEPMYIYISHPKPEGLAAAKKLCENLLQTVHAEYSRFVNQINTAVPLPG","Homo sapiens","KIAA0907, KHDC4, BLOM7, SNORA80EHG","KIAA0907 protein","1","2YQR"
"2YR3",,"SOLUTION NMR",,,,,,,,,"2YR3",10.46,,,"Solution structure of the fourth Ig-like domain from myosin light chain kinase, smooth muscle","GSSGSSGMEVAPSFSSVLKDCAVIEGQDFVLQCSVRGTPVPRITWLLNGQPIQYARSTCEAGVAELHIQDALPEDHGTYTCLAENALGQVSCSAWVTVH","Homo sapiens","MYLK, MLCK, MLCK1, MYLK1","Myosin light chain kinase, smooth muscle","1","2YR3"
"2YRA",,"SOLUTION NMR",,,,,,,,,"2YRA",7.91,,,"Solution structure of the zinc finger domains (1-87) from human F-box only protein","GSSGSSGCSDLPEIQNGWKTTSHTELVRGARITYQCDPGYDIVGSDTLTCQWDLSWSSDPPFCEKTEESGPSSG","Homo sapiens","SEZ6L, KIAA0927, UNQ2542/PRO6094","Seizure 6-like protein isoform 3","1","2YRA"
"2YRB",,"SOLUTION NMR",,,,,,,,,"2YRB",17.62,,,"Solution structure of the first C2 domain from human KIAA1005 protein","GSSGSSGDETIHLERGENLFEIHINKVTFSSEVLQASGDKEPVTFCTYAFYDFELQTTPVVRGLHPEYNFTSQYLVHVNDLFLQYIQKNTITLEVHQAYSTEYETIAACQLKFHEILEKSGRIFCTASLIGTKGDIPNFGTVEYWFRLRVSGPSSG","Homo sapiens","RPGRIP1L, FTM, KIAA1005, NPHP8","Protein fantom","1","2YRB"
"2YRC",,"SOLUTION NMR",,,,,,,,,"2YRC",6.53,,,"Solution structure of the zf-Sec23_Sec24 from human Sec23A","GSSGSSGEPVLCSRTTCRAVLNPLCQVDYRAKLWACNFCYQRNQFPPSYAGISELNQPA","Homo sapiens","SEC23A","Protein transport protein Sec23A","1","2YRC"
"2YRD",,"SOLUTION NMR",,,,,,,,,"2YRD",6.5,,,"Solution structure of the zf-Sec23_Sec24 from human Sec23A mutant V69A","GSSGSSGEPVLCSRTTCRAALNPLCQVDYRAKLWACNFCYQRNQFPPSYAGISELNQPA","Homo sapiens","SEC23A","Protein transport protein Sec23A","1","2YRD"
"2YRE",,"SOLUTION NMR",,,,,,,,,"2YRE",10.96,,,"Solution structure of the zinc finger domains (1-87) from human F-box only protein","GSSGSSGMEEELQHSHCVNCVSRRCMTRPEPGISCDLIGCPLVCGAVFHSCKADEHRLLCPFERVPCLNSDFGCPFTMARNKVAEHLEMCPASVSGPSSG","Homo sapiens","FBXO30, FBX30","F-box only protein 30","1","2YRE"
"2YRG",,"SOLUTION NMR",,,,,,,,,"2YRG",6.48,,,"Solution structure of the B-box domain from tripartite motif-containing protein 5","GSSGSSGSPEGQKVDHCARHGEKLLLFCQEDGKVICWLCERSQEHRGHHTFPTSGPSSG","Homo sapiens","TRIM5, RNF88","Tripartite motif-containing protein 5","1","2YRG"
"2YRH",,"SOLUTION NMR",,,,,,,,,"2YRH",4.59,,,"Solution structure of the C2H2-type zinc finger domain (699-729) from zinc finger protein 473","GSSGSSGKKPLVCNECGKTFRQSSCLSKHQRIHSGEKPSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YRH"
"2YRJ",,"SOLUTION NMR",,,,,,,,,"2YRJ",4.75,,,"Solution structure of the C2H2-type zinc finger domain (781-813) from zinc finger protein 473","GSSGSSGTGEKPYRCGECGKAFAQKANLTQHQRIHTGEKPSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YRJ"
"2YRL",,"SOLUTION NMR",,,,,,,,,"2YRL",10.59,,,"Solution structure of the PKD domain from KIAA 1837 protein","GSSGSSGQADAGPDKELTLPVDSTTLDGSKSSDDQKIISYLWEKTQGPDGVQLENANSSVATVTGLQVGTYVFTLTVKDERNLQSQSSVNVIVKEESGPSSG","Homo sapiens","KIAA1837, KIAA0319L, AAVR, PP791","KIAA1837 protein","1","2YRL"
"2YRM",,"SOLUTION NMR",,,,,,,,,"2YRM",4.54,,,"Solution structure of the 1st zf-C2H2 domain from Human B-cell lymphoma 6 protein","GSSGSSGNGAFFCNECDCRFSEEASLKRHTLQTHSDKSGPSSG","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","2YRM"
"2YRN",,"SOLUTION NMR",,,,,,,,,"2YRN",14.41,,,"Solution structure of the CH domain from Human Neuron navigator 2","GSSGSSGKRKPVIHGLEDQKRIYTDWANHYLAKSGHKRLIRDLQQDVTDGVLLAQIIQVVANEKIEDINGCPKNRSQMIENIDACLNFLAAKGINIQGLSAEEIRNGNLKAILGLFFSLSRYKQQQQQP","Homo sapiens","NAV2, HELAD1, KIAA1419, POMFIL2, RAINB1, STEERIN2","Neuron navigator 2 isoform 4","1","2YRN"
"2YRO",,"SOLUTION NMR",,,,,,,,,"2YRO",17.05,,,"Solution structure of the C-terminal Gal-bind lectin protein from Human Galectin-8","GSSGSSGPKSGTPQLSLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSWSGPSSG","Homo sapiens","LGALS8","Galectin-8","1","2YRO"
"2YRP",,"SOLUTION NMR",,,,,,,,,"2YRP",12.67,,,"Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4","GSSGSSGLPQVEAYSPSACSVRGGEELVLTGSNFLPDSKVVFIERGPDGKLQWEEEATVNRLQSNEVTLTLTVPEYSNKRVSRPVQVYFYVSNGRRKRSPTQSFRFLPVICKEE","Homo sapiens","NFATC4, NFAT3","Nuclear factor of activated T-cells, cytoplasmic 4","1","2YRP"
"2YRQ",,"SOLUTION NMR",,,,,,,,,"2YRQ",19.67,,,"Solution structure of the tandem HMG box domain from Human High mobility group protein B1","GSSGSSGMGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKGETKKKFKDPNAPKRPPSAFFLFCSEYRPKIKGEHPGLSIGDVAKKLGEMWNNTAADDKQPYEKKAAKLKEKYEKDIAAYRAKG","Homo sapiens","HMGB1, HMG1","High mobility group protein B1","1","2YRQ"
"2YRT",,"SOLUTION NMR",,,,,,,,,"2YRT",8.31,,,"Solution structure of the CHORD domain of human CHORD-containing protein 1","GSSGSSGMALLCYNRGCGQRFDPETNSDDACTYHPGVPVFHDALKGWSCCKRRTTDFSDFLSIVGCTKGRHNSEK","Homo sapiens","CHORDC1, CHP1","CHORD containing protein-1","1","2YRT"
"2YRV",,"SOLUTION NMR",,,,,,,,,"2YRV",12.79,,,"Solution structure of the RBB1NT domain of human RB(retinoblastoma)-binding protein 1","GSSGSSGLNDELLGKVVSVVSATERTEWYPALVISPSCNDDITVKKDQCLVRSFIDSKFYSIARKDIKEVDILNLPESELSTKPGLQKASIFLKTRVVPDNWKMDISEILESGPSSG","Homo sapiens","ARID4A, RBBP1, RBP1","AT-rich interactive domain-containing protein 4A","1","2YRV"
"2YRY",,"SOLUTION NMR",,,,,,,,,"2YRY",13.73,,,"Solution structure of the PH domain of Pleckstrin homology domain-containing family A member 6 from human","GSSGSSGGKRSHSMKRNPNAPVTKAGWLFKQASSGVKQWNKRWFVLVDRCLFYYKDEKEESILGSIPLLSFRVAAVQPSDNISRKHTFKAEHAGVRTYFFSAESPEEQEAWIQAMGEAARVQ","Homo sapiens","PLEKHA6, KIAA0969, PEPP3","Pleckstrin homology domain-containing family A member 6","1","2YRY"
"2YRZ",,"SOLUTION NMR",,,,,,,,,"2YRZ",12.79,,,"Solution structure of the fibronectin type III domain of human Integrin beta-4","GSSGSSGSHDSRLTAGVPDTPTRLVFSALGPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQVSGPSSG","Homo sapiens","ITGB4","Integrin beta-4","1","2YRZ"
"2YS0",,"SOLUTION NMR",,,,,,,,,"2YS0",5.84,,,"Solution structure of the Somatomedin B domain of human Ectonucleotide pyrophosphatase/phosphodiesterase family member","GSSGSSGWTCNKFRCGEKRLTRSLCACSDDCKDQGDCCINYSSVCQGEKSSGPSSG","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","2YS0"
"2YS1",,"SOLUTION NMR",,,,,,,,,"2YS1",13.08,,,"Solution structure of the PH domain of Dynamin-2 from human","GSSGSSGVIRRGWLTINNISLMKGGSKEYWFVLTAESLSWYKDEEEKEKKYMLPLDNLKIRDVEKGFMSNKHVFAIFNTEQRNVYKDLRQIELACDSQEDVDSWKASFLRAGV","Homo sapiens","DNM2, DYN2","Dynamin-2","1","2YS1"
"2YS2",,"SOLUTION NMR",,,,,,,,,"2YS2",5.23,,,"Solution structure of the BTK motif of human Cytoplasmic tyrosine-protein kinase BMX","GSSGSSGNPHLLVKYHSGFFVDGKFLCCQQSCKAAPGCTLWEAYSGPSSG","Homo sapiens","BMX","Cytoplasmic tyrosine-protein kinase BMX","1","2YS2"
"2YS3",,"SOLUTION NMR",,,,,,,,,"2YS3",15.48,,,"Solution structure of the PH domain of Kindlin-3 from human","GSSGSSGIPELKDHLRIFRPRKLTLKGYRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGCEVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMAGCRLASKGRTMADSSYTSEVQAILAFLSLQRT","Homo sapiens","URP2, FERMT3, KIND3, MIG2B","Unc-112-related protein 2","1","2YS3"
"2YS4",,"SOLUTION NMR",,,,,,,,,"2YS4",13.34,,,"Solution structure of the N-terminal PapD-like domain of HYDIN protein from human","GSSGSSGTEREKFIVPIKARGARAILDFPDKLNFSTCPVKYSTQKILLVRNIGNKNAVFHIKTCRPFSIEPAIGTLNVGESMQLEVEFEPQSVGDHSGRLIVCYDTGEKVFVSLYGAAIDMN","Homo sapiens","HYDIN, HYDIN1, KIAA1864","Hydrocephalus-inducing protein homolog","1","2YS4"
"2YS5",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9091-x",,"2YS5",18.68,,,"Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) of hALK","GSSGSSGLNRDSVPDNHPTKFKVTNVDDEGVELGSGVMELTQSELVLHLHRREAVRWPYLCLRRYGYDSNLFSFESGRRCQTGQGIFAFKCSRAEEIFNLLQDLMQCNSINVMEEPVIITRNSHPAELDLPRAPQPPNALGYTVSS","Homo sapiens","FRS3","Fibroblast growth factor receptor substrate 3","1","2YS5"
,,,,,,,,,,,,,,,,"LFRLRHFPCGNVNYGYQQQ",,,"ALK tyrosine kinase receptor","2","2YS5"
"2YS8",,"SOLUTION NMR",,,,,,,,,"2YS8",9.46,,,"Solution structure of the DnaJ-like domain from human ras-associated protein Rap1","GSSGSSGSSASFTKEQADAIRRIRNSKDSWDMLGVKPGASRDEVNKAYRKLAVLLHPDKCVAPGSEDAFKAVVNARTALLKNIKSGPSSG","Homo sapiens","RBJ, DNAJC27, RABJS","Rab-related GTP-binding protein RabJ","1","2YS8"
"2YS9",,"SOLUTION NMR",,,,,,,,,"2YS9",7.57,,,"structure of the third Homeodomain from the human homeobox and leucine zipper protein, Homez","GSSGSSGPLPIPPPPPDIQPLERYWAAHQQLRETDIPQLSQASRLSTQQVLDWFDSRLPQPAEVSGPSSG","Homo sapiens","HOMEZ, KIAA1443","Homeobox and leucine zipper protein Homez","1","2YS9"
"2YSA",,"SOLUTION NMR",,,,,,,,,"2YSA",6.05,,,"Solution structure of the zinc finger CCHC domain from the human retinoblastoma-binding protein 6 (Retinoblastoma-binding Q protein 1, RBQ-1)","GSSGSSGYTCFRCGKPGHYIKNCPTNGDKNFESGPRIKKSTGIPRSFMMEVKDPN","Homo sapiens","RBBP6, P2PR, PACT, RBQ1, My038","Retinoblastoma-binding protein 6","1","2YSA"
"2YSC",,"SOLUTION NMR",,,,,,,,,"2YSC",4.26,,,"Solution structure of the WW domain from the human amyloid beta A4 precursor protein-binding family B member 3, APBB3","GSSGSSGGLPPGWRKIHDAAGTYYWHVPSGSTQWQRPTW","Homo sapiens","APBB3, FE65L2","Amyloid beta A4 precursor protein-binding family B member 3","1","2YSC"
"2YSD",,"SOLUTION NMR",,,,,,,,,"2YSD",6.17,,,"Solution structure of the first WW domain from the human membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1. MAGI-1","GSSGSSGAEDNLGPLPENWEMAYTENGEVYFIDHNTKTTSWLDPRCLNKQQSGPSSG","Homo sapiens","MAGI1, AIP3, BAIAP1, BAP1, TNRC19","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2YSD"
"2YSE",,"SOLUTION NMR",,,,,,,,,"2YSE",6.62,,,"Solution structure of the second WW domain from the human membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1. MAGI-1","GSSGSSGLDSELELPAGWEKIEDPVYGIYYVDHINRKTQYENPVLEAKRKKQLESGPSSG","Homo sapiens","MAGI1, AIP3, BAIAP1, BAP1, TNRC19","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2YSE"
"2YSF",,"SOLUTION NMR",,,,,,,,,"2YSF",4.47,,,"Solution structure of the fourth WW domain from the human E3 ubiquitin-protein ligase Itchy homolog, ITCH","GSSGSSGLPEGWEMRFTVDGIPYFVDHNRRTTTYIDPRTG","Homo sapiens","ITCH","E3 ubiquitin-protein ligase Itchy homolog","1","2YSF"
"2YSG",,"SOLUTION NMR",,,,,,,,,"2YSG",4.38,,,"Solution structure of the WW domain from the human syntaxin-binding protein 4","GSSGSSGLPYGWEEAYTADGIKYFINHVTQTTSWIHPVMS","Homo sapiens","STXBP4","Syntaxin-binding protein 4","1","2YSG"
"2YSH",,"SOLUTION NMR",,,,,,,,,"2YSH",4.38,,,"Solution structure of the WW domain from the human growth-arrest-specific protein 7, GAS-7","GSSGSSGLPPGWQSYLSPQGRRYYVNTTTNETTWERPSSS","Homo sapiens","GAS7, KIAA0394","Growth-arrest-specific protein 7","1","2YSH"
"2YSJ",,"SOLUTION NMR",,,,,,,,,"2YSJ",6.84,,,"Solution structure of the RING domain (1-56) from tripartite motif-containing protein 31","GSSGSSGMASGQFVNKLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLC","Homo sapiens","TRIM31, C6orf13, RNF","Tripartite motif-containing protein 31","1","2YSJ"
"2YSL",,"SOLUTION NMR",,,,,,,,,"2YSL",8,,,"Solution structure of the RING domain (1-66) from tripartite motif-containing protein 31","GSSGSSGMASGQFVNKLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLCKTSVRKNAIR","Homo sapiens","TRIM31, C6orf13, RNF","Tripartite motif-containing protein 31","1","2YSL"
"2YSM",,"SOLUTION NMR",,,,,,,,,"2YSM",12.14,,,"Solution structure of the second and third PHD domain from Histone-lysine N-methyltransferase 2C (KMT2C/MLL3)","GSSGSSGANCAVCDSPGDLLDQFFCTTCGQHYHGMCLDIAVTPLKRAGWQCPECKVCQNCKQSGEDSKMLVCDTCDKGYHTFCLQPVMKSVPTNGWKCKNCRICISGPSSG","Homo sapiens","MLL3, HALR, KIAA1506, KMT2C","Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog","1","2YSM"
"2YSO",,"SOLUTION NMR",,,,,,,,,"2YSO",5.03,,,"Solution structure of the C2H2 type zinc finger (region 656-688) of human Zinc finger protein 95 homolog","GSSGSSGSREKSHQCRECGEIFFQYVSLIEHQVLHMGQKNSGPSSG","Homo sapiens","ZFP95, KIAA1015, ZKSCAN5","Zinc finger protein 95 homolog","1","2YSO"
"2YSP",,"SOLUTION NMR",,,,,,,,,"2YSP",4.88,,,"Solution structure of the C2H2 type zinc finger (region 507-539) of human Zinc finger protein 224","GSSGSSGTGEKPYKCEKCGKGYNSKFNLDMHQKVHTGERPSGPSSG","Homo sapiens","ZNF224, BMZF2, KOX22, ZNF233, ZNF255, ZNF27","Zinc finger protein 224","1","2YSP"
"2YSQ",,"SOLUTION NMR",,,,,,,,,"2YSQ",8.84,,,"Solution structure of the SH3 domain from Rho guanine nucleotide exchange factor 9","GSSGSSGDSIVSAEAVWDHVTMANRELAFKAGDVIKVLDASNKDWWWGQIDDEEGWFPASFVRLWVNQEDEVEEGSGPSSG","Homo sapiens","ARHGEF9, KIAA0424, ARHDH9","Rho guanine nucleotide exchange factor 9","1","2YSQ"
"2YSR",,"SOLUTION NMR",,,,,,,,,"2YSR",12.18,,,"Solution structure of the DEP domain from human DEP domain-containing protein 1","GSSGSSGYRATKLWNEVTTSFRAGMPLRKHRQHFKKYGNCFTAGEAVDWLYDLLRNNSNFGPEVTRQQTIQLLRKFLKNHVIEDIKGRWGSENVDDNNQLFRFPA","Homo sapiens","DEPDC1, DEPDC1A","DEP domain-containing protein 1","1","2YSR"
"2YST",,"SOLUTION NMR",,,,,,,,,"2YST",13.07,,,"Solution structure of the third cadherin domain from human protocadherin 7","GSSGSSGNDNSPRFEKSVYEADLAENSAPGTPILQLRAADLDVGVNGQIEYVFGAATESVRRLLRLDETSGWLSVLHRIDREEVNQLRFTVMARDRGQPPKTDKATVVLNIKDENDNVP","Homo sapiens","PCDH7, BHPCDH","Protocadherin-7","1","2YST"
"2YSV",,"SOLUTION NMR",,,,,,,,,"2YSV",4.36,,,"Solution structure of C2H2 type Zinc finger domain 17 in Zinc finger protein 473","GSSGSSGEKPYVCQECGKAFTQSSCLSIHRRVHTGESGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YSV"
"2YSX",,"SOLUTION NMR",,,,,,,,,"2YSX",13.42,,,"Solution structure of the human SHIP SH2 domain","GSSGSSGMVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLDQLIEFYKKENMGLVTHLQYPVPLEEEDTGDDP","Homo sapiens","SHIP, INPP5D, SHIP1","Signaling inositol polyphosphate phosphatase SHIP II","1","2YSX"
"2YT2",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9091-x",,"2YT2",16.95,,,"Solution structure of the chimera of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) of hALK","GSSGSSGLNRDSVPDNHPTKFKVTNVDDEGVELGSGVMELTQSELVLHLHRREAVRWPYLCLRRYGYDSNLFSFESGRRCQTGQGIFAFKCSRAEEIFNLLQDLMQCNSINVMEEPVIITSGSSGSSGSSGSSGLFRLRHFPCGNVNYGYQQQ","Homo sapiens","FRS3, ALK","Fibroblast growth factor receptor substrate 3 and ALK tyrosine kinase receptor","1","2YT2"
"2YT4",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, HANGING DROP",8,"1.8M sodium/potassium phosphate buffer pH8.0, 0.9mM CTAB (Cetyltrimethylammonium Bromide), 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb1294",,"2YT4",26.25,"2.6","2.6","Crystal structure of human DGCR8 core","GSHMSVQDAPTKKEFVINPNGKSEVCILHEYMQRVLKVRPVYNFFECENPSEPFGASVTIDGVTYGSGTASSKKLAKNKAARATLEILIPDFVKQTSEEKPKDSEELEYFNHISIEDSRVYELTSKAGLLSPYQILHECLKRNHGMGDTSIKFEVVPGKNQKSEYVMACGKHTVRGWCKNKRVGKQLASQKILQLLHPHVKNWGSLLRMYGRESSKMVKQETSDKSVIELQQ","Homo sapiens","DGCR8, C22orf12, DGCRK6, LP4941","Protein DGCR8","1","2YT4"
"2YT7",,"SOLUTION NMR",,,,,,,,,"2YT7",10.2,,,"Solution structure of the PDZ domain of Amyloid beta A4 precursor protein-binding family A member 3","GSSGSSGDNCREVHLEKRRGEGLGVALVESGWGSLLPTAVIANLLHGGPAERSGALSIGDRLTAINGTSLVGLPLAACQAAVRETKSQTSVTLSIVHCPPV","Homo sapiens","APBA3, MINT3, X11L2","Amyloid beta A4 precursor protein-binding family A member 3","1","2YT7"
"2YT8",,"SOLUTION NMR",,,,,,,,,"2YT8",10,,,"Solution structure of the PDZ domain of Amyloid beta A4 precursor protein-binding family A member 3 (Neuron- specific X11L2 protein) (Neuronal Munc18-1-interacting protein 3) (Mint-3) (Adapter protein X11gamma)","GSSGSSGVTTAIIHRPHAREQLGFCVEDGIICSLLRGGIAERGGIRVGHRIIEINGQSVVATPHARIIELLTEAYGEVHIKTMPAATYRLLTGQ","Homo sapiens","APBA3, MINT3, X11L2","Amyloid beta A4 precursor protein-binding family A member 3","1","2YT8"
"2YT9",,"SOLUTION NMR",,,,,,,,,"2YT9",10.61,,,"Solution structure of C2H2 type Zinc finger domain 345 in Zinc finger protein 278","GSSGSSGVACEICGKIFRDVYHLNRHKLSHSGEKPYSCPVCGLRFKRKDRMSYHVRSHDGSVGKPYICQSCGKGFSRPDHLNGHIKQVHSGPSSG","Homo sapiens","PATZ, RIAZ, ZBTB19, ZNF278, ZSG, PATZ1","zinc finger-containing protein 1","1","2YT9"
"2YTA",,"SOLUTION NMR",,,,,,,,,"2YTA",4.24,,,"Solution structure of C2H2 type Zinc finger domain 3 in Zinc finger protein 32","GSSGSSGEKPYQCKECGKSFSQRGSLAVHERLHTGSGPSSG","Homo sapiens","ZNF32, KOX30","Zinc finger protein 32","1","2YTA"
"2YTB",,"SOLUTION NMR",,,,,,,,,"2YTB",4.28,,,"Solution structure of C2H2 type Zinc finger domain 5 in Zinc finger protein 32","GSSGSSGGEKPYRCDQCGKAFSQKGSLIVHIRVHTGSGPSSG","Homo sapiens","ZNF32, KOX30","Zinc finger protein 32","1","2YTB"
"2YTC",,"SOLUTION NMR",,,,,,,,,"2YTC",9.47,,,"Solution structure of RNA binding domain in Pre-mRNA-splicing factor RBM22","GSSGSSGEDKTITTLYVGGLGDTITETDLRNHFYQFGEIRTITVVQRQQCAFIQFATRQAAEVAAEKSFNKLIVNGRRLNVKWGR","Homo sapiens","RBM22, ZC3H16, 199G4","Pre-mRNA-splicing factor RBM22","1","2YTC"
"2YTD",,"SOLUTION NMR",,,,,,,,,"2YTD",5,,,"Solution structure of the C2H2 type zinc finger (region 426-458) of human Zinc finger protein 473","GSSGSSGSGEKPYKCSECGKAFHRHTHLNEHRRIHTGYRPSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YTD"
"2YTE",,"SOLUTION NMR",,,,,,,,,"2YTE",4.52,,,"Solution structure of the C2H2 type zinc finger (region 484-512) of human Zinc finger protein 473","GSSGSSGEKPYSCAECKETFSDNNRLVQHQKMHTVKSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YTE"
"2YTF",,"SOLUTION NMR",,,,,,,,,"2YTF",4.81,,,"Solution structure of the C2H2 type zinc finger (region 607-639) of human Zinc finger protein 268","GSSGSSGTGEKPFECSECQKAFNTKSNLIVHQRTHTGEKPSGPSSG","Homo sapiens","ZNF268","Zinc finger protein 268","1","2YTF"
"2YTG",,"SOLUTION NMR",,,,,,,,,"2YTG",4.85,,,"Solution structure of the C2H2 type zinc finger (region 369-401) of human Zinc finger protein 95 homolog","GSSGSSGTGEKPFKCGECGKSYNQRVHLTQHQRVHTGEKPSGPSSG","Homo sapiens","ZFP95, ZKSCAN5, KIAA1015","Zinc finger protein 95 homolog","1","2YTG"
"2YTH",,"SOLUTION NMR",,,,,,,,,"2YTH",4.89,,,"Solution structure of the C2H2 type zinc finger (region 479-511) of human Zinc finger protein 224","GSSGSSGSGEKPFQCEECGKRFTQNSHLHSHQRVHTGEKPSGPSSG","Homo sapiens","ZNF224, BMZF2, KOX22, ZNF233, ZNF255, ZNF27","Zinc finger protein 224","1","2YTH"
"2YTI",,"SOLUTION NMR",,,,,,,,,"2YTI",4.79,,,"Solution structure of the C2H2 type zinc finger (region 564-596) of human Zinc finger protein 347","GSSGSSGTGEKPYKCNECGKVFTQNSHLARHRGIHTGEKPSGPSSG","Homo sapiens","ZNF347, ZNF1111","Zinc finger protein 347","1","2YTI"
"2YTJ",,"SOLUTION NMR",,,,,,,,,"2YTJ",4.84,,,"Solution structure of the C2H2 type zinc finger (region 771-803) of human Zinc finger protein 484","GSSGSSGTGEKPYICAECGKAFTIRSNLIKHQKIHTKQKPSGPSSG","Homo sapiens","ZNF484","Zinc finger protein 484","1","2YTJ"
"2YTK",,"SOLUTION NMR",,,,,,,,,"2YTK",4.89,,,"Solution structure of the C2H2 type zinc finger (region 396-428) of human Zinc finger protein 347","GSSGSSGSGEKPYKCNECGKVFTQNSHLTNHWRIHTGEKPSGPSSG","Homo sapiens","ZNF347, ZNF1111","Zinc finger protein 347","1","2YTK"
"2YTM",,"SOLUTION NMR",,,,,,,,,"2YTM",4.76,,,"Solution structure of the C2H2 type zinc finger (region 696-728) of human Zinc finger protein 28 homolog","GSSGSSGTGEKPYKCMECGKAFGDNSSCTQHQRLHTGQRPSGPSSG","Homo sapiens","ZFP28, KIAA1431","Zinc finger protein 28 homolog","1","2YTM"
"2YTN",,"SOLUTION NMR",,,,,,,,,"2YTN",4.79,,,"Solution structure of the C2H2 type zinc finger (region 732-764) of human Zinc finger protein 347","GSSGSSGTGKKPYKCNECGKVFTQNSHLARHRGIHTGEKPSGPSSG","Homo sapiens","ZNF347, ZNF1111","Zinc finger protein 347","1","2YTN"
"2YTO",,"SOLUTION NMR",,,,,,,,,"2YTO",4.79,,,"Solution structure of the C2H2 type zinc finger (region 659-691) of human Zinc finger protein 484","GSSGSSGTGEKPYKCSDCGKAFTRKSGLHIHQQSHTGERHSGPSSG","Homo sapiens","ZNF484","Zinc finger protein 484","1","2YTO"
"2YTP",,"SOLUTION NMR",,,,,,,,,"2YTP",4.87,,,"Solution structure of the C2H2 type zinc finger (region 687-719) of human Zinc finger protein 484","GSSGSSGTGERHYECSECGKAFARKSTLIMHQRIHTGEKPSGPSSG","Homo sapiens","ZNF484","Zinc finger protein 484","1","2YTP"
"2YTQ",,"SOLUTION NMR",,,,,,,,,"2YTQ",4.66,,,"Solution structure of the C2H2 type zinc finger (region 775-807) of human Zinc finger protein 268","GSSGSSGAGEKPYGCSECGKAFSSKSYLIIHMRTHSGEKPSGPSSG","Homo sapiens","ZNF268","Zinc finger protein 268","1","2YTQ"
"2YTR",,"SOLUTION NMR",,,,,,,,,"2YTR",4.8,,,"Solution structure of the C2H2 type zinc finger (region 760-792) of human Zinc finger protein 347","GSSGSSGTGEKPYKCNECGKAFSQTSKLARHQRIHTGEKPSGPSSG","Homo sapiens","ZNF347, ZNF1111","Zinc finger protein 347","1","2YTR"
"2YTS",,"SOLUTION NMR",,,,,,,,,"2YTS",4.93,,,"Solution structure of the C2H2 type zinc finger (region 715-747) of human Zinc finger protein 484","GSSGSSGTGEKPYICNECGKSFIQKSHLNRHRRIHTGEKPSGPSSG","Homo sapiens","ZNF484","Zinc finger protein 484","1","2YTS"
"2YTT",,"SOLUTION NMR",,,,,,,,,"2YTT",4.94,,,"Solution structure of the C2H2 type zinc finger (region 204-236) of human Zinc finger protein 473","GSSGSSGEGEKPYQCSECGKSFSGSYRLTQHWITHTREKPSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YTT"
"2YTU",,"SOLUTION NMR",,,,,,,,,"2YTU",14.76,,,"Solution structure of the SAM_PNT-domain of the human friend LEUKEMIAINTEGRATION 1 transcription factor","GSSGSSGMNYNSYMDEKNGPPPPNMTTNERRVIVPADPTLWTQEHVRQWLEWAIKEYSLMEIDTSFFQNMDGKELCKMNKEDFLRATTLYNTEVLLSHLSYLRESSLLAYNTTSHTDQSSRLSVKEDP","Homo sapiens","FLI1","Friend leukemia integration 1 transcription factor","1","2YTU"
"2YTV",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9081-z",,"2YTV",8.55,,,"Solution structure of the fifth cold-shock domain of the human KIAA0885 protein (unr protein)","GSSGSSGLRRATVECVKDQFGFINYEVGDSKKLFFHVKEVQDGIELQAGDEVEFSVILNQRTGKCSACNVWRVSGPSSG","Homo sapiens","KIAA0885, CSDE1, D1S155E, NRU, UNR","Cold shock domain-containing protein E1","1","2YTV"
"2YTW",,"SOLUTION NMR",,,,,,,,,"2YTW",12.77,,,"Solution structure of the PDZ-domain of human protease HTRA 1 precursor","GSSGSSGRQAKGKAITKKKYIGIRMMSLTSSKAKELKDRHRDFPDVISGAYIIEVIPDTPAEAGGLKENDVIISINGQSVVSANDVSDVIKRESTLNMVVRRGNEDIMITVIPEEIDP","Homo sapiens","HTRA1, HTRA, PRSS11","Serine protease HTRA1","1","2YTW"
"2YTX",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9081-z",,"2YTX",10.57,,,"Solution structure of the second cold-shock domain of the human KIAA0885 protein (UNR protein)","GSSGSSGNIMLLKKKQARCQGVVCAMKEAFGFIERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKEVATDVRLLPQGTVIFEDISGPSSG","Homo sapiens","KIAA0885, CSDE1, D1S155E, NRU, UNR","Cold shock domain-containing protein E1","1","2YTX"
"2YTY",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9081-z",,"2YTY",9.42,,,"Solution structure of the fourth cold-shock domain of the human KIAA0885 protein (UNR protein)","GSSGSSGRLLGRNSNSKRLLGYVATLKDNFGFIETANHDKEIFFHYSEFSGDVDSLELGDMVEYSLSKGKGNKVSAEKVNKTSGPSSG","Homo sapiens","KIAA0885, CSDE1, D1S155E, NRU, UNR","Cold shock domain-containing protein E1","1","2YTY"
"2YU1",,"X-RAY DIFFRACTION",2.23,44.93,"VAPOR DIFFUSION, HANGING DROP",8,"25% PEG 3350, 0.1M NaCl, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"2YU1",53.12,"2.7","2.7","Crystal structure of hJHDM1A complexed with a-ketoglutarate","MEPEEERIRYSQRLRGTMRRRYEDDGISDDEIEGKRTFDLEEKLHTNKYNANFVTFMEGKDFNVEYIQRGGLRDPLIFKNSDGLGIKMPDPDFTVNDVKMCVGSRRMVDVMDVNTQKGIEMTMAQWTRYYETPEEEREKLYNVISLEFSHTRLENMVQRPSTVDFIDWVDNMWPRHLKESQTESTNAILEMQYPKVQKYCLMSVRGCYTDFHVDFGGTSVWYHIHQGGKVFWLIPPTAHNLELYENWLLSGSQGDIFLGDRVSDCQRIELKQGYTFVIPSGWIHAVYTPTDTLVFGGNFLHSFNIPMQLKIYNIEDRTRVPNKFRYPFYYEMCWYVLERYVYCITNRSHLTKEFQKESLSMDLELNGLESGNGDEEAVDREPRQVHLTHFELEGLRCLVDKLESLPLHKKCVPTGIEDEDALIADVKILLEELANSDPKLALTGVPIVQWP","Homo sapiens","hJHDM1A","JmjC domain-containing histone demethylation protein 1A","1","2YU1"
,,,,,,,,,,,,,,,,,"Homo sapiens","hJHDM1A"
"2YU2",,"X-RAY DIFFRACTION",2.24,44.99,"VAPOR DIFFUSION, HANGING DROP",8,"25% PEG 3350, 0.1M NaCl, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2YU2",52.97,"2.7","2.7","Crystal structure of hJHDM1A without a-ketoglutarate","MEPEEERIRYSQRLRGTMRRRYEDDGISDDEIEGKRTFDLEEKLHTNKYNANFVTFMEGKDFNVEYIQRGGLRDPLIFKNSDGLGIKMPDPDFTVNDVKMCVGSRRMVDVMDVNTQKGIEMTMAQWTRYYETPEEEREKLYNVISLEFSHTRLENMVQRPSTVDFIDWVDNMWPRHLKESQTESTNAILEMQYPKVQKYCLMSVRGCYTDFHVDFGGTSVWYHIHQGGKVFWLIPPTAHNLELYENWLLSGSQGDIFLGDRVSDCQRIELKQGYTFVIPSGWIHAVYTPTDTLVFGGNFLHSFNIPMQLKIYNIEDRTRVPNKFRYPFYYEMCWYVLERYVYCITNRSHLTKEFQKESLSMDLELNGLESGNGDEEAVDREPRQVHLTHFELEGLRCLVDKLESLPLHKKCVPTGIEDEDALIADVKILLEELANSDPKLALTGVPIVQWP","Homo sapiens","hJHDM1A","JmjC domain-containing histone demethylation protein 1A","1","2YU2"
,,,,,,,,,,,,,,,,,"Homo sapiens","hJHDM1A"
"2YU3",,"SOLUTION NMR",,,,,,,,,"2YU3",10.3,,,"Solution structure of the domain swapped WingedHelix in DNA-directed RNA polymerase III 39 kDa polypeptide","GSSGSSGGQLDLLRSNTGLLYRIKDSQNAGKMKGSDNQEKLVYQIIEDAGNKGIWSRDVRYKSNLPLTEINKILKNLESKKLIKAVKSVSGPSSG","Homo sapiens","POLR3F, RPC39","DNA-directed RNA polymerase III 39 kDa polypeptide F variant","1","2YU3"
"2YU4",,"SOLUTION NMR",,,,,,,,,"2YU4",10.7,,,"Solution structure of the SP-RING domain in non-SMC element 2 homolog (MMS21, S. cerevisiae)","GSSGSSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLIQDEALRRAIENHNKKRHRHSESGPSSG","Homo sapiens","C8orf36, NSMCE2, MMS21","E3 SUMO-protein ligase NSE2","1","2YU4"
"2YU5",,"SOLUTION NMR",,,,,,,,,"2YU5",4.79,,,"Solution structure of the zf-C2H2 domain (669-699AA) in zinc finger protein 473","GSSGSSGAGENPFKCSKCDRVFTQRNYLVQHERTHARKSGPSSG","Homo sapiens","ZNF473, KIAA1141, ZFP100","Zinc finger protein 473","1","2YU5"
"2YU6",,"SOLUTION NMR",,,,,,,,,"2YU6",16.14,,,"Solution structure of the YTH domain in YTH domain-containing protein 2","GSSGSSGVRYFIMKSSNLRNLEISQQKGIWSTTPSNERKLNRAFWESSIVYLVFSVQGSGHFQGFSRMSSEIGREKSQDWGSAGLGGVFKVEWIRKESLPFQFAHHLLNPWNDNKKVQISRDGQELEPQVGEQLLQLWERL","Homo sapiens","YTHDC2","YTH domain-containing protein 2","1","2YU6"
"2YU7",,"SOLUTION NMR",,,,,,,,,"2YU7",14.44,,,"Solution structure of the SHP-1 C-terminal SH2 domain complexed with a tyrosine-phosphorylated peptide from NKG2A","GSSGSSGWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYSGPSSG","Homo sapiens","SHP1, PTPN6, HCP, PTP1C","Tyrosine-protein phosphatase non-receptor type 6","1","2YU7"
,,,,,,,,,,,,,,,,"ATEQEITYAELNLQK",,,"natural killer group 2A","2","2YU7"
"2YU8",,"SOLUTION NMR",,,,,,,,,"2YU8",4.8,,,"Solution structure of the C2H2 type zinc finger (region 648-680) of human Zinc finger protein 347","GSSGSSGTGEKPYKCNECGKVFTQNSHLARHRRVHTGGKPSGPSSG","Homo sapiens","ZNF347, ZNF1111","Zinc finger protein 347","1","2YU8"
"2YUA",,"SOLUTION NMR",,,,,,,,,"2YUA",10.53,,,"Solution structure of the DnaJ domain from human Williams-Beuren syndrome chromosome region 18 protein","GSSGSSGSQGDCSYSRTALYDLLGVPSTATQAQIKAAYYRQCFLYHPDRNSGSAEAAERFTRISQAYVVLGSATLRRKYDRGLLSDEDLRGPGSGPSSG","Homo sapiens","WBSCR18, DNAJC30","Williams-Beuren syndrome chromosome region 18 protein","1","2YUA"
"2YUC",,"SOLUTION NMR",,,,,,,,,"2YUC",8.36,,,"Solution structure of the TRAF-type zinc finger domains (102-164) from human TNF receptor associated factor 4","GSSGSSGHLNTCSFNVIPCPNRCPMKLSRRDLPAHLQHDCPKRRLKCEFCGCDFSGEAYESHEGMCPQESSGPSSG","Homo sapiens","TRAF4, CART1, MLN62, RNF83","TNF receptor-associated factor 4","1","2YUC"
"2YUD",,"SOLUTION NMR",,,,,,,,,"2YUD",20.24,,,"Solution structure of the YTH domain in YTH domain-containing protein 1 (Putative splicing factor YT521)","GSSGSSGVRAVRKDQTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","2YUD"
"2YUF",,"SOLUTION NMR",,,,,,,,,"2YUF",15.79,,,"Solution structure of the NCD2 domain in human transcriptional repressor Nab1 protein","GSSGSSGEALDAAAALSVAECVERMAPTLPKSDLNEVKELLKTNKKLAKMIGHIFEMNDDDPHKEEEIRKYSAIYGRFDSKRKDGKHLTLHELTVNEAAAQLCVKDNALLTRRDELFALARQISREVTYKYTYRTTSGPSSG","Homo sapiens","AB1350_G01, NAB1","NGFI-A-binding protein 1","1","2YUF"
"2YUH",,"SOLUTION NMR",,,,,,,,,"2YUH",20.01,,,"Solution structure of the C-terminal region in human tubulin folding cofactor C","GSSGSSGSWVCGFSNLESQVLEKRASELHQRDVLLTELSNCTVRLYGNPNTLRLTKAHSCKLLCGPVSTSVFLEDCSDCVLAVACQQLRIHSTKDTRIFLQVTSRAIVEDCSGIQFAPYTWSYPEIDKDFESSGLDRSKNNWNDVDDFNWLARDMASPNWSILPEEERNIQWDSGPSSG","Homo sapiens","TBCC, AB1653_A09","Tubulin-specific chaperone C","1","2YUH"
"2YUI",,"SOLUTION NMR",,,,,,,,,"2YUI",19.2,,,"Solution structure of the N-terminal domain in human cytokine-induced apoptosis inhibitor anamorsin","GSSGSSGMADFGISAGQFVAVVWDKSSPVEALKGLVDKLQALTGNEGRVSVENIKQLLQSAHKESSFDIILSGLVPGSTTLHSAEILAEIARILRPGGCLFLKEPVETAVDNNSKVKTASKLCSALTLSGLVEVKELQREPLTPEEVQSVREHLGHESDNLLFVQITGKKPNFEVGSGPSSG","Homo sapiens","IOH4051, CIAPIN1, CUA001, PRO0915","Anamorsin","1","2YUI"
"2YUJ",,"SOLUTION NMR",,,,,,,,,"2YUJ",21.27,,,"Solution structure of human ubiquitin fusion degradation protein 1 homolog UFD1","GSSGSSGIPRVFQNRFSTQYRCFSVSMLAGPNDRSDVEKGGKIIMPPSALDQLSRLNITYPMLFKLTNKNSDRMTHCGVLEFVADEGICYLPHWMMQNLLLEEGGLVQVESVNLQVATYSKFQPQSPDFLDITNPKAVLENALRNFACLTTGDVIAINYNEKIYELRVMETKPDKAVSIIECDMNVDFDA","Homo sapiens","AB1165_B04, UFD1, UFD1L","Ubiquitin fusion degradation 1-like","1","2YUJ"
"2YUK",,"SOLUTION NMR",,,,,,,,,"2YUK",10.21,,,"Solution structure of the HMG box of human Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog","GSSGSSGNAQRSTLKWEKEEALGEMATVAPVLYTNINFPNLKEEFPDWTTRVKQIAKLWRKASSQERAPYVQKARDNRAALRINKVQMSN","Homo sapiens","MLL3, KMT2C, HALR, KIAA1506","Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog","1","2YUK"
"2YUL",,"SOLUTION NMR",,,,,,,,,"2YUL",9.29,,,"Solution structure of the HMG box of human Transcription factor SOX-17","GSSGSSGIRRPMNAFMVWAKDERKRLAQQNPDLHNAELSKMLGKSWKALTLAEKRPFVEEAERLRVQHMQDHPNYKSGPSSG","Homo sapiens","SOX17","Transcription factor SOX-17","1","2YUL"
"2YUM",,"SOLUTION NMR",,,,,,,,,"2YUM",8.3,,,"Solution structure of the Myb-like DNA-binding domain of human ZZZ3 protein","GSSGSSGNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASQVQKYFIKLTKAGIPVSGPSSG","Homo sapiens","ZZZ3","Zinc finger ZZ-type-containing protein 3","1","2YUM"
"2YUN",,"SOLUTION NMR",,,,,,,,,"2YUN",8.42,,,"Solution structure of the SH3 domain of human Nostrin","GSSGSSGRLCKALYSFQARQDDELNLEKGDIVIIHEKKEEGWWFGSLNGKKGHFPAAYVEELPSNAGNTATKASGPSSG","Homo sapiens","NOSTRIN","Nostrin","1","2YUN"
"2YUP",,"SOLUTION NMR",,,,,,,,,"2YUP",9.93,,,"Solution structure of the second SH3 domain of human Vinexin","GSSGSSGKPPTYQVLEYGEAVAQYTFKGDLEVELSFRKGEHICLIRKVNENWYEGRITGTGRQGIFPASYVQVSREPRLRLCDDSGPSSG","Homo sapiens","SORBS3, SCAM1","Vinexin","1","2YUP"
"2YUQ",,"SOLUTION NMR",,,,,,,,,"2YUQ",10.01,,,"Solution structure of the SH3 domain of human Tyrosine-protein kinase ITK/TSK","GSSGSSGEDNRRPLWEPEETVVIALYDYQTNDPQELALRRNEEYCLLDSSEIHWWRVQDRNGHEGYVPSSYLVEKSPNNLETYEW","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","2YUQ"
"2YUR",,"SOLUTION NMR",,,,,,,,,"2YUR",7.82,,,"Solution structure of the Ring finger of human Retinoblastoma-binding protein 6","GSSGSSGEDDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALSGPSSG","Homo sapiens","RBBP6, P2PR, PACT, RBQ1, My038","Retinoblastoma-binding protein 6","1","2YUR"
"2YUS",,"SOLUTION NMR",,,,,,,,,"2YUS",8.62,,,"Solution structure of the SANT domain of human SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1","GSSGSSGTLAKSKGASAGREWTEQETLLLLEALEMYKDDWNKVSEHVGSRTQDECILHFLRLPIEDPYLENSDSGPSSG","Homo sapiens","SMARCC1, BAF155","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1","1","2YUS"
"2YUU",,"SOLUTION NMR",,,,,,,,,"2YUU",9.09,,,"Solution structure of the first Phorbol esters/diacylglycerol binding domain of human Protein kinase C, delta","GSSGSSGKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTSGPSSG","Homo sapiens","PRKCD, PKCD","Protein kinase C delta type","1","2YUU"
"2YUV",,"SOLUTION NMR",,,,,,,,,"2YUV",11.09,,,"Solution Structure of 2nd Immunoglobulin Domain of Slow Type Myosin-Binding Protein C","GSSGSSGAAFAKILDPAYQVDKGGRVRFVVELADPKLEVKWYKNGQEIRPSTKYIFEHKGCQRILFINNCQMTDDSEYYVTAGDEKCSTELFVRSGPSSG","Homo sapiens","MYBPC1, MYBPCS","Myosin-binding protein C, slow-type","1","2YUV"
"2YUW",,"SOLUTION NMR",,,,,,,,,"2YUW",11.66,,,"Solution Structure of 2nd Fibronectin Domain of Slow Type Myosin-Binding Protein C","GSSGSSGTSPPTLLTVDSVTDTTVTMRWRPPDHIGAAGLDGYVLEYCFEGTEDWIVANKDLIDKTKFTITGLPTDAKIFVRVKAVNAAGASEPKYYSQPILVKESGPSSG","Homo sapiens","MYBPC1, MYBPCS","Myosin binding protein C, slow type","1","2YUW"
"2YUX",,"SOLUTION NMR",,,,,,,,,"2YUX",13.27,,,"Solution Structure of 3rd Fibronectin type three Domain of slow type Myosin-Binding Protein C","GSSGSSGASIDIQIIDRPGPPQIVKIEDVWGENVALTWTPPKDDGNAAITGYTIQKADKKSMEWFTVIEHYHRTSATITELVIGNEYYFRVFSENMCGLSEDATMTKESAVIARDGKIYK","Homo sapiens","MYBPC1, MYBPCS","Myosin-binding protein C, slow-type","1","2YUX"
"2YUY",,"SOLUTION NMR",,,,,,,,,"2YUY",13.5,,,"Solution Structure of PDZ domain of Rho GTPase Activating Protein 21","GSSGSSGGPKTVTLKRTSQGFGFTLRHFIVYPPESAIQFSYKDEENGNRGGKQRNRLEPMDTIFVKQVKEGGPAFEAGLCTGDRIIKVNGESVIGKTYSQVIALIQNSDTTLELSVMPKDSGPSSG","Homo sapiens","ARHGAP21, ARHGAP10, KIAA1424","Rho GTPase activating protein 21","1","2YUY"
"2YUZ",,"SOLUTION NMR",,,,,,,,,"2YUZ",10.66,,,"Solution Structure of 4th Immunoglobulin Domain of Slow Type Myosin-Binding Protein C","GSSGSSGLKILTPLTDQTVNLGKEICLKCEISENIPGKWTKNGLPVQESDRLKVVQKGRIHKLVIANALTEDEGDYVFAPDAYNVTLPAKVHVISGPSSG","Homo sapiens","MYBPC1, MYBPCS","Myosin-binding protein C, slow-type","1","2YUZ"
"2YV6",,"X-RAY DIFFRACTION",2.03,39.54,"VAPOR DIFFUSION, HANGING DROP",5.2,"ammonium sulfate, iso-propanol, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2008.12.003",,"2YV6",18.74,"2.5","2.5","Crystal structure of human Bcl-2 family protein Bak","SEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAALNLGN","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","2YV6"
"2YV8",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Magnesium formate, 15% PEG 3350, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YV8",18.1,"1.92","1.92","Crystal structure of N-terminal domain of human galectin-8","GSSGSSGMMLSLNNLQNIIYNPVIPYVGTIPDQLDPGTLIVICGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSGPSSG","Homo sapiens","LGALS8","Galectin-8 variant","1","2YV8"
"2YVI",,"X-RAY DIFFRACTION",1.87,34.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M NaCl, 0.1M TrisCl pH8.5, 25% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2YVI",12.3,"1.92","1.92","Crystal structure of a death domain of human ankryn protein","GSSGSSGPGSLSGTEQAEMKMAVISEHLGLSWAELARELQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEGSGRQSRNLKPDR","Homo sapiens","ANK1, ANK","Ankyrin-1","1","2YVI"
"2YVQ",,"X-RAY DIFFRACTION",2.35,47.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6M (NH4)2SO4, 0.1M MES, 10%(V/V) dioxane, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YVQ",15.61,"1.98","1.98","Crystal structure of MGS domain of carbamoyl-phosphate synthetase from homo sapiens","GSSGSSGHTAFLKAMLSTGFKIPQKGILIGIQQSFRPRFLGVAEQLHNEGFKLFATEATSDWLNANNVPATPVAWPSQEGQNPSLSSIRKLIRDGSIDLVINLPNNNTKFVHDNYVIRRTAVDSGIPLLTNFQVTKLFAEAVQ","Homo sapiens","CPS1","Carbamoyl-phosphate synthase","1","2YVQ"
"2YVR",,"X-RAY DIFFRACTION",2.01,38.68,"VAPOR DIFFUSION, HANGING DROP",7.6,"HEPES, PEG4000, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2YVR",12.16,"1.8","1.8","Crystal structure of MS1043","RDGERTVYCNVHKHEPLVLFCESCDTLTCRDCQLNAHKDHQYQFLEDAVR","Homo sapiens","TRIM28, KAP1, RNF96, TIF1B","Transcription intermediary factor 1-beta","1","2YVR"
"2YW5",,"SOLUTION NMR",,,,,,,,,"2YW5",15.92,,,"Solution structure of the bromodomain from human bromodomain containing protein 3","GSSGSSGEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFYQPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTDDIVLMAQALEKIFLQKVAQMPQEEVELLPPAPKGK","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","2YW5"
"2YW8",,"X-RAY DIFFRACTION",6.8,81.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"Bis-tris, Ammonium sulfate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2YW8",9.57,"3","3","Crystal structure of human RUN and FYVE domain-containing protein","IKEVNQALKGHAWLKDDEATHCRQCEKEFSISRRKHHCRNCGHIFCNTCSSNELALPSYPKPVRVCDSCHTLLLQRCSSTAS","Homo sapiens","RUFY1, RABIP4, ZFYVE12","RUN and FYVE domain-containing protein 1","1","2YW8"
"2YWK",,"X-RAY DIFFRACTION",1.787452,31.186951,"VAPOR DIFFUSION, SITTING DROP",5,"1.26M Sodium dihydrogen phosphate, 0.14M di-Potassium hydrogen phosphate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YWK",10.34,"1.54","1.54","Crystal structure of RRM-domain derived from human putative RNA-binding protein 11","GSSGSSGMFPAQEEADRTVFVGNLEARVREEILYELFLQAGPLTKVTICKDREGKPKSFGFVCFKHPESVSYAIALLNGIRLYGRPINVSGPSSG","Homo sapiens","RBM11","Putative RNA-binding protein 11","1","2YWK"
"2YWP",,"X-RAY DIFFRACTION",2.73,54.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmcl.2006.01.028","A42","2YWP",31.4,"2.9","2.9","Crystal Structure of CHK1 with a Urea Inhibitor","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2YWP"
"2YX8",,"X-RAY DIFFRACTION",1.88,31.159447,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.1M tri-Sodium Citrate Dihydrate, 0.15M di-Ammonium Citrate, 25% PEG3350, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.036012.108",,"2YX8",10.78,"2.4","2.4","Crystal structure of the extracellular domain of human RAMP1","GSFTSSGCQEANYGALLRELCLTQFQVDMEAVGETLWCDWGRTIRSYRELADCTWHMAEKLGCFWPNAEVDRFFLAVHGRYFRSCPISGRAVR","Homo sapiens","RAMP1","Receptor activity-modifying protein 1","1","2YX8"
"2YXF",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG 4000, 25% Glycerol, 0.06M ammoniumacetate, 0.1M MOPS, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1093/jb/mvm148",,"2YXF",11.88,"1.13","1.13","The high resolution crystal structure of beta2-microglobulin under physiological conditions","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","2YXF"
"2YXJ",,"X-RAY DIFFRACTION",2.5,51.2,"VAPOR DIFFUSION, HANGING DROP",8,"0.85M Sodium Citrate, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1038/sj.cdd.4402178","N3C","2YXJ",43.36,"2.2","2.2","Crystal structure of Bcl-xL in complex with ABT-737","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","Bcl-xL","Apoptosis regulator Bcl-X","1","2YXJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","Bcl-xL"
"2YXM",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, SITTING DROP",5.7,"0.2M pottasium sodium tartrate tetrahydrate, 0.1M tri-sodium citrate dihydrate, 2M ammonium sulfate, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YXM",11.09,"1.51","1.51","Crystal structure of I-set domain of human Myosin Binding ProteinC","GSSGSSGAAFAKILDPAYQVDKGGRVRFVVELADPKLEVKWYKNGQEIRPSTKYIFEHKGCQRILFINNCQMTDDSEYYVTAGDEKCSTELFVRSGPSSG","Homo sapiens","MYBPC1, MYBPCS","Myosin-binding protein C, slow-type","1","2YXM"
"2YXS",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris, 25% PEG3350, 1mM lactose, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YXS",18.44,"2.13","2.13","Crystal Structure of N-terminal domain of human galectin-8 with D-lactose","GSSGSSGMMLSLNNLQNIIYNPVIPYVGTIPDQLDPGTLIVICGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSGPSSG","Homo sapiens","LGALS8","Galectin-8 variant","1","2YXS"
"2YXT",,"X-RAY DIFFRACTION",3.2,61.59,"VAPOR DIFFUSION, HANGING DROP",8,"20mM K-PO4 (pH 7.0), 100mM NaCl, 100mM Tris-HCl (pH 8.0), 50% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1110/ps.073022107",,"2YXT",72.56,"2","2","Human Pyridoxal Kinase","MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKWDGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAMLLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDIEDPEIVVQATVL","Homo sapiens","PDXK, PKH, PNK, C21orf124, C21orf97, PRED79","Pyridoxal kinase","1","2YXT"
"2YXU",,"X-RAY DIFFRACTION",3.15,60.96,"VAPOR DIFFUSION, HANGING DROP",8,"2mM MgATP, 20mM K-PO4 (pH 7.0), 100mM NaCl, 100mM Tris-HCl (pH 8.0), 50% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1110/ps.073022107",,"2YXU",73.29,"2.2","2.2","Human Pyridoxal Kinase","MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKWDGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAMLLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDIEDPEIVVQATVL","Homo sapiens","PDXK, PKH, PNK, C21orf124, C21orf97, PRED79","Pyridoxal kinase","1","2YXU"
"2YY0",,"X-RAY DIFFRACTION",2.72,54.86,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1M Tris-HCl, 2M NH4H2PO4, pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YY0",24.47,"2.4","2.4","Crystal Structure of MS0802, c-Myc-1 binding protein domain from Homo sapiens","NSALDFLKHHLGAATPENPEIELLRLELAEMKEKYEAIVEENKKLKAKLAQYE","Homo sapiens","MYCBP, AMY1","C-Myc-binding protein","1","2YY0"
"2YY1",,"X-RAY DIFFRACTION",1.98,37.99,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.2M sodium acetate trihydrate, 0.1M sodium cacodylate, 30% PEG 8000, 30mM L-acetyllactosamine, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YY1",17.61,"2.17","2.17","Crystal structure of N-terminal domain of human galectin-9 containing L-acetyllactosamine","GSSGSSGMAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFSGPSSG","Homo sapiens","LGALS9","Galectin-9","1","2YY1"
"2YY2",,"X-RAY DIFFRACTION",4.69,73.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"2mM IBMX, 0.1 M Hepes, 2.2M Na-formate, 3% xylitol, 20mM ZnSO4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"IBM","2YY2",78.76,"2.8","2.8","Crystal structure of the human Phosphodiesterase 9A catalytic domain complexed with IBMX","GSSGSSGPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","2YY2"
"2YYN",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.2M ammonium acetate, 0.1M HEPES, 25% PEG 3350, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YYN",61.95,"2.5","2.5","Crystal structure of human bromodomain protein","GSSGSSGKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYPEKRFPKSGPSSG","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","2YYN"
"2YYO",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 1.6M Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YYO",18.26,"2","2","Crystal structure of human SPRY domain","GSSGSSGFKHILVDGDTLSYHGNSGEVGCYVASRPLTKDSNYFEVSIVDSGVRGTIAVGLVPQYYSLDHQPGWLPDSVAYHADDGKLYNGRAKGRQFGSKCNSGDRIGCGIEPVSFDVQTAQIFFTKNGKRVGSTIMPMSPDGLFPAVGMHSLGEEVRLHLNAELSGPSSG","Homo sapiens","SPRYD3","SPRY domain-containing protein 3","1","2YYO"
"2YZ8",,"X-RAY DIFFRACTION",2.22,44.56,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M potassium sodium tartrate tetrahydrate, 0.1M tri-sodium citrate dihydrate pH 5.6, 2M ammonium sulfate   
, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2YZ8",10.84,"2","2","Crystal structure of the 32th Ig-like domain of human obscurin (KIAA1556)","GSSGSSGPVRFQEALKDLEVLEGGAATLRCVLSSVAAPVKWCYGNNVLRPGDKYSLRQEGAMLELVVRNLRPQDSGRYSCSFGDQTTSATLTVTALPSGPSSG","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","2YZ8"
"2YZA",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION, HANGING DROP",8.9,"0.1M Tris-HCl pH8.9, 16% PEG4000, 15% isopropanol, 0.1M Ammonium sulfate, Protein solution: 5mM AMPPNP, 5mM Magnesium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444911010201",,"2YZA",31.57,"3.02","3.02","Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)","GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE","Homo sapiens","PRKAA2, AMPK, AMPK2","5'-AMP-activated protein kinase catalytic subunit alpha-2","1","2YZA"
"2Z0B",,"X-RAY DIFFRACTION",3.26,62.32,"VAPOR DIFFUSION, HANGING DROP",5,"1.0M Sodium/Potassium Phosphate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0B",84.57,"2","2","Crystal structure of CBM20 domain of human putative glycerophosphodiester phosphodiesterase 5 (KIAA1434)","GSSGSSGPSQVAFEIRGTLLPGEVFAICGSCDALGNWNPQNAVALLPENDTGESMLWKATIVLSRGVSVQYRYFKGYFLEPKTIGGPCQVIVHKWETHLQPRSITPLESEIIIDDGQFGIHNGVESGPSSG","Homo sapiens","GDE5, KIAA1434, GPCPD1","Putative glycerophosphodiester phosphodiesterase 5","1","2Z0B"
"2Z0N",,"X-RAY DIFFRACTION",1.96,37.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"17.5% PEG3350, 0.2M Ammonium sulfate, 0.1M Hepes, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0N",32.71,"1.95","1.95","Crystal structure of APPL1-BAR domain","GPLGSMPGIDKLPIEETLEDSPQTRSLLGVFEEDATAISNYMNQLYQAMHRIYDAQNELSAATHLTSKLLKEYEKQRFPLGGDDEVMSSTLQQFSKVIDELSSCHAVLSTQLADAMMFPITQFKERDLKEILTLKEVFQIASNDHDAAINRYSRLSKKRENDKVKYEVTEDVYTSRKKQHQTMMHYFCALNTLQYKKKIALLEPLLGYMQAQISFFKMGSENLNEQLEEFLANIGTSVQNVRREMDSDIETMQQTIEDLEVASDPLYVPDPDPTKFPVNR","Homo sapiens","APPL1, APPL, DIP13A, KIAA1428","DCC-interacting protein 13-alpha","1","2Z0N"
"2Z0O",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG3350, 0.2M Ammonium acetate, 0.1M Bis-tris, 0.3M Non-Detergent Sulfo-betaine 195, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0O",45,"2.58","2.58","Crystal structure of APPL1-BAR-PH domain","GSMPGIDKLPIEETLEDSPQTRSLLGVFEEDATAISNYMNQLYQAMHRIYDAQNELSAATHLTSKLLKEYEKQRFPLGGDDEVMSSTLQQFSKVIDELSSCHAVLSTQLADAMMFPITQFKERDLKEILTLKEVFQIASNDHDAAINRYSRLSKKRENDKVKYEVTEDVYTSRKKQHQTMMHYFCALNTLQYKKKIALLEPLLGYMQAQISFFKMGSENLNEQLEEFLANIGTSVQNVRREMDSDIETMQQTIEDLEVASDPLYVPDPDPTKFPVNRNLTRKAGYLNARNKTGLVSSTWDRQFYFTQGGNLMSQARGDVAGGLAMDIDNCSVMAVDCEDRRYCFQITSFDGKKSSILQAESKKDHEEWICTINNISKQIYLSENPEE","Homo sapiens","APPL1, APPL, DIP13A, KIAA1428","DCC-interacting protein 13-alpha","1","2Z0O"
"2Z0P",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.2M Li2SO4, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2008.09.055",,"2Z0P",83.06,"2.58","2.58","Crystal structure of PH domain of Bruton's tyrosine kinase","AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","2Z0P"
"2Z0U",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0U",34.19,"2.2","2.2","Crystal structure of C2 domain of KIBRA protein","GSSGSSGVQRLGASEAAAFDSDESEAVGATRIQIALKYDEKNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVSMSYPALHQKTLRVDVCTTDRSHLEECLGGAQISLAEVCRSGERSTRWYNLLS","Homo sapiens","WWC1, KIAA0869","WW domain-containing protein 1","1","2Z0U"
"2Z0V",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, HANGING DROP",,"Na Formate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0V",55.13,"2.49","2.49","Crystal structure of BAR domain of Endophilin-III","GSSGSSGAEGTKLDDEFLDMERKIDVTNKVVAEILSKTTEYLQPNPAYRAKLGMLNTVSKIRGQVKTTGYPQTEGLLGDCMLKYGKELGEDSTFGNALIEVGESMKLMAEVKDSLDINVKQTFIDPLQLLQDKDLKEIGHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMFNFLENDVEQVSQLAVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPRREYK","Homo sapiens","SH3GL3, CNSA3, SH3D2C","SH3-containing GRB2-like protein 3","1","2Z0V"
"2Z0W",,"X-RAY DIFFRACTION",2.38,48.38,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.6M Li sulfate, 0.5M Ammonium Sulfate, 0.1M Na-citrate, 40% acetonitrile, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z0W",10.2,"2.5","2.5","Crystal structure of the 2nd CAP-Gly domain in human Restin-like protein 2 reveals a swapped-dimer","GSSGSSGEGELRLGERVLVVGQRLGTIRFFGTTNFAPGYWYGIELEKPHGKNDGSVGGVQYFSCSPRYGIFAPPSRVQRVTDSLDTLSEISGPSSG","Homo sapiens","CLIP4, RSNL2","CAP-Gly domain-containing linker protein 4","1","2Z0W"
"2Z13",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M Sodium iodate, 0.1M Bis-Tris, 20% PEG3350, pH7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z13",15.34,"1.84","1.84","Crystal structure of the N-terminal DUF1126 in human EF-hand domain","GSSGSSGWVAFDKQVLSFDAYLEEEVLDKSQTNYRIRYYKIYFYPEDDTIQVNEPEVKNSGLLQGTSIRRHRITLPPPDEDQFYTVYHFNVGTEVVFYGRTFKIYDCDAFTRNFLRKMGVKVNPPVQSGPSSG","Homo sapiens","EFHC2","EF-hand domain-containing family member C2","1","2Z13"
"2Z14",,"X-RAY DIFFRACTION",1.98,38.03,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M Sodium acetate trihydrate, 2.0M Ammonium Sulfate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z14",15.33,"1.68","1.68","Crystal structure of the N-terminal DUF1126 in human ef-hand domain containing 2 protein","GSSGSSGWVAFDKQVLSFDAYLEEEVLDKSQTNYRIRYYKIYFYPEDDTIQVNEPEVKNSGLLQGTSIRRHRITLPPPDEDQFYTVYHFNVGTEVVFYGRTFKIYDCDAFTRNFLRKIGVKVNPPVQSGPSSG","Homo sapiens","EFHC2","EF-hand domain-containing family member C2","1","2Z14"
"2Z15",,"X-RAY DIFFRACTION",2.85,56.79,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M Sodium acetate trihydrate, 8% PEG4000, pH4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z15",58.55,"2.3","2.3","Crystal structure of human Tob1 protein","GSSGSSGMQLEIQVALNFIISYLYNKLPRRRVNIFGEELERLLKKKYEGHWYPEKPYKGSGFRCIHIGEKVDPVIEQASKESGLDIDDVRGNLPQDLSVWIDPFEVSYQIGEKGPVKVLYVDDNSGPSSG","Homo sapiens","TOB1, TOB, TROB1","Protein Tob1","1","2Z15"
"2Z17",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES-Na, 2.0M Ammonium Sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z17",11.3,"2.7","2.7","Crystal structure of PDZ domain from human Pleckstrin homology, Sec7","GSSGSSGLSDFSWSQRKLVTVEKQDNETFGFEIQSYRPQNQNACSSEMFTLICKIQEDSPAHCAGLQAGDVLANINGVSTEGFTYKQVVDLIRSSGNLLTIETL","Homo sapiens","CYTIP, PSCDBP","Pleckstrin homology Sec7 and coiled-coil domains-binding protein","1","2Z17"
"2Z2D",,"SOLUTION NMR",,,,,,,,"HSI","2Z2D",18.88,,,"Solution structure of human macrophage elastase (MMP-12) catalytic domain complexed with a gamma-keto butanoic acid inhibitor","FREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2Z2D"
"2Z2W",,"X-RAY DIFFRACTION",2.97,58.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"NaCL, HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Z2W",32.7,"2.22","2.22","Human Wee1 kinase complexed with inhibitor PF0335770","MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","2Z2W"
"2Z3Y",,"X-RAY DIFFRACTION",3.68,66.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1mM Hepes-Na, 5% MPD, 3-4.5% PEG monomethylether 2000, 1mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1016/j.bbrc.2007.11.066",,"2Z3Y",74.57,"2.25","2.25","Crystal structure of Lysine-specific demethylase1","SGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KIAA0601, LSD1, KDM1A, AOF2, KDM1","Lysine-specific histone demethylase 1","1","2Z3Y"
"2Z4B",,"X-RAY DIFFRACTION",2.5,50.77,"VAPOR DIFFUSION",8,"0.1M Tris, pH 8.0, 2M sodium chloride, 4% PEG 6000, VAPOR DIFFUSION, temperature 289.0K",289,"10.1016/j.bmcl.2007.06.052","DC8","2Z4B",59.09,"2.34","2.34","Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand","MHHHHHHRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKS","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","2Z4B"
"2Z4F",,"SOLUTION NMR",,,,,,,"10.1038/sj.emboj.7601833",,"2Z4F",19.39,,,"Solution structure of the Discoidin Domain of DDR2","EAEFNPAICRYPLGMSGGQIPDEDITASSQWSESTAAKYGRLDSEEGDGAWCPEIPVEPDDLKEFLQIDLHTLHFITLVGTQGRHAGGHGIEFAPMYKINYSRDGTRWISWRNRHGKQVLDGNSNPYDIFLKDLEPPIVARFVRFIPVTDHSMNVCMRVELYGCVGSGSIEGR","Homo sapiens","DDR2, NTRKR3, TKT, TYRO10","Discoidin domain-containing receptor 2","1","2Z4F"
"2Z4J",,"X-RAY DIFFRACTION",2.22,44.69,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Bis-Tris Propane, 1.2M Potassium Sodium Tartrate tetrahydrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1107/S0907444907045702","DHT","2Z4J",30.36,"2.6","2.6","Crystal structure of AR LBD with SHP peptide NR Box 2","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT","Homo sapiens","AR, NR3C4, DHTR","Androgen receptor","1","2Z4J"
,,,,,,,,,,,,,,,,"PSILKKILLE",,,"Nuclear receptor 0B2","2","2Z4J"
"2Z5D",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2N NaCl, 0.1M bis-Tris, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1074/mcp.O111.013706",,"2Z5D",40.53,"2.1","2.1","Human ubiquitin-conjugating enzyme E2 H","MGSSHHHHHHSSGLVPRGSMSSPSPGKRRMDTDVIKLIESKHEVTILGGLNEFVVKFYGPQGTPYEGGVWKVRVDLPDKYPFKSPSIGFMNKIFHPNIDEASGTVCLDVINQTWTALYDLTNIFESFLPQLLAYPNPIDPLNGDAAAMYLHRPEEYKQKIKEYIQKYATEEALKEQEEG","Homo sapiens","UBE2H","Ubiquitin-conjugating enzyme E2 H","1","2Z5D"
"2Z5E",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION, HANGING DROP",8.5,"30%(w/v) PEG4000, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1038/nsmb.1386",,"2Z5E",26.24,"2","2","Crystal Structure of Proteasome Assembling Chaperone 3","MEDTPLVISKQKTEVVCGVPTQVVCTAFSSHILVVVTQFGKMGTLVSLEPSSVASDVSKPVLTTKVLLGQDEPLIHVFAKNLVAFVSQEAGNRAVLLAVAVKDKSMEGLKALREVIRVCQVW","Homo sapiens","PSMG3, C7orf48, PAC3","Proteasome Assembling Chaperone 3","1","2Z5E"
"2Z5F",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M BisTris, 0.2M ammonium sulfate, 16-20% polyethylene glycol 4000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1002/prot.21048",,"2Z5F",71.1,"2.1","2.1","Human sulfotransferase Sult1b1 in complex with PAP","GSMLSPKDILRKDLKLVHGYPMTCAFASNWEKIEQFHSRPDDIVIATYPKSGTTWVSEIIDMILNDGDIEKCKRGFITEKVPMLEMTLPGLRTSGIEQLEKNPSPRIVKTHLPTDLLPKSFWENNCKMIYLARNAKDVSVSYYHFDLMNNLQPFPGTWEEYLEKFLTGKVAYGSWFTHVKNWWKRKEEHPILFLYYEDMKENPKEEIKKIIRFLEKNLNDEILDRIIHHTSFEVMKDNPLVNYTHLPTTVMDHSKSPFMRKGTAGDWKNYFTVAQNEKFDAIYETEMSKTALQFRTEI","Homo sapiens","SULT1B1, ST1B2, SULT1B2","Sulfotransferase family cytosolic 1B member 1","1","2Z5F"
"2Z5J",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, HANGING DROP",9.8,"6% PEG 8000, 0.1M sodium dihidrogen phosphate, 0.1M CAPSO pH 9.8, 0.04M spermidine, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.molcel.2007.08.006",,"2Z5J",101.41,"3.4","3.4","Free Transportin 1","MEYEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDEPTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGELQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDVLDRPLNIMIPKFLQFFKHSSPKIRSHAVACVNQFIISRTQALMLHIDSFIENLFALAGDEEPEVRKNVCRALVMLLEVRMDRLLPHMHNIVEYMLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLVNGMKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCMQGMIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGHHLNKPEYIQMLMPPLIQKWNMLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVNLVQKTLAQAMLNNAQPDQYEAPDKDFMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIADFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVNPSGVIQDFIFFCDAVASWINPKDDLRDMFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYGV","Homo sapiens","TNPO1, KPNB2, MIP1, TRN","Transportin-1","1","2Z5J"
"2Z5M",,"X-RAY DIFFRACTION",3.69,66.65,"VAPOR DIFFUSION, HANGING DROP",8.8,"100mM Tris-HCl pH 8.8, 16-18% (w/v) PEG 8000, 0.1M NaH2PO4, 0.1M KCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.08.006",,"2Z5M",104.9,"3","3","Complex of Transportin 1 with TAP NLS, crystal form 2","MEYEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDEPTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGELQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDVLDRPLNIMIPKFLQFFKHSSPKIRSHAVACVNQFIISRTQALMLHIDSFIENLFALAGDEEPEVRKNVCRALVMLLEVRMDRLLPHMHNIVEYMLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLVNGMKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCMQGMIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGHHLNKPEYIQMLMPPLIQKWNMLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVNLVQKTLAQAMLNNAQPDQYEAPDKDFMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIADFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVNPSGVIQDFIFFCDAVASWINPKDDLRDMFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYGV","Homo sapiens","TNPO1, KPNB2, MIP1, TRN","Transportin-1","1","2Z5M"
,,,,,,,,,,,,,,,,"EEDDGDVAMSDAQDGPRVRYNPYTTRPNRR",,,"Nuclear RNA export factor 1","2","2Z5M"
"2Z5N",,"X-RAY DIFFRACTION",3.01,59.11,"VAPOR DIFFUSION, HANGING DROP",8.8,"0.1M Tris-HCl pH 8.8, 16-20%(w/v) PEG 8000, 0.1M KCl, 0.1M NaH2PO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.08.006",,"2Z5N",104.18,"3.2","3.2","Complex of Transportin 1 with hnRNP D NLS","MEYEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDEPTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGELQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDVLDRPLNIMIPKFLQFFKHSSPKIRSHAVACVNQFIISRTQALMLHIDSFIENLFALAGDEEPEVRKNVCRALVMLLEVRMDRLLPHMHNIVEYMLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLVNGMKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCMQGMIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGHHLNKPEYIQMLMPPLIQKWNMLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVNLVQKTLAQAMLNNAQPDQYEAPDKDFMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIADFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVNPSGVIQDFIFFCDAVASWINPKDDLRDMFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYGV","Homo sapiens","TNPO1, KPNB2, MIP1, TRN","Transportin-1","1","2Z5N"
,,,,,,,,,,,,,,,,"YSNQQSGYGKVSRRGGHQNSYKPY",,,"Heterogeneous nuclear ribonucleoprotein D0","2","2Z5N"
"2Z5O",,"X-RAY DIFFRACTION",3.76,67.28,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.1M Tris-HCl pH 8.6, 14% (w/v) PEG 8000, 0.1M NaH2PO4, 0.015mM Phenol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.08.006",,"2Z5O",102.28,"3.2","3.2","Complex of Transportin 1 with JKTBP NLS","MEYEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDEPTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGELQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDVLDRPLNIMIPKFLQFFKHSSPKIRSHAVACVNQFIISRTQALMLHIDSFIENLFALAGDEEPEVRKNVCRALVMLLEVRMDRLLPHMHNIVEYMLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLVNGMKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCMQGMIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGHHLNKPEYIQMLMPPLIQKWNMLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVNLVQKTLAQAMLNNAQPDQYEAPDKDFMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIADFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVNPSGVIQDFIFFCDAVASWINPKDDLRDMFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYGV","Homo sapiens","TNPO1, KPNB2, MIP1, TRN","Transportin-1","1","2Z5O"
,,,,,,,,,,,,,,,,"XXXXXXXXXX",,,"Heterogeneous nuclear ribonucleoprotein D-like","2","2Z5O"
"2Z5U",,"X-RAY DIFFRACTION",3.68,66.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1mM Hepes-Na, 5% MPD, 3-4.5% PEG monomethylether 2000, 1mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1016/j.bbrc.2007.11.066",,"2Z5U",74.57,"2.25","2.25","Crystal structure of Lysine-specific histone demethylase 1","SGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KIAA0601, LSD1, KDM1A, AOF2, KDM1","Lysine-specific histone demethylase 1","1","2Z5U"
"2Z5V",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0812956106",,"2Z5V",17.39,,,"Solution structure of the TIR domain of human MyD88","TTLDDPLGHMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","2Z5V"
"2Z5X",,"X-RAY DIFFRACTION",3.45,64.36,"VAPOR DIFFUSION, SITTING DROP",5.6,"1.6M AMMONIUM SULFATE, 100mM CITRIC ACID, pH 5.60, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0710626105","HRM","2Z5X",59.97,"2.2","2.2","Crystal Structure of Human Monoamine Oxidase A with Harmine","HMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRGAFPPVWNPIAYLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNINVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKLNHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPMGAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADRLAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYGRVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKDVPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLL","Homo sapiens","MAOA","Amine oxidase [flavin-containing] A","1","2Z5X"
"2Z5Y",,"X-RAY DIFFRACTION",3.46,64.49,"VAPOR DIFFUSION, SITTING DROP",5,"1.6M AMMONIUM SULFATE, 100mM CITRIC ACID, pH 5.00, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0710626105","HRM","2Z5Y",59.71,"2.17","2.17","Crystal Structure of Human Monoamine Oxidase A (G110A) with Harmine","HMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRAAFPPVWNPIAYLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNINVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKLNHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPMGAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADRLAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYGRVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKDVPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLL","Homo sapiens","MAOA","Amine oxidase [flavin-containing] A","1","2Z5Y"
"2Z6E",,"X-RAY DIFFRACTION",3.07,60,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 4000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/j.1365-2443.2007.01132.x",,"2Z6E",193.22,"2.8","2.8","Crystal Structure of Human DAAM1 FH2","MGLALKKKSIPQPTNALKSFNWSKLPENKLEGTVWTEIDDTKVFKILDLEDLERTFSAYQRQQDFFVNSNSKQKEADAIDDTLSSKLKVKELSVIDGRRAQNCNILLSRLKLSNDEIKRAILTMDEQEDLPKDMLEQLLKFVPEKSDIDLLEEHKHELDRMAKADRFLFEMSRINHYQQRLQSLYFKKKFAERVAEVKPKVEAIRSGSEEVFRSGALKQLLEVVLAFGNYMNKGQRGNAYGFKISSLNKIADTKSSIDKNITLLHYLITIVENKYPSVLNLNEELRDIPQAAKVNMTELDKEISTLRSGLKAVETELEYQKSQPPQPGDKFVSVVSQFITVASFSFSDVEDLLAEAKDLFTKAVKHFGEEAGKIQPDEFFGIFDQFLQAVSEAKQENENMRKKKEEEERRARMEAQLKE","Homo sapiens","DAAM1, KIAA0666","Disheveled-associated activator of morphogenesis 1","1","2Z6E"
"2Z6H",,"X-RAY DIFFRACTION",2.5,50.82,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M Na Citrate, 0.4M NaCl, 7% JEFFAMINE ED-2001, pH 5.60, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.12.021",,"2Z6H",70.42,"2.2","2.2","Crystal Structure of Beta-Catenin Armadillo Repeat Region and Its C-Terminal domain","NLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL","Homo sapiens","CTNNB1, CTNNB, OK/SW-cl.35, PRO2286","Catenin beta-1","1","2Z6H"
"2Z6M",,"X-RAY DIFFRACTION",2.86,56.98,"VAPOR DIFFUSION, HANGING DROP",4.6,"protein solution(11.0 mg/mL H8 in unbuffered 3.0mM NaN3), 2.5mL of precipitant buffer(0.1 M sodium acetate(pH 4.6), 20%(v/v) isopropanol, 0.2M CaCl2) , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi8016735",,"2Z6M",245.66,"2.72","2.72","Crystal structure of Human Ferritin H8 as biotemplate for noble metal nanoparticle synthesis","TTASTSQVRQNYDQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEERCHAEKLMKLQNQRGGRIFLQDIKKPDRDDWESGLNAMEAALQLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNCQVCAIKCLGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","2Z6M"
"2Z6O",,"X-RAY DIFFRACTION",2.04,39.62,"VAPOR DIFFUSION, HANGING DROP",8.5,"28% (w/v) PEG 4000, 0.1M Tris-HCl pH 8.5, 0.2M MgCl2 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2007.08.129",,"2Z6O",19.92,"1.6","1.6","Crystal Structure of the Ufc1, Ufm1 conjugating enzyme 1","GPLGSMADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEFDIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQHKEKCNQ","Homo sapiens","UFC1, CGI-126, HSPC155","Ufm1-conjugating enzyme 1","1","2Z6O"
"2Z6P",,"X-RAY DIFFRACTION",1.96,37.27,"VAPOR DIFFUSION, HANGING DROP",7,"1.5M ammonium sulfate, 0.1M MES pH 7.0, 10%(w/v) dioxan, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2007.08.129",,"2Z6P",20.04,"1.8","1.8","Crystal Structure of the Ufc1, Ufm1 conjugating enzyme 1","GPLGSMADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEFDIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQHKEKCNQ","Homo sapiens","UFC1, CGI-126, HSPC155","Ufm1-conjugating enzyme 1","1","2Z6P"
"2Z7Q",,"X-RAY DIFFRACTION",2.28,46.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"12-16% PEG MME 2000, 150mM DL-malic acid, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.073123707",,"2Z7Q",37.31,"2","2","Crystal structure of the N-terminal kinase domain of human RSK-1 bound to AMP-PCP","QPSKDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQPDDTFYFDT","Homo sapiens","RPS6KA1, RSK1, MAPKAPK1A","Ribosomal protein S6 kinase alpha-1","1","2Z7Q"
"2Z7R",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"12-16% PEG MME 2000, 150mM DL-malic acid, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.073123707","STU","2Z7R",37.24,"2","2","Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Staurosporine","QPSKDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQPDDTFYFDT","Homo sapiens","RPS6KA1, RSK1, MAPKAPK1A","Ribosomal protein S6 kinase alpha-1","1","2Z7R"
"2Z7S",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"12-16% PEG MME 2000, 150mM DL-malic acid , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.073123707",,"2Z7S",37.17,"2.1","2.1","Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Purvalnol A","QPSKDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQPDDTFYFDT","Homo sapiens","RPS6KA1, RSK1, MAPKAPK1A","Ribosomal protein S6 kinase alpha-1","1","2Z7S"
"2Z9A",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, SITTING DROP",4,"20 mM NaAcetate, 240 mM magnesium sulfate, 41% (v/v) pentaerythriol ethoxylate 15/4, pH 4.0, vapor diffusion, sitting drop, temperature 291K",291,"10.1016/j.str.2008.02.016",,"2Z9A",20.48,"2.5","2.5","Crystal Structure of Human Saposin C Dimer in Open Conformation","YVSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSRHHHHHH","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","2Z9A"
"2Z9T",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, PEG 4000, Ammonium acetate, glycerol, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.002",,"2Z9T",11.75,"1.8","1.8","Crystal structure of the human beta-2 microglobulin mutant W60G","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDGSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","NM_004048, B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","2Z9T"
"2Z9Y",,"X-RAY DIFFRACTION",2.05,39.92,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1073/pnas.0709191105",,"2Z9Y",29.33,"1.8","1.8","Crystal structure of CERT START domain in complex with C10-diacylglycerol","SNSLHWPTSLPSGDAFSSVGTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","Lipid-transfer protein CERT","1","2Z9Y"
"2Z9Z",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1073/pnas.0709191105",,"2Z9Z",29.29,"1.74","1.74","Crystal structure of CERT START domain(N504A mutant), in complex with C10-diacylglycerol","SNSLHWPTSLPSGDAFSSVGTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCAFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","Lipid-transfer protein CERT","1","2Z9Z"
"2ZA5",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, SITTING DROP",6.1,"pH 6.1, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.bmcl.2008.01.093","2FF","2ZA5",111.62,"2.3","2.3","Crystal Structure of human tryptase with potent non-peptide inhibitor","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPSB2, TPS2","Tryptase beta 2","1","2ZA5"
"2ZAJ",,"SOLUTION NMR",,,,,,,,,"2ZAJ",5.29,,,"Solution structure of the short-isoform of the second WW domain from the human membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI-1)","GSSGSSGLDSELELPAGWEKIEDPVYGIYYVDHINRKTQYENPSGPSSG","Homo sapiens","MAGI1, AIP3, BAIAP1, BAP1, TNRC19","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2ZAJ"
"2ZAS",,"X-RAY DIFFRACTION",2.53,51.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.05M HEPES, 0.75M sodium citrate, 5% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1016/j.bbrc.2008.06.050","1OH","2ZAS",27.92,"2","2","Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alpha-cumylphenol, a bisphenol A derivative","LGSPEFLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKVC","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2ZAS"
"2ZAV",,"X-RAY DIFFRACTION",2.36,47.87,"VAPOR DIFFUSION, HANGING DROP",7,"14% JEFFAMINE 2001, 0.1M HEPES pH 7.0, 50mM BICINE pH 8.5, 1.4mM Tymine, VAPOR DIFFUSION, HANGING DROP",,"10.1021/ja071567j",,"2ZAV",69.78,"1.7","1.7","Arginase I (homo sapiens): native and unliganded structure at 1.70 A resolution","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","2ZAV"
"2ZAZ",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.10.076","GK1","2ZAZ",41.86,"1.8","1.8","Crystal structure of P38 in complex with 4-anilino quinoline inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2ZAZ"
"2ZB0",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.10.076","GK3","2ZB0",41.83,"2.1","2.1","Crystal structure of P38 in complex with biphenyl amide inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2ZB0"
"2ZB1",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.10.076","GK4","2ZB1",41.87,"2.5","2.5","Crystal structure of P38 in complex with biphenyl amide inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2ZB1"
"2ZB2",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, HANGING DROP",6,"100mM NaMES (pH6), 22.5 % MPD, 60mM D-glucose, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2008.04.010","A46","2ZB2",196.98,"2.45","2.45","Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide","GSMAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","2ZB2"
"2ZB4",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, HANGING DROP",5.9,"0.1M MES, 2.0M ammonium sulfate, 2mM DTT, pH 5.9, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.09.007",,"2ZB4",40.44,"1.63","1.63","Crystal structure of human 15-ketoprostaglandin delta-13-reductase in complex with NADP and 15-keto-PGE2","AAAAAAMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEISL","Homo sapiens","PTGR2, ZADH1","Prostaglandin reductase 2","1","2ZB4"
"2ZB7",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",5.9,"0.1M MES, 2.0M ammonium sulfate, 2mM DTT, pH 5.9, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.09.007",,"2ZB7",39.83,"1.8","1.8","Crystal structure of human 15-ketoprostaglandin delta-13-reductase in complex with NADPH and nicotinamide","AAAAAAMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEISL","Homo sapiens","PTGR2, ZADH1","Prostaglandin reductase 2","1","2ZB7"
"2ZB8",,"X-RAY DIFFRACTION",2.55,51.84,"VAPOR DIFFUSION, HANGING DROP",5.9,"0.1M MES, pH 5.9, 2.0M ammonium sulfate, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.09.007",,"2ZB8",40.25,"2","2","Crystal structure of human 15-ketoprostaglandin delta-13-reductase in complex with NADP and indomethacin","AAAAAAMIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEISL","Homo sapiens","PTGR2, ZADH1","Prostaglandin reductase 2","1","2ZB8"
"2ZBS",,"X-RAY DIFFRACTION",2.48,50.34,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 293.4K",293.4,"10.1016/j.bbrc.2008.06.050",,"2ZBS",27.61,"1.8","1.8","Crystal structure of human estrogen-related receptor gamma ligand binding domain apo form","LGSPEFLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKVC","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2ZBS"
"2ZCB",,"X-RAY DIFFRACTION",1.98,37.98,"VAPOR DIFFUSION, SITTING DROP",6.3,"0.2M Zinc Acetate dehydrate, 20% PEG 3350, pH 6.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2ZCB",25.9,"1.6","1.6","Crystal Structure of ubiquitin P37A/P38A","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIAADQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2ZCB"
"2ZDT",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% Pentaerythritol ethoxylate (15/4 EO/OH), 0.1M ammonium sulfate, 0.1M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2008.02.028","46C","2ZDT",42.6,"2","2","Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2ZDT"
"2ZDU",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% Pentaerythritol ethoxylate (15/4 EO/OH), 0.1M ammonium sulfate, 0.1M Bis-Tris , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1016/j.bmc.2008.02.027","446","2ZDU",42.62,"2.5","2.5","Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2ZDU"
"2ZDX",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, HANGING DROP",7.1,"1.7M AMMONIUM SULFATE, 2% PEG 400, 0.1M SODIUM HEPES, 5% DMSO, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S090744491102405X","P4A","2ZDX",90.13,"2.54","2.54","Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4","GPVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM","Homo sapiens","PDK4, PDHK4","Pyruvate dehydrogenase kinase isozyme 4","1","2ZDX"
"2ZDY",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, HANGING DROP",7.1,"1.7M AMMONIUM SULFATE, 2% PEG 400, 0.1M SODIUM HEPES, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S090744491102405X",,"2ZDY",90.68,"2.4","2.4","Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4","GPVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM","Homo sapiens","PDK4, PDHK4","Pyruvate dehydrogenase kinase isozyme 4","1","2ZDY"
"2ZDZ",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, HANGING DROP",5.4,"pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.12.010","310","2ZDZ",46.93,"2","2","X-ray structure of Bace-1 in complex with compound 3.b.10","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZDZ"
"2ZE1",,"X-RAY DIFFRACTION",2.06,40.38,"VAPOR DIFFUSION, HANGING DROP",5.4,"pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.12.010","411","2ZE1",46.96,"2.2","2.2","X-ray structure of Bace-1 in complex with compound 6g","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZE1"
"2ZEB",,"X-RAY DIFFRACTION",2.69,54.24,,,,,"10.1016/j.bmcl.2008.01.093",,"2ZEB",110.76,"2.5","2.5","Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPK","Homo sapiens","TPSB2, TPSAB1, TPS1, TPS2, TPSB1","Tryptase beta 2","1","2ZEB"
"2ZEC",,"X-RAY DIFFRACTION",2.65,53.53,,,,,"10.1016/j.bmcl.2008.01.093",,"2ZEC",110.45,"2.059","2.059","Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPK","Homo sapiens","TPSB2, TPSAB1, TPS1, TPS2, TPSB1","Tryptase beta 2","1","2ZEC"
"2ZED",,"X-RAY DIFFRACTION",3.01,59.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZED",75.41,"1.7","1.7","Crystal structure of the human glutaminyl cyclase mutant S160A at 1.7 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDAAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZED"
"2ZEE",,"X-RAY DIFFRACTION",3.02,59.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEE",75.38,"1.99","1.99","Crystal structure of the human glutaminyl cyclase mutant S160G at 1.99 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDGAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEE"
"2ZEF",,"X-RAY DIFFRACTION",3.03,59.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEF",75.41,"1.67","1.67","Crystal structure of the human glutaminyl cyclase mutant E201D at 1.67 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGDEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEF"
"2ZEG",,"X-RAY DIFFRACTION",3.04,59.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEG",75.54,"2.08","2.08","Crystal structure of the human glutaminyl cyclase mutant E201L at 2.08 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGLEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEG"
"2ZEH",,"X-RAY DIFFRACTION",3.02,59.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEH",75.44,"1.8","1.8","Crystal structure of the human glutaminyl cyclase mutant E201Q at 1.8 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGQEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEH"
"2ZEJ",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, SITTING DROP",8,"30% PEG 4000, 100mM MgCl2, 0.1M Tris, 5mM GTP, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0709098105",,"2ZEJ",43.78,"2","2","Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase","NRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQ","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat kinase 2","1","2ZEJ"
"2ZEL",,"X-RAY DIFFRACTION",3.02,59.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEL",75.35,"1.97","1.97","Crystal structure of the human glutaminyl cyclase mutant D248A at 1.97 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLALIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEL"
"2ZEM",,"X-RAY DIFFRACTION",3,59.05,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEM",75.46,"2.18","2.18","Crystal structure of the human glutaminyl cyclase mutant D248Q at 2.18 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLQLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEM"
"2ZEN",,"X-RAY DIFFRACTION",3.03,59.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEN",75.35,"1.78","1.78","Crystal structure of the human glutaminyl cyclase mutant D305A at 1.78 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQADHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEN"
"2ZEO",,"X-RAY DIFFRACTION",3.03,59.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEO",75.47,"1.66","1.66","Crystal structure of the human glutaminyl cyclase mutant D305E at 1.66 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQEDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEO"
"2ZEP",,"X-RAY DIFFRACTION",3.06,59.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"2%-4% dioxane, 1.6-1.8M ammonium sulfate, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20071073",,"2ZEP",75.39,"2.1","2.1","Crystal structure of the human glutaminyl cyclase mutant H319L at 2.1 angstrom resolution","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLLLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","2ZEP"
"2ZFF",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"Phosphate buffer, Sodium Chloride, PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"53U","2ZFF",35.69,"1.47","1.47","Exploring Thrombin S1-pocket","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","2ZFF"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","2ZFF"
,,,,,,,,,,,,,,,,"GDFEEIPEEYL",,,"Hirudin variant-1","3","2ZFF"
"2ZFH",,"X-RAY DIFFRACTION",2.2,43,"MICROBATCH",4.6,"25% PEG4000, 0.17M Ammonium Acetate, 0.085M Sodium acetate, 15% glycerol, pH4.6, microbatch, temperature 295K",295,"10.1107/S1744309108009846",,"2ZFH",114.78,"2.05","2.05","Crystal structure of putative CutA1 from Homo sapiens at 2.05A resolution","MSGGRAPAVLLGGVASLLLSFVWMPALLPVASRLLLLPRVLLTMASGSPPTQPSPASDSGSGYVPGSVSAAFVTCPNEKVAKEIARAVVEKRLAACVNLIPQITSIYEWKGKIEEDSEVLMMIKTQSSLVPALTDFVRSVHPYEVAEVIALPVEQGNFPYLQWVRQVTESVSDSITVLP","Homo sapiens","CUTA, ACHAP, C6orf82","CutA","1","2ZFH"
"2ZFP",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"Phosphate Buffer, Sodium Chloride, PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2009.06.016","19U","2ZFP",35.67,"2.25","2.25","Thrombin Inibition","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","2ZFP"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","2ZFP"
,,,,,,,,,,,,,,,,"GDFEEIPEEYL",,,"Hirudin variant-1","3","2ZFP"
"2ZFU",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG 8000, 200mM Ammonium Sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2008.03.030",,"2ZFU",49.36,"2","2","Structure of the methyltransferase-like domain of nucleomethylin","MAQRLDGARFRYLNEQLYSGPSSAAQRLFQEDPEAFLLYHRGFQSQVKKWPLQPVDRIARDLRQRPASLVVADFGCGDCRLASSIRNPVHCFDLASLDPRVTVCDMAQVPLEDESVDVAVFCLSLMGTNIRDFLEEANRVLKPGGLLKVAEVSSRFEDVRTFLRAVTKLGFKIVSKDLTNSHFFLFDFQKTGPPLVGPKAQLSGLQLQPCLYKRR","Homo sapiens","KIAA0409, RRP8, NML, hucep-1","Cerebral protein 1","1","2ZFU"
"2ZFY",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 8000, 0.2 M Sodium acetate, 0.1 M Sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1042/BJ20081318",,"2ZFY",27.13,"1.69","1.69","Crystal structure of human Otubain 1","GSEIAVQNPLVSERLELSVLYKEYAEDDNIYQQKIKDLHKKYSYIRKTRPDGNCFYRAFGFSHLEALLDDSKELQRFKAVSAKSKEDLVSQGFTEFTIEDFHNTFMDLIEQVEKQTSVADLLASFNDQSTSDYLVVYLRLLTSGYLQRESKFFEHFIEGGRTVKEFCQQEVEPMCKESDHIHIIALAQALSVSIQVEYMDRGEGGTTNPHIFPEGSEPKVYLLYRPGHYDILYK","Homo sapiens","OTUB1, OTB1, OTU1, HSPC263","Ubiquitin thioesterase OTUB1","1","2ZFY"
"2ZG1",,"X-RAY DIFFRACTION",3.67,66.49,"VAPOR DIFFUSION, HANGING DROP",8,"20% MPEG 550, 0.1M TRIS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2007.10.009","SIA","2ZG1",24.64,"2.7","2.7","Crystal Structure of Two N-terminal Domains of Siglec-5 in Complex with 6'-Sialyllactose","VYELQVQKSVTVQEGLCVLVPCSFSYPWRSWYSSPPLYVYWFRDGEIPYYAEVVATNNPDRRVKPETQGRFRLLGDVQKKNCSLSIGDARMEDTGSYFFRVERGRDVKYSYQQNKLNLEVTALIEKPDIHFLEPLESGRPTRLSCSLPGSCEAGPPLTFSWTGNALSPLDPETTRSSELTLTPRPEDHGTNLTCQMKRQGAQVTTERTVQLNVS","Homo sapiens","SIGLEC5, CD33L2, OBBP2","Sialic acid-binding Ig-like lectin 5","1","2ZG1"
"2ZG2",,"X-RAY DIFFRACTION",3.5,64.88,"VAPOR DIFFUSION, HANGING DROP",8,"20% MPEG 550, 0.1M TRIS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2007.10.009",,"2ZG2",24.53,"2.85","2.85","Crystal Structure of Two N-terminal Domains of Native Siglec-5","SVYELQVQKSVTVQEGLCVLVPCSFSYPWRSWYSSPPLYVYWFRDGEIPYYAEVVATNNPDRRVKPETQGRFRLLGDVQKKNCSLSIGDARMEDTGSYFFRVERGRDVKYSYQQNKLNLEVTALIEKPDIHFLEPLESGRPTRLSCSLPGSCEAGPPLTFSWTGNALSPLDPETTRSSELTLTPRPEDHGTNLTCQMKRQGAQVTTERTVQLNVSL","Homo sapiens","SIGLEC5, CD33L2, OBBP2","Sialic acid-binding Ig-like lectin 5","1","2ZG2"
"2ZG3",,"X-RAY DIFFRACTION",3.66,66.42,"VAPOR DIFFUSION, HANGING DROP",8,"20% MPEG 550, 0.1M TRIS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2007.10.009","SIA","2ZG3",24.97,"3","3","Crystal Structure of Two N-terminal Domains of Native Siglec-5 in Complex with 3'-Sialyllactose","VYELQVQKSVTVQEGLCVLVPCSFSYPWRSWYSSPPLYVYWFRDGEIPYYAEVVATNNPDRRVKPETQGRFRLLGDVQKKNCSLSIGDARMEDTGSYFFRVERGRDVKYSYQQNKLNLEVTALIEKPDIHFLEPLESGRPTRLSCSLPGSCEAGPPLTFSWTGNALSPLDPETTRSSELTLTPRPEDHGTNLTCQMKRQGAQVTTERTVQLNVS","Homo sapiens","SIGLEC5, CD33L2, OBBP2","Sialic acid-binding Ig-like lectin 5","1","2ZG3"
"2ZGC",,"X-RAY DIFFRACTION",3.46,64.45,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M BICINE, 0.2M Li2SO4, 0.1M MGCL2, 19% PEG3350, pH8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.0803088",,"2ZGC",26.52,"1.96","1.96","Crystal Structure of Active Human Granzyme M","IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRSALEHHHHHH","Homo sapiens","GZMM, MET1","Granzyme M","1","2ZGC"
"2ZGH",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Bicine, 0.2M Li2SO4, 20% PEG3350, pH8.50, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.0803088",,"2ZGH",27.3,"2.17","2.17","Crystal Structure of active granzyme M bound to its product","IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRSALEHHHHHH","Homo sapiens","GZMM, MET1","Granzyme M","1","2ZGH"
,,,,,,,,,,,,,,,,"SSGKVPL",,,"SSGKVPL","2","2ZGH"
"2ZGJ",,"X-RAY DIFFRACTION",3.35,63.33,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Bicine, 0.2M Li2SO4, 21% PEG3350, pH8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.0803088",,"2ZGJ",27.29,"2.3","2.3","Crystal Structure of D86N-GzmM Complexed with Its Optimal Synthesized Substrate","IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRSALEHHHHHH","Homo sapiens","GZMM, MET1","Granzyme M","1","2ZGJ"
,,,,,,,,,,,,,,,,"SSGKVPLS",,,"SSGKVPLS","2","2ZGJ"
"2ZGV",,"X-RAY DIFFRACTION",2.14,42.6,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.6M NaKPO4, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkn212",,"2ZGV",45.38,"2","2","Crystal Structure of human phosphoglycerate kinase bound to D-ADP","GSHMSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","2ZGV"
"2ZHK",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M KF, 20% PEG 3350, pH 7.20, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/glycob/cwn121",,"2ZHK",34.21,"1.8","1.8","Crystal structure of human galectin-9 N-terminal CRD in complex with N-acetyllactosamine dimer (crystal 1)","MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQ","Homo sapiens","LGALS9","Galectin-9","1","2ZHK"
"2ZHL",,"X-RAY DIFFRACTION",2.01,38.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"200MM IMIDAZOLE MALATE, 22.5% PEG 10000, pH 8.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/glycob/cwn121",,"2ZHL",68.43,"1.75","1.75","Crystal structure of human galectin-9 N-terminal CRD in complex with N-acetyllactosamine dimer (crystal 2)","MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQ","Homo sapiens","LGALS9","Galectin-9","1","2ZHL"
"2ZHM",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",6.2,"200MM AMMONIUM FLUORIDE, 20% PEG 3350, pH 6.20, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/glycob/cwn121",,"2ZHM",69.74,"1.84","1.84","Crystal structure of human galectin-9 N-terminal CRD in complex with N-acetyllactosamine trimer (crystal 1)","MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQ","Homo sapiens","LGALS9","Galectin-9","1","2ZHM"
"2ZHN",,"X-RAY DIFFRACTION",2.37,47.99,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M TRI-SODIUM CITRATE (PH5.6), 1.0M MONO-AMMONIUM DEHYDRATE PHOSPHATE, pH 5.60, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/glycob/cwn121",,"2ZHN",17.68,"1.3","1.3","Crystal structure of human galectin-9 N-terminal CRD in complex with N-acetyllactosamine trimer (crystal 2)","MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQ","Homo sapiens","LGALS9","GALECTIN-9","1","2ZHN"
"2ZHR",,"X-RAY DIFFRACTION",2.71,54.65,"VAPOR DIFFUSION, SITTING DROP",6.6,"22% PEG 5000 MME, 0.2M Sodium Acetate pH 6.5, 0.2M Ammonium Iodide, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.02185-07",,"2ZHR",93.59,"2.5","2.5","Crystal structure of BACE1 in complex with OM99-2 at pH 5.0","MRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZHR"
,,,,,,,,,,,,,,,,"EVNXAEF",,,"inhibitor OM99-2","2","2ZHR"
"2ZHS",,"X-RAY DIFFRACTION",2.85,56.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"22% PEG 5000 MME, 0.2M Sodium Acetate pH 6.5, 0.2M Ammonium Iodide, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.02185-07",,"2ZHS",45.9,"2.7","2.7","Crystal structure of BACE1 at pH 4.0","MRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZHS"
"2ZHT",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, SITTING DROP",6.5,"22% PEG 5000 MME, 0.2M Sodium Acetate pH 6.5, 0.2M Ammonium Iodide, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.02185-07",,"2ZHT",45.9,"2.35","2.35","Crystal structure of BACE1 at pH 4.5","MRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZHT"
"2ZHU",,"X-RAY DIFFRACTION",2.87,57.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"22% PEG 5000 MME, 0.2M Sodium Acetate pH 6.5, 0.2M Ammonium Iodide, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.02185-07",,"2ZHU",45.9,"2.4","2.4","Crystal structure of BACE1 at pH 5.0","MRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZHU"
"2ZHV",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, SITTING DROP",6.5,"22% PEG 5000 MME, 0.2M Sodium Acetate pH 6.5, 0.2M Ammonium Iodide, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.02185-07",,"2ZHV",45.9,"1.85","1.85","Crystal structure of BACE1 at pH 7.0","MRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZHV"
"2ZI3",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2008.02.061",,"2ZI3",66.39,"2.3","2.3","C4S-E247A dCK variant of dCK in complex with D-dA+ADP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYASLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI3"
"2ZI4",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2008.02.061",,"2ZI4",33.28,"2.1","2.1","C4S dCK variant of dCK in complex with L-dA+ADP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI4"
"2ZI5",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1016/j.jmb.2008.02.061",,"2ZI5",132.91,"1.77","1.77","C4S dCK variant of dCK in complex with L-dA+UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI5"
"2ZI6",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1016/j.jmb.2008.02.061",,"2ZI6",132.91,"1.77","1.77","C4S dCK variant of dCK in complex with D-dA+UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI6"
"2ZI7",,"X-RAY DIFFRACTION",1.99,38.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm800134t",,"2ZI7",66.49,"1.97","1.97","C4S dCK variant of dCK in complex with D-dG+UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI7"
"2ZI9",,"X-RAY DIFFRACTION",2.27,45.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm800134t",,"2ZI9",66.45,"2.51","2.51","C4S-E247A dCK variant of dCK in complex with cladribine+ADP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYASLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZI9"
"2ZIA",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Sodium Citrate, 100mM Hepes, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm800134t",,"2ZIA",66.52,"1.8","1.8","C4S dCK variant of dCK in complex with cladribine+UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2ZIA"
"2ZIJ",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",6,"2.5M sodium chloride, 0.03M phosphate, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2ZIJ",14.74,"1.9","1.9","Crystal Structure of Human Lysozyme Expressed in E. coli.","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","2ZIJ"
"2ZIK",,"X-RAY DIFFRACTION",2.03,39.53,"VAPOR DIFFUSION, HANGING DROP",6,"2.5M sodium chloride, 0.03M phosphate, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2ZIK",14.74,"1.81","1.81","Crystal Structure of Human Lysozyme from Pichia pastoris","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","2ZIK"
"2ZIL",,"X-RAY DIFFRACTION",2,38.41,"VAPOR DIFFUSION, HANGING DROP",6,"2.5M sodium chloride, 0.03M phosphate, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2ZIL",14.74,"1.8","1.8","Crystal Structure of Human Lysozyme from Urine","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","2ZIL"
"2ZJ3",,"X-RAY DIFFRACTION",2.51,50.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% Isoporpanol, 0.04M Tris, 0.08M Ammonium acetate, 12% glycerol 10-fold excess of Fructose-6-Phosphate, pH 8.50, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2008.11.041",,"2ZJ3",42.58,"1.9","1.9","Isomerase domain of human glucose:fructose-6-phosphate amidotransferase","MHHHHHHQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","2ZJ3"
"2ZJ4",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% Isoporpanol, 0.04M Tris, 0.08M Ammonium acetate, 12% glycerol 10-fold excess of 2-deoxy-2-aminoglucitol-6-phosphate, pH 8.50, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2008.11.041",,"2ZJ4",42.58,"2.2","2.2","Isomerase domain of human glucose:fructose-6-phosphate amidotransferase","MHHHHHHQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","2ZJ4"
"2ZJB",,"X-RAY DIFFRACTION",2.76,55.44,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.1M sodium citrate, 50mM MgCl2, 8% PEG 2000 MME, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gkn362",,"2ZJB",75.96,"3.5","3.5","Crystal structure of the human Dmc1-M200V polymorphic variant","GSHMKEDQVVAEEPGFQDEEESLFQDIDLLQKHGINVADIKKLKSVGICTIKGIQMTTRRALCNVKGLSEAKVDKIKEAANKLIEPGFLTAFEYSEKRKMVFHITTGSQEFDKLLGGGIESMAITEAFGEFRTGKTQLSHTLCVTAQLPGAGGYPGGKIIFIDTENTFRPDRLRDIADRFNVDHDAVLDNVLYARAYTSEHQVELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQMLSRLQKISEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTRISLRKGRGELRIAKIYDSPEMPENEATFAITAGGIGDAKE","Homo sapiens","DMC1, DMC1H, LIM15","Meiotic recombination protein DMC1/LIM15 homolog","1","2ZJB"
"2ZJC",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",6.5,"VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH6.5",293,"10.1016/j.jmb.2008.11.053",,"2ZJC",51.34,"2.5","2.5","TNFR1 selectve TNF mutant; R1-6","VRSSSRTPSDMPVAHVVANPQAEGQLQWKNAGANALLANGVELRDNQLVVPSEGLYLIYSQVLFSGQGCPSTHVLLTHTISRIAVSYQTPVNLLSAIRSPCQRETPEGAEANPWYEPIYLGGVFQLEPGDRLSAEINRPDYLDFASTGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","2ZJC"
"2ZJD",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 23% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1074/jbc.M802182200",,"2ZJD",32.62,"1.56","1.56","Crystal Structure of LC3-p62 complex","GPLGSMPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETFGMKLSV","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B precursor","1","2ZJD"
,,,,,,,,,,,,,,,,"SGGDDDWTHLS",,,"undecameric peptide from Sequestosome-1","2","2ZJD"
"2ZJH",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH 6.5, 0.1M sodium chloride, 1.5M ammonium sulfate, 7.0 mg/ml Beta-secretase 1 , VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJH",45.54,"2.6","2.6","Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4-mercapto-butyramide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTCMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJH"
"2ZJI",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, SITTING DROP",,"2.0M sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJI",45.59,"2.3","2.3","Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSCGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJI"
"2ZJJ",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M imidazole pH 8.0, 0.2M Ca(OAC)2, 10% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJJ",45.42,"2.2","2.2","Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid (2-mercapto-ethyl)-amide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGCTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJJ"
"2ZJK",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Bis-Tris pH 5.5, 0.2M lithium sulfate monohydrate, 25% w/v polyethylene glycol 3350, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJK",136.66,"3","3","Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYCQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJK"
"2ZJL",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 1.26M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJL",45.67,"2.1","2.1","Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTCMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJL"
"2ZJM",,"X-RAY DIFFRACTION",2.81,56.23,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M HEPES (pH 7.5), 1.5M Li2SO4, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJM",45.65,"1.9","1.9","Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(4-sulfamoyl-phenoxy)-acetamide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJM"
"2ZJN",,"X-RAY DIFFRACTION",2.88,57.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"6mg/ml BACE1, 0.1M HEPES pH 7.5, 1.5M Li2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"2ZJN",45.78,"2.7","2.7","Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(2-methyl-4-sulfamoyl-phenoxy)-acetamide","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2ZJN"
"2ZJW",,"X-RAY DIFFRACTION",1.762411,30.209236,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% ethylene glycol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2009.04.076","REF","2ZJW",40.78,"2.4","2.4","Crystal structure of human CK2 alpha complexed with Ellagic acid","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","2ZJW"
"2ZK0",,"X-RAY DIFFRACTION",2.68,54.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK0",65.06,"2.36","2.36","Human peroxisome proliferator-activated receptor gamma ligand binding domain","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK0"
"2ZK1",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK1",65.69,"2.61","2.61","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK1"
"2ZK2",,"X-RAY DIFFRACTION",2.55,51.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK2",65.69,"2.26","2.26","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK2"
"2ZK3",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK3",65.7,"2.58","2.58","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK3"
"2ZK4",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK4",65.7,"2.57","2.57","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK4"
"2ZK5",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.039",,"2ZK5",65.66,"2.45","2.45","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK5"
"2ZK6",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197",,"2ZK6",65.87,"2.41","2.41","Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZK6"
"2ZKC",,"X-RAY DIFFRACTION",2.51,50.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.05M HEPES, 0.75M sodium citrate, 5% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2ZKC",28.06,"1.7","1.7","Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol Z","LGSPEFLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKVC","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2ZKC"
"2ZKH",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M potassium sodium tartrate, 20%W/V polyethylene glycol 3350, 19mg/ml protein concentration, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.2985",,"2ZKH",46.73,"2.04","2.04","Human thrombopoietin neutralizing antibody TN1 FAB","QVVLTQSPGIMSASPGEKVTITCSASSSVSYMYWFQQKPGTSPKLWIYSTSNLASGVPARFRGSGSGTSYSLTISRMEAEDAATYYCQQRSGYPRTFGGGTKLEIKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC","Homo sapiens",,"Monoclonal TN1 FAB light chain","1","2ZKH"
,,,,,,,,,,,,,,,,"EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAWMDWVRQSPEKGLEWVAEIRSKVNNHAIHYAESVKGRFTVSRDDSKSSVYLQMNSLRAEDTGIYYCSGWSFLYWGQGTLVTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD","Homo sapiens",,"Monoclonal TN1 FAB heavy chain","2","2ZKH"
"2ZKJ",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9M ammonium sulfate, 4% polyethylene glycol 400, 100mM potassium phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M802249200","ADP","2ZKJ",90.64,"2","2","Crystal structure of human PDK4-ADP complex","ASVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM","Homo sapiens","PDK4, PDHK4","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4","1","2ZKJ"
"2ZKM",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, SITTING DROP",8.5,"16%(v/v) isopropanol, 2%(v/v) dioxane, 100mM Tris  , pH 8.5, VAPOR DIFFUSION, sitting drop, temperature 291K",291,"10.1016/j.molcel.2008.06.018",,"2ZKM",91.07,"1.62","1.62","Crystal Structure of Phospholipase C Beta 2","MSLLNPVLLPPKVKAYLSQGERFIKWDDETTVASPVILRVDPKGYYLYWTYQSKEMEFLDITSIRDTRFGKFAKMPKSQKLRDVFNMDFPDNSFLLKTLTVVSGPDMVDLTFHNFVSYKENVGKAWAEDVLALVKHPLTANASRSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGPENSVLAQDKLLLHHDMTQPLNHYFINSSHNTYLTAGQFSGLSSAEMYRQVLLSGCRCVELDCWKGKPPDEEPIITHGFTMTTDIFFKEAIEAIAESAFKTSPYPIILSFENHVDSPRQQAKMAEYCRTIFGDMLLTEPLEKFPLKPGVPLPSPEDLRGKILIKNKKNQFSGPTSSSKDTGGEAEGSSPPSAPAVWAGEEGTELEEEEVEEEEEEESGNLDEEEIKKMQSDEGTAGLEVTAYEEMSSLVNYIQPTKFVSFEFSAQKNRSYVISSFTELKAYDLLSKASVQFVDYNKRQMSRIYPKGTRMDSSNYMPQMFWNAGCQMVALNFQTMDLPMQQNMAVFEFNGQSGYLLKHEFMRRPDKQFNPFSVDRIDVVVATTLSITVISGQFLSERSVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPELASLRVAVMEEGNKFLGHRIIPINALNSGYHHLCLHSESNMPLTMPALFIFLEMKD","Homo sapiens","PLC beta 2, PLCB2","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2","1","2ZKM"
"2ZKN",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, HANGING DROP",7,"2.0M ammonium sulfate, 20mM phosphate buffer, 5mM lactose, pH7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwn089",,"2ZKN",29.35,"1.86","1.86","X-ray structure of mutant galectin-1/lactose complex","ASGLVASNLNLKPGESLRVRGEVAPDAKSFVLNLGKDSNNLSLHFNPRFNAHGDANTIVSNSKDGGAWGTEQREAVFPFQPGSVAEVSITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKSVAFD","Homo sapiens","LGALS1","Galectin-1","1","2ZKN"
"2ZKS",,"X-RAY DIFFRACTION",3.44,64.22,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG3350, 0.2M Li2SO4, 0.1M Bicine, pH8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.0803088",,"2ZKS",27.03,"2.7","2.7","Structural insights into the proteolytic machinery of apoptosis-inducing Granzyme M","IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRSALEHHHHHH","Homo sapiens","GZMM, MET1","Granzyme M","1","2ZKS"
,,,,,,,,,,,,,,,,"XKVPLX",,,"hGzmM inhibitor","2","2ZKS"
"2ZKW",,"X-RAY DIFFRACTION",1.796609,31.537685,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.2M Ammonium iodide, 20%(w/v) PEG3350, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2ZKW",33.2,"1.9","1.9","Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group P21","GPLGSMATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2ZKW"
"2ZKX",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1M Sodium Acetate(pH 4.6), 1.5M Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2ZKX",66.4,"2.72","2.72","Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group I212121","GPLGSMATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2ZKX"
"2ZKY",,"X-RAY DIFFRACTION",3.73,67.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2ZKY",164.5,"2.4","2.4","Crystal structure of human Cu-Zn superoxide dismutase mutant G93A","GPLGSMATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDAVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2ZKY"
"2ZM1",,"X-RAY DIFFRACTION",2.18,43.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M Sodium Cacodylate, 30% PEG8000, 5.2% MPD, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2008.10.041","KSF, PTR","2ZM1",33.66,"2.1","2.1","Crystal structure of imidazo pyrazin 1 bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2ZM1"
"2ZM3",,"X-RAY DIFFRACTION",2.61,52.83,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris-HCl, pH8, 2M NaCl, 13-16% PEG6K, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.04.044","575","2ZM3",143.07,"2.5","2.5","Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor","GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK","Homo sapiens","IGF1R","Insulin-like growth factor 1 receptor","1","2ZM3"
"2ZM4",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M Sodium Cacodylate, 30% PEG8000, 5.2% MPD, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2008.10.041","PTR","2ZM4",33.74,"2.7","2.7","Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human LCK, activated form (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2ZM4"
"2ZMC",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG300, HEPES, pH6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M803026200",,"2ZMC",44.66,"3.14","3.14","Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form","HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK","Homo sapiens","TTK, MPS1L1, MPS1","Dual specificity protein kinase TTK","1","2ZMC"
"2ZMD",,"X-RAY DIFFRACTION",2.34,47.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG300, HEPES, pH6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M803026200","537","2ZMD",44.85,"2.88","2.88","Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor","HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK","Homo sapiens","TTK, MPS1L1, MPS1","Dual specificity protein kinase TTK","1","2ZMD"
"2ZMF",,"X-RAY DIFFRACTION",2.73,55,"VAPOR DIFFUSION, SITTING DROP",5.5,"Ammonium sulfate, PEG, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M800595200",,"2ZMF",43.61,"2.1","2.1","Crystal structure of the C-terminal GAF domain of human phosphodiesterase 10A","GSSGSSGQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECI","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2ZMF"
"2ZMM",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION, HANGING DROP",7,"17% PEG 4000, 0.15M MgCl2, 0.1M Hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1002/cmdc.200800188","35B","2ZMM",35.58,"2.1","2.1","Crystal structure of PTP1B-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTP1B, PTPN1","Tyrosine-protein phosphatase non-receptor type 1","1","2ZMM"
"2ZMV",,"X-RAY DIFFRACTION",3.15,60.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"2% MPD, 3% EG, 1% PEG 8000, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bbrc.2008.04.143",,"2ZMV",50.87,"2.8","2.8","Crystal structure of Synbindin","MAIFSVYVVNKAGGLIYQLDSYAPRAEAEKTFSYPLDLLLKLHDERVLVAFGQRDGIRVGHAVLAINGMDVNGRYTADGKEVLEYLGNPANYPVSIRFGRPRLTSNEKLMLASMFHSLFAIGSQLSPEQGSSGIEMLETDTFKLHCYQTLTGIKFVVLADPRQAGIDSLLRKIYEIYSDFALKNPFYSLEMPIRCELFDQNLKLALEVAEKAGTFGPGSLEHHHHHH","Homo sapiens","TRAPPC4, SBDN, CGI-104, HSPC172, PTD009","Trafficking protein particle complex subunit 4","1","2ZMV"
"2ZN7",,"X-RAY DIFFRACTION",3.4,63.88,"VAPOR DIFFUSION, HANGING DROP",7,"17% PEG 4000, 0.15M MgCl2, 0.1M Hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1002/cmdc.200800188","410","2ZN7",35.39,"2.1","2.1","CRYSTAL STRUCTURES OF PTP1B-Inhibitor Complexes","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTP1B, PTPN1","Tyrosine-protein phosphatase non-receptor type 1","1","2ZN7"
"2ZN8",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% 2-methyl-2,4-pentanediol, 100mM Cacodylate, 75mM Zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2008.07.012",,"2ZN8",22.04,"2.7","2.7","Crystal structure of Zn2+-bound form of ALG-2","AAYSYRPGPGAGPGPAAGAALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZN8"
"2ZN9",,"X-RAY DIFFRACTION",2.95,58.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG 8000, 0.1M Sodium Cacodylate, 0.2M Calcium Acetate hydrate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2008.07.012",,"2ZN9",41.56,"2.4","2.4","Crystal structure of Ca2+-bound form of des3-20ALG-2","AALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZN9"
"2ZND",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, HANGING DROP",6.5,"40% 2-methyl-2,4-pentanediol, 0.1M Na2HPO4-KH2PO4, 2mM EDTA, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.07.012",,"2ZND",21.01,"1.7","1.7","Crystal structure of Ca2+-free form of des3-20ALG-2","AALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZND"
"2ZNE",,"X-RAY DIFFRACTION",2.56,52.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% 2-propanol, 0.1M Cacodylate, 0.2M zinc acetate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2008.07.012",,"2ZNE",43.87,"2.2","2.2","Crystal structure of Zn2+-bound form of des3-23ALG-2 complexed with Alix ABS peptide","ADQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZNE"
,,,,,,,,,,,,,,,,"QGPPYPTYPGYPGYSQ",,,"16-meric peptide from Programmed cell death 6-interacting protein","2","2ZNE"
"2ZNH",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG3350, 0.2M tri-potassium citrate, pH8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nature07394",,"2ZNH",100.63,"2.8","2.8","Crystal Structure of a Domain-Swapped Serpin Dimer","HGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK","Homo sapiens","SERPINC1, AT3, PRO0309","Antithrombin-III","1","2ZNH"
"2ZNN",,"X-RAY DIFFRACTION",2.26,45.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444909015935","S44","2ZNN",31.36,"2.01","2.01","Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","2ZNN"
"2ZNO",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M Sodium citrate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444909015935","S44","2ZNO",66.07,"2.4","2.4","Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZNO"
"2ZNP",,"X-RAY DIFFRACTION",2.79,55.87,"VAPOR DIFFUSION, HANGING DROP",9.5,"14% PEG8000, 200mM KCL, 40mM Bistris ethane, 6% propanediol, 0.5% n-heptyl-beta-D-glucopyranoside, 1mM EDTA, 1mM CaCl2, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444909015935","K55","2ZNP",64.55,"3","3","Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP204","GSHMPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","2ZNP"
"2ZNQ",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",9.5,"14% PEG8000, 200mM KCL, 40mM Bistris ethane, 6% propanediol, 0.5% n-heptyl-beta-D-glucopyranoside, 1mM EDTA, 1mM CaCl2  , pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444909015935","401","2ZNQ",64.47,"2.65","2.65","Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP401","GSHMPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","2ZNQ"
"2ZNR",,"X-RAY DIFFRACTION",3.13,60.74,"VAPOR DIFFUSION, SITTING DROP",4.6,"45mM sodium acetate buffer (pH 4.6), 22% PEG 4000, 90mM ammonium acetate, 10mM praseodymium (III) acetate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature07254",,"2ZNR",20.68,"1.2","1.2","Crystal structure of the DUB domain of human AMSH-LP","GPGHMEGLRCVVLPEDLCHKFLQLAESNTVRGIETCGILCGKLTHNEFTITHVIVPKQSAGPDYCDMENVEELFNVQDQHDLLTLGWIHTHPTQTAFLSSVDLHTHCSYQLMLPEAIAIVCSPKHKDTGIFRLTNAGMLEVSACKKKGFHPHTKEPRLFSICKHVLVKDIKIIVLDLR","Homo sapiens","STAMBPL1, AMSHLP, KIAA1373","AMSH-like protease","1","2ZNR"
"2ZNS",,"X-RAY DIFFRACTION",3.13,60.73,"VAPOR DIFFUSION, HANGING DROP",4.8,"PEG3350, NaCl, EDTA, pH4.8, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1016/j.jmb.2011.08.043","GLU","2ZNS",29.24,"2","2","Crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, GluR5, in complex with glutamate","ANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCP","Homo sapiens","GRIK1, GLUR5","Glutamate receptor, ionotropic kainate 1","1","2ZNS"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIK1, GLUR5"
"2ZNT",,"X-RAY DIFFRACTION",3.18,61.37,"VAPOR DIFFUSION, HANGING DROP",4.8,"PEG3350, NaCl, EDTA, pH4.8, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1016/j.jmb.2011.08.043","DYH","2ZNT",29.79,"1.6","1.6","Crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, GluR5, in complex with a novel selective agonist, dysiherbaine","ANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCP","Homo sapiens","GRIK1, GLUR5","Glutamate receptor, ionotropic kainate 1","1","2ZNT"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIK1, GLUR5"
"2ZNU",,"X-RAY DIFFRACTION",3.18,61.37,"VAPOR DIFFUSION, HANGING DROP",4.8,"PEG3350, NaCl, EDTA, pH4.8, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1016/j.jmb.2011.08.043","NDZ","2ZNU",29.7,"1.8","1.8","Crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, GluR5, in complex with a novel selective agonist, neodysiherbaine A","ANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCP","Homo sapiens","GRIK1, GLUR5","Glutamate receptor, ionotropic kainate 1","1","2ZNU"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIK1, GLUR5"
"2ZOC",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 6000, calucium chloride, dioxisane, Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2ZOC",72.18,"2","2","Crystal structure of recombinant human annexin IV","MATKGGTVKAASGFNAMEDAQTLRKAMKGLGTDEDAIISVLAYRNTAQRQEIRTAYKSTIGRDLIDDLKSELSGNFEQVIVGMMTPTVLYDVQELRRAMKGAGTDEGCLIEILASRTPEEIRRISQTYQQQYGRSLEDDIRSDTSFMFQRVLVSLSAGGRDEGNYLDDALVRQDAQDLYEAGEKKWGTDEVKFLTVLCSRNRNHLLHVFDEYKRISQKDIEQSIKSETSGSFEDALLAIVKCMRNKSAYFAEKLYKSMKGLGTDDNTLIRVMVSRAEIDMLDIRAHFKRLYGKSLYSFIKGDTSGDYRKVLLVLCGGDD","Homo sapiens","ANXA4, ANX4","Annexin A4","1","2ZOC"
"2ZOQ",,"X-RAY DIFFRACTION",2.13,42.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"2M ammonium sulphate, 2% polyethyleneglycol400, 0.1M, pH7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbrc.2008.10.127","5ID","2ZOQ",88.08,"2.39","2.39","Structural dissection of human mitogen-activated kinase ERK1","LGSMAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP","Homo sapiens","MAPK3, ERK1, PRKM3","Mitogen-activated protein kinase 3","1","2ZOQ"
"2ZOT",,"X-RAY DIFFRACTION",2.06,40.2,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M bis-tris(pH 5.5), 0.4M ammonium acetate, 25% polyethylene glycol(PEG) 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444908028308",,"2ZOT",77.65,"2.7","2.7","Crystal structure of human F-spondin reeler domain (fragment 1)","GSFSDETLDKVPKSEGYCSRILRAQGTRREGYTEFSLRVEGDPDFYKPGTSYRVTLSAAPPSYFRGFTLIALRENREGDKEEDHAGTFQIIDEEETQFMSNCPVAVTESTPRRRTRIQVFWIAPPAGTGCVILKASIVQKRIIYFQDEGSLTKKLCEQDSTFDGVTDKPILD","Homo sapiens","SPON1, KIAA0762, VSGP","Spondin-1","1","2ZOT"
"2ZOU",,"X-RAY DIFFRACTION",2.19,43.85,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M bis-tris (pH 5.5), 0.4M ammonium acetate, 25% polyethylene glycol(PEG) 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444908028308",,"2ZOU",34.07,"1.45","1.45","Crystal structure of human F-spondin reeler domain (fragment 2)","GSSEGYCSRILRAQGTRREGYTEFSLRVEGDPDFYKPGTSYRVTLSAAPPSYFRGFTLIALRENREGDKEEDHAGTFQIIDEEETQFMSNCPVAVTESTPRRRTRIQVFWIAPPAGTGCVILKASIVQKRIIYFQDEGSLTKKLCEQDS","Homo sapiens","SPON1, KIAA0762, VSGP","Spondin-1","1","2ZOU"
"2ZOX",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.2M MgCl2, 0.1M Tris-HCl, 15% glycerol saturated concentration of pNP-Glc , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbrc.2008.07.089",,"2ZOX",55.26,"1.9","1.9","Crystal Structure of the Covalent Intermediate of Human Cytosolic beta-Glucosidase","MAFPAGFGWAAATAAYQVEGGWDADGKGPCVWDTFTHQGGERVFKNQTGDVACGSYTLWEEDLKCIKQLGLTHYRFSLSWSRLLPDGTTGFINQKGIDYYNKIIDDLLKNGVTPIVTLYHFDLPQTLEDQGGWLSEAIIESFDKYAQFCFSTFGDRVKQWITINQANVLSVMSYDLGMFPPGIPHFGTGGYQAAHNLIKAHARSWHSYDSLFRKKQKGMVSLSLFAVWLEPADPNSVSDQEAAKRAITFHLDLFAKPIFIDGDYPEVVKSQIASMSQKQGYPSSRLPEFTEEEKKMIKGTADFFAVQYYTTRLIKYQENKKGELGILQDAEIEFFPDPSWKNVDWIYVVPWGVCKLLKYIKDTYNNPVIYITENGFPQSDPAPLDDTQRWEYFRQTFQELFKAIQLDKVNLQVYCAWSLLDNFEWNQGYSSRFGLFHVDFEDPARPRVPYTSAKEYAKIIRNNGLEAHL","Homo sapiens","GBA3, CBG, CBGL1","Cytosolic beta-glucosidase","1","2ZOX"
"2ZPX",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG1500, 0.2M Calcium Acetate, 0.1M Sodium Cacodylate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/jb/mvp065",,"2ZPX",51.85,"2.83","2.83","TNF Receptor Subtype One-selective TNF Mutant with Antagonistic Activity; R1antTNF-T8","VRSSSRTPSDMPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFSGQGCPSTHVLLTHTISRITPAINRPVNLLSAIRSPCQRETPEGAEANPWYEPIYLGGVFQLEPGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","2ZPX"
"2ZQQ",,"X-RAY DIFFRACTION",2.72,54.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"DROP: 50MM HEPES, 1.0M AMMONIUM SULFATE, 1.0% PEG400, RESERVOIR: 100MM HEPES, 2.0M AMMONIUM SULFATE, 2.0% PEG400, pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22246",,"2ZQQ",175.43,"2.2","2.2","Crystal structure of human AUH (3-methylglutaconyl-coa hydratase) mixed with (AUUU)24A RNA","SSEMKTEDELRVRHLEEENRGIVVLGINRAYGKNSLSKNLIKMLSKAVDALKSDKKVRTIIIRSEVPGIFCAGADLKERAKMSSSEVGPFVSKIRAVINDIANLPVPTIAAIDGLALGGGLELALACDIRVAASSAKMGLVETKLAIIPGGGGTQRLPRAIGMSLAKELIFSARVLDGKEAKAVGLISHVLEQNQEGDAAYRKALDLAREFLPQGPVAMRVAKLAINQGMEVDLVTGLAIEEACYAQTIPTKDRLEGLLAFKEKRPPRYKGE","Homo sapiens","AUH","Methylglutaconyl-CoA hydratase","1","2ZQQ"
"2ZQR",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",6.5,"DROP: 50MM SODIUM CACODYLATE, 9% PEG8000, 100MM CALCIUM ACETATE, 100MM SODIUM ACETATE, 10MM IMIDAZOLE, RESERVOIR: 100MM SODIUM CACODYLATE, 18% PEG8000, 200MM CALCIUM ACETATE, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22246",,"2ZQR",175.43,"2.5","2.5","Crystal structure of AUH without RNA","SSEMKTEDELRVRHLEEENRGIVVLGINRAYGKNSLSKNLIKMLSKAVDALKSDKKVRTIIIRSEVPGIFCAGADLKERAKMSSSEVGPFVSKIRAVINDIANLPVPTIAAIDGLALGGGLELALACDIRVAASSAKMGLVETKLAIIPGGGGTQRLPRAIGMSLAKELIFSARVLDGKEAKAVGLISHVLEQNQEGDAAYRKALDLAREFLPQGPVAMRVAKLAINQGMEVDLVTGLAIEEACYAQTIPTKDRLEGLLAFKEKRPPRYKGE","Homo sapiens","AUH","Methylglutaconyl-CoA hydratase","1","2ZQR"
"2ZQS",,"X-RAY DIFFRACTION",2.25,45.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZQS",18.59,"1.902","1.902","Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDASSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZQS"
"2ZQT",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZQT",18.56,"1.462","1.462","Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQAQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZQT"
"2ZQU",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZQU",18.25,"2.5","2.5","Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQAERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZQU"
"2ZQV",,"X-RAY DIFFRACTION",2.94,58.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZQV",18.54,"2.498","2.498","Crystal structure of a mutant PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","MADEEKLPPGWEKRMSRSSGRVYYANHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZQV"
"2ZR4",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M ammonium sulfate, 100mM HEPES-NA(pH7.5), 2% PEG400, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZR4",18.6,"2","2","Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase","MADEEKLPPGWEKRMSRSSGRVYYFNHITNAAQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZR4"
"2ZR5",,"X-RAY DIFFRACTION",2.97,58.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M ammonium sulfate, 100mM HEPES-NA(pH7.5), 2% PEG400, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZR5",18.56,"2.6","2.6","Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase","MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVAHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZR5"
"2ZR6",,"X-RAY DIFFRACTION",2.91,57.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M ammonium sulfate, 100mM HEPES-NA(pH7.5), 2% PEG400, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2ZR6",18.53,"3.2","3.2","Crystal structure of a mutant PIN1 peptidyl-prolyl cis-trans isomerase","MADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ZR6"
"2ZRS",,"X-RAY DIFFRACTION",3.17,61.23,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM MES, 12.5% 2-propanol, 150mM calcium acetate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309108030297",,"2ZRS",159.45,"3.1","3.1","Crystal structure of Ca2+-bound form of des3-23ALG-2","DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZRS"
"2ZRT",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 15% ethanol, 200mM zinc acetate, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309108030297",,"2ZRT",160.87,"3.3","3.3","Crystal structure of Zn2+-bound form of des3-23ALG-2","DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","2ZRT"
"2ZT5",,"X-RAY DIFFRACTION",3.42,64.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"25mM Tris-HCl, 150mM NaCl, 10mM MgCl2, 4M Sodium Formate, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2ZT5",79.54,"2.5","2.5","Crystal structure of human glycyl-trna synthetase (GLYRS) in complex with AP4A (cocrystallized with ATP)","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2ZT5"
"2ZT6",,"X-RAY DIFFRACTION",3.44,64.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"25mM Tris-HCl, 150mM NaCl, 10mM MgCl2, 3.8-4.0M Sodium Formate, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2ZT6",79.21,"3.08","3.08","Crystal structure of human Glycyl-tRNA synthetase (GlyRS) in complex with AMPCPP","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2ZT6"
"2ZT7",,"X-RAY DIFFRACTION",3.42,64.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"25mM Tris-HCl, 150mM NaCl, 10mM MgCl2, 3.8-4.0M Sodium Formate, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2ZT7",79.29,"2.7","2.7","Crystal structure of human Glycyl-tRNA synthetase (GlyRS) in complex with Glycine and ATP","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2ZT7"
"2ZT8",,"X-RAY DIFFRACTION",3.49,64.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"25mM Tris-HCl, 150mM NaCl, 10mM MgCl2, 3.8-4.0M Sodium Formate, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2ZT8",79.11,"3.35","3.35","Crystal structure of human Glycyl-tRNA synthetase (GlyRS) in complex with Gly-AMP analog","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2ZT8"
"2ZV2",,"X-RAY DIFFRACTION",3.26,62.28,"VAPOR DIFFUSION, HANGING DROP",5.9,"0.1M Sodium cacodylate (pH 5.9), 0.2M Sodium acetate trihydrate, 18% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.251710","609","2ZV2",33.92,"2.4","2.4","Crystal structure of human calcium/calmodulin-dependent protein kinase kinase 2, beta, CaMKK2 kinase domain in complex with STO-609","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","2ZV2"
"2ZV6",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.3M sodium citrate, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1016/j.bbrc.2009.01.057",,"2ZV6",137.68,"2.7","2.7","Crystal structure of human squamous cell carcinoma antigen 1","MRGSHHHHHHGSNSLSEANTKFMFDLFQQFRKSKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRSGNVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGKDLSMIVLLPNEIDGLQKLEEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFNGDADLSGMTGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP","Homo sapiens","SERPINB3, SCCA, SCCA1","Serpin B3","1","2ZV6"
"2ZVK",,"X-RAY DIFFRACTION",2.78,55.76,,3.6,"pH3.6, HANGING DROP VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M809745200",,"2ZVK",93.91,"2.7","2.7","Crystal structure of PCNA in complex with DNA polymerase eta fragment","MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","2ZVK"
,,,,,,,,,,,,,,,,"CKRPRPEGMQTLESFFKPLTH",,,"DNA polymerase eta","2","2ZVK"
"2ZVL",,"X-RAY DIFFRACTION",3.2,61.6,"HANGING DROP VAPOR DIFFUSION",5.2,"pH5.2, HANGING DROP VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M809745200",,"2ZVL",183.74,"2.5","2.5","Crystal structure of PCNA in complex with DNA polymerase kappa fragment","MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","2ZVL"
,,,,,,,,,,,,,,,,"PKHTLDIFFKPLTH",,,"DNA polymerase kappa","2","2ZVL"
"2ZVM",,"X-RAY DIFFRACTION",2.76,55.36,"HANGING DROP VAPOR DIFFUSION",6.4,"pH6.4, HANGING DROP VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M809745200",,"2ZVM",94.03,"2.3","2.3","Crystal structure of PCNA in complex with DNA polymerase iota fragment","MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","2ZVM"
,,,,,,,,,,,,,,,,"ALNTAKKGLIDYYLMPSLSTTSR",,,"DNA polymerase iota","2","2ZVM"
"2ZVT",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes, 0.8M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2008.12.017",,"2ZVT",65.66,"1.9","1.9","Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGSQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2ZVT"
"2ZW3",,"X-RAY DIFFRACTION",4.2,70.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"16-18% PEG 200, 0.1M Sodium phosphate, 0.1M Sodium chloride, 0.01M DTT  
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature07869",,"2ZW3",157.48,"3.5","3.5","Structure of the connexin-26 gap junction channel at 3.5 angstrom resolution","MDWGTLQTILGGVNKHSTSIGKIWLTVLFIFRIMILVVAAKEVWGDEQADFVCNTLQPGCKNVCYDHYFPISHIRLWALQLIFVSTPALLVAMHVAYRRHEKKRKFIKGEIKSEFKDIEEIKTQKVRIEGSLWWTYTSSIFFRVIFEAAFMYVFYVMYDGFSMQRLVKCNAWPCPNTVDCFVSRPTEKTVFTVFMIAVSGICILLNVTELCYLLIRYCSGKSKKPV","Homo sapiens","GJB2","Gap junction beta-2 protein","1","2ZW3"
"2ZWB",,"NEUTRON DIFFRACTION",,,"SMALL TUBES",4.3,"PH 4.30(PD), SMALL TUBES, temperature 293K",293,,,"2ZWB",14.72,"1.8","1.8","Neutron crystal structure of wild type human lysozyme in D2O","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","2ZWB"
"2ZXF",,"X-RAY DIFFRACTION",3.5,64.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"25mM Tris-HCL, 150mM NaCl, 10mM MgCl2, 4M Sodium formate, PH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2ZXF",79.54,"3.4","3.4","Crystal structure of human glycyl-trna synthetase (GLYRS) in complex with AP4A (cocrystallized with AP4A)","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2ZXF"
"2ZXZ",,"X-RAY DIFFRACTION",1.99,38.27,"VAPOR DIFFUSION, HANGING DROP",8,"10mM Tris-HCl, 250mM NaCl, 5mM DTT, 50mM calcium acetate, 18% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1002/cmdc.200900090",,"2ZXZ",28.8,"3","3","Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide","TSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","2ZXZ"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"GRIP1 from Nuclear receptor coactivator 2","2","2ZXZ"
"2ZY0",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, HANGING DROP",8,"10mM Tris-HCl, 250mM NaCl, 5mM DTT, 50mM calcium acetate, 18% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1002/cmdc.200900090",,"2ZY0",57.67,"2.9","2.9","Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide","TSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","2ZY0"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"GRIP1 from Nuclear receptor coactivator 2","2","2ZY0"
"2ZYB",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M Sodium cacodylate, 30% PEG8000, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2008.10.041","PTR, KSL","2ZYB",33.48,"2.55","2.55","Crystal structure of phenylimidazo pyrazin 2 bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2ZYB"
"2ZZ0",,"X-RAY DIFFRACTION",3.14,60.78,"VAPOR DIFFUSION, SITTING DROP",6,"5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jinorgbio.2009.05.006",,"2ZZ0",229.49,"2.8","2.8","Crystal structure of human thioredoxin reductase I (SeCys 498 Cys)","MAHHHHHHVDDDDKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVVAQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCCG","Homo sapiens","TXNRD1, KDRF, GRIM12","Thioredoxin reductase 1, cytoplasmic","1","2ZZ0"
"2ZZB",,"X-RAY DIFFRACTION",3.13,60.69,"VAPOR DIFFUSION, SITTING DROP",6,"5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jinorgbio.2009.05.006",,"2ZZB",230.42,"3.2","3.2","Crystal structure of human thioredoxin reductase I and terpyridine platinum(II)","MAHHHHHHVDDDDKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVVAQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCCG","Homo sapiens","TXNRD1, KDRF, GRIM12","Thioredoxin reductase 1, cytoplasmic","1","2ZZB"
"2ZZC",,"X-RAY DIFFRACTION",3.13,60.74,"VAPOR DIFFUSION, SITTING DROP",6,"5% PEG 3350, 0.005M Magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jinorgbio.2009.05.006",,"2ZZC",232.08,"2.6","2.6","Crystal structure of NADP(H):human thioredoxin reductase I","MAHHHHHHVDDDDKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVVAQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCCG","Homo sapiens","TXNRD1, KDRF, GRIM12","Thioredoxin reductase 1, cytoplasmic","1","2ZZC"
"31BI",,"X-RAY DIFFRACTION",3.35,63.3,,,,,,,"31BI",17.38,"2","2","INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSSVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","INTERLEUKIN-1 BETA PRECURSOR","1","31BI"
"3A03",,"X-RAY DIFFRACTION",2.97,58.56,,,,,"10.1038/emboj.2010.53",,"3A03",7.05,"1.54","1.54","Crystal structure of Hox11L1 homeodomain","MTSFSRSQVLELERRFLRQKYLASAERAALAKALRMTDAQVKTWFQNRRTKWRRQT","Homo sapiens","TLX2, HOX11L1, NCX","T-cell leukemia homeobox protein 2","1","3A03"
"3A0I",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",6.6,"30 % PEG 1500, HEPES, PH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bmcl.2009.03.137","AJI","3A0I",51.64,"2.2","2.2","Human glucokinase in complex with a synthetic activator","TALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3A0I"
"3A1A",,"X-RAY DIFFRACTION",2.04,39.65,"VAPOR DIFFUSION, HANGING DROP",8.5,"17% PEG 8000, 0.1M Tris-HCl, 0.2M magnesium sulfate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/embor.2009.218",,"3A1A",16.57,"2.3","2.3","Crystal Structure of the DNMT3A ADD domain","GPLGSRERLVYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVLMCGNNNCCRCFCVECVDLLVGPGAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHD","Homo sapiens","DNMT3A","DNA (cytosine-5)-methyltransferase 3A","1","3A1A"
"3A1B",,"X-RAY DIFFRACTION",3.57,65.58,"VAPOR DIFFUSION, HANGING DROP",5.5,"10% PEG 2000 monomethyl ether, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/embor.2009.218",,"3A1B",18.7,"2.292","2.292","Crystal structure of the DNMT3A ADD domain in complex with histone H3","ARTKQTARKSTGGKAPRKQLRERLVYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVLMCGNNNCCRCFCVECVDLLVGPGAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHD","Homo sapiens","H3C1","DNA (cytosine-5)-methyltransferase 3A, Histone H3.1","1","3A1B"
,,,,,,,,,,,,,,,,,"Homo sapiens","H3C1"
"3A1F",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, SITTING DROP",5.6,"12% PEG 3350, 0.1M sodium acetate pH 5.6, 0.4M NiCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3A1F",21.59,"2","2","The crystal structure of NADPH binding domain of gp91(phox)","IAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF","Homo sapiens","CYBB, NOX2","Cytochrome b-245 heavy chain","1","3A1F"
"3A29",,"X-RAY DIFFRACTION",2.63,53.24,"VAPOR DIFFUSION, HANGING DROP",8.5,"8-10% PEG 3350, 0.15M NaCl, 0.1M Tris/HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2009.08.081","2T0","3A29",148.11,"2.6","2.6","Crystal structure of human liver FBPase in complex with tricyclic inhibitor","ADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","Fructose-1,6-bisphosphatase 1","1","3A29"
"3A2A",,"X-RAY DIFFRACTION",1.81,32.03,"VAPOR DIFFUSION",5,"3.2M NaCl, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, temperature 289K",289,"10.1074/jbc.M109.040360",,"3A2A",26.91,"2","2","The structure of the carboxyl-terminal domain of the human voltage-gated proton channel Hv1","GPLGSKTRSERQLLRLKQMNVQLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN","Homo sapiens","HVCN1, VSOP, UNQ578/PRO1140","Voltage-gated hydrogen channel 1","1","3A2A"
"3A2C",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444909046411","PDY","3A2C",459.15,"2.9","2.9","Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)","QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","3A2C"
"3A2I",,"X-RAY DIFFRACTION",2.54,51.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, pH 6.5, 1.2-1.6M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444910020810",,"3A2I",30.24,"3.27","3.27","Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with TEI-9647","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3A2I"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3A2J",,"X-RAY DIFFRACTION",2.54,51.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, pH 6.5, 1.2-1.6M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444910020810",,"3A2J",30.25,"2.7","2.7","Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed with TEI-9647","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEFSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3A2J"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3A3A",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, SITTING DROP",4.1,"32% PEG 1500, 0.1M sodium acetate-HCl pH 4.1, 140mM lithium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkp648",,"3A3A",28.91,"3.1","3.1","Crystal structure of human selenocystine tRNA","GCCCGGAUGAUCCUCAGUGGUCUGGGGUGCAGGCUUCAAACCUGUAGCUGUCUAGCGACAGAGUGGUUCAAUUCCACCUUUCGGGCGCCA","Homo sapiens",,"selenocysteine tRNA","1","3A3A"
"3A3Z",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",6,"10mM Tris, 100mM NaCl, 1nM TCEP, 0.05M Mes, 0.7M ammonium sulfate, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm9014636",,"3A3Z",30.46,"1.72","1.72","Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277A(C23S)","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3A3Z"
"3A40",,"X-RAY DIFFRACTION",2.56,51.99,"VAPOR DIFFUSION, SITTING DROP",6,"10mM Tris, 100mM NaCl, 1nM TCEP, 0.05M Mes, 0.7M ammonium sulfate, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm9014636",,"3A40",30.46,"1.45","1.45","Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277B(C23R)","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3A40"
"3A4D",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",5.3,"200mM citrate, 3M ammonium sulfate, pH 5.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi901677z",,"3A4D",28.02,"2","2","Crystal structure of Human Transthyretin (wild-type)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3A4D"
"3A4E",,"X-RAY DIFFRACTION",2.06,40.19,"VAPOR DIFFUSION, SITTING DROP",5.3,"200 mM citrate, 3M ammonium sulfate, pH 5.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi901677z",,"3A4E",27.88,"1.7","1.7","Crystal structure of Human Transthyretin (E54G)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGGLHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3A4E"
"3A4F",,"X-RAY DIFFRACTION",2.13,42.14,"VAPOR DIFFUSION, SITTING DROP",5.3,"200mM citrate, 3M ammonium sulfate, pH 5.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi901677z",,"3A4F",28.11,"1.99","1.99","Crystal Structure of Human Transthyretin (E54K)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGKLHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3A4F"
"3A4O",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, SITTING DROP",8.5,"pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2009.10.038","STU","3A4O",33.46,"3","3","Lyn kinase domain","KPWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQPHHHHHH","Homo sapiens","LYN, JTK8","Tyrosine-protein kinase Lyn","1","3A4O"
"3A4P",,"X-RAY DIFFRACTION",2.1,40.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"14%(w/v) PEG MME 5000, 5%(v/v) isopropanol, 12%(v/v) MPD, 0.1M Tris-Cl, 15%(v/v) Glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1016/j.bmcl.2009.12.109","DFQ","3A4P",36.56,"2.54","2.54","human c-MET kinase domain complexed with 6-benzyloxyquinoline inhibitor","GPLHMGSNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3A4P"
"3A5J",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,,,"3A5J",38.22,"1.7","1.7","Crystal structure of protein-tyrosine phosphatase 1B","MHHHHHHEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","3A5J"
"3A5K",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,,,"3A5K",35.66,"1.85","1.85","Crystal structure of protein-tyrosine phosphatase 1B","MHHHHHHEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKWAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","3A5K"
"3A60",,"X-RAY DIFFRACTION",2.9,57.62,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris, pH 5.5, 0.2M lithium sulfate, 22.5% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1074/jbc.M109.040667",,"3A60",74.81,"2.8","2.8","Crystal structure of unphosphorylated p70S6K1 (Form I)","GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3A60"
"3A61",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris, pH 5.5, 0.2M lithium sulfate, 30% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1074/jbc.M109.040667",,"3A61",37.4,"3.43","3.43","Crystal structure of unphosphorylated p70S6K1 (Form II)","GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3A61"
"3A62",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, pH 8.5, 3.5M Sodium Formate, VAPOR DIFFUSION, HANGING DROP, temperature 288.0K",288,"10.1074/jbc.M109.040667",,"3A62",37.54,"2.35","2.35","Crystal structure of phosphorylated p70S6K1","GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3A62"
"3A73",,"X-RAY DIFFRACTION",2.37,48.03,"VAPOR DIFFUSION, HANGING DROP",7,"50mM phosphate buffer pH 6.5, 28-32% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/ja908878n","PJ2","3A73",136.89,"2.19","2.19","Crystal Structure Analysis of Human serum albumin complexed with delta 12-prostaglandin J2","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3A73"
"3A77",,"X-RAY DIFFRACTION",2.68,54.04,"VAPOR DIFFUSION, SITTING DROP",5,"10% MPD, 50mM sodium acetate pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1111/j.1365-2443.2010.01427.x",,"3A77",108.42,"1.8","1.8","The crystal structure of phosphorylated IRF-3","GAMENPLKRLLVPGEEWEFEVTAFYRGRQVFQQTISCPEGLRLVGSEVGDRTLPGWPVTLPDPGMSLTDRGVMSYVRHVLSCLGGGLALWRAGQWLWAQRLGHCHTYWAVSEELLPNSGHGPDGEVPKDKEGGVFDLGPFIVDLITFTEGSGRSPRYALWFCVGESWPQDQPWTKRLVMVKVVPTCLRALVEMARVGGASSLENTVDLHISNSHPLSLTSDQYKAYLQDLVEGMDFQGPGES","Homo sapiens","IRF3","Interferon regulatory factor 3","1","3A77"
"3A78",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, SITTING DROP",6,"10mM Tris, 100mM NaCl, 1mM TCEP, 0.05M Mes, 0.7M ammonium sulfate, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3A78",30.41,"1.9","1.9","Crystal structure of the human VDR ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","3A78"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"3A7E",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH7.5, 2% (v/v) PEG 400, 2.0M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3A7E",24.65,"2.8","2.8","Crystal structure of human COMT complexed with SAM and 3,5-dinitrocatechol","GSMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKG","Homo sapiens","COMT","Catechol O-methyltransferase","1","3A7E"
"3A7F",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris-HCl, 100mM NaCl, 10%(v/v) glycerol, 5mM dithiothreitol, 0.1M Tris-HCl, 0.4M Na-formate, 10%(v/v) PEG 4000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444909047507",,"3A7F",34.34,"1.55","1.55","Human MST3 kinase","MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","Serine/threonine kinase 24 (STE20 homolog, yeast)","1","3A7F"
"3A7G",,"X-RAY DIFFRACTION",2.36,47.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris-HCl, 100mM NaCl, 10%(v/v) glycerol, 5mM dithiotheritol, 0.1M Tris-HCl, 200mM MgCl2, 13%(w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444909047507",,"3A7G",68.67,"2","2","Human MST3 kinase","MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","Serine/threonine kinase 24 (STE20 homolog, yeast)","1","3A7G"
"3A7H",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris-HCl, 100mM NaCl, 10%(v/v) glycerol, 5mM dithiothreitol, 0.1M Tris-HCl, 200mM MgCl2, 13%(v/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444909047507",,"3A7H",69.69,"1.96","1.96","Human MST3 kinase in complex with ATP","MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","Serine/threonine kinase 24 (STE20 homolog, yeast)","1","3A7H"
"3A7I",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris-HCl, 100mM NaCl, 10%(v/v) glycerol, 5mM dithiothreitol, 10mM ATP, 0.1M Tris-HCl, 200mM MgCl2, 13%(w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444909047507",,"3A7I",34.47,"1.45","1.45","Human MST3 kinase in complex with adenine","MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","Serine/threonine kinase 24 (STE20 homolog, yeast)","1","3A7I"
"3A7J",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris-HCl, 100mM NaCl, 10%(v/v) glycerol, 5mM dithiothreitol, 10mM ADP, 0.1M Tris-HCl, 180mM MgCl2, 5mM Mn-acetate, 13%(w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444909047507",,"3A7J",34.87,"1.5","1.5","Human MST3 kinase in complex with MnADP","MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","Serine/threonine kinase 24 (STE20 homolog, yeast)","1","3A7J"
"3A7S",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",8.5,"22% PEG 4000, 0.2M Magnesium chloride, 0.1M Tris-HCl, 3.5% Xylitol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bbrc.2009.10.062",,"3A7S",25.7,"2.2","2.2","Catalytic domain of UCH37","MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNAAATQAIVSVLLNCTHQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRK","Homo sapiens","UCH37, UCHL5, AD-019, CGI-70","Ubiquitin carboxyl-terminal hydrolase isozyme L5","1","3A7S"

"3A8W",,"X-RAY DIFFRACTION",2.45,49.87,"VAPOR DIFFUSION",5.5,"PEG3350, ammonium sulfate, pH 5.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444910005639",,"3A8W",80.82,"2.1","2.1","Crystal Structure of PKCiota kinase domain","GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL","Homo sapiens","PRKCI, DXS1179E","Protein kinase C iota type","1","3A8W"
"3A8X",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION",7.5,"HEPES, ammonium sulfate, PEG400, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444910005639",,"3A8X",80.09,"2","2","Crystal Structure of PKCiota kinase domain","GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL","Homo sapiens","PRKCI, DXS1179E","Protein kinase C iota type","1","3A8X"
"3A99",,"X-RAY DIFFRACTION",3.06,59.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"1 M sodium acetate, 0.1 M imidazole buffer , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M109.092452",,"3A99",37.01,"1.6","1.6","Structure of PIM-1 kinase crystallized in the presence of P27KIP1 Carboxy-terminal peptide","MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3A99"
"3AAF",,"X-RAY DIFFRACTION",3.27,62.38,"VAPOR DIFFUSION",9,"20% PEG 4000, 0.2M sodium acetate, 0.1M CAPS-NaOH, pH 9, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2009.12.011",,"3AAF",39.38,"1.9","1.9","Structure of WRN RQC domain bound to double-stranded DNA","GIRMDDSEDTSWDFGPQAFKLLSAVDILGEKFGIGLPILFLRGSNSQRLADQYRRHSLFGTGKDQTESWWKAFSRQLITEGFLVEVSRYNKFMKICALTKKGRNWLHKANTESQSLILQANEELCPKKFLLPSS","Homo sapiens","WRN, RECQ3, RECQL2","Werner syndrome ATP-dependent helicase","1","3AAF"
,,,,,,,,,,,,,,,,"ACCCTAATTAGGGT",,,"DNA (5'-D(*AP*CP*CP*CP*TP*AP*AP*TP*TP*AP*GP*GP*GP*T)-3')","2","3AAF"
"3AAJ",,"X-RAY DIFFRACTION",2.49,50.68,"VAPOR DIFFUSION, HANGING DROP",6,"0.05M Cacodylate, 2.5% PEG 4000, 0.3M Ammonium acetate, 0.01M CaCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1186/1472-6807-10-25",,"3AAJ",39.59,"2.4","2.4","Crystal structure of Ca2+-bound form of des3-23ALG-2deltaGF122","ADQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","3AAJ"
"3AAK",,"X-RAY DIFFRACTION",3.54,65.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% 2-methyl-2,4-pentanediol, 100mM Cacodylate, 50mM Zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1186/1472-6807-10-25",,"3AAK",20.28,"2.7","2.7","Crystal structure of Zn2+-bound form of des3-20ALG-2F122A","AALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGAGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFSIV","Homo sapiens","PDCD6, ALG2","Programmed cell death protein 6","1","3AAK"
"3ABH",,"X-RAY DIFFRACTION",3.25,62.15,"VAPOR DIFFUSION, HANGING DROP",8,"10% PEG 3350, 0.1M ammonium fluoride, 0.01M Tris-HCl, 0.075M NaCl, 0.001M DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1016/j.febslet.2010.02.058",,"3ABH",73.94,"2","2","Crystal structure of the EFC/F-BAR domain of human PACSIN2/Syndapin II (2.0 A)","GSSGSSGMSVTYDDSVGVEVSSDSFWEVGNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYMENMEQVFEQCQQFEEKRLRFFREVLLEVQKHLDLSNVAGYKAIYHDLEQSIRAADAVEDLRWFRANHGPGMAMNWPQFEEWS","Homo sapiens","PACSIN2","Protein kinase C and casein kinase substrate in neurons protein 2","1","3ABH"
"3ABT",,"X-RAY DIFFRACTION",3.61,65.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"3-10% PEG 2000 Monomethyl ether, 0.1M Hepes pH 7.5, 0.2M magnesium chloride, 0.1M cacodylate, 5mM Tranylcypromine-derivative, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1021/bi100299r","2PF","3ABT",74.66,"3.2","3.2","Crystal Structure of LSD1 in complex with trans-2-pentafluorophenylcyclopropylamine","SGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","Kazusa DNA KIAA 0601, KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1","1","3ABT"
"3ABU",,"X-RAY DIFFRACTION",3.61,65.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"3-10% PEG 2000 Monomethyl ether, 0.1M Hepes pH 7.5, 0.2M magnesium chloride, 0.1M cacodylate, 5mM Tranylcypromine-derivative, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1021/bi100299r","12F","3ABU",74.7,"3.1","3.1","Crystal Structure of LSD1 in complex with a 2-PCPA derivative, S1201","SGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","Kazusa DNA KIAA 0601, KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1","1","3ABU"
"3AC1",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG8000, 0.2% MPD., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC1",33.84,"1.99","1.99","Crystal structure of pyrazin derivative bound to the kinase domain of Human LCK, (Auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC1"
"3AC2",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, MPD 5.2%, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC2",33.87,"2.1","2.1","Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC2"
"3AC3",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 5.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC3",33.7,"2.55","2.55","Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC3"
"3AC4",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC4",33.74,"2.7","2.7","Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC4"
"3AC5",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC5",33.85,"2.5","2.5","Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC5"
"3AC8",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AC8",33.7,"2.3","2.3","Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AC8"
"3AC9",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1M Sodium Citrate, 35% PEG3350, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkr575",,"3AC9",44.28,"2.1","2.1","Crystal structure of human NUDT5 complexed with 8-oxo-dGDP and manganese","KQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, HSPC115, NUDIX5","ADP-sugar pyrophosphatase","1","3AC9"
"3ACA",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1M Sodium Citrate, 30% PEG3350, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkr575",,"3ACA",44.53,"2.05","2.05","Crystal structure of human NUDT5 complexed with 8-oxo-dADP and manganese","GKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, HSPC115, NUDIX5","ADP-sugar pyrophosphatase","1","3ACA"
"3ACJ",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3ACJ",33.65,"2.2","2.2","Crystal structure of imidazo pyrimidine derivative bound to the kinase domain of human LCK, (Auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3ACJ"
"3ACK",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3ACK",33.61,"2.6","2.6","Crystal structure of Pyrrolo pyrazine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3ACK"
"3ACL",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION",6.5,"34% PEG 3350, 0.1M PIPES, 0.1M MGCL2, 1.4mM INHIBITOR, PH 6.5, VAPOR DIFFUSION, TEMPERATURE 293K",293,"10.1038/nchembio.423","3F1","3ACL",33.44,"2.35","2.35","Crystal Structure of Human Pirin in complex with Triphenyl Compound","MHHHHHHGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","PIR","Pirin","1","3ACL"
"3ACO",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 3350, 0.1M calcium chloride, 0.03M glycyl-glycyl-glycine, 0.05 M Tris-HCl, 0.075M NaCl, 0.001M DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1016/j.febslet.2010.02.058",,"3ACO",82.14,"2.7","2.7","Crystal structure of the EFC/F-BAR domain of human PACSIN2/Syndapin II (2.7 A)","GSSGSSGMSVTYDDSVGVEVSSDSFWEVGNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYMENMEQVFEQCQQFEEKRLRFFREVLLEVQKHLDLSNVAGYKAIYHDLEQSIRAADAVEDLRWFRANHGPGMAMNWPQFEEWSADLNRTLSRREKKKATDGVTLTGINQTGDQSLPSKPSS","Homo sapiens","PACSIN2","Protein kinase C and casein kinase substrate in neurons protein 2","1","3ACO"
"3AD4",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AD4",33.74,"2.2","2.2","Crystal Structure of Methoxy Benzofuran Derivative bound to the Kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AD4"
"3AD5",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AD5",33.91,"2","2","Crystal structure of Triazolone derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AD5"
"3AD6",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M (NH4)2SO4, 0.1M SODIUM CACODYLATE, 30% PEG 8000, 0.2% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"PTR","3AD6",33.7,"2.15","2.15","Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3AD6"
"3ADL",,"X-RAY DIFFRACTION",2.55,51.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"AS, MgSO4, Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2010.02.006",,"3ADL",16.35,"2.2","2.2","Structure of TRBP2 and its molecule implications for miRNA processing","HHHHHHSSGLVPRGSHEVGALQELVVQKGWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGSGTSKKLAKRNAAAKMLLRVHTVPLD","Homo sapiens","TARBP2, TRBP","RISC-loading complex subunit TARBP2","1","3ADL"
,,,,,,,,,,,,,,,,"CGCGCGCGCG",,,"RNA (5'-R(P*CP*GP*CP*GP*CP*GP*CP*GP*CP*G)-3')","2","3ADL"
"3ADS",,"X-RAY DIFFRACTION",2.5,50.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","IMN","3ADS",66.46,"2.25","2.25","Human PPARgamma ligand-binding domain in complex with indomethacin","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADS"
"3ADT",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","HID","3ADT",65.77,"2.7","2.7","Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADT"
"3ADU",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","MYI","3ADU",66.41,"2.77","2.77","Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADU"
"3ADV",,"X-RAY DIFFRACTION",2.53,51.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","SRO","3ADV",65.92,"2.27","2.27","Human PPARgamma ligand-binding domain in complex with serotonin","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADV"
"3ADW",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","MYI","3ADW",66.23,"2.07","2.07","Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADW"
"3ADX",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.8M Sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2010.197","IMN","3ADX",66.4,"1.95","1.95","Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARgamma, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3ADX"
"3AG0",,"X-RAY DIFFRACTION",1.73,29.07,"batch",8,"20% PEG 3350, 20mM ammonium acetate, 5mM sodium dithionite, pH 8.0, batch, temperature 293K",293,"10.1002/prot.22950",,"3AG0",22.22,"2.6","2.6","Crystal structure of carbonmonoxy humnan cytoglobin","GSMEKVPGEMEIERRERSEELSEAERKAVQAMWARLYANCEDVGVAILVRFFVNFPSAKQYFSQFKHMEDPLEMERSPQLRKHACRVMGALNTVVENLHDPDKVSSVLALVGKAHALKHKVEPVYFKILSGVILEVVAEEFASDFPPETQRAWAKLRGLIYSHVTAAYKEVGWVQQVPNATTPPATLPSSGP","Homo sapiens","CYGB, STAP","Cytoglobin","1","3AG0"
"3AGL",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",6.9,"80 mM Mes-BisTris, 75 mM LiCl, 1.5 mM octanoyl-N-methylglucamide; mixed 2:1 with and equilibrated against 40%(v/v) MPD, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2010.08.028","A03","3AGL",83.56,"2.1","2.1","Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1039","MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PKACA, PRKACA","cAMP-dependent protein kinase catalytic subunit alpha","1","3AGL"
"3AGM",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"25 mM Tris-HCl, 25 mM NaCl, 1.5 mM octanoyl-N-methylglucamide, equilibrated against 12-15 % (v/v) methanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2010.08.028",,"3AGM",42.11,"2","2","Complex of PKA with the bisubstrate protein kinase inhibitor ARC-670","MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PKACA, PRKACA","cAMP-dependent protein kinase catalytic subunit alpha","1","3AGM"
,,,,,,,,,,,,,,,,"XXRRRRRRX",,,"N~2~-{8-OXO-8-[4-(9H-PURIN-6-YL)PIPERAZIN-1-YL]OCTANOYL}-D-ARGINYL-D-ARGINYL-D-ARGINYL-D-ARGINYL-D-ARGINYL-D-ARGININAMIDE","2","3AGM"
"3AGV",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, SITTING DROP",8,"The solution stirring technique with a rotary shaker produced the best diffracting crystals, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkq615",,"3AGV",65.62,"2.15","2.15","Crystal structure of a human IgG-aptamer complex","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3AGV"
,,,,,,,,,,,,,,,,"GGAGGUGXUXXGAAAGGAAXUXXA",,,"5'-R(*GP*GP*AP*GP*GP*(UFT)P*GP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*GP*AP*AP*A*GP*GP*AP*AP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*A)-3'","2","3AGV"
"3AGX",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION, HANGING DROP",6,"13% PEG 3350, 0.1M Na citrate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi100876n",,"3AGX",40.96,"1.85","1.85","Crystal structure of human Hsp40 Hdj1 peptide-binding domain","MDPPVTHDLRVSLEEIYSGCTKKMKISHKRLNPDGKSIRNEDKILTIEVKKGWKEGTKITFPKEGDQTSNNIPADIVFVLKDKPHNIFKRDGSDVIYPARISLREALCGCTVNVPTLDGRTIPVVFKDVIRPGMRRKVPGEGLPLPKTPEKRGDLIIEFEVIFPERIPQTSRTVLEQVLPI","Homo sapiens","DNAJB1, DNAJ1, HDJ1, HSPF1","DnaJ homolog subfamily B member 1","1","3AGX"
"3AHQ",,"X-RAY DIFFRACTION",2.59,52.42,"VAPOR DIFFUSION",8,"8% PEG4000, 50mM imidazole pH8.0, VAPOR DIFFUSION, temperature 293K",293,"10.1038/emboj.2010.222",,"3AHQ",54.96,"2.35","2.35","hyperactive human Ero1","MGSSHHHHHHSSGHIEGRHGEEQPPETAAQRCFCQVSGYLDDCTCDVETIDRFNNYRLFPRLQKLLESDYFRYYKVNLKRPCPFWNDISQCGRRDCAVKPAQSDEVPDGIKSASYKYSEEANNLIEEAEQAERLGAVDESLSEETQKAVLQWTKHDDSSDNFAEADDIQSPEAEYVDLLLNPERYTGYKGPDAWKIWNVIYEENCFKPQTIKRPLNPLASGQGTSEENTFYSWLEGLCVEKRAFYRLISGLHASINVHLSARYLLQETWLEKKWGHNITEFQQRFDGILTEGEGPRRLKNLYFLYLIELRALSKVLPFFERPDFQLFTGNKIQDEENKMLLLEILHEIKSFPLHFDENSFFAGDKKEAHKLKEDFRLHFRNISRIMDCVGCFKCRLWGKLQTQGLGTALKILFSEKLIANMPESGPSYEFHLTRQEIVSLFNAFGRISTSVKELENFRNLLQNIH","Homo sapiens","Ero1-Lalpha, ERO1A, ERO1L, UNQ434/PRO865","ERO1-like protein alpha","1","3AHQ"
"3AHR",,"X-RAY DIFFRACTION",2.52,51.17,"VAPOR DIFFUSION",8,"20% PEG1500, 80mM imidazole pH8.0, VAPOR DIFFUSION, temperature 293K",293,"10.1038/emboj.2010.222",,"3AHR",54.96,"3.07","3.07","Inactive human Ero1","MGSSHHHHHHSSGHIEGRHGEEQPPETAAQRCFCQVSGYLDDCTCDVETIDRFNNYRLFPRLQKLLESDYFRYYKVNLKRPCPFWNDISQCGRRDAAVKPAQSDEVPDGIKSASYKYSEEANNLIEECEQAERLGAVDESLSEETQKAVLQWTKHDDSSDNFAEADDIQSPEAEYVDLLLNPERYTGYKGPDAWKIWNVIYEENCFKPQTIKRPLNPLASGQGTSEENTFYSWLEGLCVEKRAFYRLISGLHASINVHLSARYLLQETWLEKKWGHNITEFQQRFDGILTEGEGPRRLKNLYFLYLIELRALSKVLPFFERPDFQLFTGNKIQDEENKMLLLEILHEIKSFPLHFDENSFFAGDKKEAHKLKEDFRLHFRNISRIMDCVGCFKCRLWGKLQTQGLGTALKILFSEKLIANMPESGPSYEFHLTRQEIVSLFNAFGRISTSVKELENFRNLLQNIH","Homo sapiens","Ero1-Lalpha, ERO1A, ERO1L, UNQ434/PRO865","ERO1-like protein alpha","1","3AHR"
"3AI8",,"X-RAY DIFFRACTION",1.97,37.59,"VAPOR DIFFUSION, SITTING DROP",3,"0.1M citric acid, 21% PEG6000, pH 3.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cmdc.201100098","HNQ","3AI8",56.55,"2.11","2.11","Cathepsin B in complex with the nitroxoline","LKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTD","Homo sapiens","CTSB, CPSB","Cathepsin B","1","3AI8"
"3AIH",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9M ammonium sulfate, 0.1M Tris-HCl, 2% PEG400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 303K",303,"10.1016/j.molcel.2010.11.017",,"3AIH",29.85,"2.1","2.1","Human OS-9 MRH domain complexed with alpha3,alpha6-Man5","GSAPCLLKTKDWWTYEFCYGRHIQQYHMEDSEIKGEVLYLGYYQSAFDWDDETAKASKQHRLKRYHSQTYGNGSKCDLNGRPREAEVRFLCDEGAGISGDYIDRVDEPLSCSYVLTIRTPRLCP","Homo sapiens","OS9","Protein OS-9","1","3AIH"
"3AJ4",,"X-RAY DIFFRACTION",1.89,34.82,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP",,"10.1073/pnas.1109101108",,"3AJ4",26.57,"1","1","Crystal structure of the PH domain of Evectin-2 from human complexed with O-phospho-L-serine","GSMAFVKSGWLLRQSTILKRWKKNWFDLWSDGHLIYYDDQTRQNIEDKVHMPMDCINIRTGQECRDTQPPDGKSKDCMLQIVCRDGKTISLCAESTDDCLAWKFTLQDSRTN","Homo sapiens","PLEKHB2, EVT2","Pleckstrin homology domain-containing family B member 2","1","3AJ4"
"3AJM",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG, 0.1M sodium cacodylate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1016/j.bbrc.2010.07.119",,"3AJM",50.29,"2.3","2.3","Crystal structure of programmed cell death 10 in complex with inositol 1,3,4,5-tetrakisphosphate","MKNEAETTSMVSMPLYAVMYPVFNELERVNLSAAQTLRAAFIKAEKENPGLTQDIIMKILEKKSVEVNFTESLLRMAADDVEEYMIERPEPEFQDLNEKARALKQILSKIPDEINDRVRFLQTIKDIASAIKELLDTVNNVFKKYQYQNRRALEHQKKEFVKYSKSFSDTLKTYFKDGKAINVFVSANRLIHQTNLILQTFKTVALEHHHHHH","Homo sapiens","PDCD10, CCM3, TFAR15","Programmed cell death protein 10","1","3AJM"
"3AJO",,"X-RAY DIFFRACTION",3.01,59.11,"VAPOR DIFFUSION, HANGING DROP",9,"2.0M magnesium chloride, 0.1M Bicine (pH 9.0), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.08.017",,"3AJO",21.42,"1.52","1.52","Crystal structure of wild-type human ferritin H chain","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","3AJO"
"3AJP",,"X-RAY DIFFRACTION",3.03,59.39,"VAPOR DIFFUSION, HANGING DROP",9,"2.0M magnesium chloride, 0.1M Bicine (pH 9.0), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.08.017",,"3AJP",21.31,"1.901","1.901","Crystal structure of human H ferritin E140A mutant","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNAQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","3AJP"
"3AJQ",,"X-RAY DIFFRACTION",2.99,58.87,"VAPOR DIFFUSION, HANGING DROP",9,"2.0M magnesium chloride, 0.1M Bicine (pH 9.0), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.08.017",,"3AJQ",21.39,"1.58","1.58","Crystal structure of human H ferritin E140Q mutant","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNQQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","3AJQ"
"3AKM",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"30-34% w/v PEG 4000, 0.2M Magnesium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"11D","3AKM",62.23,"1.9","1.9","X-ray structure of iFABP from human and rat with bound fluorescent fatty acid analogue","AFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD","Homo sapiens","FABP2, FABPI","Fatty acid-binding protein, intestinal","1","3AKM"
"3AL2",,"X-RAY DIFFRACTION",2.44,49.58,"VAPOR DIFFUSION, HANGING DROP",8,"Li2SO4, Tris-HCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M110.189555",,"3AL2",26.76,"2","2","Crystal Structure of TopBP1 BRCT7/8","GPLGSLKKQYIFQLSSLNPQERIDYCHLIEKLGGLVIEKQCFDPTCTHIVVGHPLRNEKYLASVAAGKWVLHRSYLEACRTAGHFVQEEDYEWGSSSILDVLTGINVQQRRLALAAMRWRKKIQQRQESGIVEGAFSGWKVILHVDQSREAGFKRLLQSGGAKVLPGHSVPLFKEATHLFSDLNKLKPDDSGVNIAEAAAQNVYCLRTEYIADYLMQESPPHVENYCLPEAISFI","Homo sapiens","KIAA0259, TOPBP1","DNA topoisomerase 2-binding protein 1","1","3AL2"
"3AL3",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, HANGING DROP",8,"Sodium formate, pH 8, vapor diffusion, hanging drop, temperature 298K",298,"10.1074/jbc.M110.189555",,"3AL3",27.84,"2.15","2.15","Crystal Structure of TopBP1 BRCT7/8-BACH1 peptide complex","GPLGSLKKQYIFQLSSLNPQERIDYCHLIEKLGGLVIEKQCFDPTCTHIVVGHPLRNEKYLASVAAGKWVLHRSYLEACRTAGHFVQEEDYEWGSSSILDVLTGINVQQRRLALAAMRWRKKIQQRQESGIVEGAFSGWKVILHVDQSREAGFKRLLQSGGAKVLPGHSVPLFKEATHLFSDLNKLKPDDSGVNIAEAAAQNVYCLRTEYIADYLMQESPPHVENYCLPEAISFI","Homo sapiens","KIAA0259, TOPBP1","DNA topoisomerase 2-binding protein 1","1","3AL3"
,,,,,,,,,,,,,,,,"SIYFTPELYD",,,"Peptide of Fanconi anemia group J protein","2","3AL3"
"3AL5",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, SITTING DROP",8,"200mM potassium thiocyanate, 10% (w/v) PEG3350, pH 8.0, vapor diffusion, sitting drop, temperature 293K",293,"10.1093/nar/gkq919",,"3AL5",156.68,"2.503","2.503","Crystal structure of Human TYW5","MGSSHHHHHHSSGLEVLFQGPLHMAGQHLPVPRLEGVSREQFMQHLYPQRKPLVLEGIDLGPCTSKWTVDYLSQVGGKKEVKIHVAAVAQMDFISKNFVYRTLPFDQLVQRAAEEKHKEFFVSEDEKYYLRSLGEDPRKDVADIRKQFPLLKGDIKFPEFFKEEQFFSSVFRISSPGLQLWTHYDVMDNLLIQVTGKKRVVLFSPRDAQYLYLKGTKSEVLNIDNPDLAKYPLFSKARRYECSLEAGDVLFIPALWFHNVISEEFGVGVNIFWKHLPSECYDKTDTYGNKDPTAASRAAQILDRALKTLAELPEEYRDFYARRMVLHIQDKAYSKNSE","Homo sapiens","C2orf60, TYW5","JmjC domain-containing protein C2orf60","1","3AL5"
"3AL6",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, SITTING DROP",8,"200mM potassium thiocyanate, 10% (w/v) PEG3350, pH 8.0, vapor diffusion, sitting drop, temperature 293K",293,"10.1093/nar/gkq919",,"3AL6",157.16,"2.8","2.8","Crystal structure of Human TYW5","MGSSHHHHHHSSGLEVLFQGPLHMAGQHLPVPRLEGVSREQFMQHLYPQRKPLVLEGIDLGPCTSKWTVDYLSQVGGKKEVKIHVAAVAQMDFISKNFVYRTLPFDQLVQRAAEEKHKEFFVSEDEKYYLRSLGEDPRKDVADIRKQFPLLKGDIKFPEFFKEEQFFSSVFRISSPGLQLWTHYDVMDNLLIQVTGKKRVVLFSPRDAQYLYLKGTKSEVLNIDNPDLAKYPLFSKARRYECSLEAGDVLFIPALWFHNVISEEFGVGVNIFWKHLPSECYDKTDTYGNKDPTAASRAAQILDRALKTLAELPEEYRDFYARRMVLHIQDKAYSKNSE","Homo sapiens","C2orf60, TYW5","JmjC domain-containing protein C2orf60","1","3AL6"
"3ALA",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1744309110041515",,"3ALA",595.58,"2.9","2.9","Crystal structure of vascular adhesion protein-1 in space group C2","DIVDYKDDDDKENLYFQGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","Membrane primary amine oxidase","1","3ALA"
"3ALB",,"X-RAY DIFFRACTION",2.25,45.37,"VAPOR DIFFUSION, HANGING DROP",4.6,"20% PEG 3350, 0.2M Ammonium sulfate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bbrc.2010.08.057",,"3ALB",34.69,"1.85","1.85","Cyclic Lys48-linked tetraubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","ubiquitin","1","3ALB"
"3ALN",,"X-RAY DIFFRACTION",1.95,36.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Imidazole-HCl pH6.5, 22% PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.08.071",,"3ALN",113.98,"2.3","2.3","Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP","MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDHHHHHH","Homo sapiens","JNKK1, MAP2K4, MEK4, MKK4, PRKMK4, SERK1, SEK1, SKK1","Dual specificity mitogen-activated protein kinase kinase 4","1","3ALN"
"3ALP",,"X-RAY DIFFRACTION",5.06,75.69,"VAPOR DIFFUSION, HANGING DROP",5,"1% PEG 3350, 50mM Bis-Tris propane, 50mM citric acid, 6% hexane-1,6-diol , VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M110.197368",,"3ALP",74.38,"2.804","2.804","Cell adhesion protein","MASMTGGQQMGRDPSQVVQVNDSMYGFIGTDVVLHCSFANPLPSVKITQVTWQKSTNGSKQNVAIYNPSMGVSVLAPYRERVEFLRPSFTDGTIRLSRLELEDEGVYICEFATFPTGNRESQLNLTVMAKPTNWIEGTQAVLRAKKGQDDKVLVATCTSANGKPPSVVSWETRLKGEAEYQEIRNPNGTVTVISRYRLVPSREAHQQSLACIVNYHMDRFKESLTLNVQYEPEVTIEGFDGNWYLQRMDVKLTCKADANPPATEYHWTTLNGSLPKGVEAQNRTLFFKGPINYSLAGTYICEATNPIGTRSGQVEVNITEAAALEHHHHHH","Homo sapiens","HVEC, PRR1, PVRL1, NECTIN1","Poliovirus receptor-related protein 1","1","3ALP"
"3AMY",,"X-RAY DIFFRACTION",1.697481,27.53969,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% ethylene glycol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,"AGI","3AMY",40.81,"2.3","2.3","Crystal structure of human CK2 alpha complexed with apigenin","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3AMY"
"3AN3",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M SODIUM CITRATE, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm101233f","M7S","3AN3",65.63,"2.3","2.3","Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3AN3"
"3AN4",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M SODIUM CITRATE, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm101233f","M7R","3AN4",65.63,"2.3","2.3","Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3AN4"
"3ANQ",,"X-RAY DIFFRACTION",2.56,52.02,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, 0.2M sodium acetate, 30% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms1090","EHB","3ANQ",171.56,"2.6","2.6","human DYRK1A/inhibitor complex","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","3ANQ"
"3ANR",,"X-RAY DIFFRACTION",2.57,52.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, 0.2M sodium acetate, 30% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms1090","HRM","3ANR",171.46,"2.6","2.6","human DYRK1A/harmine complex","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","3ANR"
"3ANS",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, SITTING DROP",7.3,"20%(w/v) PEG 8000, 200mM sodium iodide, pH 7.3, vapor diffusion, sitting drop, temperature 277K",277,"10.1021/jm101273e","S38","3ANS",77.82,"1.98","1.98","Human soluble epoxide hydrolase in complex with a synthetic inhibitor","MKKGHHHHHHTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Epoxide hydrolase 2","1","3ANS"
"3ANT",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, SITTING DROP",7.3,"20%(w/v) PEG 8000, 200mM sodium iodide, pH 7.3, vapor diffusion, sitting drop, temperature 277K",277,"10.1021/jm101273e","S82","3ANT",78,"2.4","2.4","Human soluble epoxide hydrolase in complex with a synthetic inhibitor","MKKGHHHHHHTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Epoxide hydrolase 2","1","3ANT"
"3AOX",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, SITTING DROP",5.5,"PEG 550 MME, maleic acid, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.ccr.2011.04.004","EMH","3AOX",39.55,"1.75","1.75","X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802","GMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","3AOX"
"3AP1",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium malonate (pH 5.0), 10% polyethylene glycol 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293.4K",293.4,"10.1038/ncomms2593",,"3AP1",78.85,"1.9","1.9","Crystal structure of human tyrosylprotein sulfotransferase-2 complexed with PAP and C4 peptide","MGSSHHHHHHSSGVPRGSHMGAMRPEQEELVMVGTNHVEYRYGKAMPLIFVGGVPRSGTTLMRAMLDAHPEVRCGEETRIIPRVLAMRQAWSKSGREKLRLDEAGVTDEVLDAAMQAFILEVIAKHGEPARVLCNKDPFTLKSSVYLSRLFPNSKFLLMVRDGRASVHSMITRKVTIAGFDLSSYRDCLTKWNKAIEVMYAQCMEVGKEKCLPVYYEQLVLHPRRSLKLILDFLGIAWSDAVLHHEDLIGKPGGVSLSKIERSTDQVIKPVNLEALSKWTGHIPGDVVRDMAQIAPMLAQLGYDPYANPPNYGNPDPFVINNTQRVLKGDYKTPANL","Homo sapiens","TPST2","Protein-tyrosine sulfotransferase 2","1","3AP1"
,,,,,,,,,,,,,,,,"EDFEDYEFD",,,"C4 peptide","2","3AP1"
"3AP2",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium malonate (pH 5.0), 10% polyethylene glycol 3350, 1M sodium/potassium phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 293.4K",293.4,,,"3AP2",78.95,"2.4","2.4","Crystal structure of human tyrosylprotein sulfotransferase-2 complexed with PAP,C4 peptide, and phosphate ion","MGSSHHHHHHSSGVPRGSHMGAMRPEQEELVMVGTNHVEYRYGKAMPLIFVGGVPRSGTTLMRAMLDAHPEVRCGEETRIIPRVLAMRQAWSKSGREKLRLDEAGVTDEVLDAAMQAFILEVIAKHGEPARVLCNKDPFTLKSSVYLSRLFPNSKFLLMVRDGRASVHSMITRKVTIAGFDLSSYRDCLTKWNKAIEVMYAQCMEVGKEKCLPVYYEQLVLHPRRSLKLILDFLGIAWSDAVLHHEDLIGKPGGVSLSKIERSTDQVIKPVNLEALSKWTGHIPGDVVRDMAQIAPMLAQLGYDPYANPPNYGNPDPFVINNTQRVLKGDYKTPANL","Homo sapiens","TPST2","Protein-tyrosine sulfotransferase 2","1","3AP2"
,,,,,,,,,,,,,,,,"EDFEDYEFD",,,"C4 peptide","2","3AP2"
"3AP3",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Tris-HCl, pH 7.0, 0.1M calcium acetate, 20 % polyethylene glycol 3000, VAPOR DIFFUSION, SITTING DROP, temperature 283.4K",283.4,"10.1038/ncomms2593",,"3AP3",160.26,"3.5","3.5","Crystal structure of human tyrosylprotein sulfotransferase-2 complexed with PAP","MGSSHHHHHHSSGVPRGSHMGAMRPEQEELVMVGTNHVVYRYGKAMPLIFVGGVPRSGTTLMRAMLDAHPEVRCGEETRIIPRVLAMRQAWSKSGREKLRLDEAGVTDEVLDAAMQAFILEVIAKHGEPARVLCNKDPFTLKSSVYLSRLFPNSKFLLMVRDGRASVHSMITRKVTIAGFDLSSYRDCLTKWNKAIEVMYAQCMEVGKEKCLPVYYEQLVLHPRRSLKLILDFLGIAWSDAVLHHEDLIGKPGGVSLSKIERSTDQVIKPVNLEALSKWTGHIPGDVVRDMAQIAPMLAQLGYDPYANPPNYGNPDPFVINNTQRVLKGDYKTPANLKGYFQVNQNSTSSHLGSS","Homo sapiens","TPST2","Protein-tyrosine sulfotransferase 2","1","3AP3"
"3AP4",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, HANGING DROP",7,"0.275mM protein, 10mM Hepes-NaOH, 2.75mM lactose, 50mM sodium chloride, 0.5mM DTT, 50mM ammonium fluoride, 12% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.195925",,"3AP4",71.06,"2.33","2.33","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain in complex with lactose","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3AP4"
"3AP5",,"X-RAY DIFFRACTION",2.76,55.44,"VAPOR DIFFUSION, HANGING DROP",7,"0.275mM protein, 10mM Hepes-NaOH, 50mM sodium chloride, 0.5mM DTT, 125mM ammonium fluoride, 8% PEG 3350 , pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.195925",,"3AP5",17.42,"1.92","1.92","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3AP5"
"3AP6",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, HANGING DROP",7,"0.275mM protein, 10mM Hepes-NaOH, 2.75mM lactose 3'-sulfate, 50mM sodium chloride, 0.5mM DTT, 50mM ammonium fluoride, 9% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.195925",,"3AP6",71.45,"1.58","1.58","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain in complex with lactose 3'-sulfate","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3AP6"
"3AP7",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",7,"0.275mM protein, 10mM Hepes-NaOH, 2.75mM lactose sialic acid, 50mM sodium chloride, 0.5mM DTT, 80mM ammonium 
fluoride, 7.5% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.195925",,"3AP7",18.09,"1.53","1.53","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain in complex with lactose sialic acid","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3AP7"
"3AP9",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",7,"0.275mM protein, 10mM Hepes-NaOH, 2.75mM Lacto-N-fucopentaose III, 50mM sodium chloride, 0.5mM DTT, 50mM ammonium fluoride, 12% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.195925",,"3AP9",18.5,"1.33","1.33","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain in complex with Lacto-N-fucopentaose III","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3AP9"
"3APA",,"X-RAY DIFFRACTION",2.09,41.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.09M MES (pH 6.5), 0.09M sodium phosphate, 0.09M potassium phosphate, 1.8M sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.11.093",,"3APA",15.63,"1.65","1.65","Crystal structure of human pancreatic secretory protein ZG16p","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3APA"
"3APB",,"X-RAY DIFFRACTION",2.78,55.77,"VAPOR DIFFUSION, HANGING DROP",7,"0.55mM protein, 10mM Hepes-NaOH, 50mM sodium chloride, 0.5mM DTT, 125mM ammonium fluoride, 8% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,,,"3APB",38.53,"1.95","1.95","Crystal structure of the galectin-8 N-terminal carbohydrate recognition domain in complex with iodide","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","3APB"
"3APC",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",7.2,"20% PEG3350, 0.2M (NH4)2SO4, 0.1M Tris-HCl, streak seeding, pH 7.2, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.01.065","MMD","3APC",111.02,"2.544","2.544","Crystal structure of human PI3K-gamma in complex with CH5132799","GPLHMGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3APC"
"3APD",,"X-RAY DIFFRACTION",2.3,46.3,"VAPOR DIFFUSION, HANGING DROP",7.2,"20% PEG3350, 0.2M (NH4)2SO4, 0.1M Tris-HCl, streak seeding, pH 7.2, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.01.065",,"3APD",111.02,"2.55","2.55","Crystal structure of human PI3K-gamma in complex with CH5108134","GPLHMGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3APD"
"3APF",,"X-RAY DIFFRACTION",2.4,47.3,"VAPOR DIFFUSION, HANGING DROP",7.2,"20% PEG3350, 0.2M (NH4)2SO4, 0.1M Tris-HCl, streak seeding, pH 7.2, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.01.065",,"3APF",111.05,"2.82","2.82","Crystal structure of human PI3K-gamma in complex with CH5039699","GPLHMGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3APF"
"3APM",,"X-RAY DIFFRACTION",2.82,56.39,"VAPOR DIFFUSION, HANGING DROP",8,"imidazole, lithium sulfate, PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444910051711",,"3APM",74.46,"2.5","2.5","Crystal structure of the human SNP PAD4 protein","GPHMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHGPPAKKKSTGSSTWPLDPGVEVTLTMKVASGSTGDQKVQISYYGPKTPPVKALLYLTGVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","3APM"
"3APN",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",8,"imidazole, lithium sulfate, PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444910051711",,"3APN",74.47,"2.7","2.7","Crystal structure of the human wild-type PAD4 protein","GPHMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHSPPAKKKSTGSSTWPLDPGVEVTLTMKAASGSTGDQKVQISYYGPKTPPVKALLYLTAVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","3APN"
"3APU",,"X-RAY DIFFRACTION",2,38.56,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 4000, 0.2M ammonium acetate, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208926",,"3APU",45.77,"2.1","2.1","Crystal structure of the A variant of human alpha1-acid glycoprotein","MQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLRIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGESHHHHHH","Homo sapiens","AGP2, ORM2","Alpha-1-acid glycoprotein 2","1","3APU"
"3APV",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 4000, 0.2M ammonium sulfate, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208926",,"3APV",46,"2.15","2.15","Crystal structure of the A variant of human alpha1-acid glycoprotein and amitriptyline complex","MQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLRIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGESHHHHHH","Homo sapiens","AGP2, ORM2","Alpha-1-acid glycoprotein 2","1","3APV"
"3APW",,"X-RAY DIFFRACTION",2.05,39.87,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 4000, 0.2M ammonium sulfate, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208926",,"3APW",46.06,"2.2","2.2","Crystal structure of the A variant of human alpha1-acid glycoprotein and disopyramide complex","MQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLRIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGESHHHHHH","Homo sapiens","AGP2, ORM2","Alpha-1-acid glycoprotein 2","1","3APW"
"3APX",,"X-RAY DIFFRACTION",1.9,35.32,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 4000, 0.2M ammonium sulfate, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208926",,"3APX",23.07,"2.2","2.2","Crystal structure of the A variant of human alpha1-acid glycoprotein and chlorpromazine complex","MQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLRIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGESHHHHHH","Homo sapiens","AGP2, ORM2","Alpha-1-acid glycoprotein 2","1","3APX"
"3AQA",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG MME 5000, 0.2M ammonium sulfate, 0.1M HEPES buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.chembiol.2011.02.009","BYH","3AQA",46.32,"2.3","2.3","Crystal structure of the human BRD2 BD1 bromodomain in complex with a BRD2-interactive compound, BIC1","GSSGSSGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","3AQA"
"3AQE",,"X-RAY DIFFRACTION",1.94,36.48,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1M Sodium-HEPES, 25% (v/v) PEG 400, 0.2M Calcium chloride di-hydrate, 0.15% Agarose , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.2003",,"3AQE",63.49,"2","2","Crystal structure of the extracellular domain of human RAMP2","GSSGSSGGTVKNYETAVQFCWNHYKDQMDPIEKDWCDWAMISRPYSTLRDCLEHFAELFDLGFPNPLAERIIFETHQIHFANCSLVQPTFS","Homo sapiens","RAMP2","Receptor activity-modifying protein 2","1","3AQE"
"3AQG",,"X-RAY DIFFRACTION",1.99,38.16,"VAPOR DIFFUSION, SITTING DROP",8,"0.4M ammonium phosphate monobasic, 5%(v/v) 1,4-dioxane, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2010.11.093",,"3AQG",34.93,"2.75","2.75","Crystal structure of human pancreatic secretory protein ZG16b","GSGKMYGPGGGKYFSTTEDYDHEITGLRVSVGLLLVKSVQVKLGDSWDVKLGALGGNTQEVTLQPGEYITKVFVAFQAFLRGMVMYTSKDRYFYFGKLDGQISSAYPSQEGQVLVGIYGQYQLLGIKSIGFEWNYPLEEPTTEPPVNLTYSANSPVGR","Homo sapiens","ZG16B, UNQ773/PRO1567","Zymogen granule protein 16 homolog B","1","3AQG"
"3AQI",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 25% PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3AQI",85.03,"1.7","1.7","H240A variant of human ferrochelatase","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADAILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","3AQI"
"3AQQ",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, HANGING DROP",4.9,"0.1M sodium acetate trihydrate, 2.0M sodium formate, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3AQQ",63.66,"2.798","2.798","Crystal structure of human CRHSP-24","MSSEPPPPPQPPTHQASVGLLDTPRSRERSPSPLRGNVVPSPLPTRRTRTFSATVRASQGPVYKGVCKCFCRSKGHGFITPADGGPDIFLHISDVEGEYVPVEGDEVTYKMCSIPPKNEKLQAVEVVITHLAPGTKHETWSGHVISS","Homo sapiens","CARHSP1","Calcium-regulated heat stable protein 1","1","3AQQ"
"3AQV",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.1M Bis-Tris (pH 6.5), 1.5M ammonium sulfate, 0.1M NaCl, 0.5mM Compound C, 5mM MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444911010201",,"3AQV",31.97,"2.08","2.08","Human AMP-activated protein kinase alpha 2 subunit kinase domain (T172D) complexed with compound C","GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE","Homo sapiens","PRKAA2, AMPK, AMPK2","5'-AMP-activated protein kinase catalytic subunit alpha-2","1","3AQV"
"3ARA",,"X-RAY DIFFRACTION",2.87,57.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"15%~20% PEG 4000, 0.05M Tris buffer, 0.05M magnesium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm201627n","MKH","3ARA",54.77,"1.7","1.7","Discovery of Novel Uracil Derivatives as Potent Human dUTPase Inhibitors","MPCSEETPAISPSKRARPAEVGGMQLRFARLSEHATAPTRGSARAAGYDLYSAYDYTIPPMEKAVVKTDIQIALPSGCYGRVAPRSGLAAKHFIDVGAGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEVQALDDTERGSGGFGSTGKN","Homo sapiens","DUT","Deoxyuridine 5'-triphosphate nucleotidohydrolase","1","3ARA"
"3ARN",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"15~20% PEG 4000, 50mM Tris, 0.1M magnesium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm201628y","MSJ","3ARN",54.6,"1.8","1.8","Human dUTPase in complex with novel uracil derivative","MPCSEETPAISPSKRARPAEVGGMQLRFARLSEHATAPTRGSARAAGYDLYSAYDYTIPPMEKAVVKTDIQIALPSGCYGRVAPRSGLAAKHFIDVGAGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEVQALDDTERGSGGFGSTGKN","Homo sapiens","DUT","Deoxyuridine 5'-triphosphate nucleotidohydrolase","1","3ARN"
"3ASX",,"X-RAY DIFFRACTION",2.54,51.56,"VAPOR DIFFUSION",5,"seeding method, pH 5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmc.2011.01.065","D99","3ASX",39.81,"2","2","Human Squalene synthase in complex with 1-{4-[{4-chloro-2-[(2-chlorophenyl)(hydroxy)methyl]phenyl}(2,2-dimethylpropyl)amino]-4-oxobutanoyl}piperidine-3-carboxylic acid","MDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3ASX"
"3AT2",,"X-RAY DIFFRACTION",2,38.39,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethyleneglycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1007/s11010-011-0960-9",,"3AT2",41.16,"1.6","1.6","Crystal structure of CK2alpha","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3AT2"
"3AT3",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethyleneglycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1007/s11010-011-0960-9","ATK","3AT3",40.88,"2.6","2.6","Crystal structure of CK2alpha with pyradine derivative","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3AT3"
"3AT4",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethyleneglycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1007/s11010-011-0960-9","CCK","3AT4",40.85,"2.2","2.2","Crystal structure of CK2alpha with pyradine derivertive","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3AT4"
"3ATU",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES-NaOH (pH 7.0), 0.15M MgCl2, 30 % PEG MME 500, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.663","ADP","3ATU",43.84,"1.65","1.65","Crystal structure of human Hsp70 NBD in the ADP- and Mg ion-bound state","GSFTMAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMGDKSENV","Homo sapiens","Hsp70, HSPA1, HSPA1A, HSPA1B, HSP72, HSX70","Heat shock 70 kDa protein 1A/1B","1","3ATU"
"3ATV",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Bis-Tris (pH 5.5), 0.25M KNO3, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.663","ADP","3ATV",43.65,"1.58","1.58","Crystal structure of human Hsp70 NBD in the ADP-bound and Mg ion-free state","GSFTMAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMGDKSENV","Homo sapiens","Hsp70, HSPA1, HSPA1A, HSPA1B, HSP72, HSX70","Heat shock 70 kDa protein 1A/1B","1","3ATV"
"3AU3",,"X-RAY DIFFRACTION",3.02,59.21,"VAPOR DIFFUSION, SITTING DROP",4.6,"100mM sodium acetate, 1.25M lithium citrate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2011.07.013",,"3AU3",38.68,"2.1","2.1","Crystal structure of armadillo repeat domain of APC","GSSGSSGDDKRGRREIRVLHLLEQIRAYCETCWEWQEAHEPGMDQDKNPMPAPVEHQICPAVCVLMKLSFDEEHRHAMNELGGLQAIAELLQVDCEMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLSALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNVSSLIATNEDHRQILRENNCLQTLLQHLKSHSLTIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKNLIHSKHKMIAMGSAAALRNLMAN","Homo sapiens","APC, DP2.5","Adenomatous polyposis coli protein","1","3AU3"
"3AU5",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 8000, 5% MPD, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2011.177",,"3AU5",126.85,"2.55","2.55","Structure of the human myosin-X MyTH4-FERM cassette","GPTRWSSAIQNVTDTKAPIDTPTQQLIQDIKENCLNSDVVEQIYKRNPILRYTHHPLHSPLLPLPYGDINLNLLKDKGYTTLQDEAIKIFNSLQQLESMSDPIPIIQGILQTGHDLRPLRDELYCQLIKQTNKVPHPGSVGNLYSWQILTCLSCTFLPSRGILKYLKFHLKRIREQFPGTEMEKYALFTYESLKKTKCREFVPSRDEIEALIHRQEMTSTVYCHGGGSCKITINSHTTAGEVVEKLIRGLAMEDSRNMFALFEYNGHVDKAIESRTVVADVLAKFEKLAATSEVGDLPWKFYFKLYCFLDTDNVPKDSVEFAFMFEQAHEAVIHGHHPAPEENLQVLAALRLQYLQGDYTLHAAIPPLEEVYSLQRLKARISQSTKTFSFRTGSVVRQKVEEEQMLDMWIKEEVSSARASIIDKWRKFQGMNQEQAMAKYMALIKEWPGYGSTLFDVECKEGGFPQELWLGVSADAVSVYKRGEGRPLEVFQYEHILSFGAPLANTYKIVVDERELLFETSEVVDVAKLMKAYISMIVKKRYSTTRSASSQGSSR","Homo sapiens","MYO10, KIAA0799","Myosin-X","1","3AU5"
"3AUL",,"X-RAY DIFFRACTION",1.83,32.84,"VAPOR DIFFUSION, HANGING DROP",6,"20% PEG 3350, 0.2M litium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1074/jbc.M111.256354",,"3AUL",17.15,"2.39","2.39","Crystal structure of wild-type Lys48-linked diubiquitin in an open conformation","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Polyubiquitin-C","1","3AUL"
"3AUQ",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja201481j",,"3AUQ",30.22,"2.64","2.64","Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","3AUQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"3AUR",,"X-RAY DIFFRACTION",2.52,51.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja201481j",,"3AUR",30.22,"2.21","2.21","Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","3AUR"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"3AUV",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Tris-HCl, 100mM MgCl2, 20% PEG 4000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0033340",,"3AUV",174.94,"2.4","2.4","Predicting Amino Acid Preferences in the Complementarity Determining Regions of an Antibody-Antigen Recognition Interface","GAMAQPAHGSGDIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGCGTKVEIKGGGGGSIEGRSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFTISDYWIHWVRQAPGKCLEWVAGITPAGGYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARFVFFLPYAMDYWGQGTLVTVSSASAAAGGGLNDIFEAQKIEWHE","Homo sapiens",,"sc-dsFv derived from the G6-Fab","1","3AUV"
"3AVE",,"X-RAY DIFFRACTION",2.78,55.7,"MICRODIALYSIS",7,"deionized water, 20% 2,3-butanediol, pH 7.0, MICRODIALYSIS, temperature 277K",277,,,"3AVE",53.19,"2","2","Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1","TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3AVE"
"3AVR",,"X-RAY DIFFRACTION",2.49,50.59,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl (pH 8.5), 0.2M Li2SO4, 18-20% PEG 3,350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1101/gad.172296.111",,"3AVR",63.48,"1.803","1.803","Catalytic fragment of UTX/KDM6A bound with histone H3K27me3 peptide, N-oxyalylglycine, and Ni(II)","GPGYQDPNSQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKSIVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEEPAHYCSICEVEVFDLLFVTNESNSRKTYIVHCQDCARKTSGNLENFVVLEQYKMEDLMQVYDQFTLAPPLPSASS","Homo sapiens","KDM6A, UTX","Lysine-specific demethylase 6A","1","3AVR"
,,,,,,,,,,,,,,,,"RKQLATKAARKSAPATGGVKKP",,,"Histone H3","2","3AVR"
"3AVS",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl (pH 8.5), 0.2M Li2SO4, 18-20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1101/gad.172296.111",,"3AVS",61.31,"1.85","1.85","Catalytic fragment of UTX/KDM6A bound with N-oxyalylglycine, and Ni(II)","GPGYQDPNSQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKSIVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEEPAHYCSICEVEVFDLLFVTNESNSRKTYIVHCQDCARKTSGNLENFVVLEQYKMEDLMQVYDQFTLAPPLPSASS","Homo sapiens","KDM6A, UTX","Lysine-specific demethylase 6A","1","3AVS"
"3AX8",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ol200828s",,"3AX8",30.25,"2.6","2.6","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3AX8"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3AXC",,"X-RAY DIFFRACTION",2.02,39.12,"VAPOR DIFFUSION",7.5,"30% PEG 4000, 0.1M Tris-HCl, 0.1M MgCl2, 30% Dioxane, 30% Isopropanol , pH 7.5, VAPOR DIFFUSION, temperature 289K",289,"10.1107/S0907444911051195",,"3AXC",17.37,"2.19","2.19","Crystal structure of linear diubiquitin","GSMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","RPS27A, UBA80, UBCEP1","Ubiquitin","1","3AXC"
,,,,,,,,,,,,,,,,,"Homo sapiens","RPS27A, UBA80, UBCEP1"
"3AXW",,"X-RAY DIFFRACTION",1.99,38.17,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethylene glycol, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2015167",,"3AXW",40.7,"2.5","2.5","Crystal structure of human CK2alpha complexed with a potent inhibitor","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CK2A1, CSNK2A1","Casein kinase II subunit alpha","1","3AXW"
"3AY5",,"X-RAY DIFFRACTION",4.91,74.97,"VAPOR DIFFUSION, SITTING DROP",8,"100mM imidazole, 500mM (NH4)2HPO4, 100mM NaCl, pH 8.0, vapor diffusion, sitting drop, temperature 293K",293,"10.1038/emboj.2012.77",,"3AY5",40.27,"2.5","2.5","Crystal structure of HHM (human homologue of murine maternal Id-like molecule)","MASATAPAAAVPTLASPLEQLRHLAEELRLLLPRVRVGEAQETTEEFNREMFWRRLNEAAVTVSREATTLTIVFSQLPLPSPQETQKFCEQVHAAIKAFIAVYYLLPKDQGITLRKLVRGATLDIVDGMAQLMEVLSVTPTQSPENNDLISYNSVWVACQQMPQIPRDNKAAALLMLTKNVDFVKDAHEEMEQAVEESDPYSGLLNDTEENNSDNHNHEDDVLGFPSNQDLYWSEDDQELIIPCLALVRASKACLKKIRMLVAENGKKDQVAQLDDIVDISDEISPSVDDLALSIYPPMSHLTVRINSAKLVSVLKKALEITKASHVTPQPEDSWIPLLINAIDHCMNRIKELTQSELEL","Homo sapiens","CCNDBP1, DIP1, GCIP, HHM","Cyclin-D1-binding protein 1","1","3AY5"
"3AY9",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, SITTING DROP",5.7,"0.05M calcium chloride, 0.1M bis-tris (pH6.5), 30% PEG MME 550, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.663","ADP","3AY9",43.81,"1.75","1.75","Crystal structure of human Hsp70 NBD in the ADP-, Mg ion-, and K ion-bound state","GSFTMAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMGDKSENV","Homo sapiens","Hsp70, HSPA1, HSPA1A, HSPA1B, HSP72, HSX70","Heat shock 70 kDa protein 1A/1B","1","3AY9"
"3AYA",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 A.S., 0.1 MBis-Tris, 5mM beta-Mercaptoethanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0025007",,"3AYA",32.02,"2","2","Crystal structure of galectin-3 CRD domian complexed with Thomsen-Friedenreich antigen","MPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3AYA"
"3AYC",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 A.S., 0.1M Bis-Tris, 5mM beta-Mercaptoethanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0025007",,"3AYC",32.55,"1.8","1.8","Crystal structure of galectin-3 CRD domian complexed with GM1 pentasaccharide","MPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3AYC"
"3AYD",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 A.S., 0.1MBis-Tris, 5mM beta-Mercaptoethanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0025007",,"3AYD",16.84,"1.9","1.9","Crystal structure of galectin-3 CRD domian complexed with TFN","MPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3AYD"
"3AYE",,"X-RAY DIFFRACTION",2.92,57.94,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 A.S., 0.1M Bis-Tris, 5mM beta-Mercaptoethanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0025007",,"3AYE",31.79,"2","2","Crystal structure of galectin-3 CRD domian complexed with lactose","MPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3AYE"
"3AYK",,"SOLUTION NMR",,,,,,,"10.1021/bi982576v","CGS","3AYK",19.43,,,"CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE","VLTEGNPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYGRSQNPVQP","Homo sapiens","MMP1, CLG","PROTEIN (COLLAGENASE)","1","3AYK"
"3AZ1",,"X-RAY DIFFRACTION",2.64,53.43,"hanging drop",6,"pH 6.0, hanging drop, temperature 277K",277,"10.1016/j.bmc.2011.07.001",,"3AZ1",29.19,"1.5","1.5","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","NR1I1, VDR","Vitamin D3 receptor","1","3AZ1"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I1, VDR"
"3AZ2",,"X-RAY DIFFRACTION",2.66,53.73,"hanging drop",,"hanging drop",,"10.1016/j.bmc.2011.07.001",,"3AZ2",29.23,"1.69","1.69","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","NR1I1, VDR","Vitamin D3 receptor","1","3AZ2"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I1, VDR"
"3AZ3",,"X-RAY DIFFRACTION",2.66,53.69,"hanging drop",,"hanging drop",,"10.1016/j.bmc.2011.07.001",,"3AZ3",29.24,"1.36","1.36","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","NR1I1, VDR","Vitamin D3 receptor","1","3AZ3"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I1, VDR"
"3B0I",,"X-RAY DIFFRACTION",1.6538,25.6238,"VAPOR DIFFUSION, HANGING DROP",6,"2.0M ammonium sulfate, 0.01M CaCl2, 0.1M MES, 28mg/ml protein, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/protein/gzs093",,"3B0I",14.36,"1.8","1.8","Crystal structure of recombinant human alpha lactalbumin","MKQFTKCELSQLLKDIDGYGGIALPELICTMFHTSGYDTQAIVENNESTEYGLFQISNKLWCKSSQVPQSRNICDISCDKFLDDDITDDIMCAKKILDIKGIDYWLAHKALCTEKLEQWLCEKL","Homo sapiens","LALBA, LYZL7","Alpha-lactalbumin","1","3B0I"
"3B0O",,"X-RAY DIFFRACTION",1.84,33.07,"VAPOR DIFFUSION, HANGING DROP",7.7,"1.8M ammonium sulphate, 10mM CaCl2, 0.1M Tris-HCl, 40mg/ml protein, pH 7.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/protein/gzs093",,"3B0O",28.27,"1.61","1.61","Crystal structure of alpha-lactalbumin","MQFTKCELSQLLKDIDGYGGIALPELICTMFHTSGYDTQAIVENNESTEYGLFQISNKLWCKSSQVPQSRNICDISCDKFLDDDITDDIMCAKKILDIKGIDYWLAHKALCTEKLEQWLCEKL","Homo sapiens","LALBA, LYZL7","Alpha-lactalbumin","1","3B0O"
"3B0Q",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M Sodium Citrate, 0.1M Hepes (pH7.5), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3B0Q",62.95,"2.1","2.1","Human PPAR gamma ligand binding domain in complex with MCC555","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3B0Q"
"3B0R",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M sodium citrate, 0.1M Hepes (pH7.5), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3B0R",63.13,"2.15","2.15","Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3B0R"
"3B0T",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Mes (pH5.5), 1.1M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3B0T",29.33,"1.3","1.3","Human VDR ligand binding domain in complex with maxacalcitol","ALRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3B0T"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3B0W",,"X-RAY DIFFRACTION",3.21,61.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2M Na formate, 3% (v/v) 2-Methyl-2,4-pentanediol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M111.254003","DGX","3B0W",58.18,"2.2","2.2","Crystal structure of the orphan nuclear receptor ROR(gamma)t ligand-binding domain in complex with digoxin","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","3B0W"
"3B1T",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm2008985","YCL","3B1T",75.81,"2.5","2.5","Crystal structure of human peptidylarginine deiminase 4 in complex with o-Cl-amidine","GPLGSPEFMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHSPPAKKKSTGSSTWPLDPGVEVTLTMKAASGSTGDQKVQISYYGPKTPPVKALLYLTAVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","3B1T"
"3B1U",,"X-RAY DIFFRACTION",2.81,56.27,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm2008985","YFF","3B1U",75.79,"2.1","2.1","Crystal structure of human peptidylarginine deiminase 4 in complex with o-F-amidine","GPLGSPEFMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHSPPAKKKSTGSSTWPLDPGVEVTLTMKAASGSTGDQKVQISYYGPKTPPVKALLYLTAVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","3B1U"
"3B24",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",8,"27%(w/v) PEG 3350, 0.3M MgCl2, 0.1M Tris-Cl, pH 8.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.08.001","B2J","3B24",51.94,"1.7","1.7","Hsp90 alpha N-terminal domain in complex with an aminotriazine fragment molecule","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3B24"
"3B25",,"X-RAY DIFFRACTION",2.9,57.5,"VAPOR DIFFUSION, HANGING DROP",8,"18%(w/v) PEG3350, 0.4M MgCl2, 0.1M Tris-Cl, pH 8.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.08.001","B2K","3B25",26.05,"1.75","1.75","Hsp90 alpha N-terminal domain in complex with an inhibitor CH4675194","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3B25"
"3B26",,"X-RAY DIFFRACTION",2.7,54.6,"VAPOR DIFFUSION, HANGING DROP",8,"24%(w/v) PEG3350, 0.3M MgCl2, 0.1M Tris-Cl, pH 8.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.08.001","B2L","3B26",51.85,"2.1","2.1","Hsp90 alpha N-terminal domain in complex with an inhibitor Ro1127850","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3B26"
"3B27",,"X-RAY DIFFRACTION",2.2,43.8,"VAPOR DIFFUSION, HANGING DROP",8,"21%(w/v) PEG3350, 0.3M MgCl2, 0.1M Tris-Cl, pH 8.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.08.001","B2T","3B27",26.04,"1.5","1.5","Hsp90 alpha N-terminal domain in complex with an inhibitor Ro4919127","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3B27"
"3B28",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",6.5,"22%(w/v) PEG2000 MME, 0.2M MgCl2, 0.1M MES-Na, pH 6.5, vapor diffusion, hanging drop, temperature 278K",278,"10.1016/j.bmcl.2011.08.001","B2X","3B28",52.41,"1.35","1.35","Hsp90 alpha N-terminal domain in complex with an inhibitor CH5015765","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3B28"
"3B29",,"X-RAY DIFFRACTION",5.73,78.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES-NaOH, 1.6M ammonium sulfate, 0.4M magnesium chloride, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1107/S1744309111042345",,"3B29",20.68,"3.2","3.2","Human leukotriene C4 synthase in complex with dodecyl-beta-D-selenomaltoside","MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWAHHHHHH","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","3B29"
"3B2H",,"X-RAY DIFFRACTION",2.21,44.4,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3B2H",16.64,"1.55","1.55","Iodide derivative of human LFABP at high resolution","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3B2H"
"3B2I",,"X-RAY DIFFRACTION",2.15,42.91,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3B2I",15.87,"1.86","1.86","Iodide derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3B2I"
"3B2J",,"X-RAY DIFFRACTION",2.17,43.38,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3B2J",15.87,"2","2","Iodide derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3B2J"
"3B2K",,"X-RAY DIFFRACTION",2.22,44.63,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3B2K",15.75,"1.73","1.73","Iodide derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3B2K"
"3B2L",,"X-RAY DIFFRACTION",2.16,42.98,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3B2L",15.75,"2.25","2.25","Iodide derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3B2L"
"3B2R",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION, HANGING DROP",4.6,"12% PEG3350, 15% glycerol, 0.1 M sodium acetate pH 4.6 , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1124/mol.107.040212","VDN","3B2R",77.38,"2.07","2.07","Crystal Structure of PDE5A1 catalytic domain in complex with Vardenafil","GSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3B2R"
"3B2T",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION, HANGING DROP",8,"0.6M sodium dihydrogen phosphate, 0.6M potassium dihydrogen phosphate, 0.1M HEPES, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0709905104","M33","3B2T",72.53,"1.8","1.8","Structure of phosphotransferase","PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNQE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","3B2T"
"3B2W",,"X-RAY DIFFRACTION",2.31,46.72,"VAPOR DIFFUSION, HANGING DROP",6,"1.0 M LiCl, 20% PEG 6000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.11.123","9NH","3B2W",32.68,"2.3","2.3","Crystal structure of pyrimidine amide 11 bound to Lck","TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3B2W"
"3B2Z",,"X-RAY DIFFRACTION",2.91,57.71,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1110/ps.073287008",,"3B2Z",274.94,"2.8","2.8","Crystal Structure of ADAMTS4 (apo form)","FASLSRFVETLVVADDKMAAFHGAGLKRYLLTVMAAAAKAFKHPSIRNPVSLVVTRLVILGSGEEGPQVGPSAAQTLRSFCAWQRGLNTPEDSDPDHFDTAILFTRQDLCGVSTCDTLGMADVGTVCDPARSCAIVEDDGLQSAFTAAHQLGHVFNMLHDNSKPCISLNGPLSTSRHVMAPVMAHVDPEEPWSPCSARFITDFLDNGYGHCLLDKPEAPLHLPVTFPGKDYDADRQCQLTFGPDSRHCPQLPPPCAALWCSGHLNGHAMCQTKHSPWADGTPCGPAQACMGGRCLHMDQLQDFNIPQADYKDDDDK","Homo sapiens","ADAMTS4, KIAA0688, UNQ769/PRO1563","ADAMTS-4","1","3B2Z"
"3B36",,"X-RAY DIFFRACTION",3.01,59.18,,7.5,"30% PEG 3000, 100 mM HEPES, 200 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,"10.1021/bi701189c",,"3B36",20.71,"1.5","1.5","Structure of M26L DJ-1","GSHMASKRALVILAKGAEEMETVIPVDVLRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","3B36"
"3B38",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3000, 100 mM HEPES, 200 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi701189c",,"3B38",20.66,"1.85","1.85","Structure of A104V DJ-1","GSHMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAVICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","3B38"
"3B3A",,"X-RAY DIFFRACTION",3.02,59.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3000, 100 mM HEPES, 200 mM NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi701189c",,"3B3A",20.39,"1.5","1.5","Structure of E163K/R145E DJ-1","GSHMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENEVEKDGLILTSRGPGTSFKFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","3B3A"
"3B3K",,"X-RAY DIFFRACTION",2.55,51.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15M Tris, pH8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm800733h","LRG","3B3K",65.38,"2.6","2.6","Crystal structure of the complex between PPARgamma and the full agonist LT175","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3B3K"
"3B3L",,"X-RAY DIFFRACTION",4.38,71.94,"VAPOR DIFFUSION, HANGING DROP",4.2,"20% PEG 3000, 0.1M sodium acetate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3B3L",130.25,"2.9","2.9","Crystal structures of alternatively-spliced isoforms of human ketohexokinase","MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","3B3L"
"3B4D",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 4.2M sodium chloride, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1002/prot.21973",,"3B4D",10.86,"2.001","2.001","Crystal Structure of Human PABPN1 RRM","MEADARSIYVGNVDYGATAEELEAHFHGCGSVNRVTILCDKFSGHPKGFAYIEFSDKESVRTSLALDESLFRGRQIKVIPKRTNRPGILEHHHHHH","Homo sapiens","PABPN1, PAB2, PABP2","Polyadenylate-binding protein 2","1","3B4D"
"3B4F",,"X-RAY DIFFRACTION",2.08,40.8,"VAPOR DIFFUSION, HANGING DROP",7.7,"Tris HCl pH 7.7-7.8 , sodium 4-(hydroxymercury)benzoate , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.10.110","TUO","3B4F",29.89,"1.89","1.89","Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3B4F"
"3B4M",,"X-RAY DIFFRACTION",1.89,34.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 4.2M sodium chloride, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1002/prot.21973",,"3B4M",43.44,"2.82","2.82","Crystal Structure of Human PABPN1 RRM","MEADARSIYVGNVDYGATAEELEAHFHGCGSVNRVTILCDKFSGHPKGFAYIEFSDKESVRTSLALDESLFRGRQIKVIPKRTNRPGILEHHHHHH","Homo sapiens","PABPN1, PAB2, PABP2","Polyadenylate-binding protein 2","1","3B4M"
"3B56",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",5,"200mM acetate buffer, 2.2M ammonium sulfate, 7% glycerol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1016/j.bbapap.2007.11.014",,"3B56",28.33,"1.55","1.55","Crystal structure of transthyretin in complex with 3,5-diiodosalicylic acid","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3B56"
"3B5G",,"X-RAY DIFFRACTION",2.45,49.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"Drops consisted of 5 microL of protein solution (7 mg/mL) plus 5 microL of Solution 7 from Crystal Screen I (Hampton Research), pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2009.11.038",,"3B5G",24.69,"1.9","1.9","Crystal Structure of the Unstable and Highly Fibrillogenic PRO7SER Mutant of the Recombinant Variable Domain 6AJL2","NFMLTQSHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","VL gene segment 6a and JL2/3 gene segment","AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP","1","3B5G"
"3B5H",,"X-RAY DIFFRACTION",4.22,70.84,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.5M ammonium sulfate, 0.1M triSodium Citrate dihydrate pH 5.60, 1.0M Lithium Sulfate monohydrate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M802694200",,"3B5H",80.63,"2.8","2.8","Crystal structure of the extracellular portion of HAb18G/CD147","AAGTVFTTVEDLGSKILLTCSLNDSATEVTGHRWLKGGVVLKEDALPGQKTEFKVDSDDQWGEYSCVFLPEPMGTANIQLHGPPRVKAVKSSEHINEGETAMLVCKSESVPPVTDWAWYKITDSEDKALMNGSESRFFVSSSQGRSELHIENLNMEADPGQYRCNGTSSKGSDQAIITLRVRSH","Homo sapiens","BSG, UNQ6505/PRO21383","Cervical EMMPRIN","1","3B5H"
"3B5R",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.09.002","B5R","3B5R",29.46,"1.8","1.8","Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-31","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3B5R"
"3B65",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.09.002","3B6","3B65",29.49,"1.8","1.8","Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-24","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3B65"
"3B66",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.09.002","B66","3B66",29.46,"1.65","1.65","Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-21","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3B66"
"3B67",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.09.002","B67","3B67",29.52,"1.9","1.9","Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-23","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3B67"
"3B68",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.09.002","B68","3B68",29.49,"1.9","1.9","Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-4","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3B68"
"3B6E",,"X-RAY DIFFRACTION",2.9,57.62,"VAPOR DIFFUSION, SITTING DROP",8,"1.2M Sodium citrate, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3B6E",24.13,"1.6","1.6","Crystal structure of human DECH-box RNA Helicase MDA5 (Melanoma differentiation-associated protein 5), DECH-domain","SMNSNMGSDSGTMGSDSDEENVAARASPEPELQLRPYQMEVAQPALEGKNIIICLPTGSGKTRVAVYIAKDHLDKKKKASEPGKVIVLVNKVLLVEQLFRKEFQPFLKKWYRVIGLSGDTQLKISFPEVVKSCDIIISTAQILENSLLNLENGEDAGVQLSDFSLIIIDECHHTNKEAVYNNIMRHYLMQKLKNNRLKKENKPVIPLPQILGLTAS","Homo sapiens","IFIH1, MDA5, RH116","Interferon-induced helicase C domain-containing protein 1","1","3B6E"
"3B6H",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization of native human prostacyclin synthase (hPGIS). The native recombinant PGIS (25 mg/ml in the gel filtration buffer containing 20 mM Tris, pH 8.0 and 150 mM NaCl) was found to crystallize spontaneously into needle clusters in the Eppendorf tube when stored at 4   C for about a week. A combination of microseeding technique and the hanging-drop vapor-diffusion method was then used to improve crystal quality. Specifically, seed stock was prepared by crushing these initial PGIS needle clusters with the Seed Bead Kit (Hampton Research). Following four 10-fold serial dilutions of the seed stock using the gel filtration buffer, 1 microliter of diluted seeds was added into a 10 microliter drop of freshly concentrated PGIS sample, and equilibrated at 4   C against 450 microliter of the gel filtration buffer.  
Crystallization of hPGIS-minoxidil complex: The inhibitor-enzyme complex was prepared by adding minoxidil (final concentration 0.1 mM) to a 20 mg/ml hPGIS stock solution. Crystals of the complex were then obtained by co-crystallization, with the technique described above using ligand-free hPGIS microcrystals as seeds., VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M707470200","MXD","3B6H",116.78,"1.62","1.62","Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil","MAKKTSSLLSRRRTRRPGEPPLDLGSIPWLGYALDFGKDAASFLTRMKEKHGDIFTILVGGRYVTVLLDPHSYDAVVWEPRTRLDFHAYAIFLMERIFDVQLPHYSPSDEKARMKLTLLHRELQALTEAMYTNLHAVLLGDATEAGSGWHEMGLLDFSYSFLLRAGYLTLYGIEALPRTHESQAQDRVHSADVFHTFRQLDRLLPKLARGSLSVGDKDHMCSVKSRLWKLLSPARLARRAHRSKWLESYLLHLEEMGVSEEMQARALVLQLWATQGNMGPAAFWLLLFLLKNPEALAAVRGELESILWQAEQPVSQTTTLPQKVLDSTPVLDSVLSESLRLTAAPFITREVVVDLAMPMADGREFNLRRGDRLLLFPFLSPQRDPEIYTDPEVFKYNRFLNPDGSEKKDFYKDGKRLKNYNMPWGAGHNHCLGRSYAVNSIKQFVFLVLVHLDLELINADVEIPEFDLSRYGFGLMQPEHDVPVRYRIRPHHHHHHHH","Homo sapiens","PTGIS, CYP8, CYP8A1","Prostacyclin synthase","1","3B6H"
"3B6R",,"X-RAY DIFFRACTION",2.28,46.07,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.febslet.2008.10.039",,"3B6R",86.16,"2","2","Crystal structure of Human Brain-type Creatine Kinase","MPFSNSHNALKLRFPAEDEFPDLSAHNNHMAKVLTPELYAELRAKSTPSGFTLDDVIQTGVDNPGHPYIMTVGCVAGDEESYEVFKDLFDPIIEDRHGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSRVRTGRSIRGFCLPPHCSRGERRAIEKLAVEALSSLDGDLAGRYYALKSMTEAEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKTFLVWVNEEDHLRVISMQKGGNMKEVFTRFCTGLTQIETLFKSKDYEFMWNPHLGYILTCPSNLGTGLRAGVHIKLPNLGKHEKFSEVLKRLRLQKRGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVKLLIEMEQRLEQGQAIDDLMPAQK","Homo sapiens","CKB, CKBB","Creatine kinase B-type","1","3B6R"
"3B6U",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION",8.5,"30% PEG 3350, 0.1 M Tris-HCl, 0.2M Lithium sulfate, pH 8.5, VAPOR DIFFUSION, temperature 291K",291,,,"3B6U",84.45,"1.8","1.8","Crystal structure of the motor domain of human kinesin family member 3B in complex with ADP","MHHHHHHSSGRENLYFQGSSESVRVVVRCRPMNGKEKAASYDKVVDVDVKLGQVSVKNPKGTAHEMPKTFTFDAVYDWNAKQFELYDETFRPLVDSVLQGFNGTIFAYGQTGTGKTYTMEGIRGDPEKRGVIPNSFDHIFTHISRSQNQQYLVRASYLEIYQEEIRDLLSKDQTKRLELKERPDTGVYVKDLSSFVTKSVKEIEHVMNVGNQNRSVGATNMNEHSSRSHAIFVITIECSEVGLDGENHIRVGKLNLVDLAGSERQAKTGAQGERLKEATKINLSLSALGNVISALVDGKSTHIPYRDSKLTRLLQDSLGGNAKTVMVANVGPASYNVEETLTTLRYANRAKNIKNKPRVNEDPKDALLREFQ","Homo sapiens","KIF3B, KIAA0359","Kinesin-like protein KIF3B","1","3B6U"
"3B6V",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION",6.5,"30% PEG MME550, 0.1M Ammonium sulfate, 0.1M Sodium cacodylate, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,,,"3B6V",86.91,"2.7","2.7","Crystal structure of the motor domain of human kinesin family member 3C in complex with ADP","MHHHHHHSSGRENLYFQGASEALKVVARCRPLSRKEEAAGHEQILTMDVKLGQVTLRNPRAAPGELPKTFTFDAVYDASSKQADLYDETVRPLIDSVLQGFNGTVFAYGQTGTGKTYTMQGTWVEPELRGVIPNAFEHIFTHISRSQNQQYLVRASYLEIYQEEIRDLLSKEPGKRLELKENPETGVYIKDLSSFVTKNVKEIEHVMNLGNQTRAVGSTHMNEVSSRSHAIFIITVECSERGSDGQDHIRVGKLNLVDLAGSERQNKAGPNTAGGAATPSSGGGGGGGGSGGGAGGERPKEASKINLSLSALGNVIAALAGNRSTHIPYRDSKLTRLLQDSLGGNAKTIMVATLGPASHSYDESLSTLRFANRAKNIKNKPRVNEDPKDTLLREF","Homo sapiens","KIF3C","Kinesin-like protein KIF3C","1","3B6V"
"3B6Y",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 4000, 0.2M Ammonium sulfate, 0.1M Sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3B6Y",45.49,"2.35","2.35","Crystal Structure of the Second HIN-200 Domain of Interferon-Inducible Protein 16","GSHMDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPKGLIRSASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDNTGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKN","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein Ifi-16","1","3B6Y"
"3B71",,"X-RAY DIFFRACTION",3.81,67.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"3.9 M NaCl, 2.5 % glycerol, 100 mM Hepes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.11.040",,"3B71",62.18,"2.82","2.82","CD4 endocytosis motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinase","LSSPADSYNEGVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLALRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQMLTAAHALAVDAKNLLDVIDQARLKMLGQTRPH","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","3B71"
,,,,,,,,,,,,,,,,"QAERMSQIKRLLSEKKTCQCPHR",,,"T-cell surface glycoprotein CD4","2","3B71"
"3B76",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.53M Potassium phosphate, 0.27M Sodium phosphate, 1% PEG 3350, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3B76",25.8,"1.75","1.75","Crystal structure of the third PDZ domain of human ligand-of-numb protein-X (LNX1) in complex with the C-terminal peptide from the coxsackievirus and adenovirus receptor","MHHHHHHSSGVDLGTENLYFQSMHEKVVNIQKDPGESLGMTVAGGASHREWDLPIYVISVEPGGVISRDGRIKTGDILLNVDGVELTEVSRSEAVALLKRTSSSIVLKALEVKEGSIV","Homo sapiens","LNX1, LNX, PDZRN2, UNQ574/PRO1136","E3 ubiquitin-protein ligase LNX","1","3B76"
"3B7B",,"X-RAY DIFFRACTION",3.51,64.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5-2.0 M Lithium Sulfate, 1-4% Peg 400 or 550, 0.1 M Tris buffer pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1038/nsmb.1384",,"3B7B",53.12,"2.99","2.99","EuHMT1 (Glp) Ankyrin Repeat Domain (Structure 1)","HMNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQDSA","Homo sapiens","EHMT1, EUHMTASE1, KIAA1876, GLP, KMT1D","Euchromatic histone-lysine N-methyltransferase 1","1","3B7B"
"3B7G",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 200mM Ammonium acetate, 100mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0012791",,"3B7G",51.36,"1.9","1.9","Human DEAD-box RNA helicase DDX20, Conserved domain I (DEAD) in complex with AMPPNP (Adenosine-(Beta,gamma)-imidotriphosphate)","SMRTAQDLSSPRTRTGDVLLAEPADFESLLLSRPVLEGLRAAGFERPSPVQLKAIPLGRCGLDLIVQAKSGTGKTCVFSTIALDSLVLENLSTQILILAPTREIAVQIHSVITAIGIKMEGLECHVFIGGTPLSQDKTRLKKCHIAVGSPGRIKQLIELDYLNPGSIRLFILDEADKLLEEGSFQEQINWIYSSLPASKQMLAVSATYPEFLANALTKYMRDPTFVRLNS","Homo sapiens","DDX20, DP103, GEMIN3","Probable ATP-dependent RNA helicase DDX20","1","3B7G"
"3B7K",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, HANGING DROP",,"350mM NaSCN, 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3B7K",113.81,"2.7","2.7","Human Acyl-coenzyme A thioesterase 12","MHHHHHHSSGVDLGTENLYFQSMGEVVMSQAIQPAHATARGELSAGQLLKWIDTTACLAAEKHAGVSCVTASVDDIQFEETARVGQVITIKAKVTRAFSTSMEISIKVMVQDMLTGIEKLVSVAFSTFVAKPVGKEKIHLKPVTLLTEQDHVEHNLAAERRKVRLQHEDTFNNLMKESSKFDDLIFDEEEGAVSTRGTSVQSIELVLPPHANHHGNTFGGQIMAWMETVATISASRLCWAHPFLKSVDMFKFRGPSTVGDRLVFTAIVNNTFQTCVEVGVRVEAFDCQEWAEGRGRHINSAFLIYNAADDKENLITFPRIQPISKDDFRRYRG","Homo sapiens","ACOT12, CACH, CACH1, STARD12, STARD15","Acyl-coenzyme A thioesterase 12","1","3B7K"
"3B7L",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M NH4Cl, 20% PEG 6000, 10% Ethylene glycol, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"M0N","3B7L",41.32,"1.95","1.95","Human farnesyl diphosphate synthase complexed with MG and minodronate","GHMMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase","1","3B7L"
"3B7O",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.15 M Na Malate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"3B7O",37.01,"1.6","1.6","Crystal structure of the human tyrosine phosphatase SHP2 (PTPN11) with an accessible active site","MHHHHHHSSGVDLGTENLYFQSMAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRI","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","3B7O"
"3B7R",,"X-RAY DIFFRACTION",2.41,48.93,"liquid-liquid diffusion",,"CO-CRYSTALLIZED WITH LTA4H BY LIQUID-LIQUID DIFFUSION IN MELTING-POINT CAPILLARIES. A TRIS-BUFFERED (10 mM, PH 7.5) SOLUTION OF PROTEIN AND INHIBITOR IN APPROXIMATELY EQUIMOLAR CONCENTRATIONS (~70 MICROM) WAS LAYERED ON THE PRECIPITATE SOLUTION CONTAINING 28% (WEIGHT/VOLUME) POLYETHYLENE GLYCOL (MW 8000), 50 mM NA ACETATE, 100 mM IMIDAZOLE, PH 6.8, AND 5 MM YBCL3, liquid-liquid diffusion, temperature 298K",298,"10.1016/j.chembiol.2008.07.018","BIR","3B7R",70.79,"1.811","1.811","Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040","HHHHHHPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3B7R"
"3B7S",,"X-RAY DIFFRACTION",2.43,49.32,"liquid-liquid diffusion",,"TRI-PEPTIDE WAS CO-CRYSTALLIZED WITH [E296Q]LTA4H BY LIQUID-LIQUID DIFFUSION IN MELTING-POINT CAPILLARIES. A TRIS-BUFFERED (10 mM, PH 7.5) SOLUTION OF PROTEIN AND TRIPEPTIDE, MOLAR RATIO 1:10 (~70 MICROM PROTEIN), WAS LAYERED ON THE PRECIPITATE SOLUTION CONTAINING 28% (WEIGHT/VOLUME) POLYETHYLENE GLYCOL (MW 8000), 50 mM NA ACETATE, 100 mM IMIDAZOLE, PH 6.8, AND 5 MM YBCL3. CRYSTALS WERE ADDITIONALLY SOAKED IN SOLUTIONS WITH INCREASED TRI-PEPTIDE CONCENTRATION PRIOR TO DATA COLLECTION., liquid-liquid diffusion, temperature 298K",298,"10.1016/j.chembiol.2008.07.018",,"3B7S",70.87,"1.465","1.465","[E296Q]LTA4H in complex with RSR substrate","HHHHHHPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHQISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3B7S"
,,,,,,,,,,,,,,,,"RSR",,,"RSR peptide","2","3B7S"
"3B7T",,"X-RAY DIFFRACTION",2.44,49.64,"liquid-liquid diffusion",,"TRI-PEPTIDE WAS CO-CRYSTALLIZED WITH [E296Q]LTA4H BY LIQUID-LIQUID DIFFUSION IN MELTING-POINT CAPILLARIES. A TRIS-BUFFERED (10 mM, PH 7.5) SOLUTION OF PROTEIN AND TRIPEPTIDE, MOLAR RATIO 1:10 (~70 MICROM PROTEIN), WAS LAYERED ON THE PRECIPITATE SOLUTION CONTAINING 28% (WEIGHT/VOLUME) POLYETHYLENE GLYCOL (MW 8000), 50 mM NA ACETATE, 100 mM IMIDAZOLE, PH 6.8, AND 5 MM YBCL3. CRYSTALS WERE ADDITIONALLY SOAKED IN SOLUTIONS WITH INCREASED TRI-PEPTIDE CONCENTRATION PRIOR TO DATA COLLECTION, liquid-liquid diffusion, temperature 298K",298,"10.1016/j.chembiol.2008.07.018",,"3B7T",70.94,"2.3","2.3","[E296Q]LTA4H in complex with Arg-Ala-Arg substrate","HHHHHHPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHQISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3B7T"
,,,,,,,,,,,,,,,,"RAR",,,"RAR peptide","2","3B7T"
"3B7U",,"X-RAY DIFFRACTION",2.4,48.76,"liquid-liquid diffusion",,"CO-CRYSTALLIZED WITH LTA4H BY LIQUID-LIQUID DIFFUSION IN MELTING-POINT CAPILLARIES. A TRIS-BUFFERED (10 mM, PH 7.5) SOLUTION OF PROTEIN AND INHIBITOR IN APPROXIMATELY EQUIMOLAR CONCENTRATIONS (~70 MICROM) WAS LAYERED ON THE PRECIPITATE SOLUTION CONTAINING 28% (WEIGHT/VOLUME) POLYETHYLENE GLYCOL (MW 8000), 50 mM NA ACETATE, 100 mM IMIDAZOLE, PH 6.8, AND 5 MM YBCL3, liquid-liquid diffusion, temperature 298K",298,"10.1016/j.chembiol.2008.07.018","KEL","3B7U",71.07,"1.9","1.9","Leukotriene A4 Hydrolase Complexed with KELatorphan","HHHHHHPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3B7U"
"3B7W",,"X-RAY DIFFRACTION",3.75,67.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 1.4M Na citrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2009.03.064",,"3B7W",63.59,"2","2","Crystal structure of human acyl-CoA synthetase medium-chain family member 2A, with L64P mutation","MGHHHHHHSSGVDLGTENLYFQSMSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRPPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRADDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVVKAFVVLASQFLSHDPEQLTKELQQHVKSVTAPYKYPRKIEFVLNLPKTVTGKIQRAKLRDKEWKMSGKARAQ","Homo sapiens","ACSM2A, ACSM2, MACS2","Acyl-coenzyme A synthetase ACSM2A, mitochondrial precursor","1","3B7W"
"3B7X",,"X-RAY DIFFRACTION",2.89,57.45,"VAPOR DIFFUSION, SITTING DROP",6.5,"Mixed equal volumes of 1.6M MgSO4, 0.1M MES pH 6.5, and 10 mg/mL protein. Crystals were cryoprotected by transferring the crystals to a drop containing mother liquor to which glycerol was added to a final concentration of 20%, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3B7X",15.07,"2.1","2.1","Crystal structure of human FK506-Binding Protein 6","GEGDDAPGQSLYERLSQRMLDISGDRGVLKDVIREGAGDLVAPDASVLVKYSGYLEHMDRPFDSNYFRKTPRLMKLGEDITLWGMELGLLSMRRGELARFLFKPNYAYGTLGCPPLIPPNTTVLFEIELLDFLD","Homo sapiens","FKBP6, FKBP36","FK506-binding protein 6","1","3B7X"
"3B7Y",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG 4000, 0.1 M Succinic acid pH 7.0, 0.01M Spermine tetra-HCl, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"3B7Y",35.58,"1.8","1.8","Crystal structure of the C2 Domain of the E3 Ubiquitin-Protein Ligase NEDD4","GMATCAVEVFGLLEDEENSRIVRVRVIAGIGLAKKDILGASDPYVRVTLYDPMNGVLTSVQTKTIKKSLNPKWNEEILFRVHPQQHRLLFEVFDENRLTRDDFLGQVDVPLYPLPTENPRLERPYTFKDFVLHPRSHKSRVKGYLRLKMTYLP","Homo sapiens","NEDD4, KIAA0093, NEDD4-1, PIG53","E3 ubiquitin-protein ligase NEDD4","1","3B7Y"
"3B83",,"X-RAY DIFFRACTION",3.01,59.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Sodium dihydrogen phosphate, 0.1 M potassium dihydrogen phosphate, 0.1M MES pH 6.5, 2.2M NaCl,100 mM Urea, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.09.013",,"3B83",89.13,"2.4","2.4","Computer-Based Redesign of a beta Sandwich Protein Suggests that Extensive Negative Design Is Not Required for De Novo beta Sheet Design.","MLQPPFNIKVTNITLTTAVVTWQPPILPIEGILVTFGRKNDPSDETTVDLTSSITSLTLTNLEPNTTYEIRIVARNGQQYSPPVSTTFTTGSLEHHHHHH","Homo sapiens",,"TEN-D3","1","3B83"
"3B84",,"X-RAY DIFFRACTION",2.38,48.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M MgCl2, 0.1M Bis-tris pH 6.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3B84",13.39,"1.74","1.74","Crystal structure of the human BTB domain of the Krueppel related Zinc Finger Protein 3 (HKR3)","SMSFVQHSVRVLQELNKQREKGQYCDATLDVGGLVFKAHWSVLACCSHFFQSLYGDGSGGSVVLPAGFAEIFGLLLDFFYTGHLALTSGNRDQVLLAARELRVPEAVELCQSFKPKTSV","Homo sapiens","ZBTB48, HKR3, TZAP, ZNF855","Zinc finger and BTB domain-containing protein 48","1","3B84"
"3B8K","8.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2007.10.024",,"3B8K",25.94,"8.8",,"Structure of the Truncated Human Dihydrolipoyl Acetyltransferase (E2)","GPGMAPVPTGVFTDIPISNIRRVIAQRLMQSKQTIPHYYLSIDVNMGEVLLVRKELNKILEGRSKISVNDFIIKASALACLKVPEANSSWMDTVIRQNHVVDVSVAVSTPAGLITPIVFNAHIKGVETIANDVVSLATKAREGKLQPHEFQGGTFTISNLGMFGIKNFSAIINPPQACILAIGASEDKLVPADNEKGFDVASMMSVTLSCDHRVVDGAVGAQWLAEFRKYLEKPITMLL","Homo sapiens","DLAT, DLTA","Dihydrolipoyllysine-residue acetyltransferase","1","3B8K"
"3B8Q",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, sodium chloride, ammonium sulfate, isopropanol, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm701097z","900","3B8Q",73.54,"2.75","2.75","Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3B8Q"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3B8R",,"X-RAY DIFFRACTION",2.29,46.19,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, sodium chloride, ammonium sulfate, isopropanol, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm701098w","887","3B8R",73.46,"2.7","2.7","Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3B8R"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3B8Z",,"X-RAY DIFFRACTION",1.88,34.41,"VAPOR DIFFUSION",8.5,"PEG 3350, ammonium acetate, pH 8.5, vapor diffusion, temperature 298K",298,"10.1074/jbc.M705879200","294","3B8Z",49.33,"1.4","1.4","High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2)","SRARQVELLLVADASMARKYGRGLQHYLLTLASIANRLYSHASIENHIRLAVVKVVVLGDKDKSLEVSKNAATTLKNFCKWQHQHNQLGDDHEEHYDAAILFTREDLCGHHSCDTLGMADVGTICSPERSCAVIEDDGLHAAFTVAHEIGHLLGLSHDDSKFCEETFGSTEDKRLMSSILTSIDASKPWSKCTSATITEFLDDGHGNCLLDLPRKQI","Homo sapiens","ADAMTS5, ADAMTS11, ADMP2","protein ADAMTS-5","1","3B8Z"
"3B92",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEGMME 550, 0.1M BIS-TRIS, 50mM CaCl2, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.11.014","440","3B92",29.65,"2","2","Novel thio-based TACE inhibitors Part 2: Rational design, synthesis and SAR of thiol-contaning aryl sufones","ADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTAWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSQCSKQSIYKTIESKAQECFQERS","Homo sapiens","ADAM17, CSVP, TACE","ADAM 17","1","3B92"
"3B93",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Lithium sulfate, 0.1M Tris, 30% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3B93",44.8,"2.2","2.2","crystal structure of human GITRL","GAMASQLETAKEPCMAKFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNANYNDVAPFEVRLYKNKDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS","Homo sapiens","TNFSF18, AITRL, GITRL, TL6, UNQ149/PRO175","Tumor necrosis factor ligand superfamily member 18","1","3B93"
"3B94",,"X-RAY DIFFRACTION",2.3,46.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3B94",59.73,"2.5","2.5","Crystal structure of human GITRL","GAMASQLETAKEPCMAKFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNANYNDVAPFEVRLYKNKDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS","Homo sapiens","TNFSF18, AITRL, GITRL, TL6, UNQ149/PRO175","Tumor necrosis factor ligand superfamily member 18","1","3B94"
"3B95",,"X-RAY DIFFRACTION",3.41,63.88,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5-2.0 M Lithium Sulfate; 1-4% Peg 400 or 550; 0.1 M Tris buffer pH=8.5 , VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1038/nsmb.1384",,"3B95",54.9,"2.99","2.99","EuHMT1 (Glp) Ankyrin Repeat Domain (Structure 2)","HMNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQDSA","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Euchromatic histone-lysine N-methyltransferase 1","1","3B95"
,,,,,,,,,,,,,,,,"ARTKQTARKSTGGKA",,,"Histone H3 N-terminal Peptide","2","3B95"
"3B96",,"X-RAY DIFFRACTION",2.37,48.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 17.6% PEG 2000, 0.047 M MgCl2, 5% glycerol, pH 7.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1074/jbc.M709135200",,"3B96",65.22,"1.91","1.91","Structural Basis for Substrate Fatty-Acyl Chain Specificity: Crystal Structure of Human Very-Long-Chain Acyl-CoA Dehydrogenase","ESKSFAVGMFKGQLTTDQVFPYPSVLNEEQTQFLKELVEPVSRFFEEVNDPAKNDALEMVEETTWQGLKELGAFGLQVPSELGGVGLCNTQYARLVEIVGMHDLGVGITLGAHQSIGFKGILLFGTKAQKEKYLPKLASGETVAAFCLTEPSSGSDAASIRTSAVPSPCGKYYTLNGSKLWISNGGLADIFTVFAKTPVTDPATGAVKEKITAFVVERGFGGITHGPPEKKMGIKASNTAEVFFDGVRVPSENVLGEVGSGFKVAMHILNNGRFGMAAALAGTMRGIIAKAVDHATNRTQFGEKIHNFGLIQEKLARMVMLQYVTESMAYMVSANMDQGATDFQIEAAISKIFGSEAAWKVTDECIQIMGGMGFMKEPGVERVLRDLRIFRIFEGTNDILRLFVALQGCMDKGKELSGLGSALKNPFGNAGLLLGEAGKQLRRRAGLGSGLSLSGLVHPELSRSGELAVRALEQFATVVEAKLIKHKKGIVNEQFLLQRLADGAIDLYAMVVVLSRASRSLSEGHPTAQHEKMLCDTWCIEAAARIREGMAALQSDPWQQELYRNFKSISKALVERGGVVTSNPLGF","Homo sapiens","ACADVL, VLCAD","Very long-chain specific acyl-CoA dehydrogenase","1","3B96"
"3B97",,"X-RAY DIFFRACTION",3.21,61.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Tris-HCl, 20-24% (w/v) PEG 3350, 200mM ammonium sulfate, 1mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S0907444908008561",,"3B97",188.97,"2.2","2.2","Crystal Structure of human Enolase 1","SILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK","Homo sapiens","ENO1, ENO1L1, MBPB1, MPB1","Alpha-enolase","1","3B97"
"3B9C",,"X-RAY DIFFRACTION",2.46,50.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Tris-HCl pH7.5, 2% PEG 400, 2M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/prot.22003",,"3B9C",66.31,"1.9","1.9","Crystal Structure of Human GRP CRD","MGHHHHHHMVPFCGHIKGGMRPGKKVLVMGIVDLNPESFAISLTCGDSEDPPADVAIELKAVFTDRQLLRNSCISGERGEEQSAIPYFPFIPDQPFRVEILCEYPRFRVFVDGHQLFDFYHRIQTLSAIDTIKINGDLQITKLG","Homo sapiens","LGALSL, GRP, HSPC159","HSPC159","1","3B9C"
"3B9L",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"32%(w/v) polyethylene glycol 3350, 50mM potassium phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1016/j.jsb.2007.12.004","AZZ","3B9L",68.7,"2.6","2.6","Human serum albumin complexed with myristate and AZT","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3B9L"
"3B9M",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"32%(w/v) polyethylene glycol 3350, 50mM potassium phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1016/j.jsb.2007.12.004","AZZ, SAL","3B9M",68.48,"2.7","2.7","Human serum albumin complexed with myristate, 3'-azido-3'-deoxythymidine (AZT) and salicylic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3B9M"
"3B9S",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:10 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1158/0008-5472.CAN-07-6227","RW1","3B9S",38.19,"1.8","1.8","Macrophage Migration Inhibitory Factor (MIF) complexed with Inhibitor, 4-IPP.","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage Migration Inhibitory Factor","1","3B9S"
"3B9U",,"X-RAY DIFFRACTION",2.1,41.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3B9U",16.7,"1.55","1.55","Crystal structure of L26N/D28N/H93G mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRINPNGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENGYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3B9U"
"3B9V",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, SITTING DROP",7,"1.1 M sodium malonate, 0.1 M Hepes, 0.5% Jeffamine ED-2001, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1074/jbc.M708536200",,"3B9V",52.22,"1.8","1.8","Crystal Structure of an Autonomous VH Domain","EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRRAPGKGEEWVASIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWGGDGFYAMDYWGQGTLVTVSS","Homo sapiens",,"heavy chain variable domain","1","3B9V"
"3BA0",,"X-RAY DIFFRACTION",2.87,57.17,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCl, 30% PEG8000, 200mM acetohydroxamic acid, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja710491y",,"3BA0",42.51,"3","3","Crystal structure of full-length human MMP-12","GPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGDPKENQRLPNPDNSEPALCDPNLSFDAVTTVGNKIFFFKDRFFWLKVSERPKTSVNLISSLWPTLPSGIEAAYEIEARNQVFLFKDDKYWLISNLRPEPNYPKSIHSFGFPNFVKKIDAAVFNPRFYRTYFFVDNQYWRYDERRQMMDPGYPKLITKNFQGIGPKIDAVFYSKNKYYYFFQGSNQFEYDFLLQRITKTLKSNSWFGC","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","3BA0"
"3BA4",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.9M Na-formate, 0.7M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BA4",33.71,"1.8","1.8","Crystal structure of L26D mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRIDPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BA4"
"3BA5",,"X-RAY DIFFRACTION",2.92,57.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"4.6M Na-formate, 0.3M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BA5",33.61,"1.75","1.75","Crystal structure of D28A mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPAGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BA5"
"3BA7",,"X-RAY DIFFRACTION",2.96,58.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.0M Na-formate, 0.5M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BA7",33.66,"1.6","1.6","Crystal structure of L26N/D28A mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRINPAGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BA7"
"3BAD",,"X-RAY DIFFRACTION",1.93,36.12,"VAPOR DIFFUSION, HANGING DROP",9.5,"25% PEG4000, 0.1M Bicine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAD",33.32,"2","2","Crystal structure of D70A/H93G mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTAGLLYGSQTPNEECLFLERLEENGYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAD"
"3BAG",,"X-RAY DIFFRACTION",2.99,58.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.8M Na-formate, 0.2M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAG",33.44,"1.75","1.75","Crystal structure of K112N/N114A mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLNKAGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAG"
"3BAH",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.9M Na-formate, 1.0M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAH",33.8,"1.65","1.65","Crystal structure of K112N mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLNKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAH"
"3BAI",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAI",56.25,"1.9","1.9","Human Pancreatic Alpha Amylase with Bound Nitrate","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAI"
"3BAJ",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAJ",57.06,"2.1","2.1","Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAJ"
"3BAK",,"X-RAY DIFFRACTION",2.12,42.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAK",56.23,"1.9","1.9","N298S mutant of Human Pancreatic Alpha-Amylase in complex with nitrate","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDSHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAK"
"3BAO",,"X-RAY DIFFRACTION",2.94,58.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.3M Na-formate, 0.7M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAO",33.66,"1.55","1.55","Crystal structure of L26N mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRINPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAO"
"3BAP",,"X-RAY DIFFRACTION",2.53,51.37,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 3350, 0.2M Magnesium chloride, 0.1M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1093/nar/gkn079",,"3BAP",26.54,"1.85","1.85","Crystal Structure of the 25 kDa Subunit of Human Cleavage Factor Im","MSVVPPNRSQTGWPRGVTQFGNKYIQQTKPLTLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","3BAP"
"3BAQ",,"X-RAY DIFFRACTION",2.91,57.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.3M Na-formate, 0.4M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAQ",33.48,"1.8","1.8","Crystal structure of L26A mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRIAPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAQ"
"3BAU",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.7M Na-formate, 0.7M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAU",33.56,"1.6","1.6","Crystal structure of K12V/L26D/D28A mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPVLLYCSNGGHFLRIDPAGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAU"
"3BAV",,"X-RAY DIFFRACTION",2.95,58.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.3M Na-formate, 0.4M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BAV",33.57,"1.62","1.62","Crystal structure of L26A/D28N mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRIAPNGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BAV"
"3BAW",,"X-RAY DIFFRACTION",2.02,39.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAW",56.38,"2","2","Human pancreatic alpha-amylase complexed with azide","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAW"
"3BAX",,"X-RAY DIFFRACTION",2.06,40.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAX",56.35,"1.9","1.9","N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Azide","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDSHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAX"
"3BAY",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methypentane-2,4-diol, 100 mM cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"3BAY",57.04,"1.99","1.99","N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDSHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3BAY"
"3BB2",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.8M Na-formate, 0.6M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2008.01.055",,"3BB2",33.61,"1.5","1.5","Crystal structure of L26D/D28N mutant of Human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRIDPNGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3BB2"
"3BBB",,"X-RAY DIFFRACTION",1.92,35.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 1500, 50 mM sodium citrate, 20 mM MgCl2, 5 mM DTT, Crystals soaked with 10 mM d(AG), pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1158/1535-7163.MCT-08-1093","DA","3BBB",105.21,"1.3","1.3","Crystal structure of the NM23-H2 transcription factor complex with dinucleotide d(AG)","ANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQHYIDLKDRPFFPGLVKYMNSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVKSAEKEISLWFKPEELVDYKSCAHDWVYE","Homo sapiens","NME2, NM23B","Nucleoside diphosphate kinase B","1","3BBB"
"3BBC",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 1500, 50 mM sodium citrate, 20 mM MgCl2, 5 mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1158/1535-7163.MCT-08-1093",,"3BBC",102.64,"1.7","1.7","Crystal structure of R88A mutant of the NM23-H2 transcription factor","ANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQHYIDLKDRPFFPGLVKYMNSGPVVAMVWEGLNVVKTGAVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVKSAEKEISLWFKPEELVDYKSCAHDWVYE","Homo sapiens","NME2, NM23B","Nucleoside diphosphate kinase B","1","3BBC"
"3BBF",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 1500, 50 mM Tris-HCl, 200 mM MgCl2, 2 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1158/1535-7163.MCT-08-1093","GDP","3BBF",106.27,"1.7","1.7","Crystal structure of the NM23-H2 transcription factor complex with GDP","ANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQHYIDLKDRPFFPGLVKYMNSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVKSAEKEISLWFKPEELVDYKSCAHDWVYE","Homo sapiens","NME2, NM23B","Nucleoside diphosphate kinase B","1","3BBF"
"3BBT",,"X-RAY DIFFRACTION",3.76,70.98,"VAPOR DIFFUSION, HANGING DROP",7,"4.3 M NaCl, 0.1 M Hepes, pH 7.0, 2% trifluoroethanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.12.016","FMM","3BBT",76.15,"2.8","2.8","crystal structure of the ErbB4 kinase in complex with lapatinib","GTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFN","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","3BBT"
"3BBW",,"X-RAY DIFFRACTION",3.68,70.42,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M NaCl, 0.2 M MgCl2, 0.1 M hepes, pH 7.0, 2% hexafluoroisopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.12.016",,"3BBW",74.98,"4","4","crystal structure of the ErbB4 kinase in its inactive conformation","GTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFN","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","3BBW"
"3BC3",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, HANGING DROP",,"17%(w/v) Polyethylene glycol 8000, 0.2M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm701190v","OPT","3BC3",50.11,"2.2","2.2","Exploring inhibitor binding at the S subsites of cathepsin L","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L heavy and light chains","1","3BC3"
"3BC5",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.4M Na-Formate, 0.3M ammonium acetate, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2009.01.030","ZAA","3BC5",34.25,"2.27","2.27","X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid","MGSSHHHHHHSSGLVPRGSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3BC5"
"3BCE",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"15% PEG3350, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.12.016",,"3BCE",112.83,"2.5","2.5","Crystal structure of the ErbB4 kinase","GTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFN","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","3BCE"
"3BCH",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",6,"pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1074/jbc.C700206200",,"3BCH",28.21,"2.15","2.15","Crystal Structure of the Human Laminin Receptor Precursor","MGSSHHHHHHSSGLVPRGSGTENLYFQGHMASGSSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEK","Homo sapiens","RPSA, LAMBR, LAMR1","40S ribosomal protein SA","1","3BCH"
"3BCJ",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AMMONIUM CITRATE, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm701514k","FIS","3BCJ",37.11,"0.78","0.78","Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.78 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3BCJ"
"3BCZ",,"X-RAY DIFFRACTION",2.26,45.64,"VAPOR DIFFUSION, HANGING DROP",5.5,"22.5% PEG 3350, 0.1 M MES pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M703523200",,"3BCZ",135.1,"2.1","2.1","Crystal structure of Memo","VVCREASHAGSWYTASGPQLNAQLEGWLSQVQSTKRPARAIIAPHAGYTYCGSCAAHAYKQVDPSITRRIFILGPSHHVPLSRCALSSVDIYRTPLYDLRIDQKIYGELWKTGMFERMSLQTDEDEHSIEMHLPYTAKAMESHKDEFTIIPVLVGALSESKEQEFGKLFSKYLADPSNLFVVSSDFCHWGQRFRYSYYDESQGEIYRSIEHLDKMGMSIIEQLDPVSFSNYLKKYHNTICGRHPIGVLLNAITELQKNGMNMSFSFLNYAQSSQCRNWQDSSVSYAAGALTVH","Homo sapiens","MEMO1, C2orf4, NS5ATP7, MEMO, CGI-27","Protein MEMO1","1","3BCZ"
"3BD0",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, HANGING DROP",5.5,"Crystal was grown in 22.5% PEG 3350, 0.1 M MES pH 5.5. Soaked in 5 mM ZnCl2, 22.5% PEG 3350 pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M703523200",,"3BD0",133.24,"3.01","3.01","Crystal structure of Memo, form II","VVCREASHAGSWYTASGPQLNAQLEGWLSQVQSTKRPARAIIAPHAGYTYCGSCAAHAYKQVDPSITRRIFILGPSHHVPLSRCALSSVDIYRTPLYDLRIDQKIYGELWKTGMFERMSLQTDEDEHSIEMHLPYTAKAMESHKDEFTIIPVLVGALSESKEQEFGKLFSKYLADPSNLFVVSSDFCHWGQRFRYSYYDESQGEIYRSIEHLDKMGMSIIEQLDPVSFSNYLKKYHNTICGRHPIGVLLNAITELQKNGMNMSFSFLNYAQSSQCRNWQDSSVSYAAGALTVH","Homo sapiens","MEMO1, C2orf4, NS5ATP7, MEMO, CGI-27","Protein MEMO1","1","3BD0"
"3BD9",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, SITTING DROP",5.6,"100 mM sodium citrate pH 5.6, 35% (v/v) t-butanol, 4mM PAP, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nchembio.66",,"3BD9",33.4,"2.3","2.3","human 3-O-sulfotransferase isoform 5 with bound PAP","MGSSHHHHHHSSGLVPRGSHMQQLPKAIIIGVRKGGTRALLEMLNLHPAVVKASQEIHFFDNDENYGKGIEWYRKKMPFSYPQQITIEKSPAYFITEEVPERIYKMNSSIKLLIIVREPTTRAISDYTQVLEGKERKNKTYYKFEKLAIDPNTCEVNTKYKAVRTSIYTKHLERWLKYFPIEQFHVVDGDRLITEPLPELQLVEKFLNLPPRISQYNLYFNATRGFYCLRFNEIFNKCLAGSKGRIHPEVDPSVITKLRKFFHPFNQKFYQITGRTLNWP","Homo sapiens","HS3ST5, 3OST5, HS3OST5","Heparan sulfate glucosamine 3-O-sulfotransferase 5","1","3BD9"
"3BDL",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, HANGING DROP",7,"50mM HEPES, pH 7.0, 150mM NaCl, 10mM mercaptoethanol, 1.44M tri-ammonium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1093/nar/gkn236",,"3BDL",64.78,"1.9","1.9","Crystal structure of a truncated human Tudor-SN","MGSSHHHHHHSSGLVPRGSHMDKQFVAKVMQVLNADAIVVKLNSGDYKTIHLSSIRPPRLEGENTQDKNKKLRPLYDIPYMFEAREFLRKKLIGKKVNVTVDYIRPASPATETVPAFSERTCATVTIGGINIAEALVSKGLATVIRYRQDDDQRSSHYDELLAAEARAIKNGKGLHSKKEVPIHRVADISGDTQKAKQFLPFLQRAGRSEAVVEYVFSGSRLKLYLPKETCLITFLLAGIECPRGARNLPGLVQEGEPFSEEATLFTKELVLQREVEVEVESMDKAGNFIGWLHIDGANLSVLLVEHALSKVHFTAERSSYYKSLLSAEEAAKQKKEKVWAHYEEQPVEEVMPVLEEKERSASYKPVFVTEITDDLHFYVQDVETGTQLEKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSA","Homo sapiens","SND1, TDRD11","Staphylococcal nuclease domain-containing protein 1","1","3BDL"
"3BDX",,"X-RAY DIFFRACTION",2.77,55.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"Drops consisted of 5 microliters of protein solution (7 mg/mL) plus 5 microliters of 0.1 M MES pH 6.5, 2.0 M Sodium acetate trihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2009.11.038",,"3BDX",36.71,"2.3","2.3","Crystal structure of the unstable and highly fibrillogenic Pro7Ser mutant of the Recombinant variable domain 6AJL2","NFMLTQSHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","VL gene segment 6a and JL2/3 gene segment","Amyloid lambda 6 light chain variable region PIP (fragment)","1","3BDX"
"3BE2",,"X-RAY DIFFRACTION",2.28,46.16,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, sodium chloride, ammonium sulfate, isopropanol, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm701097z","RAJ","3BE2",36.82,"1.75","1.75","Crystal structure of the VEGFR2 kinase domain in complex with a benzamide inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3BE2"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3BE8",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION, HANGING DROP",4.2,"10% PEG-3000, 0.1M sodium phosphate-citrate, 0.3M sodium chloride, 0.01M calcium chloride, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.neuron.2007.11.013",,"3BE8",134.33,"2.2","2.2","Crystal structure of the synaptic protein neuroligin 4","DYKDDDDKLAAAQYPVVNTNYGKIRGLRTPLPNEILGPVEQYLGVPYASPPTGERRFQPPEPPSSWTGIRNTTQFAAVCPQHLDERSLLHDMLPIWFTANLDTLMTYVQDQNEDCLYLNIYVPTEDDIHDQNSKKPVMVYIHGGSYMEGTGNMIDGSILASYGNVIVITINYRLGILGFLSTGDQAAKGNYGLLDQIQALRWIEENVGAFGGDPKRVTIFGSGAGASCVSLLTLSHYSEGLFQKAIIQSGTALSSWAVNYQPAKYTRILADKVGCNMLDTTDMVECLRNKNYKELIQQTITPATYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVDGIVDNEDGVTPNDFDFSVSNFVDNLYGYPEGKDTLRETIKFMYTDWADKENPETRRKTLVALFTDHQWVAPAVATADLHAQYGSPTYFYAFYHHCQSEMKPSWADSAHGDEVPYVFGIPMIGPTELFSCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWSRYNPKDQLYLHIGLKPRVRDHYRATKVAFWLELVPHLHNLNEIFQYVSTTTKVPPPDMT","Homo sapiens","NLGN4X, KIAA1260, NLGN4, UNQ365/PRO701","Neuroligin-4, X-linked","1","3BE8"
"3BEA",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, sodium acetate, Li2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.02.070","IXH","3BEA",38.45,"2.02","2.02","cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor","GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","3BEA"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FMS"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FMS"
"3BEI",,"X-RAY DIFFRACTION",2.89,57.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5% PEG 4000, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.0710894105",,"3BEI",35.34,"1.55","1.55","Crystal structure of the slow form of thrombin in a self_inhibited conformation","YQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","3BEI"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","3BEI"
"3BEL",,"X-RAY DIFFRACTION",2.2,44.19,"VAPOR DIFFUSION, HANGING DROP",9,"2M Na/K3PO4, 0.1M Caps pH 9.0 and 0.2M Li2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2008.05.024","POX","3BEL",36.7,"2.3","2.3","X-ray structure of EGFR in complex with oxime inhibitor","ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3BEL"
"3BER",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, SITTING DROP",5.2,"42.5% PEG 200, 100mM Sodium/potassium phosphate, 50mM Sodium chloride, pH 5.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0012791",,"3BER",28.2,"1.4","1.4","Human DEAD-box RNA-helicase DDX47, conserved domain I in complex with AMP","MHHHHHHSSGVDLGTENLYFQSMEEHDSPTEASQPIVEEEETKTFKDLGVTDVLCEACDQLGWTKPTKIQIEAIPLALQGRDIIGLAETGSGKTGAFALPILNALLETPQRLFALVLTPTRELAFQISEQFEALGSSIGVQSAVIVGGIDSMSQSLALAKKPHIIIATPGRLIDHLENTKGFNLRALKYLVMDEADRILNMDFETEVDKILKVIPRDRKTFLFSATMTKKVQKLQRAALKNPVKCAVSS","Homo sapiens","DDX47","Probable ATP-dependent RNA helicase DDX47","1","3BER"
"3BET",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, HANGING DROP",8.4,"2.8M ammonium sulphate, 0.3M sodium chloride, 0.1M TRIS-HCl pH 8.4, 1mM dithiothreitol , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm701319c","CTF","3BET",29.72,"1.85","1.85","Crystal structure of the human carbonic anhydrase II in complex with STX 641 at 1.85 angstroms resolution","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3BET"
"3BF6",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris, 25% v/v t-butanol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bbapap.2009.03.011","SVR","3BF6",35.59,"2.5","2.5","Thrombin:suramin complex","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin, LIGHT CHAIN","1","3BF6"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin, HEAVY CHAIN","2","3BF6"
,,,,,,,,,,,,,,,,"FPR",,,"PHE-PRO-ARG","3","3BF6"
"3BFO",,"X-RAY DIFFRACTION",1.88,34.75,"VAPOR DIFFUSION, HANGING DROP",6.5,"1:1 volume ratio of protein solution (50 mg/mL) and reservoir solution (30% PEG MME 550, 0.2 M Ammonium sulfate, 0.1 M Sodium cacodylate pH 6.5), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BFO",42.06,"1.15","1.15","Crystal structure of Ig-like C2-type 2 domain of the human Mucosa-associated lymphoid tissue lymphoma translocation protein 1","GSKLQICVEPTSQKLMPGSTLVLQCVAVGSPIPHYQWFKNELPLTHETKKLYMVPYVDLEHQGTYWCHVYNDRDSQDSKKVEIIIDELNNL","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (Isoform 2)","1","3BFO"
"3BFX",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION",6.5,"1.0M Na Citrate, 0.1M Cacodylate, pH 6.5, VAPOR DIFFUSION, temperature 297K",297,"10.1002/prot.21048",,"3BFX",70.56,"1.8","1.8","Crystal structure of human sulfotransferase SULT1C1 in complex with PAP","GSLTSDLGKQIKLKEVEGTLLQPATVDNWSQIQSFEAKPDDLLICTYPKAGTTWIQEIVDMIEQNGDVEKCQRAIIQHRHPFIEWARPPQPSGVEKAKAMPSPRILKTHLSTQLLPPSFWENNCKFLYVARNAKDCMVSYYHFQRMNHMLPDPGTWEEYFETFINGKVVWGSWFDHVKGWWEMKDRHQILFLFYEDIKRDPKHEIRKVMQFMGKKVDETVLDKIVQETSFEKMKENPMTNRSTVSKSILDQSISSFMRKGTVGDWKNHFTVAQNERFDEIYRRKMEGTSINFSMEL","Homo sapiens","SULT1C2, SULT1C1","Sulfotransferase 1C2","1","3BFX"
"3BG3",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"90 mM MnCl2, 0.8%(v/v)PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nsmb.1393",,"3BG3",316.16,"2.8","2.8","Crystal Structure of Human Pyruvate Carboxylase (missing the biotin carboxylase domain at the N-terminus)","MGSSHHHHHHSSGLVPRGSHMDENPELFQLRPAQNRAQKLLHYLGHVMVNGPTTPIPVKASPSPTDPVVPAVPIGPPPAGFRDILLREGPEGFARAVRNHPGLLLMDTTFRDAHQSLLATRVRTHDLKKIAPYVAHNFSKLFSMENWGGATFDVAMRFLYECPWRRLQELRELIPNIPFQMLLRGANAVGYTNYPDNVVFKFCEVAKENGMDVFRVFDSLNYLPNMLLGMEAAGSAGGVVEAAISYTGDVADPSRTKYSLQYYMGLAEELVRAGTHILCIKDMAGLLKPTACTMLVSSLRDRFPDLPLHIHTHDTSGAGVAAMLACAQAGADVVDVAADSMSGMTSQPSMGALVACTRGTPLDTEVPMERVFDYSEYWEGARGLYAAFDCTATMKSGNSDVYENEIPGGQYTNLHFQAHSMGLGSKFKEVKKAYVEANQMLGDLIKVTPSSKIVGDLAQFMVQNGLSRAEAEAQAEELSFPRSVVEFLQGYIGVPHGGFPEPFRSKVLKDLPRVEGRPGASLPPLDLQALEKELVDRHGEEVTPEDVLSAAMYPDVFAHFKDFTATFGPLDSLNTRLFLQGPKIAEEFEVELERGKTLHIKALAVSDLNRAGQRQVFFELNGQLRSILVKDTQAMKEMHFHPKALKDVKGQIGAPMPGKVIDIKVVAGAKVAKGQPLCVLSAMKMETVVTSPMEGTVRKVHVTKDMTLEGDDLILEIE","Homo sapiens","PC","Pyruvate carboxylase, mitochondrial","1","3BG3"
"3BG8",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION",7.4,"20mM Tris pH 7.4, 200mM NaCl, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm800314b",,"3BG8",27.64,"1.6","1.6","Crystal structure of Factor XIa in complex with Clavatadine A","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XIa light chain","1","3BG8"
"3BG9",,"X-RAY DIFFRACTION",2.78,55.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"200 mM ammonium tartrate, 15% (w/v) PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nsmb.1393",,"3BG9",315.1,"3","3","Crystal Structure of Human Pyruvate Carboxylase (missing the biotin carboxylase domain at the N-terminus) F1077A Mutant","MGSSHHHHHHSSGLVPRGSHMDENPELFQLRPAQNRAQKLLHYLGHVMVNGPTTPIPVKASPSPTDPVVPAVPIGPPPAGFRDILLREGPEGFARAVRNHPGLLLMDTTFRDAHQSLLATRVRTHDLKKIAPYVAHNFSKLFSMENWGGATFDVAMRFLYECPWRRLQELRELIPNIPFQMLLRGANAVGYTNYPDNVVFKFCEVAKENGMDVFRVFDSLNYLPNMLLGMEAAGSAGGVVEAAISYTGDVADPSRTKYSLQYYMGLAEELVRAGTHILCIKDMAGLLKPTACTMLVSSLRDRFPDLPLHIHTHDTSGAGVAAMLACAQAGADVVDVAADSMSGMTSQPSMGALVACTRGTPLDTEVPMERVFDYSEYWEGARGLYAAFDCTATMKSGNSDVYENEIPGGQYTNLHFQAHSMGLGSKFKEVKKAYVEANQMLGDLIKVTPSSKIVGDLAQFMVQNGLSRAEAEAQAEELSFPRSVVEFLQGYIGVPHGGFPEPFRSKVLKDLPRVEGRPGASLPPLDLQALEKELVDRHGEEVTPEDVLSAAMYPDVFAHFKDFTATFGPLDSLNTRLFLQGPKIAEEFEVELERGKTLHIKALAVSDLNRAGQRQVAFELNGQLRSILVKDTQAMKEMHFHPKALKDVKGQIGAPMPGKVIDIKVVAGAKVAKGQPLCVLSAMKMETVVTSPMEGTVRKVHVTKDMTLEGDDLILEIE","Homo sapiens","PC","Pyruvate carboxylase, mitochondrial","1","3BG9"
"3BGG",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, HANGING DROP",8.4,"Ammonium Sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BGG",32.09,"1.93","1.93","Crystal structure of Human Orotidine 5'-monophosphate Decarboxylase complexed with BMP","DAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","3BGG"
"3BGJ",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",8.4,"Ammonium Sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BGJ",64.24,"2","2","Crystal Structure of Human Orotidine 5'-monophosphate Decarboxylase Covalently Modified by 6-iodo-UMP","DAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","3BGJ"
"3BGL",,"X-RAY DIFFRACTION",2.17,43.26,,,,,"10.1016/j.bmcl.2007.11.124","RID","3BGL",192.27,"2.225","2.225","Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3BGL"
"3BGP",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"1 M ammonium phosphate dibasic, 100 mM citrate, 200 mM sodium chloride, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm701248t","VX1","3BGP",38.31,"2.8","2.8","Human Pim-1 complexed with a benzoisoxazole inhibitor VX1","MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3BGP"
"3BGQ",,"X-RAY DIFFRACTION",2.99,58.86,"VAPOR DIFFUSION, HANGING DROP",5.5,"1 M ammonium phosphate dibasic, 100 mM citrate, 200 mM NaCl, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm701248t","VX2","3BGQ",38.35,"2","2","Human Pim-1 kinase in complex with an triazolo pyridazine inhibitor VX2","MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3BGQ"
"3BGS",,"X-RAY DIFFRACTION",4.82,74.27,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M Sodium citrate pH 5.0, 2.3 M ammonium dihydrogenphosphate, Vapor diffusion, sitting drop, temperature 291K",291,"10.1021/ja710733g","DIH","3BGS",32.74,"2.099","2.099","Structure of human purine nucleoside phosphorylase with L-DADMe-ImmH and phosphate","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","purine nucleoside phosphorylase","1","3BGS"
"3BGV",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.2 M KCl, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3BGV",148.63,"2.3","2.3","Crystal structure of mRNA cap guanine-N7 methyltransferase in complex with SAH","GSQSRIFYLRNFNNWMKSVLIGEFLEKVRQKKKRDITVLDLGCGKGGDLLKWKKGRINKLVCTDIADVSVKQCQQRYEDMKNRRDSEYIFSAEFITADSSKELLIDKFRDPQMCFDICSCQFVCHYSFESYEQADMMLRNACERLSPGGYFIGTTPNSFELIRRLEASETESFGNEIYTVKFQKKGDYPLFGCKYDFNLEGVVDVPEFLVYFPLLNEMAKKYNMKLVYKKTFLEFYEEKIKNNENKMLLKRMQALEPYPANESSKLVSEKVDDYEHAAKYMKNSQVRLPLGTLSKSEWEATSIYLVFAFEKQQ","Homo sapiens","RNMT, KIAA0398","mRNA cap guanine-N7 methyltransferase","1","3BGV"
"3BGZ",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION, HANGING DROP",5.5,"1 M ammonium phosphate dibasic, 100 mM citrate, 200 mM sodium chloride, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm701248t","VX3","3BGZ",38.3,"2.4","2.4","Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3","MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3BGZ"
"3BHD",,"X-RAY DIFFRACTION",1.793,31.396,"VAPOR DIFFUSION, SITTING DROP",3.8,"50mM Citric acid, 0.2M Ammonium sulfate, 3mM Sodium tungstenate, 10mg/ml Protein, pH 3.8, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,,,"3BHD",53.32,"1.5","1.5","Crystal structure of human thiamine triphosphatase (THTPA)","MGSSHHHHHHSSGLVPRGSMAQGLIEVERKFLPGPGTEERLQELGGTLEYRVTFRDTYYDTPELSLMQADHWLRRREDSGWELKCPGAAGVLGPHTEYKELTAEPTIVAQLCKVLRADGLGAGDVAAVLGPLGLQEVASFVTKRSAWKLVLLGADEEEPQLRVDLDTADFGYAVGEVEALVHEEAEVPTALEKIHRLSSMLGVPAQETAPAKLIVYLQRFRPQDYQRLLEVNSS","Homo sapiens","THTPA","Thiamine triphosphatase","1","3BHD"
"3BHH",,"X-RAY DIFFRACTION",2.44,49.66,"VAPOR DIFFUSION, SITTING DROP",6.2,"50% PEG 300, 0.2M NaCl, 0.1M Na/KPO4 pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3BHH",134.98,"2.4","2.4","Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)","SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGA","Homo sapiens","CAMK2B, CAM2, CAMKB, CAMK2","Calcium/calmodulin-dependent protein kinase type II beta chain","1","3BHH"
"3BHI",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"vapor diffusion, hanging drop, temperature 298K, pH7.5, VAPOR DIFFUSION, HANGING DROP",298,"10.1074/jbc.M807125200",,"3BHI",31.06,"2.27","2.27","Crystal structure of human Carbonyl Reductase 1 in complex with NADP","SSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQLQAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADPTPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSCSPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTKIGVTVLSRIHARKLSEQRKGDKILLNACCPGWVRTDMAGPKATKSPEEGAETPVYLALLPPDAEGPHGQFVSEKRVEQW","Homo sapiens","CBR1, CBR, CRN, SDR21C1","Carbonyl reductase [NADPH] 1","1","3BHI"
"3BHJ",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"vapor diffusion, hanging drop, temperature 298K, pH7.5, VAPOR DIFFUSION, HANGING DROP",298,"10.1074/jbc.M807125200",,"3BHJ",33.22,"1.77","1.77","Crystal structure of human Carbonyl Reductase 1 in complex with glutathione","SSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQLQAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADPTPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSCSPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTKIGVTVLSRIHARKLSEQRKGDKILLNACCPGWVRTDMAGPKATKSPEEGAETPVYLALLPPDAEGPHGQFVSEKRVEQW","Homo sapiens","CBR1, CBR, CRN, SDR21C1","Carbonyl reductase [NADPH] 1","1","3BHJ"
"3BHM",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"vapor diffusion, hanging drop, temperature 298K, pH7.5, VAPOR DIFFUSION, HANGING DROP",298,"10.1074/jbc.M807125200",,"3BHM",32.32,"1.8","1.8","Crystal structure of human Carbonyl Reductase 1 in complex with S-hydroxymethylglutathione","SSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQLQAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADPTPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSCSPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTKIGVTVLSRIHARKLSEQRKGDKILLNACCPGWVRTDMAGPKATKSPEEGAETPVYLALLPPDAEGPHGQFVSEKRVEQW","Homo sapiens","CBR1, CBR, CRN, SDR21C1","Carbonyl reductase [NADPH] 1","1","3BHM"
"3BHO",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 3350, 0.025M Magnesium chloride, 0.1M Tris-HCL pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1093/nar/gkn079","B4P","3BHO",25.01,"1.8","1.8","Crystal Structure of the 25kDa Subunit of Human Cleavage factor Im with Ap4A","FGNKYIQQTKPLTLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","3BHO"
"3BHX",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.12.066","SPE, BHX","3BHX",83.03,"1.6","1.6","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of Asp-Glu","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3BHX"
"3BHY",,"X-RAY DIFFRACTION",1.91,35.46,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M SPG (sucrose-phosphate-glutamate buffer) pH 6.0, 30% PEG 1000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201286z",,"3BHY",32.96,"1.24","1.24","Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with a beta-carboline ligand","SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG","Homo sapiens","DAPK3, ZIPK","Death-associated protein kinase 3","1","3BHY"
"3BI0",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.12.066","BIX, EPE","3BI0",83.06,"1.67","1.67","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of Glu-Glu","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3BI0"
"3BI1",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.12.066","MPE, 3BI","3BI1",83.17,"1.5","1.5","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of methotrexate-Glu","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3BI1"
"3BI6",,"X-RAY DIFFRACTION",2.84,56.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.12.046","396","3BI6",32.85,"2.2","2.2","Wee1 kinase complex with inhibitor PD352396","GAMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","3BI6"
"3BI7",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, HANGING DROP",6,"1:1 ratio of protein (34 mg/ml) solution and well solution consisting of 1.4 M Ammonium sulfate, 0.1 M Bis-Tris pH 6.0, 0.2 M NaCl, 1 mM TCEP. Crystals cryoprotected by immersion in the well solution mixed in 1:1 ratio with a water solution containing 20% (w/v) Sucrose, 4% (w/v) Glucose, 18% (v/v) Glycerol and 18% (v/v) Ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature07273",,"3BI7",24.25,"1.7","1.7","Crystal structure of the SRA domain of E3 ubiquitin-protein ligase UHRF1","MPSNHYGPIPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTGSGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVKGGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKKLGLTMQYPEGYLEALANAHHHHHH","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","3BI7"
"3BIC",,"X-RAY DIFFRACTION",3.29,62.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.60M Na/K2PO4, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.177717",,"3BIC",169.81,"2.6","2.6","Crystal structure of human methylmalonyl-CoA mutase","MSPHYLRQVKESSGSRLIQQRLLHQQQPLHPEWAALAKKQLKGKNPEDLIWHTPEGISIKPLYSKRDTMDLPEELPGVKPFTRGPYPTMYTFRPWTIRQYAGFSTVEESNKFYKDNIKAGQQGLSVAFDLATHRGYDSDNPRVRGDVGMAGVAIDTVEDTKILFDGIPLEKMSVSMTMNGAVIPVLANFIVTGEEQGVPKEKLTGTIQNDILKEFMVRNTYIFPPEPSMKIIADIFEYTAKHMPKFNSISISGYHMQEAGADAILELAYTLADGLEYSRTGLQAGLTIDEFAPRLSFFWGIGMNFYMEIAKMRAGRRLWAHLIEKMFQPKNSKSLLLRAHCQTSGWSLTEQDPYNNIVRTAIEAMAAVFGGTQSLHTNSFDEALGLPTVKSARIARNTQIIIQEESGIPKVADPWGGSYMMECLTNDVYDAALKLINEIEEMGGMAKAVAEGIPKLRIEECAARRQARIDSGSEVIVGVNKYQLEKEDTVEVLAIDNTSVRNRQIEKLKKIKSSRDQALAERCLAALTECAASGDGNILALAVDASRARCTVGEITDALKKVFGEHKANDRMVSGAYRQEFGESKEITSAIKRVHKFMEREGRRPRLLVAKMGQDGHDRGAKVIATGFADLGFDVDIGPLFQTPREVAQQAVDADVHAVGVSTLAAGHKTLVPELIKELNSLGRPDILVMCGGVIPPQDYEFLFEVGVSNVFGPGTRIPKAAVQVLDDIEKCLEKKQQSVAENLYFQSHHHHHHDYKDDDDK","Homo sapiens","MUT, MMUT","Methylmalonyl-CoA mutase, mitochondrial precursor","1","3BIC"
"3BIN",,"X-RAY DIFFRACTION",3.86,68.12,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% ETOH, 0.1M TRIS PH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.174011",,"3BIN",34.44,"2.3","2.3","Structure of the DAL-1 and TSLC1 (372-383) complex","ASMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Band 4.1-like protein 3","1","3BIN"
,,,,,,,,,,,,,,,,"ARHKGTYFTHEA",,,"Cell adhesion molecule 1","2","3BIN"
"3BIS",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.1 M NaCacodylate, 0.2 M ammonium formate or ammonium fluoride, pH 6.50, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0712278105",,"3BIS",50.79,"2.64","2.64","Crystal Structure of the PD-L1","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERT","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","3BIS"
"3BIY",,"X-RAY DIFFRACTION",2.18,43.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES sodium pH 7.5, 20% w/v polyethylene glycol 4,000, 10% v/v 2-Propanol , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature06546",,"3BIY",45.37,"1.7","1.7","Crystal structure of p300 histone acetyltransferase domain in complex with a bisubstrate inhibitor, Lys-CoA","KFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDRHLEFSSLRRAQWSTGCMLVELHTQSQDRF","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","3BIY"
"3BIZ",,"X-RAY DIFFRACTION",2.87,57.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.12.046","61E","3BIZ",32.81,"2.2","2.2","Wee1 kinase complex with inhibitor PD331618","GAMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","3BIZ"
"3BJ4",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-16% PEG 8K, 0.1M Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1074/jbc.M707541200",,"3BJ4",10.91,"2","2","The KCNQ1 (Kv7.1) C-terminus, a multi-tiered scaffold for subunit assembly and protein interaction","ISVSEKSKDRGSNTIGARLNRVEDKVTQLDQRLALITDMLHQLLSLHGG","Homo sapiens","KCNQ1, KCNA8, KCNA9, KVLQT1","Potassium voltage-gated channel subfamily KQT member 1","1","3BJ4"
"3BJ5",,"X-RAY DIFFRACTION",1.88,34.54,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.95M Ammonium sulfate, 0.2M NaCl, 0.1M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1016/j.jmb.2008.08.085",,"3BJ5",17.37,"2.2","2.2","Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b' domain","MHHHHHHMKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFAFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQP","Homo sapiens","P4HB, ERBA2L, PDI, PDIA1, PO4DB","Protein disulfide-isomerase","1","3BJ5"
"3BJ9",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Imidazole, 
1M Sodium acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1110/ps.073269808",,"3BJ9",13.12,"2","2","Crystal structure of the Surrogate Light Chain Variable Domain VpreBJ","VLHQPPAMSSALGTTIRLTCTLRNDHDIGVYSVYWYQQRPGHPPRFLLRYFSQSDKSQGPQVPPRFSGSKDVARNRGYLSISELQPEDEAMYYCAMGARSTHVFGSGTQLTVLSAA","Homo sapiens","VPREB1, VPREB","Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1","1","3BJ9"
"3BJC",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.5,"The PDE5A1-12 complex was prepared by mixing 1 mM compound 12 with 15 mg/mL PDE5A1 that was stored in a buffer of 20 mM Tris.base, pH 7.5, 50 mM NaCl, 1 mM beta-mercaptoethanol, and 1 mM EDTA. The protein drop was prepared by mixing protein with well buffer and crystallized against a well buffer of 2.0 M sodium formate, 0.1 M sodium citrate, pH 5.6, 5% ethanol at 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1016/j.bcp.2008.01.019","WAN","3BJC",100.91,"2","2","Crystal structure of the PDE5A catalytic domain in complex with a novel inhibitor","GSHMERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSVPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3BJC"
"3BJF",,"X-RAY DIFFRACTION",2.64,53.34,,,,,"10.1038/nature06667",,"3BJF",228.5,"2.03","2.03","Pyruvate kinase M2 is a phosphotyrosine binding protein","QTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQNLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase isozymes M1/M2","1","3BJF"
"3BJL",,"X-RAY DIFFRACTION",2.76,55.4,,,,,"10.1073/pnas.93.14.7017",,"3BJL",45.54,"2.3","2.3","LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE","QSVLTQPPSASGTPGQRVTISCSGSSSNIGENSVTWYQHLSGTAPKLLIYEDNSRASGVSDRFSASKSGTSASLAISGLQPEDETDYYCAAWDDSLDVAVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER","1","3BJL"
"3BJM",,"X-RAY DIFFRACTION",2.78,55.79,,,,,"10.1110/ps.073253208","BJM","3BJM",171.33,"2.35","2.35","Crystal structure of human DPP-IV in complex with (1S,3S, 5S)-2-[(2S)-2-AMINO-2-(3-HYDROXYTRICYCLO[3.3.1.13,7]DEC-1- YL)ACETYL]-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (CAS), (1S,3S,5S)-2-((2S)-2-AMINO-2-(3-HYDROXYADAMANTAN-1- YL)ACETYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (IUPAC), OR BMS-477118","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3BJM"
"3BJT",,"X-RAY DIFFRACTION",2.45,49.85,"VAPOR DIFFUSION, HANGING DROP",7.2,"PEG3350, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature06667",,"3BJT",231.9,"2.5","2.5","Pyruvate kinase M2 is a phosphotyrosine binding protein","SKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQNLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase isozymes M1/M2","1","3BJT"
"3BJU",,"X-RAY DIFFRACTION",3.01,59.13,,5.75,"12% PEG8000, 16% Glycerol, 0.08M Na Cacodylate, 0.16M Ca(OAc)2, pH 5.75, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0712072105",,"3BJU",244.34,"2.31","2.31","Crystal Structure of tetrameric form of human lysyl-tRNA synthetase","MSVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDLMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENLEHHHHHH","Homo sapiens","KARS, KIAA0070, KARS1","Lysyl-tRNA synthetase","1","3BJU"
"3BK0",,"X-RAY DIFFRACTION",2.31,46.87,"VAPOR DIFFUSION, HANGING DROP",8.4,"Ammonium Sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BK0",62.02,"1.6","1.6","Crystal Structure of Human Orotidine 5'-monophosphate Decarboxylase Complexed with 5-CN-UMP","MGSSHHHHHHSSGLVPRGSHMKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","3BK0"
"3BKB",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Na2SO4, 0.1M Bis-Tris-Propane, 20% PEG 3350, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2008.07.047",,"3BKB",44.01,"1.78","1.78","Crystal structure of human Feline Sarcoma Viral Oncogene Homologue (v-FES)","SMIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR","Homo sapiens","FES, FPS","Proto-oncogene tyrosine-protein kinase Fes/Fps","1","3BKB"
"3BKK",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, HANGING DROP",4.7,"sodium acetate, PEG 4000, ZnSO4, pH 4.7, temperature 289K, VAPOR DIFFUSION, HANGING DROP",289,"10.1021/bi8002605","KAF","3BKK",69.92,"2.17","2.17","Tesis ACE co-crystal structure with ketone ACE inhibitor kAF","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme, somatic isoform","1","3BKK"
"3BKL",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION, HANGING DROP",4.7,"sodium acetate, PEG 4000, ZnSO4, pH 4.7, temperature 289K, VAPOR DIFFUSION, HANGING DROP",289,"10.1021/bi8002605","KAW","3BKL",70.23,"2.18","2.18","Testis ACE co-crystal structure with ketone ACE inhibitor kAW","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme, somatic isoform","1","3BKL"
"3BL0",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, HANGING DROP",7.7,"Tris.HCl pH 7.7-7.8 , sodium 4-(hydroxymercury)benzoate , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.12.022","BL0","3BL0",29.9,"1.9","1.9","Carbonic anhydrase inhibitors. Interaction of 2-N,N-Dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3BL0"
"3BL1",,"X-RAY DIFFRACTION",2.08,40.77,"VAPOR DIFFUSION, HANGING DROP",7.7,"Tris.HCl pH 7.7-7.8 , sodium 4-(hydroxymercury)benzoate , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.03.051","BL1","3BL1",29.92,"2.1","2.1","Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited old leads for new applications","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3BL1"
"3BL7",,"X-RAY DIFFRACTION",2.05,39.88,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, Ammonium Formate, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/cb800120t","DD1","3BL7",70.16,"2.31","2.31","Synthetic Gene Encoded DcpS bound to inhibitor DG156844","SAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","Scavenger mRNA-decapping enzyme DcpS","1","3BL7"
"3BL9",,"X-RAY DIFFRACTION",2.2,42.5,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Ammonium Formate, vapor diffusion, hanging drop, temperature 289K",289,"10.1021/cb800120t","DD2","3BL9",70.22,"1.8","1.8","Synthetic Gene Encoded DcpS bound to inhibitor DG157493","SAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","Scavenger mRNA-decapping enzyme DcpS","1","3BL9"
"3BLA",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Ammonium Formate, vapor diffusion, hanging drop, temperature 289K",289,"10.1021/cb800120t","DD3","3BLA",70.41,"2.6","2.6","Synthetic Gene Encoded DcpS bound to inhibitor DG153249","SAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","Scavenger mRNA-decapping enzyme DcpS","1","3BLA"
"3BLJ",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.2M Ammonium chloride, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M114.630160",,"3BLJ",51.14,"2.2","2.2","Crystal structure of human poly(ADP-ribose) polymerase 15, catalytic fragment","MHHHHHHSSGVDLGTENLYFQSMNLPEHWTDMNHQLFCMVQLEPGQSEYNTIKDKFTRTCSSYAIEKIERIQNAFLWQSYQVKKRQMDIKNDHKNNERLLFHGTDADSVPYVNQHGFNRSCAGKNAVSYGKGTYFAVDASYSAKDTYSKPDSNGRKHMYVVRVLTGVFTKGRAGLVTPPPKNPHNPTDLFDSVTNNTRSPKLFVVFFDNQAYPEYLITFTA","Homo sapiens","PARP15, BAL3","Poly(ADP-ribose) polymerase 15","1","3BLJ"
"3BLK",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, HANGING DROP",9,"45% MPD, 0.1M Tris.HCl, 10 mM calcium chloride, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3BLK",56.74,"2","2","Role of aromatic residues in starch binding","QYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLSGLLDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMWPGDIKAILDKLHNLNSNWFPEGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFMPSDRALVFVDNHDNQRGHGAGGASILTFADARLYKMAVGFMLAHPYGFTRVMSSYRWPRYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRWRQIRNMVNFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY1A, AMY1","Alpha-amylase 1","1","3BLK"
"3BLP",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, HANGING DROP",9,"45% MPD, 0.1M Tris.HCl, 10 mM calcium chloride, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3BLP",56.74,"1.6","1.6","Role of aromatic residues in human salivary alpha-amylase","QYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLSGLLDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMWPGDIKAILDKLHNLNSNWFPEGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFMPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRARQIRNMVNFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY1A, AMY1","Alpha-amylase 1","1","3BLP"
"3BM4",,"X-RAY DIFFRACTION",2.13,42.17,"VAPOR DIFFUSION, HANGING DROP",8,"29% PEG 4000, 0.25M sodium acetate, 0.1M tris hydrochloride, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2008.04.006",,"3BM4",47.76,"2","2","Crystal Structure of Human ADP-ribose Pyrophosphatase NUDT5 In complex with magnesium and AMPcpr","MESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHANAK","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","3BM4"
"3BM9",,"X-RAY DIFFRACTION",2.9,57.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.2M MAGNESIUM ACETATE, PH 7.5, TEMPERATURE 277K; FROZEN BY 1-STEP TRANSFER TO      
25% GLYCEROL, 15% PEG3350, 0.15M MAGNESIUM ACETATE, VAPOR DIFFUSION, HANGING DROP",277,"10.1021/jm701385c","BXZ","3BM9",25.73,"1.6","1.6","Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Hsp90","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3BM9"
"3BMP",,"X-RAY DIFFRACTION",3,59,,5.4,"CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 100 MM LITHIUM 
SULFATE, 12% TERT-BUTANOL, 50 MM CITRATE, PH 5.4",,"10.1006/jmbi.1999.2590",,"3BMP",13.04,"2.7","2.7","HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2)","QAKHKQRKRLKSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVNSVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR","Homo sapiens","BMP2, BMP2A","PROTEIN (BONE MORPHOGENETIC PROTEIN 2 (BMP-2))","1","3BMP"
"3BMY",,"X-RAY DIFFRACTION",2.16,43.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 1500, 20% glycerol, pH 7.5, temperature 277K; 
frozen by 1-step transfer to 18% PEG 1500, 40% glycerol;
VAPOR DIFFUSION, HANGING DROP",277,"10.1021/jm701385c","CXZ","3BMY",25.8,"1.6","1.6","Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Hsp90","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3BMY"
"3BO5",,"X-RAY DIFFRACTION",1.87,34.07,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2 M Ammonium acetate, 0.1 M Bis-Tris pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3BO5",33.13,"1.59","1.59","Crystal structure of methyltransferase domain of human Histone-lysine N-methyltransferase SETMAR","GAEFKEKPEAPTEQLDVACGQENLPVGAWPPGAAPAPFQYTPDHVVGPGADIDPTQITFPGCICVKTPCLPGTCSCLRHGENYDDNSCLRDIGSGGKYAEPVFECNVLCRCSDHCRNRVVQKGLQFHFQVFKTHKKGWGLRTLEFIPKGRFVCEYAGEVLGFSEVQRRIHLQTKSDSNYIIAIREHVYNGQVMETFVDPTYIGNIGRFLNHSCEPNLLMIPVRIDSMVPKLALFAAKDIVPEEELSYDYSGRYLNLTVSASKERLDHGKLRKPCYCGAKSCTAFLPFDSS","Homo sapiens","SETMAR","Histone-lysine N-methyltransferase SETMAR","1","3BO5"
"3BOR",,"X-RAY DIFFRACTION",1.85,33.39,"VAPOR DIFFUSION",7.3,"25% PEG 3350, 0.1M Bis-Tris, 0.2M Ammonium acetate. Chymotrypsin was added to the crystallization sample at a molar ratio of approx. 1:100, pH 7.3, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pone.0012791",,"3BOR",26.93,"1.85","1.85","Crystal structure of the DEADc domain of human translation initiation factor 4A-2","MHHHHHHSSGRENLYFQGGVIESNWNEIVDNFDDMNLKESLLRGIYAYGFEKPSAIQQRAIIPCIKGYDVIAQAQSGTGKTATFAISILQQLEIEFKETQALVLAPTRELAQQIQKVILALGDYMGATCHACIGGTNVRNEMQKLQAEAPHIVVGTPGRVFDMLNRRYLSPKWIKMFVLDEADEMLSRGFKDQIYEIFQKLNTSIQVVLLSATMPTDVLEVTKKFMRDPIRILVKKE","Homo sapiens","EIF4A2, DDX2B, EIF4F","Human initiation factor 4A-II","1","3BOR"
"3BPJ",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% PEG 3350, 0.1M Sodium acetate. Chymotrypsin was added to the crystallization sample at a molar ratio of approx. 1:100, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"3BPJ",36.73,"1.85","1.85","Crystal structure of human translation initiation factor 3, subunit 1 alpha","AVYGIDAMNPSSRDDFTEFGKLLKDKITQYEKSLYYASFLEVLVRDVCISLEIDDLKKITNSLTVLCSEKQKQEKQSKAK","Homo sapiens","EIF3J, EIF3S1, PRO0391","Eukaryotic translation initiation factor 3 subunit J","1","3BPJ"
"3BPR",,"X-RAY DIFFRACTION",2.69,54.32,,8.5,"Compound C52 (50 mM in DMSO) was added to 8 mg/ml MER protein to the final concentration of 2.5 mM. The mixture was rocked at 277 K overnight and further concentrated to about 35 mg/ml. Crystals were grown by mixing 2 microliters of MER inhibitor solution and 2 microliters of reservoir solution (100 mM Tris-HCl pH 8.5, 3.64 M NaCl) at 287 K using the hanging-drop vapor-diffusion method. Crystals were cryo-protected with a solution composed of glycerol, ethylene glycol, glucose, and fructose., VAPOR DIFFUSION, HANGING DROP, pH 8.50",287,"10.1016/j.jsb.2008.10.003","OLP","3BPR",145.04,"2.8","2.8","Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor C52","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Proto-oncogene tyrosine-protein kinase MER","1","3BPR"
"3BPT",,"X-RAY DIFFRACTION",2.18,43.57,"MATRIX SEEDING",5.5,"0.1M Citrate pH 5.5, 20% PEG 3350, 5mM Quercetin added to the protein, MATRIX SEEDING, temperature 293K",293,,,"3BPT",41.48,"1.5","1.5","Crystal structure of human beta-hydroxyisobutyryl-CoA hydrolase in complex with quercetin","MTDAAEEVLLGKKGCTGVITLNRPKFLNALTLNMIRQIYPQLKKWEQDPETFLIIIKGAGGKAFCAGGDIRVISEAEKAKQKIAPVFFREEYMLNNAVGSCQKPYVALIHGITMGGGVGLSVHGQFRVATEKCLFAMPETAIGLFPDVGGGYFLPRLQGKLGYFLALTGFRLKGRDVYRAGIATHFVDSEKLAMLEEDLLALKSPSKENIASVLENYHTESKIDRDKSFILEEHMDKINSCFSANTVEEIIENLQQDGSSFALEQLKVINKMSPTSLKITLRQLMEGSSKTLQEVLTMEYRLSQACMRGHDFHEGVRAVLIDKDQSPKWKPADLKEVTEEDLNNHFKSLGSSDLKFAENLYFQ","Homo sapiens","HIBCH","3-hydroxyisobutyryl-CoA hydrolase","1","3BPT"
"3BPU",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.05M Zn acetate pH 6.2, 30% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3BPU",9.68,"1.6","1.6","Crystal structure of the 3rd PDZ domain of human membrane associated guanylate kinase, C677S and C709S double mutant","SMELITVHIVKGPMGFGFTIADSPGGGGQRVKQIVDSPRSRGLKEGDLIVEVNKKNVQALTHNQVVDMLVESPKGSEVTLLVQRQTRL","Homo sapiens","MAGI1, BAIAP1, BAP1, TNRC19, AIP3","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","3BPU"
"3BQ7",,"X-RAY DIFFRACTION",1.96,37.3,"VAPOR DIFFUSION, HANGING DROP",8,"dibasic ammonium phosphate, tris, NaCl, beta-mercaptoethanol, pH 8.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.str.2007.12.017",,"3BQ7",57.61,"2.9","2.9","SAM domain of Diacylglycerol Kinase delta1 (E35G)","MEKTRPVHLWGTEEVAAWLEHLSLCEYKDIFTRHDIRGSGLLHLERRDLKDLGVTKVGHMKRILCGIKELSRSSRHHHHHH","Homo sapiens","DGKD, KIAA0145","Diacylglycerol kinase delta","1","3BQ7"
"3BQC",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein stock solution: 10mg/ml protein in 500mM NaCl, 25mM Tris/HCl, pH 8.5 
Emodin stock solution: 10mM in water 
Protein/emodin mixture: equal volumes of protein and emodin stock solutions were mixed and equillibrated for 30 min prior to crystallization 
Reservoir: 30% PEG4000, 0.2M lithium sulfate, 0.1M Tris/HCl, pH 8.5 
Crystallization drop: 2 mikroliters protein/emodin mixture plus 1 mikroliter reservoir solution, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2008.01.008","EMO","3BQC",40.41,"1.5","1.5","High pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3BQC"
"3BQD",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.3 M ammonium sulfate, 100 mM Tris, 8% glycerol, 3 mM n-hexadecyl-beta-maltoside, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1128/MCB.01541-07",,"3BQD",31.58,"2.5","2.5","Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol","GSLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","3BQD"
,,,,,,,,,,,,,,,,"AQQKSLLQQLLTE",,,"Nuclear receptor coactivator 1","2","3BQD"
"3BQM",,"X-RAY DIFFRACTION",2.26,45.54,"VAPOR DIFFUSION, HANGING DROP",4.5,"5% Peg400, 20% Peg3350, 50mM K2HPO4 pH 4.5, 10mM MgCl, 1mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.bmcl.2008.08.061","BQM","3BQM",42.59,"1.95","1.95","LFA-1 I domain bound to inhibitors","GNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKWKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYVI","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","3BQM"
"3BQN",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION, HANGING DROP",4.5,"5% Peg400, 20% Peg3350, 50mM K2HPO4 pH 4.5, 10mM MgCl2, 1mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.08.062","BQN","3BQN",42.78,"1.8","1.8","LFA-1 I domain bound to inhibitors","GNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKWKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYVI","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","3BQN"
"3BQP",,"X-RAY DIFFRACTION",2.25,45.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 8K, MAGNESIUM CHLORIDE, TRIS.HCL BUFFER, PH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1107/S0907444908003120",,"3BQP",17.93,"1.3","1.3","Crystal Structure of Human Saposin D (orthorhombic)","DGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPS","Homo sapiens","PSAP, GLBA, SAP1","Proactivator polypeptide","1","3BQP"
"3BQQ",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",4.6,"PEG 4K, ZINC SULFATE, SODIUM ACETATE BUFFER, PH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1107/S0907444908003120",,"3BQQ",35.71,"2","2","Crystal Structure of Human Saposin D (triclinic)","DGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPS","Homo sapiens","PSAP, GLBA, SAP1","PROACTIVATOR POLYPEPTIDE","1","3BQQ"
"3BQR",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, SITTING DROP",6.2,"25% 1,2-propanediol, 10% Glycerol, 0.1M Na/K phosphate pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3BQR",33.12,"1.75","1.75","Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand","SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG","Homo sapiens","DAPK3, ZIPK","Death-associated protein kinase 3","1","3BQR"
"3BRA",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, HANGING DROP",7,"2.5M sodium formate, 100mM HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.01.032","AEF","3BRA",45.69,"2.3","2.3","BACE-1 complexed with compound 1","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3BRA"
"3BRB",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",8.5,"MER protein (38 mg/mL) was pre-incubated with 2.5 mM ATP and 10 mM MgCl2 for 3 hours at room temperature. Crystals were obtained at 290K against 29% PEG 400, 0.2M MgCl2, and 0.1 M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP",290,"10.1016/j.jsb.2008.10.003",,"3BRB",72.95,"1.9","1.9","Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with ADP","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Proto-oncogene tyrosine-protein kinase MER","1","3BRB"
"3BRH",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Bicine, 20% PEG6000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BRH",74.72,"2.2","2.2","Protein Tyrosine Phosphatase PTPN-22 (Lyp) bound to the mono-Phosphorylated Lck active site peptide","MDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPAHDVPSSIDPILELIWDVRCYQEDDSVPICIHSSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSGTESQAKH","Homo sapiens","PTPN22, PTPN8","Tyrosine-protein phosphatase non-receptor type 22","1","3BRH"
,,,,,,,,,,,,,,,,"DNEYTAR",,,"Lck Active Site Peptide","2","3BRH"
"3BRV",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% Peg 4K, 0.1M Tris pH 8.5, 0.2M MgCl2, 10mM DTT, 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.02.012",,"3BRV",27.94,"2.2","2.2","NEMO/IKKb association domain structure","AMAPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTE",,,"Inhibitor of nuclear factor kappa-B kinase subunit beta","1","3BRV"
,,,,,,,,,,,,,,,,"MWEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEK","Homo sapiens","IKBKG, FIP3, NEMO","NF-kappa-B essential modulator","2","3BRV"
"3BS9",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, HANGING DROP",8,"1:1 mixture of protein with 15% polyethylene glycol 3350, 0.5 M KI, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bbrc.2008.01.027",,"3BS9",19.8,"1.95","1.95","X-ray structure of human TIA-1 RRM2","GPLGSHFHVFVGDLSPEITTAAIAAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTNWATRKP","Homo sapiens","TIA1","Nucleolysin TIA-1 isoform p40","1","3BS9"
"3BSB",,"X-RAY DIFFRACTION",2.25,45.27,"VAPOR DIFFUSION",6.5,"Hanging drop, pH 6.5, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.str.2008.01.006",,"3BSB",82.41,"2.8","2.8","Crystal Structure of Human Pumilio1 in Complex with CyclinB reverse RNA","UUUAAUGUU",,,"5'-R(*UP*UP*UP*AP*AP*UP*GP*UP*U)-3'","1","3BSB"
,,,,,,,,,,,,,,,,"GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMK","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","2","3BSB"
"3BSQ",,"X-RAY DIFFRACTION",2.76,55.36,"VAPOR DIFFUSION, SITTING DROP",7,"3.2M AMMONIUM SULFATE, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.jmb.2008.01.089",,"3BSQ",76.19,"2.8","2.8","Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKHHHHHH","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","3BSQ"
"3BSU",,"X-RAY DIFFRACTION",1.96,37.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.2 M NaCl, 0.1 M HEPES (pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1038/emboj.2008.44",,"3BSU",52.4,"2.1","2.1","Hybrid-binding domain of human RNase H1 in complex with 12-mer RNA/DNA","GACACCUGAUUC",,,"RNA (5'-R(*GP*AP*CP*AP*CP*CP*UP*GP*AP*UP*UP*C)-3')","1","3BSU"
,,,,,,,,,,,,,,,,"GAATCAGGUGTC",,,"DNA (5'-D(*DGP*DAP*DAP*DTP*DCP*DAP*DGP*DGP*(5IU)P*DGP*DTP*DC)-3')","2","3BSU"
,,,,,,,,,,,,,,,,"GSHMFYAVRRGRKTGVFLTWNECRAQVDRFPAARFKKFATEDEAWAFVRKSAS","Homo sapiens","RNASEH1, RNH1","Ribonuclease H1","3","3BSU"
"3BSX",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, 0.05M Sodium Cacodylate pH 6.5, 0.2M KCl, 0.1M Magnesium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.01.006",,"3BSX",86.53,"2.32","2.32","Crystal Structure of Human Pumilio 1 in complex with Puf5 RNA","UUGUAAUAUUA",,,"5'-R(*UP*UP*GP*UP*AP*AP*UP*AP*UP*UP*A)-3'","1","3BSX"
,,,,,,,,,,,,,,,,"GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMK","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","2","3BSX"
"3BT0",,"X-RAY DIFFRACTION",2.1,41.32,"VAPOR DIFFUSION",7.5,"0.066M CaCl2, 19% (w/v) PEG 400, 0.13M sodium Hepes , pH 7.5, VAPOR DIFFUSION, temperature 295K",295,"10.1111/j.1742-4658.2008.06705.x",,"3BT0",27.53,"1.59","1.59","Crystal structure of transthyretin variant V20S","GPTGTGESKCPLMVKVLDASRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3BT0"
"3BTB",,"SOLUTION NMR",,,,,,,"10.1021/bi971445b",,"3BTB",1.92,,,"NMR SOLUTION STRUCTURE OF A BAND 3 PEPTIDE INHIBITOR BOUND TO GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, 20 STRUCTURES","MEELQDDYEDMMEENX","Homo sapiens","SLC4A1, AE1, DI, EPB3","BAND 3","1","3BTB"
"3BTX",,"X-RAY DIFFRACTION",3.25,62.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG 8000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature06889",,"3BTX",31.12,"2","2","X-ray structure of human ABH2 bound to dsDNA through active site cross-linking","ASWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHIGEHRDDCRELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3BTX"
,,,,,,,,,,,,,,,,"CTGTATXATTGCG",,,"DNA (5'-D(*CP*TP*GP*TP*AP*TP*(2YR)P*AP*TP*TP*GP*CP*G)-3')","2","3BTX"
,,,,,,,,,,,,,,,,"TCGCAATAATACA",,,"DNA (5'-D(*DTP*DCP*DGP*DCP*DAP*DAP*DTP*DAP*DAP*DTP*DAP*DCP*DA)-3')","3","3BTX"
"3BTY",,"X-RAY DIFFRACTION",3.19,61.43,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG 8000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature06889",,"3BTY",31.14,"2.35","2.35","Crystal structure of human ABH2 bound to dsDNA containing 1meA through cross-linking away from active site","CTGTATAACTGCG",,,"DNA (5'-D(*DCP*DTP*DGP*DTP*DAP*DTP*(MA7)P*DAP*DCP*DTP*DGP*DCP*DG)-3')","1","3BTY"
,,,,,,,,,,,,,,,,"TCGCAGTTATACA",,,"DNA (5'-D(*DTP*DCP*DGP*DCP*DAP*DGP*DTP*DTP*DAP*DTP*DAP*DCP*DA)-3')","2","3BTY"
,,,,,,,,,,,,,,,,"SWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","3","3BTY"
"3BTZ",,"X-RAY DIFFRACTION",3.83,67.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG 4000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, 0.004M hexammine cobalt(III) chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP",,"10.1038/nature06889",,"3BTZ",30.96,"3","3","Crystal structure of human ABH2 cross-linked to dsDNA","WRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHIGEHRDDCRELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3BTZ"
,,,,,,,,,,,,,,,,"AGGTGAXAATGCG",,,"DNA (5'-D(*AP*GP*GP*TP*GP*AP*(2YR)P*AP*AP*TP*GP*CP*G)-3')","2","3BTZ"
,,,,,,,,,,,,,,,,"TCGCATTATCACC",,,"DNA (5'-D(*DTP*DCP*DGP*DCP*DAP*DTP*DTP*DAP*DTP*DCP*DAP*DCP*DC)-3')","3","3BTZ"
"3BU0",,"X-RAY DIFFRACTION",3.18,61.32,"VAPOR DIFFUSION, HANGING DROP",6.1,"16% PEG 4000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, 0.001M MnCl2, 0.002M 2-ketoglutarate, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature06889",,"3BU0",31.23,"2.5","2.5","crystal structure of human ABH2 cross-linked to dsDNA with cofactors","SWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHIGEHRDDCRELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3BU0"
,,,,,,,,,,,,,,,,"CTGTATXATTGCG",,,"DNA (5'-D(*CP*TP*GP*TP*AP*TP*(2YR)P*AP*TP*TP*GP*CP*G)-3')","2","3BU0"
,,,,,,,,,,,,,,,,"TCGCAATAATACA",,,"DNA (5'-D(*DTP*DCP*DGP*DCP*DAP*DAP*DTP*DAP*DAP*DTP*DAP*DCP*DA)-3')","3","3BU0"
"3BU3",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"28% PEG8000 
0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.1388",,"3BU3",36.75,"1.65","1.65","Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide","VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK","Homo sapiens","INSR","insulin receptor subunit beta","1","3BU3"
,,,,,,,,,,,,,,,,"AYNPYPEDYGDIEIG",,,"Insulin receptor substrate 2","2","3BU3"
"3BU5",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"28% PEG8000 
0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.1388",,"3BU5",37.28,"2.1","2.1","Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP","AYNPYPEDYGDIEIG",,,"Insulin receptor substrate 2","2","3BU5"
,,,,,,,,,,,,,,,,"VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK","Homo sapiens","INSR","insulin receptor subunit beta","1","3BU5"
"3BU6",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"28% PEG8000 
0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.1388",,"3BU6",36.83,"1.95","1.95","Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB phosphopeptide","VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK","Homo sapiens","INSR","insulin receptor subunit beta","1","3BU6"
,,,,,,,,,,,,,,,,"AYNPYPEDYGDIEIG",,,"Insulin receptor substrate 2","2","3BU6"
"3BUC",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG 8000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature06889",,"3BUC",31.35,"2.59","2.59","X-ray structure of human ABH2 bound to dsDNA with Mn(II) and 2KG","CTGTATAACTGCG",,,"DNA (5'-D(*DCP*DTP*DGP*DTP*DAP*DTP*(MA7)P*DAP*DCP*DTP*DGP*DCP*DG)-3')","1","3BUC"
,,,,,,,,,,,,,,,,"TCGCAGTTATACA",,,"DNA (5'-D(*DTP*DCP*DGP*DCP*DAP*DGP*DTP*DTP*DAP*DTP*DAP*DCP*DA)-3')","2","3BUC"
,,,,,,,,,,,,,,,,"SWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","3","3BUC"
"3BUF",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, HANGING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.01.032","AEG","3BUF",45.71,"2.3","2.3","BACE-1 complexed with compound 2","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3BUF"
"3BUG",,"X-RAY DIFFRACTION",2.84,56.76,"VAPOR DIFFUSION, HANGING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.01.032","AEH","3BUG",45.72,"2.5","2.5","BACE-1 complexed with compound 3","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","3BUG"
"3BUH",,"X-RAY DIFFRACTION",2.83,56.54,"VAPOR DIFFUSION, HANGING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.01.032","AED","3BUH",45.77,"2.3","2.3","BACE-1 complexed with compound 4","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","beta-secretase 1","1","3BUH"
"3BUR",,"X-RAY DIFFRACTION",2.36,47.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"10-20% WT/VOL PEG 4000; 1O% ISOPROPANOL; 100 MM TRIS PH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M801778200","TES","3BUR",77.84,"1.62","1.62","Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and TESTOSTERONE. RESOLUTION: 1.62 A.","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3BUR"
"3BUV",,"X-RAY DIFFRACTION",2.33,47.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"10-20% wt/vol Peg 4000; 10% isopropanol; 100mM Hepes pH 7.5; 2.0 mM NADP, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M801778200",,"3BUV",76.77,"1.35","1.35","Crystal structure of human Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and HEPES. Resolution: 1.35 A.","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3BUV"
"3BUW",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.12M ammonium acetate, 18% PEG 3350, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1038/emboj.2008.18",,"3BUW",79.47,"1.45","1.45","Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Syk","TVSFNPYEPELAP",,,"13-meric peptide from Tyrosine-protein kinase SYK","1","3BUW"
,,,,,,,,,,,,,,,,"GSLIGLMKDAFQPHHHHHHHLSPHPPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKMETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELKGIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQNPDLTG","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","2","3BUW"
"3BUX",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, HANGING DROP",7,"0.15M malic acid, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/emboj.2008.18",,"3BUX",79.58,"1.35","1.35","Crystal structure of c-Cbl-TKB domain complexed with its binding motif in c-Met","SNESVDYRATFPE",,,"13-meric peptide from Hepatocyte growth factor receptor","1","3BUX"
,,,,,,,,,,,,,,,,"GSLIGLMKDAFQPHHHHHHHLSPHPPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKMETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELKGIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQNPDLTG","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","2","3BUX"
"3BV2",,"X-RAY DIFFRACTION",2.3,46.48,,6,"1-6% (W/V) PEG-4K, 50 MM MES, 5 MM MAGNESIUM SULFATE, pH 6.0",,"10.1016/j.bmcl.2008.02.067","P38","3BV2",42.69,"2.4","2.4","Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3BV2"
"3BV3",,"X-RAY DIFFRACTION",2.3,46.48,,6,"1-6% (W/V) PEG-4K, 50 MM MES, 5 MM MAGNESIUM SULFATE, pH 6.0",,"10.1016/j.bmcl.2008.02.067","P39","3BV3",42.69,"2.59","2.59","Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3BV3"
"3BV7",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein: 5.0 mg/mL AKR1D1, 2.0 mM NADPH, 2.0 mM 5-beta-cholestan-3-one, 10.0 mM Tris (pH 7.4). Precipitant buffer: 0.1 M Tris (pH 7.0), 10-20% (wt/vol) PEG 4000, 10% isopropanol., pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M801778200",,"3BV7",76.62,"1.79","1.79","Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and glycerol. Resolution: 1.79 A.","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3BV7"
"3BV9",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 100 mM Bis/Tris, 200 mM NaI, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1111/j.1538-7836.2008.02937.x",,"3BV9",34.58,"1.8","1.8","Structure of Thrombin Bound to the Inhibitor FM19","EADCGLRPLFEKKSLEDKTERELLESYIDGR",,,"Thrombin light chain","1","3BV9"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3BV9"
,,,,,,,,,,,,,,,,"RXPAFX",,,"FM19 inhibitor","3","3BV9"
"3BVJ",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",8.4,"Ammonium Sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3BVJ",69.12,"1.8","1.8","Crystal Structure of Human Orotidine 5'-monophosphate Decarboxylase Complexed with XMP","MGSSHHHHHHSSGLVPRGSHMDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","3BVJ"
"3BVO",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution (10 mg/mL Se-Met protein, 0.050 M Sodium chloride, 0.0031 M Sodium azide, 0.0003 M TCEP, 0.005 M Bis-Tris pH 7.0) mixed in a 1:1 ratio with the Well solution (16% PEG 3350, 0.050 M Lithium sulfate, 0.10 M PIPES pH 6.5), cryoprotected with 20% PEG 3350, 0.050 M Lithium sulfate, 0.10 M PIPES pH 6.5 in four steps up to 20% Ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M804746200",,"3BVO",49.02,"3","3","Crystal structure of human co-chaperone protein HscB","SAASQAGSNYPRCWNCGGPWGPGREDRFFCPQCRALQAPDPTRDYFSLMDCNRSFRVDTAKLQHRYQQLQRLVHPDFFSQRSQTEKDFSEKHSTLVNDAYKTLLAPLSRGLYLLKLHGIEIPERTDYEMDRQFLIEIMEINEKLAEAESEAAMKEIESIVKAKQKEFTDNVSSAFEQDDFEEAKEILTKMRYFSNIEEKIKLKKIPL","Homo sapiens","HSCB, DNAJC20, HSC20","Co-chaperone protein HscB, mitochondrial precursor","1","3BVO"
"3BWE",,"X-RAY DIFFRACTION",2.76,55.39,"EVAPORATION",,"EVAPORATION",,"10.1074/jbc.M804243200",,"3BWE",141.73,"2.4","2.4","Crystal structure of aggregated form of DJ1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","3BWE"
"3BWF",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M lithium sulfate, 100 mM BisTrisPropane, 20% PEG3350, 10% ethylene glycol, 0.3% DMSO, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/chem.200800294","DWC","3BWF",36.31,"2.35","2.35","Crystal structure of the human Pim1 in complex with an osmium compound","MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3BWF"
"3BWM",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, SITTING DROP",10.5,"Tris, NaCl, MgCL2, DTT, CAPS, Na, K PO4, LiSO4, SAM, DNC, pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2008.04.040",,"3BWM",24.51,"1.98","1.98","Crystal Structure of Human Catechol O-Methyltransferase with bound SAM and DNC","GDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","3BWM"
"3BWY",,"X-RAY DIFFRACTION",2.05,40.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"Tris, NaCl, MgCL2, DTT, HEPES, MPD, SAM, DNC, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2008.04.040",,"3BWY",24.86,"1.3","1.3","Crystal Structure of Human 108M Catechol O-methyltransferase bound with S-adenosylmethionine and inhibitor dinitrocatechol","GDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGMKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGP","Homo sapiens","COMT","COMT protein","1","3BWY"
"3BX5",,"X-RAY DIFFRACTION",2.29,46.27,,,,,"10.1016/j.bmcl.2008.02.031","304","3BX5",42.45,"2.4","2.4","P38 alpha map kinase complexed with BMS-640994","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3BX5"
"3BX8",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, SITTING DROP",5.45,"1.45M ammonium sulphate, 0.1M Na-cacodylate, 0.1% (v/v) Anapoe X-405, pH 5.45, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3BX8",164.25,"2","2","Engineered Human Lipocalin 2 (LCN2), apo-form","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGLAGNRILRDDQHPMNMYATIYELKEDKSYNVTSVISSHKKCEYTIATFVPGSQPGEFTLGNIKSYGDKTSYLVRVVSTDYNQYAVVFFKLAEDNAEFFAITIYGRTKELASELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens",,"ENGINEERED HUMAN LIPOCALIN 2","1","3BX8"
"3BXM",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi900220s",,"3BXM",82.98,"1.71","1.71","Structure of an inactive mutant of human glutamate carboxypeptidase II [GCPII(E424A)] in complex with N-acetyl-Asp-Glu (NAAG)","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3BXM"
,,,,,,,,,,,,,,,,"XDE",,,"N-Acetyl-Aspartyl-Glutamate (NAAG)","2","3BXM"
"3BXW",,"X-RAY DIFFRACTION",4.02,69.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M(NH4)2SO4, 200mM NaCl, 100mM MgCl2, PH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M110.130781",,"3BXW",90.2,"2.7","2.7","Crystal Structure of Stabilin-1 Interacting Chitinase-Like Protein, SI-CLP","MRTLFNLLWLALACSPVHTTLSKSDAKKAASKTLLEKSQFSDKPVQDRGLVVTDLKAESVVLEHRSYCSAKARDRHFAGDVLGYVTPWNSHGYDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDVDQGWMRAVRKHAKGLHIVPRLLFEDWTYDDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLLSQKRVGLIHMLTHLAEALHQARLLALLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMTYDYSTAHQPGPNAPLSWVRACVQVLDPKSKWRSKILLGLNFYGMDYATSKDAREPVVGARYIQTLKDHRPRMVWDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLELARELGVGVSIWELGQGLDYFYDLL","Homo sapiens","CHID1, GL008, PSEC0104, SB139","Chitinase domain-containing protein 1","1","3BXW"
"3BY0",,"X-RAY DIFFRACTION",2.9,57.53,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ja803524w",,"3BY0",69.17,"2.572","2.572","Crystal structure of Siderocalin (NGAL, Lipocalin 2) W79A-R81A complexed with Ferric Enterobactin","MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYAIATFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, NGAL, HNL","Neutrophil gelatinase-associated lipocalin","1","3BY0"
"3BYA",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, SITTING DROP",7,"17-19% PEG 3350, 0.120mM Ammonium Phosphate, 15% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3BYA",19.65,"1.85","1.85","Structure of a Calmodulin Complex","KKKATFRAITSTLASSFKRRRSSK",,,"Glutamate [NMDA] receptor subunit zeta-1 peptide","2","3BYA"
,,,,,,,,,,,,,,,,"ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","3BYA"
"3BYI",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, SITTING DROP",7.4,"2.4M Na malate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3BYI",98.02,"2.25","2.25","Crystal structure of human Rho GTPase activating protein 15 (ARHGAP15)","SMRPSLKTLQEKGLIKDQIFGSHLHKVCERENSTVPWFVKQCIEAVEKRGLDVDGIYRVSGNLATIQKLRFIVNQEEKLNLDDSQWEDIHVVTGALKMFFRELPEPLFPYSFFEQFVEAIKKQDNNTRIEAVKSLVQKLPPPNRDTMKVLFGHLTKIVAKASKNLMSTQSLGIVFGPTLLRAENETGNMAIHMVYQNQIAELMLSEYSKIFGSE","Homo sapiens","ARHGAP15, BM-024, BM-030, BM-046","Rho GTPase activating protein 15","1","3BYI"
"3BYM",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Li2SO4, 25-35% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm701095m","AM0, PTR, AMO","3BYM",32.22,"2","2","X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lck","QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3BYM"
"3BYO",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Li2SO4, 25-35% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm701095m","AM9, PTR","3BYO",32.05,"2","2","X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one 25 bound to Lck","KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3BYO"
"3BYS",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M Sodium Citrate, 20%(v/v) Isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm7010996","AM5","3BYS",32.65,"2.2","2.2","co-crystal structure of Lck and aminopyrimidine amide 10b","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3BYS"
"3BYU",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M Sodium Citrate, 20% (v/v) Isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm7010996","AM6","3BYU",32.66,"2.3","2.3","co-crystal structure of Lck and aminopyrimidine reverse amide 23","QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","3BYU"
"3BYZ",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, HANGING DROP",5.6,"25% PEG3350, 0.1M NaCitrate, 0.2M AmAc, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm701551j","H11","3BYZ",126.06,"2.69","2.69","2-Amino-1,3-thiazol-4(5H)-ones as Potent and Selective 11-Hydroxysteroid Dehydrogenase Type 1 Inhibitors","MHHHHHHEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3BYZ"
"3BZ3",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION",7.5,"15% PEG 8000, 0.1M HEPES, 0.2M (NH4)2SO4, pH 7.5, vapor diffusion, temperature 298K",298,"10.1158/0008-5472.CAN-07-5155","YAM","3BZ3",32.27,"2.2","2.2","Crystal Structure Analysis of Focal Adhesion Kinase with a Methanesulfonamide Diaminopyrimidine Inhibitor","DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","3BZ3"
"3BZH",,"X-RAY DIFFRACTION",1.96,37.23,"VAPOR DIFFUSION, HANGING DROP",9,"2.2M (NH4)2SO4, 0.1M Bis-Tris-Propane pH 9.0, 0.001M DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1074/mcp.O111.013706",,"3BZH",21.58,"1.6","1.6","Crystal structure of human ubiquitin-conjugating enzyme E2 E1","GMSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKNSKLLSTSAKRIQKELADITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFTPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT","Homo sapiens","UBE2E1, UBCH6","Ubiquitin-conjugating enzyme E2 E1","1","3BZH"
"3BZI",,"X-RAY DIFFRACTION",2.01,38.95,"VAPOR DIFFUSION",7.5,"100mM HEPES pH 7.5, 2M ammonium formate, VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.0609131104",,"3BZI",28.55,"2.1","2.1","Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization","ETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3BZI"
,,,,,,,,,,,,,,,,"LLCSTPNGL",,,"9 mer peptide from M-phase inducer phosphatase 3","2","3BZI"
"3BZU",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, SITTING DROP",6.2,"16-18% PEG3350, 0.1 M MES, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 6.2",298,"10.1111/j.1747-0285.2007.00603.x","A21","3BZU",131.6,"2.25","2.25","Crystal structure of human 11-beta-hydroxysteroid dehydrogenase(HSD1) in complex with NADP and thiazolone inhibitor","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3BZU"
"3C0G",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, SITTING DROP",7.2,"12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.02.036",,"3C0G",79.21,"2.19","2.19","CASK CaM-Kinase Domain- 3'-AMP complex, P1 form","GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPTS","Homo sapiens","CASK, LIN2","Peripheral plasma membrane protein CASK","1","3C0G"
"3C0H",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, SITTING DROP",7.2,"12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.02.036",,"3C0H",79.21,"2.3","2.3","CASK CaM-Kinase Domain- AMPPNP complex, P1 form","GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPTS","Homo sapiens","CASK, LIN2","Peripheral plasma membrane protein CASK","1","3C0H"
"3C0I",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, SITTING DROP",7.2,"12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.02.036",,"3C0I",39.6,"1.85","1.85","CASK CaM-Kinase Domain- 3'-AMP complex, P212121 form","GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPTS","Homo sapiens","CASK, LIN2","Peripheral plasma membrane protein CASK","1","3C0I"
"3C0Y",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, SITTING DROP",7.5,"13 % PEG 3350, 0.1 M HEPES pH 7.5, 10 % Isopropanol, 1 mM DTT, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1074/jbc.M707362200",,"3C0Y",137.18,"2.1","2.1","Crystal structure of catalytic domain of human histone deacetylase HDAC7","GSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLAS","Homo sapiens","HDAC7A, HDAC7","Histone deacetylase 7a","1","3C0Y"
"3C0Z",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 % PEG 3350, 0.1 M HEPES pH 7.5, 10 % Isopropanol, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1074/jbc.M707362200","SHH","3C0Z",137.98,"2.1","2.1","Crystal structure of catalytic domain of human histone deacetylase HDAC7 in complex with SAHA","GSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLAS","Homo sapiens","HDAC7A, HDAC7","Histone deacetylase 7a","1","3C0Z"
"3C10",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 % PEG 3350, 0.1 M HEPES pH 7.5, 10 % Isopropanol, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1074/jbc.M707362200","TSN","3C10",138.09,"2","2","Crystal structure of catalytic domain of human histone deacetylase HDAC7 in complex with Trichostatin A (TSA)","GSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLAS","Homo sapiens","HDAC7A, HDAC7","Histone deacetylase 7a","1","3C10"
"3C13",,"X-RAY DIFFRACTION",1.97,37.43,"VAPOR DIFFUSION, SITTING DROP",5.6,"Protein stock solution: 10mg/ml protein in 500mM NaCl, 25mM Tris/HCl, pH 8.5 
Emodin stock solution: 10mM in water
Protein/emodin mixture: equal volumes of protein and emodin stock solutions were mixed and equillibrated for 30 min prior to crystallization
Reservoir: 30% PEG4000, 0.2M ammonium acetate, 0.1M sodium citrate, pH 5.6
Crystallization drop: 2 microliters protein/emodin mixture plus 1 microliter reservoir solution, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2008.01.008","EMO","3C13",40.41,"1.95","1.95","Low pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3C13"
"3C1V",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, SITTING DROP",9.5,"40% PEG600, 0.1M CHES, pH9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2008.04.017",,"3C1V",52.92,"1.5","1.5","The 1.5 A Crystal structure of Ca2+-bound S100A4","MRGSHHHHHHGSMACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGFPDKQPRKK","Homo sapiens","S100A4, CAPL, MTS1","Protein S100-A4","1","3C1V"
"3C1X",,"X-RAY DIFFRACTION",1.78,30.95,,,,,"10.1016/j.bmcl.2008.01.121","CKK","3C1X",42.38,"2.17","2.17","Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-MET in complex with a Pyrrolotriazine based inhibitor","MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3C1X"
"3C22",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, HANGING DROP",7,"400mM MgCl2, 25% PEG 3350, 100mM HEPES pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi802151w",,"3C22",72.1,"1.5","1.5","Crystal structure of the carbohydrate recognition domain of human Langerin","ASWSHPQFEKIEGRMQNDILQVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3C22"
"3C2I",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"26% PEG2000, 0.2M Ammonium acetate, 0.01M Mg acetate, 0.05M Na cacodylate pH6.5, 0.002M DTT, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.molcel.2007.12.028",,"3C2I",23.58,"2.5","2.5","The Crystal Structure of Methyl-CpG Binding Domain of Human MeCP2 in Complex with a Methylated DNA Sequence from BDNF","ASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIMYFEKVGDTSLDPNDFDFTVTGRGSPSRHHHHHH","Homo sapiens","MECP2","Methyl-CpG-binding protein 2","1","3C2I"
,,,,,,,,,,,,,,,,"TCTGGAACGGAATTCTTCTA",,,"DNA (5'-D(*DTP*DCP*DTP*DGP*DGP*DAP*DAP*(5CM)P*DGP*DGP*DAP*DAP*DTP*DTP*DCP*DTP*DTP*DCP*DTP*DA)-3')","2","3C2I"
,,,,,,,,,,,,,,,,"ATAGAAGAATTCCGTTCCAG",,,"DNA (5'-D(*DAP*DTP*DAP*DGP*DAP*DAP*DGP*DAP*DAP*DTP*DTP*DCP*(5CM)P*DGP*DTP*DTP*DCP*DCP*DAP*DG)-3')","3","3C2I"
"3C2K",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole pH 7.5, 350 mM Sodium Acetate, 18% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.molcel.2008.02.025",,"3C2K",48.62,"2.4","2.4","DNA POLYMERASE BETA with a gapped DNA substrate and DUMPNPP with Manganese in the active site","CCGACAGCGCATCAGC",,,"DNA (5'-D(*DCP*DCP*DGP*DAP*DCP*DAP*DGP*DCP*DGP*DCP*DAP*DTP*DCP*DAP*DGP*DC)-3')","1","3C2K"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*DGP*DCP*DTP*DGP*DAP*DTP*DGP*DCP*DGP*DC)-3')","2","3C2K"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*DGP*DTP*DCP*DGP*DG)-3')","3","3C2K"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","3C2K"
"3C2L",,"X-RAY DIFFRACTION",2.26,45.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole pH 7.5, 350 mM Sodium Acetate, 18% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.molcel.2008.02.025","F2A","3C2L",48.53,"2.6","2.6","Ternary complex of DNA POLYMERASE BETA with a C:DAPCPP mismatch in the active site","CCGACCGCGCATCAGC",,,"DNA (5'-D(*DCP*DCP*DGP*DAP*DCP*DCP*DGP*DCP*DGP*DCP*DAP*DTP*DCP*DAP*DGP*DC)-3')","1","3C2L"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*DGP*DCP*DTP*DGP*DAP*DTP*DGP*DCP*DGP*DC)-3')","2","3C2L"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*DGP*DTP*DCP*DGP*DG)-3')","3","3C2L"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","3C2L"
"3C2M",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole pH 7.5, 350 mM Sodium Acetate, 18% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.molcel.2008.02.025","F2A","3C2M",48.84,"2.15","2.15","Ternary complex of DNA POLYMERASE BETA with a G:dAPCPP mismatch in the active site","CCGACGGCGCATCAGC",,,"DNA (5'-D(*DCP*DCP*DGP*DAP*DCP*DGP*DGP*DCP*DGP*DCP*DAP*DTP*DCP*DAP*DGP*DC)-3')","1","3C2M"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*DGP*DCP*DTP*DGP*DAP*DTP*DGP*DCP*DGP*DC)-3')","2","3C2M"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*DGP*DTP*DCP*DGP*DG)-3')","3","3C2M"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","3C2M"
"3C2S",,"X-RAY DIFFRACTION",2.74,55.18,"VAPOR DIFFUSION",8,"5% PEG 3350, 200 mM Zn Acetate, 0.1 M Imidazole Malate, 5% Glycerol, pH 8.0, VAPOR DIFFUSION, temperature 298.0K",298,"10.1107/S0907444908007877",,"3C2S",27.3,"2.3","2.3","Structural Characterization of a Human Fc Fragment Engineered for Lack of Effector Functions","THTCPPCPAPEFEGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPASIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","IGHM protein","1","3C2S"
"3C39",,"X-RAY DIFFRACTION",2,38.6,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.6M NaKPO4, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkn212","3PG","3C39",90.28,"1.85","1.85","Crystal Structure of human phosphoglycerate kinase bound to 3-phosphoglycerate","GSHMSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","3C39"
"3C3A",,"X-RAY DIFFRACTION",2.05,40.01,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.6M NaKPO4, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkn212","3PG","3C3A",90.73,"2.3","2.3","Crystal Structure of human phosphoglycerate kinase bound to 3-phosphoglycerate and L-ADP","GSHMSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","3C3A"
"3C3B",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.6M NaKPO4, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkn212",,"3C3B",90.5,"1.8","1.8","Crystal Structure of human phosphoglycerate kinase bound to D-CDP","GSHMSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","3C3B"
"3C3C",,"X-RAY DIFFRACTION",2.04,39.73,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.6M NaKPO4, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkn212","3PG","3C3C",90.71,"2.4","2.4","Crystal Structure of human phosphoglycerate kinase bound to 3-phosphoglycerate and L-CDP","GSHMSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","3C3C"
"3C3O",,"X-RAY DIFFRACTION",2.75,55.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"15% PEG 8,000, 100mM Na MES pH 6.5, 200mM Na Acetate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0801567105",,"3C3O",44.35,"2.15","2.15","ALIX Bro1-domain:CHMIP4A co-crystal structure","MHHHHHHHHHHSGQNLYFQGHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMV","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","3C3O"
,,,,,,,,,,,,,,,,"DEEALKQLAEWVS",,,"Charged multivesicular body protein 4a peptide","2","3C3O"
"3C3Q",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"15% PEG 8,000, 100mM Na MES pH 6.5, 200mM Na Acetate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0801567105",,"3C3Q",44.99,"2.1","2.1","ALIX Bro1-domain:CHMIP4B co-crystal structure","MHHHHHHHHHHSGQNLYFQGHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMV","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","3C3Q"
,,,,,,,,,,,,,,,,"KEEEDDDMKELENWAGSM",,,"Charged multivesicular body protein 4b peptide","2","3C3Q"
"3C3R",,"X-RAY DIFFRACTION",2.77,55.66,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% PEG 2,000, 100mM Na MES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0801567105",,"3C3R",44.3,"2.02","2.02","ALIX BRO1 CHMP4C complex","MHHHHHHHHHHSGQNLYFQGHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMV","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","3C3R"
,,,,,,,,,,,,,,,,"EDDDIKQLAAWAT",,,"Charged multivesicular body protein 4c peptide","2","3C3R"
"3C3S",,"X-RAY DIFFRACTION",2.61,52.81,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Imidzole, 100mM Malic Acid, 3.0M Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi7024518",,"3C3S",44.65,"2.5","2.5","Role of a Glutamate Bridge Spanning the Dimeric Interface of Human Manganese Superoxide Dismutase","KHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWAHAYYLQYKNVRPDYLKAIWNVINWENVTERYMACKK","Homo sapiens","SOD2","Superoxide dismutase [Mn]","1","3C3S"
"3C3T",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Imidazole, 100mM Malic Acid, 3.0M Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi7024518",,"3C3T",44.74,"2.2","2.2","Role of a Glutamate Bridge Spanning the Dimeric Interface of Human Manganese Superoxide Dismutase","KHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWDHAYYLQYKNVRPDYLKAIWNVINWENVTERYMACKK","Homo sapiens","SOD2","Superoxide dismutase [Mn]","1","3C3T"
"3C3U",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 25% Polyglycol monomethylether 550, 0.01M Zinc sulphate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm8003575","C2U","3C3U",37.86,"1.8","1.8","Crystal structure of AKR1C1 in complex with NADP and 3,5-dichlorosalicylic acid","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWCNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAVEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C1, DDH, DDH1","Aldo-keto reductase family 1 member C1","1","3C3U"
"3C43",,"X-RAY DIFFRACTION",2.99,59,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2008.02.050","315","3C43",175.02,"2.3","2.3","Human dipeptidyl peptidase IV/CD26 in complex with a flouroolefin inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","3C43"
"3C45",,"X-RAY DIFFRACTION",2.99,59.05,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2008.02.050","317","3C45",175.03,"2.05","2.05","Human dipeptidyl peptidase IV/CD26 in complex with a fluoroolefin inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","3C45"
"3C49",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, HANGING DROP",7,"1.9 M DL-Malic acid, 0.1 M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm900052j","KU8","3C49",40.13,"2.8","2.8","Human poly(ADP-ribose) polymerase 3, catalytic fragment in complex with an inhibitor KU0058948","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly(ADP-ribose) polymerase 3","1","3C49"
"3C4C",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION, HANGING DROP",6,"100mM BisTris at pH 6.0, 12.5% 2,5-hexanediol, and 12% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1073/pnas.0711741105","324","3C4C",64.58,"2.57","2.57","B-Raf Kinase in Complex with PLX4720","RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","B-Raf proto-oncogene serine/threonine-protein kinase","1","3C4C"
"3C4E",,"X-RAY DIFFRACTION",3.6,65.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"NA ACETATE, IMIDAZOLE, PH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0711741105","C4E","3C4E",127.18,"1.98","1.98","Pim-1 Kinase Domain in Complex with 3-aminophenyl-7-azaindole","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3C4E"
"3C4F",,"X-RAY DIFFRACTION",2.71,54.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"16% PEG10k, 0.3M (NH4)2SO4, 5% Ethylene Glycol, 100 mM Bis-Tris pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0711741105","C4F","3C4F",69.45,"2.07","2.07","FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole","ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, FGFBR, FLG, FLT2, BFGFR, CEK, HBGFR","Basic fibroblast growth factor receptor 1","1","3C4F"
"3C4H",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, HANGING DROP",7,"1.9 M DL-Malic acid, 0.1 M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm900052j","DRL","3C4H",40.01,"2.1","2.1","Human poly(ADP-ribose) polymerase 3, catalytic fragment in complex with an inhibitor DR2313","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly(ADP-ribose) polymerase 3","1","3C4H"
"3C59",,"X-RAY DIFFRACTION",4.08,69.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl pH 8.5, 0.1M MgCl2, 0.4M MgTartrate, 9mM n-Decyl-beta-D-thiomaltoside, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M708740200",,"3C59",18.31,"2.3","2.3","Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain","RPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLY","Homo sapiens","Glucagon-like peptide-1 receptor(GLP1R), GLP1R","Glucagon-like peptide 1 receptor","1","3C59"
,,,,,,,,,,,,,,,,"DLSKQMEEEAVRMFIEWLKNGGPSSGAPPPS",,,"Exendin-4","2","3C59"
"3C5C",,"X-RAY DIFFRACTION",1.86,33.88,"VAPOR DIFFUSION",8.5,"0.1 M Tris-HCl pH 8.5, 28% PEG 4000, 0.2 M Magnesium chloride. In situ proteolysis with 1:100 endoproteinase Glu-C V8, VAPOR DIFFUSION, temperature 291K",291,,,"3C5C",87.66,"1.85","1.85","Crystal structure of human Ras-like, family 12 protein in complex with GDP","MHHHHHHSSGRENLYFQGPLEVNLAILGRRGAGKSALTVKFLTKRFISEYDPNLEDTYSSEETVDHQPVHLRVMDTADLDTPRNCERYLNWAHAFLVVYSVDSRQSFDSSSSYLELLALHAKETQRSIPALLLGNKLDMAQYRQVTKAEGVALAGRFGCLFFEVSACLDFEHVQHVFHEAVREARRE","Homo sapiens","RASL12, RIS","RAS-like protein 12","1","3C5C"
"3C5E",,"X-RAY DIFFRACTION",2.64,53.4,,5.5,"17% PEG 10000, 0.1M Ammonium acetate, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2009.03.064",,"3C5E",64.18,"1.6","1.6","Crystal structure of human acyl-CoA synthetase medium-chain family member 2A (L64P mutation) in complex with ATP","MGHHHHHHSSGVDLGTENLYFQSMSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRPPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRADDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVVKAFVVLASQFLSHDPEQLTKELQQHVKSVTAPYKYPRKIEFVLNLPKTVTGKIQRAKLRDKEWKMSGKARAQ","Homo sapiens","ACSM2A, ACSM2, MACS2","Acyl-coenzyme A synthetase ACSM2A, mitochondrial precursor","1","3C5E"
"3C5F",,"X-RAY DIFFRACTION",3.5,64.89,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M ammonium acetate, 100 mM Hepes, pH 7 and 10% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/embor.2008.33",,"3C5F",87.6,"2.25","2.25","Structure of a binary complex of the R517A Pol lambda mutant","CGGCCGTACTG",,,"DNA (5'-D(*DCP*DGP*DGP*DCP*DCP*DGP*DTP*DAP*DCP*DTP*DG)-3')","1","3C5F"
,,,,,,,,,,,,,,,,"CAGTAC",,,"DNA (5'-D(*DCP*DAP*DGP*DTP*DAP*DC)-3')","2","3C5F"
,,,,,,,,,,,,,,,,"GCCG",,,"DNA (5'-D(P*DGP*DCP*DCP*DG)-3')","3","3C5F"
,,,,,,,,,,,,,,,,"MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMAALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","4","3C5F"
"3C5G",,"X-RAY DIFFRACTION",3.49,64.71,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M KCl, 10 mM MgCl2, 50 mM Tris-HCl, pH 8.5 and 30% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/embor.2008.33",,"3C5G",88.81,"2.2","2.2","Structure of a ternary complex of the R517K Pol lambda mutant","MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMKALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3C5G"
,,,,,,,,,,,,,,,,"CGGCAATACTG",,,"DNA (5'-D(*DCP*DGP*DGP*DCP*DAP*DAP*DTP*DAP*DCP*DTP*DG)-3')","2","3C5G"
,,,,,,,,,,,,,,,,"CAGTAT",,,"DNA (5'-D(*DCP*DAP*DGP*DTP*DAP*(2DT))-3')","3","3C5G"
,,,,,,,,,,,,,,,,"GCCG",,,"DNA (5'-D(P*DGP*DCP*DCP*DG)-3')","4","3C5G"
"3C5H",,"X-RAY DIFFRACTION",2.63,53.25,,,"Native crystal, used for model refinement: 26% PEG 4000, 0.1M Tris-HCl, 0.2M Magnesium chloride, 0.1mM DTT, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",,,,"3C5H",29.52,"1.8","1.8","Crystal structure of the Ras homolog domain of human GRLF1 (p190RhoGAP)","MHHHHHHSSGRENLYFQGTYNISVVGLSGTEKEKGQCGIGKSCLCNRFVRPSADEFHLDHTSVLSTSDFGGRVVNNDHFLYWGEVSRSLEDCVECKMHIVEQTEFIDDQTFQPHRSTALQPYIKRAAATKLASAEKLMYFCTDQLGLEQDFEQKQMPDGKLLVDGFLLGIDVSRGMNRNFDDQLKFVSNLYNQLAKTKKPIVVVLTKCDEGVERYIRDAHTFALSKKNLQVVETSARSNVNVDLAFSTLVQLIDK","Homo sapiens","GRLF1, GRF1, KIAA1722, ARHGAP35, P190A, p190ARHOGAP","Glucocorticoid receptor DNA-binding factor 1","1","3C5H"
,,,,,,,"Seleno-methionine derivative crystal, used for MAD phasing: 33% PEG 4000, 0.1M Tris-HCl, 0.2M Magnesium chloride, 0.1mM DTT, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K. A ten-fold excess of GppNHp was added to the protein samples prior to crystallization."
"3C5K",,"X-RAY DIFFRACTION",2.09,41.23,"VAPOR DIFFUSION, SITTING DROP",7,"3.5M Na formate, 100mM Bis-tris propane pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3C5K",12.36,"1.55","1.55","Crystal structure of human HDAC6 zinc finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPHPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","3C5K"
"3C5L",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",6,"PEG3350, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.1628",,"3C5L",26.21,"2.33","2.33","Polo-like kinase 1 Polo box domain in complex with PPHSpT peptide","HLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3C5L"
,,,,,,,,,,,,,,,,"PPHST",,,"Peptide","2","3C5L"
"3C5N",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 8000, 10 mM myo-inositol 1,4,5 trisphosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3C5N",57.31,"1.8","1.8","Structure of human TULP1 in complex with IP3","PREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGYSTNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYRYPLCALQAFAIALSSFD","Homo sapiens","TULP1, TUBL1","Tubby-related protein 1","1","3C5N"
"3C5R",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 Mg Chloride, 0.1 M Tris Hydrochloride pH 8.5, 25% w/v PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M802333200",,"3C5R",29.95,"2","2","Crystal Structure of the BARD1 Ankyrin Repeat Domain and Its Functional Consequences","GIDPFTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESSSAS","Homo sapiens","BARD1","BRCA1-associated RING domain protein 1","1","3C5R"
"3C5T",,"X-RAY DIFFRACTION",4.12,70.18,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl pH 8.5, 0.1M MgCl2, 0.4M MgTartrate, 9mM n-Decyl-beta-D-thiomaltoside, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M708740200",,"3C5T",18.2,"2.1","2.1","Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain","RPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLY","Homo sapiens","Glucagon-like peptide-1 receptor(GLP1R), GLP1R","Glucagon-like peptide 1 receptor","1","3C5T"
,,,,,,,,,,,,,,,,"DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS",,,"Exendin-4","2","3C5T"
"3C5U",,"X-RAY DIFFRACTION",4.32,71.55,,,,,"10.1016/j.bmcl.2008.02.011","P41","3C5U",42.81,"2.8","2.8","P38 ALPHA map kinase complexed with a benzothiazole based inhibitor","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3C5U"
"3C5V",,"X-RAY DIFFRACTION",2.57,52.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"26% v/v Jeffamine-2001, 200mM sodium chloride, 5mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.cell.2008.02.041",,"3C5V",34.74,"2","2","PP2A-specific methylesterase apo form (PME)","RDFSPVPWSQYFESMEDVEVENETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAIISRVQCRIVALDLRSHGETKVKNPEDLSAETMAKDVGNVVEAMYGDLPPPIMLIGHSMGGAIAVHTASSNLVPSLLGLCMIDVVEGTAMDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGSKKDHPYTWRIELAKTEKYWDGWFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHAVHEDAPDKVAEAVATFLIRHRFAEPIGGFQCVFPGC","Homo sapiens","PPME1, PME1","Protein phosphatase methylesterase 1","1","3C5V"
,,,,,,,,,,,,,,,,,"Homo sapiens","PPME1, PME1"
"3C6G",,"X-RAY DIFFRACTION",3.89,68.35,"VAPOR DIFFUSION",6.5,"1.1M Ammonium sulfate, 0.1M ADA, pH 6.5, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.jmb.2008.03.065",,"3C6G",114.59,"2.8","2.8","Crystal structure of CYP2R1 in complex with vitamin D3","MAKKTKQRRPMGFPPGPPGLPFIGNIYSLAASSELPHVYMRKQSQVYGEIFSLDLGGISTVVLNGYDVVKECLVHQSEIFADRPCLPLFMKMTKMGGLLNSRYGRGWVDHRRLAVNSFRYFGYGQKSFESKILEETKFFNDAIETYKGRPFDFKQLITNAVSNITNLIIFGERFTYEDTDFQHMIELFSENVELAASASVFLYNAFPWIGILPFGKHQQLFRNAAVVYDFLSRLIEKASVNRKPQLPQHFVDAYLDEMDQGKNDPSSTFSKENLIFSVGELIIAGTETTTNVLRWAILFMALYPNIQGQVQKEIDLIMGPNGKPSWDDKCKMPYTEAVLHEVLRFCNIVPLGIFHATSEDAVVRGYSIPKGTTVITNLYSVHFDEKYWRDPEVFHPERFLDSSGYFAKKEALVPFSLGRRHCLGEHLARMEMFLFFTALLQRFHLHFPHELVPDLKPRLGMTLQPQPYLICAERRHHHH","Homo sapiens","CYP2R1","Cytochrome P450 2R1","1","3C6G"
"3C6K",,"X-RAY DIFFRACTION",2.54,51.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 20000, 0.1 M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M710323200","MTA","3C6K",173.78,"1.95","1.95","Crystal structure of human spermine synthase in complex with spermidine and 5-methylthioadenosine","MGSSHHHHHHSSGLVPRGSRHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP","Homo sapiens","SMS","Spermine synthase","1","3C6K"
"3C6M",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 3350, 0.1 M NaCl, 0.1 M Bis-Tris pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M710323200","MTA","3C6M",174.01,"2.45","2.45","Crystal structure of human spermine synthase in complex with spermine and 5-methylthioadenosine","MGSSHHHHHHSSGLVPRGSRHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP","Homo sapiens","SMS","Spermine synthase","1","3C6M"
"3C6W",,"X-RAY DIFFRACTION",2.01,38.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6 M Sodium Citrate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.15K",291.15,"10.1002/prot.22140",,"3C6W",16.55,"1.75","1.75","Crystal structure of the ING5 PHD finger in complex with H3K4me3 peptide","LVCRGSNEPTYCLCHQVSYGEMIGCDNPDCPIEWFHFACVDLTTKPKGKWFCPRCVQEK","Homo sapiens","ING5","Inhibitor of growth protein 5","1","3C6W"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"H3K4me3 histone peptide","2","3C6W"
"3C7I",,"X-RAY DIFFRACTION",1.77,30.4,"VAPOR DIFFUSION, HANGING DROP",5,"LIGAND (FPTVN) was added in a 1.5 molar excess to 15 MG/ML GRB2-SH2 in pure water. 
This solution was mixed with an equal volume of 4.0 m sodium formate., pH 5.00, VAPOR DIFFUSION, HANGING DROP, temperature 293KK",293,"10.1002/anie.200600844","TVN","3C7I",14.26,"1.7","1.7","X-RAY crystal structure of the complex between the grb2-sh2 domain and a flexible ligand, FPTVN.","IEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQHHHHHH","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","3C7I"
"3C7P",,"X-RAY DIFFRACTION",2.07,40.45,"VAPOR DIFFUSION, HANGING DROP",8.4,"2.6M Ammonium Sulphate, 0.3M Sodium Chloride, 0.1M Tris-HCl pH 8.4, 5mM mercury para-hydroxybenzoate , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1158/1535-7163.MCT-08-0195","POF, CL","3C7P",30.27,"1.7","1.7","Crystal structure of human carbonic anhydrase II in complex with STX237","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3C7P"
"3C7Q",,"X-RAY DIFFRACTION",2.38,48.25,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M HEPES, 2.1M Ammonium Sulphate, 3% PEG MME 550, 10mM Beta-Mercaptoethanol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1158/0008-5472.CAN-07-6307","XIN","3C7Q",37.58,"2.1","2.1","Structure of VEGFR2 kinase domain in complex with BIBF1120","GSMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3C7Q"
"3C7X",,"X-RAY DIFFRACTION",2.19,43.4,"VAPOR DIFFUSION, SITTING DROP",6,"2.1M malic acid, 0.1M HCl, 40% acetone, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M110.178434",,"3C7X",23.19,"1.7","1.7","Hemopexin-like domain of matrix metalloproteinase 14","PNICDGNFDTVAMLRGEMFVFKERWFWRVRNNQVMDGYPMPIGQFWRGLPASINTAYERKDGKFVFFKGDKHWVFDEASLEPGYPKHIKELGRGLPTDKIDAALFWMPNGKTYFFRGNKYYRFNEELRAVDSEYPKNIKVWEGIPESPRGSFMGSDEVFTYFYKGNKYWKFNNQKLKVEPGYPKSALRDWMGCPSG","Homo sapiens","MMP14","Matrix metalloproteinase-14","1","3C7X"
"3C8X",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, SITTING DROP",5.5,"AN IN-SITU PROTEOLYSIS STRATEGY WAS USED TO GENERATE HIGH QUALITY CRYSTALS. TRYPSIN WAS ADDED FROM A 1.5 GRAM/L STOCK TO A PROTEIN SAMPLE (AT 6.2 GRAM/L) TO A FINAL TRYPSIN CONC OF 6.2 MICROGRAM/L BEFORE CRYSTAL PLATES WERE SET AT 291.2K. 25% PEG 3350, 0.1 M AMMONIUM SULFATE, 0.1 M BIS-TRIS PH 5.5. PARATONE-N WAS USED AS THE CRYOPROTECTANT, VAPOR DIFFUSION, SITTING DROP",291.2,"10.1073/pnas.1004148107",,"3C8X",23.57,"1.95","1.95","Crystal structure of the ligand binding domain of human Ephrin A2 (Epha2) receptor protein kinase","APEHHHHHHDYDIPTTENLYFQGAMDAAQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCP","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","3C8X"
"3C9E",,"X-RAY DIFFRACTION",2.8,56.08,"VAPOR DIFFUSION, HANGING DROP",4.5,"Cathepsin K:chondroitin sulfate complex was made at 1:1 ratio. Precipitant contained
30% MPD, 0.1M sodium acetate buffer, 20mM calcium chloride, pH 4.5, VAPOR DIFFUSION, 
HANGING DROP, temperature 295K, VAPOR DIFFUSION, HANGING DROP",295,"10.1016/j.jmb.2008.07.038","E64","3C9E",25.32,"1.8","1.8","Crystal structure of the cathepsin K : chondroitin sulfate complex.","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","3C9E"
"3C9Q",,"X-RAY DIFFRACTION",2.6,52.73,,,"Protein solution (10 mg/mL Se-Met protein, 0.050 M Sodium chloride, 0.003 M Sodium azide, 0.0003 M TCEP, Bis-Tris pH 7.0) mixed in a 1:1 ratio with the Well solution (1% Ethylene glycol, 1.8 M Ammonium sulfate, 0.10 M MES pH 6.0). Cryoprotected in four stages with well solution using 0 to 25 % ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3C9Q",24.85,"1.5","1.5","Crystal structure of the uncharacterized human protein C8orf32 with bound peptide","SEGNGPAAVHYQPASPPRDACVYSSCYCEENVWKLCEYIKNHDQYPLEECYAVFISNERKMIPIWKQQARPGDGPVIWDYHVVLLHVSSGGQSFIYDLDTVLPFPCLFDTYVEDAIKSDDDIHPQFRRKFRVICADSYLKNFASDRSHMKDSSGNWREPPPPYPCIETGDSKMNLNDFISMDPKVGWGAVYTLSEFTHRFGSKNC","Homo sapiens","C8orf32, NTAQ1, WDYHV1","Uncharacterized protein C8orf32","1","3C9Q"
,,,,,,,,,,,,,,,,"STA",,,"Synthetic peptide","2","3C9Q"
"3CA2",,"X-RAY DIFFRACTION",2.16,42.94,,,,,"10.1002/prot.340040407",,"3CA2",30,"2","2","CRYSTALLOGRAPHIC STUDIES OF INHIBITOR BINDING SITES IN HUMAN CARBONIC ANHYDRASE II. A PENTACOORDINATED BINDING OF THE SCN-ION TO THE ZINC AT HIGH P*H","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE II","1","3CA2"
"3CAA",,"X-RAY DIFFRACTION",2.75,55,,5.6,"10% PEG MONOMETHYLETHER 5000 0.2 M MAGNESIUM ACETATE 0.1 M SODIUM CITRATE PH 5.6 PROTEIN AT 3 MG/ML",,"10.1021/bi972359e",,"3CAA",42.97,"2.4","2.4","CLEAVED ANTICHYMOTRYPSIN A347R","THVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTERSAATAVKITLL","Homo sapiens","ACT, SERPINA3, AACT, GIG24, GIG25","ANTICHYMOTRYPSIN","1","3CAA"
,,,,,,,,,,,,,,,,"VETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA","Homo sapiens","ACT, SERPINA3, AACT, GIG24, GIG25","ANTICHYMOTRYPSIN","2","3CAA"
"3CAF",,"X-RAY DIFFRACTION",2.73,54.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"20%(w/v) PEG3350, 0.1M (NH3)2SO4, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3CAF",11.61,"1.96","1.96","Crystal Structure of hFGFR2 D2 Domain","NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVV","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","3CAF"
"3CAJ",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5M ammonium sulphate, 0.3M sodium chloride, 0.1M Tris-HCl, 1mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2008.03.023","EZL, CL","3CAJ",30.06,"1.8","1.8","Crystal structure of the human carbonic anhydrase II in complex with ethoxzolamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3CAJ"
"3CAQ",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG-4000 20%, 0.1M Tris, 5% MPD, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi801276h","NDP","3CAQ",76.93,"2.2","2.2","Crystal structure of 5beta-reductase (AKR1D1) in complex with NADPH","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3CAQ"
"3CAS",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, SITTING DROP",7.7,"PEG-4000 21%, 0.1M Tris, MPD 5% CaCl2 0.05M, pH 7.7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi801276h",,"3CAS",77.37,"2","2","Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 4-androstenedione","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3CAS"
"3CAV",,"X-RAY DIFFRACTION",2.46,50.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG-4000 20%, 0.1M NaCaco, 0.2M NaCitrate, 0.5M (NH4)2SO4, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi800572s",,"3CAV",77.44,"1.9","1.9","Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-pregnan-3,20-dione","MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3CAV"
"3CB2",,"X-RAY DIFFRACTION",2.16,42.97,"VAPOR DIFFUSION",7.2,"top solution: 83 mM HEPES pH 7.2, 1.2M KCl, 20% PEG6000, 1mM GDP; 
reservoir: 83mM HEPES pH 7.2, 0.6M KCl, 20% PEG6000, 1 mM GDP.
Protein was mixed 1:1 or 1:2 with top solution, and equilibrated over the reservoir solution., VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.0801155105",,"3CB2",108.97,"2.303","2.303","Crystal structure of human gamma-tubulin bound to GDP","MPREIITLQLGQCGNQIGFEFWKQLCAEHGISPEAIVEEFATEGTDRKDVFFYQADDEHYIPRAVLLDLEPRVIHSILNSPYAKLYNPENIYLSEHGGGAGNNWASGFSQGEKIHEDIFDIIDREADGSDSLEGFVLCHSIAGGTGSGLGSYLLERLNDRYPKKLVQTYSVFPNQDEMSDVVVQPYNSLLTLKRLTQNADCLVVLDNTALNRIATDRLHIQNPSFSQINQLVSTIMSASTTTLRYPGYMNNDLIGLIASLIPTPRLHFLMTGYTPLTTDQSVASVRKTTVLDVMRRLLQPKNVMVSTGRDRQTNHCYIAILNIIQGEVDPTQVHKSLQRIRERKLANFIPWGPASIQVALSRKSPYLPSAHRVSGLMMANHTSISSLFERTCRQYDKLRKREAFLEQFRKEDMFKDNFDEMDTSREIVQQLIDEYHAATRPDYISWGTQEQVDVDGGQKLISEEDLLLEHHHHHH","Homo sapiens","TUBG1, TUBG","tubulin gamma-1 chain","1","3CB2"
"3CBB",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, HANGING DROP",4.8,"26% PEG 4000, 80mM Magnesium acetate, 50mM Sodium citrate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M806213200",,"3CBB",31.26,"2","2","Crystal Structure of Hepatocyte Nuclear Factor 4alpha in complex with DNA: Diabetes Gene Product","ALCAICGDRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVDKDKRNQCRYCRLKKCFRAGMKKEAVQNERD","Homo sapiens","HNF4A, HNF4, NR2A1, TCF14","Hepatocyte Nuclear Factor 4-alpha, DNA binding domain","3","3CBB"
,,,,,,,,,,,,,,,,"TGAAGTCCAAAGTTCAGTCCC",,,"Hepatocyte Nuclear Factor 4-alpha promoter element DNA","1","3CBB"
,,,,,,,,,,,,,,,,"AGGGACTGAACTTTGGACTTC",,,"Hepatocyte Nuclear Factor 4-alpha promoter element DNA","2","3CBB"
"3CBC",,"X-RAY DIFFRACTION",2.89,57.39,"VAPOR DIFFUSION, HANGING DROP",4.5,"Ammonium sulfate, Sodium Chloride, Lithium Sulfate, Sodium Acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ja803524w",,"3CBC",69.34,"2.17","2.17","Crystal structure of Siderocalin (NGAL, Lipocalin 2) Y106F complexed with Ferric Enterobactin","MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSFLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3CBC"
"3CBL",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.1M Na Malate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2008.07.047",,"3CBL",44.81,"1.75","1.75","Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide","SMIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR","Homo sapiens","FES, FPS","Proto-oncogene tyrosine-protein kinase Fes/Fps","1","3CBL"
,,,,,,,,,,,,,,,,"XIYESL",,,"Synthetic peptide","2","3CBL"
"3CBO",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION",8,"40-42.5% PEG3350, 100 mM Tris, pH 8.0, VAPOR DIFFUSION",,"10.1016/j.molcel.2008.03.022","SAH","3CBO",30.44,"1.65","1.65","SET7/9-ER-AdoHcy complex","KDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQK","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","3CBO"
,,,,,,,,,,,,,,,,"IKRSKKNSLA",,,"Estrogen receptor","2","3CBO"
"3CBP",,"X-RAY DIFFRACTION",2.21,44.38,,8,"40-42.5% PEG3350, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, pH 8.00",,"10.1016/j.molcel.2008.03.022","SFG","3CBP",30.42,"1.42","1.42","Set7/9-ER-Sinefungin complex","KDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQK","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","3CBP"
,,,,,,,,,,,,,,,,"IKRSKKNSLA",,,"Estrogen receptor","2","3CBP"
"3CBQ",,"X-RAY DIFFRACTION",1.72,28.39,"VAPOR DIFFUSION",,"20% PEG 3350, 0.2M KCl, VAPOR DIFFUSION, temperature 291K",291,,,"3CBQ",22.57,"1.82","1.82","Crystal structure of the human REM2 GTPase with bound GDP","MHHHHHHSSGRENLYFQGQKDGIFKVMLVGESGVGKSTLAGTFGGLQGDSAHEPENPEDTYERRIMVDKEEVTLVVYDIWEQGDAGGWLRDHCLQTGDAFLIVFSVTDRRSFSKVPETLLRLRAGRPHHDLPVILVGNKSDLARSREVSLEEGRHLAGTLSCKHIETSAALHHNTRELFEGAVRQIRLRRGRNHA","Homo sapiens","REM2, GI:134105571","GTP-binding protein REM 2","1","3CBQ"
"3CBR",,"X-RAY DIFFRACTION",2.09,41.09,"VAPOR DIFFUSION, HANGING DROP",3.5,"5-7 mg/ml protein, 0.1 M sodium acetate, 20 % PEG 3350, 0.3-0.5 M ammonium sulfate equilibrated against 2.0M ammonium sulfate, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.jmb.2008.07.029",,"3CBR",27.55,"1.7","1.7","Crystal structure of human Transthyretin (TTR) at pH3.5","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CBR"
"3CBS",,"X-RAY DIFFRACTION",2.47,50.22,,8.5,"20% MONOMETHYL PEG 5000 
0.2 M TRIS-HCL 
0.2 M LICL 
, pH 8.5",,"10.1107/s0907444999011026","R12","3CBS",15.89,"2","2","CELLULAR RETINOIC ACID BINDING PROTEIN II IN COMPLEX WITH A SYNTHETIC RETINOIC ACID (RO-12 7310)","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTRVYVRE","Homo sapiens","CRABP2","PROTEIN (CRABP-II)","1","3CBS"
"3CBX",,"X-RAY DIFFRACTION",2.25,45.42,,4.8,"60% 2-Methyl-2,4-pentanediol, 0.1 M sodium acetate, pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/nchembio.152",,"3CBX",23.12,"1.7","1.7","The Dvl2 PDZ Domain in Complex with the C1 Inhibitory Peptide","GSHMNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKSGGGWKWYGWF","Homo sapiens","DVL2","Dishevelled-2","1","3CBX"
"3CBY",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M tri-sodium citrate, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/nchembio.152",,"3CBY",23.37,"1.5","1.5","The Dvl2 PDZ Domain in Complex with the N1 Inhibitory Peptide","GSHMNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKSGGGWKDYGWIDGK","Homo sapiens","DVL2","Dishevelled-2","1","3CBY"
"3CBZ",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, 0.8 M sodium phosphate, 0.8 M Potassium phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/nchembio.152",,"3CBZ",11.64,"1.38","1.38","The Dvl2 PDZ Domain in Complex with the N2 Inhibitory Peptide","GSHMNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKSGGGSGNEVWIDGP","Homo sapiens","DVL2","Dishevelled-2","1","3CBZ"
"3CC0",,"X-RAY DIFFRACTION",1.99,38.04,,7,"1.0 M Ammonium citrate tribasic, 0.1 M BIS-TRIS propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/nchembio.152",,"3CC0",34.44,"1.75","1.75","The Dvl2 PDZ Domain in Complex with the N3 Inhibitory Peptide","GSHMNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKSGGGGEIVLWSDIP","Homo sapiens","DVL2","Dishevelled-2","1","3CC0"
"3CC6",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.05M Magnesium chloride, 0.1M Bis-tris, 17.5% PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3CC6",32.64,"1.6","1.6","Crystal structure of kinase domain of protein tyrosine kinase 2 beta (PTK2B)","SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein tyrosine kinase 2 beta","1","3CC6"
"3CCB",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION, SITTING DROP",7.8,"22.5% PEG 2000mme, 0.1M Bicine, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.02.071","B2Y, BY2","3CCB",348.61,"2.49","2.49","Crystal Structure of Human DPP4 in complex with a benzimidazole derivative","ADPGGSHHHHHHSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3CCB"
"3CCC",,"X-RAY DIFFRACTION",2.71,54.53,"VAPOR DIFFUSION, SITTING DROP",7.8,"22.5% PEG 2000mme, 0.1M Bicine, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.02.071","7AC","3CCC",348.64,"2.71","2.71","Crystal Structure of Human DPP4 in complex with a benzimidazole derivative","ADPGGSHHHHHHSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3CCC"
"3CCK",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3400, 0.1M Arginine.HCl, 10mM CaCl2, 1mM NaN3, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1111/j.1742-4658.2008.06683.x",,"3CCK",27.72,"1.8","1.8","Human CD69","VSSCSEDWVGYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREEHWVGLKKEPGHPWKWSNGKEFNNWFNVTGSDKCVFLKNTEVSSMECEKNLYWICNKPYK","Homo sapiens","CD69, CLEC2C","Early activation antigen CD69","1","3CCK"
"3CCN",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION",7.8,"0.1M HEPES pH 7.8, 15% PEG 4K, 6% 2-Propanol, 40mM BME, and 3% Ethanol., VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm800043g","LKG","3CCN",35.65,"1.9","1.9","X-ray structure of c-Met with triazolopyridazine inhibitor.","MQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3CCN"
"3CCT",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","3HI","3CCT",192.22,"2.12","2.12","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CCT"
"3CCW",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","4HI","3CCW",191.91,"2.1","2.1","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CCW"
"3CCZ",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","5HI","3CCZ",192.41,"1.7","1.7","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CCZ"
"3CD0",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","6HI","3CD0",191.98,"2.4","2.4","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CD0"
"3CD3",,"X-RAY DIFFRACTION",2.36,47.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG MME 2000, 0.15M Sodium bromide, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2008.07.047",,"3CD3",44.96,"1.98","1.98","Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide","SMIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR","Homo sapiens","FES, FPS","Proto-oncogene tyrosine-protein kinase Fes/Fps","1","3CD3"
,,,,,,,,,,,,,,,,"XIYESL",,,"Synthetic peptide","2","3CD3"
"3CD4",,"X-RAY DIFFRACTION",2.5,50.76,,,,,"10.1006/jmbi.1993.1625",,"3CD4",20.2,"2.2","2.2","REFINEMENT AND ANALYSIS OF THE FIRST TWO DOMAINS OF HUMAN CD4","KKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKA","Homo sapiens","CD4","T CELL SURFACE GLYCOPROTEIN CD4","1","3CD4"
"3CD5",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","7HI","3CD5",192.38,"2.39","2.39","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CD5"
"3CD7",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","882","3CD7",192.22,"2.05","2.05","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CD7"
"3CD8",,"X-RAY DIFFRACTION",2.03,39.44,"VAPOR DIFFUSION",7.8,"0.1M HEPES pH 7.8, 15% PEG 4K, 6% 2-Propanol, 40mM BME, and 3% Ethanol, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm800043g","L5G","3CD8",35.73,"2","2","X-ray Structure of c-Met with triazolopyridazine Inhibitor.","MQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3CD8"
"3CDA",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","8HI","3CDA",192.47,"2.07","2.07","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CDA"
"3CDB",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, HANGING DROP",8,"protein 15-20 mg/ml, Ligand (saturated),PEG 4000, MgCl2 0.2M, Tris-HCL pH8 0.1M, 7-10 days, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm7015057","9HI","3CDB",192.54,"2.3","2.3","Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","3CDB"
"3CDC",,"X-RAY DIFFRACTION",3.16,61.11,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.1 M sodium citrate in 0.1 M Tris buffer, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M804822200",,"3CDC",23.89,"1.53","1.53","kI O18/O8 N34I/Y87H immunoglobulin light chain variable domain","STDIQMTQSPSSLSASVGDRVTITCQASQDISNYLIWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYHCQQYDNLPYTFGQGTKLEIK","Homo sapiens","kI O18/O8 germline, IGKV1-33","Light Chain Amyloidogenic","1","3CDC"
"3CDF",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION, HANGING DROP",8.1,"1.2 M sodium citrate in 0.1 M Tris buffer, pH 8.1, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M804822200",,"3CDF",71.68,"1.53","1.53","kI O18/O8 Y87H immunoglobulin light chain variable domain","STDIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYHCQQYDNLPYTFGQGTKLEIK","Homo sapiens","kI O18/O8 germline, IGKV1-33","IMMUNOGLOBULIN LIGHT CHAIN","1","3CDF"
"3CDP",,"X-RAY DIFFRACTION",2.55,51.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15mM Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2012.01.025","YRG","3CDP",65.34,"2.8","2.8","Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3CDP"
"3CDS",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15mM Tris, pH 8.000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm800733h","GRR","3CDS",65.33,"2.65","2.65","Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3CDS"
"3CDY",,"X-RAY DIFFRACTION",3.15,60.98,"VAPOR DIFFUSION, HANGING DROP",8.3,"30% w/v polyethylene glycol 4000 and 0.2 M Li2SO4 in 0.1 M Tris buffer, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M804822200",,"3CDY",23.99,"2.43","2.43","AL-09 H87Y, immunoglobulin light chain variable domain","STDIQMTQSPSSLSASVGDRVTITCQASQDINNYLIWYQQKPGQAPKLLIYDASTLETGVPSRFSGSGSGTEFTFTISSLQPEDLATYYCQQYDNLPYTFGQGTKLEIK","Homo sapiens","kI O18/O8 germline, IGKV1-33","IMMUNOGLOBULIN LIGHT CHAIN","1","3CDY"
"3CDZ",,"X-RAY DIFFRACTION",4.75,74.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 10% EtOH, 7% PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2008.03.001",,"3CDZ",167.25,"3.98","3.98","Crystal structure of human factor VIII","ATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRSFSQNPPVLKRHQR","Homo sapiens","F8, F8C","Coagulation factor VIII heavy chain","1","3CDZ"
,,,,,,,,,,,,,,,,"EITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFLTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY","Homo sapiens","F8, F8C","Coagulation factor VIII light chain","2","3CDZ"
"3CE0",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, HANGING DROP",7,"1.9 M DL-Malic acid, 0.1 M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm900052j","P34","3CE0",40.05,"2.8","2.8","Human poly(ADP-ribose) polymerase 3, catalytic fragment in complex with an inhibitor PJ34","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly [ADP-ribose] polymerase 3","1","3CE0"
"3CE3",,"X-RAY DIFFRACTION",2.38,48.26,,7.1,"12% MEPEG 5000, 0.1M HEPES, 11% 2-PROPANOL., pH 7.1",,"10.1021/jm800476q","1FN","3CE3",35.89,"2.4","2.4","Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a Pyrrolopyridinepyridone based inhibitor","GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3CE3"
"3CE4",,"X-RAY DIFFRACTION",2.73,54.88,,7.5,"50% saturated ammonium sulfate, 4% isopropanol, 0.1M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi8014423",,"3CE4",38.46,"1.55","1.55","Structure of Macrophage Migration Inhibitory Factor Covalently Inhibited by PMSF Treatment","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","3CE4"
"3CEG",,"X-RAY DIFFRACTION",3.35,63.3,,10,"11 % PEG 8000, 0.1 M Gycine buffer pH 10.0, 0.001 M DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/mcp.O111.013706",,"3CEG",74.11,"2.008","2.008","Crystal structure of the UBC domain of baculoviral IAP repeat-containing protein 6","ANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLAQEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSILNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHFYLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPD","Homo sapiens","BIRC6, KIAA1289","Baculoviral IAP repeat-containing protein 6","1","3CEG"
"3CEH",,"X-RAY DIFFRACTION",2.93,57.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"7 mg/ml in 20 mM BES, 1 mM EDTA, 0.5 mM DTT, pH 6.5, 50 mM NBG, 2.5 mM AVE5688, VAPOR DIFFUSION, HANGING DROP",,"10.1021/bi702397d",,"3CEH",188.33,"2.8","2.8","Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688","NVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSD","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3CEH"
"3CEJ",,"X-RAY DIFFRACTION",2.87,57.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"VAPOR DIFFUSION, HANGING DROP, 7 mg/ml in 20 mM BES, 1 mM EDTA, 0.5 mM DTT, pH 6.5, 50 mM NBG, 2.5 mM AVF (AVE2865)",,"10.1021/bi702397d",,"3CEJ",187.98,"3.3","3.3","Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865","NVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSD","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3CEJ"
"3CEK",,"X-RAY DIFFRACTION",2.91,57.68,"VAPOR DIFFUSION, SITTING DROP",6.4,"55% PEG 300, 0.25M NaCl, Na/K Phosphate pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nchembio.345",,"3CEK",36.74,"2.3","2.3","Crystal structure of human dual specificity protein kinase (TTK)","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1L1, MPS1","Dual specificity protein kinase TTK","1","3CEK"
"3CEM",,"X-RAY DIFFRACTION",2.96,58.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"7 mg/ml in 20 mM BES, 1 mM EDTA, 0.5 mM DTT, pH 6.5, 50 mM NBG, 2.5 mM AVD (AVE9423), VAPOR DIFFUSION, HANGING DROP",,"10.1021/bi702397d","AVD","3CEM",188.07,"2.47","2.47","Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423","NVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSD","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3CEM"
"3CEN",,"X-RAY DIFFRACTION",2.54,51.51,"VAPOR DIFFUSION, HANGING DROP",5.5,"200 mM Sodium Acetate, pH 5.5, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2008.03.092","FXA","3CEN",32.52,"1.6","1.6","Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","COAGULATION FACTOR X, HEAVY CHAIN","1","3CEN"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","COAGULATION FACTOR X, LIGHT CHAIN","2","3CEN"
"3CEQ",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, SITTING DROP",6.6,"1.46 M Ammonium Sulfate, 0.2 M Sodium Acetate, 0.1 M Bis-Tris pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3CEQ",63.99,"2.75","2.75","The TPR domain of Human Kinesin Light Chain 2 (hKLC2)","MGSSHHHHHHSSGLVPRGSAVPLCKQALEDLEKTSGHDHPDVATMLNILALVYRDQNKYKEAAHLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKFHPDVAKQLSNLALLCQNQGKAEEVEYYYRRALEIYATRLGPDDPNVAKTKNNLASCYLKQGKYQDAETLYKEILTRAHEKEFGSVNGDNKPIWMHAEEREESKDKRRDSAPYGEYGSWYKACKVDSPTVNTTLRSLGALYRRQGKLEAAHTLEDCASRNRK","Homo sapiens","KLC2","Kinesin light chain 2","1","3CEQ"
"3CEY",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",5.6,"10% PEG 3350, 0.1M NaAcetate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1093/nar/gkp086",,"3CEY",108.69,"2.2","2.2","Crystal structure of L3MBTL2","MHHHHHHSSGRENLYFQGTGQDALVLGFDWGKFLKDHSYKAAPVSCFKHVPLYDQWEDVMKGMKVEVLNSDAVLPSRVYWIASVIQTAGYRVLLRYEGFENDASHDFWCNLGTVDVHPIGWCAINSKILVPPRTIHAKFTDWKGYLMKRLVGSRTLPVDFHIKMVESMKYPFRQGMRLEVVDKSQVSRTRMAVVDTVIGGRLRLLYEDGDSDDDFWCHMWSPLIHPVGWSRRVGHGIKMSERRSDMAHHPTFRKIYCDAVPYLFKKVRAVYTEGGWFEEGMKLEAIDPLNLGNICVATVCKVLLDGYLMICVDGGPSTDGLDWFCYHASSHAIFPATFCQKNDIELTPPKGYEAQTFNWENYLEKTKSKAAPSRLFNMDCPNHGFKVGMKLEAVDLMEPRLICVATVKRVVHRLLSIHFDGWDSEYDQWVDCESPDIYPVGWCELTGYQLQPPVAAEPATPLKAKEATKKKKKQ","Homo sapiens","L3MBTL2","Lethal(3)malignant brain tumor-like 2 protein","1","3CEY"
"3CFM",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"Mother liquor: 100 mM tris pH 7.5, 100 mM KCl, 20 % v/v PEG 400; drop 1 uL mother liquor + 1 uL TTR 10 mg/mL; crystals appeared in about 5 days, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmc.2009.11.025",,"3CFM",25.92,"1.6","1.6","Crystal structure of the apo form of human wild-type transthyretin","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CFM"
"3CFN",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"mother liquor: 100 mM Tris, pH 7.5, 100 mM KCl, 20 % v/v PEG 400; drop consisting of 1 uL mother liquor and 1 uL wtTTR 10 mg/mL; crystals appeared in about 5 days; complex obtained by soaking in mother liquor supplemented with saturating amount of ligand., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmc.2009.11.025","2AN","3CFN",26.52,"1.87","1.87","Crystal structure of human transthyretin in complex with 1-anilino-8-naphthalene sulfonate","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CFN"
"3CFQ",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"mother liquor: 100 mM Tris, pH7.5, 100 mM KCl, 20 % v/v PEG400; drop: 1 uL mother liquor + 1 uL wtTTR 10 mg/mL; crystals appeared in 5 days; complexes obtained by soaking in mother liquor supplemented with saturating amount of diclofenac, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmc.2009.11.025","DIF","3CFQ",26.52,"2.09","2.09","Crystal structure of human wild-type transthyretin in complex with diclofenac","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CFQ"
"3CFT",,"X-RAY DIFFRACTION",2.26,45.64,,,,,"10.1016/j.bmc.2009.11.025","5NS","3CFT",26.59,"1.87","1.87","Crystal structure of human transthyretin in complex with 1-amino-5-naphthalene sulfonate","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CFT"
"3CFV",,"X-RAY DIFFRACTION",2.72,54.72,"VAPOR DIFFUSION, HANGING DROP",6.3,"13% PEG 2000, 0.2M Ca acetate, 0.1M Na Cacodylate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.05.006",,"3CFV",98.57,"2.6","2.6","Structural basis of the interaction of RbAp46/RbAp48 with histone H4","HMAMASKEMFEDTVEERVINEEYKIWKKNTPFLYDLVMTHALQWPSLTVQWLPEVTKPEGKDYALHWLVLGTHTSDEQNHLVVARVHIPNDDAQFDASHCDSDKGEFGGFGSVTGKIECEIKINHEGEVNRARYMPQNPHIIATKTPSSDVLVFDYTKHPAKPDPSGECNPDLRLRGHQKEGYGLSWNSNLSGHLLSASDDHTVCLWDINAGPKEGKIVDAKAIFTGHSAVVEDVAWHLLHESLFGSVADDQKLMIWDTRSNTTSKPSHLVDAHTAEVNCLSFNPYSEFILATGSADKTVALWDLRNLKLKLHTFESHKDEIFQVHWSPHNETILASSGTDRRLNVWDLSKIGEEQSAEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQIWQMAENIYNDE","Homo sapiens","RBBP7, RBAP46","Histone-binding protein RBBP7","1","3CFV"
,,,,,,,,,,,,,,,,"DNIQGITKPAIRRLARRG",,,"Histone H4 peptide","2","3CFV"
"3CFW",,"X-RAY DIFFRACTION",3.8,67.61,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.17 M Sodium acetate trihydrate, 0.085 M Tris-HCl, pH 8.5, 25.5 % w/v PEG 4000,15% v/v Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M116.767186",,"3CFW",20.38,"2.2","2.2","L-selectin lectin and EGF domains","WTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPNNKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINNYTCNCDVGYYGPQCQFVQVDPRLID","Homo sapiens","L-selectin, SELL, LNHR, LYAM1","L-selectin","1","3CFW"
"3CGA",,"X-RAY DIFFRACTION",2.57,48.8,,8.5,"20% (w/v) PEG 3350 and 100 mM Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 8.50",298,"10.1016/j.jmb.2008.04.076",,"3CGA",23.65,"2.03","2.03","Crystal structure of metastasis-associated protein S100A4 in the active, calcium-bound form","MACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGFPDKQPRKK","Homo sapiens","S100A4, CAPL, MTS1","Protein S100-A4","1","3CGA"
"3CGF",,"X-RAY DIFFRACTION",2.36,47.9,,7,"pH7.0",,"10.1016/j.bmcl.2008.04.039","JNF","3CGF",42.42,"3","3","IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3CGF"
"3CGO",,"X-RAY DIFFRACTION",2.36,47.9,,7,"pH7.0",,"10.1016/j.bmcl.2008.04.039","JNO","3CGO",42.48,"3","3","IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3CGO"
"3CH4",,"X-RAY DIFFRACTION",1.89,34.77,"VAPOR DIFFUSION, SITTING DROP",7.6,"15-20% (v/v) Pentaerythritol ethoxylate (15/4 EO/OH), 15% (v/v) MPD, 0.1M Hepes, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1002/prot.22151",,"3CH4",23.67,"1.76","1.76","The Crystal Structure of Human Phosphomavelonate Kinase At 1.8 A Resolution","GSMAPLGGAPRLVLLFSGKRKSGKDFVTEALQSRLGADVCAVLRLSGPLKEQYAQEHGLNFQRLLDTSTYKEAFRKDMIRWGEEKRQADPGFFCRKIVEGISQPIWLVSDTRRVSDIQWFREAYGAVTQTVRVVALEQSRQQRGWVFTPGVDDAESECGLDNFGDFDWVIENHGVEQRLEEQLENLIEFIRSRLKLHHHHHH","Homo sapiens","PMVK, PMKI","Phosphomevalonate kinase","1","3CH4"
"3CH6",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2008.04.069","311","3CH6",129.66,"2.35","2.35","Crystal Structure of 11beta-HSD1 Double Mutant (L262R, F278E) Complexed with (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3CH6"
"3CH8",,"X-RAY DIFFRACTION",2.93,58,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% isopropanol, 0.1M HEPES, 0.2M MgCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2009.07.067",,"3CH8",21.95,"1.9","1.9","The crystal structure of PDZ-Fibronectin fusion protein","GSPELGFSISGGVGGRGNPFRPDDDGIFVTRVQPEGPASKLLQPGDKIIQANGYSFINIEHGQAVSLLKTFQNTVELIIVREVGNGAKQEIRVRVEKDGGSGGVSSVPTNLEVVAATPTSLLISWDAYRELPVSYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYAHYNYHYYSSPISINYRT","Homo sapiens","ERBIN, ERBB2IP, KIAA1225, LAP2","fusion protein PDZ-Fibronectin","1","3CH8"
,,,,,,,,,,,,,,,,"PQPVDSWV",,,"C-terminal octapeptide from protein ARVCF","2","3CH8"
"3CHO",,"X-RAY DIFFRACTION",2.45,49.76,"LIQUID DIFFUSION",8,"PEG 8000, SODIUM ACETATE, IMIDEAZOLE PH 6.8, YBCL2, BESTATIN, LIQUID DIFFUSION, TEMPERATURE 298K, pH 8.00",298,"10.1016/j.bmc.2008.03.042","4BG","3CHO",69.79,"1.8","1.8","Crystal structure of leukotriene a4 hydrolase in complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-acetamide","PEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3CHO"
"3CHP",,"X-RAY DIFFRACTION",2.73,55,"LIQUID DIFFUSION",8,"PEG 8000, SODIUM ACETATE, IMIDEAZOLE PH 6.8, YBCL2, BESTATIN, LIQUID DIFFUSION, TEMPERATURE 298K, pH 8.00",298,"10.1016/j.bmc.2008.03.042","4BO","3CHP",69.91,"2.1","2.1","Crystal structure of leukotriene a4 hydrolase in complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid","PEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3CHP"
"3CHQ",,"X-RAY DIFFRACTION",2.78,55.72,"LIQUID DIFFUSION",8,"PEG 8000, SODIUM ACETATE, IMIDEAZOLE PH 6.8, YBCL2, BESTATIN, LIQUID DIFFUSION, TEMPERATURE 298K,pH 8.00",298,"10.1016/j.bmc.2008.03.042","4BQ","3CHQ",70.21,"2.09","2.09","Crystal structure of leukotriene a4 hydrolase in complex with N5-[4-(phenylmethoxy)phenyl]-L-glutamine","PEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3CHQ"
"3CHR",,"X-RAY DIFFRACTION",2.69,54.31,"LIQUID DIFFUSION",8,"PEG 8000, SODIUM ACETATE, IMIDEAZOLE PH 6.8, YBCL2, BESTATIN, LIQUID DIFFUSION, TEMPERATURE 298K, pH 8.00",298,"10.1016/j.bmc.2008.03.042","4BS","3CHR",69.82,"2.2","2.2","Crystal structure of leukotriene A4 hydrolase in complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-butanamide","PEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3CHR"
"3CHS",,"X-RAY DIFFRACTION",2.72,54.81,"LIQUID DIFFUSION",8,"PEG 8000, SODIUM ACETATE, IMIDEAZOLE PH 6.8, YBCL2, BESTATIN, PH 8.0, LIQUID DIFFUSION, TEMPERATURE 298K, pH 8.00",298,"10.1016/j.bmc.2008.03.042","4BU","3CHS",70.24,"2.55","2.55","Crystal structure of leukotriene A4 hydrolase in complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-phenyl-ethoxy]phenyl]amino]-5-oxo-pentanoic acid","PEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3CHS"
"3CI9",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.7M Ammonium Sulfate,15%(v/v) Glycerol, 20mM Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/prot.22216",,"3CI9",10.96,"1.8","1.8","Crystal Structure of the human HSBP1","PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA","Homo sapiens","HSBP1, HSF1BP","Heat shock factor-binding protein 1","1","3CI9"
"3CIB",,"X-RAY DIFFRACTION",2.93,58.06,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2008.04.050","314","3CIB",88.36,"1.72","1.72","Structure of BACE Bound to SCH727596","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3CIB"
"3CIC",,"X-RAY DIFFRACTION",2.89,57.5,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2008.04.050","316","3CIC",88.39,"1.75","1.75","Structure of BACE Bound to SCH709583","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3CIC"
"3CID",,"X-RAY DIFFRACTION",2.89,57.46,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2008.04.050","318","3CID",88.52,"1.8","1.8","Structure of BACE Bound to SCH726222","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3CID"
"3CIQ",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, SITTING DROP",7.4,"28% PEG 3350, 200 mM ammonium tartrate dibasic, pH 7.40, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1038/nsmb.1483",,"3CIQ",143.57,"2.9","2.9","A regulatable switch mediates self-association in an immunoglobulin fold","MIQRTPKIQVYSRFPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","3CIQ"
"3CJF",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm800566m","SAV","3CJF",36.28,"2.15","2.15","Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine","MDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3CJF"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3CJG",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm800566m",,"3CJG",36.06,"2.25","2.25","Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine","MDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3CJG"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3CJJ",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Na cacodylate, 0.2M Zn acetate, 11% PEG 8000, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.str.2010.05.017",,"3CJJ",24.33,"1.85","1.85","Crystal structure of human rage ligand-binding domain","MAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQL","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","3CJJ"
"3CJO",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, HANGING DROP",8,"PEG3350, Potassium Phosphate, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm800386y","K30","3CJO",83.67,"2.28","2.28","Crystal structure of KSP in complex with inhibitor 30","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","3CJO"
"3CJW",,"X-RAY DIFFRACTION",1.81,32.12,"hanging drop",5.6,"1.5M Imidazole, pH 5.6, hanging drop, temperature 293K",293,"10.1371/journal.pbio.0060227",,"3CJW",27.31,"1.48","1.48","Crystal structure of the human COUP-TFII ligand binding domain","GSNSHSYLSGYISLLLRAEPYPTSRFGSQCMQPNNIMGIENICELAARMLFSAVEWARNIPFFPDLQITDQVALLRLTWSELFVLNAAQCSMPLHVAPLLAAAGLHASPMSADRVVAFMDHIRIFQEQVEKLKALHVDSAEYSCLKAIVLFTSDACGLSDVAHVESLQEKSQCALEEYVRSQYPNQPTRFGKLLLRLPSLRTVSSSVIEQLFFVRLVGKTPIETLIRDMLLSGSSFNWPYMAIQ","Homo sapiens","NR2F2, ARP1, TFCOUP2","COUP transcription factor 2","1","3CJW"
"3CKH",,"X-RAY DIFFRACTION",2.91,57.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG4000, 16% isopropanol, 0.1M Hepes, pH7.5, vapor diffusion, hanging drop, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1074/jbc.M804114200",,"3CKH",41.69,"2.8","2.8","Crystal structure of Eph A4 receptor","NEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKAPLTVR","Homo sapiens","EPHA4, HEK8, SEK, TYRO1","Ephrin type-A receptor 4","1","3CKH"
"3CKK",,"X-RAY DIFFRACTION",2.39,48.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.0 M Ammonium sulfate, 2% PEG 400, 0.1 M Na HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,,"3CKK",27.53,"1.55","1.55","Crystal structure of human methyltransferase-like protein 1","GDHTLRYPVKPEEMDWSELYPEFFAPLTQNQSHDDPKDKKEKRAQAQVEFADIGCGYGGLLVELSPLFPDTLILGLEIRVKVSDYVQDRIRALRAAPAGGFQNIACLRSNAMKHLPNFFYKGQLTKMFFLFPDPHFKRTKHKWRIISPTLLAEYAYVLRVGGLVYTITDVLELHDWMCTHFEEHPLFERVPLEDLSEDPVVGHLGTSTEEGKKVLRNGGKNFPAIFRRIQDPVLQ","Homo sapiens","METTL1, C12orf1","tRNA (guanine-N(7)-)-methyltransferase","1","3CKK"
"3CKL",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, SITTING DROP",6,"17% PEG 3350, 0.1M Ammonium sulfate, 0.001M DTT, 0.1M Bis-Tris pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3CKL",71.5,"2","2","Crystal structure of human cytosolic sulfotransferase SULT1B1 in complex with PAP and resveratrol","GSMLSPKDILRKDLKLVHGYPMTCAFASNWEKIEQFHSRPDDIVIATYPKSGTTWVSEIIDMILNDGDIEKCKRGFITEKVPMLEMTLPGLRTSGIEQLEKNPSPRIVKTHLPTDLLPKSFWENNCKMIYLARNAKDVSVSYYHFDLMNNLQPFPGTWEEYLEKFLTGKVAYGSWFTHVKNWWKKKEEHPILFLYYEDMKENPKEEIKKIIRFLEKNLNDEILDRIIHHTSFEVMKDNPLVNYTHLPTTVMDHSKSPFMRKGTAGDWKNYFTVAQNEKFDAIYETEMSKTALQFRTEI","Homo sapiens","SULT1B1, ST1B2, SULT1B2","Sulfotransferase family cytosolic 1B member 1","1","3CKL"
"3CKP",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION, SITTING DROP",,"vapor diffusion, sitting drop",,"10.1016/j.bmcl.2008.03.081","012","3CKP",139.73,"2.3","2.3","Crystal structure of BACE-1 in complex with inhibitor","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3CKP"
"3CKR",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",,"vapor diffusion, sitting drop",,"10.1016/j.bmcl.2008.03.081","009","3CKR",139.59,"2.7","2.7","Crystal structure of BACE-1 in complex with inhibitor","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3CKR"
"3CKW",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION",8.5,"22% PEG 4000, 100 mM Tris-HCl, 200 mM Sodium acetate, pH 8.5, VAPOR DIFFUSION, temperature 292K",292,,,"3CKW",34.97,"1.96","1.96","Crystal structure of sterile 20-like kinase 3 (MST3, STK24)","MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAEEGHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","3CKW"
"3CKX",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION",8.5,"22% PEG 4000, 100 mM Tris-HCl, 200 mM Sodium acetate, pH 8.5, VAPOR DIFFUSION, temperature 292K",292,,,"3CKX",35.12,"2.7","2.7","Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine","MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAEEGHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","3CKX"
"3CLD",,"X-RAY DIFFRACTION",2.9,57.59,"VAPOR DIFFUSION, HANGING DROP",7,"100mM BisTrisPropane, 2.2M NaCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm800279t","GW6","3CLD",64.01,"2.84","2.84","Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate","KENALLRYLLDK",,,"Tif2 coactivator motif","2","3CLD"
,,,,,,,,,,,,,,,,"GSVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","3CLD"
"3CLX",,"X-RAY DIFFRACTION",2.6,52.68,,8.3,"15% PEG 8000, pH 8.3, VAPOR DIFFUSION, temperature 293K, pH 8.30",293,"10.1016/j.jmb.2008.09.064","X22","3CLX",61.92,"2.7","2.7","Crystal structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac005","MASMTGGQQMGRGSSDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTT","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","3CLX"
"3CLY",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH7.5, 26% PEG 4000, 200 mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0807752105",,"3CLY",39.01,"2","2","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQ","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","3CLY"
"3CLZ",,"X-RAY DIFFRACTION",3.25,61.84,"VAPOR DIFFUSION, HANGING DROP",7,"12 % PEG 1500, 0.1 M BIS-TRIS, 0.2 M NACL, 0.001 M TCEP, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature07273",,"3CLZ",124.45,"2.2","2.2","The set and ring associated (SRA) domain of UHRF1 bound to methylated DNA","MPSNHYGPIPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTGSGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVKGGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKKLGLTMQYPEGYLEALANAHHHHHH","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","3CLZ"
,,,,,,,,,,,,,,,,"GGGCCCGCAGGG",,,"5'-D(*DGP*DGP*DGP*DCP*DCP*(5CM)P*DGP*DCP*DAP*DGP*DGP*DG)-3'","2","3CLZ"
,,,,,,,,,,,,,,,,"CCCTGCGGGCCC",,,"5'-D(*DCP*DCP*DCP*DTP*DGP*DCP*DGP*DGP*DGP*DCP*DCP*DC)-3'","3","3CLZ"
"3CM2",,"X-RAY DIFFRACTION",3.22,61.85,"VAPOR DIFFUSION",8.5,"12% PEG 10K, 10% glycerol, 0.1M NaCl, pH 8.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2008.09.064","X23","3CM2",152.32,"2.5","2.5","Crystal Structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac010","MASMTGGQQMGRGSSDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTT","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","3CM2"
"3CM7",,"X-RAY DIFFRACTION",3.18,61.36,"VAPOR DIFFUSION",8.4,"15% PEG 8000, pH 8.4, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2008.09.064","X22","3CM7",61.92,"3.1","3.1","Crystal Structure of XIAP-BIR3 domain in complex with Smac-mimetic compuond, Smac005","MASMTGGQQMGRGSSDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTT","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","3CM7"
"3CMF",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION",7,"Isopropanol, Peg 4000, Tris-HCl, pH 7.0, VAPOR DIFFUSION, temperature 277K",277,"10.1074/jbc.M801778200",,"3CMF",81.4,"1.9","1.9","Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and CORTISONE. Resolution 1.90 A.","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3CMF"
"3CMP",,"X-RAY DIFFRACTION",2.9,57.59,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.2M Ammonium sulfate, 30% PEG4000, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3CMP",70.16,"2.8","2.8","Crystal structure of Siderocalin (NGAL, Lipocalin 2) K125A mutant complexed with Ferric Enterobactin","MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKAVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3CMP"
"3CMQ",,"X-RAY DIFFRACTION",2.44,49.69,"VAPOR DIFFUSION, HANGING DROP",7,"2 mM DTT, 100 mM Bis-Tris Propane,1.8 M Na-acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.str.2008.03.020",,"3CMQ",49.02,"2.2","2.2","Crystal structure of human mitochondrial phenylalanine tRNA synthetase","MAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF","Homo sapiens","FARS2, FARS1, HSPC320","Phenylalanyl-tRNA synthetase, mitochondrial","1","3CMQ"
"3CMY",,"X-RAY DIFFRACTION",1.94,36.53,"VAPOR DIFFUSION, SITTING DROP",7.6,"19-22% polyethylene glycol 8000, 100 mM ammonium sulphate, 20mM magnesium chloride, 15% 2-methyl-2,4-pentanediol, 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi802052y",,"3CMY",16.16,"1.95","1.95","Structure of a homeodomain in complex with DNA","GQRRSRTTFTAEQLEELERAFERTHYPDIYTREELAQRAKLTEARVQVWFSNRRARWRKQA","Homo sapiens","PAX3, HUP2","Paired box protein Pax-3","1","3CMY"
,,,,,,,,,,,,,,,,"ACATAATCGATTAC",,,"5'-D(*DAP*DCP*DAP*DTP*DAP*DAP*DP*DCP*DGP*DAP*DTP*DTP*DAP*DC)-3'","2","3CMY"
,,,,,,,,,,,,,,,,"TGTAATCGATTATG",,,"5'-D(*DTP*DGP*DTP*DAP*DAP*DTP*DCP*DGP*DAP*DTP*DTP*DAP*DTP*DG)-3'","3","3CMY"
"3CN0",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 
and co-crystallized at room temperature using the vapor diffusion sitting 
drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol 
at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M 
sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, 
temperature 298.0K",298,"10.1021/jm800435s","LJ1","3CN0",28,"1.52","1.52","Human transthyretin (TTR) in complex with 3,5-Dimethyl-4-hydroxystilbene","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CN0"
"3CN1",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, 
at pH 7.6 and co-crystallized at room temperature using the vapor 
diffusion sitting drop method. Crystals were grown from 1.395 M 
sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were 
frozen using a cryo-protectant solution of 1.395 M sodium citrate, 
pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, 
temperature 298.0K",298,"10.1021/jm800435s",,"3CN1",28.26,"1.52","1.52","Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxystilbene","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CN1"
"3CN2",,"X-RAY DIFFRACTION",2.16,42.99,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, 
at pH 7.6 and co-crystallized at room temperature using the vapor 
diffusion sitting drop method. Crystals were grown from 1.395 M 
sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were 
frozen using a cryo-protectant solution of 1.395 M sodium citrate, 
pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, 
temperature 298.0K",298,"10.1021/jm800435s",,"3CN2",28.21,"1.52","1.52","Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxybiphenyl","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CN2"
"3CN3",,"X-RAY DIFFRACTION",2.14,42.48,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, 
at pH 7.6 and co-crystallized at room temperature using the vapor 
diffusion sitting drop method. Crystals were grown from 1.395 M 
sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were 
frozen using a cryo-protectant solution of 1.395 M sodium citrate, 
pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, 
temperature 298.0K",298,"10.1021/jm800435s",,"3CN3",28.24,"1.8","1.8","Human transthyretin (TTR) in complex with 1,3-Dibromo-2-hydroxy-5-phenoxybenzene","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CN3"
"3CN4",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, 
at pH 7.6 and co-crystallized at room temperature using the vapor 
diffusion sitting drop method. Crystals were grown from 1.395 M 
sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen 
using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, 
containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, 
temperature 298.0K",298,"10.1021/jm800435s",,"3CN4",28.3,"1.4","1.4","Human transthyretin (TTR) in complex with N-(3,5-Dibromo-4-hydroxyphenyl)benzamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CN4"
"3CNK",,"X-RAY DIFFRACTION",2.89,57.47,,8.2,"0.1M Tris, 30% PEG 3350, 0.2M Lithium Sulfate, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH 8.20",293,"10.1002/prot.22336",,"3CNK",19.58,"1.65","1.65","Crystal Structure of the dimerization domain of human filamin A","KVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGHEHIPGSPYRVVVP","Homo sapiens","FLNA, FLN, FLN1","Filamin-A","1","3CNK"
"3CO1",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.04M potassium phosphate, 16% PEG 8000, 20% glycerol anhydrous, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1083/jcb.200807179",,"3CO1",15.4,"1.4","1.4","Crystal structure of microtubule binding domain of human EB3","GSMAVNVYSTSVTSENLSRHDMLAWVNDSLHLNYTKIEQLCSGAAYCQFMDMLFPGCVHLRKVKFQAKLEHEYIHNFKVLQAAFKKMGVDKIIPVEKLVKGKFQDNFEFIQWFKKFFDANYDGKDYNPLLAR","Homo sapiens","MAPRE3","Microtubule-associated protein RP/EB family member 3","1","3CO1"
"3CO6",,"X-RAY DIFFRACTION",3.04,59.56,"VAPOR DIFFUSION, HANGING DROP",7.9,"22% PEG 4000, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.06.013",,"3CO6",21.1,"2.1","2.1","Crystal Structure of FoxO1 DBD Bound to DBE1 DNA","TGGTTTGTTTACCTTG",,,"DNA (5'-D(*DTP*DGP*DGP*DTP*DTP*DTP*DGP*DTP*DTP*DTP*DAP*DCP*DCP*DTP*DTP*DG)-3')","1","3CO6"
,,,,,,,,,,,,,,,,"CAAGGTAAACAAACCA",,,"DNA (5'-D(*DCP*DAP*DAP*DGP*DGP*DTP*DAP*DAP*DAP*DCP*DAP*DAP*DAP*DCP*DCP*DA)-3')","2","3CO6"
,,,,,,,,,,,,,,,,"SKSSSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKS","Homo sapiens","FOXO1, FKHR, FOXO1A","Forkhead box protein O1","3","3CO6"
"3CO7",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6.4,"21% PEG 4000, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.06.013",,"3CO7",45.89,"2.91","2.91","Crystal Structure of FoxO1 DBD Bound to DBE2 DNA","TCTTGTTTACATTTTG",,,"DNA (5'-D(*DTP*DCP*DTP*DTP*DGP*DTP*DTP*DTP*DAP*DCP*DAP*DTP*DTP*DTP*DTP*DG)-3')","1","3CO7"
,,,,,,,,,,,,,,,,"CAAAATGTAAACAAGA",,,"DNA (5'-D(*DCP*DAP*DAP*DAP*DAP*DTP*DGP*DTP*DAP*DAP*DAP*DCP*DAP*DAP*DGP*DA)-3')","2","3CO7"
,,,,,,,,,,,,,,,,"SKSSSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKS","Homo sapiens","FOXO1, FKHR, FOXO1A","Forkhead box protein O1","3","3CO7"
"3COA",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, HANGING DROP",6.8,"30% PEG 4000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2008.06.013",,"3COA",45.98,"2.2","2.2","Crystal Structure of FoxO1 DBD Bound to IRE DNA","TGGTTTGTTTTGCTTG",,,"DNA (5'-D(*DTP*DGP*DGP*DTP*DTP*DTP*DGP*DTP*DTP*DTP*DTP*DGP*DCP*DTP*DTP*DG)-3')","1","3COA"
,,,,,,,,,,,,,,,,"CAAGCAAAACAAACCA",,,"DNA (5'-D(*DCP*DAP*DAP*DGP*DCP*DAP*DAP*DAP*DAP*DCP*DAP*DAP*DAP*DCP*DCP*DA)-3')","2","3COA"
,,,,,,,,,,,,,,,,"SKSSSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKS","Homo sapiens","FOXO1, FKHR, FOXO1A","Forkhead box protein O1","3","3COA"
"3COG",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.2M Di-ammonium hydrogen citrate, 20% PEG 3350. Streak seeding used, apo crystal soaked with inhibitor, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M805459200",,"3COG",179.18,"2","2","Crystal structure of human cystathionase (Cystathionine gamma lyase) in complex with DL-propargylglycine","SMQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSG","Homo sapiens","CTH","Cystathionine gamma-lyase","1","3COG"
"3COH",,"X-RAY DIFFRACTION",2.77,55.64,"EVAPORATION",7.5,"30% PEG 3350, 0.2 M Ammonium sulfate, 0.1 M HEPES, pH 7.5, EVAPORATION, temperature 291K",291,"10.1021/jm800052b","83H","3COH",62.71,"2.7","2.7","Crystal structure of Aurora-A in complex with a pentacyclic inhibitor","AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6, AIRK1, AYK1, IAK1","Serine/threonine-protein kinase 6","1","3COH"
"3COI",,"X-RAY DIFFRACTION",2.85,56.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% Glycerol, 20mM Hepes pH 7.5, 150mM Sodium chloride, 10mM Methionine, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3COI",40.65,"2.09","2.09","Crystal structure of p38delta kinase","SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSPI","Homo sapiens","MAPK13, PRKM13, SAPK4","Mitogen-activated protein kinase 13","1","3COI"
"3COK",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, SITTING DROP",6,"100mM Sodium citrate pH 6.0, 16% PEG 4000, 200mM Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,,,"3COK",64.84,"2.25","2.25","Crystal structure of PLK4 kinase","SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG","Homo sapiens","PLK4, SAK, STK18","Serine/threonine-protein kinase PLK4","1","3COK"
"3COM",,"X-RAY DIFFRACTION",3.05,59.74,"VAPOR DIFFUSION, SITTING DROP",10.5,"1700mM Ammonium sulfate, 300mM Lithium sulfate, 100mM CAPS pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,,,"3COM",71.59,"2.2","2.2","Crystal structure of Mst1 kinase","SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREEG","Homo sapiens","STK4, MST1, KRS2","Serine/threonine-protein kinase 4","1","3COM"
"3CON",,"X-RAY DIFFRACTION",1.78,30.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"30.0% PEG 3350, 0.2M Magnesium chloride, 0.1 M Tris-HCl, GDP was added to the concentrated protein to a final concentration of 5mM. Crystallization were set up with 1:100 chymotrypsin, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"3CON",22.31,"1.649","1.649","Crystal structure of the human NRAS GTPase bound with GDP","MHHHHHHSSGRENLYFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLN","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","3CON"
"3COO",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.2M Ammonium sulfate, 30% (W/V) PEG 4000, 0.1M Sodium Citrate tribasic dehydrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.06.045",,"3COO",41,"2","2","The crystal structure of Reelin-N domain of F-spondin","RSPWPGFSDETLDKVPKSEGYCSRILRAQGTRREGYTEFSLRVEGDPDFYKPGTSYRVTLSAAPPSYFRGFTLIALRENREGDKEEDHAGTFQIIDEEETQFMSNCPVAVTESTPRRRTRIQVFWIAPPAGTGCVILKASIVQKRIIYFQDEGSLTKKLCEQDSTFDGVTDKTGHHHHHH","Homo sapiens","Homo sapiens, SPON1, KIAA0762, VSGP","Spondin-1","1","3COO"
"3COS",,"X-RAY DIFFRACTION",2.77,55.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M Ammonium acetate, 0.1 M Bis-tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3COS",165.33,"2.1","2.1","Crystal structure of human class II alcohol dehydrogenase (ADH4) in complex with NAD and Zn","SMGTKGKVIKCKAAIAWEAGKPLCIEEVEVAPPKAHEVRIQIIATSLCHTDATVIDSKFEGLAFPVIVGHEAAGIVESIGPGVTNVKPGDKVIPLYAPLCRKCKFCLSPLTNLCGKISNLKSPASDQQLMEDKTSRFTCKGKPVYHFFGTSTFSQYTVVSDINLAKIDDDANLERVCLLGCGFSTGYGAAINNAKVTPGSTCAVFGLGGVGLSAVMGCKAAGASRIIGIDINSEKFVKAKALGATDCLNPRDLHKPIQEVIIELTKGGVDFALDCAGGSETMKAALDCTTAGWGSCTFIGVAAGSKGLTVFPEELIIGRTINGTFFGGWKSVDSIPKLVTDYKNKKFNLDALVTHTLPFDKISEAFDLMNQGKSIRTILIF","Homo sapiens","ADH4","Alcohol dehydrogenase 4","1","3COS"
"3COT",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"isopropanol 10%,peg 4000, tris-HCl 100 mM pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M801778200",,"3COT",81.31,"2.03","2.03","Crystal structure of human liver delta(4)-3-ketosteroid 5beta-reductase (akr1d1) in complex with progesterone and nadp. Resolution: 2.03 A.","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3COT"
"3COU",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1M CHES pH 9.5, 20% (w/v) PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3COU",23.89,"1.8","1.8","Crystal structure of human Nudix motif 16 (NUDT16)","MHHHHHHSSGVDLGTENLYFQSMAGARRLELGEALALGSGWRHVCHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","Nucleoside diphosphate-linked moiety X motif 16","1","3COU"
"3CP6",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4Cl, 20% PEG 6000, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3CP6",43.6,"1.95","1.95","Crystal structure of human farnesyl diphosphate synthase (T201A mutant) complexed with Mg and biphosphonate inhibitor","MGSSHHHHHHSSGRENLYFQGHMMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKAAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase","1","3CP6"
"3CP9",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, ammonium sulfate, sodium chloride, isopropanol, beta-mercaptoethanol 
, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm800188g","C19","3CP9",73.36,"2.5","2.5","Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3CP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3CPB",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, ammonium sulfate, sodium chloride, isopropanol, beta-mercaptoethanol 
, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm800188g","C92","3CPB",73.3,"2.7","2.7","Crystal structure of the VEGFR2 kinase domain in complex with a bisamide inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3CPB"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3CPC",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION",8,"PEG 5000 MME, HEPES, ammonium sulfate, sodium chloride, isopropanol, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm800188g","C52","3CPC",73.36,"2.4","2.4","Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3CPC"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3CPF",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"22% PEG 3350, 0.2M Ammonium sulfate, 0.1M Sodium cacodylate. Cryoprotected with 20% PEG 3350 and 20% Ethylene glycol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/prot.22378",,"3CPF",30.34,"2.5","2.5","Crystal structure of human eukaryotic translation initiation factor EIF5A","GSATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGKEIEQKYDCGEEILITVLSAMTEEAAVAIKA","Homo sapiens","EIF5A","Eukaryotic translation initiation factor 5A-1","1","3CPF"
"3CPU",,"X-RAY DIFFRACTION",2.43,49.3,,7.5,"pH 7.5",,"10.1021/bi9921182",,"3CPU",56.35,"2","2","SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHNNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","3CPU"
"3CQA",,"X-RAY DIFFRACTION",2.99,58.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.3 M sodium formate and 0.4 M ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309109036987",,"3CQA",32.87,"1.8","1.8","Crystal structure of human fibroblast growth factor-1 with mutations Glu81Ala and Lys101Ala","HHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNAECLFLERLEENHYNTYISKAHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3CQA"
"3CQE",,"X-RAY DIFFRACTION",2.93,58.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP",,,,"3CQE",32.9,"2.5","2.5","Wee1 kinase complex with inhibitor PD074291","GAMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","3CQE"
"3CQP",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",7,"2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M801522200",,"3CQP",64.37,"1.95","1.95","Human SOD1 G85R Variant, Structure I","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","3CQP"
"3CQQ",,"X-RAY DIFFRACTION",1.92,35.86,"VAPOR DIFFUSION, HANGING DROP",7,"2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M801522200",,"3CQQ",32.13,"1.9","1.9","Human SOD1 G85R Variant, Structure II","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLRNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","3CQQ"
"3CQV",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION",7.6,"1.6 M Ammonium sulfate, 0.1 M Na Hepes pH 7.6, 4% Jeffamine M-600, VAPOR DIFFUSION, temperature 297K",297,"10.1371/journal.pbio.1000043",,"3CQV",23.49,"1.9","1.9","Crystal structure of Reverb beta in complex with heme","HLVCPMSKSPYVDPHKSGHEIWEEFSMSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLSGKKYSVDDLHSMGAGDLLNSMFEFSEKLNALQLSDEEMSLFTAVVLVSADRSGIENVNSVEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSLNNMHSEELLAFKVHP","Homo sapiens","NR1D2","Nuclear receptor subfamily 1 group D member 2","1","3CQV"
"3CR0",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3CR0",32.78,"2.3","2.3","Wee1 kinase complex with inhibitor PD259_809","GAMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","3CR0"
"3CR6",,"X-RAY DIFFRACTION",1.93,36.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M sodium citrate, 0.2M ammonium acetate, 26% PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3CR6",15.77,"1.22","1.22","Crystal Structure of the R132K:R111L:A32E Mutant of Cellular Retinoic Acid Binding Protein Type II Complexed with C15-aldehyde (a retinal analog) at 1.22 Angstrom resolution.","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIEVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELILTMTADDVVCTKVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","3CR6"
"3CRD",,"SOLUTION NMR",,,,,,,"10.1016/s0092-8674(00)81417-8",,"3CRD",11.45,,,"NMR STRUCTURE OF THE RAIDD CARD DOMAIN, 15 STRUCTURES","MEARDKQVLRSLRLELGAEVLVEGLVLQYLYQEGILTENHIQEINAQTTGLRKTMLLLDILPSRGPKAFDTFLDSLQEFPWVREKLKKAREEAMTDLPAG","Homo sapiens","CRADD, RAIDD","RAIDD","1","3CRD"
"3CRG",,"X-RAY DIFFRACTION",2.98,58.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.1 M sodium formate and 0.4 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309109036987",,"3CRG",33.53,"1.85","1.85","Crystal structure of human fibroblast growth factor-1 with mutations Glu81Ala, Glu82Asn and Lys101Ala","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNANCLFLERLEENHYNTYISKAHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3CRG"
"3CRH",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M sodium formate and 0.4 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309109036987",,"3CRH",33.65,"2.15","2.15","Crystal structure of human fibroblast growth factor-1 with mutations Glu81Ser and Lys101Ala","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNSECLFLERLEENHYNTYISKAHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3CRH"
"3CRI",,"X-RAY DIFFRACTION",2.96,58.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.3 M sodium formate and 0.4 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309109036987",,"3CRI",33.43,"2.1","2.1","Crystal structure of human fibroblast growth factor-1 with mutations Glu81Ser, Glu82Asn and Lys101Ala","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNSNCLFLERLEENHYNTYISKAHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3CRI"
"3CRY",,"X-RAY DIFFRACTION",2.04,39.76,"VAPOR DIFFUSION, HANGING DROP",5,"50% PEG 4000, 0.2M ammonium acetate, 0.1M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803623200",,"3CRY",42.23,"1.7","1.7","Gamma-glutamyl cyclotransferase","MANSGCKDVTGPDEESFLYFAYGSNLLTERIHLRNPSAAFFCVARLQDFKLDFGNSQGKTSQTWHGGIATIFQSPGDEVWGVVWKMNKSNLNSLDEQQGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSPQYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIEDIIKKGETQTL","Homo sapiens","GGCT, C7orf24, CRF21","Gamma-glutamyl cyclotransferase","1","3CRY"
"3CS4",,"X-RAY DIFFRACTION",2.56,52.04,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Mes-KOH and 1.4 M ammonium sulphate at pH 6.0., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.chembiol.2008.03.016",,"3CS4",30.25,"2","2","Structure-based design of a superagonist ligand for the vitamin D nuclear receptor","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3CS4"
"3CS6",,"X-RAY DIFFRACTION",2.57,52.13,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Mes-KOH and 1.4 M ammonium sulphate at pH 6.0., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.chembiol.2008.03.016",,"3CS6",30.25,"1.8","1.8","Structure-based design of a superagonist ligand for the vitamin D nuclear receptor","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3CS6"
"3CS7",,"X-RAY DIFFRACTION",2.53,51.36,,5.5,"200 mM Sodium Acetate, pH 5.5, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K, pH 5.50",277,"10.1016/j.bmcl.2008.05.095","LG0","3CS7",32.59,"2.2","2.2","FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Coagulation factor X","1","3CS7"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X","2","3CS7"
"3CS8",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, HANGING DROP",6.2,"20% PEG3350, 0.2M Ammonium Iodide, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M802040200","BRL","3CS8",33.3,"2.3","2.3","Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a","RGGSPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARGC1A, LEM6, PGC1, PGC1A, PPARGC1, PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3CS8"
,,,,,,,,,,,,,,,,"PSLLKKLLLAPA",,,"PGC-1alfa peptide","2","3CS8"
"3CS9",,"X-RAY DIFFRACTION",2.68,54.02,"VAPOR DIFFUSION, HANGING DROP",5.5,"10.5 % PEG 5000 MME, 0.1 M MES pH 5.5, 0.05 ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ccr.2005.01.007","NIL","3CS9",130.32,"2.21","2.21","Human ABL kinase in complex with nilotinib","GAMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","3CS9"
"3CSF",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",7.2,"21% PEG 4000, 0.2M Ammonium Sulfate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb800039y",,"3CSF",111.22,"2.8","2.8","Crystal structure of PI3K p110gamma catalytical domain in complex with organoruthenium inhibitor DW2","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3CSF"
"3CSH",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",5.5,"Solid chlorambucil was added to preformed GST crystals cocrystallised with glutathione , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2008.04.066",,"3CSH",48.86,"1.55","1.55","Crystal Structure of Glutathione Transferase Pi in complex with the Chlorambucil-Glutathione Conjugate","PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","3CSH"
"3CSI",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, HANGING DROP",6,"Resevior solution contained: 100mM MES, 22% PEG 8000, 20mM CaCl2, 10mM DTT and 10mM GSH.  
Soaking conditions as above, minus DTT, plus 2mM Chlorambucil dissolved in ethanol., pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2008.04.066",,"3CSI",97.58,"1.9","1.9","Crystal Structure of the Glutathione Transferase Pi allelic variant*C, I104V/A113V, in complex with the Chlorambucil-Glutathione Conjugate","PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYVSLIYTNYEVGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","3CSI"
"3CSJ",,"X-RAY DIFFRACTION",2.58,52.26,"VAPOR DIFFUSION, HANGING DROP",5.4,"Resevior solution contained: 25% (w/v) ammonium sulfate, 60mM DTT, 100mM MES and 10% (v/v) glycerol. Solid chlorambucil was streaked into the drop., pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2008.04.066",,"3CSJ",47.22,"1.9","1.9","Human glutathione s-transferase p1-1 in complex with chlorambucil","PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","3CSJ"
"3CST",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, HANGING DROP",7.2,"21% PEG 4000, 0.2M ammonium sulfate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb800039y","E52","3CST",111.39,"3.2","3.2","Crystal structure of PI3K p110gamma catalytical domain in complex with organoruthenium inhibitor E5E2","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3CST"
"3CTB",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION",7,"10-30% MPD or isopropanol, 100 mM imidazole, pH 7, VAPOR DIFFUSION, temperature 277K",277,"10.1093/protein/gzn017",,"3CTB",78.37,"2","2","Tethered PXR-LBD/SRC-1p apoprotein","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSGGSGGSSHSSLTERHKILHRLLQEGSPS","Homo sapiens","NR1I2, PXR","Pregnane X receptor, Linker, Steroid receptor coactivator 1","1","3CTB"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I2, PXR"
"3CTH",,"X-RAY DIFFRACTION",2.19,43.85,,7.1,"12% MEPEG 5000, 0.1M HEPES (PH 7.1) 11% 2-PROPANOL",,"10.1016/j.bmcl.2008.04.047","319","3CTH",35.83,"2.3","2.3","Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor","GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3CTH"
"3CTJ",,"X-RAY DIFFRACTION",2.18,43.65,,7.1,"12% MEPEG 5000, 0.1M HEPES (PH 7.1) 11% 2-PROPANOL",,"10.1016/j.bmcl.2008.04.047","320","3CTJ",35.86,"2.5","2.5","Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor","GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3CTJ"
"3CTQ",,"X-RAY DIFFRACTION",2.25,45.39,,,,,"10.1016/j.bmcl.2008.04.043","337","3CTQ",40.39,"1.95","1.95","Structure of MAP kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamide","RPTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPP","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3CTQ"
"3CTR",,"X-RAY DIFFRACTION",2.71,54.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"2 M LiSO4, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.07.073","MGP","3CTR",12.36,"2.1","2.1","Crystal structure of the RRM-domain of the poly(A)-specific ribonuclease PARN bound to m7GTP","GPLGSDHVLHVTFPKEWKTSDLYQLFSAFGNIQISWIDDTSAFVSLSQPEQVKIAVNTSKYAESYRIQTYAEYMGRKQEEKQIKRKWTEDSWKEADSKRLN","Homo sapiens","PARN, DAN","Poly(A)-specific ribonuclease PARN","1","3CTR"
"3CTT",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M sodium sulfate, 4% 1,1,1,3,3,3-hexafluoro-2-propanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/chem.200801578","3CU","3CTT",100.16,"2.1","2.1","Crystal complex of N-terminal Human Maltase-Glucoamylase with Casuarine","SAECPVVNELERINCIPDQPPTKATCDQRGCCWNPQGAVSVPWCYYSKNHSYHVEGNLVNTNAGFTARLKNLPSSPVFGSNVDNVLLTAEYQTSNRFHFKLTDQTNNRFEVPHEHVQSFSGNAAASLTYQVEISRQPFSIKVTRRSNNRVLFDSSIGPLLFADQFLQLSTRLPSTNVYGLGEHVHQQYRHDMNWKTWPIFNRDTTPNGNGTNLYGAQTFFLCLEDASGLSFGVFLMNSNAMEVVLQPAPAITYRTIGGILDFYVFLGNTPEQVVQEYLELIGRPALPSYWALGFHLSRYEYGTLDNMREVVERNRAAQLPYDVQHADIDYMDERRDFTYDSVDFKGFPEFVNELHNNGQKLVIIVDPAISNNSSSSKPYGPYDRGSDMKIWVNSSDGVTPLIGEVWPGQTVFPDYTNPNCAVWWTKEFELFHNQVEFDGIWIDMNEVSNFVDGSVSGCSTNNLNNPPFTPRILDGYLFCKTLCMDAVQHWGKQYDIHNLYGYSMAVATAEAAKTVFPNKRSFILTRSTFAGSGKFAAHWLGDNTATWDDLRWSIPGVLEFNLFGIPMVGPDICGFALDTPEELCRRWMQLGAFYPFSRNHNGQGYKDQDPASFGADSLLLNSSRHYLNIRYTLLPYLYTLFFRAHSRGDTVARPLLHEFYEDNSTWDVHQQFLWGPGLLITPVLDEGAEKVMAYVPDAVWYDYETGSQVRWRKQKVEMELPGDKIGLHLRGGYIFPTQQPNTTTLASRKNPLGLIIALDENKEAKGELFWDDGETKDTVANKVYLLCEFSVTQNRLEVNISQSTYKDPNNLAFNEIKILGTEEPSNVTVKHNGVPSQTSPTVTYDSNLKVAIITDIDLLLGEAYTVEWAH","Homo sapiens","MGAM, MGA, MGAML","Maltase-glucoamylase","1","3CTT"
"3CTZ",,"X-RAY DIFFRACTION",2.83,56.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 0.15M calcium chloride, 20% PEG 400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M710274200",,"3CTZ",70.48,"1.6","1.6","Structure of human cytosolic X-prolyl aminopeptidase","MPPKVTSELLRQLRQAMRNSEYVTEPIQAYIIPSGDAHQSEYIAPCDCRRAFVSGFDGSAGTAIITEEHAAMWTDGRYFLQAAKQMDSNWTLMKMGLKDTPTQEDWLVSVLPEGSRVGVDPLIIPTDYWKKMAKVLRSAGHHLIPVKENLVDKIWTDRPERPCKPLLTLGLDYTGISWKDKVADLRLKMAERNVMWFVVTALDEIAWLFNLRGSDVEHNPVFFSYAIIGLETIMLFIDGDRIDAPSVKEHLLLDLGLEAEYRIQVHPYKSILSELKALCADLSPREKVWVSDKASYAVSETIPKDHRCCMPYTPICIAKAVKNSAESEGMRRAHIKDAVALCELFNWLEKEVPKGGVTEISAADKAEEFRRQQADFVDLSFPTISSTGPTGAIIHYAPVPETNRTLSLDEVYLIDSGAQYKDGTTDVTRTMHFETPTAYEKECFTYVLKGHIAVSAAVFPTGTKGHLLDSFARSALWDSGLDYLHGTGHGVGSFLNVHEGPCGISYKTFSDEPLEAGMIVTDEPGYYEDGAFGIRIENVVLVVPVKTKYNFNNRGSLTLEPLTLVPIQTKMIDVDSLTDKECDWLNNYHLTCRDVIGKELQKQGRQEALEWLIRETQPISKQH","Homo sapiens","XPNPEP1, XPNPEPL, XPNPEPL1","Xaa-Pro aminopeptidase 1","1","3CTZ"
"3CU0",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, HANGING DROP",6,"50mM NaCl 
10mM MnCl2 
10mM UDPGlcUA 
.1M MES pH 6.0 
21% MMEPEG2000, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M709556200",,"3CU0",64.12,"1.9","1.9","human beta 1,3-glucuronyltransferase I (GlcAT-I) in complex with UDP and GAL-GAL(6-SO4)-XYL(2-PO4)-O-SER","MGSSHHHHHHSSGLVPRGSHMTIYVVTPTYARLVQKAELVRLSQTLSLVPRLHWLLVEDAEGPTPLVSGLLAASGLLFTHLVVLTPKAQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVYFADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHTAWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDPKDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV","Homo sapiens","B3GAT3","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3","1","3CU0"
"3CU7",,"X-RAY DIFFRACTION",3.84,67.97,"VAPOR DIFFUSION, HANGING DROP",6.8,"100mM NaCl, 1.5-3mM MES pH 5.5, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/ni.1625",,"3CU7",379.36,"3.105","3.105","Human Complement Component 5","MGLLGILCFLIFLGKTWGQEQTYVISAPKIFRVGASENIVIQVYGYTEAFDATISIKSYPDKKFSYSSGHVHLSSENKFQNSAILTIQPKQLPGGQNPVSYVYLEVVSKHFSKSKRMPITYDNGFLFIHTDKPVYTPDQSVKVRVYSLNDDLKPAKRETVLTFIDPEGSEVDMVEEIDHIGIISFPDFKIPSNPRYGMWTIKAKYKEDFSTTGTAYFEVKEYVLPHFSVSIEPEYNFIGYKNFKNFEITIKARYFYNKVVTEADVYITFGIREDLKDDQKEMMQTAMQNTMLINGIAQVTFDSETAVKELSYYSLEDLNNKYLYIAVTVIESTGGFSEEAEIPGIKYVLSPYKLNLVATPLFLKPGIPYPIKVQVKDSLDQLVGGVPVTLNAQTIDVNQETSDLDPSKSVTRVDDGVASFVLNLPSGVTVLEFNVKTDAPDLPEENQAREGYRAIAYSSLSQSYLYIDWTDNHKALLVGEHLNIIVTPKSPYIDKITHYNYLILSKGKIIHFGTREKFSDASYQSINIPVTQNMVPSSRLLVYYIVTGEQTAELVSDSVWLNIEEKCGNQLQVHLSPDADAYSPGQTVSLNMATGMDSWVALAAVDSAVYGVQRGAKKPLERVFQFLEKSDLGCGAGGGLNNANVFHLAGLTFLTNANADDSQENDEPCKEILRPRRTLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISHKDMQLGRLHMKTLLPVSKPEIRSYFPESWLWEVHLVPRRKQLQFALPDSLTTWEIQGIGISNTGICVADTVKAKVFKDVFLEMNIPYSVVRGEQIQLKGTVYNYRTSGMQFCVKMSAVEGICTSESPVIDHQGTKSSKCVRQKVEGSSSHLVTFTVLPLEIGLHNINFSLETWFGKEILVKTLRVVPEGVKRESYSGVTLDPRGIYGTISRRKEFPYRIPLDLVPKTEIKRILSVKGLLVGEILSAVLSQEGINILTHLPKGSAEAELMSVVPVFYVFHYLETGNHWNIFHSDPLIEKQKLKKKLKEGMLSIMSYRNADYSYSVWKGGSASTWLTAFALRVLGQVNKYVEQNQNSICNSLLWLVENYQLDNGSFKENSQYQPIKLQGTLPVEARENSLYLTAFTVIGIRKAFDICPLVKIDTALIKADNFLLENTLPAQSTFTLAISAYALSLGDKTHPQFRSIVSALKREALVKGNPPIYRFWKDNLQHKDSSVPNTGTARMVETTAYALLTSLNLKDINYVNPVIKWLSEEQRYGGGFYSTQDTINAIEGLTEYSLLVKQLRLSMDIDVSYKHKGALHNYKMTDKNFLGRPVEVLLNDDLIVSTGFGSGLATVHVTTVVHKTSTSEEVCSFYLKIDTQDIEASHYRGYGNSDYKRIVACASYKPSREESSSGSSHAVMDISLPTGISANEEDLKALVEGVDQLFTDYQIKDGHVILQLNSIPSSDFLCVRFRIFELFEVGFLSPATFTVYEYHRPDKQCTMFYSTSNIKIQKVCEGAACKCVEADCGQMQEELDLTISAETRKQTACKPEIAYAYKVSITSITVENVFVKYKATLLDIYKTGEAVAEKDSEITFIKKVTCTNAELVKGRQYLIMGKEALQIKYNFSFRYIYPLDSLTWIEYWPRDTTCSSCQAFLANLDEFAEDIFLNGC","Homo sapiens","C5, CPAMD4","Complement C5","1","3CU7"
"3CUK",,"X-RAY DIFFRACTION",2.21,44.38,"VAPOR DIFFUSION, SITTING DROP",7.8,"15% PEG 3350, 0.15M POTASSIUM TRICITR TRIS-HCL, pH 7.80, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.04.020","4P5","3CUK",161.83,"2.49","2.49","Crystal structure of human D-amino acid oxidase: bound to an inhibitor","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","3CUK"
"3CUL",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION",7,"100 mM magnesium formate, 15% PEG 3000, 1 M lithium chloride, pH 7.0, VAPOR DIFFUSION, temperature 295K",295,"10.1038/nature07033",,"3CUL",82.91,"2.8","2.8","Aminoacyl-tRNA synthetase ribozyme","GGAUGGCGAAAGCCAUUUCCGCAGGCCCCAUUGCACUCCGGGGUAUUGGCGUUAGGUGGUGGUACGAGGUUCGAAUCCUCGUACCGCAGCCA",,,"RNA (92-MER)","1","3CUL"
,,,,,,,,,,,,,,,,"GGAUGGCGAAAGCCAUUUCCGCAGGCCCCAUUGCACUCCGGGGUAUUGGCGUUAGGUGGUGGUACGAGGUUCGAAUCCUCGUACCGCAGCCA",,,"RNA (92-MER)","2","3CUL"
,,,,,,,,,,,,,,,,"MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","3","3CUL"
"3CUN",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION",7,"100 mM magenesium formate pH 7.0, 15% PEG 3000, 1 M lithium chloride, VAPOR DIFFUSION, temperature 295K",295,"10.1038/nature07033",,"3CUN",83.11,"3","3","Aminoacyl-tRNA synthetase ribozyme","GGAUGGCGAAAGCCAUUUCCGCAGGCCCCAUUGCACUCCGGGGUAUUGGCGUUAGGUGGUGGUACGAGGUUCGAAUCCUCGUACCGCAGCCA",,,"RNA (92-MER)","1","3CUN"
,,,,,,,,,,,,,,,,"MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","2","3CUN"
"3CVA",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, HANGING DROP",5.8,"1.9M ammonium sulfate, 50mM MES, pH 5.8, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.abb.2009.01.003",,"3CVA",24.6,"2.7","2.7","Human Bcl-xL containing a Trp to Ala mutation at position 137","MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNAGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNLEHHHHHH","Homo sapiens","bcl-xl, BCL2L1, BCL2L, BCLX","Apoptosis regulator Bcl-X","1","3CVA"
"3CVF",,"X-RAY DIFFRACTION",7.83,84.29,"hanging drop",7.6,"0.1 M Tris, 4.2 M NaCl, 10% glycerol, pH 7.6, hanging drop, temperature 297K",297,"10.1016/j.cell.2009.01.050",,"3CVF",36.25,"2.9","2.9","Crystal Structure of the carboxy terminus of Homer3","GSHMAAEREETQQKVQDLETRNAELEHQLRAMERSLEEARAERERARAEVGRAAQLLDVSLFELSELREGLARLAEAAP","Homo sapiens","HOMER3","Homer protein homolog 3","1","3CVF"
"3CVM",,"X-RAY DIFFRACTION",3.47,64.6,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 4.5M Ammonium Acetate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.036707.108",,"3CVM",88.56,"2.02","2.02","High resolution structure of a stable Plasminogen activator inhibitor type-1 in its protease cleaved form","MRGSHHHHHHGSAVHHPPSYVARLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","SERPINE1, PAI1, PLANH1","Plasminogen activator inhibitor 1","1","3CVM"
"3CW3",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.3-1.5M NaCitrate;0.1M HepesNa 7.5; 
3%isopropanol (or)0.4M NaCl, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.jmb.2008.06.019",,"3CW3",10.91,"1.88","1.88","Crystal structure of AIM1g1","GKVVIYSEPDVSEKCIEVFSDIQDCSSWSLSPVILIKVVRGCWILYEQPNFEGHSIPLEEGELELSGLWGIEDILERHEEAESDKPVVIGSIRHVV","Homo sapiens","AIM1, CRYBG1","Absent in melanoma 1 protein","1","3CW3"
"3CWD",,"X-RAY DIFFRACTION",2.69,54.27,,,,,"10.1038/nsmb.1447","LNB","3CWD",66.85,"2.4","2.4","Molecular recognition of nitro-fatty acids by PPAR gamma","SADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3CWD"
,,,,,,,,,,,,,,,,"ERHKILHRLLQEGSPS",,,"SRC1-2 PEPTIDE","2","3CWD"
"3CWE",,"X-RAY DIFFRACTION",3.52,65.07,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350, MGCL2, HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 284K",284,"10.1016/j.bmcl.2008.04.064","825","3CWE",34.28,"1.6","1.6","PTP1B in complex with a phosphonic acid inhibitor","AADKLEFMEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMG","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","3CWE"
"3CWK",,"X-RAY DIFFRACTION",2.58,52.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 30% (W/V) PEG 5000, 0.2 M AMMONIUM SULFATE, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444908032216","REA","3CWK",15.9,"1.6","1.6","Crystal Structure of the R132K:Y134F:R111L:T54V:L121E Mutant of Cellular Retinoic Acid Binding Protein Type II in Complex with All-trans-Retinoic Acid at 1.57 Angstroms Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKVSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELIETMTADDVVCTKVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","3CWK"
"3CWL",,"X-RAY DIFFRACTION",2.37,48.07,,8.4,"27% PEG 4000, 0.2M Sodium Acetate, 100mM Tris-HCl, pH 8.4, vapor diffusion, hanging drop, temperature 295K, pH 8.40",295,"10.1110/ps.037234.108",,"3CWL",44.45,"2.44","2.44","Crystal structure of alpha-1-antitrypsin, crystal form B","EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","3CWL"
"3CWM",,"X-RAY DIFFRACTION",2.41,49.01,"VAPOR DIFFUSION, HANGING DROP",8.4,"27% PEG 4000, 0.2M Sodium Acetate, 100mM Tris-HCl, pH 8.4, vapor diffusion, hanging drop, temperature 295K",295,"10.1110/ps.037234.108",,"3CWM",44.6,"2.51","2.51","Crystal structure of alpha-1-antitrypsin complexed with citrate","EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","3CWM"
"3CWW",,"X-RAY DIFFRACTION",3.94,68.81,"VAPOR DIFFUSION",7,"13% PEGMME 5000, 100mM HEPES, pH 7.0, 10%, Tacsimate, 10% dioxane, vapor diffusion, temperature 291K",291,"10.1021/bi801192h",,"3CWW",229.3,"1.96","1.96","Crystal Structure of IDE-bradykinin complex","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKAGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDAVIAKWQNAALNGKFKLPTKNEFIPTNFEILPLEAAATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEARFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALADVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLAAYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKADIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTAFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE, RP11-366I13.1-001, hCG_1810909","Insulin-degrading enzyme","1","3CWW"
,,,,,,,,,,,,,,,,"APPA",,,"bradykinin N-terminal tetrapeptide analogue","2","3CWW"
"3CX2",,"X-RAY DIFFRACTION",2.35,47.77,"VAPOR DIFFUSION, HANGING DROP",6.9,"Crystals were grown at 20 C using the hanging drop method with a 2  microlitre drop containing a 1:1 mixture of protein solution and crystallising solution consisting of 8.5% PEG 3350 and 0.05M Hepes pH 6.8 over 500 microlitres of crystallising solution in the reservoir, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444908008792",,"3CX2",12.05,"1.3","1.3","Crystal structure of the C1 domain of cardiac isoform of myosin binding protein-C at 1.3A","DDPIGLFVMRPQDGEVTVGGSITFSARVAGASLLKPPVVKWFKGKWVDLSSKVGQHLQLHDSYDRASKVYLFELHITDAQPAFTGSYRCEVSTKDKFDCSNFNLTVHE","Homo sapiens","MYBPC3","Myosin-binding protein C, cardiac-type","1","3CX2"
"3CX9",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"35% PEG 3350, 85mM potassium phosphate, 5mM sodium azide, pH7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1042/BJ20090913","LPX","3CX9",67.87,"2.8","2.8","Crystal Structure of Human serum albumin complexed with Myristic acid and lysophosphatidylethanolamine","HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3CX9"
"3CXF",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION",5.6,"0.066M CaCl2, 19 % (w/v) PEG 400, 0.13M sodium Hepes, pH 5.6, VAPOR DIFFUSION, temperature 295K",295,"10.1111/j.1742-4658.2008.06705.x",,"3CXF",27.5,"2.3","2.3","Crystal structure of transthyretin variant Y114H","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPHSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3CXF"
"3CXL",,"X-RAY DIFFRACTION",4.32,71.53,"VAPOR DIFFUSION, HANGING DROP",9.5,"1.4M Ammonium sulfate, 0.1M Glycine, 0.01M Magnesium chloride, 5% MPD, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3CXL",53.93,"2.6","2.6","Crystal structure of human chimerin 1 (CHN1)","MHHHHHHSSGRENLYFQGVWKSYLYQLQQEAPHPRRITCTCEVENRPKYYGREFHGMISREAADQLLIVAEGSYLIRESQRQPGTYTLALRFGSQTRNFRLYYDGKHFVGEKRFESIHDLVTDGLITLYIETKAAEYIAKMTINPIYEHVGYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVHTFRGPHWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVPNDCKPDLKHVKKVYSCDLTTLVKAHTTKRPMVVDMCIREIESRGLNSEGLYRVSGFSDLIEDVKMAFDRDGEKADISVNMYEDINIITGALKLYFRDLPIPLITYDAYPKFIESAKIMDPDEQLETLHEALKLLPPAHCETLRYLMAHLKRVTLHEKENLMNAENLGIVFGPTLMRSPELDAMAALNDIRYQRLVVELLIKNEDILF","Homo sapiens","CHN1, ARHGAP2, CHN","N-chimerin","1","3CXL"
"3CXP",,"X-RAY DIFFRACTION",2.29,45.76,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.1M K Thiocyanate, 30% w/v PEG MME 2000, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.febslet.2008.07.040",,"3CXP",20.75,"2.01","2.01","Crystal structure of human glucosamine 6-phosphate N-acetyltransferase 1 mutant E156A","MKPDETPMFDPSLLKEVDWSQNTATFSPAISPTHPGEGLVLRPLCTADLNRGFFKVLGQLTETGVVSPEQFMKSFEHMKKSGDYYVTVVEDVTLGQIVATATLIIEHKFIHSCAKRGRVEDVVVSDECRGKQLGKLLLSTLTLLSKKLNCYKITLACLPQNVGFYKKFGYTVSEENYMCRRFLK","Homo sapiens","GNPNAT1, GNA1","Glucosamine 6-phosphate N-acetyltransferase","1","3CXP"
"3CXQ",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Na formate, 25% w/v PEG 3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.febslet.2008.07.040",,"3CXQ",21.04,"2.3","2.3","Crystal structure of human glucosamine 6-phosphate N-acetyltransferase 1 bound to GlcN6P","MKPDETPMFDPSLLKEVDWSQNTATFSPAISPTHPGEGLVLRPLCTADLNRGFFKVLGQLTETGVVSPEQFMKSFEHMKKSGDYYVTVVEDVTLGQIVATATLIIEHKFIHSCAKRGRVEDVVVSDECRGKQLGKLLLSTLTLLSKKLNCYKITLECLPQNVGFYKKFGYTVSEENYMCRRFLK","Homo sapiens","GNPNAT1, GNA1","Glucosamine 6-phosphate N-acetyltransferase","1","3CXQ"
"3CXS",,"X-RAY DIFFRACTION",2.12,42.96,"VAPOR DIFFUSION, HANGING DROP",6.3,"0.2M MgCl2, 0.1M Bis-Tris pH 6.3, 25% w/v PEG 3350, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.febslet.2008.07.040",,"3CXS",20.78,"2.7","2.7","Crystal structure of human GNA1","MKPDETPMFDPSLLKEVDWSQNTATFSPAISPTHPGEGLVLRPLCTADLNRGFFKVLGQLTETGVVSPEQFMKSFEHMKKSGDYYVTVVEDVTLGQIVATATLIIEHKFIHSCAKRGRVEDVVVSDECRGKQLGKLLLSTLTLLSKKLNCYKITLECLPQNVGFYKKFGYTVSEENYMCRRFLK","Homo sapiens","GNPNAT1, GNA1","Glucosamine 6-phosphate N-acetyltransferase","1","3CXS"
"3CXW",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.14 M Sodium malonate, 0.07 M Bis-Tris-Propane pH 7.5, 14 % PEG 3350, 7 % Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201286z",,"3CXW",37.73,"2.1","2.1","Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I","SMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1, Isoform 2","1","3CXW"
,,,,,,,,,,,,,,,,"ARKRRRHPSGPPTA",,,"Pimtide peptide","2","3CXW"
"3CY2",,"X-RAY DIFFRACTION",3.06,59.74,"VAPOR DIFFUSION, SITTING DROP",7,"0.56 M Na succinate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201286z","MB9","3CY2",37.74,"2.01","2.01","Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand II","SMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1, Isoform 2","1","3CY2"
,,,,,,,,,,,,,,,,"ARKRRRHPSGPPTA",,,"Pimtide peptide","2","3CY2"
"3CY6",,"X-RAY DIFFRACTION",2.9,57.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M sodium citrate, 50 mM HEPES, 10 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi800282d",,"3CY6",20.99,"1.35","1.35","Crystal Structure of E18Q DJ-1","MASKRALVILAKGAEEMQTVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","3CY6"
"3CYF",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, 50 mM HEPES, 10 mM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi800282d",,"3CYF",21.01,"1.6","1.6","Crystal Structure of E18N DJ-1","MASKRALVILAKGAEEMNTVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","3CYF"
"3CYH",,"X-RAY DIFFRACTION",2.67,54,,,,,"10.1021/bi960278x",,"3CYH",18.13,"1.9","1.9","CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","CYCLOPHILIN, PPIA, CYPA","CYCLOPHILIN A","1","3CYH"
"3CYI",,"X-RAY DIFFRACTION",2.88,57.31,"VAPOR DIFFUSION, SITTING DROP",8.8,"MPD, sodium/potassium phosphate, pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M803244200",,"3CYI",12.55,"1.8","1.8","Crystal Structure of Human Sulfiredoxin (Srx) in Complex with ATP:Mg2+","GPHMSIHSGRIAAVHNVPLSVLIRPLPSVLDPAKVQSLVDTIREDPDSVPPIDVLWIKGAQGGDYFYSFGGSHRYAAYQQLQRETIPAKLVQSTLSDLRVYLGASTPDLQ","Homo sapiens","SRXN1, C20orf139, SRX, SRX1","Sulfiredoxin-1","1","3CYI"
"3CYN",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, SITTING DROP",7,"2 M ammonium sulfate, 1.5 % PEG 400, 0.1 M hepes, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3CYN",66.51,"2","2","The structure of human GPX8","MHHHHHHSSGVDLGTENLYFQSMINSFYAFEVKDAKGRTVSLEKYKGKVSLVVNVASDCQLTDRNYLGLKELHKEFGPSHFSVLAFPCNQFGESEPRPSKEVESFARKNYGVTFPIFHKIKILGSEGEPAFRFLVDSSKKEPRWNFWKYLVNPEGQVVKFWRPEEPIEVIRPDIAALVRQVIIKKKEDL","Homo sapiens","LOC493869, GPX8, UNQ847/PRO1785","Probable glutathione peroxidase 8","1","3CYN"
"3CYU",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"27-32% PEG 3350, 0.05M Tris-sulfate, 3.5mM 2-mercaptoethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja802214x","OCR, 1CR, 0CR","3CYU",32.46,"1.7","1.7","Human Carbonic Anhydrase II complexed with Cryptophane biosensor and xenon","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3CYU"
"3CYY",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M CaCl2, 0.1M HEPES, 14%(w/v) polyethylene glycol 400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/emboj.2008.138",,"3CYY",22.53,"2.4","2.4","The crystal structure of ZO-1 PDZ2 in complex with the Cx43 peptide","AKPTKVTLVKSAKNEEYGLRLASHIFVKEISQDSLAARDGNIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKLKMVVQRDERATLLNVPD","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","3CYY"
,,,,,,,,,,,,,,,,"RPRPDDLEI",,,"peptide from Gap junction alpha-1 protein","2","3CYY"
"3CZ9",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M sodium citrate, 50 mM HEPES, 10 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi800282d",,"3CZ9",21.3,"1.15","1.15","Crystal Structure of E18L DJ-1","MASKRALVILAKGAEEMLTVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","3CZ9"
"3CZA",,"X-RAY DIFFRACTION",2.88,57.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M sodium citrate, 50 mM HEPES, 10 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi800282d",,"3CZA",21.08,"1.2","1.2","Crystal Structure of E18D DJ-1","MASKRALVILAKGAEEMDTVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLEHHHHHH","Homo sapiens","PARK7","Protein DJ-1","1","3CZA"
"3CZD",,"X-RAY DIFFRACTION",5.38,77.1,"VAPOR DIFFUSION, HANGING DROP",7,"1.4M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, 10mM L-glutamate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109",,"3CZD",35.12,"2.4","2.4","Crystal structure of human glutaminase in complex with L-glutamate","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform","1","3CZD"
"3CZH",,"X-RAY DIFFRACTION",3.85,68.09,"VAPOR DIFFUSION",6.5,"1.2M Ammonium sulfate, 0.1M ADA, pH 6.5, VAPOR DIFFUSION, temperature 291K",291,,,"3CZH",115.17,"2.3","2.3","Crystal structure of CYP2R1 in complex with vitamin D2","MAKKTKQRRPMGFPPGPPGLPFIGNIYSLAASSELPHVYMRKQSQVYGEIFSLDLGGISTVVLNGYDVVKECLVHQSEIFADRPCLPLFMKMTKMGGLLNSRYGRGWVDHRRLAVNSFRYFGYGQKSFESKILEETKFFNDAIETYKGRPFDFKQLITNAVSNITNLIIFGERFTYEDTDFQHMIELFSENVELAASASVFLYNAFPWIGILPFGKHQQLFRNAAVVYDFLSRLIEKASVNRKPQLPQHFVDAYLDEMDQGKNDPSSTFSKENLIFSVGELIIAGTETTTNVLRWAILFMALYPNIQGQVQKEIDLIMGPNGKPSWDDKCKMPYTEAVLHEVLRFCNIVPLGIFHATSEDAVVRGYSIPKGTTVITNLYSVHFDEKYWRDPEVFHPERFLDSSGYFAKKEALVPFSLGRRHCLGEHLARMEMFLFFTALLQRFHLHFPHELVPDLKPRLGMTLQPQPYLICAERRHHHHHH","Homo sapiens","CYP2R1","Cytochrome P450 2R1","1","3CZH"
"3CZR",,"X-RAY DIFFRACTION",3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",6.4,"16% PEG 3350, 0.1 M MES 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.bmcl.2008.05.025","3CZ","3CZR",66.19,"2.35","2.35","Crystal Structure of Human 11-beta-Hydroxysteroid Dehydrogenase (HSD1) in Complex with Arylsulfonylpiperazine Inhibitor","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3CZR"
"3CZT",,"X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, SITTING DROP",9,"0.02 M TAPS, pH 9.0, 30% PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bbamcr.2010.10.006",,"3CZT",10.91,"1.4","1.4","Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 9","MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE","Homo sapiens","S100B","Protein S100-B","1","3CZT"
"3CZV",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, HANGING DROP",5.6,"30% (w/v) PEG 4000, 0.2 M Ammonium acetate, 0.1 M Sodium citrate pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.22144","AZM","3CZV",59.92,"2","2","Crystal structure of the human carbonic anhydrase XIII in complex with acetazolamide","GSMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","3CZV"
"3CZY",,"X-RAY DIFFRACTION",1.89,34.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.16M ammonium sulfate, 0.9% 1,6-hexanediol, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm800505m",,"3CZY",55.52,"1.54","1.54","Crystal Structure of Human Heme Oxygenase-1 in Complex with 1-(Adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone","MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKRLHEVGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATKFKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRA","Homo sapiens","HMOX1, HO, HO1","Heme oxygenase 1","1","3CZY"
"3D05",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2M Sodium Acetate, 20% PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D05",22.5,"1.7","1.7","Human p53 core domain with hot spot mutation R249S (II)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3D05"
"3D06",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.15M Sodium acetate, 20% PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D06",22.5,"1.2","1.2","Human p53 core domain with hot spot mutation R249S (I)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3D06"
"3D07",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2M Sodium Acetate, 20% PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D07",45,"2.2","2.2","Human p53 core domain with hot spot mutation R249S (III)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3D07"
"3D08",,"X-RAY DIFFRACTION",2.25,45.45,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2M Sodium acetate, 20% PEG3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D08",22.52,"1.4","1.4","Human p53 core domain with hot spot mutation R249S and second-site suppressor mutation H168R","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQRMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3D08"
"3D09",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2M Sodium Acetate, 20% PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D09",22.49,"1.9","1.9","Human p53 core domain with hot spot mutation R249S and second-site suppressor mutations H168R and T123A","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVACTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQRMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3D09"
"3D0A",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2 M ammonium formate, 20% PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.10.063",,"3D0A",104.74,"1.8","1.8","Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQRMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRSPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","2","3D0A"
,,,,,,,,,,,,,,,,"CGGGCATGCCCG",,,"DNA (5'-D(*DCP*DGP*DGP*DGP*DCP*DAP*DTP*DGP*DCP*DCP*DCP*DG)-3')","1","3D0A"
"3D0B",,"X-RAY DIFFRACTION",2.84,56.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"Crystals were grown in 0.2M MgCl2, 0.1M Bis-Tris pH 6.5, and 20% PEG 
3350. Crystals were generated by adding 0.5ul protein to 0.5ul of 
reservoir in a sitting drop and incubating at 277K, VAPOR DIFFUSION, SITTING DROP",277,"10.1016/j.bmcl.2008.05.023","SNX","3D0B",26.53,"1.74","1.74","Crystal Structure of Benzamide Tetrahydro-4H-carbazol-4-one bound to Hsp90","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSD","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3D0B"
"3D0E",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION",8,"14% PEG 4K, 10% isopropanol, pH 8.0, vapor diffusion, temperature 298K",298,"10.1021/jm8004527","G93","3D0E",79,"2","2","Crystal structure of human Akt2 in complex with GSK690693","KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFDYSASIR","Homo sapiens","AKT2","RAC-beta serine/threonine-protein kinase","1","3D0E"
"3D0N",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 4000, 0.2 M ammonium acetate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.22144",,"3D0N",59.59,"1.55","1.55","Crystal structure of human carbonic anhydrase XIII","GSMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","3D0N"
"3D0Y",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5 21% PEG5000MME, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.bbamcr.2010.10.006",,"3D0Y",21.97,"1.5","1.5","Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 6.5","MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE","Homo sapiens","S100B","Protein S100-B","1","3D0Y"
,,,,,,,,,,,,,,,,"MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE","Homo sapiens","S100B","Protein S100-B","2","3D0Y"
"3D10",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, HANGING DROP",10,"0.02 M CAPS pH 10.0, 23% PEG5000MME, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bbamcr.2010.10.006",,"3D10",21.9,"1.65","1.65","Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 10.0","MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE","Homo sapiens","S100B","Protein S100-B","1","3D10"
"3D1N",,"X-RAY DIFFRACTION",2.9,57.61,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1 M K-Na Tartrate Tetrahydrate, 0.05 M MgCl2, 20 % PEG3350, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2009.05.003",,"3D1N",175.75,"2.51","2.51","Structure of human Brn-5 transcription factor in complex with corticotrophin-releasing hormone gene promoter","AGCATAAATAATAA",,,"5'-D(*DAP*DGP*DCP*DAP*DTP*DAP*DAP*DAP*DTP*DAP*DAP*DTP*DAP*DA)-3'","1","3D1N"
,,,,,,,,,,,,,,,,"TTATTATTTATGCT",,,"5'-D(*DTP*DTP*DAP*DTP*DTP*DAP*DTP*DTP*DTP*DAP*DTP*DGP*DCP*DT)-3'","2","3D1N"
,,,,,,,,,,,,,,,,"INMEEIREFAKNFKIRRLSLGLTQTQVGQAMTATEGPAYSQSAISRFEKLDITPKSAQKLKPVLEKWLNEAELRNQEGQQNLMEFVGGEPSKKRKRRTSFTPQAIEALNAYFEKNPLPTGQEITEMAKELNYDREVVRVWFSNRRQTLKNT","Homo sapiens","POU6F1, BRN5, MPOU, TCFB1","POU domain, class 6, transcription factor 1","3","3D1N"
"3D1V",,"X-RAY DIFFRACTION",4.92,75,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.05M CITRATE BUFFER, 19%AMMONIUM SULPHATE, PH 5.30, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.abb.2008.08.015","D1V","3D1V",32.65,"2.7","2.7","Crystal structure of human PNP complexed with 2-mercapto(3H) quinazolinone","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","Purine nucleoside phosphorylase","1","3D1V"
"3D24",,"X-RAY DIFFRACTION",2.47,50.28,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 15% PEG 3350, 0.2 M Mg(NO3)2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1074/jbc.M801920200",,"3D24",60.5,"2.11","2.11","Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha)","MRSHHHHHHGPGLVPRGSKTAAPVNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREALHEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFLEMLEAMMD","Homo sapiens","ESRRA, ERR1, ESRL1, NR3B1","Steroid hormone receptor ERR1","1","3D24"
,,,,,,,,,,,,,,,,"QQQKPQRRPCSELLKYLTTNDD",,,"Peroxisome proliferator-activated receptor gamma coactivator 1-alpha","2","3D24"
"3D2N",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION",7.2,"20% PEG 4000, 0.1M sodium citrate, 20 % isopropanol, pH 7.2, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nsmb.1519",,"3D2N",9.75,"2.7","2.7","Crystal structure of MBNL1 tandem zinc finger 1 and 2 domain","SRDTKWLTLEVCREFQRGTCSRPDTECKFAHPSKSCQVENGRVIACFDSLKGRCSRENCKYLHPPPHLKTQLEINGRNNLIQQ","Homo sapiens","MBNL1, EXP, KIAA0428, MBNL","Muscleblind-like protein 1","1","3D2N"
"3D2Q",,"X-RAY DIFFRACTION",1.95,36.79,"VAPOR DIFFUSION",6.8,"18% PEG 3350, 0.1M Mg acetate, 0.2 M sodium fluoride, pH 6.8, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nsmb.1519",,"3D2Q",33.2,"1.5","1.5","Crystal structure of MBNL1 tandem zinc finger 3 and 4 domain","SRTDRLEVCREYQRGNCNRGENDCRFAHPADSTMIDTNDNTVTVCMDYIKGRCSREKCKYFHPPAHLQAK","Homo sapiens","MBNL1, EXP, KIAA0428, MBNL","Muscleblind-like protein 1","1","3D2Q"
"3D2R",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9M ammonium sulfate, 4% polyethylene glycol 400, 100 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M802249200","ADP","3D2R",90.64,"2.03","2.03","Crystal structure of pyruvate dehydrogenase kinase isoform 4 in complex with ADP","ASVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM","Homo sapiens","PDK4, PDHK4","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4","1","3D2R"
"3D2S",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION",5.5,"25% PEG 3350, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nsmb.1519",,"3D2S",40.67,"1.7","1.7","Crystal structure of MBNL1 tandem zinc finger 3 and 4 domain in complex with CGCUGU RNA","CGCUGU",,,"5'-R(*CP*GP*CP*UP*GP*U)-3'","1","3D2S"
,,,,,,,,,,,,,,,,"SRTDRLEVCREYQRGNCNRGENDCRFAHPADSTMIDTNDNTVTVCMDYIKGRCSREKCKYFHPPAHLQAK","Homo sapiens","MBNL1, EXP, KIAA0428, MBNL","Muscleblind-like protein 1","2","3D2S"
"3D2T",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",7,"5-7 mg/ml protein, in 0.3 M AMMONIUM SULFATE, 100 MM KCL, 1 MM EDTA, 10 MM SODIUM PHOSPHATE equilibrated against 2 M ammonium sulfate; SOAKED WITH THE INHIBITOR., pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/jm030347n","1FL","3D2T",28.06,"1.85","1.85","Human transthyretin (ttr) complexed with diflunisal","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3D2T"
"3D34",,"X-RAY DIFFRACTION",1.92,35.96,"VAPOR DIFFUSION, HANGING DROP",9,"0-6% PEG2000, 100mM Tris-HCl, 10mM NiCl2, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/emboj.2008.288",,"3D34",49.77,"1.8","1.8","Structure of the F-spondin domain of mindin","QPLGGESICSARAPAKYSITFTGKWSQTAFPKQYPLFRPPAQWSSLLGAAHSSDYSMWRKNQYVSNGLRDFAERGEAWALMKEIEAAGEALQSVHEVFSAPAVPSGTGQTSAELEVQRRHSLVSFVVRIVPSPDWFVGVDSLDLCDGDRWREQAALDLYPYDAGTDSGFTFSSPNFATIPQDTVTEITSSSPSHPANSFYYPRLKALPPIARVTLLRLRQSPR","Homo sapiens","SPON2, DIL1, UNQ435/PRO866","Spondin-2","1","3D34"
"3D3E",,"X-RAY DIFFRACTION",2.51,50.92,,6.4,"19% PEG 3350, 0.1 M MES 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/jm800310g","D3E","3D3E",132.05,"2.6","2.6","Crystal Structure of Human 11-beta-Hydroxysteroid Dehydrogenase (HSD1) in Complex with Benzamide Inhibitor","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3D3E"
"3D3J",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 6000, sodium cacodylate, magnesium acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1128/MCB.00761-08",,"3D3J",34.17,"2.8","2.8","Crystal structure of human Edc3p","DFDFEGNLALFDKAAVFEEIDTYERRSGTRSRGIPNERPTRYRHDENILESEPIVYRRIIVPHNVSKEFCTDSGLVVPSISYELHKKLLSVAEKHGLTLERRLEMTGVCASQMALTLLGGPNRLNPKNVHQRPTVALLCGPHVKGAQGISCGRHLANHDVQVILFLPNFVKMLESITNELSLFSKTQGQQVSSLKDLPTSPVDLVINCLDCPENVFLRDQPWYKAAVAWANQNRAPVLSIDPPVHEVEQGIDAKWSLALGLPLPLGEHAGRIYLCDIGIPQQVFQEVGINYHSPFGCKFVIPLHSA","Homo sapiens","EDC3, LSM16, YJDC, YJEFN2, PP844","Enhancer of mRNA-decapping protein 3","1","3D3J"
"3D3K",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/MCB.00761-08",,"3D3K",114.35,"2.2","2.2","Crystal structure of human Edc3p","ILESEPIVYRRIIVPHNVSKEFCTDSGLVVPSISYELHKKLLSVAEKHGLTLERRLEMTGVCASQMALTLLGGPNRLNPKNVHQRPTVALLCGPHVKGAQGISCGRHLANHDVQVILFLPNFVKMLESITNELSLFSKTQGQQVSSLKDLPTSPVDLVINCLDCPENVFLRDQPWYKAAVAWANQNRAPVLSIDPPVHEVEQGIDAKWSLALGLPLPLGEHAGRIYLCDIGIPQQVFQEVGINYHSPFGCKFVIPLHSA","Homo sapiens","EDC3, LSM16, YJDC, YJEFN2, PP844","Enhancer of mRNA-decapping protein 3","1","3D3K"
"3D3L",,"X-RAY DIFFRACTION",2.25,45.38,"VAPOR DIFFUSION, SITTING DROP",4,"1.0M LiCl2, 0.1M Citric acid pH 4.0, 20% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3D3L",122.43,"2.6","2.6","The 2.6 A crystal structure of the lipoxygenase domain of human arachidonate 12-lipoxygenase, 12S-type","MHHHHHHSSGVDLGTENLDFEWTLKAGALEMALKRVYTLLSSWNCLEDFDQIFWGQKSALAEKVRQCWQDDELFSYQFLNGANPMLLRRSTSLPSRLVLPSGMEELRAQLEKELQNGSLFEADFILLDGIPANVIRGEKQYLAAPLVMLKMEPNGKLQPMVIQIQPPNPSSPTPTLFLPSDPPLAWLLAKSWVRNSDFQLHEIQYHLLNTHLVAEVIAVATMRCLPGLHPIFKFLIPHIRYTMEINTRARTQLISDGGIFDKAVSTGGGGHVQLLRRAAAQLTYCSLCPPDDLADRGLLGLPGALYAHDALRLWEIIARYVEGIVHLFYQRDDIVKGDPELQAWCREITEVGLCQAQDRGFPVSFQSQSQLCHFLTMCVFTCTAQHAAINQGQLDWYAWVPNAPCTMRMPPPTTKEDVTMATVMGSLPDVRQACLQMAISWHLSRRQPDMVPLGHHKEKYFSGPKPKAVLNQFRTDLEKLEKEITARNEQLDWPYEYLKPSCIENSVTSDSKGGYGSEFELRRQACGRTRAPPPPPLRSGC","Homo sapiens","ALOX12, LOG12, 12LO","Arachidonate 12-lipoxygenase, 12S-type","1","3D3L"
"3D3M",,"X-RAY DIFFRACTION",2.18,43.71,"Microbatch under oil",6,"100mM MMT (D,L Maleic acid, MES and Tris) pH=6,  
and 20% PEG 1,500, Microbatch under oil, temperature 293K",293,"10.1016/j.jmb.2008.08.013",,"3D3M",39.32,"1.9","1.9","The Crystal Structure of the C-terminal region of Death Associated Protein 5(DAP5)","LLKLEKELLKQIKLDPSPQTIYKWIKDNISPKLHVDKGFVNILMTSFLQYISSEVNPPSDETDSSSAPSKEQLEQEKQLLLSFKPVMQKFLHDHVDLQVSALYALQVHCYNSNFPKGMLLRFFVHFYDMEIIEEEAFLAWKEDITQEFPGKGKALFQVNQWLTWLETA","Homo sapiens","EIF4G2, DAP5, OK/SW-cl.75","Eukaryotic translation initiation factor 4 gamma 2","1","3D3M"
"3D3P",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION, SITTING DROP",6.5,"14-18% PEG 3000, 10% Glycerol, 50mM Sodium Cacodylate pH 6.5, 100mM Sodium Acetate, 1M Sodium Chloride, 1% DMF, 5mM DTT, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.05.052","20A","3D3P",41.28,"1.75","1.75","Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor","MSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLM","Homo sapiens","PDE4B, DPDE4","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","3D3P"
"3D3W",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG8000, POTASSIUM DIHYDROGENPHOSPHATE, MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K",295,"10.1007/s00018-009-9065-y",,"3D3W",53.48,"1.87","1.87","Structure of L-Xylulose Reductase with bound coenzyme, phosphate and hydroxide.","MELFLAGRRVLVTGAGKGIGRGTVQALHATGARVVAVSRTQADLDSLVRECPGIEPVCVDLGDWEATERALGSVGPVDLLVNNAAVALLQPFLEVTKEAFDRSFEVNLRAVIQVSQIVARGLIARGVPGAIVNVSSQCSQRAVTNHSVYCSTKGALDMLTKVMALELGPHKIRVNAVNPTVVMTSMGQATWSDPHKAKTMLNRIPLGKFAEVEHVVNAILFLLSDRSGMTTGSTLPVEGGFWAC","Homo sapiens","DCXR, SDR20C1","L-xylulose reductase","1","3D3W"
,,,,,,,,,,,,,,,,"MELFLAGRRVLVTGAGKGIGRGTVQALHATGARVVAVSRTQADLDSLVRECPGIEPVCVDLGDWEATERALGSVGPVDLLVNNAAVALLQPFLEVTKEAFDRSFEVNLRAVIQVSQIVARGLIARGVPGAIVNVSSQCSQRAVTNHSVYCSTKGALDMLTKVMALELGPHKIRVNAVNPTVVMTSMGQATWSDPHKAKTMLNRIPLGKFAEVEHVVNAILFLLSDRSGMTTGSTLPVEGGFWAC","Homo sapiens","DCXR, SDR20C1","L-xylulose reductase","2","3D3W"
"3D42",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",6.6,"0.2 M AMMONIUM TARTRATE DIBASIC, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi801724n",,"3D42",36.48,"2.46","2.46","Crystal structure of HePTP in complex with a monophosphorylated Erk2 peptide","MGSDKIHHHHHHNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKDILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPDHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHSSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIQTAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","3D42"
,,,,,,,,,,,,,,,,"LTEYVATR",,,"Mitogen-activated protein kinase 1 peptide","2","3D42"
"3D44",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, SITTING DROP",5,"1.0 M LITHIUM CHLORIDE, 0.1 M CITRATE, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi801724n",,"3D44",36.45,"1.9","1.9","Crystal structure of HePTP in complex with a dually phosphorylated Erk2 peptide mimetic","MGSDKIHHHHHHNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKDILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPDHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHSSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIQTAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","3D44"
,,,,,,,,,,,,,,,,"LDEYVATR",,,"Mitogen-activated protein kinase 1 peptide","2","3D44"
"3D4J",,"X-RAY DIFFRACTION",2.39,46.6,"VAPOR DIFFUSION",6.5,"MES buffer, PEG5KMME, Ammonium Sulfate, NaCl, pH 6.5, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.abb.2008.08.024",,"3D4J",87.1,"2.4","2.4","Crystal structure of Human mevalonate diphosphate decarboxylase","MASEKPLAAVTCTAPVNIAVIKYWGKRDEELVLPINSSLSVTLHQDQLKTTTTAVISKDFTEDRIWLNGREEDVGQPRLQACLREIRCLARKRRNSRDGDPLPSSLSCKVHVASVNNFPTAAGLASSAAGYACLAYTLARVYGVESDLSEVARRGSGSACRSLYGGFVEWQMGEQADGKDSIARQVAPESHWPELRVLILVVSAEKKLTGSTVGMRASVETSPLLRFRAESVVPARMAEMARCIRERDFPSFAQLTMKDSNQFHATCLDTFPPISYLNAISWRIIHLVHRFNAHHGDTKVAYTFDAGPNAVIFTLDDTVAEFVAAVWHGFPPGSNGDTFLKGLQVRPAPLSAELQAALAMEPTPGGVKYIIVTQVGPGPQILDDPCAHLLGPDGLPKPAA","Homo sapiens","MVD, MPD","Diphosphomevalonate decarboxylase","1","3D4J"
"3D4L",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2008.05.061","605","3D4L",174.83,"2","2","Human dipeptidyl peptidase IV/CD26 in complex with a novel inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","3D4L"
"3D4N",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION",6.4,"19% PEG 3350, 0.1 M MES 6.4, vapor diffusion, temperature 289K",289,"10.1021/jm800310g","D4N","3D4N",132.12,"2.5","2.5","Crystal Structure of Human 11-beta-Hydroxysteroid Dehydrogenase (HSD1) in Complex with Sulfonamide Inhibitor","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3D4N"
"3D4Q",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, HANGING DROP",7.8,"5% PEG 3350 
0.1M Tris 
10% Tacsimate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1016/j.bmcl.2008.07.002","SM5","3D4Q",71.18,"2.8","2.8","Pyrazole-based inhibitors of B-Raf kinase","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","B-Raf proto-oncogene serine/threonine-protein kinase","1","3D4Q"
"3D57",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, HANGING DROP",7,"25% ethylene glycol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22225","4HY","3D57",61.6,"2.2","2.2","TR Variant D355R","MGSSHHHHHHSQDPGHKPEPTDEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNAPEGGKVDLEAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVTRGQLKNGGLGVVSDAIFRLGMSLSSFNLDDTEVALLQAVLLMSSDRPGLACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFE","Homo sapiens","7068, ERBA2, NR1A2, THR1, THRB","Thyroid hormone receptor beta","1","3D57"
"3D59",,"X-RAY DIFFRACTION",2.47,49.36,,6.6,"PH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K, pH 6.60",293,"10.1074/jbc.M804750200",,"3D59",88.89,"1.5","1.5","Crystal structure of human plasma platelet activating factor acetylhydrolase","AAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","3D59"
"3D5E",,"X-RAY DIFFRACTION",2.47,49.36,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M804750200",,"3D5E",88,"2.1","2.1","Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited by paraoxon","AAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","3D5E"
"3D5F",,"X-RAY DIFFRACTION",2.86,57.01,"VAPOR DIFFUSION",6.5,"PEG 8000, pH 6.5, vapor diffusion, temperature 298K",298,,"L41","3D5F",61.94,"2.2","2.2","Crystal Structure of PPAR-delta complex","LKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQQLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","3D5F"
"3D5Q",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION",6.4,"19% PEG 3350, 0.1 M MES 6.4, vapor diffusion, temperature 289K",289,"10.1016/j.bmc.2008.08.065","T30","3D5Q",124.51,"2.55","2.55","Crystal Structure of 11b-HSD1 in Complex with Triazole Inhibitor","QPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3D5Q"
"3D66",,"X-RAY DIFFRACTION",3.61,65.89,"VAPOR DIFFUSION",6,"16-18% PEG 3000, 0.18-0.22mM Na/K-tartrate, 50mM L-glutamate, 50 mM L-arginine, pH 6.0, VAPOR DIFFUSION, temperature 277K",277,"10.1182/blood-2008-03-146001",,"3D66",148.19,"3.1","3.1","Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)","GSHHHHHHDYDIPSSENLYFQGSAQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYYEQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQTAKNAIWIDCGIHAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKTSKNTRYTHGHGSETLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVIRNV","Homo sapiens","CPB2","Carboxypeptidase B2","1","3D66"
"3D67",,"X-RAY DIFFRACTION",3.56,65.49,"VAPOR DIFFUSION",6,"16-18% PEG 3000, 0.18-0.22mM Na/K-tartrate, 50mM L-glutamate, 50mM L-arginine, 1mM GEMSA, pH 6.0, VAPOR DIFFUSION, temperature 277K",277,"10.1182/blood-2008-03-146001","GEM","3D67",149.34,"3.4","3.4","Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) in complex with 2-guanidino-ethyl-mercaptosuccinic acid (GEMSA)","GSHHHHHHDYDIPSSENLYFQGSAQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYYEQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQTAKNAIWIDCGIHAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKTSKNTRYTHGHGSETLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVIRNV","Homo sapiens","CPB2","Carboxypeptidase B2","1","3D67"
"3D68",,"X-RAY DIFFRACTION",3.5,64.81,"VAPOR DIFFUSION",6,"16-18% PEG 3000, 0.18-0.22mM Na/K-tartrate, 50mM L-glutamate, 50mM L-arginine, pH 6.0, VAPOR DIFFUSION, temperature 277K",277,"10.1182/blood-2008-03-146001",,"3D68",149.28,"2.8","2.8","Crystal structure of a T325I/T329I/H333Y/H335Q mutant of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI-IIYQ)","GSHHHHHHDYDIPSSENLYFQGSAQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYYEQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQTAKNAIWIDCGIHAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKISKNIRYTYGQGSETLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVIRNV","Homo sapiens","CPB2","Carboxypeptidase B2","1","3D68"
"3D69",,"X-RAY DIFFRACTION",4.45,72.37,"VAPOR DIFFUSION",7.5,"3.0M ammonium sulfate, 0.1M HEPES, 2%MPD, pH7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M314011200",,"3D69",93.5,"3.77","3.77","Crystal Structure of the Fab Fragment of an Anti-Factor IX Antibody 10C12","QSVLTQPPSVSAAPGQKVTISCSGSTSNIGNNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNSASLDISGLQSEDEADYYCAAWDDSLSEFLFGTGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"anti-factor IX antibody, 10C12","1","3D69"
,,,,,,,,,,,,,,,,"GVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAIISYDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARASIAAARVLDYWGRGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"anti-factor IX antibody, 10C12","2","3D69"
"3D6D",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15M Tris, pH8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm800733h","LRG","3D6D",65.38,"2.4","2.4","Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3D6D"
"3D6F",,"X-RAY DIFFRACTION",2.73,54.99,"VAPOR DIFFUSION, HANGING DROP",6,"Crystals obtained by hanging-drop vapor diffusion at 4  C (277K) against a reservoir of 0.1 M PIPES pH 6.0, 75-175 mM (NH4)2SO4, 25% PEG 2000 MME, 10 mM DTT, 3 mM NaN3, and 2 mM MgCl2. All crystals cryoprotected in mother liquors supplemented with 20% (v/v) glycerol for 30-90 sec and immersion in liquid nitrogen., VAPOR DIFFUSION, HANGING DROP",277,,,"3D6F",30.83,"1.9","1.9","Crystal structure of human caspase-1 with a naturally-occurring Arg240->Gln substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK)","MNPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIQEGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKD","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","1","3D6F"
,,,,,,,,,,,,,,,,"MAIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","2","3D6F"
,,,,,,,,,,,,,,,,"XVADX",,,"N-[(benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxobutan-2-yl]-L-alaninamide","3","3D6F"
"3D6G",,"X-RAY DIFFRACTION",2.88,57.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"10-20% PEG 20K, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jp909405b",,"3D6G",52.65,"2.3","2.3","Fc fragment of IgG1 (Herceptin) with protein-A mimetic peptide dendrimer ligand.","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSP","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3D6G"
"3D6H",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, HANGING DROP",6,"Crystals obtained by hanging-drop vapor diffusion at 4  C (277K) against a reservoir of 0.1 M PIPES pH 6.0, 75-175 mM (NH4)2SO4, 25% PEG 2000 MME, 10 mM DTT, 3 mM NaN3, and 2 mM MgCl2. All crystals cryoprotected in mother liquors supplemented with 20% (v/v) glycerol for 30-90 sec and immersion in liquid nitrogen.                    , VAPOR DIFFUSION, HANGING DROP",277,,,"3D6H",30.84,"2","2","Crystal structure of human caspase-1 with a naturally-occurring Asn263->Ser substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK)","MNPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQVPDILQLNAIFSMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKD","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","1","3D6H"
,,,,,,,,,,,,,,,,"MAIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1 precursor","2","3D6H"
,,,,,,,,,,,,,,,,"XVADX",,,"N-[(benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxobutan-2-yl]-L-alaninamide","3","3D6H"
"3D6M",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, HANGING DROP",6,"Crystals obtained by hanging-drop vapor diffusion at 4  C (277K) against a reservoir of 0.1 M PIPES pH 6.0, 75-175 mM (NH4)2SO4, 25% PEG 2000 MME, 10 mM DTT, 3 mM NaN3, and 2 mM MgCl2. All crystals cryoprotected in mother liquors supplemented with 20% (v/v) glycerol for 30-90 sec and immersion in liquid nitrogen., VAPOR DIFFUSION, HANGING DROP",277,,,"3D6M",30.89,"1.8","1.8","Crystal structure of human caspase-1 with a naturally-occurring Lys319->Arg substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK)","MNPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKD","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","1","3D6M"
,,,,,,,,,,,,,,,,"MAIRKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","2","3D6M"
,,,,,,,,,,,,,,,,"XVADX",,,"N-[(benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxobutan-2-yl]-L-alaninamide","3","3D6M"
"3D6T",,"X-RAY DIFFRACTION",1.85,33.49,"VAPOR DIFFUSION, SITTING DROP",8,"30% PEG 4000, 100mM MgCl2, 0.1M Tris, 5mM GTP, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0709098105",,"3D6T",20.27,"2.43","2.43","Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase","MKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTII","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","3D6T"
"3D7C",,"X-RAY DIFFRACTION",2.36,47.95,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl pH 8.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3D7C",26.57,"2.06","2.06","Crystal structure of the bromodomain of human GCN5, the general control of amino-acid synthesis protein 5-like 2","SMEDPDQLYTTLKNLLAQIKSHPSAWPFMEPVKKSEAPDYYEVIRFPIDLKTMTERLRSRYYVTRKLFVADLQRVIANCREYNPPDSEYCRCASALEKFFYFKLKEGGLIDK","Homo sapiens","GCN5L2, GCN5, HGCN5, KAT2A","General control of amino acid synthesis protein 5-like 2","1","3D7C"
"3D7D",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm800765e","FBD","3D7D",83.32,"1.69","1.69","A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCFBD, a urea-based inhibitor","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3D7D"
"3D7F",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm800765e","YBY","3D7F",83.39,"1.54","1.54","A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCIT, a urea-based inhibitor","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3D7F"
"3D7G",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm800765e","MUD","3D7G",83.22,"1.75","1.75","A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCMC, a urea-based inhibitor","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3D7G"
"3D7H",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm800765e","YC2","3D7H",83.46,"1.55","1.55","A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCIBzL, a urea-based inhibitor","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3D7H"
"3D7P",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, HANGING DROP",4,"TTR pH 4.0 crystals were grown in the presence of 0.1 M sodium acetate (pH 4.0), 100 mM KCl, 1 mM EDTA and 0.3-0.5 M ammonium sulfate which was equilibrated against 2 M ammonium sulfate in hanging drop, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.jmb.2008.07.029",,"3D7P",27.55,"1.72","1.72","Crystal structure of human Transthyretin (TTR) at pH 4.0","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3D7P"
"3D7Z",,"X-RAY DIFFRACTION",2.96,58.5,"VAPOR DIFFUSION",6.5,"Authors suggest to see publication for details, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2008.06.048","GK5","3D7Z",41.9,"2.1","2.1","Crystal Structure of P38 Kinase in Complex with a biphenyl amide inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3D7Z"
"3D83",,"X-RAY DIFFRACTION",3.07,59.97,"VAPOR DIFFUSION",6.5,"Authors suggest to see publication for details, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2008.06.028","GK6","3D83",41.94,"1.9","1.9","Crystal structure of P38 kinase in complex with a biphenyl amide inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3D83"
"3D8B",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M NaCl, 0.1M Bis-Tris, 0.02M ADP, 0.01M MgCl2, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3D8B",79.87,"2","2","Crystal structure of human fidgetin-like protein 1 in complex with ADP","MHHHHHHSSGVDLGTENLYFQSMVPPIPKQDGGEQNGGMQCKPYGAGPTEPAHPVDERLKNLEPKMIELIMNEIMDHGPPVNWEDIAGVEFAKATIKEIVVWPMLRPDIFTGLRGPPKGILLFGPPGTGKTLIGKCIASQSGATFFSISASSLTSKWVGEGEKMVRALFAVARCQQPAVIFIDEIDSLLSQRGDGEHESSRRIKTEFLVQLDGATTSSEDRILVVGATNRPQEIDEAARRRLVKRLYIPLPEASARKQIVINLMSKEQCCLSEEEIEQIVQQSDAFSGADMTQLCREASLGPIRSLQTADIATITPDQVRPIAYIDFENAFRTVRPSVSPKDLELYENWNKTFGCGK","Homo sapiens","FIGNL1","Fidgetin-like protein 1","1","3D8B"
"3D8C",,"X-RAY DIFFRACTION",3.08,63,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG400, 0.1M HEPES PH7.5, 24MG/ML PROTEIN WITH 1MM FE(II)SO4, 1MM ALPHA-KETOGLUTARATE, 1MM HIF-1ALPHA PEPTIDE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K, PH 7.50",298,"10.1074/jbc.M804999200",,"3D8C",42.82,"2.1","2.1","Factor inhibiting HIF-1 alpha D201G mutant in complex with ZN(II), alpha-ketoglutarate and HIF-1 alpha 19mer","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYGEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1 alpha inhibitor","1","3D8C"
,,,,,,,,,,,,,,,,"DESGLPQLTSYDCEVNAPI",,,"HYPOXIA-INDUCIBLE FACTOR 1 ALPHA","2","3D8C"
"3D8D",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION",7.5,"100mM HEPES, 5% (v/v) ethylene glycol, 8% (w/v) PEG 3350, 1mM CH3HgCl, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M800861200",,"3D8D",34.83,"2.2","2.2","Crystal structure of the human Fe65-PTB1 domain","GIKCFAVRSLGWVEMTEEELAPGRSSVAVNNCIRQLSYHKNNLHDPMSGGWGEGKDLLLQLEDETLKLVEPQSQALLHAQPIISIRVWGVGRDSGRERDFAYVARDKLTQMLKCHVFRCEAPAKNIATSLHEICSKIMAELEHHHHHH","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 precursor protein-binding family B member 1","1","3D8D"
"3D8E",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION",7.5,"100mM HEPES, 5% (v/v) ethylene glycol, 10% (w/v) PEG 3350, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M800861200",,"3D8E",67.13,"2.8","2.8","Crystal structure of the human Fe65-PTB1 domain (trigonal crystal form)","GIKCFAVRSLGWVEMTEEELAPGRSSVAVNNCIRQLSYHKNNLHDPMSGGWGEGKDLLLQLEDETLKLVEPQSQALLHAQPIISIRVWGVGRDSGRERDFAYVARDKLTQMLKCHVFRCEAPAKNIATSLHEICSKIMAELEHHHHHH","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 precursor protein-binding family B member 1","1","3D8E"
"3D8F",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION",7.5,"100mM HEPES, 5% (v/v) ethylene glycol, 50mM Na2HPO4, 10% (w/v) PEG 3350, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M800861200",,"3D8F",67.32,"2.7","2.7","Crystal structure of the human Fe65-PTB1 domain with bound phosphate (trigonal crystal form)","GIKCFAVRSLGWVEMTEEELAPGRSSVAVNNCIRQLSYHKNNLHDPMSGGWGEGKDLLLQLEDETLKLVEPQSQALLHAQPIISIRVWGVGRDSGRERDFAYVARDKLTQMLKCHVFRCEAPAKNIATSLHEICSKIMAELEHHHHHH","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 precursor protein-binding family B member 1","1","3D8F"
"3D8W",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, HANGING DROP",7.8,"100mM tris-HCl, 1.3 m Sodium citrate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","D8W","3D8W",29.67,"1.7","1.7","Use of a carbonic Anhydrase II, IX Active-site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase II","1","3D8W"
"3D90",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG3350, x300mM MgSO4, 10% Glycerol 10%, 50mM PIPES, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1124/mol.108.054312",,"3D90",60.1,"2.26","2.26","Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel","SPGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","Progesterone receptor","1","3D90"
"3D91",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, SITTING DROP",4.75,"26% PEG4000, 0.6M NaCl, 0.1M Citrate , pH 4.75, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"REM","3D91",76.23,"2.2","2.2","Human renin in complex with remikiren","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALARH","Homo sapiens","REN","Renin","1","3D91"
"3D92",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3M sodium citrate, 100mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M805353200",,"3D92",29.63,"1.1","1.1","Human carbonic anhydrase II bound with substrate carbon dioxide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","HCA2, CA2","carbonic anhydrase II","1","3D92"
"3D93",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M Ammonium citrate, 100 mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M805353200",,"3D93",29.47,"1.1","1.1","Apo Human carbonic anhydrase II bound with substrate carbon dioxide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","HCA2, CA2","carbonic anhydrase II","1","3D93"
"3D94",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION",7.5,"12% PEG8000, 0.1 M imidazole, pH 7.5 and 0.2 M calcium acetate, VAPOR DIFFUSION, temperature 293K",293,"10.1038/emboj.2008.116","D94","3D94",34.98,"2.3","2.3","Crystal structure of the insulin-like growth factor-1 receptor kinase in complex with PQIP","VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK","Homo sapiens","IGF1R","Insulin-like growth factor 1 receptor beta chain","1","3D94"
"3D95",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, HANGING DROP",5.8,"20% (W/V) PEG 6000, 0.1 M SODIUM ACETATE, 5% ETHANOL, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444908032216",,"3D95",31.02,"1.2","1.2","Crystal Structure of the R132K:Y134F:R111L:L121E:T54V Mutant of Apo-Cellular Retinoic Acid Binding Protein Type II at 1.20 Angstroms Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKVSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELIETMTADDVVCTKVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","3D95"
"3D96",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% (W/V) PEG 4000, 0.1 M TRIS-HCL, 0.2 M SODIUM ACETATE, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444908032216",,"3D96",31.13,"1.71","1.71","Crystal Structure of the R132K:Y134F Mutant of Apo-Cellular Retinoic Acid Binding Protein Type II at 1.71 Angstroms Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTKVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","3D96"
"3D97",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% (w/v) PEG 4000, 0.1 M Bis-TRIS Propane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3D97",31.38,"1.5","1.5","Crystal Structure of the R132K:R111L:L121E Mutant of Apo-Cellular Retinoic Acid Binding Protein Type II At 1.50 Angstroms Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELIETMTADDVVCTKVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","3D97"
"3D9C",,"X-RAY DIFFRACTION",3.25,66.67,"VAPOR DIFFUSION, HANGING DROP",7.7,"20% w/v PEG 3350, 200 mM Magnesium Acetate tetrahydrate, 100 mM HEPES, pH 7.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja804489m",,"3D9C",37.77,"2.3","2.3","Crystal Structure PTP1B complex with aryl Seleninic acid","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","3D9C"
"3D9H",,"X-RAY DIFFRACTION",2.96,58.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Imidazole pH 6.5, 1.0M Sodium acetate trihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"3D9H",30.43,"2.2","2.2","Crystal Structure of the Splice Variant of Human ASB9 (hASB9-2), an Ankyrin Repeat Protein","MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESDLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQGKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPLAQLFLEREGASLPKPKP","Homo sapiens","hASB9-2, ASB9","cDNA FLJ77766, highly similar to Homo sapiens ankyrin repeat and SOCS box-containing 9 (ASB9), transcript variant 2, mRNA","1","3D9H"
"3D9I",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M citric acid, 2.8 M (NH4)2SO4, 1% (v/v) glycerol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9I",35.38,"1.907","1.907","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLMDMKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9I"
"3D9J",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M citric acid, 2.8 M (NH4)2SO4, 1% (v/v) glycerol , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9J",35.43,"1.6","1.6","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9J"
"3D9K",,"X-RAY DIFFRACTION",2.27,45.84,"VAPOR DIFFUSION, HANGING DROP",,"1.2M Li2SO4, 1.6M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9K",38.3,"2.2","2.2","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9K"
,,,,,,,,,,,,,,,,"YSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9K"
"3D9L",,"X-RAY DIFFRACTION",2.28,46.02,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M potassium thiocyanate, 30% (w/v) PEG2000MME, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9L",37.72,"2.2","2.2","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9L"
,,,,,,,,,,,,,,,,"XYSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9L"
"3D9M",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, HANGING DROP",,"1.2M Li2SO4, 1.6M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9M",37.82,"1.75","1.75","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9M"
,,,,,,,,,,,,,,,,"YSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9M"
"3D9N",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, HANGING DROP",,"3.2 M (NH4)2SO4, 1% (v/v) ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9N",38.4,"1.6","1.6","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9N"
,,,,,,,,,,,,,,,,"YSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9N"
"3D9O",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, HANGING DROP",,"1.2M Li2SO4, 1.6M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9O",36.39,"2","2","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLMDMKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVRVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9O"
,,,,,,,,,,,,,,,,"YSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9O"
"3D9P",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, HANGING DROP",,"1.2 M Li2SO4, 1.6 M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M803540200",,"3D9P",38.28,"2.1","2.1","Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy-Terminal Domain of RNA-Polymerase II","MEAVKTFNSELYSLNDYKPPISKAKMTQITKAAIKAIKFYKHVVQSVEKFIQKCKPEYKVPGLYVIDSIVRQSRHQFGQEKDVFAPRFSNNIISTFQNLYRCPGDDKSKIVTVLNLWQKNNVFKSEIIQPLLDMAAALEHHHHHH","Homo sapiens","RBM16, KIAA1116, SCAF8, CCAP7","RNA-binding protein 16","1","3D9P"
,,,,,,,,,,,,,,,,"YSPTSPSYSPTSPS",,,"CTD-PEPTIDE","2","3D9P"
"3D9S",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",7.6,"19% polyethylene glycol 400, 0.1M Tris HCl pH 7.6, 0.1M NaCl, 6% v/v 1,6-hexanediol, 3% v/v 1,4-butanediol or 3% v/v 1,3-propanediol, VAPOR DIFFUSION, HANGING DROP, temperature 281K",281,"10.1073/pnas.0801466105",,"3D9S",114.16,"2","2","Human Aquaporin 5 (AQP5) - High Resolution X-ray Structure","MSKKEVCSVAFLKAVFAEFLATLIFVFFGLGSALKWPSALPTILQIALAFGLAIGTLAQALGPVSGGHINPAITLALLVGNQISLLRAFFYVAAQLVGAIAGAGILYGVAPLNARGNLAVNALNNNTTQGQAMVVELILTFQLALCIFASTDSRRTSPVGSPALSIGLSVTLGHLVGIYFTGCSMNPARSFGPAVVMNRFSPAHWVFWVGPIVGAVLAAILYFYLLFPNSLSLSERVAIIKGTYEPDEDWEEQREERKKTMELTTR","Homo sapiens","AQP5","Aquaporin-5","1","3D9S"
"3D9T",,"X-RAY DIFFRACTION",2.67,53.92,"VAPOR DIFFUSION, HANGING DROP",,"3.1M NA FORMATE,10% GLYCEROL,1.5MM PEPTIDE, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444908039243",,"3D9T",23.86,"1.5","1.5","CIAP1-BIR3 in complex with N-terminal peptide from Caspase-9 (ATPFQE)","GPGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","BIRC2, API1, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","3D9T"
,,,,,,,,,,,,,,,,"ATPFQE",,,"Caspase-9","2","3D9T"
"3D9U",,"X-RAY DIFFRACTION",2.8,56.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M BIS-TRIS PH 6.5, 0.2 M MGCL2, 22% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444908039243",,"3D9U",11.84,"2.3","2.3","The BIR3 domain of cIAP1 in complex with the N terminal peptide from SMAC/DIABLO (AVPIAQ).","GPGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","BIRC2, API1, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","3D9U"
,,,,,,,,,,,,,,,,"AVPIAQ",,,"SMAC/DIABLO","2","3D9U"
"3D9V",,"X-RAY DIFFRACTION",4.65,73.52,"VAPOR DIFFUSION",5.5,"4.5% PEG3350, 100mM MES, PH 5.5,0.45mM PROTEIN, 50mM CACL2, 10mM DTT, pH 5.50, vapor diffusion, temperature 298K",298,"10.1074/jbc.M508847200","H52","3D9V",96.66,"3.3","3.3","CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI-METHYLATED VARIANT OF FASUDIL","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","3D9V"
"3D9Z",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","D9Z","3D9Z",29.63,"1.65","1.65","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3D9Z"
"3DA2",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG 3350, 0.2M (NH4)2H(citrate), pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"CL","3DA2",59.81,"2.05","2.05","X-ray structure of human carbonic anhydrase 13 in complex with inhibitor","SMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASF","Homo sapiens","CA13","Carbonic anhydrase 13","1","3DA2"
"3DA6",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES/HCl, pH7.5 , 20mM 2-Mercaptoethanol , 27% PEG 550MME, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2008.11.056","BZ9","3DA6",42.53,"2","2","Crystal Structure of human JNK3 complexed with N-(3-methyl-4-(3-(2-(methylamino)pyrimidin-4-yl)pyridin-2-yloxy)naphthalen-1-yl)-1H-benzo[d]imidazol-2-amine","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3DA6"
"3DA9",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, HANGING DROP",7.3,"The drop was made by mixing 1.5 ul of the thrombin-hirudin complex and 1.5 ul of reservior solution containing: Phosphate buffer pH7.3, 28% PEG, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm8011849","44U","3DA9",35.46,"1.8","1.8","Crystal structure of thrombin in complex with inhibitor","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","3DA9"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3DA9"
,,,,,,,,,,,,,,,,"DFEEIPGEY",,,"Hirudin peptide","3","3DA9"
"3DAB",,"X-RAY DIFFRACTION",2.15,42.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1M MES, pH6.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.4161/cc.6365",,"3DAB",48.33,"1.9","1.9","Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain","IQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Mdm4 protein","1","3DAB"
,,,,,,,,,,,,,,,,"SQETFSDLWKLLPEN",,,"Cellular tumor antigen p53","2","3DAB"
"3DAD",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2008.06.008",,"3DAD",74.55,"2.3","2.3","Crystal structure of the N-terminal regulatory domains of the formin FHOD1","MAGGEDRGDGEPVSVVTVRVQYLEDTDPFASANFPEPRRAPTCSLDGALPLGAQIPAVHRLLGAPLKLEDSALQVSPSGYYLDTELSLEEQREMLEGFYEEISKGRKPTLILRTQLSVRVNAILEKLYSSSGPELRRSLFSLKQIFQEDKDLVPEFVHSEGLSCLIRVGAAADHNYQSYILRALGQLMLFVDGMLGVVAHSDTIQWLYTLCASLSRLVVKTALKLLLVFVEYSENNAPLFIRAVNSVASTTGAPPWANLVSILEEKNGADPELLVYTVTLINKTLAALPDQDSFYDVTDALEQQGMEALVQRHLGTAGTDVDLRTQLVLYENALKLEDG","Homo sapiens","FHOD1, FHOS, FHOS1","FH1/FH2 domain-containing protein 1","1","3DAD"
"3DAI",,"X-RAY DIFFRACTION",4.07,69.79,"VAPOR DIFFUSION, SITTING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3DAI",15.68,"1.95","1.95","Crystal structure of the bromodomain of the human ATAD2","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","3DAI"
"3DAK",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, Tri-Lithium Citrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/pro.27",,"3DAK",131.84,"2.25","2.25","Crystal Structure of Domain-Swapped OSR1 kinase domain","SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK","Homo sapiens","OXSR1, KIAA1101, OSR1","Serine/threonine-protein kinase OSR1","1","3DAK"
"3DAL",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",4.6,"Purified PRDM1 was crystallized using hanging drop vapor diffusion method at 
20   C by mixing 1.5   l of the protein solution with 1.5   l of the reservoir 
solution containing 2.0 M Na Formide, 0.1 M sodium acetate, pH 4.6., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3DAL",45.38,"1.65","1.65","Methyltransferase domain of human PR domain-containing protein 1","SSGLVPRGSKKMDMEDADMTLWTEAEFEEKCTYIVNDHPWDSGADGGTSVQAEASLPRNLLFKYATNSEEVIGVMSKEYIPKGTRFGPLIGEIYTNDTVPKNANRKYFWRIYSRGELHHFIDGFNEEKSNWMRYVNPAHSPREQNLAACQNGMNIYFYTIKPIPANQELLVWYCRDFAERLHYPYPGELTMMNLTQ","Homo sapiens","PRDM1, BLIMP1","PR domain zinc finger protein 1","1","3DAL"
"3DAR",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M sodium acetate, 0.1 M Tris-HCl, 30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K, pH 8.5",291,,,"3DAR",24.37,"2.2","2.2","Crystal structure of D2 domain from human FGFR2","MENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVV","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","3DAR"
"3DAX",,"X-RAY DIFFRACTION",3,58.3,"VAPOR DIFFUSION",5.5,"20% PEG400, 0.1M potassium chloride, 0.1M trisodium citrate, pH 5.5, vapor diffusion, temperature 291K",291,,,"3DAX",114.17,"2.15","2.15","Crystal structure of human CYP7A1","MAKKTSSRRRQTGEPPLENGLIPYLGCALQFGANPLEFLRANQRKHGHVFTCKLMGKYVHFITNPLSYHKVLCHGKYFDWKKFHFATSAKAFGHRSIDPMDGNTTENINDTFIKTLQGHALNSLTESMMENLQRIMRPPVSSNSKTAAWVTEGMYSFCYRVMFEAGYLTIFGRDLTRRDTQKAHILNNLDNFKQFDKVFPALVAGLPIHMFRTAHNAREKLAESLRHENLQKRESISELISLRMFLNDTLSTFDDLEKAKTHLVVLWASQANTIPATFWSLFQMIRNPEAMKAATEEVKRTLENAGQKVSLEGNPICLSQAELNDLPVLDSIIKESLRLSSASLNIRTAKEDFTLHLEDGSYNIRKDDIIALYPQLMHLDPEIYPDPLTFKYDRYLDENGKTKTTFYCNGLKLKYYYMPFGSGATICPGRLFAIHEIKQFLILMLSYFELELIEGQAKCPPLDQSRAGLGILPPLNDIEFKYKFKHHHHHH","Homo sapiens","CYP7A1, CYP7","Cytochrome P450 7A1","1","3DAX"
,,,3,58.3
"3DAY",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.20M NaCl, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2009.03.064",,"3DAY",64.21,"1.95","1.95","Crystal structure of human acyl-CoA synthetase medium-chain family member 2A (L64P mutation) in complex with AMP-CPP","MGHHHHHHSSGVDLGTENLYFQSMSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRPPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRADDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVVKAFVVLASQFLSHDPEQLTKELQQHVKSVTAPYKYPRKIEFVLNLPKTVTGKIQRAKLRDKEWKMSGKARAQ","Homo sapiens","ACSM2A, ACSM2, MACS2","Acyl-coenzyme A synthetase ACSM2A, mitochondrial precursor","1","3DAY"
"3DAZ",,"X-RAY DIFFRACTION",2.149972,42.79,,9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","MZM","3DAZ",29.59,"1.6","1.6","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DAZ"
"3DB3",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, HANGING DROP",5,"3 M SODIUM FORMATE, 0.1 M SODIUM ACETATE, pH 5.00, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.234104",,"3DB3",19.72,"2.4","2.4","Crystal structure of the tandem tudor domains of the E3 ubiquitin-protein ligase UHRF1 in complex with trimethylated histone H3-K9 peptide","GMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGE","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","3DB3"
,,,,,,,,,,,,,,,,"TARKST",,,"Trimethylated histone H3-K9 peptide","2","3DB3"
"3DB4",,"X-RAY DIFFRACTION",3.2,61.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"10 % PEG 8000, 0.1 M SODIUM CACODYLATE, 0.2 M AMMONIUM SULFATE, 0.001 M TCEP, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.234104",,"3DB4",19.11,"2.4","2.4","Crystal structure of the tandem tudor domains of the E3 ubiquitin-protein ligase UHRF1","GMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGE","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","3DB4"
"3DB5",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.5 microliter protein solution, 1.5 microliter reservoir solution containing 23% PEG 3350, 0.2 M Ammonium acetate, 0.1 M Bis-Tris pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3DB5",35.05,"2.15","2.15","Crystal structure of methyltransferase domain of human PR domain-containing protein 4","EHGPVTFVPDTPIESRARLSLPKQLVLRQSIVGAEVGVWTGETIPVRTCFGPLIGQQSHSMEVAEWTDKAVNHIWKIYHNGVLEFCIITTDENECNWMMFVRKARNREEQNLVAYPHDGKIFFCTSQDIPPENELLFYYSRDYAQQIGVPE","Homo sapiens","PRDM4, PFM1","PR domain zinc finger protein 4","1","3DB5"
"3DBP",,"X-RAY DIFFRACTION",2.27,45.85,"VAPOR DIFFUSION, HANGING DROP",8.4,"Ammonium Sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3DBP",61.81,"1.5","1.5","Crystal Structure of Human Orotidine 5'-Monophosphate Decarboxylase Complexed with 6-NH2-UMP","MGSSHHHHHHSSGLVPRGSHMKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Orotidine 5'-phosphate decarboxylase","1","3DBP"
"3DBQ",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION, HANGING DROP",6.33,"11% PEG 5000 MME, 100mM NaCl, 0.05M Na2HPO4/KH2PO4, pH 6.33, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1582-4934.2008.00605.x",,"3DBQ",39.28,"2.7","2.7","Crystal structure of TTK kinase domain","NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK","Homo sapiens","TTK, MPS1L1, MPS1","Dual specificity protein kinase TTK","1","3DBQ"
"3DBS",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, HANGING DROP",7.2,"PEG4000, Li2SO4, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm800295d","GD9","3DBS",110.41,"2.8","2.8","Structure of PI3K gamma in complex with GDC0941","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3DBS"
"3DBU",,"X-RAY DIFFRACTION",2.16,43.07,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","D8W","3DBU",29.7,"1.7","1.7","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DBU"
"3DBZ",,"X-RAY DIFFRACTION",3.19,61.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"150MM NACL, 10MM CACL2, 12% PEG8000, 100MM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi800626h",,"3DBZ",52.41,"1.8","1.8","human surfactant protein D","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","3DBZ"
"3DC1",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, 15% PEG 10000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1042/BSR20080085",,"3DC1",191.21,"2.5","2.5","Crystal structure of kynurenine aminotransferase II complex with alpha-ketoglutarate","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase mitochondrial","1","3DC1"
"3DC3",,"X-RAY DIFFRACTION",2.16,43.09,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","AZM","3DC3",29.61,"1.7","1.7","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DC3"
"3DC9",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f",,"3DC9",29.38,"1.6","1.6","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DC9"
"3DCC",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","D9Z","3DCC",29.66,"1.6","1.6","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DCC"
"3DCS",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","MZM","3DCS",29.62,"1.8","1.8","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DCS"
"3DCT",,"X-RAY DIFFRACTION",2.87,57.1,"hanging drop",6.5,"0.2M Li2SO4, 0.1M Bis-Tris pH6.5, 25% PEG3350, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2008.06.073","064","3DCT",30.7,"2.5","2.5","FXR with SRC1 and GW4064","SCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ","Homo sapiens","NR1H4, BAR, FXR, HRR1, RIP14","Bile acid receptor","1","3DCT"
,,,,,,,,,,,,,,,,"KESKDHQLLRYLLDKDEKDLR",,,"Nuclear receptor coactivator 1","2","3DCT"
"3DCU",,"X-RAY DIFFRACTION",2.82,56.43,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Li2SO4, 0.1M Bis-Tris pH6.5, 25% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.06.073","O62","3DCU",30.69,"2.95","2.95","FXR with SRC1 and GSK8062","SCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ","Homo sapiens","NR1H4, BAR, FXR, HRR1, RIP14","Bile acid receptor","1","3DCU"
,,,,,,,,,,,,,,,,"KESKDHQLLRYLLDKDEKDLR",,,"Nuclear receptor coactivator 1","2","3DCU"
"3DCV",,"X-RAY DIFFRACTION",2.97,58.6,"VAPOR DIFFUSION, HANGING DROP",5.5,"600mM (NH4)2HPO4, 250mM NaCl, 100mM Na Citrate pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.07.061","55E","3DCV",37.88,"2.7","2.7","Crystal structure of human Pim1 kinase complexed with 4-(4-hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1H)-one","MAHHHHHHLEVLFQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","3DCV"
"3DCW",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","EZL","3DCW",29.64,"1.5","1.5","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DCW"
"3DCY",,"X-RAY DIFFRACTION",2.1,40.6,"VAPOR DIFFUSION, HANGING DROP",6,"PROTEIN SOLUTION (10 MG/ML SEMET PROTEIN, 0.050 M NACL, 0.0003 M TCEP, 0.005 M MES PH 6.0) MIXED IN A 1:1 RATIO WITH WELL SOLUTION (20% PEG 3350, 0.10 M MES PH 6.0) CRYOPROTECTED WITH 20% ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K",297,,,"3DCY",31.24,"1.748","1.748","Crystal Structure a TP53-induced glycolysis and apoptosis regulator protein from Homo sapiens.","NLYFQSARFALTVVRHGETRFNKEKIIQGQGVDEPLSETGFKQAAAAGIFLNNVKFTHAFSSDLMRTKQTMHGILERSKFCKDMTVKYDSRLRERKYGVVEGKALSELRAMAKAAREECPVFTPPGGETLDQVKMRGIDFFEFLCQLILKEADQKEQFSQGSPSNCLETSLAEIFPLGKNHSSKVNSDSGIPGLAASVLVVSHGAYMRSLFDYFLTDLKCSLPATLSRSELMSVTPNTGMSLFIINFEEGREVKPTVQCICMNLQDHLNGLTETR","Homo sapiens","C12orf5, TIGAR","REGULATOR PROTEIN","1","3DCY"
"3DD0",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 100mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi802035f","EZL","3DD0",29.61,"1.48","1.48","Use of Carbonic Anhydrase II, IX Active-Site Mimic, for the Purpose of Screening Inhibitors for Possible Anti-Cancer Properties","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DD0"
"3DD1",,"X-RAY DIFFRACTION",2.81,56.29,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Na MES pH 5.8-6.1, 12-25% MPD, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bmcl.2008.12.085","CFF, 25D","3DD1",197.99,"2.57","2.57","Crystal structure of glycogen phophorylase complexed with an anthranilimide based inhibitor GSK254","GGAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3DD1"
"3DD2",,"X-RAY DIFFRACTION",2.98,58.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, Magnesium Acetate, Sodium Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1261/rna.1239308",,"3DD2",42.97,"1.9","1.9","Crystal structure of an RNA aptamer bound to human thrombin","GEADCGLRPLFEKKSLEDKTERELLESYID","Homo sapiens","F2","Thrombin light chain","1","3DD2"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG","Homo sapiens","F2","Thrombin heavy chain","2","3DD2"
,,,,,,,,,,,,,,,,"GGGAACAAAGCUGAAGUACUUACCCT",,,"RNA (26-MER)","3","3DD2"
"3DD3",,"X-RAY DIFFRACTION",2.51,50.99,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM MES buffer pH 5.5 or 6.0, 22%(w/v) PEG 8000, 20mM CaCl2, 10mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/anie.200900185",,"3DD3",47.94,"2.25","2.25","Crystal Structure of the Glutathione Transferase Pi enzyme in complex with the bifunctional inhibitor, Etharapta","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","3DD3"
"3DDS",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, HANGING DROP",6,"12-25% MPD, 0.1M MES buffer pH 6.0, 5mm Caffeine, 30mM GlcNac, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2008.12.085","26B, CFF","3DDS",197.93,"1.8","1.8","Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261","GGAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3DDS"
"3DDT",,"X-RAY DIFFRACTION",3.89,68.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.8M ammonium sulfate, 0.1M Tris pH 8.5, 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi800733z",,"3DDT",16.22,"1.9","1.9","Crystal structure of the B2 box from MuRF1 in dimeric state","GAMGSHPMCKEHEDEKINIYCLTCEVPTCSMCKVFGIHKACEVAPLQS","Homo sapiens","TRIM63, IRF, MURF1, RNF28, SMRZ","E3 ubiquitin-protein ligase TRIM63","1","3DDT"
"3DDU",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION",4.6,"0 .2M NaoAc 4.6, 9% Peg 4000, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.bmcl.2008.06.067","552","3DDU",81.46,"1.56","1.56","Prolyl Oligopeptidase with GSK552","LSFQYPDVYRDETAVQDYHGHKICDPYAWLEDPDSEQTKAFVEAQNKITVPFLEQCPIRGLYKERMTELYDYPKYSCHFKKGKRYFYFYNTGLQNQRVLYVQDSLEGEARVFLDPNILSDDGTVALRGYAFSEDGEYFAYGLSASGSDWVTIKFMKVDGAKELPDVLERVKFSCMAWTHDGKGMFYNSYPQQDGKSDGTETSTNLHQKLYYHVLGTDQSEDILCAEFPDEPKWMGGAELSDDGRYVLLSIREGCDPVNRLWYCDLQQESSGIAGILKWVKLIDNFEGEYDYVTNEGTVFTFKTNRHSPNYRVINIDFTDPEESKWKVLVPEHEKDVLEWIACVRSNFLVLCYLHDVKNTLQLHDLTTGALLKIFPLDVGSIVGYSGQKKDTEIFYQFTSFLSPGIIYHCDLTKEELEPRVFREVTVKGIDASDYQTVQIFYPSKDGTKIPMFIVHKKGIKLDGSHPAFLYGYGGFNISITPNYSVSRLIFVRHMGGILAVANIRGGGEYGETWHKGGILANKQNCFDDFQCAAEYLIKEGYTSPKRLTINGGSNGGLLVAACANQRPDLFGCVIAQVGVMDMLKFHKYTIGHAWTTDYGCSDSKQHFEWLVKYSPLHNVKLPEADDIQYPSMLLLTADHDDRVVPLHSLKFIATLQYIVGRSRKQNNPLLIHVDTKAGHGAGKPTAKVIEEVSDMFAFIARCLNVDWIP","Homo sapiens","PREP, PEP","Prolyl endopeptidase","1","3DDU"
"3DDW",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, HANGING DROP",6,"12-25% MPD, 0.1M Na MES Buffer pH 6.0, 5mM Caffeine, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bmcl.2008.12.085","CFF, 055","3DDW",197.61,"1.9","1.9","Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055","GGAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","3DDW"
"3DEH",,"X-RAY DIFFRACTION",2.49,50.53,"VAPOR DIFFUSION, HANGING DROP",7.4,"4-6% polyethylene glycol 6000, 0.1M HEPES pH 7.6, 20mM L-cysteine, 5% glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803347200","RXA","3DEH",114.44,"2.5","2.5","Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVDADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3DEH"
"3DEI",,"X-RAY DIFFRACTION",2.48,50.48,"VAPOR DIFFUSION, HANGING DROP",7.4,"4-6% polyethylene glycol 6000, 0.1M HEPES pH 7.6, 20mM L-cysteine, 5% glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803347200","RXB","3DEI",114.63,"2.8","2.8","Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVDADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3DEI"
"3DEJ",,"X-RAY DIFFRACTION",2.5,50.75,"VAPOR DIFFUSION, HANGING DROP",7.4,"4-6% polyethylene glycol 6000, 0.1M HEPES pH 7.6, 20mM L-cysteine, 5% glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803347200","RXC","3DEJ",114.67,"2.6","2.6","Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVDADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3DEJ"
"3DEK",,"X-RAY DIFFRACTION",2.48,50.3,"VAPOR DIFFUSION, HANGING DROP",7.4,"4-6% polyethylene glycol 6000, 0.1M HEPES pH 7.6, 20mM L-cysteine, 5% glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803347200","RXD","3DEK",114.69,"2.4","2.4","Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVDADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3DEK"
"3DEM",,"X-RAY DIFFRACTION",3.72,66.93,"VAPOR DIFFUSION, HANGING DROP",7,"18-20% PEG 8000, 3% glycerol, 0.1M Hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M803551200",,"3DEM",64.47,"2.3","2.3","CUB1-EGF-CUB2 domain of HUMAN MASP-1/3","HTVELNNMFGQIQSPGYPDSYPSDSEVTWNITVPDGFRIKLYFMHFNLESSYLCEYDYVKVETEDQVLATFCGRETTDTEQTPGQEVVLSPGSFMSITFRSDFSNEERFTGFDAHYMAVDVDECKEREDEELSCDHYCHNYIGGYYCSCRFGYILHTDNRTCRVECSDNLFTQRTGVITSPDFPNPYPKSSECLYTIELEEGFMVNLQFEDIFDIEDHPEVPCPYDYIKIKVGPKVLGPFCGEKAPEPISTQSHSVLILFHSDNSGENRGWRLSYRAA","Homo sapiens","MASP1, CRARF, CRARF1, PRSS5","Complement factor MASP-3","1","3DEM"
"3DEY",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"3DEY",35.27,"1.7","1.7","Crystal structure of 17beta-HSD1 with DHT in normal and reverse orientation.","ARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRSAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","3DEY"
"3DFC",,"X-RAY DIFFRACTION",1.9,35.38,"VAPOR DIFFUSION, SITTING DROP",,"0.2M lithium nitrate, 2.2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"3DFC",34.43,"1.9","1.9","Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain with AMPPNP","MTVFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFEK","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","3DFC"
"3DFJ",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION",5.8,"100mM Bis-Tris pH 5.8, 21-26% PEG 3350, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M805262200",,"3DFJ",28.46,"1.45","1.45","Crystal structure of human Prostasin","ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTELQLVPRGSGSGSLEHHHHHH","Homo sapiens","PRSS8","Prostasin","1","3DFJ"
"3DFL",,"X-RAY DIFFRACTION",2.15,42.84,"VAPOR DIFFUSION",5.8,"100mM Bis-Tris pH 5.8, 21-26% PEG 3350, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M805262200",,"3DFL",28.57,"2","2","Crystal structure of human Prostasin complexed to 4-guanidinobenzoic acid","ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTELQLVPRGSGSGSLEHHHHHH","Homo sapiens","PRSS8","Prostasin","1","3DFL"
"3DGD",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",4.6,"ZINC ACETATE 0.2 M, SODIUM CITRATE 0.1 M, AMMONIUM SULFATE 2,0M, PH 4,6; CRYSTALS WERE SOAKED IN MOTHER LIQUOR SUPPLEMENTED WITH 10 % GLYCEROL BEFORE FREEZING IN LIQUID NITROGEN, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K, pH 4.60",293,"10.1074/jbc.M110.157206",,"3DGD",57.08,"1.383","1.383","Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPMHEHAEVVFTANDSGPRRYTIAAMLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PLAB, PALB","Transthyretin","1","3DGD"
"3DGG",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"2M Ammonium sulfate, 5% v/v Isopropanol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.pep.2008.06.017",,"3DGG",97.81,"2.3","2.3","Crystal structure of FabOX108","DIVLTQSPASLAVSLGQRATISCRASKSVSTSGYSYMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELLTFGAGTKLELKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC","Homo sapiens",,"FabOX108 Light Chain Fragment","1","3DGG"
,,,,,,,,,,,,,,,,"EVKLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDDTNYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREDYYGSRWGYWGQGTTLTVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDCGKHHHHHH","Homo sapiens",,"FabOX108 Heavy Chain Fragment","2","3DGG"
"3DGK",,"X-RAY DIFFRACTION",1.92,36.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM Tris pH 7.5, 0.8 M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3DGK",33.93,"1.7","1.7","Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain","MTVFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFEK","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","3DGK"
"3DGQ",,"X-RAY DIFFRACTION",2.56,52.04,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM MES BUFFER PH 5.5, 22%(W/V) PEG 8000, 20mM CACL2, 10mM DTT, Small amounts of solid compound were streaked through the drops containing preformed crystals. These were soaked for 48hours., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/anie.200900185","EAA","3DGQ",47.66,"1.6","1.6","Crystal structure of the glutathione transferase PI enzyme in complex with the bifunctional inhibitor, etharapta","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","3DGQ"
"3DGR",,"X-RAY DIFFRACTION",2.46,50.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"200mM NaCl, 100mM Tris-HCl, 15% PEG 3350, 20% Glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0903898106",,"3DGR",110.46,"2.1","2.1","Crystal structure of human NAMPT complexed with ADP analogue","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNI","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","3DGR"
"3DH1",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M Ammonium acetate, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3DH1",85.56,"2.8","2.8","Crystal structure of human tRNA-specific adenosine-34 deaminase subunit ADAT2","MHHHHHHSSGVDLGTENLYFQSMEETEKWMEEAMHMAKEALENTEVPVGCLMVYNNEVVGKGRNEVNQTKNATRHAEMVAIDQVLDWCRQSGKSPSEVFEHTVLYVTVEPCIMCAAALRLMKIPLVVYGCQNERFGGCGSVLNIASADLPNTGRPFQCIPGYRAEEAVEMLKTFYKQENPNAPKSKVRK","Homo sapiens","ADAT2, DEADC1","tRNA-specific adenosine deaminase 2","1","3DH1"
"3DHD",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, SITTING DROP",8.5,"200mM NaCl, 100mM Tris-HCl, 15% PEG 3350, 20% Glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0903898106",,"3DHD",110.73,"2","2","Crystal structure of human NAMPT complexed with nicotinamide mononucleotide and pyrophosphate","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNI","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","3DHD"
"3DHE",,"X-RAY DIFFRACTION",2.43,49,,7.2,"pH 7.20",,"10.1074/jbc.275.2.1105",,"3DHE",35.18,"2.3","2.3","ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED DEHYDROEPIANDROSTERONE","ARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRSAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE","1","3DHE"
"3DHF",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"200mM NaCl, 100mM Tris-HCl, 15% PEG 3350, 20% Glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0903898106",,"3DHF",110.86,"1.8","1.8","Crystal structure of phosphorylated mimic form of human NAMPT complexed with nicotinamide mononucleotide and pyrophosphate","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNI","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","3DHF"
"3DHJ",,"X-RAY DIFFRACTION",2.26,45.58,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M Na acetate, PEG 4000, Ammonium acetate, glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2008.09.108",,"3DHJ",11.8,"2","2","Beta 2 microglobulin mutant W60C","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDCSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","NM_004048, B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","3DHJ"
"3DHK",,"X-RAY DIFFRACTION",2.52,51.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"Phosphate Buffer, Sodium Chloride, PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2009.06.016","23U","3DHK",35.81,"1.73","1.73","Bisphenylic Thrombin Inhibitors","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","3DHK"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3DHK"
,,,,,,,,,,,,,,,,"GDFEEIPEEYL",,,"Hirudin variant-1","3","3DHK"
"3DHM",,"X-RAY DIFFRACTION",2.27,45.82,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M Na acetate, PEG 4000, Ammonium acetate, glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2008.09.108",,"3DHM",11.86,"1.8","1.8","Beta 2 microglobulin mutant D59P","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKPWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","NM_004048, B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","3DHM"
"3DHP",,"X-RAY DIFFRACTION",2.36,47.82,"hanging drop",9,"MPD, pH 9.0, hanging drop, temperature 298K",298,,,"3DHP",56.04,"1.5","1.5","Probing the role of aromatic residues at the secondary saccharide binding sites of human salivary alpha-amylase in substrate hydrolysis and bacterial binding","QYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGADFNDGKCKTGSGDIENYNDATQVRDCRLSGLLDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMAPGDIKAILDKLHNLNSNWFPEGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSALKNWGEGAGFMPSDRALVFVDNHDNQRGHGAGGASILTFADARLYKMAVGFMLAHPYGFTRVMSSYRWPRYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRARQIRNMVNFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY1A, AMY1","Alpha-amylase 1","1","3DHP"
"3DID",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, HANGING DROP",4.6,"ZINC ACETATE 0.2 M, SODIUM CITRATE 0.1 M, AMMONIUM SULFATE 2,0M, PH 4,6; CRYSTALS WERE SOAKED IN MOTHER LIQUOR SUPPLEMENTED WITH 10 % GLYCEROL BEFORE FREEZING IN LIQUID NITROGEN, pH 4.60, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.157206",,"3DID",56.44,"1.78","1.78","Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6 soaked","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPMHEHAEVVFTANDSGPRRYTIAAMLSPYSYSTTAVVTNPKE","Homo sapiens","TTR PLAB, TTR, PALB","Transthyretin","1","3DID"
"3DIF",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"85% of 0.2M Ammonium sulfate, 30% w/v PEG 4000 in 15% water - with 10 microliters of 1M NaOH per 1ml crystallization solution, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.pep.2008.06.017",,"3DIF",96.87,"2.4","2.4","Crystal structure of FabOX117","DIVITQSPKFMSTSVGDRVSITCKASQDVSTAVAWFQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPWTFGGGTKLEIKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC","Homo sapiens",,"FabOX117 Light Chain Fragment","1","3DIF"
,,,,,,,,,,,,,,,,"EVKLQQSGPELVKPGASVKISCKASGYSFTSYYIHWVKQRPGQGLEWIGWVFPGSGNTKYNEKFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCARGNYDRAWFAYWGQGTLVTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDCGKHHHHHH","Homo sapiens",,"FabOX117 Heavy Chain Fragment","2","3DIF"
"3DJ8",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, HANGING DROP",7,"25% JEFFAMINE, 100mM Hepes, 2.0mM Thymine. Soaking 40mM epoxide no thymine, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1039/b811797g",,"3DJ8",70.13,"1.51","1.51","Synthesis of (2S)-2-amino-7,8-epoxyoctanoic acid and structure of its metal-bridging complex with human arginase I","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3DJ8"
"3DJ9",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION, HANGING DROP",7.2,"30% PEG 1500, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1107/S0907444908025274",,"3DJ9",12.09,"1.75","1.75","Crystal Structure of an isolated, unglycosylated antibody CH2 domain","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQ","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3DJ9"
"3DJG",,"X-RAY DIFFRACTION",2.73,54.98,,7,"3% ammonium sulfate, 0.1 M potassium phosphate and 0.1% beta-octyl glucoside, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2008.06.083",,"3DJG",53.1,"1.8","1.8","Catalytic cycle of human glutathione reductase near 1 A resolution","ACRQEPQPQGPPPAAGVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase","1","3DJG"
"3DJH",,"X-RAY DIFFRACTION",2.72,54.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"50% Saturated ammonium sulfate, 3% Isopropanol, 0.1 M Tris(hydroxymethyl)aminomethane, mixed with protein in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi8014423",,"3DJH",38.19,"1.25","1.25","Macrophage Migration Inhibitory Factor (MIF) at 1.25 A Resolution","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","3DJH"
"3DJI",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M Ammonium sulfate, 3% Isopropanol, 0.1 M Tris(hydroxymethyl)aminomethane, mixed with protein-inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi8014423",,"3DJI",74.96,"1.95","1.95","Crystal Structure of Macrophage Migration Inhibitory Factor Bound to an Acetaminophen Dimer Derived from NAPQI","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","3DJI"
"3DJJ",,"X-RAY DIFFRACTION",2.66,53.67,,7,"3% ammonium sulfate, 0.1 M potassium phosphate and 0.1% beta-octyl glucoside, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2008.06.083",,"3DJJ",54.76,"1.1","1.1","Catalytic cycle of human glutathione reductase near 1 A resolution","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase, mitochondrial precursor","1","3DJJ"
"3DJR",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION",7.5,"32% PEG 400, 0.05-0.2M CaCl2, 0.1M NaHepes, pH 7.5, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DJR",27.6,"2.02","2.02","CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L58H at neutral pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGHTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DJR"
"3DJS",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION",4.6,"32% PEG 2000, 0.1M NaAc, 0.2M Am2SO4 , pH 4.6, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DJS",27.6,"1.8","1.8","Crystal structure of transthyretin variant L58H at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGHTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DJS"
"3DJT",,"X-RAY DIFFRACTION",2.19,43.85,"VAPOR DIFFUSION",4.6,"32% PEG 2000, 0.1M NaAc, 0.2M Am2SO4 
, pH 4.6, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DJT",27.62,"2.3","2.3","Crystal structure of transthyretin variant V30M at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DJT"
"3DJU",,"X-RAY DIFFRACTION",1.98,37.73,"VAPOR DIFFUSION, HANGING DROP",6.1,"100mM BIS-TRIS, 0.2M Sodium chloride, 21% (v/v) PEG 3350, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1093/nar/gkn825",,"3DJU",13.77,"2.26","2.26","Crystal structure of human BTG2","TDMLPEIAAAVGFLSSLLRTRGCVSEQRLKVFSGALQEALTEHYKHHWFPEKPSKGSGYRCIRINHKMDPIISRVASQIGLSQPQLHQLLPSELTLWVDPYEVSYRIGEDGSICVLYEEAPL","Homo sapiens","BTG2, B-cell translocation gene 2, PC3","Protein BTG2","1","3DJU"
"3DJY",,"X-RAY DIFFRACTION",3.27,62.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M Ammonium sulfate, 100 mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja804941z",,"3DJY",62.21,"2.1","2.1","Nonaged Form of Human Butyrylcholinesterase Inhibited by Tabun","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","3DJY"
"3DJZ",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION",7.5,"32% PEG 400, 0.05-0.2M CaCl2, 0.1M NaHepes , pH 7.5, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DJZ",27.52,"1.82","1.82","Crystal structure of transthyretin variant L55P at neutral pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DJZ"
"3DK0",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION",4.6,"32% PEG 400, 0.05-0.2M CaCl2, 0.1M NaHepes , pH 4.6, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DK0",27.52,"1.87","1.87","Crystal structure of transthyretin variant L55P at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DK0"
"3DK2",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION",4.6,"Na Citrate 0.1 M, Ammonium sulfate 2M , pH 4.6, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M109.017657",,"3DK2",27.5,"2.35","2.35","Crystal structure of transthyretin variant Y114H at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPHSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DK2"
"3DK4",,"X-RAY DIFFRACTION",2.67,53.85,,7,"3% ammonium sulfate, 0.1 M potassium phosphate and 0.1% beta-octyl glucoside, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2008.06.083",,"3DK4",53.88,"1.2","1.2","Catalytic cycle of human glutathione reductase near 1 A resolution","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase","1","3DK4"
"3DK8",,"X-RAY DIFFRACTION",2.67,53.85,,7,"3% ammonium sulfate, 0.1 M potassium phosphate and 0.1% beta-octyl glucoside, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2008.06.083",,"3DK8",53.6,"1.1","1.1","Catalytic cycle of human glutathione reductase near 1 A resolution","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase","1","3DK8"
"3DK9",,"X-RAY DIFFRACTION",2.67,54.01,,7,"3% ammonium sulfate, 0.1 M potassium phosphate and 0.1% beta-octyl glucoside, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2008.06.083",,"3DK9",52.71,"0.95","0.95","Catalytic cycle of human glutathione reductase near 1 A resolution","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase","1","3DK9"
"3DKB",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"1 M ammonium sulfate, 300 mM Na thiocyanate, 5 mM MgSO4, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2007.11.092",,"3DKB",274.02,"2.5","2.5","Crystal Structure of A20, 2.5 angstrom","MGSSHHHHHHSSGLVPRGSHMAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWGVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRREGHAQ","Homo sapiens","TNFAIP3, OTUD7C","Tumor necrosis factor, alpha-induced protein 3","1","3DKB"
"3DKC",,"X-RAY DIFFRACTION",2.27,45.79,"VAPOR DIFFUSION",6.2,"11% ISOPROPANOL, 2.5% PEG 5K MME, 100 mM BIS-TRIS, pH 6.2, VAPOR DIFFUSION, temperature 292K",292,"10.1158/1535-7163.MCT-09-0477",,"3DKC",36.32,"1.52","1.52","Structure of MET receptor tyrosine kinase in complex with ATP","GSLNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKEG","Homo sapiens","MET, hCG_38705, tcag7.66","Hepatocyte growth factor receptor","1","3DKC"
"3DKF",,"X-RAY DIFFRACTION",2.23,44.82,"VAPOR DIFFUSION",7.5,"20% ISOPROPANOL, 200 mM AMMONIUM ACETATE, 100 mM TRIS, pH 7.5, VAPOR DIFFUSION, temperature 292K",292,"10.1158/1535-7163.MCT-09-0477","SX8","3DKF",36.15,"1.8","1.8","Structure of MET receptor tyrosine kinase in complex with inhibitor SGX-523","GSLNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKEG","Homo sapiens","MET, hCG_38705, tcag7.66","Hepatocyte growth factor receptor","1","3DKF"
"3DKG",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION",5.8,"11% ISOPROPANOL, 3% PEG 5K MME, 100 mM BIS-TRIS, pH 5.8, VAPOR DIFFUSION, temperature 292K",292,"10.1158/1535-7163.MCT-09-0477","SX8","3DKG",36.1,"1.91","1.91","Structure of Mutant(Y1248L) MET receptor tyrosine kinase in complex with inhibitor SGX-523","GSLNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKEG","Homo sapiens","MET, hCG_38705, tcag7.66","Hepatocyte growth factor receptor","1","3DKG"
"3DKJ",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, SITTING DROP",8.5,"200mM NaCl, 100mM Tris-HCl, 15% PEG 3350, 20% Glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0903898106","PRP","3DKJ",110.63,"2","2","Crystal structure of human NAMPT complexed with benzamide and phosphoribosyl pyrophosphate","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNI","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","3DKJ"
"3DKK",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.1 M Ammonium sulfate, 100 mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja804941z",,"3DKK",62.18,"2.31","2.31","Aged Form of Human Butyrylcholinesterase Inhibited by Tabun","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","3DKK"
"3DKL",,"X-RAY DIFFRACTION",2.46,49.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"200mM NaCl, 100mM Tris-HCl, 15% PEG 3350, 20% Glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0903898106",,"3DKL",110.86,"1.89","1.89","Crystal structure of phosphorylated mimic form of human NAMPT complexed with benzamide and phosphoribosyl pyrophosphate","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNI","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","3DKL"
"3DKM",,"X-RAY DIFFRACTION",1.89,34.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"20 % PEG 5000, 0.1 M BIS-TRIS, PH 6.50, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3DKM",10.04,"1.6","1.6","Crystal structure of the HECTD1 CPH domain","MHHHHHHSSGRENLYFQGLKYMVPGARVTRGLDWKWRDQDGSPQGEGTVTGELHNGWIDVTWDAGGSNSYRMGAEGKFDLKLAPGYDPD","Homo sapiens","HECTD1, KIAA1131","E3 ubiquitin-protein ligase HECTD1","1","3DKM"
"3DKO",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"WELL SOLUTION: 25% PEG 3350, 0.1 M NH4 SULPHATE, 0.1 M HEPES PH 7.5. PROTEIN SOLUTION: 15 MG/ML. DROPS: 1:1 RATIO OF WELL:PROTEIN SOLUTION. CRYSTALS CRYOPROTECTED BY TRANSFER TO DROP CONTAINING MOTHER LIQUOR TO WHICH MPD WAS ADDED TO 25%, , pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"3DKO",36.65,"2","2","Complex between the kinase domain of human ephrin type-a receptor 7 (epha7) and inhibitor alw-ii-49-7","MQEGDEELYFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNSAHHHHHH","Homo sapiens","EPHA7, EHK3, HEK11","Ephrin type-A receptor 7","1","3DKO"
"3DKP",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, SITTING DROP",8,"10% PEG 8000, 100 mM Imidazole, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0012791",,"3DKP",28.4,"2.1","2.1","Human DEAD-box RNA-helicase DDX52, conserved domain I in complex with ADP","SMKINFLRNKHKIHVQGTDLPDPIATFQQLDQEYKINSRLLQNILDAGFQMPTPIQMQAIPVMLHGRELLASAPTGSGKTLAFSIPILMQLKQPANKGFRALIISPTRELASQIHRELIKISEGTGFRIHMIHKAAVAAKKFGPKSSKKFDILVTTPNRLIYLLKQDPPGIDLASVEWLVVDESDKLFEDGKTGFRDQLASIFLACTSHKVRRAMFSATFAYDVEQWCKLNLDNVISVSIGARNS","Homo sapiens","DDX52, ROK1, HUSSY-19","Probable ATP-dependent RNA helicase DDX52","1","3DKP"
"3DL2",,"X-RAY DIFFRACTION",3.23,61.98,,6.5,"1.6 M Sodium/potassium phosphate pH 6.5, 0.2 M Sodium chloride, 0.002 M Dithiothreitol, VAPOR DIFFUSION, HANGING DROP, temperature 290.9K",290.9,,,"3DL2",65.97,"2.1","2.1","Hexagonal structure of the LDH domain of Human Ubiquitin-conjugating Enzyme E2-like Isoform A","GSSKSWANHENKTVNKITVVGGGELGIACTLAISAKGIADRLVLLDLSEGTKGATMDLEIFNLPNVEISKDLSASAHSKVVIFTVNSLGSSQSYLDVVQSNVDMFRALVPALGHYSQHSVLLVASQPVEIMTYVTWKLSTFPANRVIGIGCNLDSQRLQYIITNVLKAQTSGKEVWVIGEQGEDKVLTWSGQEEVVSHTSQVQLSNRAMELLRVKGQRSWSVGLSVADMVDSIVNNKKKVHSVSALAKGYYDINSEVFLSLPCILGTNGVSEVIKTTLKEDTVTEKLQSSASSIHSLQQQLKL","Homo sapiens","UEVLD, UEV3","Ubiquitin-conjugating enzyme E2 variant 3","1","3DL2"
"3DL9",,"X-RAY DIFFRACTION",3.87,68.23,"VAPOR DIFFUSION",6.5,"1.2M Ammounium sulfate, 0.1M ADA, pH 6.5, VAPOR DIFFUSION, temperature 291K",291,,,"3DL9",114.65,"2.721","2.721","Crystal structure of CYP2R1 in complex with 1-alpha-hydroxy-vitamin D2","MAKKTKQRRPMGFPPGPPGLPFIGNIYSLAASSELPHVYMRKQSQVYGEIFSLDLGGISTVVLNGYDVVKECLVHQSEIFADRPCLPLFMKMTKMGGLLNSRYGRGWVDHRRLAVNSFRYFGYGQKSFESKILEETKFFNDAIETYKGRPFDFKQLITNAVSNITNLIIFGERFTYEDTDFQHMIELFSENVELAASASVFLYNAFPWIGILPFGKHQQLFRNAAVVYDFLSRLIEKASVNRKPQLPQHFVDAYLDEMDQGKNDPSSTFSKENLIFSVGELIIAGTETTTNVLRWAILFMALYPNIQGQVQKEIDLIMGPNGKPSWDDKCKMPYTEAVLHEVLRFCNIVPLGIFHATSEDAVVRGYSIPKGTTVITNLYSVHFDEKYWRDPEVFHPERFLDSSGYFAKKEALVPFSLGRRHCLGEHLARMEMFLFFTALLQRFHLHFPHELVPDLKPRLGMTLQPQPYLICAERRHHHH","Homo sapiens","CYP2R1","Cytochrome P450 2R1","1","3DL9"
"3DLJ",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 4000, 0.2M Ammonium sulfate, 0.1M Na Cacodylate pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3DLJ",108.95,"2.26","2.26","Crystal structure of human carnosine dipeptidase 1","GAMDSPSPPPALLEKVFQYIDLHQDEFVQTLKEWVAIESDSVQPVPRFRQELFRMMAVAADTLQRLGARVASVDMGPQQLPDGQSLPIPPVILAELGSDPTKGTVCFYGHLDVQPADRGDGWLTDPYVLTEVDGKLYGRGATDNKGPVLAWINAVSAFRALEQDLPVNIKFIIEGMEEAGSVALEELVEKEKDRFFSGVDYIVISDNLWISQRKPAITYGTRGNSYFMVEVKCRDQDFHSGTFGGILHEPMADLVALLGSLVDSSGHILVPGIYDEVVPLTEEEINTYKAIHLDLEEYRNSSRVEKFLFDTKEEILMHLWRYPSLSIHGIEGAFDEPGTKTVIPGRVIGKFSIRLVPHMNVSAVEKQVTRHLEDVFSKRNSSNKMVVSMTLGLHPWIANIDDTQYLAAKRAIRTVFGTEPDMIRDGSTIPIAKMFQEIVHKSVVLIPLGAVDDGEHSQNEKINRWNYIEGTKLFAAFFLEMAQLH","Homo sapiens","CNDP1, CN1, CPGL2, UNQ1915/PRO4380","Beta-Ala-His dipeptidase","1","3DLJ"
"3DLM",,"X-RAY DIFFRACTION",2.41,51.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 microliter of the protein solution was mixed with 1.5 microliter of the reservoir solution containing 0.2 M Disodium tartrate, 20% PEG 3350 and 0.1M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3DLM",24.89,"1.77","1.77","Crystal structure of Tudor domain of human Histone-lysine N-methyltransferase SETDB1","ENLYFQGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMK","Homo sapiens","SETDB1, KIAA0067, KMT1E, ESET","Histone-lysine N-methyltransferase SETDB1","1","3DLM"
"3DLS",,"X-RAY DIFFRACTION",2.56,51.93,"VAPOR DIFFUSION",7.5,"10% GLYCEROL, 18% PEG 3350, 150 mM CALCIUM ACETATE, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M110.157594",,"3DLS",230.28,"2.3","2.3","Crystal structure of human PAS kinase bound to ADP","MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHHHHH","Homo sapiens","PASK, KIAA0135","PAS domain-containing serine/threonine-protein kinase","1","3DLS"
"3DLW",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 10,000, HEPES buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.jmb.2010.09.007",,"3DLW",46.67,"2.7","2.7","Antichymotrypsin","MRGSHHHHHHTDPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASGTTAVKITLLSALVETRTITRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","3DLW"
"3DLX",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",9,"25% PEG 3350, 0.2 M NaCl, 0.1 M Tris-HCl, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3DLX",212.79,"2.2","2.2","Crystal structure of human 3-oxoacid CoA transferase 1","MTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIANAENLYFQ","Homo sapiens","OXCT1, OXCT, SCOT","Succinyl-CoA:3-ketoacid-coenzyme A transferase 1","1","3DLX"
"3DLZ",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Li2SO4, 0.1M HEPES pH 7.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0901989106",,"3DLZ",41.21,"1.85","1.85","Crystal structure of human haspin in complex with AMP","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","GSG2, HASPIN","Serine/threonine-protein kinase haspin","1","3DLZ"
"3DM1",,"X-RAY DIFFRACTION",3.36,63.36,"VAPOR DIFFUSION, HANGING DROP",,"1.5 microliter of the protein solution mixed with with 1.5 microliter of the reservoir solution containing 40% PEG 550 MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0035376",,"3DM1",33.2,"2.4","2.4","Crystal structure of the complex of human chromobox homolog 3 (CBX3) with peptide","EFVVEKVLDRRVVNGKVEYFLKWKGFTDADNTWEPEENLDCPELIEAFLNSQKAGKEK","Homo sapiens","CBX3","Chromobox protein homolog 3","1","3DM1"
,,,,,,,,,,,,,,,,"KVHRARKTMSKP",,,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3","2","3DM1"
"3DM6",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, HANGING DROP",5,"16% PEG8000, 0.1M Citrate, 0.3M Lithium sulphate, 0.1M Sodium Chloride, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K",299,"10.1016/j.bmc.2008.09.041","757","3DM6",139.01,"2.6","2.6","Beta-secretase 1 complexed with statine-based inhibitor","MRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3DM6"
"3DN5",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, HANGING DROP",5,"12% PEG 6000, 50mM Ammonium citrate pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/cmdc.200800410","53N","3DN5",36.92,"1.45","1.45","Aldose Reductase in complex with novel biarylic inhibitor","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","3DN5"
"3DNG",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, HANGING DROP",6,"Hanging droplets were made by mixing 1.5-3.0ml of protein/inhibitor solution with 5ml of PEG solution (10% PEG6000, 0.2M Mes-NaOH, 0.02% NaN3, pH6.0). Droplets were concentrated against a reservoir buffer containing 1.0-2.0M sodium phosphate, 0.02% NaN3, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm801166j","AXA","3DNG",37.58,"2","2","Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor","MLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","3DNG"
"3DNK",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION, HANGING DROP",6.4,"20% PEG 6000, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"3DNK",48.02,"2.84","2.84","Enzyme deglycosylated Human IgG1 Fc fragment","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYDSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHM, IGHG1","IGHM protein","1","3DNK"
"3DO3",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, HANGING DROP",6.4,"20% PEG 3350, 0.2M NaCl pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"3DO3",51.27,"2.5","2.5","Human 1gG1 Fc fragment, 2.5 Angstrom structure","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3DO3"
"3DO4",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION",4.6,"15% PEG 4000, 0.05M NaAcetate, 0.1M AmmoniumAcetate , pH 4.6, VAPOR DIFFUSION, temperature 298K",298,,,"3DO4",110.27,"2.4","2.4","Crystal structure of transthyretin variant T60A at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTAEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3DO4"
"3DOP",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, HANGING DROP",7,"ISOPROPANOL, PEG 4000, TRIS-HCL, PH 7.0, 10.0mM 5bDHT, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.mce.2008.09.013",,"3DOP",80.98,"2","2","Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-dihydrotestosterone, Resolution 2.00A","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3DOP"
"3DOW",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 27% v/v PEG MME 550, 10 mM ZnSO4, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1111/j.1742-4658.2008.06857.x",,"3DOW",15.48,"2.3","2.3","Complex structure of GABA type A receptor associated protein and its binding epitope on calreticulin","GSMKFVYKEEHPFEKRRSEGEKIRKKYPDRVPVIVEKAPKARIGDLDKKKYLVPSDLTVGQFYFLIRKRIHLRAEDALFFFVNNVIPPTSATMGQLYQEHHEEDFFLYIAYSDESVYGL","Homo sapiens","GABARAP, FLC3B, HT004","Gamma-aminobutyric acid receptor-associated protein","1","3DOW"
,,,,,,,,,,,,,,,,"SLEDDWDFLPPX",,,"CRT peptide","2","3DOW"
"3DPD",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",7.25,"19% PEG 4000, 0.25M (NH4)2SO4, 0.1M TRIS PH 7.2 
, pH 7.25  , VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bmcl.2008.06.104","41A","3DPD",111.02,"2.85","2.85","Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-Dihydro-2H-benzo[1,4]oxazines","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3DPD"
"3DPE",,"X-RAY DIFFRACTION",1.94,36.61,"VAPOR DIFFUSION, HANGING DROP",6,"Hanging droplets were made by mixing 1.5-3.0ml of protein/inhibitor solution with 5ml of PEG solution (10% PEG6000, 0.2M Mes-NaOH, 0.02% NaN3, pH6.0). Droplets were concentrated against a reservoir buffer containing 1.0-2.0M sodium phosphate, 0.02% NaN3, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm801166j","AXB","3DPE",18.86,"1.6","1.6","Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor","MLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","3DPE"
"3DPF",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, HANGING DROP",6,"Hanging droplets were made by mixing 1.5-3.0ml of protein/inhibitor solution with 5ml of PEG solution (10% PEG6000, 0.2M Mes-NaOH, 0.02% NaN3, pH6.0). Droplets were concentrated against a reservoir buffer containing 1.0-2.0M sodium phosphate, 0.02% NaN3, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm801166j","AXB","3DPF",37.8,"2.1","2.1","Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor","MLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","3DPF"
"3DPK",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, SODIUM ACETATE, LI2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm801406h","8C5","3DPK",38.84,"1.95","1.95","cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor","GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R, FGFBR, FGFR1, FLG, FLT2, FMS, BFGFR, CEK, HBGFR","Macrophage colony-stimulating factor 1 receptor, Fibroblast growth factor receptor 1","1","3DPK"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FGFBR, FGFR1, FLG, FLT2, FMS, BFGFR, CEK, HBGFR"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FGFBR, FGFR1, FLG, FLT2, FMS, BFGFR, CEK, HBGFR"
"3DRB",,"X-RAY DIFFRACTION",2.33,47.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M tris-HCl, 20% PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.febslet.2008.10.039",,"3DRB",85.85,"2","2","Crystal structure of Human Brain-type Creatine Kinase","MPFSNSHNALKLRFPAEDEFPDLSAHNNHMAKVLTPELYAELRAKSTPSGFTLDDVIQTGVDNPGHPYIMTVGCVAGDEESYEVFKDLFDPIIEDRHGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSRVRTGRSIRGFCLPPHCSRGERRAIEKLAVEALSSLDGDLAGRYYALKSMTEAEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKTFLVWVNEEDHLRVISMQKGGNMKEVFTRFCTGLTQIETLFKSKDYEFMWNPHLGYILTCPSNLGTGLRAGVHIKLPNLGKHEKFSEVLKRLRLQKRGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVKLLIEMEQRLEQGQAIDDLMPAQK","Homo sapiens","CKB, CKBB","Creatine kinase B-type","1","3DRB"
"3DRE",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl 
20% PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.febslet.2008.10.039",,"3DRE",85.4,"2.2","2.2","Crystal structure of Human Brain-type Creatine Kinase","MPFSNSHNALKLRFPAEDEFPDLSAHNNHMAKVLTPELYAELRAKSTPSGFTLDDVIQTGVDNPGHPYIMTVGCVAGDEESYEVFKDLFDPIIEDRHGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSRVRTGRSIRGFCLPPHCSRGERRAIEKLAVEALSSLDGDLAGRYYALKSMTEAEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKTFLVWVNEEDHLRVISMQKGGNMKEVFTRFCTGLTQIETLFKSKDYEFMWNPHLGYILTCPSNLGTGLRAGVHIKLPNLGKHEKFSEVLKRLRLQKRGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVKLLIEMEQRLEQGQAIDDLMPAQK","Homo sapiens","CKB, CKBB","Creatine kinase B-type","1","3DRE"
"3DRM",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 4000, Li2SO4, Tris/HCl, pH 8.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.jmb.2009.01.069",,"3DRM",45.66,"2.2","2.2","2.2 Angstrom Crystal Structure of Thr114Phe Alpha1-Antitrypsin","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTFGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","3DRM"
"3DRO",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, HANGING DROP",5.6,"Fab fragment and peptide are incubated in a solution containing 0.01% Tween-20. Crystals are obatined from reservoir solution containing 0.1 M Nacitrate pH 5.6, 1.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"3DRO",49.97,"3.9","3.9","Crystal structure of the HIV-1 Cross Neutralizing Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN grown in ammonium sulfate","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2F5 Fab light chain","1","3DRO"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"2F5 Fab heavy chain","2","3DRO"
,,,,,,,,,,,,,,,,"ELLELDKWASLWN",,,"ELLELDKWASLWN gp41 peptide","3","3DRO"
"3DRQ",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, HANGING DROP",5.6,"Crystals grown in 0.1 M Nacitrate pH 5.6, 1.6 M ammonium sulfate, 0.01% Tween-20 and soaked for 36h in 0.1 M Nacitrate pH 5.6, 16% PEG 4K, 16% 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"3DRQ",52.26,"2","2","Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671 soaked in PEG/2-propanol solution","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2F5 Fab' light chain","1","3DRQ"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"2F5 Fab' heavy chain","2","3DRQ"
,,,,,,,,,,,,,,,,"GIGALFLGFLGAAGSKKXKNEQELLELDKWASLWN",,,"gp41 peptide epitope","3","3DRQ"
"3DRT",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, HANGING DROP",5.6,"Crystals were grown in reservoir solution containing 0.1 M Na citrate pH 5.6, 16% 2-propanol, 16% PEG 4K, 0.01% Tween-20, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jp905965h",,"3DRT",52.26,"3.3","3.3","Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 scrambledFP-MPER scrHyb3K construct GIGAFGLLGFLAAGSKK-Ahx-K656NEQELLELDKWASLWN671","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2F5 Fab' light chain","1","3DRT"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"2F5 Fab' heavy chain","2","3DRT"
,,,,,,,,,,,,,,,,"GIGAFGLLGFLAAGSKKXKNEQELLELDKWASLWN",,,"scrHyb3K construct","3","3DRT"
"3DRU",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 4000, Li2SO4, Tris/HCl, pH 8.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.jmb.2009.01.069",,"3DRU",137.11,"3.2","3.2","Crystal Structure of Gly117Phe Alpha1-Antitrypsin","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNFLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","3DRU"
"3DRX",,"X-RAY DIFFRACTION",3.1,60.33,"VAPOR DIFFUSION",8.5,"3.2 M NaCl, 100 mM Tris-HCl, pH 8.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2009.01.030",,"3DRX",115.21,"3.11","3.11","X-ray crystal structure of human KCTD5 protein crystallized in high-salt buffer","SALAQRPGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAEFYNITSLIKLVKDKIRERDSKTSQVPVKHVYRVLQCQEEELTQMVSTMSDGWKFEQLVSIGSSYNYGNEDQAEFLCVVSKELHNTPYGTASEPSEKAKILQERGSRM","Homo sapiens","KCTD5","BTB/POZ domain-containing protein KCTD5","1","3DRX"
"3DRY",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION",7.5,"0.2 M proline, 100 mM HEPES, 7% (w/v) PEG 3350, pH 7.5, VAPOR DIFFUSION",,"10.1016/j.jmb.2009.01.030",,"3DRY",115.21,"3.3","3.3","X-ray crystal structure of human KCTD5 protein crystallized in low-salt buffer","SALAQRPGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAEFYNITSLIKLVKDKIRERDSKTSQVPVKHVYRVLQCQEEELTQMVSTMSDGWKFEQLVSIGSSYNYGNEDQAEFLCVVSKELHNTPYGTASEPSEKAKILQERGSRM","Homo sapiens","KCTD5","BTB/POZ domain-containing protein KCTD5","1","3DRY"
"3DRZ",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION",7.5,"24% (w/v) PEG 3350, 100 mM MgCl2, 100 M HEPES, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2009.01.030",,"3DRZ",61.6,"1.9","1.9","X-ray crystal structure of the N-terminal BTB domain of human KCTD5 protein","SGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAEFYNITSLIKLVKDKIRER","Homo sapiens","KCTD5","BTB/POZ domain-containing protein KCTD5","1","3DRZ"
"3DS6",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION",5.6,"31% PEG 4000, 100mM NaCitrate, 200mM ammonium acetate, 10mM DTT, pH 5.6, VAPOR DIFFUSION, temperature 295K",295,"10.1021/jm8005417","A17","3DS6",169.57,"2.9","2.9","P38 complex with a phthalazine inhibitor","GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3DS6"
"3DSH",,"X-RAY DIFFRACTION",3.45,64.37,"VAPOR DIFFUSION, HANGING DROP",7,"0.5-2.0% PEG 6000, 100mM imidazole, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.1496",,"3DSH",28.6,"2","2","Crystal structure of dimeric interferon regulatory factor 5 (IRF-5) transactivation domain","EQLLPDLLISPHMLPLTDLEIKFQYRGRPPRALTISNPHGCRLFYSQLEATQEQVELFGPISLEQVRFPSPEDIPSDKQRFYTNQLLDVLDRGLILQLQGQDLYAIRLCQCKVFWSGPCASAHDSCPNPIQREVKTKLFSLEHFLNELILFQKGQTNTPPPFEIFFCFGEEWPDRKPREKKLITVQVVPVAARLLLEMFSGELSWSADDIRLQISNPDLKDRMVEQFKELHHIWQSQQRLQPVAQA","Homo sapiens","IRF5","Interferon regulatory factor 5","1","3DSH"
"3DSZ",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, HANGING DROP",5.5,"22% polyethylene glycol 3350, 0.1M Bistris/HCl, pH5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja806857r","LIZ","3DSZ",44.3,"2","2","Engineered human lipocalin 2 in complex with Y-DTPA","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYQVGRAGNAALREDKDPQKMTAQIYELKEDKSYNVTAVRFRKKKCDYLTMTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFSITLLGRTKELASELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAHHHHHH","Homo sapiens","LCN2, variant Tb7.N9, HNL, NGAL","engineered human lipocalin 2","1","3DSZ"
"3DT1",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION",7.5,"1.6 M ammonium sulfate, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, temperature 295K",295,"10.1021/jm8005417","P40","3DT1",44.32,"2.8","2.8","P38 Complexed with a quinazoline inhibitor","MGSSHHHHHHSSGLVPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3DT1"
"3DT3",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes pH7.0, 12% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.07.121",,"3DT3",58.96,"2.4","2.4","Human Estrogen receptor alpha LBD with GW368","GSKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","3DT3"
"3DTC",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG20000, 0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1021/jm8005838","VIN","3DTC",30.77,"2.6","2.6","Crystal structure of mixed-lineage kinase MLK1 complexed with compound 16","LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI","Homo sapiens","MAP3K9, MLK1, PRKE1","Mitogen-activated protein kinase kinase kinase 9","1","3DTC"
"3DTQ",,"X-RAY DIFFRACTION",3.05,59.62,"VAPOR DIFFUSION, HANGING DROP",7,"2.0 M ammonium sulfate, 0.2 M lithium sulfate, 0.1 M Tris/HCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja806857r",,"3DTQ",63.91,"2.5","2.5","Engineered human lipocalin 2 with specificity for Y-DTPA, apo-form","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYQVGRAGNAALREDKDPQKMTAQIYELKEDKSYNVTAVRFRKKKCDYATMTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFSITLLGRTKELASELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAHHHHHH","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3DTQ"
"3DTW",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION",8,"polyethylene glycol 5000 monomethyl ether, sodium chloride, 
ammonium sulfate, isopropanol, HEPES, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.bmcl.2008.07.111","A96","3DTW",73.44,"2.9","2.9","Crystal structure of the VEGFR2 kinase domain in complex with a benzisoxazole inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","3DTW"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"3DU8",,"X-RAY DIFFRACTION",3.36,63.39,"VAPOR DIFFUSION, HANGING DROP",8,"20% w/v PEG 3350, 100 mM Hepes pH 8.0, 20 mM MgCl2, 10% v/v Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm800977q","553","3DU8",94.46,"2.2","2.2","Crystal structure of GSK-3 beta in complex with NMS-869553A","GPMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","3DU8"
"3DUY",,"X-RAY DIFFRACTION",3.1,60.26,,,"1.0M Ammonium sulfate in water, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K. Protein stock was BACE MUT46B batch XII 8.5 mg/mL in 10mM Tris-HCl pH 7.4, 25mM NaCl, with a 5-fold excess of NVP-AFJ144-NX-2 added from a 50mM stock solution in 90% DMSO-D6 (1.8% DMSO in drop). A solution containing 1.2M Ammonium sulfate, 25% Glycerol, 1mM NVP-AFJ144-NX-2 and 1.8% DMSO was used as cryo-protectant",,"10.1016/j.bmcl.2009.01.036","AFJ","3DUY",135.8,"1.97","1.97","Crystal structure of human beta-secretase in complex with NVP-AFJ144","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3DUY"
"3DV1",,"X-RAY DIFFRACTION",3.05,59.69,,,"1.0M Ammonium sulfate in water, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K. Protein stock was BACE 7.3 mg/mL in 10mM Tris-HCl pH 7.4, 25mM NaCl. Crystals were grown in 96-well Corning Microtiter plates. Cryo-protectant was 80% well solution, 20% 1,2-Propanediol",,"10.1016/j.bmcl.2009.01.055","AR9","3DV1",135.65,"2.1","2.1","Crystal structure of human beta-secretase in complex with NVP-ARV999","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3DV1"
"3DV3",,"X-RAY DIFFRACTION",3.49,64.73,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2008.10.108","MEK","3DV3",36.96,"2.3","2.3","MEK1 with PF-04622664 Bound","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3DV3"
"3DV5",,"X-RAY DIFFRACTION",3.04,59.48,,,"1.0M Ammonium phosphate, 0.1M Sodium citrate, VAPOR DIFFUSION, HANGING DROP, pH 5.1, temperature 292K. Protein stock was BACE 8.45 mg/mL in 10mM Tris-HCl pH 7.4, 25mM NaCl, with a 3.8-fold excess of NVP-BAV544-AA-1 added from a 50mM stock solution in DMSO (1.4% DMSO in drop). Cryo-protectant was 20% v/v 1,2-Propanediol, 80% Reservoir solution",,"10.1016/j.bmcl.2009.01.055","BAV","3DV5",135.8,"2.1","2.1","Crystal structure of human beta-secretase in complex with NVP-BAV544","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3DV5"
"3DV7",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, HANGING DROP",7.9,"1.3 M Sodium Citrate, 50mM Tris-HCl, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi801473w",,"3DV7",29.18,"1.7","1.7","Role of Hydrophilic Residues in Proton Transfer During Catalysis by Human Carbonic Anhydrase II (N62A)","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNAGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DV7"
"3DVB",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, HANGING DROP",7.9,"50mM Tris-HCl 
1.3 M Sodium Citrate, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi801473w",,"3DVB",29.21,"1.7","1.7","X-ray crystal structure of mutant N62V human Carbonic Anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNVGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DVB"
"3DVC",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, HANGING DROP",7.9,"50mM Tris-HCl 
1.3 M Sodium Citrate, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi801473w",,"3DVC",29.21,"1.6","1.6","X-ray crystal structure of mutant N62T of human Carbonic Anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNTGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DVC"
"3DVD",,"X-RAY DIFFRACTION",2.16,42.96,"VAPOR DIFFUSION, HANGING DROP",7.9,"50mM Tris-HCl 
1.3 M Sodium Citrate, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi801473w",,"3DVD",29.22,"1.6","1.6","X-ray crystal structure of mutant N62D of human Carbonic Anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNDGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3DVD"
"3DVF",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, HANGING DROP",,"Protein: 923 mM in 10 mM Tris-HCl buffer, pH 7.4. Mother Liquor: 20% w/v polyethylene glycol 4000, 0.2 M Li2SO4, 0.1 M Tris buffer, pH 6.8, under 60% paraffin oil and 40% silicon oil, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2009.04.010",,"3DVF",11.74,"1.8","1.8","Structure of amyloidogenic kappa 1 Bence Jones protein","DIQMTQSPSSLSASVGDRVTITCQASQDITNHLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGRGSGTHFTFTISSLQPADIATYYCQEYDYLPQTFGGGTKVEIK","Homo sapiens","Mutant of vk1 o18/o8 germline","Amyloidogenic immunoglobulin light chain protein AL-12","1","3DVF"
"3DVI",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, HANGING DROP",5.4,"Protein: 1.26 mM. Mother Liquor: 15% w/v polyethylene glycol 8000, 0.05 M magnesium acetate, 0.1 M sodium acetate, 0.1 M Tris buffer, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2009.04.010",,"3DVI",11.97,"1.53","1.53","Crystal structure of kappa 1 amyloidogenic light chain variable domain","TDIQMTQSPSSLSASVGDRVTITCQASQDISNYLIWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYHNLPPYTFGPGTKLEIK","Homo sapiens","Mutant of vk1 o18/o8 germline","Amyloidogenic light chain variable domain AL-103","1","3DVI"
"3DWB",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION",6,"30% Jeffamine D2001, 0.1M bis Tris, pH 6.0, VAPOR DIFFUSION, temperature 294K",294,"10.1016/j.jmb.2008.10.052","RDF","3DWB",77.28,"2.38","2.38","structure of human ECE-1 complexed with phosphoramidon","SEACVSVTSSILSSMDPTVDPCHDFFSYACGGWIKANPVPDGHSRWGTFSNLWEHNQAIIKHLLENSTASVSEAERKAQVYYRACMNETRIEELRAKPLMELIERLGGWNITGPWAKDNFQDTLQVVTAHYRTSPFFSVYVSADSKNSNSNVIQVDQSGLGLPSRDYYLNKTENEKVLTGYLNYMVQLGKLLGGGDEEAIRPQMQQILDFETALANITIPQEKRRDEELIYHKVTAAELQTLAPAINWLPFLNTIFYPVEINESEPIVVYDKEYLEQISTLINTTDRCLLNNYMIWNLVRKTSSFLDQRFQDADEKFMEVMYGTKKTSLPRWKFCVSDTENNLGFALGPMFVKATFAEDSKSIATEIILEIKKAFEESLSTLKWMDEETRKSAKEKADAIYNMIGYPNFIMDPKELDKVFNDYTAVPDLYFENAMRFFNFSWRVTADQLRKAPNRDQWSMTPPMVNAYYSPTKNEIVFPAGILQAPFYTRSSPKALNFGGIGVVVGHELTHAFDDQGREYDKDGNLRPWWKNSSVEAFKRQTECMVEQYSNYSVNGEPVNGRHTLGENIADNGGLKAAYRAYQNWVKKNGAEHSLPTLGLTNNQLFFLGFAQVWCSVRTPESSHEGLITDPHSPSRFRVIGSLSNSKEFSEHFRCPPGSPMNPPHKCEVW","Homo sapiens","ECE1","Endothelin-converting enzyme 1","1","3DWB"
"3DWD",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"3.5M Sodium Formate, 0.1M Tris, 1:100 chymotrypsin, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,,,"3DWD",33.83,"2.4","2.4","Crystal structure of the ArfGAP domain of human ARFGAP1","MGSSHHHHHHSSGLVPRGSMASPRTRKVLKEVRVQDENNVCFECGAFNPQWVSVTYGIWICLECSGRHRGLGVHLSFVRSVTMDKWKDIELEKMKAGGNAKFREFLESQEDYDPCWSLQEKYNSRAAALFRDKVVALAEGREWSLES","Homo sapiens","ARFGAP1, ARF1GAP","ADP-ribosylation factor GTPase-activating protein 1","1","3DWD"
"3DWH",,"X-RAY DIFFRACTION",2.56,51.86,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Tris-Hcl 
1.2M ammonium Sulfate 
0.2M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.C800169200",,"3DWH",23.44,"1.95","1.95","Structural and Functional Analysis of SRA domain","GSHMPSNHYGPIPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTGSGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVKGGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKKLGLTMQYPEGYLEALAN","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","3DWH"
"3DWW","3.5","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1073/pnas.0802894105",,"3DWW",54.78,"3.5",,"Electron crystallographic structure of human microsomal prostaglandin E synthase 1","HHHHHHMPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","Prostaglandin E synthase","1","3DWW"
"3DWY",,"X-RAY DIFFRACTION",2.02,38.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN, 25% PEG3350, 5% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3DWY",28.63,"1.98","1.98","Crystal Structure of the Bromodomain of Human CREBBP","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","3DWY"
"3DX9",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, HANGING DROP",7,"Hepes, Magnesium Formate, PEG 3350, pH 7.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1084/jem.20082136",,"3DX9",100.53,"2.75","2.75","Crystal Structure of the DM1 TCR at 2.75A","AKTTQPTSMDCAEGRAANLPCNHSTISGNEYVYWYRQIHSQGPQYIIHGLKNNETNEMASLIITEDRKSSTLILPHATLRDTAVYYCIVWGGYQKVTFGTGTKLQVIPIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSP","Homo sapiens",,"DM1 T cell receptor alpha chain","1","3DX9"
,,,,,,,,,,,,,,,,"TGVSQNPRHKITKRGQNVTFRCDPISEHNRLYWYRQTLGQGPEFLTYFQNEAQLEKSRLLSDRFSAERPKGSFSTLEIQRTEQGDSAMYLCASRYRDDSYNEQFFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"DM1 T cell receptor beta chain","2","3DX9"
"3DXF",,"X-RAY DIFFRACTION",2.46,50.07,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.96M ammonium sulfate, 0.1M sodium Hepes pH 7.2, 2% MPD, 20mM potassium chloride, 5mM Phenol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2009.02.049",,"3DXF",66.61,"2.2","2.2","Crystal structure of the HSCARG R37A mutant","MVDKKLVVVFGGTGAQGGSVARTLLEDGTFKVRVVTANPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVTNYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAPDGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLANMFRFYALRPDRDIELTLRLNPKALTLDQWLEQHKGDFNLL","Homo sapiens","NMRAL1, HSCARG","NmrA-like family domain-containing protein 1","1","3DXF"
"3DXT",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"hepes, 2.0M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3DXT",41.52,"1.8","1.8","Crystal structure of the catalytic core domain of JMJD2D","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDRAVVDHMEPRVPA","Homo sapiens","JMJD2D, KDM4D, JHDM3D","JmjC domain-containing histone demethylation protein 3D","1","3DXT"
"3DXU",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"Ammonium sulfate, pH6.50, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"3DXU",39.53,"2.2","2.2","The crystal structure of core JMJD2D complexed with FE and N-oxalylglycine","GSTAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDGST","Homo sapiens","JMJD2D, JHDM3D, KDM4D","JmjC domain-containing histone demethylation protein 3D","1","3DXU"
"3DY0",,"X-RAY DIFFRACTION",2.2,44.11,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.12M Lithium Nitrate, 12% PEG 3350, 25% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M805974200",,"3DY0",42.64,"1.55","1.55","Crystal Structure of Cleaved PCI Bound to Heparin","GATVAPSSRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKGKIVDLLKNLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTF","Homo sapiens","SERPINA5, PCI, PLANH3, PROCI","N-terminus Plasma serine protease inhibitor","1","3DY0"
,,,,,,,,,,,,,,,,"RSQRLVFNRPFLMFIVDNNILFLGKVNRP","Homo sapiens","SERPINA5, PCI, PLANH3, PROCI","C-terminus Plasma serine protease inhibitor","2","3DY0"
"3DY6",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, HANGING DROP",9,"100mM potassium iodide, PEG3500, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2008.08.011","DY6","3DY6",63.03,"2.9","2.9","PPARdelta complexed with an anthranilic acid partial agonist","QVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","3DY6"
"3DY7",,"X-RAY DIFFRACTION",3.28,62.48,"VAPOR DIFFUSION, HANGING DROP",5,"PEG8K, Ammonium phosphate, Imidazole-malate, DTT, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1016/j.bmcl.2008.10.108",,"3DY7",38.91,"2.7","2.7","X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a complex with ligand and MgATP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3DY7"
"3DY8",,"X-RAY DIFFRACTION",4.63,73.45,,,,,"10.1073/pnas.0708850105",,"3DY8",78.52,"2.15","2.15","Human Phosphodiesterase 9 in complex with product 5'-GMP (E+P complex)","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","human phosphodiesterase 9","1","3DY8"
"3DYD",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% MPD, 0.1M Na-Acetate pH 4.6, 3mM PLP, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3DYD",95.96,"2.3","2.3","Human Tyrosine Aminotransferase","MHHHHHHSSGVDLGTENLYFQSMWSVRPSDMAKKTFNPIRAIVDNMKVKPNPNKTMISLSIGDPTVFGNLPTDPEVTQAMKDALDSGKYNGYAPSIGFLSSREEIASYYHCPEAPLEAKDVILTSGCSQAIDLCLAVLANPGQNILVPRPGFSLYKTLAESMGIEVKLYNLLPEKSWEIDLKQLEYLIDEKTACLIVNNPSNPCGSVFSKRHLQKILAVAARQCVPILADEIYGDMVFSDCKYEPLATLSTDVPILSCGGLAKRWLVPGWRLGWILIHDRRDIFGNEIRDGLVKLSQRILGPCTIVQGALKSILCRTPGEFYHNTLSFLKSNADLCYGALAAIPGLRPVRPSGAMYLMVGIEMEHFPEFENDVEFTERLVAEQSVHCLPATCFEYPNFIRVVITVPEVMMLEACSRIQEFCEQHYHC","Homo sapiens","TAT","Tyrosine aminotransferase","1","3DYD"
"3DYL",,"X-RAY DIFFRACTION",4.67,73.68,,,,,"10.1073/pnas.0708850105",,"3DYL",78.5,"2.7","2.7","human phosphdiesterase 9 substrate complex (ES complex)","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","human phosphodiesterase 9","1","3DYL"
"3DYN",,"X-RAY DIFFRACTION",4.69,73.75,,,,,"10.1073/pnas.0708850105",,"3DYN",78.82,"2.1","2.1","human phosphodiestrase 9 in complex with cGMP (Zn inhibited)","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","3DYN"
"3DYQ",,"X-RAY DIFFRACTION",4.66,73.58,,,,,"10.1073/pnas.0708850105",,"3DYQ",78.39,"2.5","2.5","human phosphodiestrase 9 (inhibited by omitting divalent cation) in complex with cGMP","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","3DYQ"
"3DYS",,"X-RAY DIFFRACTION",4.69,73.78,,,,,"10.1073/pnas.0708850105",,"3DYS",78.63,"2.3","2.3","human phosphodiestrase-5'GMP complex (EP), produced by soaking with 20mM cGMP+20 mM MnCl2+20 mM MgCl2 for 2 hours, and flash-cooled to liquid nitrogen temperature when substrate was still abudant.","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","3DYS"
"3DYT",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.8M Ammonium sulfate, 0.1M Tris-HCl pH 8.5, 5% PEG 400, 0.05M MgSO4, 15% Xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1016/j.str.2008.07.016",,"3DYT",43.18,"2.08","2.08","Crystal structure of Snx9PX-BAR (230-595), C2221","EKIPIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVISESEVFQQFLNFRDEKEWKTGKRKAERDELAGVMIFSTMEPEAPDLDLVEIEQKCEAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLATVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGTHKGAIEKVKESDKLVATSKITLQDKQNMVKRVSIMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM","Homo sapiens","SNX9, SH3PX1, SH3PXD3A","Sorting nexin-9","1","3DYT"
"3DYU",,"X-RAY DIFFRACTION",3.73,67.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.8M Ammonium sulfate, 0.1M Tris-HCl pH 8.5, 5% PEG 400, 0.05M MgSO4, 15% Xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1016/j.str.2008.07.016",,"3DYU",127.27,"4.1","4.1","Crystal structure of Snx9PX-BAR (230-595), H32","EKIPIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVISESEVFQQFLNFRDEKEWKTGKRKAERDELAGVMIFSTMEPEAPDLDLVEIEQKCEAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLATVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGTHKGAIEKVKESDKLVATSKITLQDKQNMVKRVSIMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM","Homo sapiens","SNX9, SH3PX1, SH3PXD3A","Sorting nexin-9","1","3DYU"
"3DZ2",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a","A8M","3DZ2",38.82,"1.86","1.86","Human AdoMetDC with 5'-[(3-aminopropyl)methylamino]-5'deoxy-8-methyladenosine","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ2"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ2"
"3DZ3",,"X-RAY DIFFRACTION",1.9,35.28,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a",,"3DZ3",38.81,"2.62","2.62","Human AdoMetDC F223A mutant with covalently bound S-Adenosylmethionine methyl ester","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ3"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMANPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ3"
"3DZ4",,"X-RAY DIFFRACTION",2.2,44.14,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a","C8M","3DZ4",38.83,"1.84","1.84","Human AdoMetDC with 5'-[(2-carboxamidoethyl)methylamino]-5'-deoxy-8-methyladenosine","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ4"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ4"
"3DZ5",,"X-RAY DIFFRACTION",1.92,35.84,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a","M8M","3DZ5",38.82,"2.43","2.43","Human AdoMetDC with covalently bound 5'-[(2-aminooxyethyl)methylamino]-5'-deoxy-8-methyladenosine","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ5"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ5"
"3DZ6",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a","M8E","3DZ6",38.86,"1.83","1.83","Human AdoMetDC with 5'-[(4-aminooxybutyl)methylamino]-5'deoxy-8-ethyladenosine","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ6"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ6"
"3DZ7",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 8000, 100 mM Tris, 10 mM DTT, pH 8.0, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/jm801126a",,"3DZ7",38.82,"1.91","1.91","Human AdoMetDC with 5'-[(carboxamidomethyl)methylamino]-5'-deoxy-8-methyladenosine","MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSE","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase beta chain","1","3DZ7"
,,,,,,,,,,,,,,,,"XSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS","Homo sapiens","AMD1, AMD","S-adenosylmethionine decarboxylase alpha chain","2","3DZ7"
"3DZ8",,"X-RAY DIFFRACTION",2.4,48.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"2M ammonium sulfate, 0.2M sodium acetate, 0.1M HEPES, 5% MPD, pH 7.5, vapor diffusion, sitting drop, temperature 291K",291,,,"3DZ8",22.63,"1.9","1.9","Crystal structure of human Rab3B GTPase bound with GDP","MHHHHHHSSGRENLYFQGNFDYMFKLLIIGNSSVGKTSFLFRYADDTFTPAFVSTVGIDFKVKTVYRHEKRVKLQIWDTAGQERYRTITTAYYRGAMGFILMYDITNEESFNAVQDWATQIKTYSWDNAQVILVGNKCDMEEERVVPTEKGQLLAEQLGFDFFEASAKENISVRQAFERLVDAICDKMSDS","Homo sapiens","RAB3B","Ras-related protein Rab-3B","1","3DZ8"
"3DZF",,"X-RAY DIFFRACTION",2.22,44.69,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZF",183.67,"2.01","2.01","Crystal structure of human CD38 extracellular domain complexed with a covalent intermediate, ara-F-ribose-5'-phosphate","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZF"
"3DZG",,"X-RAY DIFFRACTION",2.26,45.65,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZG",61.47,"1.65","1.65","Crystal structure of human CD38 extracellular domain, ara-F-ribose-5'-phosphate/nicotinamide complex","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZG"
"3DZH",,"X-RAY DIFFRACTION",2.25,45.34,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZH",61.81,"1.6","1.6","Crystal structure of human CD38 extracellular domain, GTP complex","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZH"
"3DZI",,"X-RAY DIFFRACTION",2.23,44.74,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZI",62.23,"1.73","1.73","Crystal structure of human CD38 extracellular domain, ribose-5'-phosphate intermediate/GTP complex","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZI"
"3DZJ",,"X-RAY DIFFRACTION",2.3,46.61,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZJ",61.34,"1.9","1.9","Crystal structure of human CD38 extracellular domain E226Q mutant, NMN complex","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZJ"
"3DZK",,"X-RAY DIFFRACTION",2.3,46.47,,6,"100 mM MES pH 6.0, 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.chembiol.2008.08.007",,"3DZK",61.43,"1.81","1.81","Crystal structure of human CD38 extracellular domain, NMN complex","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3DZK"
"3DZQ",,"X-RAY DIFFRACTION",1.87,34.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"20 mg/mL protein, 30% PEG 4000, 0.2M Ammonium sulfate, 0.1M Sodium cacodylate pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3DZQ",40.93,"1.75","1.75","Human EphA3 kinase domain in complex with inhibitor AWL-II-38.3","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","3DZQ"
"3E04",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 10% ethanediol, 0.2 M sodium acetate, 0.1 M bis-tris propane, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3E04",212.03,"1.95","1.95","Crystal structure of human fumarate hydratase","MHHHHHHSSGVDLGTENLYFQSMMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK","Homo sapiens","FH","Fumarate hydratase","1","3E04"
"3E0C",,"X-RAY DIFFRACTION",2.57,52.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis tris, pH 6.5,0.2 M Lithium sulfate, 25% PEG 3350, 1:6000 Protein:Chymotrypsin , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1007/s13238-011-1018-1",,"3E0C",127.1,"2.41","2.41","Crystal Structure of DNA Damage-Binding protein 1(DDB1)","MSYNYVVTAQKPTAVNGCVTGHFTSAEDLNLLIAKNTRLEIYVVTAEGLRPVKEVGMYGKIAVMELFRPKGESKDLLFILTAKYNACILEYKQSGESIDIITRAHGNVQDRIGRPSETGIIGIIDPECRMIGLRLYDGLFKVIPLDRDNKELKAFNIRLEELHVIDVKFLYGCQAPTICFVYQDPQGRHVKTYEVSLREKEFNKGPWKQENVEAEASMVIAVPEPFGGAIIIGQESITYHNGDKYLAIAPPIIKQSTIVCHNRVDPNGSRYLLGDMEGRLFMLLLEKEEQMDGTVTLKDLRVELLGETSIAECLTYLDNGVVFVGSRLGDSQLVKLNVDSNEQGSYVVAMETFTNLGPIVDMCVVDLERQGQGQLVTCSGAFKEGSLRIIRNGIGIHEHASIDLPGIKGLWPLRSDPNRETDDTLVLSFVGQTRVLMLNGEEVEETELMGFVDDQQTFFCGNVAHQQLIQITSASVRLVSQEPKALVSEWKEPQAKNISVASCNSSQVVVAVGRALYYLQIHPQELRQISHTEMEHEVACLDITPLGDSNGLSPLCAIGLWTDISARILKLPSFELLHKEMLGGEIIPRSILMTTFESSHYLLCALGDGALFYFGLNIETGLLSDRKKVTLGTQPTVLRTFRSLSTTNVFACSDRPTVIYSSNHKLVFSNVNLKEVNYMCPLNSDGYPDSLALANNSTLTIGTIDEIQKLHIRTVPLYESPRKICYQEVSQCFGVLSSRIEVQDTSGGTTALRPSASTQALSSSVSSSKLFSSSTAPHETSFGEEVEVHNLLIIDQHTFEVLHAHQFLQNEYALSLVSCKLGKDPNTYFIVGTAMVYPEEAEPKQGRIVVFQYSDGKLQTVAEKEVKGAVYSMVEFNGKLLASINSTVRLYEWTTEKELRTECNHYNNIMALYLKTKGDFILVGDLMRSVLLLAYKPMEGNFEEIARDFNPNWMSAVEILDDDNFLGAENAFNLFVCQKDSAATTDEERQHLQEVGLFHLGEFVNVFCHGSLVMQNLGETSTPTQGSVLFGTVNGMIGLVTSLSESWYNLLLDMQNRLNKVIKSVGKIEHSFWRSFHTERKTEPATGFIDGDLIESFLDISRPKMQEVVANLQYDDGSGMKREATADDLIKVVEELTRIH","Homo sapiens","DDB1, XAP1","DNA damage-binding protein 1","1","3E0C"
"3E0G",,"X-RAY DIFFRACTION",4.42,72.17,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M Sodium Citrate pH 5.0, 0.1 M Lithium Sulfate, 8% PEG-3350, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.molcel.2008.08.011",,"3E0G",57.07,"3.1","3.1","Structure of the Leukemia Inhibitory Factor Receptor (LIF-R) domains D1-D5","DLKCVTNNLQVWQCSWKAPSGTGRGTDYEVCIEQRSRSCYQLEKTSIKIPALSHGDYEITINSLHDFGSSTSKFTLNEQNVSLIPDTPEILQLSADFSTSTLYLKWNDRGSVFPHRSNVIWEIKVLRKESMELVKLVTHQTTLNGKDTLHHWSWASDMPLECAIHFVEIRCYIDNLHFSGLEEWSDWSPVKQISWIPDSQTKVFPQDKVILVGSDITFCCVSQEKVLSALIGHTNCPLIHLDGENVAIKIRNISVSASSGTNVVFTTEDNIFGTVIFAGYPPDTPQQLNCETHDLKEIICSWNPGRVTALVGPRATSYTLVESFSGKYVRLKRAEAPTNESYQLLFQMLPNQEIYNFTLNAHNPLGRSQSTILVNITEKVYPHTPTSFKVKDINSTAVKLSWHLPGNFAKINFLCEIEIKKSNSVQEQRNVTIQGVENSSYLVALDKLNPYTLYTFRIRCSTETFWKWSKWSNKKQHLTTEAS","Homo sapiens","LIFR","Leukemia inhibitory factor receptor","1","3E0G"
"3E0L",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"10mg/ml HGDA with 0.2mM AD against well solution of 1.8M AS, 0.2M NaCl, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0811070106",,"3E0L",102.08,"2.37","2.37","Computationally Designed Ammelide Deaminase","GSHMCAAQMPPLAHIFRGTFVHSTWTCPMEVLRDHLLGVSDSGKIVFLEEASQQEKLAKEWCFKPCEIRELSHHEFFMPGLVDTHIHASQYSFAGSSIDLPLLEWLTKYTFPAEHRFQNIDFAEEVYTRVVRRTLKNGTTTACYFATIHTDSSLLLADITDKFGQRAFVGKVCMDLNDTFPEYKETTEESIKETERFVSEMLQKNYSRVKPIVTPGNGVSETLMGELGNIAKTRDLHIQSHISENRDEVEAVKNLYPSYKNYTSVYDKNNLLTNKTVMAHGCYLSAEELNVFHERGASIAHCPNSNLSLSSGFLNVLEVLKHEVKIGLGTDVAGGYSYSMLDAIRRAVMVSNILLINKVNEKSLTLKEVFRLATLGGSQALGLDGEIGNFEVGKEFDAILINPKASDSPIDLFYGDFFGDISEAVIQKFLYLGDDRNIEEVYVGGKQVVPFSSSV","Homo sapiens","GDA, KIAA1258","Guanine deaminase","1","3E0L"
"3E0N",,"X-RAY DIFFRACTION",1.91,35.65,,,,,"10.1002/pro.118",,"3E0N",30.58,"1.7","1.7","The X-ray structure of Human Prostasin in complex with DFFR-chloromethyl ketone inhibitor","ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTELQPRVVPQTQESQPDSNLHHHHHHHHHH","Homo sapiens","PRSS8","Prostasin","1","3E0N"
